activity_comment,activity_id,activity_properties,assay_chembl_id,assay_description,assay_type,assay_variant_accession,assay_variant_mutation,bao_endpoint,bao_format,bao_label,canonical_smiles,data_validity_comment,data_validity_description,document_chembl_id,document_journal,document_year,ligand_efficiency,molecule_chembl_id,molecule_pref_name,parent_molecule_chembl_id,pchembl_value,potential_duplicate,qudt_units,record_id,relation,src_id,standard_flag,standard_relation,standard_text_value,standard_type,standard_units,standard_upper_value,standard_value,target_chembl_id,target_organism,target_pref_name,target_tax_id,text_value,toid,type,units,uo_units,upper_value,value
,1424130,[],CHEMBL828042,Inhibitory concentration against MDM2-p53 interaction in SJSA human sarcoma cells,B,,,BAO_0000190,BAO_0000219,cell-based format,CCCN1C(=O)c2ccccc2C1(NC(=O)c1ccc(C(C)(C)C)cc1)c1ccc(OCOCC[Si](C)(C)C)cc1,,,CHEMBL1142026,Bioorg. Med. Chem. Lett.,2005,"{'bei': '7.98', 'le': None, 'lle': None, 'sei': None}",CHEMBL179549,,CHEMBL179549,4.57,False,http://www.openphacts.org/units/Nanomolar,366176,=,1,True,=,,IC50,nM,,27000.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,uM,UO_0000065,,27.0
,1424131,[],CHEMBL828042,Inhibitory concentration against MDM2-p53 interaction in SJSA human sarcoma cells,B,,,BAO_0000190,BAO_0000219,cell-based format,CCCN1C(=O)c2ccccc2C1(NC(=O)c1ccccc1)c1ccc(C(C)(C)C)cc1,,,CHEMBL1142026,Bioorg. Med. Chem. Lett.,2005,"{'bei': '9.80', 'le': '0.18', 'lle': '-1.30', 'sei': '8.46'}",CHEMBL360920,,CHEMBL360920,4.18,False,http://www.openphacts.org/units/Nanomolar,366182,=,1,True,=,,IC50,nM,,66000.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,uM,UO_0000065,,66.0
,1424132,[],CHEMBL828042,Inhibitory concentration against MDM2-p53 interaction in SJSA human sarcoma cells,B,,,BAO_0000190,BAO_0000219,cell-based format,CCCOC1(c2ccccc2)c2ccccc2C(=O)N1C(Cc1ccc(O)cc1)C(=O)OC,,,CHEMBL1142026,Bioorg. Med. Chem. Lett.,2005,"{'bei': '9.08', 'le': '0.17', 'lle': '-0.21', 'sei': '5.32'}",CHEMBL182052,,CHEMBL182052,4.05,False,http://www.openphacts.org/units/Nanomolar,366189,=,1,True,=,,IC50,nM,,90000.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,uM,UO_0000065,,90.0
,1424135,[],CHEMBL828042,Inhibitory concentration against MDM2-p53 interaction in SJSA human sarcoma cells,B,,,BAO_0000190,BAO_0000219,cell-based format,OCC(NC1(c2ccccc2)c2ccccc2CC1Cc1ccccc1)C(O)c1ccccc1,,,CHEMBL1142026,Bioorg. Med. Chem. Lett.,2005,"{'bei': '9.05', 'le': '0.16', 'lle': '-0.96', 'sei': '7.75'}",CHEMBL179662,,CHEMBL179662,4.07,False,http://www.openphacts.org/units/Nanomolar,366201,=,1,True,=,,IC50,nM,,85000.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,uM,UO_0000065,,85.0
,1424136,[],CHEMBL828042,Inhibitory concentration against MDM2-p53 interaction in SJSA human sarcoma cells,B,,,BAO_0000190,BAO_0000219,cell-based format,CC(C)(C)c1ccc(COC2(c3ccccc3)c3ccccc3C(=O)N2Cc2ccccc2)cc1,,,CHEMBL1142026,Bioorg. Med. Chem. Lett.,2005,"{'bei': '8.74', 'le': '0.16', 'lle': '-3.02', 'sei': '13.66'}",CHEMBL181688,,CHEMBL181688,4.04,False,http://www.openphacts.org/units/Nanomolar,366206,=,1,True,=,,IC50,nM,,92000.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,uM,UO_0000065,,92.0
,1424137,[],CHEMBL828042,Inhibitory concentration against MDM2-p53 interaction in SJSA human sarcoma cells,B,,,BAO_0000190,BAO_0000219,cell-based format,COc1ccc(C(O)CNC2(c3ccccc3)c3ccccc3C(=O)N2Cc2ccccc2)cc1,,,CHEMBL1142026,Bioorg. Med. Chem. Lett.,2005,"{'bei': '8.94', 'le': '0.16', 'lle': '-0.73', 'sei': '6.72'}",CHEMBL179114,,CHEMBL179114,4.16,False,http://www.openphacts.org/units/Nanomolar,366211,=,1,True,=,,IC50,nM,,70000.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,uM,UO_0000065,,70.0
,1424233,[],CHEMBL828042,Inhibitory concentration against MDM2-p53 interaction in SJSA human sarcoma cells,B,,,BAO_0000190,BAO_0000219,cell-based format,O=C1c2ccccc2C(OCCCO)(c2ccc(Cl)cc2)N1Cc1ccccc1,,,CHEMBL1142026,Bioorg. Med. Chem. Lett.,2005,"{'bei': '11.76', 'le': '0.23', 'lle': '0.20', 'sei': '9.64'}",CHEMBL360719,,CHEMBL360719,4.80,False,http://www.openphacts.org/units/Nanomolar,366216,=,1,True,=,,IC50,nM,,15900.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,uM,UO_0000065,,15.9
,1424234,[],CHEMBL828042,Inhibitory concentration against MDM2-p53 interaction in SJSA human sarcoma cells,B,,,BAO_0000190,BAO_0000219,cell-based format,CC(C)(C)c1ccc(COC2(c3ccccc3)c3ccccc3C(=O)N2Cc2ccccc2)cc1,,,CHEMBL1142026,Bioorg. Med. Chem. Lett.,2005,"{'bei': '8.74', 'le': '0.16', 'lle': '-3.02', 'sei': '13.66'}",CHEMBL181688,,CHEMBL181688,4.04,False,http://www.openphacts.org/units/Nanomolar,366222,=,1,True,=,,IC50,nM,,92000.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,uM,UO_0000065,,92.0
,1424235,[],CHEMBL828042,Inhibitory concentration against MDM2-p53 interaction in SJSA human sarcoma cells,B,,,BAO_0000190,BAO_0000219,cell-based format,CC(=O)NCCN1C(=O)c2ccccc2C1(OCc1ccc(C(C)(C)C)cc1)c1ccccc1,,,CHEMBL1142026,Bioorg. Med. Chem. Lett.,2005,"{'bei': '10.63', 'le': '0.19', 'lle': '-0.14', 'sei': '8.28'}",CHEMBL360141,,CHEMBL360141,4.85,False,http://www.openphacts.org/units/Nanomolar,366227,=,1,True,=,,IC50,nM,,14000.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,uM,UO_0000065,,14.0
,1424236,[],CHEMBL828042,Inhibitory concentration against MDM2-p53 interaction in SJSA human sarcoma cells,B,,,BAO_0000190,BAO_0000219,cell-based format,O=C1c2ccccc2C(OCCc2ccccn2)(c2ccc(Cl)cc2)N1Cc1ccccc1,,,CHEMBL1142026,Bioorg. Med. Chem. Lett.,2005,"{'bei': '10.07', 'le': '0.19', 'lle': '-1.27', 'sei': '10.80'}",CHEMBL361115,,CHEMBL361115,4.58,False,http://www.openphacts.org/units/Nanomolar,366233,=,1,True,=,,IC50,nM,,26200.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,uM,UO_0000065,,26.2
,1424237,[],CHEMBL828042,Inhibitory concentration against MDM2-p53 interaction in SJSA human sarcoma cells,B,,,BAO_0000190,BAO_0000219,cell-based format,COc1cc(COC2(c3ccccc3)c3ccccc3C(=O)N2Cc2ccccc2)cc(OC)c1O,,,CHEMBL1142026,Bioorg. Med. Chem. Lett.,2005,"{'bei': '9.86', 'le': '0.18', 'lle': '-0.73', 'sei': '6.96'}",CHEMBL178106,,CHEMBL178106,4.75,False,http://www.openphacts.org/units/Nanomolar,366238,=,1,True,=,,IC50,nM,,17900.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,uM,UO_0000065,,17.9
,1424238,[],CHEMBL828042,Inhibitory concentration against MDM2-p53 interaction in SJSA human sarcoma cells,B,,,BAO_0000190,BAO_0000219,cell-based format,O=C1c2ccccc2C(OCCCO)(c2ccccc2)N1Cc1ccccc1,Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL1142026,Bioorg. Med. Chem. Lett.,2005,,CHEMBL180866,,CHEMBL180866,,False,http://www.openphacts.org/units/Nanomolar,366246,=,1,True,=,,IC50,nM,,245000.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,uM,UO_0000065,,245.0
,1424239,[],CHEMBL828042,Inhibitory concentration against MDM2-p53 interaction in SJSA human sarcoma cells,B,,,BAO_0000190,BAO_0000219,cell-based format,O=C1c2ccccc2C(OCCc2ccccn2)(c2ccccc2)N1Cc1ccccc1,Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL1142026,Bioorg. Med. Chem. Lett.,2005,,CHEMBL368017,,CHEMBL368017,,False,http://www.openphacts.org/units/Nanomolar,366256,=,1,True,=,,IC50,nM,,206000.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,uM,UO_0000065,,206.0
,1424242,[],CHEMBL828042,Inhibitory concentration against MDM2-p53 interaction in SJSA human sarcoma cells,B,,,BAO_0000190,BAO_0000219,cell-based format,CCCN1C(=O)c2ccccc2C1(OCc1ccc(C(C)(C)C)cc1)c1ccccc1,Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL1142026,Bioorg. Med. Chem. Lett.,2005,,CHEMBL180579,,CHEMBL180579,,False,http://www.openphacts.org/units/Nanomolar,366266,>,1,True,>,,IC50,nM,,500000.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,uM,UO_0000065,,500.0
,1424243,[],CHEMBL828042,Inhibitory concentration against MDM2-p53 interaction in SJSA human sarcoma cells,B,,,BAO_0000190,BAO_0000219,cell-based format,CCCN1C(=O)c2ccccc2C1(OCc1cc(OC)c(O)c(OC)c1)c1ccccc1,,,CHEMBL1142026,Bioorg. Med. Chem. Lett.,2005,"{'bei': '9.43', 'le': '0.17', 'lle': '-0.60', 'sei': '5.99'}",CHEMBL362452,,CHEMBL362452,4.09,False,http://www.openphacts.org/units/Nanomolar,366172,=,1,True,=,,IC50,nM,,82000.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,uM,UO_0000065,,82.0
,1424244,[],CHEMBL828042,Inhibitory concentration against MDM2-p53 interaction in SJSA human sarcoma cells,B,,,BAO_0000190,BAO_0000219,cell-based format,CCCN1C(=O)c2ccccc2C1(OCCCO)c1ccccc1,Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL1142026,Bioorg. Med. Chem. Lett.,2005,,CHEMBL178320,,CHEMBL178320,,False,http://www.openphacts.org/units/Nanomolar,366177,>,1,True,>,,IC50,nM,,500000.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,uM,UO_0000065,,500.0
,1424245,[],CHEMBL828042,Inhibitory concentration against MDM2-p53 interaction in SJSA human sarcoma cells,B,,,BAO_0000190,BAO_0000219,cell-based format,CCCN1C(=O)c2ccccc2C1(OCCc1ccccn1)c1ccccc1,,,CHEMBL1142026,Bioorg. Med. Chem. Lett.,2005,"{'bei': '10.74', 'le': '0.20', 'lle': '-0.41', 'sei': '9.43'}",CHEMBL178504,,CHEMBL178504,4.00,False,http://www.openphacts.org/units/Nanomolar,366183,=,1,True,=,,IC50,nM,,100000.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,uM,UO_0000065,,100.0
,1424246,[],CHEMBL828042,Inhibitory concentration against MDM2-p53 interaction in SJSA human sarcoma cells,B,,,BAO_0000190,BAO_0000219,cell-based format,CC(C)(C)c1ccc(COC2(c3ccc(Cl)cc3)c3ccccc3C(=O)N2Cc2ccccc2)cc1,,,CHEMBL1142026,Bioorg. Med. Chem. Lett.,2005,"{'bei': '8.07', 'le': '0.15', 'lle': '-3.71', 'sei': '13.56'}",CHEMBL180862,,CHEMBL180862,4.00,False,http://www.openphacts.org/units/Nanomolar,366190,=,1,True,=,,IC50,nM,,99000.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,uM,UO_0000065,,99.0
,1424247,[],CHEMBL828042,Inhibitory concentration against MDM2-p53 interaction in SJSA human sarcoma cells,B,,,BAO_0000190,BAO_0000219,cell-based format,COc1cc(COC2(c3ccc(Cl)cc3)c3ccccc3C(=O)N2Cc2ccccc2)cc(OC)c1O,,,CHEMBL1142026,Bioorg. Med. Chem. Lett.,2005,"{'bei': '8.48', 'le': '0.16', 'lle': '-1.76', 'sei': '6.41'}",CHEMBL181083,,CHEMBL181083,4.38,False,http://www.openphacts.org/units/Nanomolar,366196,=,1,True,=,,IC50,nM,,42000.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,uM,UO_0000065,,42.0
,1424248,[],CHEMBL828042,Inhibitory concentration against MDM2-p53 interaction in SJSA human sarcoma cells,B,,,BAO_0000190,BAO_0000219,cell-based format,CCCN1C(=O)c2ccccc2C1(OCc1ccc(C(C)(C)C)cc1)c1ccc(Cl)cc1,Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL1142026,Bioorg. Med. Chem. Lett.,2005,,CHEMBL361345,,CHEMBL361345,,False,http://www.openphacts.org/units/Nanomolar,366202,=,1,True,=,,IC50,nM,,187000.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,uM,UO_0000065,,187.0
,1424249,[],CHEMBL828042,Inhibitory concentration against MDM2-p53 interaction in SJSA human sarcoma cells,B,,,BAO_0000190,BAO_0000219,cell-based format,CCCN1C(=O)c2ccccc2C1(OCc1cc(OC)c(O)c(OC)c1)c1ccc(Cl)cc1,,,CHEMBL1142026,Bioorg. Med. Chem. Lett.,2005,"{'bei': '11.27', 'le': '0.22', 'lle': '-0.07', 'sei': '7.73'}",CHEMBL360944,,CHEMBL360944,5.28,False,http://www.openphacts.org/units/Nanomolar,366207,=,1,True,=,,IC50,nM,,5300.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,uM,UO_0000065,,5.3
,1424250,[],CHEMBL828042,Inhibitory concentration against MDM2-p53 interaction in SJSA human sarcoma cells,B,,,BAO_0000190,BAO_0000219,cell-based format,CCCN1C(=O)c2ccccc2C1(OCCCO)c1ccc(Cl)cc1,,,CHEMBL1142026,Bioorg. Med. Chem. Lett.,2005,"{'bei': '13.30', 'le': '0.26', 'lle': '0.98', 'sei': '9.61'}",CHEMBL433949,,CHEMBL433949,4.79,False,http://www.openphacts.org/units/Nanomolar,366212,=,1,True,=,,IC50,nM,,16400.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,uM,UO_0000065,,16.4
,1424251,[],CHEMBL828042,Inhibitory concentration against MDM2-p53 interaction in SJSA human sarcoma cells,B,,,BAO_0000190,BAO_0000219,cell-based format,CCCN1C(=O)c2ccccc2C1(OCCc1ccccn1)c1ccc(Cl)cc1,,,CHEMBL1142026,Bioorg. Med. Chem. Lett.,2005,"{'bei': '10.43', 'le': '0.20', 'lle': '-0.82', 'sei': '10.00'}",CHEMBL362614,,CHEMBL362614,4.24,False,http://www.openphacts.org/units/Nanomolar,366217,=,1,True,=,,IC50,nM,,57000.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,uM,UO_0000065,,57.0
,1424255,[],CHEMBL828042,Inhibitory concentration against MDM2-p53 interaction in SJSA human sarcoma cells,B,,,BAO_0000190,BAO_0000219,cell-based format,CC(=O)NCCN1C(=O)c2ccccc2C1(OCc1ccc(C(C)(C)C)cc1)c1ccc(Cl)cc1,,,CHEMBL1142026,Bioorg. Med. Chem. Lett.,2005,"{'bei': '8.23', 'le': '0.16', 'lle': '-1.61', 'sei': '6.89'}",CHEMBL361354,,CHEMBL361354,4.04,False,http://www.openphacts.org/units/Nanomolar,366234,=,1,True,=,,IC50,nM,,91400.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,uM,UO_0000065,,91.4
,1424256,[],CHEMBL828042,Inhibitory concentration against MDM2-p53 interaction in SJSA human sarcoma cells,B,,,BAO_0000190,BAO_0000219,cell-based format,COc1cc(COC2(c3ccc(Cl)cc3)c3ccccc3C(=O)N2CCNC(C)=O)cc(OC)c1O,,,CHEMBL1142026,Bioorg. Med. Chem. Lett.,2005,"{'bei': '8.06', 'le': '0.16', 'lle': '0.05', 'sei': '4.23'}",CHEMBL179339,,CHEMBL179339,4.12,False,http://www.openphacts.org/units/Nanomolar,366239,=,1,True,=,,IC50,nM,,76000.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,uM,UO_0000065,,76.0
,1424668,[],CHEMBL828042,Inhibitory concentration against MDM2-p53 interaction in SJSA human sarcoma cells,B,,,BAO_0000190,BAO_0000219,cell-based format,COc1cc(COC2(c3ccc(OCOCC[Si](C)(C)C)cc3)c3ccccc3C(=O)N2Cc2ccccc2)cc(OC)c1O,Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL1142026,Bioorg. Med. Chem. Lett.,2005,,CHEMBL362410,,CHEMBL362410,,False,http://www.openphacts.org/units/Nanomolar,366240,=,1,True,=,,IC50,nM,,257000.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,uM,UO_0000065,,257.0
,1424669,[],CHEMBL828042,Inhibitory concentration against MDM2-p53 interaction in SJSA human sarcoma cells,B,,,BAO_0000190,BAO_0000219,cell-based format,CCCN1C(=O)c2ccccc2C1(OCc1ccc(C(C)(C)C)cc1)c1ccc(OCOCC[Si](C)(C)C)cc1,Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL1142026,Bioorg. Med. Chem. Lett.,2005,,CHEMBL178215,,CHEMBL178215,,False,http://www.openphacts.org/units/Nanomolar,366247,=,1,True,=,,IC50,nM,,464000.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,uM,UO_0000065,,464.0
,1424670,[],CHEMBL828042,Inhibitory concentration against MDM2-p53 interaction in SJSA human sarcoma cells,B,,,BAO_0000190,BAO_0000219,cell-based format,CCCN1C(=O)c2ccccc2C1(OCc1cc(OC)c(O)c(OC)c1)c1ccc(OCOCC[Si](C)(C)C)cc1,Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL1142026,Bioorg. Med. Chem. Lett.,2005,,CHEMBL361630,,CHEMBL361630,,False,http://www.openphacts.org/units/Nanomolar,366259,=,1,True,=,,IC50,nM,,118000.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,uM,UO_0000065,,118.0
,1424671,[],CHEMBL828042,Inhibitory concentration against MDM2-p53 interaction in SJSA human sarcoma cells,B,,,BAO_0000190,BAO_0000219,cell-based format,CCCN1C(=O)c2ccccc2C1(OCCCO)c1ccc(OCOCC[Si](C)(C)C)cc1,Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL1142026,Bioorg. Med. Chem. Lett.,2005,,CHEMBL447529,,CHEMBL447529,,False,http://www.openphacts.org/units/Nanomolar,366267,=,1,True,=,,IC50,nM,,476000.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,uM,UO_0000065,,476.0
,1424672,[],CHEMBL828042,Inhibitory concentration against MDM2-p53 interaction in SJSA human sarcoma cells,B,,,BAO_0000190,BAO_0000219,cell-based format,CCCN1C(=O)c2ccccc2C1(OCCc1ccccn1)c1ccc(OCOCC[Si](C)(C)C)cc1,Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL1142026,Bioorg. Med. Chem. Lett.,2005,,CHEMBL426784,,CHEMBL426784,,False,http://www.openphacts.org/units/Nanomolar,366173,=,1,True,=,,IC50,nM,,312000.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,uM,UO_0000065,,312.0
,1429025,[],CHEMBL833471,Inhibition of p53-binding to HDM2 (human MDM2) by fluorescence polarization peptide displacement assay,B,,,BAO_0000190,BAO_0000224,protein format,CC(C)c1ccc([C@@H](C(=O)O)N2C(=O)c3cc(I)ccc3NC(=O)[C@@H]2c2ccc(Cl)cc2)cc1,,,CHEMBL1140282,Bioorg. Med. Chem. Lett.,2005,"{'bei': '9.87', 'le': '0.23', 'lle': '-0.22', 'sei': '6.70'}",CHEMBL179446,,CHEMBL179446,5.81,False,http://www.openphacts.org/units/Nanomolar,368101,=,1,True,=,,IC50,nM,,1550.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,uM,UO_0000065,,1.55
,1429027,[],CHEMBL833471,Inhibition of p53-binding to HDM2 (human MDM2) by fluorescence polarization peptide displacement assay,B,,,BAO_0000190,BAO_0000224,protein format,CC(C)(C)c1ccc([C@@H](C(=O)O)N2C(=O)c3cc(I)ccc3NC(=O)[C@@H]2c2ccc(Cl)cc2)cc1,,,CHEMBL1140282,Bioorg. Med. Chem. Lett.,2005,"{'bei': '9.36', 'le': '0.22', 'lle': '-0.56', 'sei': '6.51'}",CHEMBL180799,,CHEMBL180799,5.64,False,http://www.openphacts.org/units/Nanomolar,368107,=,1,True,=,,IC50,nM,,2270.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,uM,UO_0000065,,2.27
,1429028,[],CHEMBL833471,Inhibition of p53-binding to HDM2 (human MDM2) by fluorescence polarization peptide displacement assay,B,,,BAO_0000190,BAO_0000224,protein format,O=C(O)[C@H](c1ccc(C(F)(F)F)cc1)N1C(=O)c2cc(I)ccc2NC(=O)[C@@H]1c1ccc(Cl)cc1,,,CHEMBL1140282,Bioorg. Med. Chem. Lett.,2005,"{'bei': '10.04', 'le': '0.24', 'lle': '0.25', 'sei': '7.12'}",CHEMBL178301,,CHEMBL178301,6.17,False,http://www.openphacts.org/units/Nanomolar,368113,=,1,True,=,,IC50,nM,,670.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,uM,UO_0000065,,0.67
,1429029,[],CHEMBL833471,Inhibition of p53-binding to HDM2 (human MDM2) by fluorescence polarization peptide displacement assay,B,,,BAO_0000190,BAO_0000224,protein format,O=C(O)[C@H](c1ccc(O)cc1)N1C(=O)c2cc(I)ccc2NC(=O)[C@@H]1c1ccc(Cl)cc1,,,CHEMBL1140282,Bioorg. Med. Chem. Lett.,2005,"{'bei': '8.50', 'le': '0.20', 'lle': '0.17', 'sei': '4.47'}",CHEMBL361220,,CHEMBL361220,4.78,False,http://www.openphacts.org/units/Nanomolar,368118,=,1,True,=,,IC50,nM,,16500.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,uM,UO_0000065,,16.5
,1429031,[],CHEMBL833471,Inhibition of p53-binding to HDM2 (human MDM2) by fluorescence polarization peptide displacement assay,B,,,BAO_0000190,BAO_0000224,protein format,O=C(O)[C@H](c1ccc(Cl)cc1)N1C(=O)c2cc(I)ccc2NC(=O)[C@@H]1c1ccc(Cl)cc1,,,CHEMBL1140282,Bioorg. Med. Chem. Lett.,2005,"{'bei': '10.97', 'le': '0.27', 'lle': '0.82', 'sei': '7.35'}",CHEMBL361103,,CHEMBL361103,6.38,False,http://www.openphacts.org/units/Nanomolar,368123,=,1,True,=,,IC50,nM,,420.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,uM,UO_0000065,,0.42
,1429034,[],CHEMBL833471,Inhibition of p53-binding to HDM2 (human MDM2) by fluorescence polarization peptide displacement assay,B,,,BAO_0000190,BAO_0000224,protein format,O=C(O)[C@H](c1ccc(Br)cc1)N1C(=O)c2cc(I)ccc2NC(=O)[C@@H]1c1ccc(Cl)cc1,,,CHEMBL1140282,Bioorg. Med. Chem. Lett.,2005,"{'bei': '9.92', 'le': '0.26', 'lle': '0.54', 'sei': '7.16'}",CHEMBL181148,,CHEMBL181148,6.21,False,http://www.openphacts.org/units/Nanomolar,368127,=,1,True,=,,IC50,nM,,620.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,uM,UO_0000065,,0.62
,1429036,[],CHEMBL833471,Inhibition of p53-binding to HDM2 (human MDM2) by fluorescence polarization peptide displacement assay,B,,,BAO_0000190,BAO_0000224,protein format,O=C(O)[C@H](c1ccc(Cl)cc1)N1C(=O)c2cc(I)ccc2NC(=O)[C@@H]1c1ccc(C(F)(F)F)cc1,,,CHEMBL1140282,Bioorg. Med. Chem. Lett.,2005,"{'bei': '10.10', 'le': '0.24', 'lle': '0.29', 'sei': '7.16'}",CHEMBL181252,,CHEMBL181252,6.21,False,http://www.openphacts.org/units/Nanomolar,368043,=,1,True,=,,IC50,nM,,620.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,uM,UO_0000065,,0.62
,1429039,[],CHEMBL833471,Inhibition of p53-binding to HDM2 (human MDM2) by fluorescence polarization peptide displacement assay,B,,,BAO_0000190,BAO_0000224,protein format,O=C(O)[C@H](c1ccc(Cl)cc1)N1C(=O)c2cc(I)ccc2NC(=O)[C@@H]1c1ccc(OC(F)(F)F)cc1,,,CHEMBL1140282,Bioorg. Med. Chem. Lett.,2005,"{'bei': '11.23', 'le': '0.27', 'lle': '1.28', 'sei': '7.38'}",CHEMBL369560,,CHEMBL369560,7.08,False,http://www.openphacts.org/units/Nanomolar,368053,=,1,True,=,,IC50,nM,,83.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,uM,UO_0000065,,0.083
,1429041,[],CHEMBL833471,Inhibition of p53-binding to HDM2 (human MDM2) by fluorescence polarization peptide displacement assay,B,,,BAO_0000190,BAO_0000224,protein format,O=C(O)[C@H](c1cccc(Cl)c1)N1C(=O)c2cc(I)ccc2NC(=O)[C@@H]1c1ccc(Cl)cc1,,,CHEMBL1140282,Bioorg. Med. Chem. Lett.,2005,"{'bei': '9.58', 'le': '0.24', 'lle': '0.01', 'sei': '6.42'}",CHEMBL367821,,CHEMBL367821,5.57,False,http://www.openphacts.org/units/Nanomolar,368059,=,1,True,=,,IC50,nM,,2700.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,uM,UO_0000065,,2.7
,1429042,[],CHEMBL833471,Inhibition of p53-binding to HDM2 (human MDM2) by fluorescence polarization peptide displacement assay,B,,,BAO_0000190,BAO_0000224,protein format,O=C1Nc2ccc(I)cc2C(=O)N([C@H](C(=O)O)c2ccccc2Cl)[C@H]1c1ccc(Cl)cc1,,,CHEMBL1140282,Bioorg. Med. Chem. Lett.,2005,"{'bei': '8.09', 'le': '0.20', 'lle': '-0.86', 'sei': '5.42'}",CHEMBL179931,,CHEMBL179931,4.70,False,http://www.openphacts.org/units/Nanomolar,368065,=,1,True,=,,IC50,nM,,20000.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,uM,UO_0000065,,20.0
,1429043,[],CHEMBL833471,Inhibition of p53-binding to HDM2 (human MDM2) by fluorescence polarization peptide displacement assay,B,,,BAO_0000190,BAO_0000224,protein format,O=C(O)[C@H](c1ccc(Cl)cc1)N1C(=O)c2ccccc2NC(=O)[C@@H]1c1ccc(Cl)cc1,,,CHEMBL1140282,Bioorg. Med. Chem. Lett.,2005,"{'bei': '10.61', 'le': '0.21', 'lle': '-0.12', 'sei': '5.57'}",CHEMBL181138,,CHEMBL181138,4.83,False,http://www.openphacts.org/units/Nanomolar,368069,=,1,True,=,,IC50,nM,,14800.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,uM,UO_0000065,,14.8
,1429045,[],CHEMBL833471,Inhibition of p53-binding to HDM2 (human MDM2) by fluorescence polarization peptide displacement assay,B,,,BAO_0000190,BAO_0000224,protein format,CCc1ccc2c(c1)C(=O)N([C@H](C(=O)O)c1ccc(Cl)cc1)[C@@H](c1ccc(Cl)cc1)C(=O)N2,,,CHEMBL1140282,Bioorg. Med. Chem. Lett.,2005,"{'bei': '12.05', 'le': '0.24', 'lle': '0.30', 'sei': '6.72'}",CHEMBL359740,,CHEMBL359740,5.82,False,http://www.openphacts.org/units/Nanomolar,368075,=,1,True,=,,IC50,nM,,1500.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,uM,UO_0000065,,1.5
,1429046,[],CHEMBL833471,Inhibition of p53-binding to HDM2 (human MDM2) by fluorescence polarization peptide displacement assay,B,,,BAO_0000190,BAO_0000224,protein format,CC(C)c1ccc2c(c1)C(=O)N([C@H](C(=O)O)c1ccc(Cl)cc1)[C@@H](c1ccc(Cl)cc1)C(=O)N2,,,CHEMBL1140282,Bioorg. Med. Chem. Lett.,2005,"{'bei': '12.05', 'le': '0.24', 'lle': '-0.09', 'sei': '6.91'}",CHEMBL182149,,CHEMBL182149,5.99,False,http://www.openphacts.org/units/Nanomolar,368080,=,1,True,=,,IC50,nM,,1020.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,uM,UO_0000065,,1.02
,1429047,[],CHEMBL833471,Inhibition of p53-binding to HDM2 (human MDM2) by fluorescence polarization peptide displacement assay,B,,,BAO_0000190,BAO_0000224,protein format,CC(C)(C)c1ccc2c(c1)C(=O)N([C@H](C(=O)O)c1ccc(Cl)cc1)[C@@H](c1ccc(Cl)cc1)C(=O)N2,,,CHEMBL1140282,Bioorg. Med. Chem. Lett.,2005,"{'bei': '11.04', 'le': '0.22', 'lle': '-0.61', 'sei': '6.51'}",CHEMBL181607,,CHEMBL181607,5.64,False,http://www.openphacts.org/units/Nanomolar,368089,=,1,True,=,,IC50,nM,,2270.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,uM,UO_0000065,,2.27
,1429048,[],CHEMBL833471,Inhibition of p53-binding to HDM2 (human MDM2) by fluorescence polarization peptide displacement assay,B,,,BAO_0000190,BAO_0000224,protein format,O=C(O)[C@H](c1ccc(Cl)cc1)N1C(=O)c2cc(Cl)ccc2NC(=O)[C@@H]1c1ccc(Cl)cc1,,,CHEMBL1140282,Bioorg. Med. Chem. Lett.,2005,"{'bei': '12.42', 'le': '0.26', 'lle': '0.47', 'sei': '7.01'}",CHEMBL361168,,CHEMBL361168,6.08,False,http://www.openphacts.org/units/Nanomolar,368097,=,1,True,=,,IC50,nM,,830.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,uM,UO_0000065,,0.83
,1429447,[],CHEMBL833471,Inhibition of p53-binding to HDM2 (human MDM2) by fluorescence polarization peptide displacement assay,B,,,BAO_0000190,BAO_0000224,protein format,O=C(O)[C@H](c1ccc(Cl)cc1)N1C(=O)c2cc(Br)ccc2NC(=O)[C@@H]1c1ccc(Cl)cc1,,,CHEMBL1140282,Bioorg. Med. Chem. Lett.,2005,"{'bei': '11.38', 'le': '0.26', 'lle': '0.36', 'sei': '7.01'}",CHEMBL369321,,CHEMBL369321,6.08,False,http://www.openphacts.org/units/Nanomolar,368102,=,1,True,=,,IC50,nM,,830.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,uM,UO_0000065,,0.83
,1429449,[],CHEMBL833471,Inhibition of p53-binding to HDM2 (human MDM2) by fluorescence polarization peptide displacement assay,B,,,BAO_0000190,BAO_0000224,protein format,O=C(O)[C@H](c1ccc(Cl)cc1)N1C(=O)c2ccc(Cl)cc2NC(=O)[C@@H]1c1ccc(Cl)cc1,,,CHEMBL1140282,Bioorg. Med. Chem. Lett.,2005,"{'bei': '10.62', 'le': '0.22', 'lle': '-0.41', 'sei': '6.00'}",CHEMBL179890,,CHEMBL179890,5.20,False,http://www.openphacts.org/units/Nanomolar,368108,=,1,True,=,,IC50,nM,,6300.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,uM,UO_0000065,,6.3
,1429452,[],CHEMBL833471,Inhibition of p53-binding to HDM2 (human MDM2) by fluorescence polarization peptide displacement assay,B,,,BAO_0000190,BAO_0000224,protein format,O=C(O)[C@H](c1ccc(Cl)cc1)N1C(=O)c2cc(I)c(Cl)cc2NC(=O)[C@@H]1c1ccc(Cl)cc1,,,CHEMBL1140282,Bioorg. Med. Chem. Lett.,2005,"{'bei': '10.00', 'le': '0.25', 'lle': '-0.06', 'sei': '7.10'}",CHEMBL361770,,CHEMBL361770,6.16,False,http://www.openphacts.org/units/Nanomolar,368114,=,1,True,=,,IC50,nM,,700.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,uM,UO_0000065,,0.7
,1429454,[],CHEMBL833471,Inhibition of p53-binding to HDM2 (human MDM2) by fluorescence polarization peptide displacement assay,B,,,BAO_0000190,BAO_0000224,protein format,O=C(O)[C@H](c1ccc(Cl)cc1)N1C(=O)c2cc(CO)ccc2NC(=O)[C@@H]1c1ccc(Cl)cc1,,,CHEMBL1140282,Bioorg. Med. Chem. Lett.,2005,"{'bei': '11.29', 'le': '0.23', 'lle': '1.03', 'sei': '5.13'}",CHEMBL359846,,CHEMBL359846,5.48,False,http://www.openphacts.org/units/Nanomolar,368119,=,1,True,=,,IC50,nM,,3300.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,uM,UO_0000065,,3.3
,1429455,[],CHEMBL833471,Inhibition of p53-binding to HDM2 (human MDM2) by fluorescence polarization peptide displacement assay,B,,,BAO_0000190,BAO_0000224,protein format,O=C(O)[C@H](c1ccc(Cl)cc1)N1C(=O)c2cc(CCO)ccc2NC(=O)[C@@H]1c1ccc(Cl)cc1,,,CHEMBL1140282,Bioorg. Med. Chem. Lett.,2005,"{'bei': '11.25', 'le': '0.23', 'lle': '1.13', 'sei': '5.26'}",CHEMBL179987,,CHEMBL179987,5.62,False,http://www.openphacts.org/units/Nanomolar,368124,=,1,True,=,,IC50,nM,,2400.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,uM,UO_0000065,,2.4
,1429456,[],CHEMBL833471,Inhibition of p53-binding to HDM2 (human MDM2) by fluorescence polarization peptide displacement assay,B,,,BAO_0000190,BAO_0000224,protein format,CC(=O)Nc1ccc2c(c1)C(=O)N([C@H](C(=O)O)c1ccc(Cl)cc1)[C@@H](c1ccc(Cl)cc1)C(=O)N2,Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL1140282,Bioorg. Med. Chem. Lett.,2005,,CHEMBL361589,,CHEMBL361589,,False,http://www.openphacts.org/units/Nanomolar,368128,>,1,True,>,,IC50,nM,,125000.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,uM,UO_0000065,,125.0
,1429457,[],CHEMBL833471,Inhibition of p53-binding to HDM2 (human MDM2) by fluorescence polarization peptide displacement assay,B,,,BAO_0000190,BAO_0000224,protein format,N#Cc1ccc2c(c1)C(=O)N([C@H](C(=O)O)c1ccc(Cl)cc1)[C@@H](c1ccc(Cl)cc1)C(=O)N2,,,CHEMBL1140282,Bioorg. Med. Chem. Lett.,2005,"{'bei': '10.06', 'le': '0.20', 'lle': '0.00', 'sei': '4.37'}",CHEMBL360484,,CHEMBL360484,4.83,False,http://www.openphacts.org/units/Nanomolar,368044,=,1,True,=,,IC50,nM,,14800.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,uM,UO_0000065,,14.8
,1429459,[],CHEMBL833471,Inhibition of p53-binding to HDM2 (human MDM2) by fluorescence polarization peptide displacement assay,B,,,BAO_0000190,BAO_0000224,protein format,C#Cc1ccc2c(c1)C(=O)N([C@H](C(=O)O)c1ccc(Cl)cc1)[C@@H](c1ccc(Cl)cc1)C(=O)N2,,,CHEMBL1140282,Bioorg. Med. Chem. Lett.,2005,"{'bei': '12.64', 'le': '0.25', 'lle': '1.12', 'sei': '6.99'}",CHEMBL359897,,CHEMBL359897,6.06,False,http://www.openphacts.org/units/Nanomolar,368049,=,1,True,=,,IC50,nM,,870.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,uM,UO_0000065,,0.87
,1429566,[],CHEMBL833471,Inhibition of p53-binding to HDM2 (human MDM2) by fluorescence polarization peptide displacement assay,B,,,BAO_0000190,BAO_0000224,protein format,O=C(O)[C@H](c1ccc(Cl)nc1)N1C(=O)c2cc(I)ccc2NC(=O)[C@@H]1c1ccc(Cl)cc1,,,CHEMBL1140282,Bioorg. Med. Chem. Lett.,2005,"{'bei': '10.02', 'le': '0.25', 'lle': '0.88', 'sei': '5.86'}",CHEMBL180205,,CHEMBL180205,5.83,False,http://www.openphacts.org/units/Nanomolar,368054,=,1,True,=,,IC50,nM,,1470.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,uM,UO_0000065,,1.47
,1429567,[],CHEMBL833471,Inhibition of p53-binding to HDM2 (human MDM2) by fluorescence polarization peptide displacement assay,B,,,BAO_0000190,BAO_0000224,protein format,O=C(O)[C@H](c1ccc(Cl)cc1)N1C(=O)c2cc(I)ccc2NC(=O)[C@@H]1c1ccc(Cl)nc1,,,CHEMBL1140282,Bioorg. Med. Chem. Lett.,2005,"{'bei': '8.81', 'le': '0.22', 'lle': '0.18', 'sei': '5.15'}",CHEMBL368244,,CHEMBL368244,5.13,False,http://www.openphacts.org/units/Nanomolar,368060,=,1,True,=,,IC50,nM,,7400.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,uM,UO_0000065,,7.4
,1429568,[],CHEMBL833471,Inhibition of p53-binding to HDM2 (human MDM2) by fluorescence polarization peptide displacement assay,B,,,BAO_0000190,BAO_0000224,protein format,O=C(O)[C@H](c1ccc(Cl)nc1)N1C(=O)c2cc(I)ccc2NC(=O)[C@@H]1c1c[nH]c2ccccc12,,,CHEMBL1140282,Bioorg. Med. Chem. Lett.,2005,"{'bei': '7.26', 'le': '0.17', 'lle': '-0.52', 'sei': '3.69'}",CHEMBL359676,,CHEMBL359676,4.26,False,http://www.openphacts.org/units/Nanomolar,368066,=,1,True,=,,IC50,nM,,55000.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,uM,UO_0000065,,55.0
,1429569,[],CHEMBL833471,Inhibition of p53-binding to HDM2 (human MDM2) by fluorescence polarization peptide displacement assay,B,,,BAO_0000190,BAO_0000224,protein format,O=C(O)[C@H](c1ccc(Cl)nc1)N1C(=O)c2cc(I)ccc2NC(=O)[C@@H]1c1cc2ccccc2[nH]1,,,CHEMBL1140282,Bioorg. Med. Chem. Lett.,2005,"{'bei': '8.70', 'le': '0.20', 'lle': '0.32', 'sei': '4.42'}",CHEMBL180179,,CHEMBL180179,5.10,False,http://www.openphacts.org/units/Nanomolar,368501,=,1,True,=,,IC50,nM,,7900.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,uM,UO_0000065,,7.9
,1429571,[],CHEMBL833471,Inhibition of p53-binding to HDM2 (human MDM2) by fluorescence polarization peptide displacement assay,B,,,BAO_0000190,BAO_0000224,protein format,O=C(O)[C@H](c1ccc(Cl)cc1)N1C(=O)c2cc(I)ccc2NC[C@@H]1c1ccc(Cl)cc1,,,CHEMBL1140282,Bioorg. Med. Chem. Lett.,2005,"{'bei': '11.12', 'le': '0.28', 'lle': '0.28', 'sei': '9.06'}",CHEMBL180433,,CHEMBL180433,6.31,False,http://www.openphacts.org/units/Nanomolar,368506,=,1,True,=,,IC50,nM,,490.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,uM,UO_0000065,,0.49
,1429572,[],CHEMBL833471,Inhibition of p53-binding to HDM2 (human MDM2) by fluorescence polarization peptide displacement assay,B,,,BAO_0000190,BAO_0000224,protein format,O=C(O)[C@H](c1ccc(Cl)cc1)N1Cc2cc(I)ccc2NC[C@@H]1c1ccc(Cl)cc1,Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL1140282,Bioorg. Med. Chem. Lett.,2005,,CHEMBL369570,,CHEMBL369570,,False,http://www.openphacts.org/units/Nanomolar,368511,>,1,True,>,,IC50,nM,,125000.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,uM,UO_0000065,,125.0
,1430657,[],CHEMBL833471,Inhibition of p53-binding to HDM2 (human MDM2) by fluorescence polarization peptide displacement assay,B,,,BAO_0000190,BAO_0000224,protein format,O=C(O)C(c1ccccc1)N1C(=O)c2cc(I)ccc2NC(=O)C1c1ccc(C(F)(F)F)cc1,,,CHEMBL1140282,Bioorg. Med. Chem. Lett.,2005,"{'bei': '7.77', 'le': '0.18', 'lle': '-0.76', 'sei': '5.20'}",CHEMBL367147,,CHEMBL367147,4.51,False,http://www.openphacts.org/units/Nanomolar,368100,=,1,True,=,,IC50,nM,,31000.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,uM,UO_0000065,,31.0
,1430658,[],CHEMBL833471,Inhibition of p53-binding to HDM2 (human MDM2) by fluorescence polarization peptide displacement assay,B,,,BAO_0000190,BAO_0000224,protein format,O=C(O)[C@H](c1ccccc1)N1C(=O)c2cc(I)ccc2NC(=O)[C@@H]1c1ccc(C(F)(F)F)cc1,,,CHEMBL1140282,Bioorg. Med. Chem. Lett.,2005,"{'bei': '9.75', 'le': '0.23', 'lle': '0.39', 'sei': '6.52'}",CHEMBL178578,,CHEMBL178578,5.66,False,http://www.openphacts.org/units/Nanomolar,368105,=,1,True,=,,IC50,nM,,2200.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,uM,UO_0000065,,2.2
,1430660,[],CHEMBL833471,Inhibition of p53-binding to HDM2 (human MDM2) by fluorescence polarization peptide displacement assay,B,,,BAO_0000190,BAO_0000224,protein format,O=C(O)[C@H](c1ccccc1)N1C(=O)c2cc(I)ccc2NC(=O)[C@@H]1c1ccccc1,,,CHEMBL1140282,Bioorg. Med. Chem. Lett.,2005,"{'bei': '8.63', 'le': '0.20', 'lle': '0.17', 'sei': '5.10'}",CHEMBL178661,,CHEMBL178661,4.42,False,http://www.openphacts.org/units/Nanomolar,368112,=,1,True,=,,IC50,nM,,38000.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,uM,UO_0000065,,38.0
,1431066,[],CHEMBL833471,Inhibition of p53-binding to HDM2 (human MDM2) by fluorescence polarization peptide displacement assay,B,,,BAO_0000190,BAO_0000224,protein format,Cc1ccc([C@H]2C(=O)Nc3ccc(I)cc3C(=O)N2[C@H](C(=O)O)c2ccccc2)cc1,,,CHEMBL1140282,Bioorg. Med. Chem. Lett.,2005,"{'bei': '9.26', 'le': '0.21', 'lle': '0.32', 'sei': '5.62'}",CHEMBL179820,,CHEMBL179820,4.88,False,http://www.openphacts.org/units/Nanomolar,368117,=,1,True,=,,IC50,nM,,13300.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,uM,UO_0000065,,13.3
,1431067,[],CHEMBL833471,Inhibition of p53-binding to HDM2 (human MDM2) by fluorescence polarization peptide displacement assay,B,,,BAO_0000190,BAO_0000224,protein format,CCc1ccc([C@H]2C(=O)Nc3ccc(I)cc3C(=O)N2[C@H](C(=O)O)c2ccccc2)cc1,,,CHEMBL1140282,Bioorg. Med. Chem. Lett.,2005,"{'bei': '9.48', 'le': '0.22', 'lle': '0.30', 'sei': '5.91'}",CHEMBL361575,,CHEMBL361575,5.12,False,http://www.openphacts.org/units/Nanomolar,368122,=,1,True,=,,IC50,nM,,7500.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,uM,UO_0000065,,7.5
,1431068,[],CHEMBL833471,Inhibition of p53-binding to HDM2 (human MDM2) by fluorescence polarization peptide displacement assay,B,,,BAO_0000190,BAO_0000224,protein format,CC(C)c1ccc([C@H]2C(=O)Nc3ccc(I)cc3C(=O)N2[C@H](C(=O)O)c2ccccc2)cc1,,,CHEMBL1140282,Bioorg. Med. Chem. Lett.,2005,"{'bei': '8.56', 'le': '0.20', 'lle': '-0.64', 'sei': '5.47'}",CHEMBL362794,,CHEMBL362794,4.75,False,http://www.openphacts.org/units/Nanomolar,368126,=,1,True,=,,IC50,nM,,18000.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,uM,UO_0000065,,18.0
,1431069,[],CHEMBL833471,Inhibition of p53-binding to HDM2 (human MDM2) by fluorescence polarization peptide displacement assay,B,,,BAO_0000190,BAO_0000224,protein format,O=C(O)[C@H](c1ccccc1)N1C(=O)c2cc(I)ccc2NC(=O)[C@@H]1c1ccc(Cl)cc1,,,CHEMBL1140282,Bioorg. Med. Chem. Lett.,2005,"{'bei': '10.25', 'le': '0.25', 'lle': '0.69', 'sei': '6.46'}",CHEMBL362222,,CHEMBL362222,5.60,False,http://www.openphacts.org/units/Nanomolar,368047,=,1,True,=,,IC50,nM,,2500.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,uM,UO_0000065,,2.5
,1431070,[],CHEMBL833471,Inhibition of p53-binding to HDM2 (human MDM2) by fluorescence polarization peptide displacement assay,B,,,BAO_0000190,BAO_0000224,protein format,O=C(O)[C@H](c1ccccc1)N1C(=O)c2cc(I)ccc2NC(=O)[C@@H]1c1ccc(OC(F)(F)F)cc1,,,CHEMBL1140282,Bioorg. Med. Chem. Lett.,2005,"{'bei': '9.86', 'le': '0.23', 'lle': '0.73', 'sei': '6.13'}",CHEMBL359856,,CHEMBL359856,5.88,False,http://www.openphacts.org/units/Nanomolar,368051,=,1,True,=,,IC50,nM,,1320.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,uM,UO_0000065,,1.32
,1431071,[],CHEMBL833471,Inhibition of p53-binding to HDM2 (human MDM2) by fluorescence polarization peptide displacement assay,B,,,BAO_0000190,BAO_0000224,protein format,O=C(O)[C@H](c1ccccc1)N1C(=O)c2cc(I)ccc2NC(=O)[C@@H]1c1ccccc1C(F)(F)F,Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL1140282,Bioorg. Med. Chem. Lett.,2005,,CHEMBL433753,,CHEMBL433753,,False,http://www.openphacts.org/units/Nanomolar,368058,>,1,True,>,,IC50,nM,,125000.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,uM,UO_0000065,,125.0
,1431072,[],CHEMBL833471,Inhibition of p53-binding to HDM2 (human MDM2) by fluorescence polarization peptide displacement assay,B,,,BAO_0000190,BAO_0000224,protein format,O=C(O)[C@H](c1ccccc1)N1C(=O)c2cc(I)ccc2NC(=O)[C@@H]1c1cccc(C(F)(F)F)c1,,,CHEMBL1140282,Bioorg. Med. Chem. Lett.,2005,"{'bei': '7.49', 'le': '0.17', 'lle': '-0.92', 'sei': '5.01'}",CHEMBL179879,,CHEMBL179879,4.35,False,http://www.openphacts.org/units/Nanomolar,368064,=,1,True,=,,IC50,nM,,45000.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,uM,UO_0000065,,45.0
,1431073,[],CHEMBL833471,Inhibition of p53-binding to HDM2 (human MDM2) by fluorescence polarization peptide displacement assay,B,,,BAO_0000190,BAO_0000224,protein format,O=C1Nc2ccc(I)cc2C(=O)N([C@H](C(=O)O)C2CCCCC2)[C@H]1c1ccc(Cl)cc1,,,CHEMBL1140282,Bioorg. Med. Chem. Lett.,2005,"{'bei': '7.59', 'le': '0.18', 'lle': '-0.92', 'sei': '4.84'}",CHEMBL362474,,CHEMBL362474,4.19,False,http://www.openphacts.org/units/Nanomolar,368068,=,1,True,=,,IC50,nM,,64000.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,uM,UO_0000065,,64.0
,1431074,[],CHEMBL833471,Inhibition of p53-binding to HDM2 (human MDM2) by fluorescence polarization peptide displacement assay,B,,,BAO_0000190,BAO_0000224,protein format,CCCC[C@@H](C(=O)O)N1C(=O)c2cc(I)ccc2NC(=O)[C@@H]1c1ccc(Cl)cc1,,,CHEMBL1140282,Bioorg. Med. Chem. Lett.,2005,"{'bei': '9.21', 'le': '0.23', 'lle': '0.13', 'sei': '5.60'}",CHEMBL182335,,CHEMBL182335,4.85,False,http://www.openphacts.org/units/Nanomolar,368073,=,1,True,=,,IC50,nM,,14000.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,uM,UO_0000065,,14.0
,1431076,[],CHEMBL833471,Inhibition of p53-binding to HDM2 (human MDM2) by fluorescence polarization peptide displacement assay,B,,,BAO_0000190,BAO_0000224,protein format,CC(C)CC[C@@H](C(=O)O)N1C(=O)c2cc(I)ccc2NC(=O)[C@@H]1c1ccc(Cl)cc1,,,CHEMBL1140282,Bioorg. Med. Chem. Lett.,2005,"{'bei': '9.10', 'le': '0.22', 'lle': '-0.05', 'sei': '5.68'}",CHEMBL361559,,CHEMBL361559,4.92,False,http://www.openphacts.org/units/Nanomolar,368079,=,1,True,=,,IC50,nM,,12000.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,uM,UO_0000065,,12.0
,1431077,[],CHEMBL833471,Inhibition of p53-binding to HDM2 (human MDM2) by fluorescence polarization peptide displacement assay,B,,,BAO_0000190,BAO_0000224,protein format,O=C(O)[C@H](Cc1ccccc1)N1C(=O)c2cc(I)ccc2NC(=O)[C@@H]1c1ccc(Cl)cc1,,,CHEMBL1140282,Bioorg. Med. Chem. Lett.,2005,"{'bei': '8.77', 'le': '0.21', 'lle': '0.14', 'sei': '5.68'}",CHEMBL361733,,CHEMBL361733,4.92,False,http://www.openphacts.org/units/Nanomolar,368088,=,1,True,=,,IC50,nM,,12000.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,uM,UO_0000065,,12.0
,1431078,[],CHEMBL833471,Inhibition of p53-binding to HDM2 (human MDM2) by fluorescence polarization peptide displacement assay,B,,,BAO_0000190,BAO_0000224,protein format,Cc1ccc([C@@H](C(=O)O)N2C(=O)c3cc(I)ccc3NC(=O)[C@@H]2c2ccc(Cl)cc2)cc1,,,CHEMBL1140282,Bioorg. Med. Chem. Lett.,2005,"{'bei': '10.34', 'le': '0.25', 'lle': '0.59', 'sei': '6.69'}",CHEMBL180335,,CHEMBL180335,5.80,False,http://www.openphacts.org/units/Nanomolar,368096,=,1,True,=,,IC50,nM,,1590.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,uM,UO_0000065,,1.59
,1437356,[],CHEMBL828042,Inhibitory concentration against MDM2-p53 interaction in SJSA human sarcoma cells,B,,,BAO_0000190,BAO_0000219,cell-based format,CCCNC1(c2ccccc2)c2ccccc2C(=O)N1Cc1ccccc1,Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL1142026,Bioorg. Med. Chem. Lett.,2005,,CHEMBL180897,,CHEMBL180897,,False,http://www.openphacts.org/units/Nanomolar,369963,~,1,True,~,,IC50,nM,,200000.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,uM,UO_0000065,,200.0
,1437357,[],CHEMBL828042,Inhibitory concentration against MDM2-p53 interaction in SJSA human sarcoma cells,B,,,BAO_0000190,BAO_0000219,cell-based format,CCCOC1(c2ccccc2)c2ccccc2C(=O)N1Cc1ccccc1,Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL1142026,Bioorg. Med. Chem. Lett.,2005,,CHEMBL180048,,CHEMBL180048,,False,http://www.openphacts.org/units/Nanomolar,369969,~,1,True,~,,IC50,nM,,200000.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,uM,UO_0000065,,200.0
,1437358,[],CHEMBL828042,Inhibitory concentration against MDM2-p53 interaction in SJSA human sarcoma cells,B,,,BAO_0000190,BAO_0000219,cell-based format,CCCOC1(c2ccccc2)c2ccccc2C(=O)N1CCC,Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL1142026,Bioorg. Med. Chem. Lett.,2005,,CHEMBL360160,,CHEMBL360160,,False,http://www.openphacts.org/units/Nanomolar,369970,~,1,True,~,,IC50,nM,,200000.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,uM,UO_0000065,,200.0
,1462675,[],CHEMBL832457,In vitro inhibitory concentration against p53-mdm2 interaction,B,,,BAO_0000190,BAO_0000224,protein format,CC(C)Oc1ccc(C(=O)NS(=O)(=O)c2ccc(NN=C3C(=O)N(c4ccccc4)N(c4ccccc4)C3=O)cc2)cc1,,,CHEMBL1137206,J. Med. Chem.,2004,"{'bei': '7.53', 'le': '0.14', 'lle': '0.14', 'sei': '3.27'}",CHEMBL361676,,CHEMBL361676,4.50,False,http://www.openphacts.org/units/Nanomolar,378832,=,1,True,=,,IC50,nM,,31800.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,uM,UO_0000065,,31.8
,1475232,[],CHEMBL831913,In vitro inhibitory concentration against p53-mdm2 interaction; Range = 9.6 to 14 uM,B,,,BAO_0000190,BAO_0000224,protein format,CC(C)C[C@H](NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)[C@H](CCC(=O)O)NC(=O)[C@@H](N)CCC(N)=O)[C@@H](C)O)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)O,,,CHEMBL1137206,J. Med. Chem.,2004,"{'bei': '3.31', 'le': None, 'lle': None, 'sei': None}",CHEMBL2371818,,CHEMBL2371818,4.89,False,http://www.openphacts.org/units/Nanomolar,382083,=,1,True,=,,IC50,nM,,12900.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,uM,UO_0000065,,12.9
,1490346,[],CHEMBL828551,Inhibitory activity against MDM2 (murine double minute-2 gene) binding to p53,B,,,BAO_0000190,BAO_0000224,protein format,CC(C)Oc1ccc(C(=O)NS(=O)(=O)c2ccc(NN=C3C(=O)N(c4ccccc4)N(c4ccccc4)C3=O)cc2)cc1,,,CHEMBL1140309,J. Med. Chem.,2005,"{'bei': '7.57', 'le': '0.14', 'lle': '0.16', 'sei': '3.29'}",CHEMBL361676,,CHEMBL361676,4.52,False,http://www.openphacts.org/units/Nanomolar,385244,=,1,True,=,,IC50,nM,,30000.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,uM,UO_0000065,,30.0
,1776871,[],CHEMBL908897,Inhibition of p53-MDM2 interaction by ELISA,B,,,BAO_0000190,BAO_0000224,protein format,CN(CCOC1(c2ccccc2)c2ccccc2C(=O)N1Cc1ccccc1)c1ccc(C=O)cc1,Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL1137314,J. Med. Chem.,2006,,CHEMBL214180,,CHEMBL214180,,False,http://www.openphacts.org/units/Nanomolar,588137,=,1,True,=,,IC50,nM,,191000.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,uM,UO_0000065,,191.0
,1779367,[],CHEMBL908897,Inhibition of p53-MDM2 interaction by ELISA,B,,,BAO_0000190,BAO_0000224,protein format,Cc1ccc([N+](=O)[O-])c(COC2(c3ccccc3)c3ccccc3C(=O)N2Cc2ccccc2)c1,Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL1137314,J. Med. Chem.,2006,,CHEMBL386814,,CHEMBL386814,,False,http://www.openphacts.org/units/Nanomolar,588138,=,1,True,=,,IC50,nM,,232000.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,uM,UO_0000065,,232.0
,1780706,[],CHEMBL908897,Inhibition of p53-MDM2 interaction by ELISA,B,,,BAO_0000190,BAO_0000224,protein format,CC(C)(C)c1ccc(COC2(c3ccccc3)c3ccccc3C(=O)N2Cc2ccccc2)cc1,,,CHEMBL1137314,J. Med. Chem.,2006,"{'bei': '8.74', 'le': '0.16', 'lle': '-3.02', 'sei': '13.66'}",CHEMBL181688,,CHEMBL181688,4.04,False,http://www.openphacts.org/units/Nanomolar,588115,=,1,True,=,,IC50,nM,,92000.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,uM,UO_0000065,,92.0
,1780707,[],CHEMBL908897,Inhibition of p53-MDM2 interaction by ELISA,B,,,BAO_0000190,BAO_0000224,protein format,COc1ccc(C(O)CNC2(c3ccccc3)c3ccccc3C(=O)N2Cc2ccccc2)cc1,,,CHEMBL1137314,J. Med. Chem.,2006,"{'bei': '8.94', 'le': '0.16', 'lle': '-0.73', 'sei': '6.72'}",CHEMBL179114,,CHEMBL179114,4.16,False,http://www.openphacts.org/units/Nanomolar,588120,=,1,True,=,,IC50,nM,,70000.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,uM,UO_0000065,,70.0
,1780708,[],CHEMBL908897,Inhibition of p53-MDM2 interaction by ELISA,B,,,BAO_0000190,BAO_0000224,protein format,CCCN1C(=O)c2ccccc2C1(NC(=O)c1ccccc1)c1ccc(C(C)(C)C)cc1,,,CHEMBL1137314,J. Med. Chem.,2006,"{'bei': '9.80', 'le': '0.18', 'lle': '-1.30', 'sei': '8.46'}",CHEMBL360920,,CHEMBL360920,4.18,False,http://www.openphacts.org/units/Nanomolar,588119,=,1,True,=,,IC50,nM,,66000.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,uM,UO_0000065,,66.0
,1780709,[],CHEMBL908897,Inhibition of p53-MDM2 interaction by ELISA,B,,,BAO_0000190,BAO_0000224,protein format,CCCN1C(=O)c2ccccc2C1(NC(=O)c1ccc(C(C)(C)C)cc1)c1ccc(OCOCC[Si](C)(C)C)cc1,,,CHEMBL1137314,J. Med. Chem.,2006,"{'bei': '7.98', 'le': None, 'lle': None, 'sei': None}",CHEMBL179549,,CHEMBL179549,4.57,False,http://www.openphacts.org/units/Nanomolar,588118,=,1,True,=,,IC50,nM,,27000.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,uM,UO_0000065,,27.0
,1780710,[],CHEMBL908897,Inhibition of p53-MDM2 interaction by ELISA,B,,,BAO_0000190,BAO_0000224,protein format,CCCOC1(c2ccccc2)c2ccccc2C(=O)N1C(Cc1ccc(O)cc1)C(=O)OC,,,CHEMBL1137314,J. Med. Chem.,2006,"{'bei': '9.08', 'le': '0.17', 'lle': '-0.21', 'sei': '5.32'}",CHEMBL182052,,CHEMBL182052,4.05,False,http://www.openphacts.org/units/Nanomolar,588116,=,1,True,=,,IC50,nM,,90000.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,uM,UO_0000065,,90.0
,1780711,[],CHEMBL908897,Inhibition of p53-MDM2 interaction by ELISA,B,,,BAO_0000190,BAO_0000224,protein format,O=C1c2ccccc2C(N[C@@H](CO)[C@@H](O)c2ccccc2)(c2ccccc2)N1Cc1ccccc1,,,CHEMBL1137314,J. Med. Chem.,2006,"{'bei': '8.76', 'le': '0.16', 'lle': '-0.16', 'sei': '5.59'}",CHEMBL217792,,CHEMBL217792,4.07,False,http://www.openphacts.org/units/Nanomolar,588117,=,1,True,=,,IC50,nM,,85000.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,uM,UO_0000065,,85.0
,1780712,[],CHEMBL908897,Inhibition of p53-MDM2 interaction by ELISA,B,,,BAO_0000190,BAO_0000224,protein format,O=C1c2ccccc2C(OCc2cccc([N+](=O)[O-])c2)(c2ccccc2)N1Cc1ccccc1,Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL1137314,J. Med. Chem.,2006,,CHEMBL387459,,CHEMBL387459,,False,http://www.openphacts.org/units/Nanomolar,588121,=,1,True,=,,IC50,nM,,284000.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,uM,UO_0000065,,284.0
,1780713,[],CHEMBL908897,Inhibition of p53-MDM2 interaction by ELISA,B,,,BAO_0000190,BAO_0000224,protein format,COC(=O)COC1(c2ccccc2)c2ccccc2C(=O)N1Cc1ccccc1,Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL1137314,J. Med. Chem.,2006,,CHEMBL386190,,CHEMBL386190,,False,http://www.openphacts.org/units/Nanomolar,588143,>,1,True,>,,IC50,nM,,500000.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,uM,UO_0000065,,500.0
,1780714,[],CHEMBL908897,Inhibition of p53-MDM2 interaction by ELISA,B,,,BAO_0000190,BAO_0000224,protein format,COCCOC1(c2ccccc2)c2ccccc2C(=O)N1Cc1ccccc1,Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL1137314,J. Med. Chem.,2006,,CHEMBL217621,,CHEMBL217621,,False,http://www.openphacts.org/units/Nanomolar,588142,=,1,True,=,,IC50,nM,,490000.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,uM,UO_0000065,,490.0
,1780715,[],CHEMBL908897,Inhibition of p53-MDM2 interaction by ELISA,B,,,BAO_0000190,BAO_0000224,protein format,COc1ccc([C@@H](O)COC2(c3ccccc3)c3ccccc3C(=O)N2CCCO)cc1,Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL1137314,J. Med. Chem.,2006,,CHEMBL387225,,CHEMBL387225,,False,http://www.openphacts.org/units/Nanomolar,588141,=,1,True,=,,IC50,nM,,326000.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,uM,UO_0000065,,326.0
,1780716,[],CHEMBL908897,Inhibition of p53-MDM2 interaction by ELISA,B,,,BAO_0000190,BAO_0000224,protein format,O=C1c2ccccc2C(OCCS(=O)(=O)[O-])(c2ccccc2)N1Cc1ccccc1.[Na+],Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL1137314,J. Med. Chem.,2006,,CHEMBL217884,,CHEMBL1206133,,False,http://www.openphacts.org/units/Nanomolar,588140,=,1,True,=,,IC50,nM,,345000.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,uM,UO_0000065,,345.0
,1780717,[],CHEMBL908897,Inhibition of p53-MDM2 interaction by ELISA,B,,,BAO_0000190,BAO_0000224,protein format,COc1cc(COC2(c3ccccc3)c3ccccc3C(=O)N2Cc2ccccc2)cc(OC)c1O,,,CHEMBL1137314,J. Med. Chem.,2006,"{'bei': '9.86', 'le': '0.18', 'lle': '-0.73', 'sei': '6.96'}",CHEMBL178106,,CHEMBL178106,4.75,False,http://www.openphacts.org/units/Nanomolar,588139,=,1,True,=,,IC50,nM,,17900.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,uM,UO_0000065,,17.9
,1780974,[],CHEMBL908897,Inhibition of p53-MDM2 interaction by ELISA,B,,,BAO_0000190,BAO_0000224,protein format,Cc1cccc(N(CCC#N)CCOC2(c3ccccc3)c3ccccc3C(=O)N2Cc2ccccc2)c1,Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL1137314,J. Med. Chem.,2006,,CHEMBL384798,,CHEMBL384798,,False,http://www.openphacts.org/units/Nanomolar,588136,=,1,True,=,,IC50,nM,,243000.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,uM,UO_0000065,,243.0
,1780975,[],CHEMBL908897,Inhibition of p53-MDM2 interaction by ELISA,B,,,BAO_0000190,BAO_0000224,protein format,O=C1c2ccccc2C(OCCNc2ccccc2)(c2ccccc2)N1Cc1ccccc1,Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL1137314,J. Med. Chem.,2006,,CHEMBL439183,,CHEMBL439183,,False,http://www.openphacts.org/units/Nanomolar,588135,=,1,True,=,,IC50,nM,,116000.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,uM,UO_0000065,,116.0
,1780976,[],CHEMBL908897,Inhibition of p53-MDM2 interaction by ELISA,B,,,BAO_0000190,BAO_0000224,protein format,O=C(NCCOC1(c2ccccc2)c2ccccc2C(=O)N1Cc1ccccc1)c1ccc(O)cc1O,,,CHEMBL1137314,J. Med. Chem.,2006,"{'bei': '8.12', 'le': '0.15', 'lle': '-0.38', 'sei': '4.05'}",CHEMBL384379,,CHEMBL384379,4.02,False,http://www.openphacts.org/units/Nanomolar,588134,=,1,True,=,,IC50,nM,,96000.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,uM,UO_0000065,,96.0
,1780977,[],CHEMBL908897,Inhibition of p53-MDM2 interaction by ELISA,B,,,BAO_0000190,BAO_0000224,protein format,O=Cc1ccc(COC2(c3ccccc3)c3ccccc3C(=O)N2Cc2ccccc2)o1,,,CHEMBL1137314,J. Med. Chem.,2006,"{'bei': '9.48', 'le': '0.17', 'lle': '-1.16', 'sei': '6.72'}",CHEMBL386085,,CHEMBL386085,4.01,False,http://www.openphacts.org/units/Nanomolar,588133,=,1,True,=,,IC50,nM,,97000.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,uM,UO_0000065,,97.0
,1780978,[],CHEMBL908897,Inhibition of p53-MDM2 interaction by ELISA,B,,,BAO_0000190,BAO_0000224,protein format,CC(C)(C)c1ccc(COC2(c3ccccc3)c3ccccc3C(=O)N2CCc2c[nH]cn2)cc1,Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL1137314,J. Med. Chem.,2006,,CHEMBL216799,,CHEMBL216799,,False,http://www.openphacts.org/units/Nanomolar,588132,=,1,True,=,,IC50,nM,,214000.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,uM,UO_0000065,,214.0
,1780979,[],CHEMBL908897,Inhibition of p53-MDM2 interaction by ELISA,B,,,BAO_0000190,BAO_0000224,protein format,O=C1c2ccccc2C(OCCOc2ccccc2O)(c2ccccc2)N1Cc1ccccc1,Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL1137314,J. Med. Chem.,2006,,CHEMBL217831,,CHEMBL217831,,False,http://www.openphacts.org/units/Nanomolar,588131,=,1,True,=,,IC50,nM,,221000.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,uM,UO_0000065,,221.0
,1780980,[],CHEMBL908897,Inhibition of p53-MDM2 interaction by ELISA,B,,,BAO_0000190,BAO_0000224,protein format,O=C1c2ccccc2C(OCc2ccc(Cl)c([N+](=O)[O-])c2)(c2ccccc2)N1Cc1ccccc1,Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL1137314,J. Med. Chem.,2006,,CHEMBL384251,,CHEMBL384251,,False,http://www.openphacts.org/units/Nanomolar,588130,=,1,True,=,,IC50,nM,,206000.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,uM,UO_0000065,,206.0
,1780981,[],CHEMBL908897,Inhibition of p53-MDM2 interaction by ELISA,B,,,BAO_0000190,BAO_0000224,protein format,O=C1c2ccccc2C(OCc2cccc(O)c2)(c2ccccc2)N1Cc1ccccc1,,,CHEMBL1137314,J. Med. Chem.,2006,"{'bei': '10.05', 'le': '0.18', 'lle': '-1.23', 'sei': '8.51'}",CHEMBL214545,,CHEMBL214545,4.24,False,http://www.openphacts.org/units/Nanomolar,588129,=,1,True,=,,IC50,nM,,58000.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,uM,UO_0000065,,58.0
,1780982,[],CHEMBL908897,Inhibition of p53-MDM2 interaction by ELISA,B,,,BAO_0000190,BAO_0000224,protein format,O=C1c2ccccc2C(OCCN2CCNCC2)(c2ccccc2)N1Cc1ccccc1,Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL1137314,J. Med. Chem.,2006,,CHEMBL385387,,CHEMBL385387,,False,http://www.openphacts.org/units/Nanomolar,588128,=,1,True,=,,IC50,nM,,315000.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,uM,UO_0000065,,315.0
,1780983,[],CHEMBL908897,Inhibition of p53-MDM2 interaction by ELISA,B,,,BAO_0000190,BAO_0000224,protein format,CC(=O)NCCOC1(c2ccccc2)c2ccccc2C(=O)N1Cc1ccccc1,Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL1137314,J. Med. Chem.,2006,,CHEMBL216487,,CHEMBL216487,,False,http://www.openphacts.org/units/Nanomolar,588127,=,1,True,=,,IC50,nM,,281000.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,uM,UO_0000065,,281.0
,1780984,[],CHEMBL908897,Inhibition of p53-MDM2 interaction by ELISA,B,,,BAO_0000190,BAO_0000224,protein format,COc1ccc(CCOC2(c3ccccc3)c3ccccc3C(=O)N2Cc2ccccc2)cc1OC,Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL1137314,J. Med. Chem.,2006,,CHEMBL217146,,CHEMBL217146,,False,http://www.openphacts.org/units/Nanomolar,588126,=,1,True,=,,IC50,nM,,311000.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,uM,UO_0000065,,311.0
,1780985,[],CHEMBL908897,Inhibition of p53-MDM2 interaction by ELISA,B,,,BAO_0000190,BAO_0000224,protein format,O=C1c2ccccc2C(OCc2ccc(O)cc2)(c2ccccc2)N1Cc1ccccc1,,,CHEMBL1137314,J. Med. Chem.,2006,"{'bei': '9.73', 'le': '0.18', 'lle': '-1.37', 'sei': '8.24'}",CHEMBL214459,,CHEMBL214459,4.10,False,http://www.openphacts.org/units/Nanomolar,588125,=,1,True,=,,IC50,nM,,79000.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,uM,UO_0000065,,79.0
,1780986,[],CHEMBL908897,Inhibition of p53-MDM2 interaction by ELISA,B,,,BAO_0000190,BAO_0000224,protein format,CCCCc1nc(COC2(c3ccccc3)c3ccccc3C(=O)N2Cc2ccccc2)c[nH]1,,,CHEMBL1137314,J. Med. Chem.,2006,"{'bei': '9.10', 'le': '0.17', 'lle': '-1.72', 'sei': '7.06'}",CHEMBL424731,,CHEMBL424731,4.11,False,http://www.openphacts.org/units/Nanomolar,588124,=,1,True,=,,IC50,nM,,78000.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,uM,UO_0000065,,78.0
,1780987,[],CHEMBL908897,Inhibition of p53-MDM2 interaction by ELISA,B,,,BAO_0000190,BAO_0000224,protein format,C=CC(=O)OCCOC1(c2ccccc2)c2ccccc2C(=O)N1Cc1ccccc1,Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL1137314,J. Med. Chem.,2006,,CHEMBL217054,,CHEMBL217054,,False,http://www.openphacts.org/units/Nanomolar,588123,=,1,True,=,,IC50,nM,,439000.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,uM,UO_0000065,,439.0
,1780988,[],CHEMBL908897,Inhibition of p53-MDM2 interaction by ELISA,B,,,BAO_0000190,BAO_0000224,protein format,O=C1CCCN1CCOC1(c2ccccc2)c2ccccc2C(=O)N1Cc1ccccc1,Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL1137314,J. Med. Chem.,2006,,CHEMBL386804,,CHEMBL386804,,False,http://www.openphacts.org/units/Nanomolar,588122,=,1,True,=,,IC50,nM,,393000.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,uM,UO_0000065,,393.0
,1780989,[],CHEMBL908897,Inhibition of p53-MDM2 interaction by ELISA,B,,,BAO_0000190,BAO_0000224,protein format,C=C(C)C(=O)OCCN1C(=O)c2ccccc2C1(N[C@@H](CO)[C@@H](O)c1ccccc1)c1ccccc1,Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL1137314,J. Med. Chem.,2006,,CHEMBL214623,,CHEMBL214623,,False,http://www.openphacts.org/units/Nanomolar,588159,=,1,True,=,,IC50,nM,,103000.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,uM,UO_0000065,,103.0
,1780990,[],CHEMBL908897,Inhibition of p53-MDM2 interaction by ELISA,B,,,BAO_0000190,BAO_0000224,protein format,CC(=O)NCCN1C(=O)c2ccccc2C1(OCc1ccc(C(C)(C)C)cc1)c1ccccc1,,,CHEMBL1137314,J. Med. Chem.,2006,"{'bei': '10.60', 'le': '0.19', 'lle': '-0.15', 'sei': '8.26'}",CHEMBL360141,,CHEMBL360141,4.84,False,http://www.openphacts.org/units/Nanomolar,588158,=,1,True,=,,IC50,nM,,14400.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,uM,UO_0000065,,14.4
,1780991,[],CHEMBL908897,Inhibition of p53-MDM2 interaction by ELISA,B,,,BAO_0000190,BAO_0000224,protein format,CCCN1C(=O)c2ccccc2C1(OCc1cc([N+](=O)[O-])c(C)c([N+](=O)[O-])c1)c1ccc(OCOCC[Si](C)(C)C)cc1,Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL1137314,J. Med. Chem.,2006,,CHEMBL438472,,CHEMBL438472,,False,http://www.openphacts.org/units/Nanomolar,588157,=,1,True,=,,IC50,nM,,103000.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,uM,UO_0000065,,103.0
,1780992,[],CHEMBL908897,Inhibition of p53-MDM2 interaction by ELISA,B,,,BAO_0000190,BAO_0000224,protein format,CCCN1C(=O)c2ccccc2C1(OCc1[nH]cnc1C)c1ccc(C(C)(C)C)cc1,,,CHEMBL1137314,J. Med. Chem.,2006,"{'bei': '10.04', 'le': '0.18', 'lle': '-1.11', 'sei': '7.20'}",CHEMBL264505,,CHEMBL264505,4.19,False,http://www.openphacts.org/units/Nanomolar,588156,=,1,True,=,,IC50,nM,,64300.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,uM,UO_0000065,,64.3
,1780993,[],CHEMBL908897,Inhibition of p53-MDM2 interaction by ELISA,B,,,BAO_0000190,BAO_0000224,protein format,CCCN1C(=O)c2ccccc2C1(OCCN1CCNC1=O)c1ccc(C(C)(C)C)cc1,,,CHEMBL1137314,J. Med. Chem.,2006,"{'bei': '9.48', 'le': '0.18', 'lle': '0.04', 'sei': '6.67'}",CHEMBL217399,,CHEMBL217399,4.13,False,http://www.openphacts.org/units/Nanomolar,588155,=,1,True,=,,IC50,nM,,74300.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,uM,UO_0000065,,74.3
,1780994,[],CHEMBL908897,Inhibition of p53-MDM2 interaction by ELISA,B,,,BAO_0000190,BAO_0000224,protein format,CCCN1C(=O)c2ccccc2C1(OCCc1ccc(O)cc1)c1ccc(C(C)(C)C)cc1,,,CHEMBL1137314,J. Med. Chem.,2006,"{'bei': '9.37', 'le': '0.17', 'lle': '-1.86', 'sei': '8.35'}",CHEMBL217774,,CHEMBL217774,4.16,False,http://www.openphacts.org/units/Nanomolar,588154,=,1,True,=,,IC50,nM,,69700.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,uM,UO_0000065,,69.7
,1780995,[],CHEMBL908897,Inhibition of p53-MDM2 interaction by ELISA,B,,,BAO_0000190,BAO_0000224,protein format,CCCN1C(=O)c2ccccc2C1(OCc1cc2c(cc1[N+](=O)[O-])OCO2)c1ccc(C(C)(C)C)cc1,,,CHEMBL1137314,J. Med. Chem.,2006,"{'bei': '8.26', 'le': '0.15', 'lle': '-1.75', 'sei': '4.56'}",CHEMBL218294,,CHEMBL218294,4.15,False,http://www.openphacts.org/units/Nanomolar,588153,=,1,True,=,,IC50,nM,,70200.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,uM,UO_0000065,,70.2
,1780996,[],CHEMBL908897,Inhibition of p53-MDM2 interaction by ELISA,B,,,BAO_0000190,BAO_0000224,protein format,CCCN1C(=O)c2ccccc2C1(OCCNC(=O)c1ccccc1O)c1ccc(C(C)(C)C)cc1,,,CHEMBL1137314,J. Med. Chem.,2006,"{'bei': '8.54', 'le': '0.16', 'lle': '-1.05', 'sei': '5.27'}",CHEMBL216364,,CHEMBL216364,4.15,False,http://www.openphacts.org/units/Nanomolar,588152,=,1,True,=,,IC50,nM,,70100.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,uM,UO_0000065,,70.1
,1780997,[],CHEMBL908897,Inhibition of p53-MDM2 interaction by ELISA,B,,,BAO_0000190,BAO_0000224,protein format,CCCN1C(=O)c2ccccc2C1(OCCS(C)(=O)=O)c1ccc(C(C)(C)C)cc1,Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL1137314,J. Med. Chem.,2006,,CHEMBL217718,,CHEMBL217718,,False,http://www.openphacts.org/units/Nanomolar,588151,=,1,True,=,,IC50,nM,,290000.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,uM,UO_0000065,,290.0
,1780998,[],CHEMBL908897,Inhibition of p53-MDM2 interaction by ELISA,B,,,BAO_0000190,BAO_0000224,protein format,CCCOC1(c2ccccc2)c2ccccc2C(=O)N1CCCC(OC)OC,,,CHEMBL1137314,J. Med. Chem.,2006,"{'bei': '10.83', 'le': '0.20', 'lle': '-0.02', 'sei': '8.66'}",CHEMBL384464,,CHEMBL384464,4.16,False,http://www.openphacts.org/units/Nanomolar,588150,=,1,True,=,,IC50,nM,,70000.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,uM,UO_0000065,,70.0
,1780999,[],CHEMBL908897,Inhibition of p53-MDM2 interaction by ELISA,B,,,BAO_0000190,BAO_0000224,protein format,CCCOC1(c2ccccc2)c2ccccc2C(=O)N1CCO,Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL1137314,J. Med. Chem.,2006,,CHEMBL386911,,CHEMBL386911,,False,http://www.openphacts.org/units/Nanomolar,588149,>,1,True,>,,IC50,nM,,500000.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,uM,UO_0000065,,500.0
,1781000,[],CHEMBL908897,Inhibition of p53-MDM2 interaction by ELISA,B,,,BAO_0000190,BAO_0000224,protein format,COC(=O)C(Cc1ccc(O)cc1)N1C(=O)c2ccccc2C1(OCCOC(C)=O)c1ccccc1,Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL1137314,J. Med. Chem.,2006,,CHEMBL213917,,CHEMBL213917,,False,http://www.openphacts.org/units/Nanomolar,588148,=,1,True,=,,IC50,nM,,380000.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,uM,UO_0000065,,380.0
,1781001,[],CHEMBL908897,Inhibition of p53-MDM2 interaction by ELISA,B,,,BAO_0000190,BAO_0000224,protein format,COC(=O)C(Cc1ccc(O)cc1)N1C(=O)c2ccccc2C1(OCCn1c([N+](=O)[O-])cnc1C)c1ccccc1,Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL1137314,J. Med. Chem.,2006,,CHEMBL387279,,CHEMBL387279,,False,http://www.openphacts.org/units/Nanomolar,588147,=,1,True,=,,IC50,nM,,275000.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,uM,UO_0000065,,275.0
,1781002,[],CHEMBL908897,Inhibition of p53-MDM2 interaction by ELISA,B,,,BAO_0000190,BAO_0000224,protein format,COC(=O)C(Cc1ccc(O)cc1)N1C(=O)c2ccccc2C1(OCCN(CCC#N)c1ccccc1)c1ccccc1,,,CHEMBL1137314,J. Med. Chem.,2006,"{'bei': '7.04', 'le': '0.13', 'lle': '-1.21', 'sei': '3.93'}",CHEMBL386519,,CHEMBL386519,4.06,False,http://www.openphacts.org/units/Nanomolar,588146,=,1,True,=,,IC50,nM,,88000.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,uM,UO_0000065,,88.0
,1781003,[],CHEMBL908897,Inhibition of p53-MDM2 interaction by ELISA,B,,,BAO_0000190,BAO_0000224,protein format,CCCOC1(c2ccccc2)c2ccccc2C(=O)N1Cc1ccc(OC)cc1,Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL1137314,J. Med. Chem.,2006,,CHEMBL215683,,CHEMBL215683,,False,http://www.openphacts.org/units/Nanomolar,588145,=,1,True,=,,IC50,nM,,413000.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,uM,UO_0000065,,413.0
,1781004,[],CHEMBL908897,Inhibition of p53-MDM2 interaction by ELISA,B,,,BAO_0000190,BAO_0000224,protein format,COc1ccc([C@@H](O)COC2(c3ccccc3)c3ccccc3C(=O)N2Cc2ccco2)cc1,Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL1137314,J. Med. Chem.,2006,,CHEMBL216341,,CHEMBL216341,,False,http://www.openphacts.org/units/Nanomolar,588144,=,1,True,=,,IC50,nM,,181000.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,uM,UO_0000065,,181.0
,1781005,[],CHEMBL908897,Inhibition of p53-MDM2 interaction by ELISA,B,,,BAO_0000190,BAO_0000224,protein format,COc1cc(COC2(c3ccc(OCOCC[Si](C)(C)C)cc3)c3ccccc3C(=O)N2Cc2ccccc2)cc(OC)c1O,Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL1137314,J. Med. Chem.,2006,,CHEMBL362410,,CHEMBL362410,,False,http://www.openphacts.org/units/Nanomolar,588180,=,1,True,=,,IC50,nM,,257000.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,uM,UO_0000065,,257.0
,1781006,[],CHEMBL908897,Inhibition of p53-MDM2 interaction by ELISA,B,,,BAO_0000190,BAO_0000224,protein format,CCCN1C(=O)c2ccccc2C1(OCCc1ccccn1)c1ccc(OCOCC[Si](C)(C)C)cc1,Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL1137314,J. Med. Chem.,2006,,CHEMBL426784,,CHEMBL426784,,False,http://www.openphacts.org/units/Nanomolar,588179,=,1,True,=,,IC50,nM,,312000.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,uM,UO_0000065,,312.0
,1781007,[],CHEMBL908897,Inhibition of p53-MDM2 interaction by ELISA,B,,,BAO_0000190,BAO_0000224,protein format,C[Si](C)(C)CCOCOc1ccc(C2(OCCCO)c3ccccc3C(=O)N2Cc2ccccc2)cc1,Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL1137314,J. Med. Chem.,2006,,CHEMBL385595,,CHEMBL385595,,False,http://www.openphacts.org/units/Nanomolar,588178,=,1,True,=,,IC50,nM,,476000.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,uM,UO_0000065,,476.0
,1781008,[],CHEMBL908897,Inhibition of p53-MDM2 interaction by ELISA,B,,,BAO_0000190,BAO_0000224,protein format,CCCN1C(=O)c2ccccc2C1(OCc1cc(OC)c(O)c(OC)c1)c1ccc(OCOCC[Si](C)(C)C)cc1,Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL1137314,J. Med. Chem.,2006,,CHEMBL361630,,CHEMBL361630,,False,http://www.openphacts.org/units/Nanomolar,588177,=,1,True,=,,IC50,nM,,118000.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,uM,UO_0000065,,118.0
,1781009,[],CHEMBL908897,Inhibition of p53-MDM2 interaction by ELISA,B,,,BAO_0000190,BAO_0000224,protein format,CCCN1C(=O)c2ccccc2C1(OCc1ccc(C(C)(C)C)cc1)c1ccc(OCOCC[Si](C)(C)C)cc1,Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL1137314,J. Med. Chem.,2006,,CHEMBL178215,,CHEMBL178215,,False,http://www.openphacts.org/units/Nanomolar,588176,=,1,True,=,,IC50,nM,,464000.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,uM,UO_0000065,,464.0
,1781010,[],CHEMBL908897,Inhibition of p53-MDM2 interaction by ELISA,B,,,BAO_0000190,BAO_0000224,protein format,COc1cc(COC2(c3ccc(Cl)cc3)c3ccccc3C(=O)N2CCNC(C)=O)cc(OC)c1O,,,CHEMBL1137314,J. Med. Chem.,2006,"{'bei': '8.06', 'le': '0.16', 'lle': '0.05', 'sei': '4.23'}",CHEMBL179339,,CHEMBL179339,4.12,False,http://www.openphacts.org/units/Nanomolar,588175,=,1,True,=,,IC50,nM,,76000.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,uM,UO_0000065,,76.0
,1781011,[],CHEMBL908897,Inhibition of p53-MDM2 interaction by ELISA,B,,,BAO_0000190,BAO_0000224,protein format,CC(=O)NCCN1C(=O)c2ccccc2C1(OCc1ccc(C(C)(C)C)cc1)c1ccc(Cl)cc1,,,CHEMBL1137314,J. Med. Chem.,2006,"{'bei': '8.23', 'le': '0.16', 'lle': '-1.61', 'sei': '6.89'}",CHEMBL361354,,CHEMBL361354,4.04,False,http://www.openphacts.org/units/Nanomolar,588174,=,1,True,=,,IC50,nM,,91400.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,uM,UO_0000065,,91.4
,1781012,[],CHEMBL908897,Inhibition of p53-MDM2 interaction by ELISA,B,,,BAO_0000190,BAO_0000224,protein format,CCCN1C(=O)c2ccccc2C1(OCCc1ccccn1)c1ccc(Cl)cc1,,,CHEMBL1137314,J. Med. Chem.,2006,"{'bei': '10.43', 'le': '0.20', 'lle': '-0.82', 'sei': '10.00'}",CHEMBL362614,,CHEMBL362614,4.24,False,http://www.openphacts.org/units/Nanomolar,588173,=,1,True,=,,IC50,nM,,57000.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,uM,UO_0000065,,57.0
,1781013,[],CHEMBL908897,Inhibition of p53-MDM2 interaction by ELISA,B,,,BAO_0000190,BAO_0000224,protein format,CCCN1C(=O)c2ccccc2C1(OCCCO)c1ccc(Cl)cc1,,,CHEMBL1137314,J. Med. Chem.,2006,"{'bei': '13.30', 'le': '0.26', 'lle': '0.98', 'sei': '9.61'}",CHEMBL433949,,CHEMBL433949,4.79,False,http://www.openphacts.org/units/Nanomolar,588172,=,1,True,=,,IC50,nM,,16400.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,uM,UO_0000065,,16.4
,1781014,[],CHEMBL908897,Inhibition of p53-MDM2 interaction by ELISA,B,,,BAO_0000190,BAO_0000224,protein format,CCCN1C(=O)c2ccccc2C1(OCc1cc(OC)c(O)c(OC)c1)c1ccc(Cl)cc1,,,CHEMBL1137314,J. Med. Chem.,2006,"{'bei': '11.27', 'le': '0.22', 'lle': '-0.07', 'sei': '7.73'}",CHEMBL360944,,CHEMBL360944,5.28,False,http://www.openphacts.org/units/Nanomolar,588171,=,1,True,=,,IC50,nM,,5300.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,uM,UO_0000065,,5.3
,1781015,[],CHEMBL908897,Inhibition of p53-MDM2 interaction by ELISA,B,,,BAO_0000190,BAO_0000224,protein format,CCCN1C(=O)c2ccccc2C1(OCc1ccc(C(C)(C)C)cc1)c1ccc(Cl)cc1,Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL1137314,J. Med. Chem.,2006,,CHEMBL361345,,CHEMBL361345,,False,http://www.openphacts.org/units/Nanomolar,588170,=,1,True,=,,IC50,nM,,187000.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,uM,UO_0000065,,187.0
,1781016,[],CHEMBL908897,Inhibition of p53-MDM2 interaction by ELISA,B,,,BAO_0000190,BAO_0000224,protein format,O=C1c2ccccc2C(OCCc2ccccn2)(c2ccc(Cl)cc2)N1Cc1ccccc1,,,CHEMBL1137314,J. Med. Chem.,2006,"{'bei': '10.07', 'le': '0.19', 'lle': '-1.27', 'sei': '10.80'}",CHEMBL361115,,CHEMBL361115,4.58,False,http://www.openphacts.org/units/Nanomolar,588169,=,1,True,=,,IC50,nM,,26200.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,uM,UO_0000065,,26.2
,1781017,[],CHEMBL908897,Inhibition of p53-MDM2 interaction by ELISA,B,,,BAO_0000190,BAO_0000224,protein format,O=C1c2ccccc2C(OCCCO)(c2ccc(Cl)cc2)N1Cc1ccccc1,,,CHEMBL1137314,J. Med. Chem.,2006,"{'bei': '11.76', 'le': '0.23', 'lle': '0.20', 'sei': '9.64'}",CHEMBL360719,,CHEMBL360719,4.80,False,http://www.openphacts.org/units/Nanomolar,588168,=,1,True,=,,IC50,nM,,15900.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,uM,UO_0000065,,15.9
,1781018,[],CHEMBL908897,Inhibition of p53-MDM2 interaction by ELISA,B,,,BAO_0000190,BAO_0000224,protein format,COc1cc(COC2(c3ccc(Cl)cc3)c3ccccc3C(=O)N2Cc2ccccc2)cc(OC)c1O,,,CHEMBL1137314,J. Med. Chem.,2006,"{'bei': '8.48', 'le': '0.16', 'lle': '-1.76', 'sei': '6.41'}",CHEMBL181083,,CHEMBL181083,4.38,False,http://www.openphacts.org/units/Nanomolar,588167,=,1,True,=,,IC50,nM,,42000.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,uM,UO_0000065,,42.0
,1781019,[],CHEMBL908897,Inhibition of p53-MDM2 interaction by ELISA,B,,,BAO_0000190,BAO_0000224,protein format,CC(C)(C)c1ccc(COC2(c3ccc(Cl)cc3)c3ccccc3C(=O)N2Cc2ccccc2)cc1,,,CHEMBL1137314,J. Med. Chem.,2006,"{'bei': '8.07', 'le': '0.15', 'lle': '-3.71', 'sei': '13.56'}",CHEMBL180862,,CHEMBL180862,4.00,False,http://www.openphacts.org/units/Nanomolar,588166,=,1,True,=,,IC50,nM,,99000.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,uM,UO_0000065,,99.0
,1781020,[],CHEMBL908897,Inhibition of p53-MDM2 interaction by ELISA,B,,,BAO_0000190,BAO_0000224,protein format,CCCN1C(=O)c2ccccc2C1(OCCc1ccccn1)c1ccccc1,,,CHEMBL1137314,J. Med. Chem.,2006,"{'bei': '10.74', 'le': '0.20', 'lle': '-0.41', 'sei': '9.43'}",CHEMBL178504,,CHEMBL178504,4.00,False,http://www.openphacts.org/units/Nanomolar,588165,=,1,True,=,,IC50,nM,,100000.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,uM,UO_0000065,,100.0
,1781021,[],CHEMBL908897,Inhibition of p53-MDM2 interaction by ELISA,B,,,BAO_0000190,BAO_0000224,protein format,CCCN1C(=O)c2ccccc2C1(OCCCO)c1ccccc1,Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL1137314,J. Med. Chem.,2006,,CHEMBL178320,,CHEMBL178320,,False,http://www.openphacts.org/units/Nanomolar,588164,>,1,True,>,,IC50,nM,,500000.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,uM,UO_0000065,,500.0
,1781022,[],CHEMBL908897,Inhibition of p53-MDM2 interaction by ELISA,B,,,BAO_0000190,BAO_0000224,protein format,CCCN1C(=O)c2ccccc2C1(OCc1cc(OC)c(O)c(OC)c1)c1ccccc1,,,CHEMBL1137314,J. Med. Chem.,2006,"{'bei': '9.43', 'le': '0.17', 'lle': '-0.60', 'sei': '5.99'}",CHEMBL362452,,CHEMBL362452,4.09,False,http://www.openphacts.org/units/Nanomolar,588163,=,1,True,=,,IC50,nM,,82000.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,uM,UO_0000065,,82.0
,1781023,[],CHEMBL908897,Inhibition of p53-MDM2 interaction by ELISA,B,,,BAO_0000190,BAO_0000224,protein format,CCCN1C(=O)c2ccccc2C1(OCc1ccc(C(C)(C)C)cc1)c1ccccc1,Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL1137314,J. Med. Chem.,2006,,CHEMBL180579,,CHEMBL180579,,False,http://www.openphacts.org/units/Nanomolar,588162,>,1,True,>,,IC50,nM,,500000.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,uM,UO_0000065,,500.0
,1781024,[],CHEMBL908897,Inhibition of p53-MDM2 interaction by ELISA,B,,,BAO_0000190,BAO_0000224,protein format,O=C1c2ccccc2C(OCCc2ccccn2)(c2ccccc2)N1Cc1ccccc1,Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL1137314,J. Med. Chem.,2006,,CHEMBL368017,,CHEMBL368017,,False,http://www.openphacts.org/units/Nanomolar,588161,=,1,True,=,,IC50,nM,,206000.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,uM,UO_0000065,,206.0
,1781025,[],CHEMBL908897,Inhibition of p53-MDM2 interaction by ELISA,B,,,BAO_0000190,BAO_0000224,protein format,O=C1c2ccccc2C(OCCCO)(c2ccccc2)N1Cc1ccccc1,Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL1137314,J. Med. Chem.,2006,,CHEMBL180866,,CHEMBL180866,,False,http://www.openphacts.org/units/Nanomolar,588160,=,1,True,=,,IC50,nM,,245000.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,uM,UO_0000065,,245.0
,1781026,[],CHEMBL908897,Inhibition of p53-MDM2 interaction by ELISA,B,,,BAO_0000190,BAO_0000224,protein format,O=C1c2ccccc2C(OC/C=C/c2ccccc2)(c2ccccc2)N1Cc1ccccc1,Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL1137314,J. Med. Chem.,2006,,CHEMBL439349,,CHEMBL439349,,False,http://www.openphacts.org/units/Nanomolar,588181,=,1,True,=,,IC50,nM,,334000.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,uM,UO_0000065,,334.0
,1781027,[],CHEMBL908897,Inhibition of p53-MDM2 interaction by ELISA,B,,,BAO_0000190,BAO_0000224,protein format,CCCOC1(c2ccccc2)c2ccccc2C(=O)N1[C@@H](CCCCN)C(=O)OC,,,CHEMBL1137314,J. Med. Chem.,2006,"{'bei': '9.99', 'le': '0.19', 'lle': '0.66', 'sei': '5.01'}",CHEMBL384376,,CHEMBL384376,4.10,False,http://www.openphacts.org/units/Nanomolar,588186,=,1,True,=,,IC50,nM,,79000.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,uM,UO_0000065,,79.0
,1781028,[],CHEMBL908897,Inhibition of p53-MDM2 interaction by ELISA,B,,,BAO_0000190,BAO_0000224,protein format,CCCOC1(c2ccccc2)c2ccccc2C(=O)N1[C@H](C(=O)OC)c1ccc(O)cc1,,,CHEMBL1137314,J. Med. Chem.,2006,"{'bei': '9.38', 'le': '0.17', 'lle': '-0.34', 'sei': '5.32'}",CHEMBL441538,,CHEMBL441538,4.05,False,http://www.openphacts.org/units/Nanomolar,588185,=,1,True,=,,IC50,nM,,90000.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,uM,UO_0000065,,90.0
,1781029,[],CHEMBL908897,Inhibition of p53-MDM2 interaction by ELISA,B,,,BAO_0000190,BAO_0000224,protein format,O=C1c2ccccc2C(OCCN2CCOCC2)(c2ccccc2)N1Cc1ccccc1,Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL1137314,J. Med. Chem.,2006,,CHEMBL384995,,CHEMBL384995,,False,http://www.openphacts.org/units/Nanomolar,588182,>,1,True,>,,IC50,nM,,500000.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,uM,UO_0000065,,500.0
,1781030,[],CHEMBL908897,Inhibition of p53-MDM2 interaction by ELISA,B,,,BAO_0000190,BAO_0000224,protein format,O=C1c2ccccc2C(OCc2ccco2)(c2ccccc2)N1Cc1ccccc1,Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL1137314,J. Med. Chem.,2006,,CHEMBL438289,,CHEMBL438289,,False,http://www.openphacts.org/units/Nanomolar,588183,>,1,True,>,,IC50,nM,,500000.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,uM,UO_0000065,,500.0
,1781031,[],CHEMBL908897,Inhibition of p53-MDM2 interaction by ELISA,B,,,BAO_0000190,BAO_0000224,protein format,O=C1c2ccccc2C(OCCc2ccccc2)(c2ccccc2)N1Cc1ccccc1,Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL1137314,J. Med. Chem.,2006,,CHEMBL214430,,CHEMBL214430,,False,http://www.openphacts.org/units/Nanomolar,588184,>,1,True,>,,IC50,nM,,500000.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,uM,UO_0000065,,500.0
,1781032,[],CHEMBL908897,Inhibition of p53-MDM2 interaction by ELISA,B,,,BAO_0000190,BAO_0000224,protein format,COC(=O)[C@@H](C)COC1(c2ccccc2)c2ccccc2C(=O)N1Cc1ccccc1,Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL1137314,J. Med. Chem.,2006,,CHEMBL437916,,CHEMBL437916,,False,http://www.openphacts.org/units/Nanomolar,588193,=,1,True,=,,IC50,nM,,330000.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,uM,UO_0000065,,330.0
,1781033,[],CHEMBL908897,Inhibition of p53-MDM2 interaction by ELISA,B,,,BAO_0000190,BAO_0000224,protein format,C=CCNC(=S)NCCOC1(c2ccccc2)c2ccccc2C(=O)N1Cc1ccccc1,Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL1137314,J. Med. Chem.,2006,,CHEMBL216416,,CHEMBL216416,,False,http://www.openphacts.org/units/Nanomolar,588192,=,1,True,=,,IC50,nM,,408000.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,uM,UO_0000065,,408.0
,1781034,[],CHEMBL908897,Inhibition of p53-MDM2 interaction by ELISA,B,,,BAO_0000190,BAO_0000224,protein format,O=C(NCCOC1(c2ccccc2)c2ccccc2C(=O)N1Cc1ccccc1)c1ccncc1,Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL1137314,J. Med. Chem.,2006,,CHEMBL217043,,CHEMBL217043,,False,http://www.openphacts.org/units/Nanomolar,588191,=,1,True,=,,IC50,nM,,278000.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,uM,UO_0000065,,278.0
,1781035,[],CHEMBL908897,Inhibition of p53-MDM2 interaction by ELISA,B,,,BAO_0000190,BAO_0000224,protein format,O=C1c2ccccc2C(OCCNC(=O)C(F)(F)F)(c2ccccc2)N1Cc1ccccc1,Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL1137314,J. Med. Chem.,2006,,CHEMBL217719,,CHEMBL217719,,False,http://www.openphacts.org/units/Nanomolar,588190,=,1,True,=,,IC50,nM,,409000.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,uM,UO_0000065,,409.0
,1781036,[],CHEMBL908897,Inhibition of p53-MDM2 interaction by ELISA,B,,,BAO_0000190,BAO_0000224,protein format,O=C1c2ccccc2C(=O)N1CCCOC1(c2ccccc2)c2ccccc2C(=O)N1Cc1ccccc1,Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL1137314,J. Med. Chem.,2006,,CHEMBL384875,,CHEMBL384875,,False,http://www.openphacts.org/units/Nanomolar,588189,=,1,True,=,,IC50,nM,,189000.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,uM,UO_0000065,,189.0
,1781037,[],CHEMBL908897,Inhibition of p53-MDM2 interaction by ELISA,B,,,BAO_0000190,BAO_0000224,protein format,O=C1CCC(=O)N1CCOC1(c2ccccc2)c2ccccc2C(=O)N1Cc1ccccc1,Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL1137314,J. Med. Chem.,2006,,CHEMBL213918,,CHEMBL213918,,False,http://www.openphacts.org/units/Nanomolar,588188,=,1,True,=,,IC50,nM,,284000.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,uM,UO_0000065,,284.0
,1781038,[],CHEMBL908897,Inhibition of p53-MDM2 interaction by ELISA,B,,,BAO_0000190,BAO_0000224,protein format,O=C1c2ccccc2C(=O)N1CCOC1(c2ccccc2)c2ccccc2C(=O)N1Cc1ccccc1,Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL1137314,J. Med. Chem.,2006,,CHEMBL214460,,CHEMBL214460,,False,http://www.openphacts.org/units/Nanomolar,588187,=,1,True,=,,IC50,nM,,152000.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,uM,UO_0000065,,152.0
,1781039,[],CHEMBL908897,Inhibition of p53-MDM2 interaction by ELISA,B,,,BAO_0000190,BAO_0000224,protein format,CCOC(=O)CCC(NC1(c2ccccc2)c2ccccc2C(=O)N1Cc1ccccc1)C(=O)OCC,Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL1137314,J. Med. Chem.,2006,,CHEMBL216211,,CHEMBL216211,,False,http://www.openphacts.org/units/Nanomolar,588204,>,1,True,>,,IC50,nM,,500000.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,uM,UO_0000065,,500.0
,1781040,[],CHEMBL908897,Inhibition of p53-MDM2 interaction by ELISA,B,,,BAO_0000190,BAO_0000224,protein format,C=C(C)C(=O)OCCNC1(c2ccccc2)c2ccccc2C(=O)N1Cc1ccccc1,Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL1137314,J. Med. Chem.,2006,,CHEMBL216358,,CHEMBL216358,,False,http://www.openphacts.org/units/Nanomolar,588203,=,1,True,=,,IC50,nM,,353000.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,uM,UO_0000065,,353.0
,1781041,[],CHEMBL908897,Inhibition of p53-MDM2 interaction by ELISA,B,,,BAO_0000190,BAO_0000224,protein format,O=C1c2ccccc2C(NCC(O)c2cccc(O)c2)(c2ccccc2)N1Cc1ccccc1,,,CHEMBL1137314,J. Med. Chem.,2006,"{'bei': '9.05', 'le': '0.16', 'lle': '-0.49', 'sei': '5.60'}",CHEMBL387183,,CHEMBL387183,4.08,False,http://www.openphacts.org/units/Nanomolar,588197,=,1,True,=,,IC50,nM,,84000.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,uM,UO_0000065,,84.0
,1781042,[],CHEMBL908897,Inhibition of p53-MDM2 interaction by ELISA,B,,,BAO_0000190,BAO_0000224,protein format,CC(NC1(c2ccccc2)c2ccccc2C(=O)N1Cc1ccccc1)C(O)c1ccc(O)cc1,Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL1137314,J. Med. Chem.,2006,,CHEMBL217248,,CHEMBL217248,,False,http://www.openphacts.org/units/Nanomolar,588196,=,1,True,=,,IC50,nM,,185000.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,uM,UO_0000065,,185.0
,1781043,[],CHEMBL908897,Inhibition of p53-MDM2 interaction by ELISA,B,,,BAO_0000190,BAO_0000224,protein format,NC(=O)COC1(c2ccccc2)c2ccccc2C(=O)N1Cc1ccccc1,Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL1137314,J. Med. Chem.,2006,,CHEMBL217488,,CHEMBL217488,,False,http://www.openphacts.org/units/Nanomolar,588194,>,1,True,>,,IC50,nM,,500000.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,uM,UO_0000065,,500.0
,1781044,[],CHEMBL908897,Inhibition of p53-MDM2 interaction by ELISA,B,,,BAO_0000190,BAO_0000224,protein format,CC(=O)NCCNC1(c2ccccc2)c2ccccc2C(=O)N1Cc1ccccc1,Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL1137314,J. Med. Chem.,2006,,CHEMBL428667,,CHEMBL428667,,False,http://www.openphacts.org/units/Nanomolar,588199,>,1,True,>,,IC50,nM,,500000.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,uM,UO_0000065,,500.0
,1781045,[],CHEMBL908897,Inhibition of p53-MDM2 interaction by ELISA,B,,,BAO_0000190,BAO_0000224,protein format,COC(=O)CCNC1(c2ccccc2)c2ccccc2C(=O)N1Cc1ccccc1,Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL1137314,J. Med. Chem.,2006,,CHEMBL385829,,CHEMBL385829,,False,http://www.openphacts.org/units/Nanomolar,588198,>,1,True,>,,IC50,nM,,500000.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,uM,UO_0000065,,500.0
,1781046,[],CHEMBL908897,Inhibition of p53-MDM2 interaction by ELISA,B,,,BAO_0000190,BAO_0000224,protein format,O=C1c2ccccc2C(NCC(O)c2ccc(O)cc2)(c2ccccc2)N1Cc1ccccc1,Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL1137314,J. Med. Chem.,2006,,CHEMBL385219,,CHEMBL385219,,False,http://www.openphacts.org/units/Nanomolar,588195,=,1,True,=,,IC50,nM,,227000.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,uM,UO_0000065,,227.0
,1781047,[],CHEMBL908897,Inhibition of p53-MDM2 interaction by ELISA,B,,,BAO_0000190,BAO_0000224,protein format,O=C1c2ccccc2C(NC(CO)C(O)c2ccccc2)(c2ccccc2)N1Cc1ccccc1,,,CHEMBL1137314,J. Med. Chem.,2006,"{'bei': '8.76', 'le': '0.16', 'lle': '-0.16', 'sei': '5.59'}",CHEMBL215009,,CHEMBL215009,4.07,False,http://www.openphacts.org/units/Nanomolar,588200,=,1,True,=,,IC50,nM,,85000.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,uM,UO_0000065,,85.0
,1781048,[],CHEMBL908897,Inhibition of p53-MDM2 interaction by ELISA,B,,,BAO_0000190,BAO_0000224,protein format,O=C1c2ccccc2C(NCCO)(c2ccccc2)N1Cc1ccccc1,Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL1137314,J. Med. Chem.,2006,,CHEMBL217044,,CHEMBL217044,,False,http://www.openphacts.org/units/Nanomolar,588202,>,1,True,>,,IC50,nM,,500000.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,uM,UO_0000065,,500.0
,1781049,[],CHEMBL908897,Inhibition of p53-MDM2 interaction by ELISA,B,,,BAO_0000190,BAO_0000224,protein format,N#CCCNC1(c2ccccc2)c2ccccc2C(=O)N1Cc1ccccc1,Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL1137314,J. Med. Chem.,2006,,CHEMBL216139,,CHEMBL216139,,False,http://www.openphacts.org/units/Nanomolar,588201,=,1,True,=,,IC50,nM,,190000.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,uM,UO_0000065,,190.0
,1781058,[],CHEMBL908897,Inhibition of p53-MDM2 interaction by ELISA,B,,,BAO_0000190,BAO_0000224,protein format,CCCOC1(c2ccccc2)c2ccccc2C(=O)N1CCC,Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL1137314,J. Med. Chem.,2006,,CHEMBL360160,,CHEMBL360160,,False,http://www.openphacts.org/units/Nanomolar,588207,>,1,True,>,,IC50,nM,,200000.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,uM,UO_0000065,,200.0
,1781059,[],CHEMBL908897,Inhibition of p53-MDM2 interaction by ELISA,B,,,BAO_0000190,BAO_0000224,protein format,CCCNC1(c2ccccc2)c2ccccc2C(=O)N1Cc1ccccc1,Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL1137314,J. Med. Chem.,2006,,CHEMBL180897,,CHEMBL180897,,False,http://www.openphacts.org/units/Nanomolar,588206,=,1,True,=,,IC50,nM,,200000.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,uM,UO_0000065,,200.0
,1781060,[],CHEMBL908897,Inhibition of p53-MDM2 interaction by ELISA,B,,,BAO_0000190,BAO_0000224,protein format,CCCOC1(c2ccccc2)c2ccccc2C(=O)N1Cc1ccccc1,Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL1137314,J. Med. Chem.,2006,,CHEMBL180048,,CHEMBL180048,,False,http://www.openphacts.org/units/Nanomolar,588205,>,1,True,>,,IC50,nM,,200000.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,uM,UO_0000065,,200.0
,2950218,[],CHEMBL1052159,Inhibition of human MDM2/P53 interaction by HTRF assay,B,,,BAO_0000190,BAO_0000224,protein format,Brc1ccc(C2Oc3ccccc3C3=C2C(c2ccc(Br)cc2)n2ncnc2N3)cc1,,,CHEMBL1154659,J. Med. Chem.,2009,"{'bei': '10.09', 'le': '0.24', 'lle': '-0.95', 'sei': '10.41'}",CHEMBL584303,,CHEMBL584303,5.41,False,http://www.openphacts.org/units/Nanomolar,852120,=,1,True,=,,IC50,nM,,3880.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,microM,UO_0000065,,3.88
,2950219,[],CHEMBL1052159,Inhibition of human MDM2/P53 interaction by HTRF assay,B,,,BAO_0000190,BAO_0000224,protein format,Brc1ccc([C@H]2C3=C(N=C4NC=NN42)c2ccccc2O[C@@H]3c2ccc(Br)cc2)cc1,,,CHEMBL1154659,J. Med. Chem.,2009,"{'bei': '11.02', 'le': '0.26', 'lle': '-0.11', 'sei': '12.01'}",CHEMBL567426,,CHEMBL567426,5.91,False,http://www.openphacts.org/units/Nanomolar,852121,=,1,True,=,,IC50,nM,,1230.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,microM,UO_0000065,,1.23
,2950220,[],CHEMBL1052159,Inhibition of human MDM2/P53 interaction by HTRF assay,B,,,BAO_0000190,BAO_0000224,protein format,Brc1ccc([C@@H]2Oc3ccccc3C3=C2[C@@H](c2ccc(Br)cc2)n2ncnc2N3)cc1,,,CHEMBL1154659,J. Med. Chem.,2009,,CHEMBL565706,,CHEMBL565706,,False,http://www.openphacts.org/units/Nanomolar,852134,>,1,True,>,,IC50,nM,,100000.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,microM,UO_0000065,,100.0
,2950221,[],CHEMBL1052159,Inhibition of human MDM2/P53 interaction by HTRF assay,B,,,BAO_0000190,BAO_0000224,protein format,Brc1ccc([C@@H]2Oc3ccccc3C3=C2[C@H](c2ccc(Br)cc2)n2ncnc2N3)cc1,,,CHEMBL1154659,J. Med. Chem.,2009,,CHEMBL584088,,CHEMBL584088,,False,http://www.openphacts.org/units/Nanomolar,851954,>,1,True,>,,IC50,nM,,100000.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,microM,UO_0000065,,100.0
,2950222,[],CHEMBL1052159,Inhibition of human MDM2/P53 interaction by HTRF assay,B,,,BAO_0000190,BAO_0000224,protein format,Brc1ccc([C@H]2Oc3ccccc3C3=C2[C@@H](c2ccc(Br)cc2)n2ncnc2N3)cc1,,,CHEMBL1154659,J. Med. Chem.,2009,,CHEMBL583427,,CHEMBL583427,,False,http://www.openphacts.org/units/Nanomolar,851975,>,1,True,>,,IC50,nM,,100000.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,microM,UO_0000065,,100.0
,2950223,[],CHEMBL1052159,Inhibition of human MDM2/P53 interaction by HTRF assay,B,,,BAO_0000190,BAO_0000224,protein format,CN1C2=C(C(c3ccc(F)cc3)Oc3ccccc32)C(c2ccc(F)cc2)n2ncnc21,,,CHEMBL1154659,J. Med. Chem.,2009,"{'bei': '11.27', 'le': '0.21', 'lle': '-0.31', 'sei': '11.19'}",CHEMBL583842,,CHEMBL583842,4.83,False,http://www.openphacts.org/units/Nanomolar,852017,=,1,True,=,,IC50,nM,,14800.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,microM,UO_0000065,,14.8
,2950224,[],CHEMBL1052159,Inhibition of human MDM2/P53 interaction by HTRF assay,B,,,BAO_0000190,BAO_0000224,protein format,CN1C2=C(C(c3ccc(Cl)cc3)Oc3ccccc32)C(c2ccc(Cl)cc2)n2ncnc21,,,CHEMBL1154659,J. Med. Chem.,2009,"{'bei': '12.83', 'le': '0.25', 'lle': '-0.25', 'sei': '13.70'}",CHEMBL584299,,CHEMBL584299,5.92,False,http://www.openphacts.org/units/Nanomolar,852039,=,1,True,=,,IC50,nM,,1210.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,microM,UO_0000065,,1.21
,2950225,[],CHEMBL1052159,Inhibition of human MDM2/P53 interaction by HTRF assay,B,,,BAO_0000190,BAO_0000224,protein format,CN1C2=C(C(c3ccc(Br)cc3)Oc3ccccc32)C(c2ccc(Br)cc2)n2ncnc21,,,CHEMBL1154659,J. Med. Chem.,2009,"{'bei': '10.78', 'le': '0.25', 'lle': '-0.46', 'sei': '13.74'}",CHEMBL568530,,CHEMBL568530,5.93,False,http://www.openphacts.org/units/Nanomolar,852073,=,1,True,=,,IC50,nM,,1170.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,microM,UO_0000065,,1.17
,2950226,[],CHEMBL1052159,Inhibition of human MDM2/P53 interaction by HTRF assay,B,,,BAO_0000190,BAO_0000224,protein format,CN1C2=C(C(c3ccc(F)cc3)Oc3ccccc32)C(c2ccc(Br)cc2)n2ncnc21,,,CHEMBL1154659,J. Med. Chem.,2009,"{'bei': '10.59', 'le': '0.22', 'lle': '-0.58', 'sei': '12.00'}",CHEMBL567635,,CHEMBL567635,5.18,False,http://www.openphacts.org/units/Nanomolar,852122,=,1,True,=,,IC50,nM,,6570.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,microM,UO_0000065,,6.57
,2950227,[],CHEMBL1052159,Inhibition of human MDM2/P53 interaction by HTRF assay,B,,,BAO_0000190,BAO_0000224,protein format,CN1C2=C(C(c3ccc(Cl)cc3)Oc3ccccc32)C(c2ccc(Br)cc2)n2ncnc21,,,CHEMBL1154659,J. Med. Chem.,2009,"{'bei': '11.96', 'le': '0.26', 'lle': '-0.23', 'sei': '14.01'}",CHEMBL567636,,CHEMBL567636,6.05,False,http://www.openphacts.org/units/Nanomolar,852123,=,1,True,=,,IC50,nM,,890.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,microM,UO_0000065,,0.89
,2950228,[],CHEMBL1052159,Inhibition of human MDM2/P53 interaction by HTRF assay,B,,,BAO_0000190,BAO_0000224,protein format,Cc1ccc(C2Oc3ccccc3C3=C2C(c2ccc(Br)cc2)n2ncnc2N3C)cc1,,,CHEMBL1154659,J. Med. Chem.,2009,"{'bei': '10.99', 'le': '0.23', 'lle': '-0.60', 'sei': '12.35'}",CHEMBL584289,,CHEMBL584289,5.33,False,http://www.openphacts.org/units/Nanomolar,851993,=,1,True,=,,IC50,nM,,4630.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,microM,UO_0000065,,4.63
,2950229,[],CHEMBL1052159,Inhibition of human MDM2/P53 interaction by HTRF assay,B,,,BAO_0000190,BAO_0000224,protein format,CN1C2=C(C(c3ccc(C#N)cc3)Oc3ccccc32)C(c2ccc(Br)cc2)n2ncnc21,,,CHEMBL1154659,J. Med. Chem.,2009,"{'bei': '11.45', 'le': '0.24', 'lle': '0.18', 'sei': '8.48'}",CHEMBL566560,,CHEMBL566560,5.68,False,http://www.openphacts.org/units/Nanomolar,851994,=,1,True,=,,IC50,nM,,2080.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,microM,UO_0000065,,2.08
,2950230,[],CHEMBL1052159,Inhibition of human MDM2/P53 interaction by HTRF assay,B,,,BAO_0000190,BAO_0000224,protein format,C#Cc1ccc(C2Oc3ccccc3C3=C2C(c2ccc(Br)cc2)n2ncnc2N3C)cc1,,,CHEMBL1154659,J. Med. Chem.,2009,"{'bei': '11.32', 'le': '0.23', 'lle': '0.00', 'sei': '12.99'}",CHEMBL584501,,CHEMBL584501,5.61,False,http://www.openphacts.org/units/Nanomolar,852074,=,1,True,=,,IC50,nM,,2470.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,microM,UO_0000065,,2.47
,2950231,[],CHEMBL1052159,Inhibition of human MDM2/P53 interaction by HTRF assay,B,,,BAO_0000190,BAO_0000224,protein format,CC#Cc1ccc(C2Oc3ccccc3C3=C2C(c2ccc(Br)cc2)n2ncnc2N3C)cc1,,,CHEMBL1154659,J. Med. Chem.,2009,"{'bei': '9.90', 'le': '0.20', 'lle': '-0.96', 'sei': '11.68'}",CHEMBL582243,,CHEMBL582243,5.04,False,http://www.openphacts.org/units/Nanomolar,852093,=,1,True,=,,IC50,nM,,9070.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,microM,UO_0000065,,9.07
,2950232,[],CHEMBL1052159,Inhibition of human MDM2/P53 interaction by HTRF assay,B,,,BAO_0000190,BAO_0000224,protein format,CCc1ccc(C2Oc3ccccc3C3=C2C(c2ccc(Br)cc2)n2ncnc2N3C)cc1,,,CHEMBL1154659,J. Med. Chem.,2009,,CHEMBL584576,,CHEMBL584576,,False,http://www.openphacts.org/units/Nanomolar,852094,>,1,True,>,,IC50,nM,,100000.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,microM,UO_0000065,,100.0
,2950233,[],CHEMBL1052159,Inhibition of human MDM2/P53 interaction by HTRF assay,B,,,BAO_0000190,BAO_0000224,protein format,CN1C2=C(C(c3ccc(Br)cc3)Oc3ccccc32)C(c2ccc(F)cc2)n2ncnc21,,,CHEMBL1154659,J. Med. Chem.,2009,"{'bei': '11.70', 'le': '0.24', 'lle': '-0.03', 'sei': '13.26'}",CHEMBL565916,,CHEMBL565916,5.73,False,http://www.openphacts.org/units/Nanomolar,852135,=,1,True,=,,IC50,nM,,1880.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,microM,UO_0000065,,1.88
,2950234,[],CHEMBL1052159,Inhibition of human MDM2/P53 interaction by HTRF assay,B,,,BAO_0000190,BAO_0000224,protein format,Cc1ccc(C2C3=C(c4ccccc4OC3c3ccc(Br)cc3)N(C)c3ncnn32)cc1,,,CHEMBL1154659,J. Med. Chem.,2009,"{'bei': '10.97', 'le': '0.23', 'lle': '-0.61', 'sei': '12.33'}",CHEMBL568519,,CHEMBL568519,5.32,False,http://www.openphacts.org/units/Nanomolar,852136,=,1,True,=,,IC50,nM,,4740.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,microM,UO_0000065,,4.74
,2950235,[],CHEMBL1052159,Inhibition of human MDM2/P53 interaction by HTRF assay,B,,,BAO_0000190,BAO_0000224,protein format,CN1C2=C(C(c3ccc(Br)cc3)Oc3ccccc32)C(c2ccc(C#N)cc2)n2ncnc21,,,CHEMBL1154659,J. Med. Chem.,2009,"{'bei': '10.54', 'le': '0.22', 'lle': '-0.27', 'sei': '7.81'}",CHEMBL568499,,CHEMBL568499,5.23,False,http://www.openphacts.org/units/Nanomolar,851955,=,1,True,=,,IC50,nM,,5840.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,microM,UO_0000065,,5.84
,2950236,[],CHEMBL1052159,Inhibition of human MDM2/P53 interaction by HTRF assay,B,,,BAO_0000190,BAO_0000224,protein format,CN1C2=C(C(c3ccc(Br)cc3)Oc3cccc(F)c32)C(c2ccc(Br)cc2)n2ncnc21,,,CHEMBL1154659,J. Med. Chem.,2009,"{'bei': '10.14', 'le': '0.24', 'lle': '-0.77', 'sei': '13.35'}",CHEMBL565262,,CHEMBL565262,5.76,False,http://www.openphacts.org/units/Nanomolar,851966,=,1,True,=,,IC50,nM,,1720.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,microM,UO_0000065,,1.72
,2950237,[],CHEMBL1052159,Inhibition of human MDM2/P53 interaction by HTRF assay,B,,,BAO_0000190,BAO_0000224,protein format,COc1cccc2c1C1=C(C(c3ccc(Br)cc3)O2)C(c2ccc(Br)cc2)n2ncnc2N1C,,,CHEMBL1154659,J. Med. Chem.,2009,"{'bei': '11.24', 'le': '0.26', 'lle': '0.12', 'sei': '12.45'}",CHEMBL582438,,CHEMBL582438,6.52,False,http://www.openphacts.org/units/Nanomolar,851967,=,1,True,=,,IC50,nM,,300.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,microM,UO_0000065,,0.3
,2950238,[],CHEMBL1052159,Inhibition of human MDM2/P53 interaction by HTRF assay,B,,,BAO_0000190,BAO_0000224,protein format,CCOc1cccc2c1C1=C(C(c3ccc(Br)cc3)O2)C(c2ccc(Br)cc2)n2ncnc2N1C,,,CHEMBL1154659,J. Med. Chem.,2009,"{'bei': '10.16', 'le': '0.24', 'lle': '-0.75', 'sei': '11.53'}",CHEMBL583626,,CHEMBL583626,6.04,False,http://www.openphacts.org/units/Nanomolar,851995,=,1,True,=,,IC50,nM,,910.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,microM,UO_0000065,,0.91
,2950239,[],CHEMBL1052159,Inhibition of human MDM2/P53 interaction by HTRF assay,B,,,BAO_0000190,BAO_0000224,protein format,CN1C2=C(C(c3ccc(Br)cc3)Oc3ccc(F)cc32)C(c2ccc(Br)cc2)n2ncnc21,,,CHEMBL1154659,J. Med. Chem.,2009,"{'bei': '10.14', 'le': '0.24', 'lle': '-0.77', 'sei': '13.34'}",CHEMBL567403,,CHEMBL567403,5.76,False,http://www.openphacts.org/units/Nanomolar,852008,=,1,True,=,,IC50,nM,,1730.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,microM,UO_0000065,,1.73
,2950240,[],CHEMBL1052159,Inhibition of human MDM2/P53 interaction by HTRF assay,B,,,BAO_0000190,BAO_0000224,protein format,CN1C2=C(C(c3ccc(Br)cc3)Oc3ccc(Cl)cc32)C(c2ccc(Br)cc2)n2ncnc21,,,CHEMBL1154659,J. Med. Chem.,2009,"{'bei': '10.01', 'le': '0.24', 'lle': '-1.19', 'sei': '13.56'}",CHEMBL565896,,CHEMBL565896,5.85,False,http://www.openphacts.org/units/Nanomolar,852018,=,1,True,=,,IC50,nM,,1400.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,microM,UO_0000065,,1.4
,2950241,[],CHEMBL1052159,Inhibition of human MDM2/P53 interaction by HTRF assay,B,,,BAO_0000190,BAO_0000224,protein format,Cc1ccc2c(c1)C1=C(C(c3ccc(Br)cc3)O2)C(c2ccc(Br)cc2)n2ncnc2N1C,,,CHEMBL1154659,J. Med. Chem.,2009,"{'bei': '11.26', 'le': '0.26', 'lle': '-0.34', 'sei': '14.72'}",CHEMBL583413,,CHEMBL583413,6.36,False,http://www.openphacts.org/units/Nanomolar,852019,=,1,True,=,,IC50,nM,,440.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,microM,UO_0000065,,0.44
,2950242,[],CHEMBL1052159,Inhibition of human MDM2/P53 interaction by HTRF assay,B,,,BAO_0000190,BAO_0000224,protein format,CCc1ccc2c(c1)C1=C(C(c3ccc(Br)cc3)O2)C(c2ccc(Br)cc2)n2ncnc2N1C,,,CHEMBL1154659,J. Med. Chem.,2009,"{'bei': '9.50', 'le': '0.22', 'lle': '-1.46', 'sei': '12.73'}",CHEMBL568293,,CHEMBL568293,5.50,False,http://www.openphacts.org/units/Nanomolar,852040,=,1,True,=,,IC50,nM,,3200.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,microM,UO_0000065,,3.2
,2950243,[],CHEMBL1052159,Inhibition of human MDM2/P53 interaction by HTRF assay,B,,,BAO_0000190,BAO_0000224,protein format,CN1C2=C(C(c3ccc(Br)cc3)Oc3ccc(C#N)cc32)C(c2ccc(Br)cc2)n2ncnc21,,,CHEMBL1154659,J. Med. Chem.,2009,"{'bei': '9.59', 'le': '0.22', 'lle': '-0.75', 'sei': '8.23'}",CHEMBL566551,,CHEMBL566551,5.51,False,http://www.openphacts.org/units/Nanomolar,852047,=,1,True,=,,IC50,nM,,3060.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,microM,UO_0000065,,3.06
,2950244,[],CHEMBL1052159,Inhibition of human MDM2/P53 interaction by HTRF assay,B,,,BAO_0000190,BAO_0000224,protein format,CN1C2=C(C(c3ccc(Br)cc3)Oc3cc(F)ccc32)C(c2ccc(Br)cc2)n2ncnc21,,,CHEMBL1154659,J. Med. Chem.,2009,"{'bei': '10.57', 'le': '0.25', 'lle': '-0.53', 'sei': '13.91'}",CHEMBL567435,,CHEMBL567435,6.00,False,http://www.openphacts.org/units/Nanomolar,852056,=,1,True,=,,IC50,nM,,990.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,microM,UO_0000065,,0.99
,2950245,[],CHEMBL1052159,Inhibition of human MDM2/P53 interaction by HTRF assay,B,,,BAO_0000190,BAO_0000224,protein format,CN1C2=C(C(c3ccc(Br)cc3)Oc3cc(Cl)ccc32)C(c2ccc(Br)cc2)n2ncnc21,,,CHEMBL1154659,J. Med. Chem.,2009,"{'bei': '8.25', 'le': '0.20', 'lle': '-2.22', 'sei': '11.16'}",CHEMBL584497,,CHEMBL584497,4.82,False,http://www.openphacts.org/units/Nanomolar,852057,=,1,True,=,,IC50,nM,,15100.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,microM,UO_0000065,,15.1
,2950246,[],CHEMBL1052159,Inhibition of human MDM2/P53 interaction by HTRF assay,B,,,BAO_0000190,BAO_0000224,protein format,CN1C2=C(C(c3ccc(Br)cc3)Oc3c(Cl)cccc32)C(c2ccc(Br)cc2)n2ncnc21,,,CHEMBL1154659,J. Med. Chem.,2009,"{'bei': '9.33', 'le': '0.23', 'lle': '-1.58', 'sei': '12.64'}",CHEMBL567616,,CHEMBL567616,5.46,False,http://www.openphacts.org/units/Nanomolar,852075,=,1,True,=,,IC50,nM,,3500.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,microM,UO_0000065,,3.5
,2950247,[],CHEMBL1052159,Inhibition of human MDM2/P53 interaction by HTRF assay,B,,,BAO_0000190,BAO_0000224,protein format,COc1c(C)ccc2c1C1=C(C(c3ccc(Br)cc3)O2)C(c2ccc(Br)cc2)n2ncnc2N1C,,,CHEMBL1154659,J. Med. Chem.,2009,"{'bei': '9.09', 'le': '0.21', 'lle': '-1.30', 'sei': '10.31'}",CHEMBL565254,,CHEMBL565254,5.41,False,http://www.openphacts.org/units/Nanomolar,852095,=,1,True,=,,IC50,nM,,3940.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,microM,UO_0000065,,3.94
,2950248,[],CHEMBL1052159,Inhibition of human MDM2/P53 interaction by HTRF assay,B,,,BAO_0000190,BAO_0000224,protein format,Cc1cc2c(cc1F)OC(c1ccc(Br)cc1)C1=C2N(C)c2ncnn2C1c1ccc(Br)cc1,,,CHEMBL1154659,J. Med. Chem.,2009,"{'bei': '10.85', 'le': '0.25', 'lle': '-0.51', 'sei': '14.63'}",CHEMBL584512,,CHEMBL584512,6.32,False,http://www.openphacts.org/units/Nanomolar,852137,=,1,True,=,,IC50,nM,,480.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,microM,UO_0000065,,0.48
,2950249,[],CHEMBL1052159,Inhibition of human MDM2/P53 interaction by HTRF assay,B,,,BAO_0000190,BAO_0000224,protein format,CN1C2=C(C(c3ccc(Br)cc3)Oc3c(Cl)cc(Cl)cc32)C(c2ccc(Br)cc2)n2ncnc21,,,CHEMBL1154659,J. Med. Chem.,2009,,CHEMBL568520,,CHEMBL568520,,False,http://www.openphacts.org/units/Nanomolar,852138,>,1,True,>,,IC50,nM,,100000.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,microM,UO_0000065,,100.0
,6177409,[],CHEMBL1772463,Inhibition of human GST-fused HDM2-p53 protein-protein interaction by HTRF assay,B,,,BAO_0000190,BAO_0000224,protein format,CC(C)(O)CN1C2=C(C(c3ccc(Br)cc3)Oc3ccccc32)C(c2ccc(Br)cc2)n2ncnc21,,,CHEMBL1770142,Bioorg. Med. Chem. Lett.,2011,"{'bei': '10.57', 'le': '0.24', 'lle': '-0.10', 'sei': '10.14'}",CHEMBL1771730,,CHEMBL1771730,6.43,False,http://www.openphacts.org/units/Nanomolar,1420549,=,1,True,=,,IC50,nM,,370.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,uM,UO_0000065,,0.37
,6177410,[],CHEMBL1772463,Inhibition of human GST-fused HDM2-p53 protein-protein interaction by HTRF assay,B,,,BAO_0000190,BAO_0000224,protein format,N#CCN1C2=C(C(c3ccc(Br)cc3)Oc3ccccc32)C(c2ccc(Br)cc2)n2ncnc21,,,CHEMBL1770142,Bioorg. Med. Chem. Lett.,2011,"{'bei': '10.67', 'le': '0.25', 'lle': '-0.14', 'sei': '9.16'}",CHEMBL1771729,,CHEMBL1771729,6.14,False,http://www.openphacts.org/units/Nanomolar,1420548,=,1,True,=,,IC50,nM,,730.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,uM,UO_0000065,,0.73
,6177411,[],CHEMBL1772463,Inhibition of human GST-fused HDM2-p53 protein-protein interaction by HTRF assay,B,,,BAO_0000190,BAO_0000224,protein format,NC(=O)CN1C2=C(C(c3ccc(Br)cc3)Oc3ccccc32)C(c2ccc(Br)cc2)n2ncnc21,,,CHEMBL1770142,Bioorg. Med. Chem. Lett.,2011,"{'bei': '10.56', 'le': '0.24', 'lle': '1.03', 'sei': '7.27'}",CHEMBL1771728,,CHEMBL1771728,6.27,False,http://www.openphacts.org/units/Nanomolar,1420547,=,1,True,=,,IC50,nM,,540.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,uM,UO_0000065,,0.54
,6177412,[],CHEMBL1772463,Inhibition of human GST-fused HDM2-p53 protein-protein interaction by HTRF assay,B,,,BAO_0000190,BAO_0000224,protein format,O=C(O)CCCCN1C2=C([C@H](c3ccc(Br)cc3)n3ncnc31)[C@@H](c1ccc(Br)cc1)Oc1ccccc12,,,CHEMBL1770142,Bioorg. Med. Chem. Lett.,2011,"{'bei': '10.15', 'le': '0.23', 'lle': '-0.55', 'sei': '8.02'}",CHEMBL1771727,,CHEMBL1771727,6.46,False,http://www.openphacts.org/units/Nanomolar,1420546,=,1,True,=,,IC50,nM,,350.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,uM,UO_0000065,,0.35
,6177413,[],CHEMBL1772463,Inhibition of human GST-fused HDM2-p53 protein-protein interaction by HTRF assay,B,,,BAO_0000190,BAO_0000224,protein format,O=C(O)CCCCN1C2=C(C(c3ccc(Br)cc3)Oc3ccccc32)C(c2ccc(Br)cc2)n2ncnc21,,,CHEMBL1770142,Bioorg. Med. Chem. Lett.,2011,"{'bei': '9.62', 'le': '0.22', 'lle': '-0.89', 'sei': '7.60'}",CHEMBL1771726,,CHEMBL1771726,6.12,False,http://www.openphacts.org/units/Nanomolar,1420545,=,1,True,=,,IC50,nM,,760.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,uM,UO_0000065,,0.76
,6177414,[],CHEMBL1772463,Inhibition of human GST-fused HDM2-p53 protein-protein interaction by HTRF assay,B,,,BAO_0000190,BAO_0000224,protein format,O=C(O)CCCN1C2=C(C(c3ccc(Br)cc3)Oc3ccccc32)C(c2ccc(Br)cc2)n2ncnc21,,,CHEMBL1770142,Bioorg. Med. Chem. Lett.,2011,"{'bei': '9.94', 'le': '0.23', 'lle': '-0.43', 'sei': '7.69'}",CHEMBL1771725,,CHEMBL1771725,6.19,False,http://www.openphacts.org/units/Nanomolar,1420544,=,1,True,=,,IC50,nM,,650.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,uM,UO_0000065,,0.65
,6177415,[],CHEMBL1772463,Inhibition of human GST-fused HDM2-p53 protein-protein interaction by HTRF assay,B,,,BAO_0000190,BAO_0000224,protein format,O=C(O)CN1C2=C([C@H](c3ccc(Br)cc3)n3ncnc31)[C@@H](c1ccc(Br)cc1)Oc1ccccc12,,,CHEMBL1770142,Bioorg. Med. Chem. Lett.,2011,"{'bei': '10.63', 'le': '0.25', 'lle': '0.48', 'sei': '7.85'}",CHEMBL1771611,,CHEMBL1771611,6.32,False,http://www.openphacts.org/units/Nanomolar,1420416,=,1,True,=,,IC50,nM,,480.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,uM,UO_0000065,,0.48
,6177416,[],CHEMBL1772463,Inhibition of human GST-fused HDM2-p53 protein-protein interaction by HTRF assay,B,,,BAO_0000190,BAO_0000224,protein format,O=C(O)CN1C2=C(C(c3ccc(Br)cc3)Oc3ccccc32)C(c2ccc(Br)cc2)n2ncnc21,,,CHEMBL1770142,Bioorg. Med. Chem. Lett.,2011,"{'bei': '10.17', 'le': '0.24', 'lle': '0.20', 'sei': '7.51'}",CHEMBL1771610,,CHEMBL1771610,6.04,False,http://www.openphacts.org/units/Nanomolar,1420415,=,1,True,=,,IC50,nM,,910.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,uM,UO_0000065,,0.91
,6177417,[],CHEMBL1772463,Inhibition of human GST-fused HDM2-p53 protein-protein interaction by HTRF assay,B,,,BAO_0000190,BAO_0000224,protein format,CN(C)CCCN1C2=C(C(c3ccc(Br)cc3)Oc3ccccc32)C(c2ccc(Br)cc2)n2ncnc21.O=C(O)C(F)(F)F,,,CHEMBL1770142,Bioorg. Med. Chem. Lett.,2011,"{'bei': '8.25', 'le': '0.19', 'lle': '-1.59', 'sei': '11.04'}",CHEMBL1771609,,CHEMBL1789482,5.12,False,http://www.openphacts.org/units/Nanomolar,1420414,=,1,True,=,,IC50,nM,,7500.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,uM,UO_0000065,,7.5
,6177418,[],CHEMBL1772463,Inhibition of human GST-fused HDM2-p53 protein-protein interaction by HTRF assay,B,,,BAO_0000190,BAO_0000224,protein format,NCCCN1C2=C(C(c3ccc(Br)cc3)Oc3ccccc32)C(c2ccc(Br)cc2)n2ncnc21.O=C(O)C(F)(F)F,,,CHEMBL1770142,Bioorg. Med. Chem. Lett.,2011,"{'bei': '9.15', 'le': '0.21', 'lle': '-0.68', 'sei': '7.85'}",CHEMBL1771608,,CHEMBL1789501,5.43,False,http://www.openphacts.org/units/Nanomolar,1420413,=,1,True,=,,IC50,nM,,3700.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,uM,UO_0000065,,3.7
,6177419,[],CHEMBL1772463,Inhibition of human GST-fused HDM2-p53 protein-protein interaction by HTRF assay,B,,,BAO_0000190,BAO_0000224,protein format,CC(C)(C)C(=O)ONCCCN1C2=C(C(c3ccc(Br)cc3)Oc3ccccc32)C(c2ccc(Br)cc2)n2ncnc21,,,CHEMBL1770142,Bioorg. Med. Chem. Lett.,2011,"{'bei': '7.72', 'le': '0.17', 'lle': '-1.88', 'sei': '6.57'}",CHEMBL1771607,,CHEMBL1771607,5.36,False,http://www.openphacts.org/units/Nanomolar,1420412,=,1,True,=,,IC50,nM,,4400.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,uM,UO_0000065,,4.4
,6177420,[],CHEMBL1772463,Inhibition of human GST-fused HDM2-p53 protein-protein interaction by HTRF assay,B,,,BAO_0000190,BAO_0000224,protein format,CS(=O)(=O)CN1C2=C(C(c3ccc(Br)cc3)Oc3ccccc32)C(c2ccc(Br)cc2)n2ncnc21,,,CHEMBL1770142,Bioorg. Med. Chem. Lett.,2011,"{'bei': '10.01', 'le': '0.24', 'lle': '0.53', 'sei': '8.14'}",CHEMBL1771606,,CHEMBL1771606,6.29,False,http://www.openphacts.org/units/Nanomolar,1420411,=,1,True,=,,IC50,nM,,510.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,uM,UO_0000065,,0.51
,6177421,[],CHEMBL1772463,Inhibition of human GST-fused HDM2-p53 protein-protein interaction by HTRF assay,B,,,BAO_0000190,BAO_0000224,protein format,O=C(O)CCN1C2=C(C(c3ccc(Br)cc3)Oc3ccccc32)C(c2ccc(Br)cc2)n2ncnc21,,,CHEMBL1770142,Bioorg. Med. Chem. Lett.,2011,"{'bei': '10.34', 'le': '0.24', 'lle': '0.06', 'sei': '7.82'}",CHEMBL1771605,,CHEMBL1771605,6.29,False,http://www.openphacts.org/units/Nanomolar,1420410,=,1,True,=,,IC50,nM,,510.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,uM,UO_0000065,,0.51
,6177422,[],CHEMBL1772463,Inhibition of human GST-fused HDM2-p53 protein-protein interaction by HTRF assay,B,,,BAO_0000190,BAO_0000224,protein format,OCCCN1C2=C(C(c3ccc(Br)cc3)Oc3ccccc32)C(c2ccc(Br)cc2)n2ncnc21,,,CHEMBL1770142,Bioorg. Med. Chem. Lett.,2011,"{'bei': '10.71', 'le': '0.25', 'lle': '0.23', 'sei': '10.04'}",CHEMBL1771604,,CHEMBL1771604,6.37,False,http://www.openphacts.org/units/Nanomolar,1420409,=,1,True,=,,IC50,nM,,430.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,uM,UO_0000065,,0.43
,6177423,[],CHEMBL1772463,Inhibition of human GST-fused HDM2-p53 protein-protein interaction by HTRF assay,B,,,BAO_0000190,BAO_0000224,protein format,CCN1C2=C(C(c3ccc(Br)cc3)Oc3ccccc32)C(c2ccc(Br)cc2)n2ncnc21,,,CHEMBL1770142,Bioorg. Med. Chem. Lett.,2011,"{'bei': '10.18', 'le': '0.24', 'lle': '-1.04', 'sei': '13.30'}",CHEMBL1771708,,CHEMBL1771708,5.75,False,http://www.openphacts.org/units/Nanomolar,1420527,=,1,True,=,,IC50,nM,,1800.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,uM,UO_0000065,,1.8
,6177424,[],CHEMBL1772463,Inhibition of human GST-fused HDM2-p53 protein-protein interaction by HTRF assay,B,,,BAO_0000190,BAO_0000224,protein format,C=CCN1C2=C(C(c3ccc(Br)cc3)Oc3ccccc32)C(c2ccc(Br)cc2)n2ncnc21,,,CHEMBL1770142,Bioorg. Med. Chem. Lett.,2011,"{'bei': '9.75', 'le': '0.23', 'lle': '-1.32', 'sei': '13.01'}",CHEMBL1771707,,CHEMBL1771707,5.62,False,http://www.openphacts.org/units/Nanomolar,1420526,=,1,True,=,,IC50,nM,,2400.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,uM,UO_0000065,,2.4
,6177458,[],CHEMBL1772463,Inhibition of human GST-fused HDM2-p53 protein-protein interaction by HTRF assay,B,,,BAO_0000190,BAO_0000224,protein format,CN1C2=C([C@H](c3ccc(Br)cc3)n3ncnc31)[C@@H](c1ccc(Br)cc1)Oc1ccccc12,,,CHEMBL1770142,Bioorg. Med. Chem. Lett.,2011,"{'bei': '10.64', 'le': '0.25', 'lle': '-0.54', 'sei': '13.56'}",CHEMBL1771706,,CHEMBL1771706,5.85,False,http://www.openphacts.org/units/Nanomolar,1420525,=,1,True,=,,IC50,nM,,1400.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,uM,UO_0000065,,1.4
,6387110,[],CHEMBL1838865,Inhibition of human MDM2-p53 interaction after 20 mins by ELSA method,B,,,BAO_0000190,BAO_0000224,protein format,O=C1c2ccccc2C(OCC2(CO)CC2)(c2ccc(Cl)cc2)N1Cc1ccc([N+](=O)[O-])cc1,,,CHEMBL1833901,Bioorg. Med. Chem. Lett.,2011,"{'bei': '13.88', 'le': '0.27', 'lle': '1.76', 'sei': '7.16'}",CHEMBL1688274,,CHEMBL1688274,6.65,False,http://www.openphacts.org/units/Nanomolar,1460282,=,1,True,=,,IC50,nM,,225.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,225.0
,6387111,[],CHEMBL1838865,Inhibition of human MDM2-p53 interaction after 20 mins by ELSA method,B,,,BAO_0000190,BAO_0000224,protein format,O=C1c2ccccc2C(OCC2(CO)CC2)(c2ccc(Cl)cc2)N1Cc1ccc(Br)cc1,,,CHEMBL1833901,Bioorg. Med. Chem. Lett.,2011,"{'bei': '11.55', 'le': '0.25', 'lle': '0.17', 'sei': '11.90'}",CHEMBL1688280,,CHEMBL1688280,5.92,False,http://www.openphacts.org/units/Nanomolar,1460283,=,1,True,=,,IC50,nM,,1200.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,1200.0
,6387112,[],CHEMBL1838865,Inhibition of human MDM2-p53 interaction after 20 mins by ELSA method,B,,,BAO_0000190,BAO_0000224,protein format,N#Cc1ccc(CN2C(=O)c3ccccc3C2(OCC2(CO)CC2)c2ccc(Cl)cc2)cc1,,,CHEMBL1833901,Bioorg. Med. Chem. Lett.,2011,"{'bei': '12.52', 'le': '0.24', 'lle': '0.88', 'sei': '7.81'}",CHEMBL1688277,,CHEMBL1688277,5.75,False,http://www.openphacts.org/units/Nanomolar,1460284,=,1,True,=,,IC50,nM,,1800.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,1800.0
,6387113,[],CHEMBL1838865,Inhibition of human MDM2-p53 interaction after 20 mins by ELSA method,B,,,BAO_0000190,BAO_0000224,protein format,O=C1c2cccc(Cl)c2C(OCC2(CO)CC2)(c2ccc(Cl)cc2)N1Cc1ccc([N+](=O)[O-])cc1,,,CHEMBL1833901,Bioorg. Med. Chem. Lett.,2011,"{'bei': '14.33', 'le': '0.29', 'lle': '1.81', 'sei': '7.92'}",CHEMBL1834286,,CHEMBL1834286,7.36,False,http://www.openphacts.org/units/Nanomolar,1460287,=,1,True,=,,IC50,nM,,44.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,44.0
,6387114,[],CHEMBL1838865,Inhibition of human MDM2-p53 interaction after 20 mins by ELSA method,B,,,BAO_0000190,BAO_0000224,protein format,O=C1c2cccc(Cl)c2C(OCC2(CO)CC2)(c2ccc(Cl)cc2)N1Cc1ccc(Br)cc1,,,CHEMBL1833901,Bioorg. Med. Chem. Lett.,2011,"{'bei': '12.54', 'le': '0.28', 'lle': '0.46', 'sei': '13.79'}",CHEMBL1834287,,CHEMBL1834287,6.86,False,http://www.openphacts.org/units/Nanomolar,1460290,=,1,True,=,,IC50,nM,,137.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,137.0
,6387115,[],CHEMBL1838865,Inhibition of human MDM2-p53 interaction after 20 mins by ELSA method,B,,,BAO_0000190,BAO_0000224,protein format,N#Cc1ccc(CN2C(=O)c3cccc(Cl)c3C2(OCC2(CO)CC2)c2ccc(Cl)cc2)cc1,,,CHEMBL1833901,Bioorg. Med. Chem. Lett.,2011,"{'bei': '13.92', 'le': '0.28', 'lle': '1.36', 'sei': '9.33'}",CHEMBL1834288,,CHEMBL1834288,6.87,False,http://www.openphacts.org/units/Nanomolar,1460385,=,1,True,=,,IC50,nM,,136.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,136.0
,6387116,[],CHEMBL1838865,Inhibition of human MDM2-p53 interaction after 20 mins by ELSA method,B,,,BAO_0000190,BAO_0000224,protein format,O=C1c2cccc(Cl)c2C(OCC2(CO)CC2)(c2ccc(Cl)cc2)N1Cc1ccc([N+](=O)[O-])cc1,,,CHEMBL1833901,Bioorg. Med. Chem. Lett.,2011,"{'bei': '11.92', 'le': '0.24', 'lle': '0.57', 'sei': '6.58'}",CHEMBL1834286,,CHEMBL1834286,6.12,False,http://www.openphacts.org/units/Nanomolar,1460286,=,1,True,=,,IC50,nM,,763.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,763.0
,6387117,[],CHEMBL1838865,Inhibition of human MDM2-p53 interaction after 20 mins by ELSA method,B,,,BAO_0000190,BAO_0000224,protein format,O=C1c2cccc(Cl)c2C(OCC2(CO)CC2)(c2ccc(Cl)cc2)N1Cc1ccc(Br)cc1,,,CHEMBL1833901,Bioorg. Med. Chem. Lett.,2011,"{'bei': '9.86', 'le': '0.22', 'lle': '-1.00', 'sei': '10.84'}",CHEMBL1834287,,CHEMBL1834287,5.40,False,http://www.openphacts.org/units/Nanomolar,1460289,=,1,True,=,,IC50,nM,,4015.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,4015.0
,6387118,[],CHEMBL1838865,Inhibition of human MDM2-p53 interaction after 20 mins by ELSA method,B,,,BAO_0000190,BAO_0000224,protein format,N#Cc1ccc(CN2C(=O)c3cccc(Cl)c3C2(OCC2(CO)CC2)c2ccc(Cl)cc2)cc1,,,CHEMBL1833901,Bioorg. Med. Chem. Lett.,2011,"{'bei': '10.92', 'le': '0.22', 'lle': '-0.12', 'sei': '7.33'}",CHEMBL1834288,,CHEMBL1834288,5.39,False,http://www.openphacts.org/units/Nanomolar,1460384,=,1,True,=,,IC50,nM,,4077.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,4077.0
,6387119,[],CHEMBL1838865,Inhibition of human MDM2-p53 interaction after 20 mins by ELSA method,B,,,BAO_0000190,BAO_0000224,protein format,O=C1c2cccc(Cl)c2C(OCC2(CO)CC2)(c2ccc(Cl)cc2)N1Cc1ccc([N+](=O)[O-])cc1,,,CHEMBL1833901,Bioorg. Med. Chem. Lett.,2011,"{'bei': '13.69', 'le': '0.27', 'lle': '1.48', 'sei': '7.56'}",CHEMBL1834286,,CHEMBL1834286,7.03,False,http://www.openphacts.org/units/Nanomolar,1460285,=,1,True,=,,IC50,nM,,94.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,94.0
,6388051,[],CHEMBL1838865,Inhibition of human MDM2-p53 interaction after 20 mins by ELSA method,B,,,BAO_0000190,BAO_0000224,protein format,O=C1c2cccc(Cl)c2C(OCC2(CO)CC2)(c2ccc(Cl)cc2)N1Cc1ccc(Br)cc1,,,CHEMBL1833901,Bioorg. Med. Chem. Lett.,2011,"{'bei': '12.37', 'le': '0.28', 'lle': '0.37', 'sei': '13.61'}",CHEMBL1834287,,CHEMBL1834287,6.77,False,http://www.openphacts.org/units/Nanomolar,1460288,=,1,True,=,,IC50,nM,,169.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,169.0
,6388052,[],CHEMBL1838865,Inhibition of human MDM2-p53 interaction after 20 mins by ELSA method,B,,,BAO_0000190,BAO_0000224,protein format,N#Cc1ccc(CN2C(=O)c3cccc(Cl)c3C2(OCC2(CO)CC2)c2ccc(Cl)cc2)cc1,,,CHEMBL1833901,Bioorg. Med. Chem. Lett.,2011,"{'bei': '13.65', 'le': '0.27', 'lle': '1.22', 'sei': '9.15'}",CHEMBL1834288,,CHEMBL1834288,6.73,False,http://www.openphacts.org/units/Nanomolar,1460291,=,1,True,=,,IC50,nM,,185.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,185.0
,6388053,[],CHEMBL1838865,Inhibition of human MDM2-p53 interaction after 20 mins by ELSA method,B,,,BAO_0000190,BAO_0000224,protein format,O=C1c2cccc(Cl)c2C(OCC2(CO)CC2)(c2ccc(Cl)cc2)N1Cc1ccc(S(=O)(=O)C(F)(F)F)cc1,,,CHEMBL1833901,Bioorg. Med. Chem. Lett.,2011,"{'bei': '8.40', 'le': '0.18', 'lle': '-0.88', 'sei': '6.01'}",CHEMBL1834372,,CHEMBL1834372,5.05,False,http://www.openphacts.org/units/Nanomolar,1460386,=,1,True,=,,IC50,nM,,9000.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,9000.0
,6388054,[],CHEMBL1838865,Inhibition of human MDM2-p53 interaction after 20 mins by ELSA method,B,,,BAO_0000190,BAO_0000224,protein format,Cc1cccc2c1C(OCC1(CO)CC1)(c1ccc(Cl)cc1)N(Cc1ccc([N+](=O)[O-])cc1)C2=O,,,CHEMBL1833901,Bioorg. Med. Chem. Lett.,2011,"{'bei': '13.31', 'le': '0.26', 'lle': '1.36', 'sei': '7.06'}",CHEMBL1834373,,CHEMBL1834373,6.56,False,http://www.openphacts.org/units/Nanomolar,1460387,=,1,True,=,,IC50,nM,,274.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,274.0
,6388055,[],CHEMBL1838865,Inhibition of human MDM2-p53 interaction after 20 mins by ELSA method,B,,,BAO_0000190,BAO_0000224,protein format,O=C1c2ccc(F)cc2C(OCC2(CO)CC2)(c2ccc(Cl)cc2)N1Cc1ccc([N+](=O)[O-])cc1,,,CHEMBL1833901,Bioorg. Med. Chem. Lett.,2011,"{'bei': '13.14', 'le': '0.25', 'lle': '1.50', 'sei': '7.03'}",CHEMBL1834374,,CHEMBL1834374,6.53,False,http://www.openphacts.org/units/Nanomolar,1460388,=,1,True,=,,IC50,nM,,295.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,295.0
,6388056,[],CHEMBL1838865,Inhibition of human MDM2-p53 interaction after 20 mins by ELSA method,B,,,BAO_0000190,BAO_0000224,protein format,Cc1ccc2c(c1)C(OCC1(CO)CC1)(c1ccc(Cl)cc1)N(Cc1ccc([N+](=O)[O-])cc1)C2=O,,,CHEMBL1833901,Bioorg. Med. Chem. Lett.,2011,"{'bei': '12.80', 'le': '0.25', 'lle': '1.11', 'sei': '6.79'}",CHEMBL1834375,,CHEMBL1834375,6.31,False,http://www.openphacts.org/units/Nanomolar,1460389,=,1,True,=,,IC50,nM,,492.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,492.0
,6388057,[],CHEMBL1838865,Inhibition of human MDM2-p53 interaction after 20 mins by ELSA method,B,,,BAO_0000190,BAO_0000224,protein format,CC(C)(C)c1ccc2c(c1)C(OCC1(CO)CC1)(c1ccc(Cl)cc1)N(Cc1ccc([N+](=O)[O-])cc1)C2=O,,,CHEMBL1833901,Bioorg. Med. Chem. Lett.,2011,"{'bei': '11.47', 'le': '0.22', 'lle': '-0.06', 'sei': '6.60'}",CHEMBL1834376,,CHEMBL1834376,6.13,False,http://www.openphacts.org/units/Nanomolar,1460390,=,1,True,=,,IC50,nM,,733.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,733.0
,6388058,[],CHEMBL1838865,Inhibition of human MDM2-p53 interaction after 20 mins by ELSA method,B,,,BAO_0000190,BAO_0000224,protein format,O=C1c2ccc(Br)cc2C(OCC2(CO)CC2)(c2ccc(Cl)cc2)N1Cc1ccc([N+](=O)[O-])cc1,,,CHEMBL1833901,Bioorg. Med. Chem. Lett.,2011,"{'bei': '10.84', 'le': '0.24', 'lle': '0.38', 'sei': '6.51'}",CHEMBL1834377,,CHEMBL1834377,6.04,False,http://www.openphacts.org/units/Nanomolar,1460391,=,1,True,=,,IC50,nM,,902.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,902.0
,6388059,[],CHEMBL1838865,Inhibition of human MDM2-p53 interaction after 20 mins by ELSA method,B,,,BAO_0000190,BAO_0000224,protein format,CC(C)(C)c1ccc2c(c1)C(=O)N(Cc1ccc([N+](=O)[O-])cc1)C2(OCC1(CO)CC1)c1ccc(Cl)cc1,,,CHEMBL1833901,Bioorg. Med. Chem. Lett.,2011,"{'bei': '12.74', 'le': '0.25', 'lle': '0.63', 'sei': '7.34'}",CHEMBL1834378,,CHEMBL1834378,6.82,False,http://www.openphacts.org/units/Nanomolar,1460392,=,1,True,=,,IC50,nM,,152.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,152.0
,6388060,[],CHEMBL1838865,Inhibition of human MDM2-p53 interaction after 20 mins by ELSA method,B,,,BAO_0000190,BAO_0000224,protein format,O=C1c2cc(F)ccc2C(OCC2(CO)CC2)(c2ccc(Cl)cc2)N1Cc1ccc([N+](=O)[O-])cc1,,,CHEMBL1833901,Bioorg. Med. Chem. Lett.,2011,"{'bei': '12.21', 'le': '0.24', 'lle': '1.04', 'sei': '6.53'}",CHEMBL1834379,,CHEMBL1834379,6.07,False,http://www.openphacts.org/units/Nanomolar,1460393,=,1,True,=,,IC50,nM,,852.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,852.0
,6388061,[],CHEMBL1838865,Inhibition of human MDM2-p53 interaction after 20 mins by ELSA method,B,,,BAO_0000190,BAO_0000224,protein format,O=C1c2cc(Br)ccc2C(OCC2(CO)CC2)(c2ccc(Cl)cc2)N1Cc1ccc([N+](=O)[O-])cc1,,,CHEMBL1833901,Bioorg. Med. Chem. Lett.,2011,"{'bei': '10.73', 'le': '0.23', 'lle': '0.33', 'sei': '6.44'}",CHEMBL1834380,,CHEMBL1834380,5.99,False,http://www.openphacts.org/units/Nanomolar,1460394,=,1,True,=,,IC50,nM,,1030.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,1030.0
,6388062,[],CHEMBL1838865,Inhibition of human MDM2-p53 interaction after 20 mins by ELSA method,B,,,BAO_0000190,BAO_0000224,protein format,O=C1c2cc(Cl)c(Cl)cc2C(OCC2(CO)CC2)(c2ccc(Cl)cc2)N1Cc1ccc([N+](=O)[O-])cc1,,,CHEMBL1833901,Bioorg. Med. Chem. Lett.,2011,"{'bei': '9.92', 'le': '0.21', 'lle': '-0.76', 'sei': '5.85'}",CHEMBL1834381,,CHEMBL1834381,5.43,False,http://www.openphacts.org/units/Nanomolar,1460395,=,1,True,=,,IC50,nM,,3670.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,3670.0
,6388063,[],CHEMBL1838865,Inhibition of human MDM2-p53 interaction after 20 mins by ELSA method,B,,,BAO_0000190,BAO_0000224,protein format,O=C1C2=C(CCCC2)C(OCC2(CO)CC2)(c2ccc(Cl)cc2)N1Cc1ccc([N+](=O)[O-])cc1,,,CHEMBL1833901,Bioorg. Med. Chem. Lett.,2011,"{'bei': '11.30', 'le': '0.22', 'lle': '0.36', 'sei': '5.88'}",CHEMBL1834382,,CHEMBL1834382,5.46,False,http://www.openphacts.org/units/Nanomolar,1460396,=,1,True,=,,IC50,nM,,3470.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,3470.0
,6388064,[],CHEMBL1838865,Inhibition of human MDM2-p53 interaction after 20 mins by ELSA method,B,,,BAO_0000190,BAO_0000224,protein format,CC1=C(C)C(OCC2(CO)CC2)(c2ccc(Cl)cc2)N(Cc2ccccc2)C1=O,,,CHEMBL1833901,Bioorg. Med. Chem. Lett.,2011,"{'bei': '13.26', 'le': '0.26', 'lle': '0.80', 'sei': '10.97'}",CHEMBL1834383,,CHEMBL1834383,5.46,False,http://www.openphacts.org/units/Nanomolar,1460397,=,1,True,=,,IC50,nM,,3450.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,3450.0
,6388065,[],CHEMBL1838865,Inhibition of human MDM2-p53 interaction after 20 mins by ELSA method,B,,,BAO_0000190,BAO_0000224,protein format,CCCN1C(=O)C(C)=C(C)C1(OCC1(CO)CC1)c1ccc(Cl)cc1,,,CHEMBL1833901,Bioorg. Med. Chem. Lett.,2011,"{'bei': '13.88', 'le': '0.28', 'lle': '1.18', 'sei': '10.15'}",CHEMBL1834384,,CHEMBL1834384,5.05,False,http://www.openphacts.org/units/Nanomolar,1460398,=,1,True,=,,IC50,nM,,8900.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,8900.0
,7989222,[],CHEMBL1936335,Inhibition of p53-MDM2 interaction by ELISA,B,,,BAO_0000190,BAO_0000224,protein format,CC(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H]1CSCc2ccc(cn2)-c2ccc(nc2)CSC[C@@H](C(=O)N[C@@H](CO)C(=O)NCCCNCCCCNCCCN)NC(=O)[C@H](C(C)C)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](C)NC(=O)[C@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@H](Cc2cnc[nH]2)NC1=O)[C@@H](C)O,,,CHEMBL1933030,Bioorg. Med. Chem. Lett.,2011,"{'bei': '4.15', 'le': None, 'lle': None, 'sei': None}",CHEMBL1933133,,CHEMBL1933133,7.75,False,http://www.openphacts.org/units/Nanomolar,1566878,=,1,True,=,,IC50,nM,,18.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,18.0
,7989223,[],CHEMBL1936335,Inhibition of p53-MDM2 interaction by ELISA,B,,,BAO_0000190,BAO_0000224,protein format,CC(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H]1CSCc2ccc(cn2)-c2ccc(nc2)CSC[C@@H](C(=O)N[C@@H](CO)C(N)=O)NC(=O)[C@H](C(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](C)NC(=O)[C@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@H](CCCNC(=N)N)NC1=O)[C@@H](C)O,,,CHEMBL1933030,Bioorg. Med. Chem. Lett.,2011,"{'bei': '4.05', 'le': None, 'lle': None, 'sei': None}",CHEMBL1933132,,CHEMBL1933132,6.99,False,http://www.openphacts.org/units/Nanomolar,1566877,=,1,True,=,,IC50,nM,,102.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,102.0
,7989224,[],CHEMBL1936335,Inhibition of p53-MDM2 interaction by ELISA,B,,,BAO_0000190,BAO_0000224,protein format,CC(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H]1CSCc2ccc(cn2)-c2ccc(nc2)CSC[C@@H](C(=O)N[C@@H](CO)C(N)=O)NC(=O)[C@H](C(C)C)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](C)NC(=O)[C@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@H](Cc2cnc[nH]2)NC1=O)[C@@H](C)O,,,CHEMBL1933030,Bioorg. Med. Chem. Lett.,2011,"{'bei': '4.94', 'le': None, 'lle': None, 'sei': None}",CHEMBL1933131,,CHEMBL1933131,8.30,False,http://www.openphacts.org/units/Nanomolar,1566876,=,1,True,=,,IC50,nM,,5.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,5.0
,7989225,[],CHEMBL1936335,Inhibition of p53-MDM2 interaction by ELISA,B,,,BAO_0000190,BAO_0000224,protein format,CC(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](CS)C(=O)N[C@@H](Cc1cnc[nH]1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CS)C(=O)N[C@@H](CO)C(N)=O)[C@@H](C)O,,,CHEMBL1933030,Bioorg. Med. Chem. Lett.,2011,"{'bei': '5.21', 'le': None, 'lle': None, 'sei': None}",CHEMBL1933130,,CHEMBL1933130,7.89,False,http://www.openphacts.org/units/Nanomolar,1566875,=,1,True,=,,IC50,nM,,13.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,13.0
,7989226,[],CHEMBL1936335,Inhibition of p53-MDM2 interaction by ELISA,B,,,BAO_0000190,BAO_0000224,protein format,CC(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H]1CSCc2ccc(cn2)-c2ccc(nc2)CSC[C@@H](C(=O)N[C@@H](CO)C(=O)NCCCNCCCCNCCCN)NC(=O)[C@H](C(C)C)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](C)NC(=O)[C@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@H](Cc2cnc[nH]2)NC1=O)[C@@H](C)O,,,CHEMBL1933030,Bioorg. Med. Chem. Lett.,2011,"{'bei': '3.94', 'le': None, 'lle': None, 'sei': None}",CHEMBL1933129,,CHEMBL1933129,7.34,False,http://www.openphacts.org/units/Nanomolar,1566874,=,1,True,=,,IC50,nM,,46.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,46.0
,7989227,[],CHEMBL1936335,Inhibition of p53-MDM2 interaction by ELISA,B,,,BAO_0000190,BAO_0000224,protein format,CC(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H]1CSCc2ccc(cn2)-c2ccc(nc2)CSC[C@@H](C(=O)N[C@@H](CO)C(N)=O)NC(=O)[C@H](C(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](C)NC(=O)[C@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@H](CCCNC(=N)N)NC1=O)[C@@H](C)O,,,CHEMBL1933030,Bioorg. Med. Chem. Lett.,2011,"{'bei': '3.84', 'le': None, 'lle': None, 'sei': None}",CHEMBL1933128,,CHEMBL1933128,6.62,False,http://www.openphacts.org/units/Nanomolar,1566873,=,1,True,=,,IC50,nM,,237.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,237.0
,7989228,[],CHEMBL1936335,Inhibition of p53-MDM2 interaction by ELISA,B,,,BAO_0000190,BAO_0000224,protein format,CC(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H]1CSCc2ccc(cn2)-c2ccc(nc2)CSC[C@@H](C(=O)N[C@@H](CO)C(N)=O)NC(=O)[C@H](C(C)C)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](C)NC(=O)[C@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@H](Cc2cnc[nH]2)NC1=O)[C@@H](C)O,,,CHEMBL1933030,Bioorg. Med. Chem. Lett.,2011,"{'bei': '4.44', 'le': None, 'lle': None, 'sei': None}",CHEMBL1933127,,CHEMBL1933127,7.46,False,http://www.openphacts.org/units/Nanomolar,1566872,=,1,True,=,,IC50,nM,,35.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,35.0
,7989229,[],CHEMBL1936335,Inhibition of p53-MDM2 interaction by ELISA,B,,,BAO_0000190,BAO_0000224,protein format,CC(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CS)C(=O)N[C@@H](Cc1cnc[nH]1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CS)C(=O)N[C@@H](CO)C(N)=O)[C@@H](C)O,,,CHEMBL1933030,Bioorg. Med. Chem. Lett.,2011,"{'bei': '4.79', 'le': None, 'lle': None, 'sei': None}",CHEMBL1933126,,CHEMBL1933126,7.24,False,http://www.openphacts.org/units/Nanomolar,1566871,=,1,True,=,,IC50,nM,,57.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,57.0
,8018280,[],CHEMBL1949022,Competitive inhibition of MDM2/P53 interaction after 1 hr by fluorescence polarization assay,B,,,BAO_0000190,BAO_0000224,protein format,COc1ccc(C2=NC(c3ccc(Cl)cc3)C(c3ccc(Cl)cc3)N2C(=O)N2CCN(C(C)=O)CC2)c(OC(C)C)c1,,,CHEMBL1944528,Bioorg. Med. Chem.,2012,"{'bei': '8.73', 'le': '0.17', 'lle': '-1.30', 'sei': '7.12'}",CHEMBL1818538,,CHEMBL1818538,5.32,False,http://www.openphacts.org/units/Nanomolar,1573678,=,1,True,=,,IC50,nM,,4780.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,uM,UO_0000065,,4.78
,8018281,[],CHEMBL1949022,Competitive inhibition of MDM2/P53 interaction after 1 hr by fluorescence polarization assay,B,,,BAO_0000190,BAO_0000224,protein format,CCOC(=O)CNC(=O)N1C(c2ccc(OC)cc2OC(C)C)=N[C@H](c2ccc(Cl)cc2)[C@@H]1c1ccc(Cl)cc1,,,CHEMBL1944528,Bioorg. Med. Chem.,2012,"{'bei': '9.18', 'le': '0.18', 'lle': '-1.24', 'sei': '6.00'}",CHEMBL1944935,,CHEMBL1944935,5.37,False,http://www.openphacts.org/units/Nanomolar,1573826,=,1,True,=,,IC50,nM,,4290.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,uM,UO_0000065,,4.29
,8018282,[],CHEMBL1949022,Competitive inhibition of MDM2/P53 interaction after 1 hr by fluorescence polarization assay,B,,,BAO_0000190,BAO_0000224,protein format,CCOC(=O)CCNC(=O)N1C(c2ccc(OC)cc2OC(C)C)=N[C@H](c2ccc(Cl)cc2)[C@@H]1c1ccc(Cl)cc1,,,CHEMBL1944528,Bioorg. Med. Chem.,2012,"{'bei': '9.15', 'le': '0.18', 'lle': '-1.53', 'sei': '6.12'}",CHEMBL1944936,,CHEMBL1944936,5.47,False,http://www.openphacts.org/units/Nanomolar,1573827,=,1,True,=,,IC50,nM,,3360.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,uM,UO_0000065,,3.36
,8018283,[],CHEMBL1949022,Competitive inhibition of MDM2/P53 interaction after 1 hr by fluorescence polarization assay,B,,,BAO_0000190,BAO_0000224,protein format,CCOC(=O)[C@@H](C)NC(=O)N1C(c2ccc(OC)cc2OC(C)C)=N[C@H](c2ccc(Cl)cc2)[C@@H]1c1ccc(Cl)cc1,,,CHEMBL1944528,Bioorg. Med. Chem.,2012,"{'bei': '10.41', 'le': '0.21', 'lle': '-0.77', 'sei': '6.96'}",CHEMBL1944937,,CHEMBL1944937,6.23,False,http://www.openphacts.org/units/Nanomolar,1573828,=,1,True,=,,IC50,nM,,590.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,uM,UO_0000065,,0.59
,8018284,[],CHEMBL1949022,Competitive inhibition of MDM2/P53 interaction after 1 hr by fluorescence polarization assay,B,,,BAO_0000190,BAO_0000224,protein format,CCOC(=O)[C@H](C)NC(=O)N1C(c2ccc(OC)cc2OC(C)C)=N[C@H](c2ccc(Cl)cc2)[C@@H]1c1ccc(Cl)cc1,,,CHEMBL1944528,Bioorg. Med. Chem.,2012,"{'bei': '10.15', 'le': '0.20', 'lle': '-0.92', 'sei': '6.79'}",CHEMBL1944938,,CHEMBL1944938,6.08,False,http://www.openphacts.org/units/Nanomolar,1573829,=,1,True,=,,IC50,nM,,840.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,uM,UO_0000065,,0.84
,8018285,[],CHEMBL1949022,Competitive inhibition of MDM2/P53 interaction after 1 hr by fluorescence polarization assay,B,,,BAO_0000190,BAO_0000224,protein format,CCOC(=O)CCCNC(=O)N1C(c2ccc(OC)cc2OC(C)C)=N[C@H](c2ccc(Cl)cc2)[C@@H]1c1ccc(Cl)cc1,,,CHEMBL1944528,Bioorg. Med. Chem.,2012,"{'bei': '9.44', 'le': '0.19', 'lle': '-1.61', 'sei': '6.46'}",CHEMBL1944939,,CHEMBL1944939,5.78,False,http://www.openphacts.org/units/Nanomolar,1573830,=,1,True,=,,IC50,nM,,1660.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,uM,UO_0000065,,1.66
,8018286,[],CHEMBL1949022,Competitive inhibition of MDM2/P53 interaction after 1 hr by fluorescence polarization assay,B,,,BAO_0000190,BAO_0000224,protein format,COc1ccc(C2=N[C@H](c3ccc(Cl)cc3)[C@H](c3ccc(Cl)cc3)N2C(=O)NCC(=O)O)c(OC(C)C)c1,,,CHEMBL1944528,Bioorg. Med. Chem.,2012,"{'bei': '9.36', 'le': '0.19', 'lle': '-0.92', 'sei': '5.19'}",CHEMBL1944940,,CHEMBL1944940,5.21,False,http://www.openphacts.org/units/Nanomolar,1573831,=,1,True,=,,IC50,nM,,6180.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,uM,UO_0000065,,6.18
,8018287,[],CHEMBL1949022,Competitive inhibition of MDM2/P53 interaction after 1 hr by fluorescence polarization assay,B,,,BAO_0000190,BAO_0000224,protein format,COc1ccc(C2=N[C@H](c3ccc(Cl)cc3)[C@H](c3ccc(Cl)cc3)N2C(=O)NCCC(=O)O)c(OC(C)C)c1,,,CHEMBL1944528,Bioorg. Med. Chem.,2012,"{'bei': '10.47', 'le': '0.21', 'lle': '-0.55', 'sei': '5.94'}",CHEMBL1944941,,CHEMBL1944941,5.97,False,http://www.openphacts.org/units/Nanomolar,1573832,=,1,True,=,,IC50,nM,,1070.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,uM,UO_0000065,,1.07
,8018288,[],CHEMBL1949022,Competitive inhibition of MDM2/P53 interaction after 1 hr by fluorescence polarization assay,B,,,BAO_0000190,BAO_0000224,protein format,COc1ccc(C2=N[C@H](c3ccc(Cl)cc3)[C@H](c3ccc(Cl)cc3)N2C(=O)N[C@H](C)C(=O)O)c(OC(C)C)c1,,,CHEMBL1944528,Bioorg. Med. Chem.,2012,"{'bei': '9.62', 'le': '0.19', 'lle': '-1.03', 'sei': '5.46'}",CHEMBL1944942,,CHEMBL1944942,5.49,False,http://www.openphacts.org/units/Nanomolar,1573833,=,1,True,=,,IC50,nM,,3270.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,uM,UO_0000065,,3.27
,8018289,[],CHEMBL1949022,Competitive inhibition of MDM2/P53 interaction after 1 hr by fluorescence polarization assay,B,,,BAO_0000190,BAO_0000224,protein format,COc1ccc(C2=N[C@H](c3ccc(Cl)cc3)[C@H](c3ccc(Cl)cc3)N2C(=O)N[C@@H](C)C(=O)O)c(OC(C)C)c1,,,CHEMBL1944528,Bioorg. Med. Chem.,2012,"{'bei': '9.59', 'le': '0.19', 'lle': '-1.05', 'sei': '5.44'}",CHEMBL1944943,,CHEMBL1944943,5.47,False,http://www.openphacts.org/units/Nanomolar,1573834,=,1,True,=,,IC50,nM,,3390.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,uM,UO_0000065,,3.39
,8018290,[],CHEMBL1949022,Competitive inhibition of MDM2/P53 interaction after 1 hr by fluorescence polarization assay,B,,,BAO_0000190,BAO_0000224,protein format,COc1ccc(C2=N[C@H](c3ccc(Cl)cc3)[C@H](c3ccc(Cl)cc3)N2C(=O)NCCCC(=O)O)c(OC(C)C)c1,,,CHEMBL1944528,Bioorg. Med. Chem.,2012,"{'bei': '9.73', 'le': '0.19', 'lle': '-1.22', 'sei': '5.66'}",CHEMBL1945119,,CHEMBL1945119,5.69,False,http://www.openphacts.org/units/Nanomolar,1574055,=,1,True,=,,IC50,nM,,2050.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,uM,UO_0000065,,2.05
,8018291,[],CHEMBL1949022,Competitive inhibition of MDM2/P53 interaction after 1 hr by fluorescence polarization assay,B,,,BAO_0000190,BAO_0000224,protein format,COc1ccc(C2=N[C@H](c3ccc(Cl)cc3)[C@H](c3ccc(Cl)cc3)N2C(=O)NCC(=O)N2CCOCC2)c(OC(C)C)c1,,,CHEMBL1944528,Bioorg. Med. Chem.,2012,"{'bei': '8.44', 'le': '0.17', 'lle': '-0.62', 'sei': '5.69'}",CHEMBL1945120,,CHEMBL1945120,5.28,False,http://www.openphacts.org/units/Nanomolar,1574056,=,1,True,=,,IC50,nM,,5270.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,uM,UO_0000065,,5.27
,8018292,[],CHEMBL1949022,Competitive inhibition of MDM2/P53 interaction after 1 hr by fluorescence polarization assay,B,,,BAO_0000190,BAO_0000224,protein format,CCN(CC)C(=O)CNC(=O)N1C(c2ccc(OC)cc2OC(C)C)=N[C@H](c2ccc(Cl)cc2)[C@@H]1c1ccc(Cl)cc1,,,CHEMBL1944528,Bioorg. Med. Chem.,2012,"{'bei': '8.22', 'le': '0.16', 'lle': '-1.88', 'sei': '6.02'}",CHEMBL1945121,,CHEMBL1945121,5.03,False,http://www.openphacts.org/units/Nanomolar,1574057,=,1,True,=,,IC50,nM,,9410.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,uM,UO_0000065,,9.41
,8018293,[],CHEMBL1949022,Competitive inhibition of MDM2/P53 interaction after 1 hr by fluorescence polarization assay,B,,,BAO_0000190,BAO_0000224,protein format,COc1ccc(C2=N[C@H](c3ccc(Cl)cc3)[C@H](c3ccc(Cl)cc3)N2C(=O)NCC(=O)N2CCCC2)c(OC(C)C)c1,,,CHEMBL1944528,Bioorg. Med. Chem.,2012,"{'bei': '8.18', 'le': '0.16', 'lle': '-1.68', 'sei': '5.97'}",CHEMBL1945122,,CHEMBL1945122,4.99,False,http://www.openphacts.org/units/Nanomolar,1574058,=,1,True,=,,IC50,nM,,10350.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,uM,UO_0000065,,10.35
,8018294,[],CHEMBL1949022,Competitive inhibition of MDM2/P53 interaction after 1 hr by fluorescence polarization assay,B,,,BAO_0000190,BAO_0000224,protein format,COc1ccc(C2=N[C@H](c3ccc(Cl)cc3)[C@H](c3ccc(Cl)cc3)N2C(=O)NCC(=O)N2CCN(C(C)=O)CC2)c(OC(C)C)c1,,,CHEMBL1944528,Bioorg. Med. Chem.,2012,"{'bei': '7.90', 'le': '0.16', 'lle': '-0.46', 'sei': '5.07'}",CHEMBL1945123,,CHEMBL1945123,5.26,False,http://www.openphacts.org/units/Nanomolar,1574059,=,1,True,=,,IC50,nM,,5430.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,uM,UO_0000065,,5.43
,8018295,[],CHEMBL1949022,Competitive inhibition of MDM2/P53 interaction after 1 hr by fluorescence polarization assay,B,,,BAO_0000190,BAO_0000224,protein format,COc1ccc(C2=N[C@H](c3ccc(Cl)cc3)[C@H](c3ccc(Cl)cc3)N2C(=O)NCC(=O)N2CCN(C)CC2)c(OC(C)C)c1,,,CHEMBL1944528,Bioorg. Med. Chem.,2012,"{'bei': '7.34', 'le': '0.15', 'lle': '-1.13', 'sei': '5.40'}",CHEMBL1945124,,CHEMBL1945124,4.68,False,http://www.openphacts.org/units/Nanomolar,1574060,=,1,True,=,,IC50,nM,,20650.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,uM,UO_0000065,,20.65
,8018296,[],CHEMBL1949022,Competitive inhibition of MDM2/P53 interaction after 1 hr by fluorescence polarization assay,B,,,BAO_0000190,BAO_0000224,protein format,COc1ccc(C2=N[C@H](c3ccc(Cl)cc3)[C@H](c3ccc(Cl)cc3)N2C(=O)NCCC(=O)N2CCOCC2)c(OC(C)C)c1,,,CHEMBL1944528,Bioorg. Med. Chem.,2012,"{'bei': '8.84', 'le': '0.18', 'lle': '-0.64', 'sei': '6.10'}",CHEMBL1945232,,CHEMBL1945232,5.65,False,http://www.openphacts.org/units/Nanomolar,1574253,=,1,True,=,,IC50,nM,,2230.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,uM,UO_0000065,,2.23
,8018297,[],CHEMBL1949022,Competitive inhibition of MDM2/P53 interaction after 1 hr by fluorescence polarization assay,B,,,BAO_0000190,BAO_0000224,protein format,CCN(CC)C(=O)CCNC(=O)N1C(c2ccc(OC)cc2OC(C)C)=N[C@H](c2ccc(Cl)cc2)[C@@H]1c1ccc(Cl)cc1,,,CHEMBL1944528,Bioorg. Med. Chem.,2012,"{'bei': '9.89', 'le': '0.20', 'lle': '-1.11', 'sei': '7.41'}",CHEMBL1945233,,CHEMBL1945233,6.19,False,http://www.openphacts.org/units/Nanomolar,1574254,=,1,True,=,,IC50,nM,,650.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,uM,UO_0000065,,0.65
,8018298,[],CHEMBL1949022,Competitive inhibition of MDM2/P53 interaction after 1 hr by fluorescence polarization assay,B,,,BAO_0000190,BAO_0000224,protein format,COc1ccc(C2=N[C@H](c3ccc(Cl)cc3)[C@H](c3ccc(Cl)cc3)N2C(=O)NCCC(=O)N2CCN(C)CC2)c(OC(C)C)c1,,,CHEMBL1944528,Bioorg. Med. Chem.,2012,"{'bei': '8.02', 'le': '0.16', 'lle': '-0.98', 'sei': '6.04'}",CHEMBL1945234,,CHEMBL1945234,5.23,False,http://www.openphacts.org/units/Nanomolar,1574255,=,1,True,=,,IC50,nM,,5830.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,uM,UO_0000065,,5.83
,8018299,[],CHEMBL1949022,Competitive inhibition of MDM2/P53 interaction after 1 hr by fluorescence polarization assay,B,,,BAO_0000190,BAO_0000224,protein format,CCN(CC)C(=O)[C@H](C)NC(=O)N1C(c2ccc(OC)cc2OC(C)C)=N[C@H](c2ccc(Cl)cc2)[C@@H]1c1ccc(Cl)cc1,,,CHEMBL1944528,Bioorg. Med. Chem.,2012,"{'bei': '7.83', 'le': '0.16', 'lle': '-2.40', 'sei': '5.87'}",CHEMBL1945439,,CHEMBL1945439,4.90,False,http://www.openphacts.org/units/Nanomolar,1574528,=,1,True,=,,IC50,nM,,12620.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,uM,UO_0000065,,12.62
,8018300,[],CHEMBL1949022,Competitive inhibition of MDM2/P53 interaction after 1 hr by fluorescence polarization assay,B,,,BAO_0000190,BAO_0000224,protein format,COc1ccc(C2=N[C@H](c3ccc(Cl)cc3)[C@H](c3ccc(Cl)cc3)N2C(=O)N[C@@H](C)C(=O)N2CCN(C)CC2)c(OC(C)C)c1,,,CHEMBL1944528,Bioorg. Med. Chem.,2012,"{'bei': '8.01', 'le': '0.16', 'lle': '-0.99', 'sei': '6.03'}",CHEMBL1945440,,CHEMBL1945440,5.22,False,http://www.openphacts.org/units/Nanomolar,1574529,=,1,True,=,,IC50,nM,,5960.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,uM,UO_0000065,,5.96
,8018301,[],CHEMBL1949022,Competitive inhibition of MDM2/P53 interaction after 1 hr by fluorescence polarization assay,B,,,BAO_0000190,BAO_0000224,protein format,CCN(CC)C(=O)[C@@H](C)NC(=O)N1C(c2ccc(OC)cc2OC(C)C)=N[C@H](c2ccc(Cl)cc2)[C@@H]1c1ccc(Cl)cc1,,,CHEMBL1944528,Bioorg. Med. Chem.,2012,"{'bei': '8.47', 'le': '0.17', 'lle': '-2.00', 'sei': '6.35'}",CHEMBL1945441,,CHEMBL1945441,5.30,False,http://www.openphacts.org/units/Nanomolar,1574530,=,1,True,=,,IC50,nM,,5010.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,uM,UO_0000065,,5.01
,8018302,[],CHEMBL1949022,Competitive inhibition of MDM2/P53 interaction after 1 hr by fluorescence polarization assay,B,,,BAO_0000190,BAO_0000224,protein format,COc1ccc(C2=N[C@H](c3ccc(Cl)cc3)[C@H](c3ccc(Cl)cc3)N2C(=O)N[C@H](C)C(=O)N2CCN(C)CC2)c(OC(C)C)c1,,,CHEMBL1944528,Bioorg. Med. Chem.,2012,"{'bei': '8.01', 'le': '0.16', 'lle': '-0.99', 'sei': '6.03'}",CHEMBL1945442,,CHEMBL1945442,5.22,False,http://www.openphacts.org/units/Nanomolar,1574531,=,1,True,=,,IC50,nM,,5960.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,uM,UO_0000065,,5.96
,8018303,[],CHEMBL1949022,Competitive inhibition of MDM2/P53 interaction after 1 hr by fluorescence polarization assay,B,,,BAO_0000190,BAO_0000224,protein format,CCN(CC)C(=O)CCCNC(=O)N1C(c2ccc(OC)cc2OC(C)C)=N[C@H](c2ccc(Cl)cc2)[C@@H]1c1ccc(Cl)cc1,,,CHEMBL1944528,Bioorg. Med. Chem.,2012,"{'bei': '8.41', 'le': '0.17', 'lle': '-2.31', 'sei': '6.44'}",CHEMBL1945443,,CHEMBL1945443,5.38,False,http://www.openphacts.org/units/Nanomolar,1574532,=,1,True,=,,IC50,nM,,4180.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,uM,UO_0000065,,4.18
,8018425,[],CHEMBL1949022,Competitive inhibition of MDM2/P53 interaction after 1 hr by fluorescence polarization assay,B,,,BAO_0000190,BAO_0000224,protein format,CCOC(=O)[C@@H](C)NC(=O)N1C(c2ccc(OC)cc2OC(C)C)=N[C@H](c2ccc(Cl)cc2)[C@@H]1c1ccc(Cl)cc1,,,CHEMBL1944528,Bioorg. Med. Chem.,2012,"{'bei': '10.41', 'le': '0.21', 'lle': '-0.77', 'sei': '6.96'}",CHEMBL1944937,,CHEMBL1944937,6.23,False,http://www.openphacts.org/units/Nanomolar,1573828,=,1,True,=,,IC50,nM,,588.84,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,pIC50,,UO_0000065,,6.23
,8018426,[],CHEMBL1949022,Competitive inhibition of MDM2/P53 interaction after 1 hr by fluorescence polarization assay,B,,,BAO_0000190,BAO_0000224,protein format,CCOC(=O)CCCNC(=O)N1C(c2ccc(OC)cc2OC(C)C)=N[C@H](c2ccc(Cl)cc2)[C@@H]1c1ccc(Cl)cc1,,,CHEMBL1944528,Bioorg. Med. Chem.,2012,"{'bei': '9.44', 'le': '0.19', 'lle': '-1.61', 'sei': '6.46'}",CHEMBL1944939,,CHEMBL1944939,5.78,False,http://www.openphacts.org/units/Nanomolar,1573830,=,1,True,=,,IC50,nM,,1659.59,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,pIC50,,UO_0000065,,5.78
,8018427,[],CHEMBL1949022,Competitive inhibition of MDM2/P53 interaction after 1 hr by fluorescence polarization assay,B,,,BAO_0000190,BAO_0000224,protein format,COc1ccc(C2=N[C@H](c3ccc(Cl)cc3)[C@H](c3ccc(Cl)cc3)N2C(=O)NCC(=O)O)c(OC(C)C)c1,,,CHEMBL1944528,Bioorg. Med. Chem.,2012,"{'bei': '9.36', 'le': '0.19', 'lle': '-0.92', 'sei': '5.19'}",CHEMBL1944940,,CHEMBL1944940,5.21,False,http://www.openphacts.org/units/Nanomolar,1573831,=,1,True,=,,IC50,nM,,6165.95,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,pIC50,,UO_0000065,,5.21
,8018428,[],CHEMBL1949022,Competitive inhibition of MDM2/P53 interaction after 1 hr by fluorescence polarization assay,B,,,BAO_0000190,BAO_0000224,protein format,COc1ccc(C2=N[C@H](c3ccc(Cl)cc3)[C@H](c3ccc(Cl)cc3)N2C(=O)N[C@H](C)C(=O)O)c(OC(C)C)c1,,,CHEMBL1944528,Bioorg. Med. Chem.,2012,"{'bei': '9.62', 'le': '0.19', 'lle': '-1.03', 'sei': '5.46'}",CHEMBL1944942,,CHEMBL1944942,5.49,False,http://www.openphacts.org/units/Nanomolar,1573833,=,1,True,=,,IC50,nM,,3235.94,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,pIC50,,UO_0000065,,5.49
,8018429,[],CHEMBL1949022,Competitive inhibition of MDM2/P53 interaction after 1 hr by fluorescence polarization assay,B,,,BAO_0000190,BAO_0000224,protein format,COc1ccc(C2=N[C@H](c3ccc(Cl)cc3)[C@H](c3ccc(Cl)cc3)N2C(=O)NCCCC(=O)O)c(OC(C)C)c1,,,CHEMBL1944528,Bioorg. Med. Chem.,2012,"{'bei': '9.73', 'le': '0.19', 'lle': '-1.22', 'sei': '5.66'}",CHEMBL1945119,,CHEMBL1945119,5.69,False,http://www.openphacts.org/units/Nanomolar,1574055,=,1,True,=,,IC50,nM,,2041.74,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,pIC50,,UO_0000065,,5.69
,8018430,[],CHEMBL1949022,Competitive inhibition of MDM2/P53 interaction after 1 hr by fluorescence polarization assay,B,,,BAO_0000190,BAO_0000224,protein format,COc1ccc(C2=N[C@H](c3ccc(Cl)cc3)[C@H](c3ccc(Cl)cc3)N2C(=O)NCC(=O)N2CCOCC2)c(OC(C)C)c1,,,CHEMBL1944528,Bioorg. Med. Chem.,2012,"{'bei': '8.38', 'le': '0.17', 'lle': '-0.66', 'sei': '5.65'}",CHEMBL1945120,,CHEMBL1945120,5.24,False,http://www.openphacts.org/units/Nanomolar,1574056,=,1,True,=,,IC50,nM,,5754.4,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,pIC50,,UO_0000065,,5.24
,8018431,[],CHEMBL1949022,Competitive inhibition of MDM2/P53 interaction after 1 hr by fluorescence polarization assay,B,,,BAO_0000190,BAO_0000224,protein format,CCN(CC)C(=O)CNC(=O)N1C(c2ccc(OC)cc2OC(C)C)=N[C@H](c2ccc(Cl)cc2)[C@@H]1c1ccc(Cl)cc1,,,CHEMBL1944528,Bioorg. Med. Chem.,2012,"{'bei': '8.22', 'le': '0.16', 'lle': '-1.88', 'sei': '6.03'}",CHEMBL1945121,,CHEMBL1945121,5.03,False,http://www.openphacts.org/units/Nanomolar,1574057,=,1,True,=,,IC50,nM,,9332.54,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,pIC50,,UO_0000065,,5.03
,8018432,[],CHEMBL1949022,Competitive inhibition of MDM2/P53 interaction after 1 hr by fluorescence polarization assay,B,,,BAO_0000190,BAO_0000224,protein format,COc1ccc(C2=N[C@H](c3ccc(Cl)cc3)[C@H](c3ccc(Cl)cc3)N2C(=O)NCC(=O)N2CCCC2)c(OC(C)C)c1,,,CHEMBL1944528,Bioorg. Med. Chem.,2012,"{'bei': '8.19', 'le': '0.16', 'lle': '-1.68', 'sei': '5.98'}",CHEMBL1945122,,CHEMBL1945122,4.99,False,http://www.openphacts.org/units/Nanomolar,1574058,=,1,True,=,,IC50,nM,,10232.93,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,pIC50,,UO_0000065,,4.99
,8018433,[],CHEMBL1949022,Competitive inhibition of MDM2/P53 interaction after 1 hr by fluorescence polarization assay,B,,,BAO_0000190,BAO_0000224,protein format,COc1ccc(C2=N[C@H](c3ccc(Cl)cc3)[C@H](c3ccc(Cl)cc3)N2C(=O)NCC(=O)N2CCN(C(C)=O)CC2)c(OC(C)C)c1,,,CHEMBL1944528,Bioorg. Med. Chem.,2012,"{'bei': '7.91', 'le': '0.16', 'lle': '-0.46', 'sei': '5.08'}",CHEMBL1945123,,CHEMBL1945123,5.27,False,http://www.openphacts.org/units/Nanomolar,1574059,=,1,True,=,,IC50,nM,,5370.32,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,pIC50,,UO_0000065,,5.27
,8018434,[],CHEMBL1949022,Competitive inhibition of MDM2/P53 interaction after 1 hr by fluorescence polarization assay,B,,,BAO_0000190,BAO_0000224,protein format,COc1ccc(C2=N[C@H](c3ccc(Cl)cc3)[C@H](c3ccc(Cl)cc3)N2C(=O)NCCC(=O)N2CCN(C)CC2)c(OC(C)C)c1,,,CHEMBL1944528,Bioorg. Med. Chem.,2012,"{'bei': '8.01', 'le': '0.16', 'lle': '-0.98', 'sei': '6.03'}",CHEMBL1945234,,CHEMBL1945234,5.23,False,http://www.openphacts.org/units/Nanomolar,1574255,=,1,True,=,,IC50,nM,,5888.44,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,pIC50,,UO_0000065,,5.23
,8018435,[],CHEMBL1949022,Competitive inhibition of MDM2/P53 interaction after 1 hr by fluorescence polarization assay,B,,,BAO_0000190,BAO_0000224,protein format,CCN(CC)C(=O)[C@H](C)NC(=O)N1C(c2ccc(OC)cc2OC(C)C)=N[C@H](c2ccc(Cl)cc2)[C@@H]1c1ccc(Cl)cc1,,,CHEMBL1944528,Bioorg. Med. Chem.,2012,"{'bei': '7.83', 'le': '0.16', 'lle': '-2.40', 'sei': '5.87'}",CHEMBL1945439,,CHEMBL1945439,4.90,False,http://www.openphacts.org/units/Nanomolar,1574528,=,1,True,=,,IC50,nM,,12589.25,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,pIC50,,UO_0000065,,4.9
,8018436,[],CHEMBL1949022,Competitive inhibition of MDM2/P53 interaction after 1 hr by fluorescence polarization assay,B,,,BAO_0000190,BAO_0000224,protein format,COc1ccc(C2=N[C@H](c3ccc(Cl)cc3)[C@H](c3ccc(Cl)cc3)N2C(=O)N[C@@H](C)C(=O)N2CCN(C)CC2)c(OC(C)C)c1,,,CHEMBL1944528,Bioorg. Med. Chem.,2012,"{'bei': '8.00', 'le': '0.16', 'lle': '-0.99', 'sei': '6.02'}",CHEMBL1945440,,CHEMBL1945440,5.22,False,http://www.openphacts.org/units/Nanomolar,1574529,=,1,True,=,,IC50,nM,,6025.6,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,pIC50,,UO_0000065,,5.22
,8018437,[],CHEMBL1949022,Competitive inhibition of MDM2/P53 interaction after 1 hr by fluorescence polarization assay,B,,,BAO_0000190,BAO_0000224,protein format,CCN(CC)C(=O)[C@@H](C)NC(=O)N1C(c2ccc(OC)cc2OC(C)C)=N[C@H](c2ccc(Cl)cc2)[C@@H]1c1ccc(Cl)cc1,,,CHEMBL1944528,Bioorg. Med. Chem.,2012,"{'bei': '8.47', 'le': '0.17', 'lle': '-2.00', 'sei': '6.35'}",CHEMBL1945441,,CHEMBL1945441,5.30,False,http://www.openphacts.org/units/Nanomolar,1574530,=,1,True,=,,IC50,nM,,5011.87,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,pIC50,,UO_0000065,,5.3
,8018438,[],CHEMBL1949022,Competitive inhibition of MDM2/P53 interaction after 1 hr by fluorescence polarization assay,B,,,BAO_0000190,BAO_0000224,protein format,CCN(CC)C(=O)CCCNC(=O)N1C(c2ccc(OC)cc2OC(C)C)=N[C@H](c2ccc(Cl)cc2)[C@@H]1c1ccc(Cl)cc1,,,CHEMBL1944528,Bioorg. Med. Chem.,2012,"{'bei': '8.41', 'le': '0.17', 'lle': '-2.31', 'sei': '6.45'}",CHEMBL1945443,,CHEMBL1945443,5.38,False,http://www.openphacts.org/units/Nanomolar,1574532,=,1,True,=,,IC50,nM,,4168.69,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,pIC50,,UO_0000065,,5.38
,10872743,[],CHEMBL2027062,Inhibition of p53 (18 to 26)-MDM2 (2 to 188) interaction using fluorescent dye Cy5 by TR-FRET assay,B,,,BAO_0000190,BAO_0000224,protein format,COc1ccc(Cn2c(C)nc(Cc3ccc(N)cc3)c2Cc2ccc(Cl)cc2)cc1,,,CHEMBL2021844,Bioorg. Med. Chem. Lett.,2012,"{'bei': '12.66', 'le': '0.24', 'lle': '-0.20', 'sei': '10.30'}",CHEMBL2024320,,CHEMBL2024320,5.47,False,http://www.openphacts.org/units/Nanomolar,1640152,=,1,True,=,,IC50,nM,,3400.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,uM,UO_0000065,,3.4
,10872744,[],CHEMBL2027062,Inhibition of p53 (18 to 26)-MDM2 (2 to 188) interaction using fluorescent dye Cy5 by TR-FRET assay,B,,,BAO_0000190,BAO_0000224,protein format,CC(C)CCn1cnc(-c2ccccc2)c1-c1c[nH]c2cc(Cl)ccc12,,,CHEMBL2021844,Bioorg. Med. Chem. Lett.,2012,"{'bei': '16.61', 'le': '0.32', 'lle': '-0.35', 'sei': '17.99'}",CHEMBL2024321,,CHEMBL2024321,6.05,False,http://www.openphacts.org/units/Nanomolar,1640153,=,1,True,=,,IC50,nM,,900.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,uM,UO_0000065,,0.9
,10872745,[],CHEMBL2027062,Inhibition of p53 (18 to 26)-MDM2 (2 to 188) interaction using fluorescent dye Cy5 by TR-FRET assay,B,,,BAO_0000190,BAO_0000224,protein format,Clc1ccc(Cn2cnc(-c3ccccc3)c2-c2c[nH]c3cc(Cl)ccc23)cc1,,,CHEMBL2021844,Bioorg. Med. Chem. Lett.,2012,"{'bei': '16.01', 'le': '0.32', 'lle': '-0.35', 'sei': '19.93'}",CHEMBL2024322,,CHEMBL2024322,6.70,False,http://www.openphacts.org/units/Nanomolar,1640154,=,1,True,=,,IC50,nM,,200.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,uM,UO_0000065,,0.2
,10872746,[],CHEMBL2027062,Inhibition of p53 (18 to 26)-MDM2 (2 to 188) interaction using fluorescent dye Cy5 by TR-FRET assay,B,,,BAO_0000190,BAO_0000224,protein format,O=C(NCCN1CCOCC1)c1[nH]c2cc(Cl)ccc2c1-c1c(-c2ccccc2)ncn1Cc1ccc(Cl)cc1,,,CHEMBL2021844,Bioorg. Med. Chem. Lett.,2012,"{'bei': '13.09', 'le': '0.26', 'lle': '1.40', 'sei': '10.01'}",CHEMBL2024323,,CHEMBL2024323,7.52,False,http://www.openphacts.org/units/Nanomolar,1640155,=,1,True,=,,IC50,nM,,30.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,uM,UO_0000065,,0.03
,10872747,[],CHEMBL2027062,Inhibition of p53 (18 to 26)-MDM2 (2 to 188) interaction using fluorescent dye Cy5 by TR-FRET assay,B,,,BAO_0000190,BAO_0000224,protein format,COc1ccc(C2=N[C@@H](c3ccc(Cl)cc3)[C@@H](c3ccc(Cl)cc3)N2C(=O)N2CCNC(=O)C2)c(OC(C)C)c1,,,CHEMBL2021844,Bioorg. Med. Chem. Lett.,2012,"{'bei': '13.76', 'le': '0.27', 'lle': '2.11', 'sei': '9.58'}",CHEMBL191334,NUTLIN-3,CHEMBL191334,8.00,False,http://www.openphacts.org/units/Nanomolar,1640156,=,1,True,=,,IC50,nM,,10.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,uM,UO_0000065,,0.01
,10963658,[],CHEMBL2060736,Inhibition of interaction of MDM2-p53 by HTRF assay,B,,,BAO_0000190,BAO_0000224,protein format,O=C(O)C[C@@H]1C[C@@H](c2cccc(Cl)c2)[C@@H](c2ccc(Cl)cc2)N(CC2CC2)C1=O,,,CHEMBL2057187,J. Med. Chem.,2012,"{'bei': '12.99', 'le': '0.26', 'lle': '0.07', 'sei': '9.75'}",CHEMBL2059299,,CHEMBL2059299,5.62,False,http://www.openphacts.org/units/Nanomolar,1657464,=,1,True,=,,IC50,nM,,2420.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,uM,UO_0000065,,2.42
,10963659,[],CHEMBL2060736,Inhibition of interaction of MDM2-p53 by HTRF assay,B,,,BAO_0000190,BAO_0000224,protein format,CC[C@@H](C(=O)OC(C)(C)C)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1,,,CHEMBL2057187,J. Med. Chem.,2012,"{'bei': '16.20', 'le': '0.33', 'lle': '2.01', 'sei': '10.32'}",CHEMBL2059300,,CHEMBL2059300,8.66,False,http://www.openphacts.org/units/Nanomolar,1657465,=,1,True,=,,IC50,nM,,2.2,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,2.2
,12141347,[],CHEMBL2182643,Inhibition of human MDM2-p53 interaction after 18 hrs by HTRF assay in presence of 15% human serum,B,,,BAO_0000190,BAO_0000224,protein format,CC(C)(C)C[C@H]1N[C@@H](C(=O)NCCN2CCOCC2)[C@H](c2cccc(Cl)c2F)[C@@]12C(=O)Nc1cc(Cl)ccc12,,,CHEMBL2176930,J. Med. Chem.,2012,"{'bei': '13.29', 'le': '0.27', 'lle': '3.35', 'sei': '9.28'}",CHEMBL379173,,CHEMBL379173,7.68,False,http://www.openphacts.org/units/Nanomolar,1749827,=,1,True,=,,IC50,nM,,21.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,uM,UO_0000065,,0.021
,12141348,[],CHEMBL2182643,Inhibition of human MDM2-p53 interaction after 18 hrs by HTRF assay in presence of 15% human serum,B,,,BAO_0000190,BAO_0000224,protein format,COc1ccc(C2=N[C@@H](c3ccc(Cl)cc3)[C@@H](c3ccc(Cl)cc3)N2C(=O)N2CCNC(=O)C2)c(OC(C)C)c1,,,CHEMBL2176930,J. Med. Chem.,2012,"{'bei': '12.12', 'le': '0.24', 'lle': '1.16', 'sei': '8.45'}",CHEMBL191334,NUTLIN-3,CHEMBL191334,7.05,False,http://www.openphacts.org/units/Nanomolar,1749829,=,1,True,=,,IC50,nM,,89.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,89.0
,12141349,[],CHEMBL2182643,Inhibition of human MDM2-p53 interaction after 18 hrs by HTRF assay in presence of 15% human serum,B,,,BAO_0000190,BAO_0000224,protein format,CC[C@@H]([C@H](C)O)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1,,,CHEMBL2176930,J. Med. Chem.,2012,"{'bei': '17.51', 'le': '0.36', 'lle': '2.69', 'sei': '10.76'}",CHEMBL2059435,,CHEMBL2059435,8.38,False,http://www.openphacts.org/units/Nanomolar,1749828,=,1,True,=,,IC50,nM,,4.2,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,4.2
,12141350,[],CHEMBL2182643,Inhibition of human MDM2-p53 interaction after 18 hrs by HTRF assay in presence of 15% human serum,B,,,BAO_0000190,BAO_0000224,protein format,CC[C@@H](CO)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1,,,CHEMBL2176930,J. Med. Chem.,2012,"{'bei': '17.59', 'le': '0.36', 'lle': '2.87', 'sei': '10.49'}",CHEMBL2177191,,CHEMBL2177191,8.17,False,http://www.openphacts.org/units/Nanomolar,1749841,=,1,True,=,,IC50,nM,,6.8,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,6.8
,12141351,[],CHEMBL2182643,Inhibition of human MDM2-p53 interaction after 18 hrs by HTRF assay in presence of 15% human serum,B,,,BAO_0000190,BAO_0000224,protein format,CCC(CC)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1,,,CHEMBL2176930,J. Med. Chem.,2012,"{'bei': '16.09', 'le': '0.33', 'lle': '0.72', 'sei': '12.91'}",CHEMBL2177190,,CHEMBL2177190,7.44,False,http://www.openphacts.org/units/Nanomolar,1749840,=,1,True,=,,IC50,nM,,36.3,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,36.3
,12141352,[],CHEMBL2182643,Inhibition of human MDM2-p53 interaction after 18 hrs by HTRF assay in presence of 15% human serum,B,,,BAO_0000190,BAO_0000224,protein format,CC[C@@H](C(=O)OC(C)(C)C)N1C(=O)[C@@](C)(Cc2nnn[nH]2)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1,,,CHEMBL2176930,J. Med. Chem.,2012,"{'bei': '14.41', 'le': '0.29', 'lle': '2.12', 'sei': '7.96'}",CHEMBL2177189,,CHEMBL2177189,8.05,False,http://www.openphacts.org/units/Nanomolar,1749839,=,1,True,=,,IC50,nM,,9.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,9.0
,12141353,[],CHEMBL2182643,Inhibition of human MDM2-p53 interaction after 18 hrs by HTRF assay in presence of 15% human serum,B,,,BAO_0000190,BAO_0000224,protein format,CC[C@@H](C(=O)OC(C)(C)C)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1,,,CHEMBL2176930,J. Med. Chem.,2012,"{'bei': '14.41', 'le': '0.29', 'lle': '1.05', 'sei': '9.18'}",CHEMBL2059300,,CHEMBL2059300,7.70,False,http://www.openphacts.org/units/Nanomolar,1749838,=,1,True,=,,IC50,nM,,19.9,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,19.9
,12141354,[],CHEMBL2182643,Inhibition of human MDM2-p53 interaction after 18 hrs by HTRF assay in presence of 15% human serum,B,,,BAO_0000190,BAO_0000224,protein format,CC[C@@H](C(=O)OC(C)(C)C)N1C(=O)[C@@H](Cc2nnn[nH]2)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1,,,CHEMBL2176930,J. Med. Chem.,2012,"{'bei': '14.13', 'le': '0.28', 'lle': '2.15', 'sei': '7.61'}",CHEMBL2177188,,CHEMBL2177188,7.69,False,http://www.openphacts.org/units/Nanomolar,1749837,=,1,True,=,,IC50,nM,,20.3,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,20.3
,12141355,[],CHEMBL2182643,Inhibition of human MDM2-p53 interaction after 18 hrs by HTRF assay in presence of 15% human serum,B,,,BAO_0000190,BAO_0000224,protein format,CC[C@@H](C(=O)OC(C)(C)C)N1C(=O)[C@@H](CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1,,,CHEMBL2176930,J. Med. Chem.,2012,"{'bei': '14.15', 'le': '0.29', 'lle': '1.10', 'sei': '8.78'}",CHEMBL2177187,,CHEMBL2177187,7.36,False,http://www.openphacts.org/units/Nanomolar,1749836,=,1,True,=,,IC50,nM,,43.3,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,43.3
,12141356,[],CHEMBL2182643,Inhibition of human MDM2-p53 interaction after 18 hrs by HTRF assay in presence of 15% human serum,B,,,BAO_0000190,BAO_0000224,protein format,CCOC(=O)[C@H](CC)N1C(=O)[C@@H](CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1,,,CHEMBL2176930,J. Med. Chem.,2012,"{'bei': '14.35', 'le': '0.29', 'lle': '1.59', 'sei': '8.42'}",CHEMBL2177186,,CHEMBL2177186,7.07,False,http://www.openphacts.org/units/Nanomolar,1749835,=,1,True,=,,IC50,nM,,86.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,86.0
,12141357,[],CHEMBL2182643,Inhibition of human MDM2-p53 interaction after 18 hrs by HTRF assay in presence of 15% human serum,B,,,BAO_0000190,BAO_0000224,protein format,O=C1[C@@H](Cc2nnn[nH]2)C[C@H](c2cccc(Cl)c2)[C@@H](c2ccc(Cl)cc2)N1CC1CC1,,,CHEMBL2176930,J. Med. Chem.,2012,"{'bei': '14.73', 'le': '0.30', 'lle': '1.89', 'sei': '8.99'}",CHEMBL2177185,,CHEMBL2177185,6.72,False,http://www.openphacts.org/units/Nanomolar,1749834,=,1,True,=,,IC50,nM,,190.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,uM,UO_0000065,,0.19
,12141358,[],CHEMBL2182643,Inhibition of human MDM2-p53 interaction after 18 hrs by HTRF assay in presence of 15% human serum,B,,,BAO_0000190,BAO_0000224,protein format,N#CC[C@H]1C[C@H](c2cccc(Cl)c2)[C@@H](c2ccc(Cl)cc2)N(CC2CC2)C1=O,,,CHEMBL2176930,J. Med. Chem.,2012,,CHEMBL2177184,,CHEMBL2177184,,False,http://www.openphacts.org/units/Nanomolar,1749833,>,1,True,>,,IC50,nM,,30000.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,uM,UO_0000065,,30.0
,12141359,[],CHEMBL2182643,Inhibition of human MDM2-p53 interaction after 18 hrs by HTRF assay in presence of 15% human serum,B,,,BAO_0000190,BAO_0000224,protein format,NC(=O)C[C@H]1C[C@H](c2cccc(Cl)c2)[C@@H](c2ccc(Cl)cc2)N(CC2CC2)C1=O,,,CHEMBL2176930,J. Med. Chem.,2012,"{'bei': '11.86', 'le': '0.24', 'lle': '0.17', 'sei': '8.07'}",CHEMBL2177183,,CHEMBL2177183,5.12,False,http://www.openphacts.org/units/Nanomolar,1749832,=,1,True,=,,IC50,nM,,7630.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,uM,UO_0000065,,7.63
,12141360,[],CHEMBL2182643,Inhibition of human MDM2-p53 interaction after 18 hrs by HTRF assay in presence of 15% human serum,B,,,BAO_0000190,BAO_0000224,protein format,COC(=O)C[C@H]1C[C@H](c2cccc(Cl)c2)[C@@H](c2ccc(Cl)cc2)N(CC2CC2)C1=O,,,CHEMBL2176930,J. Med. Chem.,2012,,CHEMBL2177182,,CHEMBL2177182,,False,http://www.openphacts.org/units/Nanomolar,1749831,>,1,True,>,,IC50,nM,,30000.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,uM,UO_0000065,,30.0
,12141361,[],CHEMBL2182643,Inhibition of human MDM2-p53 interaction after 18 hrs by HTRF assay in presence of 15% human serum,B,,,BAO_0000190,BAO_0000224,protein format,O=C(O)CC[C@@H]1C[C@H](c2cccc(Cl)c2)[C@@H](c2ccc(Cl)cc2)N(CC2CC2)C1=O,,,CHEMBL2176930,J. Med. Chem.,2012,"{'bei': '11.60', 'le': '0.24', 'lle': '-0.76', 'sei': '8.99'}",CHEMBL2177181,,CHEMBL2177181,5.18,False,http://www.openphacts.org/units/Nanomolar,1749830,=,1,True,=,,IC50,nM,,6640.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,uM,UO_0000065,,6.64
,12143165,[],CHEMBL2182643,Inhibition of human MDM2-p53 interaction after 18 hrs by HTRF assay in presence of 15% human serum,B,,,BAO_0000190,BAO_0000224,protein format,O=C(O)CC[C@H]1C[C@H](c2cccc(Cl)c2)[C@@H](c2ccc(Cl)cc2)N(CC2CC2)C1=O,,,CHEMBL2176930,J. Med. Chem.,2012,"{'bei': '11.60', 'le': '0.24', 'lle': '-0.76', 'sei': '8.99'}",CHEMBL2177812,,CHEMBL2177812,5.18,False,http://www.openphacts.org/units/Nanomolar,1750608,=,1,True,=,,IC50,nM,,6630.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,uM,UO_0000065,,6.63
,12143166,[],CHEMBL2182643,Inhibition of human MDM2-p53 interaction after 18 hrs by HTRF assay in presence of 15% human serum,B,,,BAO_0000190,BAO_0000224,protein format,C=CC[C@H]1C[C@H](c2cccc(Cl)c2)[C@@H](c2ccc(Cl)cc2)N(CC2CC2)C1=O,,,CHEMBL2176930,J. Med. Chem.,2012,,CHEMBL2177112,,CHEMBL2177112,,False,http://www.openphacts.org/units/Nanomolar,1750607,>,1,True,>,,IC50,nM,,30000.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,uM,UO_0000065,,30.0
,12143167,[],CHEMBL2182643,Inhibition of human MDM2-p53 interaction after 18 hrs by HTRF assay in presence of 15% human serum,B,,,BAO_0000190,BAO_0000224,protein format,O=C(O)C[C@@H]1C[C@H](c2cccc(Cl)c2)[C@@H](c2ccc(Cl)cc2)N(CC2CC2)C1=O,,,CHEMBL2176930,J. Med. Chem.,2012,"{'bei': '13.77', 'le': '0.28', 'lle': '0.40', 'sei': '10.34'}",CHEMBL2177203,,CHEMBL2177203,5.96,False,http://www.openphacts.org/units/Nanomolar,1749853,=,1,True,=,,IC50,nM,,1110.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,uM,UO_0000065,,1.11
,12143168,[],CHEMBL2182643,Inhibition of human MDM2-p53 interaction after 18 hrs by HTRF assay in presence of 15% human serum,B,,,BAO_0000190,BAO_0000224,protein format,COC(=O)CN1C(=O)CC[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1,,,CHEMBL2176930,J. Med. Chem.,2012,,CHEMBL2177202,,CHEMBL2177202,,False,http://www.openphacts.org/units/Nanomolar,1749852,>,1,True,>,,IC50,nM,,30000.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,uM,UO_0000065,,30.0
,12143169,[],CHEMBL2182643,Inhibition of human MDM2-p53 interaction after 18 hrs by HTRF assay in presence of 15% human serum,B,,,BAO_0000190,BAO_0000224,protein format,CCOC(=O)[C@H](C)N1C(=O)CC[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1,,,CHEMBL2176930,J. Med. Chem.,2012,,CHEMBL2177201,,CHEMBL2177201,,False,http://www.openphacts.org/units/Nanomolar,1749851,>,1,True,>,,IC50,nM,,30000.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,uM,UO_0000065,,30.0
,12143170,[],CHEMBL2182643,Inhibition of human MDM2-p53 interaction after 18 hrs by HTRF assay in presence of 15% human serum,B,,,BAO_0000190,BAO_0000224,protein format,CCC[C@@H](C(=O)OCC)N1C(=O)CC[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1,,,CHEMBL2176930,J. Med. Chem.,2012,,CHEMBL2177200,,CHEMBL2177200,,False,http://www.openphacts.org/units/Nanomolar,1749850,>,1,True,>,,IC50,nM,,30000.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,uM,UO_0000065,,30.0
,12143171,[],CHEMBL2182643,Inhibition of human MDM2-p53 interaction after 18 hrs by HTRF assay in presence of 15% human serum,B,,,BAO_0000190,BAO_0000224,protein format,CCOC(=O)[C@@H](CC)N1C(=O)CC[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1,,,CHEMBL2176930,J. Med. Chem.,2012,,CHEMBL2177199,,CHEMBL2177199,,False,http://www.openphacts.org/units/Nanomolar,1749849,>,1,True,>,,IC50,nM,,30000.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,uM,UO_0000065,,30.0
,12143172,[],CHEMBL2182643,Inhibition of human MDM2-p53 interaction after 18 hrs by HTRF assay in presence of 15% human serum,B,,,BAO_0000190,BAO_0000224,protein format,CCOC(=O)[C@H](CC)N1C(=O)CC[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1,,,CHEMBL2176930,J. Med. Chem.,2012,"{'bei': '10.89', 'le': '0.22', 'lle': '-1.05', 'sei': '10.14'}",CHEMBL2177198,,CHEMBL2177198,4.73,False,http://www.openphacts.org/units/Nanomolar,1749848,=,1,True,=,,IC50,nM,,18700.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,uM,UO_0000065,,18.7
,12143173,[],CHEMBL2182643,Inhibition of human MDM2-p53 interaction after 18 hrs by HTRF assay in presence of 15% human serum,B,,,BAO_0000190,BAO_0000224,protein format,O=C1CC[C@H](c2cccc(Cl)c2)[C@@H](c2ccc(Cl)cc2)N1Cc1ccccc1,,,CHEMBL2176930,J. Med. Chem.,2012,,CHEMBL2177197,,CHEMBL2177197,,False,http://www.openphacts.org/units/Nanomolar,1749847,>,1,True,>,,IC50,nM,,30000.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,uM,UO_0000065,,30.0
,12143174,[],CHEMBL2182643,Inhibition of human MDM2-p53 interaction after 18 hrs by HTRF assay in presence of 15% human serum,B,,,BAO_0000190,BAO_0000224,protein format,CCCCN1C(=O)CC[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1,,,CHEMBL2176930,J. Med. Chem.,2012,,CHEMBL2177196,,CHEMBL2177196,,False,http://www.openphacts.org/units/Nanomolar,1749846,>,1,True,>,,IC50,nM,,30000.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,uM,UO_0000065,,30.0
,12143175,[],CHEMBL2182643,Inhibition of human MDM2-p53 interaction after 18 hrs by HTRF assay in presence of 15% human serum,B,,,BAO_0000190,BAO_0000224,protein format,CC(C)CN1C(=O)CC[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1,,,CHEMBL2176930,J. Med. Chem.,2012,,CHEMBL2177195,,CHEMBL2177195,,False,http://www.openphacts.org/units/Nanomolar,1749845,>,1,True,>,,IC50,nM,,30000.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,uM,UO_0000065,,30.0
,12143176,[],CHEMBL2182643,Inhibition of human MDM2-p53 interaction after 18 hrs by HTRF assay in presence of 15% human serum,B,,,BAO_0000190,BAO_0000224,protein format,CCCN1C(=O)CC[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1,,,CHEMBL2176930,J. Med. Chem.,2012,,CHEMBL2177194,,CHEMBL2177194,,False,http://www.openphacts.org/units/Nanomolar,1749844,>,1,True,>,,IC50,nM,,30000.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,uM,UO_0000065,,30.0
,12143177,[],CHEMBL2182643,Inhibition of human MDM2-p53 interaction after 18 hrs by HTRF assay in presence of 15% human serum,B,,,BAO_0000190,BAO_0000224,protein format,O=C1CC[C@@H](c2cccc(Cl)c2)[C@H](c2ccc(Cl)cc2)N1CC1CC1,,,CHEMBL2176930,J. Med. Chem.,2012,,CHEMBL2177193,,CHEMBL2177193,,False,http://www.openphacts.org/units/Nanomolar,1749843,>,1,True,>,,IC50,nM,,30000.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,uM,UO_0000065,,30.0
,12143178,[],CHEMBL2182643,Inhibition of human MDM2-p53 interaction after 18 hrs by HTRF assay in presence of 15% human serum,B,,,BAO_0000190,BAO_0000224,protein format,O=C1CC[C@H](c2cccc(Cl)c2)[C@@H](c2ccc(Cl)cc2)N1CC1CC1,,,CHEMBL2176930,J. Med. Chem.,2012,,CHEMBL2177192,,CHEMBL2177192,,False,http://www.openphacts.org/units/Nanomolar,1749842,>,1,True,>,,IC50,nM,,30000.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,uM,UO_0000065,,30.0
,12143179,[],CHEMBL2182643,Inhibition of human MDM2-p53 interaction after 18 hrs by HTRF assay in presence of 15% human serum,B,,,BAO_0000190,BAO_0000224,protein format,O=C1CC[C@H](c2cccc(Cl)c2)[C@@H](c2ccc(Cl)cc2)N1CC1CC1,,,CHEMBL2176930,J. Med. Chem.,2012,,CHEMBL2177192,,CHEMBL2177192,,False,http://www.openphacts.org/units/Nanomolar,1750612,>,1,True,>,,IC50,nM,,30000.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,uM,UO_0000065,,30.0
,12143180,[],CHEMBL2182643,Inhibition of human MDM2-p53 interaction after 18 hrs by HTRF assay in presence of 15% human serum,B,,,BAO_0000190,BAO_0000224,protein format,O=C1CC[C@H](c2cccc(Cl)c2)[C@@H](c2ccc(Cl)cc2)N1,,,CHEMBL2176930,J. Med. Chem.,2012,,CHEMBL2177814,,CHEMBL2177814,,False,http://www.openphacts.org/units/Nanomolar,1750611,>,1,True,>,,IC50,nM,,30000.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,uM,UO_0000065,,30.0
,12143181,[],CHEMBL2182643,Inhibition of human MDM2-p53 interaction after 18 hrs by HTRF assay in presence of 15% human serum,B,,,BAO_0000190,BAO_0000224,protein format,O=C(O)C[C@H]1C[C@H](c2cccc(Cl)c2)[C@@H](c2ccc(Cl)cc2)N(CC2CC2)C1=O,,,CHEMBL2176930,J. Med. Chem.,2012,"{'bei': '14.88', 'le': '0.30', 'lle': '0.88', 'sei': '11.16'}",CHEMBL2177813,,CHEMBL2177813,6.43,False,http://www.openphacts.org/units/Nanomolar,1750610,=,1,True,=,,IC50,nM,,370.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,uM,UO_0000065,,0.37
,12143182,[],CHEMBL2182643,Inhibition of human MDM2-p53 interaction after 18 hrs by HTRF assay in presence of 15% human serum,B,,,BAO_0000190,BAO_0000224,protein format,O=C(O)C[C@@H]1C[C@@H](c2cccc(Cl)c2)[C@@H](c2ccc(Cl)cc2)N(CC2CC2)C1=O,,,CHEMBL2176930,J. Med. Chem.,2012,"{'bei': '10.93', 'le': '0.22', 'lle': '-0.83', 'sei': '8.20'}",CHEMBL2059299,,CHEMBL2059299,4.72,False,http://www.openphacts.org/units/Nanomolar,1750609,=,1,True,=,,IC50,nM,,18900.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,uM,UO_0000065,,18.9
,12143183,[],CHEMBL2182642,Inhibition of human MDM2-p53 interaction after 18 hrs by HTRF assay,B,,,BAO_0000190,BAO_0000224,protein format,CC(C)(C)C[C@H]1N[C@@H](C(=O)NCCN2CCOCC2)[C@H](c2cccc(Cl)c2F)[C@@]12C(=O)Nc1cc(Cl)ccc12,,,CHEMBL2176930,J. Med. Chem.,2012,"{'bei': '13.93', 'le': '0.28', 'lle': '3.72', 'sei': '9.73'}",CHEMBL379173,,CHEMBL379173,8.05,False,http://www.openphacts.org/units/Nanomolar,1749827,=,1,True,=,,IC50,nM,,9.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,uM,UO_0000065,,0.009
,12143184,[],CHEMBL2182642,Inhibition of human MDM2-p53 interaction after 18 hrs by HTRF assay,B,,,BAO_0000190,BAO_0000224,protein format,COc1ccc(C2=N[C@@H](c3ccc(Cl)cc3)[C@@H](c3ccc(Cl)cc3)N2C(=O)N2CCNC(=O)C2)c(OC(C)C)c1,,,CHEMBL2176930,J. Med. Chem.,2012,"{'bei': '13.33', 'le': '0.26', 'lle': '1.86', 'sei': '9.28'}",CHEMBL191334,NUTLIN-3,CHEMBL191334,7.75,False,http://www.openphacts.org/units/Nanomolar,1749829,=,1,True,=,,IC50,nM,,17.8,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,17.8
,12143185,[],CHEMBL2182642,Inhibition of human MDM2-p53 interaction after 18 hrs by HTRF assay,B,,,BAO_0000190,BAO_0000224,protein format,CC[C@@H]([C@H](C)O)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1,,,CHEMBL2176930,J. Med. Chem.,2012,"{'bei': '18.73', 'le': '0.38', 'lle': '3.27', 'sei': '11.51'}",CHEMBL2059435,,CHEMBL2059435,8.96,False,http://www.openphacts.org/units/Nanomolar,1749828,=,1,True,=,,IC50,nM,,1.1,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,1.1
,12143186,[],CHEMBL2182642,Inhibition of human MDM2-p53 interaction after 18 hrs by HTRF assay,B,,,BAO_0000190,BAO_0000224,protein format,CC[C@@H](CO)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1,,,CHEMBL2176930,J. Med. Chem.,2012,"{'bei': '18.88', 'le': '0.39', 'lle': '3.47', 'sei': '11.27'}",CHEMBL2177191,,CHEMBL2177191,8.77,False,http://www.openphacts.org/units/Nanomolar,1749841,=,1,True,=,,IC50,nM,,1.7,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,1.7
,12143187,[],CHEMBL2182642,Inhibition of human MDM2-p53 interaction after 18 hrs by HTRF assay,B,,,BAO_0000190,BAO_0000224,protein format,CCC(CC)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1,,,CHEMBL2176930,J. Med. Chem.,2012,"{'bei': '18.50', 'le': '0.38', 'lle': '1.83', 'sei': '14.85'}",CHEMBL2177190,,CHEMBL2177190,8.55,False,http://www.openphacts.org/units/Nanomolar,1749840,=,1,True,=,,IC50,nM,,2.8,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,2.8
,12143188,[],CHEMBL2182642,Inhibition of human MDM2-p53 interaction after 18 hrs by HTRF assay,B,,,BAO_0000190,BAO_0000224,protein format,CC[C@@H](C(=O)OC(C)(C)C)N1C(=O)[C@@](C)(Cc2nnn[nH]2)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1,,,CHEMBL2176930,J. Med. Chem.,2012,"{'bei': '16.20', 'le': '0.33', 'lle': '3.12', 'sei': '8.95'}",CHEMBL2177189,,CHEMBL2177189,9.05,False,http://www.openphacts.org/units/Nanomolar,1749839,=,1,True,=,,IC50,nM,,0.9,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,0.9
,12143189,[],CHEMBL2182642,Inhibition of human MDM2-p53 interaction after 18 hrs by HTRF assay,B,,,BAO_0000190,BAO_0000224,protein format,CC[C@@H](C(=O)OC(C)(C)C)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1,,,CHEMBL2176930,J. Med. Chem.,2012,"{'bei': '16.20', 'le': '0.33', 'lle': '2.01', 'sei': '10.32'}",CHEMBL2059300,,CHEMBL2059300,8.66,False,http://www.openphacts.org/units/Nanomolar,1749838,=,1,True,=,,IC50,nM,,2.2,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,2.2
,12143190,[],CHEMBL2182642,Inhibition of human MDM2-p53 interaction after 18 hrs by HTRF assay,B,,,BAO_0000190,BAO_0000224,protein format,CC[C@@H](C(=O)OC(C)(C)C)N1C(=O)[C@@H](Cc2nnn[nH]2)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1,,,CHEMBL2176930,J. Med. Chem.,2012,"{'bei': '16.06', 'le': '0.32', 'lle': '3.20', 'sei': '8.65'}",CHEMBL2177188,,CHEMBL2177188,8.74,False,http://www.openphacts.org/units/Nanomolar,1749837,=,1,True,=,,IC50,nM,,1.8,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,1.8
,12143191,[],CHEMBL2182642,Inhibition of human MDM2-p53 interaction after 18 hrs by HTRF assay,B,,,BAO_0000190,BAO_0000224,protein format,CC[C@@H](C(=O)OC(C)(C)C)N1C(=O)[C@@H](CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1,,,CHEMBL2176930,J. Med. Chem.,2012,"{'bei': '16.10', 'le': '0.33', 'lle': '2.12', 'sei': '9.98'}",CHEMBL2177187,,CHEMBL2177187,8.38,False,http://www.openphacts.org/units/Nanomolar,1749836,=,1,True,=,,IC50,nM,,4.2,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,4.2
,12143192,[],CHEMBL2182642,Inhibition of human MDM2-p53 interaction after 18 hrs by HTRF assay,B,,,BAO_0000190,BAO_0000224,protein format,CCOC(=O)[C@H](CC)N1C(=O)[C@@H](CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1,,,CHEMBL2176930,J. Med. Chem.,2012,"{'bei': '16.49', 'le': '0.34', 'lle': '2.64', 'sei': '9.68'}",CHEMBL2177186,,CHEMBL2177186,8.12,False,http://www.openphacts.org/units/Nanomolar,1749835,=,1,True,=,,IC50,nM,,7.6,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,7.6
,12143193,[],CHEMBL2182642,Inhibition of human MDM2-p53 interaction after 18 hrs by HTRF assay,B,,,BAO_0000190,BAO_0000224,protein format,O=C1[C@@H](Cc2nnn[nH]2)C[C@H](c2cccc(Cl)c2)[C@@H](c2ccc(Cl)cc2)N1CC1CC1,,,CHEMBL2176930,J. Med. Chem.,2012,"{'bei': '17.21', 'le': '0.35', 'lle': '3.02', 'sei': '10.50'}",CHEMBL2177185,,CHEMBL2177185,7.85,False,http://www.openphacts.org/units/Nanomolar,1749834,=,1,True,=,,IC50,nM,,14.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,uM,UO_0000065,,0.014
,12143194,[],CHEMBL2182642,Inhibition of human MDM2-p53 interaction after 18 hrs by HTRF assay,B,,,BAO_0000190,BAO_0000224,protein format,N#CC[C@H]1C[C@H](c2cccc(Cl)c2)[C@@H](c2ccc(Cl)cc2)N(CC2CC2)C1=O,,,CHEMBL2176930,J. Med. Chem.,2012,"{'bei': '13.62', 'le': '0.27', 'lle': '-0.36', 'sei': '12.77'}",CHEMBL2177184,,CHEMBL2177184,5.63,False,http://www.openphacts.org/units/Nanomolar,1749833,=,1,True,=,,IC50,nM,,2340.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,uM,UO_0000065,,2.34
,12143195,[],CHEMBL2182642,Inhibition of human MDM2-p53 interaction after 18 hrs by HTRF assay,B,,,BAO_0000190,BAO_0000224,protein format,NC(=O)C[C@H]1C[C@H](c2cccc(Cl)c2)[C@@H](c2ccc(Cl)cc2)N(CC2CC2)C1=O,,,CHEMBL2176930,J. Med. Chem.,2012,"{'bei': '15.23', 'le': '0.31', 'lle': '1.62', 'sei': '10.36'}",CHEMBL2177183,,CHEMBL2177183,6.57,False,http://www.openphacts.org/units/Nanomolar,1749832,=,1,True,=,,IC50,nM,,270.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,uM,UO_0000065,,0.27
,12143196,[],CHEMBL2182642,Inhibition of human MDM2-p53 interaction after 18 hrs by HTRF assay,B,,,BAO_0000190,BAO_0000224,protein format,COC(=O)C[C@H]1C[C@H](c2cccc(Cl)c2)[C@@H](c2ccc(Cl)cc2)N(CC2CC2)C1=O,,,CHEMBL2176930,J. Med. Chem.,2012,"{'bei': '13.67', 'le': '0.28', 'lle': '0.46', 'sei': '13.09'}",CHEMBL2177182,,CHEMBL2177182,6.10,False,http://www.openphacts.org/units/Nanomolar,1749831,=,1,True,=,,IC50,nM,,790.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,uM,UO_0000065,,0.79
,12143197,[],CHEMBL2182642,Inhibition of human MDM2-p53 interaction after 18 hrs by HTRF assay,B,,,BAO_0000190,BAO_0000224,protein format,O=C(O)CC[C@@H]1C[C@H](c2cccc(Cl)c2)[C@@H](c2ccc(Cl)cc2)N(CC2CC2)C1=O,,,CHEMBL2176930,J. Med. Chem.,2012,"{'bei': '14.49', 'le': '0.29', 'lle': '0.53', 'sei': '11.23'}",CHEMBL2177181,,CHEMBL2177181,6.47,False,http://www.openphacts.org/units/Nanomolar,1749830,=,1,True,=,,IC50,nM,,340.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,uM,UO_0000065,,0.34
,12143198,[],CHEMBL2182642,Inhibition of human MDM2-p53 interaction after 18 hrs by HTRF assay,B,,,BAO_0000190,BAO_0000224,protein format,O=C(O)CC[C@H]1C[C@H](c2cccc(Cl)c2)[C@@H](c2ccc(Cl)cc2)N(CC2CC2)C1=O,,,CHEMBL2176930,J. Med. Chem.,2012,"{'bei': '13.99', 'le': '0.28', 'lle': '0.30', 'sei': '10.84'}",CHEMBL2177812,,CHEMBL2177812,6.24,False,http://www.openphacts.org/units/Nanomolar,1750608,=,1,True,=,,IC50,nM,,570.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,uM,UO_0000065,,0.57
,12143199,[],CHEMBL2182642,Inhibition of human MDM2-p53 interaction after 18 hrs by HTRF assay,B,,,BAO_0000190,BAO_0000224,protein format,C=CC[C@H]1C[C@H](c2cccc(Cl)c2)[C@@H](c2ccc(Cl)cc2)N(CC2CC2)C1=O,,,CHEMBL2176930,J. Med. Chem.,2012,"{'bei': '12.52', 'le': '0.25', 'lle': '-1.46', 'sei': '25.54'}",CHEMBL2177112,,CHEMBL2177112,5.19,False,http://www.openphacts.org/units/Nanomolar,1750607,=,1,True,=,,IC50,nM,,6500.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,uM,UO_0000065,,6.5
,12143200,[],CHEMBL2182642,Inhibition of human MDM2-p53 interaction after 18 hrs by HTRF assay,B,,,BAO_0000190,BAO_0000224,protein format,O=C(O)C[C@@H]1C[C@H](c2cccc(Cl)c2)[C@@H](c2ccc(Cl)cc2)N(CC2CC2)C1=O,,,CHEMBL2176930,J. Med. Chem.,2012,"{'bei': '16.47', 'le': '0.34', 'lle': '1.57', 'sei': '12.36'}",CHEMBL2177203,,CHEMBL2177203,7.12,False,http://www.openphacts.org/units/Nanomolar,1749853,=,1,True,=,,IC50,nM,,76.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,uM,UO_0000065,,0.076
,12143201,[],CHEMBL2182642,Inhibition of human MDM2-p53 interaction after 18 hrs by HTRF assay,B,,,BAO_0000190,BAO_0000224,protein format,COC(=O)CN1C(=O)CC[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1,,,CHEMBL2176930,J. Med. Chem.,2012,"{'bei': '13.41', 'le': '0.28', 'lle': '0.65', 'sei': '11.28'}",CHEMBL2177202,,CHEMBL2177202,5.26,False,http://www.openphacts.org/units/Nanomolar,1749852,=,1,True,=,,IC50,nM,,5500.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,uM,UO_0000065,,5.5
,12143202,[],CHEMBL2182642,Inhibition of human MDM2-p53 interaction after 18 hrs by HTRF assay,B,,,BAO_0000190,BAO_0000224,protein format,CCOC(=O)[C@H](C)N1C(=O)CC[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1,,,CHEMBL2176930,J. Med. Chem.,2012,"{'bei': '13.73', 'le': '0.28', 'lle': '0.38', 'sei': '12.38'}",CHEMBL2177201,,CHEMBL2177201,5.77,False,http://www.openphacts.org/units/Nanomolar,1749851,=,1,True,=,,IC50,nM,,1700.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,uM,UO_0000065,,1.7
,12143203,[],CHEMBL2182642,Inhibition of human MDM2-p53 interaction after 18 hrs by HTRF assay,B,,,BAO_0000190,BAO_0000224,protein format,CCC[C@@H](C(=O)OCC)N1C(=O)CC[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1,,,CHEMBL2176930,J. Med. Chem.,2012,"{'bei': '13.06', 'le': '0.27', 'lle': '-0.32', 'sei': '12.56'}",CHEMBL2177200,,CHEMBL2177200,5.85,False,http://www.openphacts.org/units/Nanomolar,1749850,=,1,True,=,,IC50,nM,,1400.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,uM,UO_0000065,,1.4
,12143204,[],CHEMBL2182642,Inhibition of human MDM2-p53 interaction after 18 hrs by HTRF assay,B,,,BAO_0000190,BAO_0000224,protein format,CCOC(=O)[C@@H](CC)N1C(=O)CC[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1,,,CHEMBL2176930,J. Med. Chem.,2012,"{'bei': '12.56', 'le': '0.26', 'lle': '-0.32', 'sei': '11.71'}",CHEMBL2177199,,CHEMBL2177199,5.46,False,http://www.openphacts.org/units/Nanomolar,1749849,=,1,True,=,,IC50,nM,,3500.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,uM,UO_0000065,,3.5
,12143205,[],CHEMBL2182642,Inhibition of human MDM2-p53 interaction after 18 hrs by HTRF assay,B,,,BAO_0000190,BAO_0000224,protein format,CCOC(=O)[C@H](CC)N1C(=O)CC[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1,,,CHEMBL2176930,J. Med. Chem.,2012,"{'bei': '13.88', 'le': '0.28', 'lle': '0.25', 'sei': '12.93'}",CHEMBL2177198,,CHEMBL2177198,6.03,False,http://www.openphacts.org/units/Nanomolar,1749848,=,1,True,=,,IC50,nM,,940.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,uM,UO_0000065,,0.94
,12143206,[],CHEMBL2182642,Inhibition of human MDM2-p53 interaction after 18 hrs by HTRF assay,B,,,BAO_0000190,BAO_0000224,protein format,O=C1CC[C@H](c2cccc(Cl)c2)[C@@H](c2ccc(Cl)cc2)N1Cc1ccccc1,,,CHEMBL2176930,J. Med. Chem.,2012,"{'bei': '12.84', 'le': '0.26', 'lle': '-1.37', 'sei': '25.94'}",CHEMBL2177197,,CHEMBL2177197,5.27,False,http://www.openphacts.org/units/Nanomolar,1749847,=,1,True,=,,IC50,nM,,5400.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,uM,UO_0000065,,5.4
,12143207,[],CHEMBL2182642,Inhibition of human MDM2-p53 interaction after 18 hrs by HTRF assay,B,,,BAO_0000190,BAO_0000224,protein format,CCCCN1C(=O)CC[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1,,,CHEMBL2176930,J. Med. Chem.,2012,"{'bei': '14.80', 'le': '0.30', 'lle': '-0.67', 'sei': '27.42'}",CHEMBL2177196,,CHEMBL2177196,5.57,False,http://www.openphacts.org/units/Nanomolar,1749846,=,1,True,=,,IC50,nM,,2700.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,uM,UO_0000065,,2.7
,12143208,[],CHEMBL2182642,Inhibition of human MDM2-p53 interaction after 18 hrs by HTRF assay,B,,,BAO_0000190,BAO_0000224,protein format,CC(C)CN1C(=O)CC[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1,,,CHEMBL2176930,J. Med. Chem.,2012,"{'bei': '14.98', 'le': '0.31', 'lle': '-0.46', 'sei': '27.76'}",CHEMBL2177195,,CHEMBL2177195,5.64,False,http://www.openphacts.org/units/Nanomolar,1749845,=,1,True,=,,IC50,nM,,2300.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,uM,UO_0000065,,2.3
,12143209,[],CHEMBL2182642,Inhibition of human MDM2-p53 interaction after 18 hrs by HTRF assay,B,,,BAO_0000190,BAO_0000224,protein format,CCCN1C(=O)CC[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1,,,CHEMBL2176930,J. Med. Chem.,2012,"{'bei': '15.79', 'le': '0.33', 'lle': '-0.13', 'sei': '28.17'}",CHEMBL2177194,,CHEMBL2177194,5.72,False,http://www.openphacts.org/units/Nanomolar,1749844,=,1,True,=,,IC50,nM,,1900.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,uM,UO_0000065,,1.9
,12143210,[],CHEMBL2182642,Inhibition of human MDM2-p53 interaction after 18 hrs by HTRF assay,B,,,BAO_0000190,BAO_0000224,protein format,O=C1CC[C@@H](c2cccc(Cl)c2)[C@H](c2ccc(Cl)cc2)N1CC1CC1,,,CHEMBL2176930,J. Med. Chem.,2012,,CHEMBL2177193,,CHEMBL2177193,,False,http://www.openphacts.org/units/Nanomolar,1749843,>,1,True,>,,IC50,nM,,30000.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,uM,UO_0000065,,30.0
,12143211,[],CHEMBL2182642,Inhibition of human MDM2-p53 interaction after 18 hrs by HTRF assay,B,,,BAO_0000190,BAO_0000224,protein format,O=C1CC[C@H](c2cccc(Cl)c2)[C@@H](c2ccc(Cl)cc2)N1CC1CC1,,,CHEMBL2176930,J. Med. Chem.,2012,"{'bei': '16.26', 'le': '0.33', 'lle': '0.24', 'sei': '29.97'}",CHEMBL2177192,,CHEMBL2177192,6.09,False,http://www.openphacts.org/units/Nanomolar,1749842,=,1,True,=,,IC50,nM,,820.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,uM,UO_0000065,,0.82
,12143212,[],CHEMBL2182642,Inhibition of human MDM2-p53 interaction after 18 hrs by HTRF assay,B,,,BAO_0000190,BAO_0000224,protein format,O=C1CC[C@H](c2cccc(Cl)c2)[C@@H](c2ccc(Cl)cc2)N1CC1CC1,,,CHEMBL2176930,J. Med. Chem.,2012,"{'bei': '15.56', 'le': '0.32', 'lle': '-0.03', 'sei': '28.68'}",CHEMBL2177192,,CHEMBL2177192,5.82,False,http://www.openphacts.org/units/Nanomolar,1750612,=,1,True,=,,IC50,nM,,1500.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,uM,UO_0000065,,1.5
,12143213,[],CHEMBL2182642,Inhibition of human MDM2-p53 interaction after 18 hrs by HTRF assay,B,,,BAO_0000190,BAO_0000224,protein format,O=C1CC[C@H](c2cccc(Cl)c2)[C@@H](c2ccc(Cl)cc2)N1,,,CHEMBL2176930,J. Med. Chem.,2012,"{'bei': '15.61', 'le': '0.33', 'lle': '0.27', 'sei': '17.18'}",CHEMBL2177814,,CHEMBL2177814,5.00,False,http://www.openphacts.org/units/Nanomolar,1750611,=,1,True,=,,IC50,nM,,10000.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,uM,UO_0000065,,10.0
,12143214,[],CHEMBL2182642,Inhibition of human MDM2-p53 interaction after 18 hrs by HTRF assay,B,,,BAO_0000190,BAO_0000224,protein format,O=C(O)C[C@H]1C[C@H](c2cccc(Cl)c2)[C@@H](c2ccc(Cl)cc2)N(CC2CC2)C1=O,,,CHEMBL2176930,J. Med. Chem.,2012,"{'bei': '17.27', 'le': '0.35', 'lle': '1.92', 'sei': '12.96'}",CHEMBL2177813,,CHEMBL2177813,7.47,False,http://www.openphacts.org/units/Nanomolar,1750610,=,1,True,=,,IC50,nM,,34.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,uM,UO_0000065,,0.034
,12143215,[],CHEMBL2182642,Inhibition of human MDM2-p53 interaction after 18 hrs by HTRF assay,B,,,BAO_0000190,BAO_0000224,protein format,O=C(O)C[C@@H]1C[C@@H](c2cccc(Cl)c2)[C@@H](c2ccc(Cl)cc2)N(CC2CC2)C1=O,,,CHEMBL2176930,J. Med. Chem.,2012,"{'bei': '12.99', 'le': '0.26', 'lle': '0.07', 'sei': '9.75'}",CHEMBL2059299,,CHEMBL2059299,5.62,False,http://www.openphacts.org/units/Nanomolar,1750609,=,1,True,=,,IC50,nM,,2420.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,uM,UO_0000065,,2.42
,12639924,[],CHEMBL2321368,Inhibition of human p53/MDM2 interaction,B,,,BAO_0000190,BAO_0000224,protein format,COc1ccc(C2=N[C@@H](c3ccc(Cl)cc3)[C@@H](c3ccc(Cl)cc3)N2C(=O)N2CCNC(=O)C2)c(OC(C)C)c1,,,CHEMBL2311336,Bioorg. Med. Chem. Lett.,2013,"{'bei': '12.12', 'le': '0.24', 'lle': '1.16', 'sei': '8.44'}",CHEMBL191334,NUTLIN-3,CHEMBL191334,7.05,False,http://www.openphacts.org/units/Nanomolar,1846198,=,1,True,=,,IC50,nM,,90.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,uM,UO_0000065,,0.09
,12639926,[],CHEMBL2321370,Inhibition of human His-tagged p53/GST-tagged MDM2 interaction after 60 mins by chemiluminescence assay,B,,,BAO_0000190,BAO_0000224,protein format,CC(C)C1=C(C(=O)N2CCC[C@H]2C(=O)N2C[C@H](C)N[C@H](C)C2)SC2=N[C@@](C)(c3ccc(Cl)cc3)[C@@H](c3ccc(Cl)cc3)N21,,,CHEMBL2311336,Bioorg. Med. Chem. Lett.,2013,"{'bei': '11.60', 'le': '0.24', 'lle': '0.99', 'sei': '10.89'}",CHEMBL2315852,,CHEMBL2315852,7.43,False,http://www.openphacts.org/units/Nanomolar,1846218,=,1,True,=,,IC50,nM,,37.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,uM,UO_0000065,,0.037
,12639927,[],CHEMBL2321370,Inhibition of human His-tagged p53/GST-tagged MDM2 interaction after 60 mins by chemiluminescence assay,B,,,BAO_0000190,BAO_0000224,protein format,CC(C)C1=C(C(=O)N2CCC[C@H]2C(=O)N2CCN(C)CC2)SC2=N[C@@](C)(c3ccc(Cl)cc3)[C@@H](c3ccc(Cl)cc3)N21,,,CHEMBL2311336,Bioorg. Med. Chem. Lett.,2013,"{'bei': '12.19', 'le': '0.25', 'lle': '1.64', 'sei': '12.85'}",CHEMBL2315851,,CHEMBL2315851,7.64,False,http://www.openphacts.org/units/Nanomolar,1846217,=,1,True,=,,IC50,nM,,23.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,uM,UO_0000065,,0.023
,12639928,[],CHEMBL2321370,Inhibition of human His-tagged p53/GST-tagged MDM2 interaction after 60 mins by chemiluminescence assay,B,,,BAO_0000190,BAO_0000224,protein format,CC(C)C1=C(C(=O)N2CCC[C@H]2C(=O)N2CCNC(=O)C2)SC2=N[C@@](C)(c3ccc(Cl)cc3)[C@@H](c3ccc(Cl)cc3)N21,,,CHEMBL2311336,Bioorg. Med. Chem. Lett.,2013,"{'bei': '11.33', 'le': '0.23', 'lle': '1.91', 'sei': '8.32'}",CHEMBL2315850,,CHEMBL2315850,7.10,False,http://www.openphacts.org/units/Nanomolar,1846216,=,1,True,=,,IC50,nM,,79.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,uM,UO_0000065,,0.079
,12639929,[],CHEMBL2321370,Inhibition of human His-tagged p53/GST-tagged MDM2 interaction after 60 mins by chemiluminescence assay,B,,,BAO_0000190,BAO_0000224,protein format,CC(=O)N1CCN(C(=O)[C@@H]2CCCN2C(=O)C2=C(C(C)C)N3C(=N[C@@](C)(c4ccc(Cl)cc4)[C@H]3c3ccc(Cl)cc3)S2)CC1,,,CHEMBL2311336,Bioorg. Med. Chem. Lett.,2013,"{'bei': '10.97', 'le': '0.22', 'lle': '1.26', 'sei': '9.38'}",CHEMBL2315849,,CHEMBL2315849,7.18,False,http://www.openphacts.org/units/Nanomolar,1846215,=,1,True,=,,IC50,nM,,66.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,uM,UO_0000065,,0.066
,12639930,[],CHEMBL2321370,Inhibition of human His-tagged p53/GST-tagged MDM2 interaction after 60 mins by chemiluminescence assay,B,,,BAO_0000190,BAO_0000224,protein format,CC(C)C1=C(C(=O)N2CCC[C@H]2C(=O)N2CCOCC2)SC2=N[C@@](C)(c3ccc(Cl)cc3)[C@@H](c3ccc(Cl)cc3)N21,,,CHEMBL2311336,Bioorg. Med. Chem. Lett.,2013,"{'bei': '12.36', 'le': '0.25', 'lle': '1.50', 'sei': '11.59'}",CHEMBL2315848,,CHEMBL2315848,7.58,False,http://www.openphacts.org/units/Nanomolar,1846214,=,1,True,=,,IC50,nM,,26.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,uM,UO_0000065,,0.026
,12639931,[],CHEMBL2321370,Inhibition of human His-tagged p53/GST-tagged MDM2 interaction after 60 mins by chemiluminescence assay,B,,,BAO_0000190,BAO_0000224,protein format,COCCN(C)C(=O)[C@@H]1CCCN1C(=O)C1=C(C(C)C)N2C(=N[C@@](C)(c3ccc(Cl)cc3)[C@H]2c2ccc(Cl)cc2)S1,,,CHEMBL2311336,Bioorg. Med. Chem. Lett.,2013,"{'bei': '11.92', 'le': '0.24', 'lle': '1.01', 'sei': '11.21'}",CHEMBL2315847,,CHEMBL2315847,7.34,False,http://www.openphacts.org/units/Nanomolar,1846213,=,1,True,=,,IC50,nM,,46.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,uM,UO_0000065,,0.046
,12639932,[],CHEMBL2321370,Inhibition of human His-tagged p53/GST-tagged MDM2 interaction after 60 mins by chemiluminescence assay,B,,,BAO_0000190,BAO_0000224,protein format,CC(C)C1=C(C(=O)N2CCCC[C@H]2C(=O)N(C)C)SC2=NC(C)(c3ccc(Cl)cc3)C(c3ccc(Cl)cc3)N21,,,CHEMBL2311336,Bioorg. Med. Chem. Lett.,2013,"{'bei': '11.56', 'le': '0.24', 'lle': '0.06', 'sei': '12.04'}",CHEMBL2315845,,CHEMBL2315845,6.77,False,http://www.openphacts.org/units/Nanomolar,1846211,=,1,True,=,,IC50,nM,,170.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,uM,UO_0000065,,0.17
,12639933,[],CHEMBL2321370,Inhibition of human His-tagged p53/GST-tagged MDM2 interaction after 60 mins by chemiluminescence assay,B,,,BAO_0000190,BAO_0000224,protein format,CC(C)C1=C(C(=O)N2CCC[C@@H]2C(=O)N(C)C)SC2=NC(C)(c3ccc(Cl)cc3)C(c3ccc(Cl)cc3)N21,,,CHEMBL2311336,Bioorg. Med. Chem. Lett.,2013,"{'bei': '10.73', 'le': '0.22', 'lle': '-0.19', 'sei': '10.90'}",CHEMBL2315844,,CHEMBL2315844,6.13,False,http://www.openphacts.org/units/Nanomolar,1846210,=,1,True,=,,IC50,nM,,740.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,uM,UO_0000065,,0.74
,12639934,[],CHEMBL2321370,Inhibition of human His-tagged p53/GST-tagged MDM2 interaction after 60 mins by chemiluminescence assay,B,,,BAO_0000190,BAO_0000224,protein format,CC(C)C1=C(C(=O)N2CCC[C@H]2C(=O)N(C)C)SC2=N[C@@](C)(c3ccc(Cl)cc3)[C@@H](c3ccc(Cl)cc3)N21,,,CHEMBL2311336,Bioorg. Med. Chem. Lett.,2013,"{'bei': '14.06', 'le': '0.29', 'lle': '1.72', 'sei': '14.29'}",CHEMBL2315843,,CHEMBL2315843,8.04,False,http://www.openphacts.org/units/Nanomolar,1846209,=,1,True,=,,IC50,nM,,9.2,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,uM,UO_0000065,,0.0092
,12639935,[],CHEMBL2321370,Inhibition of human His-tagged p53/GST-tagged MDM2 interaction after 60 mins by chemiluminescence assay,B,,,BAO_0000190,BAO_0000224,protein format,CC(C)C1=C(C(=O)N2CCC[C@H]2C(=O)N(C)C)SC2=NC(C)(c3ccc(Cl)cc3)C(c3ccc(Cl)cc3)N21,,,CHEMBL2311336,Bioorg. Med. Chem. Lett.,2013,"{'bei': '12.65', 'le': '0.26', 'lle': '0.91', 'sei': '12.86'}",CHEMBL2315842,,CHEMBL2315842,7.23,False,http://www.openphacts.org/units/Nanomolar,1846208,=,1,True,=,,IC50,nM,,59.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,uM,UO_0000065,,0.059
,12639936,[],CHEMBL2321370,Inhibition of human His-tagged p53/GST-tagged MDM2 interaction after 60 mins by chemiluminescence assay,B,,,BAO_0000190,BAO_0000224,protein format,CC(C)C1=C(C(=O)N2CNC(=O)C2)SC2=NC(C)(c3ccc(Cl)cc3)C(c3ccc(Cl)cc3)N21,,,CHEMBL2311336,Bioorg. Med. Chem. Lett.,2013,"{'bei': '11.69', 'le': '0.24', 'lle': '0.88', 'sei': '9.27'}",CHEMBL2315841,,CHEMBL2315841,6.03,False,http://www.openphacts.org/units/Nanomolar,1846207,=,1,True,=,,IC50,nM,,940.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,uM,UO_0000065,,0.94
,12639937,[],CHEMBL2321370,Inhibition of human His-tagged p53/GST-tagged MDM2 interaction after 60 mins by chemiluminescence assay,B,,,BAO_0000190,BAO_0000224,protein format,CC(C)C1=C(C(=O)N2CCCC2)SC2=NC(C)(c3ccc(Cl)cc3)C(c3ccc(Cl)cc3)N21,,,CHEMBL2311336,Bioorg. Med. Chem. Lett.,2013,"{'bei': '13.38', 'le': '0.28', 'lle': '-0.16', 'sei': '18.65'}",CHEMBL2315840,,CHEMBL2315840,6.70,False,http://www.openphacts.org/units/Nanomolar,1846206,=,1,True,=,,IC50,nM,,200.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,uM,UO_0000065,,0.2
,12639938,[],CHEMBL2321370,Inhibition of human His-tagged p53/GST-tagged MDM2 interaction after 60 mins by chemiluminescence assay,B,,,BAO_0000190,BAO_0000224,protein format,CC(C)C1=C(C(=O)N(C)C)SC2=N[C@@](C)(c3ccc(Cl)cc3)[C@@H](c3ccc(Cl)cc3)N21,,,CHEMBL2311336,Bioorg. Med. Chem. Lett.,2013,"{'bei': '15.99', 'le': '0.33', 'lle': '1.27', 'sei': '21.12'}",CHEMBL2315839,,CHEMBL2315839,7.58,False,http://www.openphacts.org/units/Nanomolar,1846205,=,1,True,=,,IC50,nM,,26.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,uM,UO_0000065,,0.026
,12639939,[],CHEMBL2321370,Inhibition of human His-tagged p53/GST-tagged MDM2 interaction after 60 mins by chemiluminescence assay,B,,,BAO_0000190,BAO_0000224,protein format,CC(C)C1=C(C(=O)N(C)C)SC2=NC(C)(c3ccc(Cl)cc3)C(c3ccc(Cl)cc3)N21,,,CHEMBL2311336,Bioorg. Med. Chem. Lett.,2013,"{'bei': '15.55', 'le': '0.32', 'lle': '1.06', 'sei': '20.54'}",CHEMBL2315838,,CHEMBL2315838,7.38,False,http://www.openphacts.org/units/Nanomolar,1846204,=,1,True,=,,IC50,nM,,42.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,uM,UO_0000065,,0.042
,12639940,[],CHEMBL2321370,Inhibition of human His-tagged p53/GST-tagged MDM2 interaction after 60 mins by chemiluminescence assay,B,,,BAO_0000190,BAO_0000224,protein format,CNC(=O)C1=C(C(C)C)N2C(=NC(C)(c3ccc(Cl)cc3)C2c2ccc(Cl)cc2)S1,,,CHEMBL2311336,Bioorg. Med. Chem. Lett.,2013,"{'bei': '12.94', 'le': '0.27', 'lle': '-0.02', 'sei': '13.33'}",CHEMBL2315837,,CHEMBL2315837,5.96,False,http://www.openphacts.org/units/Nanomolar,1846203,=,1,True,=,,IC50,nM,,1100.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,uM,UO_0000065,,1.1
,12639941,[],CHEMBL2321370,Inhibition of human His-tagged p53/GST-tagged MDM2 interaction after 60 mins by chemiluminescence assay,B,,,BAO_0000190,BAO_0000224,protein format,CC(C)C1=C(C(N)=O)SC2=NC(C)(c3ccc(Cl)cc3)C(c3ccc(Cl)cc3)N21,,,CHEMBL2311336,Bioorg. Med. Chem. Lett.,2013,"{'bei': '13.68', 'le': '0.29', 'lle': '0.39', 'sei': '10.41'}",CHEMBL2315836,,CHEMBL2315836,6.11,False,http://www.openphacts.org/units/Nanomolar,1846202,=,1,True,=,,IC50,nM,,780.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,uM,UO_0000065,,0.78
,12639942,[],CHEMBL2321370,Inhibition of human His-tagged p53/GST-tagged MDM2 interaction after 60 mins by chemiluminescence assay,B,,,BAO_0000190,BAO_0000224,protein format,CC(C)C1=C(C(=O)N2CCNC(=O)C2)SC2=N[C@](C)(c3ccc(Cl)cc3)[C@H](c3ccc(Cl)cc3)N21,,,CHEMBL2311336,Bioorg. Med. Chem. Lett.,2013,"{'bei': '11.00', 'le': '0.23', 'lle': '0.63', 'sei': '8.96'}",CHEMBL2315835,,CHEMBL2315835,5.82,False,http://www.openphacts.org/units/Nanomolar,1846201,=,1,True,=,,IC50,nM,,1500.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,uM,UO_0000065,,1.5
,12639943,[],CHEMBL2321370,Inhibition of human His-tagged p53/GST-tagged MDM2 interaction after 60 mins by chemiluminescence assay,B,,,BAO_0000190,BAO_0000224,protein format,CC(C)C1=C(C(=O)N2CCNC(=O)C2)SC2=N[C@@](C)(c3ccc(Cl)cc3)[C@@H](c3ccc(Cl)cc3)N21,,,CHEMBL2311336,Bioorg. Med. Chem. Lett.,2013,"{'bei': '13.29', 'le': '0.27', 'lle': '1.85', 'sei': '10.82'}",CHEMBL2315834,,CHEMBL2315834,7.04,False,http://www.openphacts.org/units/Nanomolar,1846200,=,1,True,=,,IC50,nM,,92.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,uM,UO_0000065,,0.092
,12639944,[],CHEMBL2321370,Inhibition of human His-tagged p53/GST-tagged MDM2 interaction after 60 mins by chemiluminescence assay,B,,,BAO_0000190,BAO_0000224,protein format,CC(C)C1=C(C(=O)N2CCNC(=O)C2)SC2=NC(C)(c3ccc(Cl)cc3)C(c3ccc(Cl)cc3)N21,,,CHEMBL2311336,Bioorg. Med. Chem. Lett.,2013,"{'bei': '12.06', 'le': '0.25', 'lle': '1.20', 'sei': '9.82'}",CHEMBL2315833,,CHEMBL2315833,6.39,False,http://www.openphacts.org/units/Nanomolar,1846199,=,1,True,=,,IC50,nM,,410.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,uM,UO_0000065,,0.41
,13360488,[],CHEMBL2401351,"Inhibition of GST-tagged MDM2 (25 to 108, L33E)/His-tagged p53 (1 to 132) interaction (unknown origin) after 1 hr by HTRF assay",B,Q00987,L33E,BAO_0000190,BAO_0000224,protein format,CC[C@@H]1CC[C@@H](C(=O)N2CCOCC2)N1C(=O)C1=C(C(C)C)N2C(=N[C@@](C)(c3ccc(Cl)cc3)[C@H]2c2ccc(Cl)cc2)S1,,,CHEMBL2396597,Bioorg. Med. Chem.,2013,"{'bei': '11.17', 'le': '0.23', 'lle': '0.31', 'sei': '10.95'}",CHEMBL2398245,,CHEMBL2398245,7.17,False,http://www.openphacts.org/units/Nanomolar,1903846,=,1,True,=,,IC50,nM,,68.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,uM,UO_0000065,,0.068
,13360489,[],CHEMBL2401351,"Inhibition of GST-tagged MDM2 (25 to 108, L33E)/His-tagged p53 (1 to 132) interaction (unknown origin) after 1 hr by HTRF assay",B,Q00987,L33E,BAO_0000190,BAO_0000224,protein format,CC[C@@H]1CC[C@@H](C(=O)N2CCN(C(C)=O)[C@@H](C)C2)N1C(=O)C1=C(C(C)C)N2C(=N[C@@](C)(c3ccc(Cl)cc3)[C@H]2c2ccc(Cl)cc2)S1,,,CHEMBL2396597,Bioorg. Med. Chem.,2013,"{'bei': '10.38', 'le': '0.21', 'lle': '0.15', 'sei': '9.45'}",CHEMBL2398243,,CHEMBL2398243,7.23,False,http://www.openphacts.org/units/Nanomolar,1903844,=,1,True,=,,IC50,nM,,59.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,uM,UO_0000065,,0.059
,13360490,[],CHEMBL2401351,"Inhibition of GST-tagged MDM2 (25 to 108, L33E)/His-tagged p53 (1 to 132) interaction (unknown origin) after 1 hr by HTRF assay",B,Q00987,L33E,BAO_0000190,BAO_0000224,protein format,CC[C@@H]1CC[C@@H](C(=O)N2CCN(C(C)=O)[C@H](C)C2)N1C(=O)C1=C(C(C)C)N2C(=N[C@@](C)(c3ccc(Cl)cc3)[C@H]2c2ccc(Cl)cc2)S1,,,CHEMBL2396597,Bioorg. Med. Chem.,2013,"{'bei': '10.39', 'le': '0.21', 'lle': '0.16', 'sei': '9.46'}",CHEMBL2398242,,CHEMBL2398242,7.24,False,http://www.openphacts.org/units/Nanomolar,1903843,=,1,True,=,,IC50,nM,,58.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,uM,UO_0000065,,0.058
,13360491,[],CHEMBL2401351,"Inhibition of GST-tagged MDM2 (25 to 108, L33E)/His-tagged p53 (1 to 132) interaction (unknown origin) after 1 hr by HTRF assay",B,Q00987,L33E,BAO_0000190,BAO_0000224,protein format,CC[C@@H]1CC[C@@H](C(=O)N2CCN(C(C)=O)CC2)N1C(=O)C1=C(C(C)C)N2C(=N[C@@](C)(c3ccc(Cl)cc3)[C@H]2c2ccc(Cl)cc2)S1,,,CHEMBL2396597,Bioorg. Med. Chem.,2013,"{'bei': '10.79', 'le': '0.22', 'lle': '0.67', 'sei': '9.63'}",CHEMBL2398244,,CHEMBL2398244,7.37,False,http://www.openphacts.org/units/Nanomolar,1903845,=,1,True,=,,IC50,nM,,43.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,uM,UO_0000065,,0.043
,13360492,[],CHEMBL2401351,"Inhibition of GST-tagged MDM2 (25 to 108, L33E)/His-tagged p53 (1 to 132) interaction (unknown origin) after 1 hr by HTRF assay",B,Q00987,L33E,BAO_0000190,BAO_0000224,protein format,CC[C@H]1CC[C@@H](C(=O)N(C)C)N1C(=O)C1=C(C(C)C)N2C(=N[C@@](C)(c3ccc(Cl)cc3)[C@H]2c2ccc(Cl)cc2)S1,,,CHEMBL2396597,Bioorg. Med. Chem.,2013,"{'bei': '12.36', 'le': '0.25', 'lle': '0.32', 'sei': '13.18'}",CHEMBL2398341,,CHEMBL2398341,7.41,False,http://www.openphacts.org/units/Nanomolar,1903951,=,1,True,=,,IC50,nM,,39.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,uM,UO_0000065,,0.039
,13360493,[],CHEMBL2401351,"Inhibition of GST-tagged MDM2 (25 to 108, L33E)/His-tagged p53 (1 to 132) interaction (unknown origin) after 1 hr by HTRF assay",B,Q00987,L33E,BAO_0000190,BAO_0000224,protein format,CC(=O)N1CCN(C(=O)[C@@H]2CC[C@@H](C)N2C(=O)C2=C(C(C)C)N3C(=N[C@@](C)(c4ccc(Cl)cc4)[C@H]3c3ccc(Cl)cc3)S2)C[C@@H]1C,,,CHEMBL2396597,Bioorg. Med. Chem.,2013,"{'bei': '10.89', 'le': '0.22', 'lle': '0.74', 'sei': '9.71'}",CHEMBL2398238,,CHEMBL2398238,7.43,False,http://www.openphacts.org/units/Nanomolar,1903839,=,1,True,=,,IC50,nM,,37.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,uM,UO_0000065,,0.037
,13360494,[],CHEMBL2401351,"Inhibition of GST-tagged MDM2 (25 to 108, L33E)/His-tagged p53 (1 to 132) interaction (unknown origin) after 1 hr by HTRF assay",B,Q00987,L33E,BAO_0000190,BAO_0000224,protein format,CC[C@@H]1CC[C@@H](C(=O)N2CCN(C)[C@@H](C)C2)N1C(=O)C1=C(C(C)C)N2C(=N[C@@](C)(c3ccc(Cl)cc3)[C@H]2c2ccc(Cl)cc2)S1,,,CHEMBL2396597,Bioorg. Med. Chem.,2013,"{'bei': '11.25', 'le': '0.23', 'lle': '0.35', 'sei': '12.65'}",CHEMBL2398241,,CHEMBL2398241,7.52,False,http://www.openphacts.org/units/Nanomolar,1903842,=,1,True,=,,IC50,nM,,30.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,uM,UO_0000065,,0.03
,13361381,[],CHEMBL2401351,"Inhibition of GST-tagged MDM2 (25 to 108, L33E)/His-tagged p53 (1 to 132) interaction (unknown origin) after 1 hr by HTRF assay",B,Q00987,L33E,BAO_0000190,BAO_0000224,protein format,CC(=O)N1CCN(C(=O)[C@@H]2CC[C@@H](C)N2C(=O)C2=C(C(C)C)N3C(=N[C@@](C)(c4ccc(Cl)cc4)[C@H]3c3ccc(Cl)cc3)S2)C[C@H]1C,,,CHEMBL2396597,Bioorg. Med. Chem.,2013,"{'bei': '11.02', 'le': '0.22', 'lle': '0.83', 'sei': '9.83'}",CHEMBL2398237,,CHEMBL2398237,7.52,False,http://www.openphacts.org/units/Nanomolar,1903838,=,1,True,=,,IC50,nM,,30.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,uM,UO_0000065,,0.03
,13361382,[],CHEMBL2401351,"Inhibition of GST-tagged MDM2 (25 to 108, L33E)/His-tagged p53 (1 to 132) interaction (unknown origin) after 1 hr by HTRF assay",B,Q00987,L33E,BAO_0000190,BAO_0000224,protein format,CC[C@@H]1CC[C@@H](C(=O)N2CCN(C)CC2)N1C(=O)C1=C(C(C)C)N2C(=N[C@@](C)(c3ccc(Cl)cc3)[C@H]2c2ccc(Cl)cc2)S1,,,CHEMBL2396597,Bioorg. Med. Chem.,2013,"{'bei': '11.49', 'le': '0.23', 'lle': '0.74', 'sei': '12.65'}",CHEMBL2398346,,CHEMBL2398346,7.52,False,http://www.openphacts.org/units/Nanomolar,1903956,=,1,True,=,,IC50,nM,,30.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,uM,UO_0000065,,0.03
,13361383,[],CHEMBL2401351,"Inhibition of GST-tagged MDM2 (25 to 108, L33E)/His-tagged p53 (1 to 132) interaction (unknown origin) after 1 hr by HTRF assay",B,Q00987,L33E,BAO_0000190,BAO_0000224,protein format,CC[C@@H]1CC[C@@H](C(=O)N2CCN(C)[C@H](C)C2)N1C(=O)C1=C(C(C)C)N2C(=N[C@@](C)(c3ccc(Cl)cc3)[C@H]2c2ccc(Cl)cc2)S1,,,CHEMBL2396597,Bioorg. Med. Chem.,2013,"{'bei': '11.27', 'le': '0.23', 'lle': '0.37', 'sei': '12.68'}",CHEMBL2398240,,CHEMBL2398240,7.54,False,http://www.openphacts.org/units/Nanomolar,1903841,=,1,True,=,,IC50,nM,,29.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,uM,UO_0000065,,0.029
,13361384,[],CHEMBL2401351,"Inhibition of GST-tagged MDM2 (25 to 108, L33E)/His-tagged p53 (1 to 132) interaction (unknown origin) after 1 hr by HTRF assay",B,Q00987,L33E,BAO_0000190,BAO_0000224,protein format,CC(=O)N1CCN(C(=O)[C@@H]2CC[C@@H](C)N2C(=O)C2=C(C(C)C)N3C(=N[C@@](C)(c4ccc(Cl)cc4)[C@H]3c3ccc(Cl)cc3)S2)CC1,,,CHEMBL2396597,Bioorg. Med. Chem.,2013,"{'bei': '11.34', 'le': '0.23', 'lle': '1.28', 'sei': '9.91'}",CHEMBL2398345,,CHEMBL2398345,7.58,False,http://www.openphacts.org/units/Nanomolar,1903955,=,1,True,=,,IC50,nM,,26.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,uM,UO_0000065,,0.026
,13361386,[],CHEMBL2401351,"Inhibition of GST-tagged MDM2 (25 to 108, L33E)/His-tagged p53 (1 to 132) interaction (unknown origin) after 1 hr by HTRF assay",B,Q00987,L33E,BAO_0000190,BAO_0000224,protein format,CC(C)C1=C(C(=O)N2[C@H](C(=O)N3CCN(C)C(C)(C)C3)CC[C@H]2C)SC2=N[C@@](C)(c3ccc(Cl)cc3)[C@@H](c3ccc(Cl)cc3)N21,,,CHEMBL2396597,Bioorg. Med. Chem.,2013,"{'bei': '11.58', 'le': '0.24', 'lle': '0.57', 'sei': '13.03'}",CHEMBL2398239,,CHEMBL2398239,7.75,False,http://www.openphacts.org/units/Nanomolar,1903840,=,1,True,=,,IC50,nM,,18.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,uM,UO_0000065,,0.018
,13361387,[],CHEMBL2401351,"Inhibition of GST-tagged MDM2 (25 to 108, L33E)/His-tagged p53 (1 to 132) interaction (unknown origin) after 1 hr by HTRF assay",B,Q00987,L33E,BAO_0000190,BAO_0000224,protein format,CC[C@@H]1CC[C@@H](C(=O)N(C)C)N1C(=O)C1=C(C(C)C)N2C(=N[C@@](C)(c3ccc(Cl)cc3)[C@H]2c2ccc(Cl)cc2)S1,,,CHEMBL2396597,Bioorg. Med. Chem.,2013,"{'bei': '12.92', 'le': '0.26', 'lle': '0.65', 'sei': '13.78'}",CHEMBL2398343,,CHEMBL2398343,7.75,False,http://www.openphacts.org/units/Nanomolar,1903953,=,1,True,=,,IC50,nM,,18.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,uM,UO_0000065,,0.018
,13361388,[],CHEMBL2401351,"Inhibition of GST-tagged MDM2 (25 to 108, L33E)/His-tagged p53 (1 to 132) interaction (unknown origin) after 1 hr by HTRF assay",B,Q00987,L33E,BAO_0000190,BAO_0000224,protein format,CC(C)C1=C(C(=O)N2[C@H](C(=O)N3CCN(C)[C@@H](C)C3)CC[C@H]2C)SC2=N[C@@](C)(c3ccc(Cl)cc3)[C@@H](c3ccc(Cl)cc3)N21,,,CHEMBL2396597,Bioorg. Med. Chem.,2013,"{'bei': '11.91', 'le': '0.24', 'lle': '1.02', 'sei': '13.11'}",CHEMBL2398247,,CHEMBL2398247,7.80,False,http://www.openphacts.org/units/Nanomolar,1903848,=,1,True,=,,IC50,nM,,16.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,uM,UO_0000065,,0.016
,13361389,[],CHEMBL2401351,"Inhibition of GST-tagged MDM2 (25 to 108, L33E)/His-tagged p53 (1 to 132) interaction (unknown origin) after 1 hr by HTRF assay",B,Q00987,L33E,BAO_0000190,BAO_0000224,protein format,CC(C)C1=C(C(=O)N2[C@H](C(=O)N3CCN(C)CC3)CC[C@H]2C)SC2=N[C@@](C)(c3ccc(Cl)cc3)[C@@H](c3ccc(Cl)cc3)N21,,,CHEMBL2396597,Bioorg. Med. Chem.,2013,"{'bei': '12.17', 'le': '0.25', 'lle': '1.41', 'sei': '13.11'}",CHEMBL2398344,,CHEMBL2398344,7.80,False,http://www.openphacts.org/units/Nanomolar,1903954,=,1,True,=,,IC50,nM,,16.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,uM,UO_0000065,,0.016
,13361390,[],CHEMBL2401351,"Inhibition of GST-tagged MDM2 (25 to 108, L33E)/His-tagged p53 (1 to 132) interaction (unknown origin) after 1 hr by HTRF assay",B,Q00987,L33E,BAO_0000190,BAO_0000224,protein format,CC(C)C1=C(C(=O)N2[C@H](C(=O)N3CCN(C)[C@H](C)C3)CC[C@H]2C)SC2=N[C@@](C)(c3ccc(Cl)cc3)[C@@H](c3ccc(Cl)cc3)N21,,,CHEMBL2396597,Bioorg. Med. Chem.,2013,"{'bei': '11.95', 'le': '0.24', 'lle': '1.04', 'sei': '13.16'}",CHEMBL2398246,,CHEMBL2398246,7.82,False,http://www.openphacts.org/units/Nanomolar,1903847,=,1,True,=,,IC50,nM,,15.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,uM,UO_0000065,,0.015
,13361391,[],CHEMBL2401351,"Inhibition of GST-tagged MDM2 (25 to 108, L33E)/His-tagged p53 (1 to 132) interaction (unknown origin) after 1 hr by HTRF assay",B,Q00987,L33E,BAO_0000190,BAO_0000224,protein format,CC(C)C1=C(C(=O)N2[C@H](C(=O)N(C)C)CC[C@H]2C)SC2=N[C@@](C)(c3ccc(Cl)cc3)[C@@H](c3ccc(Cl)cc3)N21,,,CHEMBL2396597,Bioorg. Med. Chem.,2013,"{'bei': '13.41', 'le': '0.28', 'lle': '1.15', 'sei': '13.97'}",CHEMBL2398342,,CHEMBL2398342,7.85,False,http://www.openphacts.org/units/Nanomolar,1903952,=,1,True,=,,IC50,nM,,14.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,uM,UO_0000065,,0.014
,13361392,[],CHEMBL2401351,"Inhibition of GST-tagged MDM2 (25 to 108, L33E)/His-tagged p53 (1 to 132) interaction (unknown origin) after 1 hr by HTRF assay",B,Q00987,L33E,BAO_0000190,BAO_0000224,protein format,CC(C)C1=C(C(=O)N2[C@@H](C)CC[C@H]2C(=O)N(C)C)SC2=N[C@@](C)(c3ccc(Cl)cc3)[C@@H](c3ccc(Cl)cc3)N21,,,CHEMBL2396597,Bioorg. Med. Chem.,2013,"{'bei': '13.41', 'le': '0.28', 'lle': '1.15', 'sei': '13.97'}",CHEMBL2398248,,CHEMBL2398248,7.85,False,http://www.openphacts.org/units/Nanomolar,1903850,=,1,True,=,,IC50,nM,,14.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,uM,UO_0000065,,0.014
,13361393,[],CHEMBL2401351,"Inhibition of GST-tagged MDM2 (25 to 108, L33E)/His-tagged p53 (1 to 132) interaction (unknown origin) after 1 hr by HTRF assay",B,Q00987,L33E,BAO_0000190,BAO_0000224,protein format,CC(C)C1=C(C(=O)N2CCC[C@H]2C(=O)N(C)C)SC2=N[C@@](C)(c3ccc(Cl)cc3)[C@@H](c3ccc(Cl)cc3)N21,,,CHEMBL2396597,Bioorg. Med. Chem.,2013,"{'bei': '14.14', 'le': '0.29', 'lle': '1.76', 'sei': '14.37'}",CHEMBL2315843,,CHEMBL2315843,8.08,False,http://www.openphacts.org/units/Nanomolar,1903849,=,1,True,=,,IC50,nM,,8.3,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,uM,UO_0000065,,0.0083
,13903513,[],CHEMBL3119571,Inhibition of human MDM2/p53 interaction by fluorescence polarization assay,B,,,BAO_0000190,BAO_0000224,protein format,Cl.O=C(NCCc1ccccc1)C1(Oc2ccc(C(F)(F)F)cc2)CCCN(C(=O)C2(c3ccc(Cl)cc3)CC2)C1,,,CHEMBL3112574,Bioorg. Med. Chem. Lett.,2014,"{'bei': '10.25', 'le': '0.20', 'lle': '-0.34', 'sei': '9.98'}",CHEMBL3112777,,CHEMBL3139640,5.85,False,http://www.openphacts.org/units/Nanomolar,1963355,=,1,True,=,,IC50,nM,,1400.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,uM,UO_0000065,,1.4
,13903514,[],CHEMBL3119571,Inhibition of human MDM2/p53 interaction by fluorescence polarization assay,B,,,BAO_0000190,BAO_0000224,protein format,COCCOc1ccccc1N1CCN(C(=O)C2(Oc3ccc(C(F)(F)F)cc3)CCCN(C(=O)c3cnccc3C(F)(F)F)C2)CC1.Cl,,,CHEMBL3112574,Bioorg. Med. Chem. Lett.,2014,"{'bei': '9.98', 'le': '0.19', 'lle': '1.25', 'sei': '8.05'}",CHEMBL3112778,,CHEMBL3139643,6.80,False,http://www.openphacts.org/units/Nanomolar,1963356,=,1,True,=,,IC50,nM,,160.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,160.0
,13903526,[],CHEMBL3119571,Inhibition of human MDM2/p53 interaction by fluorescence polarization assay,B,,,BAO_0000190,BAO_0000224,protein format,CC(C)S(=O)(=O)N1CCCC(Oc2ccc(C(F)(F)F)cc2)(C(=O)N2CCN(c3ccccn3)CC2)C1.Cl,,,CHEMBL3112574,Bioorg. Med. Chem. Lett.,2014,"{'bei': '9.55', 'le': '0.19', 'lle': '1.76', 'sei': '6.21'}",CHEMBL3112827,,CHEMBL3139382,5.16,False,http://www.openphacts.org/units/Nanomolar,1963406,=,1,True,=,,IC50,nM,,6900.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,uM,UO_0000065,,6.9
,13903527,[],CHEMBL3119571,Inhibition of human MDM2/p53 interaction by fluorescence polarization assay,B,,,BAO_0000190,BAO_0000224,protein format,Cl.O=C(N1CCN(c2ccccn2)CC1)C1(Oc2ccc(C(F)(F)F)cc2)CCCN(S(=O)(=O)c2ccc(Cl)cc2)C1,,,CHEMBL3112574,Bioorg. Med. Chem. Lett.,2014,"{'bei': '7.06', 'le': '0.14', 'lle': '-0.40', 'sei': '5.18'}",CHEMBL3112826,,CHEMBL3139627,4.30,False,http://www.openphacts.org/units/Nanomolar,1963405,=,1,True,=,,IC50,nM,,50000.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,uM,UO_0000065,,50.0
,13903528,[],CHEMBL3119571,Inhibition of human MDM2/p53 interaction by fluorescence polarization assay,B,,,BAO_0000190,BAO_0000224,protein format,Cl.O=C(N1CCN(c2ccccn2)CC1)C1(Oc2ccc(C(F)(F)F)cc2)CCCN(S(=O)(=O)c2ccccc2Cl)C1,,,CHEMBL3112574,Bioorg. Med. Chem. Lett.,2014,"{'bei': '7.40', 'le': '0.15', 'lle': '-0.19', 'sei': '5.43'}",CHEMBL3112825,,CHEMBL3139472,4.51,False,http://www.openphacts.org/units/Nanomolar,1963404,=,1,True,=,,IC50,nM,,31000.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,uM,UO_0000065,,31.0
,13903529,[],CHEMBL3119571,Inhibition of human MDM2/p53 interaction by fluorescence polarization assay,B,,,BAO_0000190,BAO_0000224,protein format,Cl.O=C(N1CCN(c2ccccn2)CC1)C1(Oc2ccc(C(F)(F)F)cc2)CCCN(S(=O)(=O)c2ccccc2C(F)(F)F)C1,,,CHEMBL3112574,Bioorg. Med. Chem. Lett.,2014,"{'bei': '6.83', 'le': '0.14', 'lle': '-0.68', 'sei': '5.28'}",CHEMBL3112824,,CHEMBL3139256,4.39,False,http://www.openphacts.org/units/Nanomolar,1963403,=,1,True,=,,IC50,nM,,41000.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,uM,UO_0000065,,41.0
,13903530,[],CHEMBL3119571,Inhibition of human MDM2/p53 interaction by fluorescence polarization assay,B,,,BAO_0000190,BAO_0000224,protein format,Cl.O=C(N1CCN(c2ccccn2)CC1)C1(Oc2ccc(C(F)(F)F)cc2)CCCN(S(=O)(=O)c2ccccc2)C1,,,CHEMBL3112574,Bioorg. Med. Chem. Lett.,2014,"{'bei': '7.98', 'le': '0.16', 'lle': '0.54', 'sei': '5.52'}",CHEMBL3112823,,CHEMBL3139305,4.58,False,http://www.openphacts.org/units/Nanomolar,1963402,=,1,True,=,,IC50,nM,,26000.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,uM,UO_0000065,,26.0
,13903531,[],CHEMBL3119571,Inhibition of human MDM2/p53 interaction by fluorescence polarization assay,B,,,BAO_0000190,BAO_0000224,protein format,Cl.O=C(N1CCN(c2ccccn2)CC1)C1(Oc2ccc(C(F)(F)F)cc2)CCCN(C(=O)C2(c3ccc(Cl)cc3)CC2)C1,,,CHEMBL3112574,Bioorg. Med. Chem. Lett.,2014,"{'bei': '9.33', 'le': '0.18', 'lle': '0.15', 'sei': '8.67'}",CHEMBL3112822,,CHEMBL3139388,5.72,False,http://www.openphacts.org/units/Nanomolar,1963401,=,1,True,=,,IC50,nM,,1900.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,uM,UO_0000065,,1.9
,13903532,[],CHEMBL3119571,Inhibition of human MDM2/p53 interaction by fluorescence polarization assay,B,,,BAO_0000190,BAO_0000224,protein format,CC(C)(C)C(=O)N1CCCC(Oc2ccc(C(F)(F)F)cc2)(C(=O)N2CCN(c3ccccn3)CC2)C1.Cl,,,CHEMBL3112574,Bioorg. Med. Chem. Lett.,2014,"{'bei': '8.98', 'le': '0.17', 'lle': '0.42', 'sei': '7.06'}",CHEMBL3112821,,CHEMBL3139387,4.66,False,http://www.openphacts.org/units/Nanomolar,1963400,=,1,True,=,,IC50,nM,,22000.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,uM,UO_0000065,,22.0
,13903533,[],CHEMBL3119571,Inhibition of human MDM2/p53 interaction by fluorescence polarization assay,B,,,BAO_0000190,BAO_0000224,protein format,CC(C)(C)CC(=O)N1CCCC(Oc2ccc(C(F)(F)F)cc2)(C(=O)N2CCN(c3ccccn3)CC2)C1.Cl,,,CHEMBL3112574,Bioorg. Med. Chem. Lett.,2014,"{'bei': '10.37', 'le': '0.20', 'lle': '0.89', 'sei': '8.37'}",CHEMBL3112820,,CHEMBL3139304,5.52,False,http://www.openphacts.org/units/Nanomolar,1963399,=,1,True,=,,IC50,nM,,3000.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,uM,UO_0000065,,3.0
,13903534,[],CHEMBL3119571,Inhibition of human MDM2/p53 interaction by fluorescence polarization assay,B,,,BAO_0000190,BAO_0000224,protein format,Cl.O=C(N1CCN(c2ccccn2)CC1)C1(Oc2ccc(C(F)(F)F)cc2)CCCN(CC2CCCCC2)C1,,,CHEMBL3112574,Bioorg. Med. Chem. Lett.,2014,"{'bei': '9.97', 'le': '0.19', 'lle': '0.05', 'sei': '10.82'}",CHEMBL3112819,,CHEMBL3139386,5.29,False,http://www.openphacts.org/units/Nanomolar,1963398,=,1,True,=,,IC50,nM,,5100.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,uM,UO_0000065,,5.1
,13903535,[],CHEMBL3119571,Inhibition of human MDM2/p53 interaction by fluorescence polarization assay,B,,,BAO_0000190,BAO_0000224,protein format,CC(C)(C)CCN1CCCC(Oc2ccc(C(F)(F)F)cc2)(C(=O)N2CCN(c3ccccn3)CC2)C1.Cl,,,CHEMBL3112574,Bioorg. Med. Chem. Lett.,2014,"{'bei': '9.95', 'le': '0.19', 'lle': '0.06', 'sei': '10.55'}",CHEMBL3112818,,CHEMBL3139310,5.16,False,http://www.openphacts.org/units/Nanomolar,1963397,=,1,True,=,,IC50,nM,,6900.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,uM,UO_0000065,,6.9
,13903536,[],CHEMBL3119571,Inhibition of human MDM2/p53 interaction by fluorescence polarization assay,B,,,BAO_0000190,BAO_0000224,protein format,CCCN1CCCC(Oc2ccc(C(F)(F)F)cc2)(C(=O)N2CCN(c3ccccn3)CC2)C1.Cl,,,CHEMBL3112574,Bioorg. Med. Chem. Lett.,2014,"{'bei': '10.88', 'le': '0.21', 'lle': '1.12', 'sei': '10.61'}",CHEMBL3112817,,CHEMBL3139630,5.19,False,http://www.openphacts.org/units/Nanomolar,1963396,=,1,True,=,,IC50,nM,,6500.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,uM,UO_0000065,,6.5
,13903537,[],CHEMBL3119571,Inhibition of human MDM2/p53 interaction by fluorescence polarization assay,B,,,BAO_0000190,BAO_0000224,protein format,Cl.O=C(N1CCN(c2ccccn2)CC1)C1(Oc2ccc(C(F)(F)F)cc2)CCCN(Cc2ccccc2C(F)(F)F)C1,,,CHEMBL3112574,Bioorg. Med. Chem. Lett.,2014,"{'bei': '8.19', 'le': '0.16', 'lle': '-1.03', 'sei': '9.92'}",CHEMBL3112816,,CHEMBL3139309,4.85,False,http://www.openphacts.org/units/Nanomolar,1963395,=,1,True,=,,IC50,nM,,14000.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,uM,UO_0000065,,14.0
,13903538,[],CHEMBL3119571,Inhibition of human MDM2/p53 interaction by fluorescence polarization assay,B,,,BAO_0000190,BAO_0000224,protein format,Cl.O=C(c1ccccc1C(F)(F)F)N1CCCC(Oc2ccc(C(F)(F)F)cc2)(C(=O)N2CCN(c3ccccn3)CC2)C1,,,CHEMBL3112574,Bioorg. Med. Chem. Lett.,2014,"{'bei': '8.55', 'le': '0.16', 'lle': '-0.33', 'sei': '7.86'}",CHEMBL3112815,,CHEMBL3139532,5.19,False,http://www.openphacts.org/units/Nanomolar,1963394,=,1,True,=,,IC50,nM,,6500.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,uM,UO_0000065,,6.5
,13903539,[],CHEMBL3119571,Inhibition of human MDM2/p53 interaction by fluorescence polarization assay,B,,,BAO_0000190,BAO_0000224,protein format,Cl.O=C(CC1NC(=O)NC1=O)Nc1ccccc1N1CCN(C(=O)C2(Oc3ccc(C(F)(F)F)cc3)CCCN(C(=O)c3cnccc3C(F)(F)F)C2)CC1,,,CHEMBL3112574,Bioorg. Med. Chem. Lett.,2014,"{'bei': '8.62', 'le': '0.17', 'lle': '2.51', 'sei': '4.29'}",CHEMBL3112814,,CHEMBL3139287,6.57,False,http://www.openphacts.org/units/Nanomolar,1963393,=,1,True,=,,IC50,nM,,270.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,uM,UO_0000065,,0.27
,13903540,[],CHEMBL3119571,Inhibition of human MDM2/p53 interaction by fluorescence polarization assay,B,,,BAO_0000190,BAO_0000224,protein format,Cc1cc(CC(=O)Nc2ccccc2N2CCN(C(=O)C3(Oc4ccc(C(F)(F)F)cc4)CCCN(C(=O)c4cnccc4C(F)(F)F)C3)CC2)on1.Cl,,,CHEMBL3112574,Bioorg. Med. Chem. Lett.,2014,"{'bei': '8.33', 'le': '0.16', 'lle': '0.20', 'sei': '5.12'}",CHEMBL3112813,,CHEMBL3138998,6.20,False,http://www.openphacts.org/units/Nanomolar,1963392,=,1,True,=,,IC50,nM,,630.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,uM,UO_0000065,,0.63
,13903541,[],CHEMBL3119571,Inhibition of human MDM2/p53 interaction by fluorescence polarization assay,B,,,BAO_0000190,BAO_0000224,protein format,CN(C)CCCC(=O)Nc1ccccc1N1CCN(C(=O)C2(Oc3ccc(C(F)(F)F)cc3)CCCN(C(=O)c3cnccc3C(F)(F)F)C2)CC1.Cl,,,CHEMBL3112574,Bioorg. Med. Chem. Lett.,2014,"{'bei': '8.12', 'le': '0.16', 'lle': '0.17', 'sei': '6.07'}",CHEMBL3112812,,CHEMBL3139558,5.97,False,http://www.openphacts.org/units/Nanomolar,1963391,=,1,True,=,,IC50,nM,,1080.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,uM,UO_0000065,,1.08
,13903542,[],CHEMBL3119571,Inhibition of human MDM2/p53 interaction by fluorescence polarization assay,B,,,BAO_0000190,BAO_0000224,protein format,CN(C)CCC(=O)Nc1ccccc1N1CCN(C(=O)C2(Oc3ccc(C(F)(F)F)cc3)CCCN(C(=O)c3cnccc3C(F)(F)F)C2)CC1.Cl,,,CHEMBL3112574,Bioorg. Med. Chem. Lett.,2014,"{'bei': '8.64', 'le': '0.17', 'lle': '0.82', 'sei': '6.34'}",CHEMBL3112811,,CHEMBL3139645,6.23,False,http://www.openphacts.org/units/Nanomolar,1963390,=,1,True,=,,IC50,nM,,590.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,uM,UO_0000065,,0.59
,13903543,[],CHEMBL3119571,Inhibition of human MDM2/p53 interaction by fluorescence polarization assay,B,,,BAO_0000190,BAO_0000224,protein format,CN(C)CC(=O)Nc1ccccc1N1CCN(C(=O)C2(Oc3ccc(C(F)(F)F)cc3)CCCN(C(=O)c3cnccc3C(F)(F)F)C2)CC1.Cl,,,CHEMBL3112574,Bioorg. Med. Chem. Lett.,2014,"{'bei': '8.74', 'le': '0.17', 'lle': '1.15', 'sei': '6.28'}",CHEMBL3112810,,CHEMBL3139644,6.17,False,http://www.openphacts.org/units/Nanomolar,1963389,=,1,True,=,,IC50,nM,,670.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,uM,UO_0000065,,0.67
,13903544,[],CHEMBL3119571,Inhibition of human MDM2/p53 interaction by fluorescence polarization assay,B,,,BAO_0000190,BAO_0000224,protein format,COCC(=O)Nc1ccccc1N1CCN(C(=O)C2(Oc3ccc(C(F)(F)F)cc3)CCCN(C(=O)c3cnccc3C(F)(F)F)C2)CC1.Cl,,,CHEMBL3112574,Bioorg. Med. Chem. Lett.,2014,"{'bei': '9.04', 'le': '0.17', 'lle': '1.16', 'sei': '6.01'}",CHEMBL3112809,,CHEMBL3139314,6.27,False,http://www.openphacts.org/units/Nanomolar,1963388,=,1,True,=,,IC50,nM,,540.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,uM,UO_0000065,,0.54
,13903545,[],CHEMBL3119571,Inhibition of human MDM2/p53 interaction by fluorescence polarization assay,B,,,BAO_0000190,BAO_0000224,protein format,CCC(=O)Nc1ccccc1N1CCN(C(=O)C2(Oc3ccc(C(F)(F)F)cc3)CCCN(C(=O)c3cnccc3C(F)(F)F)C2)CC1.Cl,,,CHEMBL3112574,Bioorg. Med. Chem. Lett.,2014,"{'bei': '9.49', 'le': '0.18', 'lle': '0.56', 'sei': '6.76'}",CHEMBL3112808,,CHEMBL3139288,6.43,False,http://www.openphacts.org/units/Nanomolar,1963387,=,1,True,=,,IC50,nM,,370.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,uM,UO_0000065,,0.37
,13903546,[],CHEMBL3119571,Inhibition of human MDM2/p53 interaction by fluorescence polarization assay,B,,,BAO_0000190,BAO_0000224,protein format,CC(=O)Nc1ccccc1N1CCN(C(=O)C2(Oc3ccc(C(F)(F)F)cc3)CCCN(C(=O)c3cnccc3C(F)(F)F)C2)CC1.Cl,,,CHEMBL3112574,Bioorg. Med. Chem. Lett.,2014,"{'bei': '9.67', 'le': '0.19', 'lle': '0.94', 'sei': '6.75'}",CHEMBL3112807,,CHEMBL3138990,6.42,False,http://www.openphacts.org/units/Nanomolar,1963386,=,1,True,=,,IC50,nM,,380.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,uM,UO_0000065,,0.38
,13903547,[],CHEMBL3119571,Inhibition of human MDM2/p53 interaction by fluorescence polarization assay,B,,,BAO_0000190,BAO_0000224,protein format,COCCOc1ccccc1N1CCN(C(=O)C2(Oc3ccc(C(F)(F)F)cc3)CCCN(C(=O)c3cnccc3C(F)(F)F)C2)CC1.Cl,,,CHEMBL3112574,Bioorg. Med. Chem. Lett.,2014,"{'bei': '9.52', 'le': '0.18', 'lle': '0.93', 'sei': '7.68'}",CHEMBL3112778,,CHEMBL3139643,6.48,False,http://www.openphacts.org/units/Nanomolar,1963385,=,1,True,=,,IC50,nM,,330.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,uM,UO_0000065,,0.33
,13903548,[],CHEMBL3119571,Inhibition of human MDM2/p53 interaction by fluorescence polarization assay,B,,,BAO_0000190,BAO_0000224,protein format,CCOc1ccccc1N1CCN(C(=O)C2(Oc3ccc(C(F)(F)F)cc3)CCCN(C(=O)c3cnccc3C(F)(F)F)C2)CC1.Cl,,,CHEMBL3112574,Bioorg. Med. Chem. Lett.,2014,"{'bei': '9.57', 'le': '0.18', 'lle': '0.31', 'sei': '8.28'}",CHEMBL3112806,,CHEMBL3139317,6.23,False,http://www.openphacts.org/units/Nanomolar,1963384,=,1,True,=,,IC50,nM,,590.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,uM,UO_0000065,,0.59
,13903549,[],CHEMBL3119571,Inhibition of human MDM2/p53 interaction by fluorescence polarization assay,B,,,BAO_0000190,BAO_0000224,protein format,Cl.O=C(c1cnccc1C(F)(F)F)N1CCCC(Oc2ccc(C(F)(F)F)cc2)(C(=O)N2CCN(c3ccccc3O)CC2)C1,,,CHEMBL3112574,Bioorg. Med. Chem. Lett.,2014,"{'bei': '9.66', 'le': '0.19', 'lle': '0.78', 'sei': '6.98'}",CHEMBL3112805,,CHEMBL3139565,6.01,False,http://www.openphacts.org/units/Nanomolar,1963383,=,1,True,=,,IC50,nM,,970.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,uM,UO_0000065,,0.97
,13903550,[],CHEMBL3119571,Inhibition of human MDM2/p53 interaction by fluorescence polarization assay,B,,,BAO_0000190,BAO_0000224,protein format,COc1ccc(N2CCN(C(=O)C3(Oc4ccc(C(F)(F)F)cc4)CCCN(C(=O)c4cnccc4C(F)(F)F)C3)CC2)cc1.Cl,,,CHEMBL3112574,Bioorg. Med. Chem. Lett.,2014,"{'bei': '7.29', 'le': '0.14', 'lle': '-0.89', 'sei': '6.17'}",CHEMBL3112804,,CHEMBL3139460,4.64,False,http://www.openphacts.org/units/Nanomolar,1963382,=,1,True,=,,IC50,nM,,23000.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,uM,UO_0000065,,23.0
,13903551,[],CHEMBL3119571,Inhibition of human MDM2/p53 interaction by fluorescence polarization assay,B,,,BAO_0000190,BAO_0000224,protein format,COc1cccc(N2CCN(C(=O)C3(Oc4ccc(C(F)(F)F)cc4)CCCN(C(=O)c4cnccc4C(F)(F)F)C3)CC2)c1.Cl,,,CHEMBL3112574,Bioorg. Med. Chem. Lett.,2014,,CHEMBL3112803,,CHEMBL3139540,,False,http://www.openphacts.org/units/Nanomolar,1963381,>,1,True,>,,IC50,nM,,50000.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,uM,UO_0000065,,50.0
,13903552,[],CHEMBL3119571,Inhibition of human MDM2/p53 interaction by fluorescence polarization assay,B,,,BAO_0000190,BAO_0000224,protein format,COc1ccccc1N1CCN(C(=O)C2(Oc3ccc(C(F)(F)F)cc3)CCCN(C(=O)c3cnccc3C(F)(F)F)C2)CC1.Cl,,,CHEMBL3112574,Bioorg. Med. Chem. Lett.,2014,"{'bei': '9.82', 'le': '0.19', 'lle': '0.72', 'sei': '8.31'}",CHEMBL3112802,,CHEMBL3139619,6.25,False,http://www.openphacts.org/units/Nanomolar,1963380,=,1,True,=,,IC50,nM,,560.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,uM,UO_0000065,,0.56
,13903553,[],CHEMBL3119571,Inhibition of human MDM2/p53 interaction by fluorescence polarization assay,B,,,BAO_0000190,BAO_0000224,protein format,Cl.O=C(c1cnccc1C(F)(F)F)N1CCCC(Oc2ccc(C(F)(F)F)cc2)(C(=O)NCCc2ccccc2)C1,,,CHEMBL3112574,Bioorg. Med. Chem. Lett.,2014,"{'bei': '9.65', 'le': '0.19', 'lle': '-0.07', 'sei': '7.63'}",CHEMBL3112801,,CHEMBL3139374,5.46,False,http://www.openphacts.org/units/Nanomolar,1963379,=,1,True,=,,IC50,nM,,3500.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,uM,UO_0000065,,3.5
,13903554,[],CHEMBL3119571,Inhibition of human MDM2/p53 interaction by fluorescence polarization assay,B,,,BAO_0000190,BAO_0000224,protein format,Cl.O=C(c1cnccc1C(F)(F)F)N1CCCC(Oc2ccc(C(F)(F)F)cc2)(C(=O)NCc2ccc(Cl)cc2)C1,,,CHEMBL3112574,Bioorg. Med. Chem. Lett.,2014,"{'bei': '9.94', 'le': '0.20', 'lle': '-0.32', 'sei': '8.14'}",CHEMBL3112800,,CHEMBL3139465,5.82,False,http://www.openphacts.org/units/Nanomolar,1963378,=,1,True,=,,IC50,nM,,1500.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,uM,UO_0000065,,1.5
,13903555,[],CHEMBL3119571,Inhibition of human MDM2/p53 interaction by fluorescence polarization assay,B,,,BAO_0000190,BAO_0000224,protein format,Cl.O=C(c1cnccc1C(F)(F)F)N1CCCC(Oc2ccc(C(F)(F)F)cc2)(C(=O)N2CCc3ccccc3C2)C1,,,CHEMBL3112574,Bioorg. Med. Chem. Lett.,2014,"{'bei': '10.14', 'le': '0.19', 'lle': '0.09', 'sei': '9.33'}",CHEMBL3112799,,CHEMBL3139653,5.85,False,http://www.openphacts.org/units/Nanomolar,1963377,=,1,True,=,,IC50,nM,,1400.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,uM,UO_0000065,,1.4
,13903556,[],CHEMBL3119571,Inhibition of human MDM2/p53 interaction by fluorescence polarization assay,B,,,BAO_0000190,BAO_0000224,protein format,Cl.O=C(c1cnccc1C(F)(F)F)N1CCCC(Oc2ccc(C(F)(F)F)cc2)(C(=O)N2CCC(c3ccccn3)C2)C1,,,CHEMBL3112574,Bioorg. Med. Chem. Lett.,2014,"{'bei': '9.17', 'le': '0.18', 'lle': '-0.15', 'sei': '7.18'}",CHEMBL3112798,,CHEMBL3139652,5.43,False,http://www.openphacts.org/units/Nanomolar,1963376,=,1,True,=,,IC50,nM,,3700.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,uM,UO_0000065,,3.7
,13903557,[],CHEMBL3119571,Inhibition of human MDM2/p53 interaction by fluorescence polarization assay,B,,,BAO_0000190,BAO_0000224,protein format,Cl.O=C(c1cnccc1C(F)(F)F)N1CCCC(Oc2ccc(C(F)(F)F)cc2)(C(=O)N2CC=C(c3ccccc3)CC2)C1,,,CHEMBL3112574,Bioorg. Med. Chem. Lett.,2014,"{'bei': '9.70', 'le': '0.19', 'lle': '-0.64', 'sei': '9.33'}",CHEMBL3112797,,CHEMBL3139471,5.85,False,http://www.openphacts.org/units/Nanomolar,1963375,=,1,True,=,,IC50,nM,,1400.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,uM,UO_0000065,,1.4
,13903558,[],CHEMBL3119571,Inhibition of human MDM2/p53 interaction by fluorescence polarization assay,B,,,BAO_0000190,BAO_0000224,protein format,Cl.O=C(c1cnccc1C(F)(F)F)N1CCCC(Oc2ccc(C(F)(F)F)cc2)(C(=O)N2CCN(Cc3ccccc3)CC2)C1,,,CHEMBL3112574,Bioorg. Med. Chem. Lett.,2014,"{'bei': '7.10', 'le': '0.14', 'lle': '-1.11', 'sei': '6.68'}",CHEMBL3112796,,CHEMBL3139380,4.41,False,http://www.openphacts.org/units/Nanomolar,1963374,=,1,True,=,,IC50,nM,,39000.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,uM,UO_0000065,,39.0
,13903559,[],CHEMBL3119571,Inhibition of human MDM2/p53 interaction by fluorescence polarization assay,B,,,BAO_0000190,BAO_0000224,protein format,CN1CCN(C(=O)C2(Oc3ccc(C(F)(F)F)cc3)CCCN(C(=O)c3cnccc3C(F)(F)F)C2)CC1.Cl,,,CHEMBL3112574,Bioorg. Med. Chem. Lett.,2014,"{'bei': '9.04', 'le': '0.18', 'lle': '0.97', 'sei': '7.46'}",CHEMBL3112795,,CHEMBL3139474,4.92,False,http://www.openphacts.org/units/Nanomolar,1963373,=,1,True,=,,IC50,nM,,12000.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,uM,UO_0000065,,12.0
,13903560,[],CHEMBL3119571,Inhibition of human MDM2/p53 interaction by fluorescence polarization assay,B,,,BAO_0000190,BAO_0000224,protein format,CC(=O)N1CCN(C(=O)C2(Oc3ccc(C(F)(F)F)cc3)CCCN(C(=O)c3cnccc3C(F)(F)F)C2)CC1.Cl,,,CHEMBL3112574,Bioorg. Med. Chem. Lett.,2014,"{'bei': '7.76', 'le': '0.15', 'lle': '0.58', 'sei': '5.35'}",CHEMBL3112794,,CHEMBL3139656,4.44,False,http://www.openphacts.org/units/Nanomolar,1963372,=,1,True,=,,IC50,nM,,36000.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,uM,UO_0000065,,36.0
,13903561,[],CHEMBL3119571,Inhibition of human MDM2/p53 interaction by fluorescence polarization assay,B,,,BAO_0000190,BAO_0000224,protein format,Cl.O=C(c1cnccc1C(F)(F)F)N1CCCC(Oc2ccc(C(F)(F)F)cc2)(C(=O)N2CCN(C3CCCCC3)CC2)C1,,,CHEMBL3112574,Bioorg. Med. Chem. Lett.,2014,"{'bei': '8.78', 'le': '0.17', 'lle': '-0.27', 'sei': '8.15'}",CHEMBL3112793,,CHEMBL3139550,5.38,False,http://www.openphacts.org/units/Nanomolar,1963371,=,1,True,=,,IC50,nM,,4200.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,uM,UO_0000065,,4.2
,13903562,[],CHEMBL3119571,Inhibition of human MDM2/p53 interaction by fluorescence polarization assay,B,,,BAO_0000190,BAO_0000224,protein format,Cl.O=C(c1cnccc1C(F)(F)F)N1CCCC(Oc2ccc(C(F)(F)F)cc2)(C(=O)N2CCN(c3ncccn3)CC2)C1,,,CHEMBL3112574,Bioorg. Med. Chem. Lett.,2014,"{'bei': '7.32', 'le': '0.14', 'lle': '0.15', 'sei': '4.86'}",CHEMBL3112792,,CHEMBL3139257,4.46,False,http://www.openphacts.org/units/Nanomolar,1963370,=,1,True,=,,IC50,nM,,35000.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,uM,UO_0000065,,35.0
,13903563,[],CHEMBL3119571,Inhibition of human MDM2/p53 interaction by fluorescence polarization assay,B,,,BAO_0000190,BAO_0000224,protein format,Cl.O=C(c1cnccc1C(F)(F)F)N1CCCC(Oc2ccc(C(F)(F)F)cc2)(C(=O)N2CCN(c3ccncn3)CC2)C1,,,CHEMBL3112574,Bioorg. Med. Chem. Lett.,2014,"{'bei': '7.80', 'le': '0.15', 'lle': '0.43', 'sei': '5.17'}",CHEMBL3112791,,CHEMBL3139659,4.75,False,http://www.openphacts.org/units/Nanomolar,1963369,=,1,True,=,,IC50,nM,,18000.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,uM,UO_0000065,,18.0
,13903564,[],CHEMBL3119571,Inhibition of human MDM2/p53 interaction by fluorescence polarization assay,B,,,BAO_0000190,BAO_0000224,protein format,Cl.O=C(c1cnccc1C(F)(F)F)N1CCCC(Oc2ccc(C(F)(F)F)cc2)(C(=O)N2CCN(c3ccccc3)CC2)C1,,,CHEMBL3112574,Bioorg. Med. Chem. Lett.,2014,"{'bei': '9.15', 'le': '0.18', 'lle': '0.03', 'sei': '8.42'}",CHEMBL3112790,,CHEMBL3139449,5.55,False,http://www.openphacts.org/units/Nanomolar,1963368,=,1,True,=,,IC50,nM,,2800.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,uM,UO_0000065,,2.8
,13903565,[],CHEMBL3119571,Inhibition of human MDM2/p53 interaction by fluorescence polarization assay,B,,,BAO_0000190,BAO_0000224,protein format,Cl.O=C(c1cnccc1C(F)(F)F)N1CCCC(Oc2ccc(C(F)(F)F)cc2)(C(=O)N2CCN(c3ccccn3)CC2)C1,,,CHEMBL3112574,Bioorg. Med. Chem. Lett.,2014,"{'bei': '9.28', 'le': '0.18', 'lle': '0.72', 'sei': '7.15'}",CHEMBL3112789,,CHEMBL3139629,5.64,False,http://www.openphacts.org/units/Nanomolar,1963367,=,1,True,=,,IC50,nM,,2300.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,uM,UO_0000065,,2.3
,13903566,[],CHEMBL3119571,Inhibition of human MDM2/p53 interaction by fluorescence polarization assay,B,,,BAO_0000190,BAO_0000224,protein format,Cc1ccc(OC2(C(=O)N3CCN(c4ccccn4)CC3)CCCN(C(=O)c3cnccc3C(F)(F)F)C2)cc1.Cl,,,CHEMBL3112574,Bioorg. Med. Chem. Lett.,2014,"{'bei': '10.52', 'le': '0.20', 'lle': '1.61', 'sei': '7.38'}",CHEMBL3112788,,CHEMBL3139303,5.82,False,http://www.openphacts.org/units/Nanomolar,1963366,=,1,True,=,,IC50,nM,,1500.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,uM,UO_0000065,,1.5
,13903567,[],CHEMBL3119571,Inhibition of human MDM2/p53 interaction by fluorescence polarization assay,B,,,BAO_0000190,BAO_0000224,protein format,COc1ccc(OC2(C(=O)N3CCN(c4ccccn4)CC3)CCCN(C(=O)c3cnccc3C(F)(F)F)C2)cc1.Cl,,,CHEMBL3112574,Bioorg. Med. Chem. Lett.,2014,"{'bei': '7.87', 'le': '0.15', 'lle': '0.57', 'sei': '5.09'}",CHEMBL3112787,,CHEMBL3139658,4.48,False,http://www.openphacts.org/units/Nanomolar,1963365,=,1,True,=,,IC50,nM,,33000.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,uM,UO_0000065,,33.0
,13903568,[],CHEMBL3119571,Inhibition of human MDM2/p53 interaction by fluorescence polarization assay,B,,,BAO_0000190,BAO_0000224,protein format,Cl.O=C(c1cnccc1C(F)(F)F)N1CCCC(Oc2ccc(-c3ccccc3)cc2)(C(=O)N2CCN(c3ccccn3)CC2)C1,,,CHEMBL3112574,Bioorg. Med. Chem. Lett.,2014,"{'bei': '7.01', 'le': '0.13', 'lle': '-1.25', 'sei': '5.48'}",CHEMBL3112786,,CHEMBL3139263,4.32,False,http://www.openphacts.org/units/Nanomolar,1963364,=,1,True,=,,IC50,nM,,48000.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,uM,UO_0000065,,48.0
,13903569,[],CHEMBL3119571,Inhibition of human MDM2/p53 interaction by fluorescence polarization assay,B,,,BAO_0000190,BAO_0000224,protein format,Cc1nc2cc(OC3(C(=O)N4CCN(c5ccccn5)CC4)CCCN(C(=O)c4cnccc4C(F)(F)F)C3)ccc2s1.Cl,,,CHEMBL3112574,Bioorg. Med. Chem. Lett.,2014,"{'bei': '7.18', 'le': '0.14', 'lle': '-0.43', 'sei': '4.78'}",CHEMBL3112785,,CHEMBL3139635,4.39,False,http://www.openphacts.org/units/Nanomolar,1963363,=,1,True,=,,IC50,nM,,41000.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,uM,UO_0000065,,41.0
,13903570,[],CHEMBL3119571,Inhibition of human MDM2/p53 interaction by fluorescence polarization assay,B,,,BAO_0000190,BAO_0000224,protein format,Cl.O=C(c1cnccc1C(F)(F)F)N1CCCC(Oc2ccc(Cl)c(F)c2)(C(=O)N2CCN(c3ccccn3)CC2)C1,,,CHEMBL3112574,Bioorg. Med. Chem. Lett.,2014,"{'bei': '9.89', 'le': '0.19', 'lle': '1.16', 'sei': '7.42'}",CHEMBL3112784,,CHEMBL3139259,5.85,False,http://www.openphacts.org/units/Nanomolar,1963362,=,1,True,=,,IC50,nM,,1400.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,uM,UO_0000065,,1.4
,13903571,[],CHEMBL3119571,Inhibition of human MDM2/p53 interaction by fluorescence polarization assay,B,,,BAO_0000190,BAO_0000224,protein format,Cl.O=C(c1cnccc1C(F)(F)F)N1CCCC(Oc2ccc(Br)c(F)c2)(C(=O)N2CCN(c3ccccn3)CC2)C1,,,CHEMBL3112574,Bioorg. Med. Chem. Lett.,2014,"{'bei': '8.70', 'le': '0.18', 'lle': '0.74', 'sei': '7.02'}",CHEMBL3112783,,CHEMBL3139476,5.54,False,http://www.openphacts.org/units/Nanomolar,1963361,=,1,True,=,,IC50,nM,,2900.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,uM,UO_0000065,,2.9
,13903572,[],CHEMBL3119571,Inhibition of human MDM2/p53 interaction by fluorescence polarization assay,B,,,BAO_0000190,BAO_0000224,protein format,Cl.O=C(c1cnccc1C(F)(F)F)N1CCCC(Oc2ccc(Br)cc2)(C(=O)N2CCN(c3ccccn3)CC2)C1,,,CHEMBL3112574,Bioorg. Med. Chem. Lett.,2014,"{'bei': '9.25', 'le': '0.20', 'lle': '1.06', 'sei': '7.25'}",CHEMBL3112782,,CHEMBL3139301,5.72,False,http://www.openphacts.org/units/Nanomolar,1963360,=,1,True,=,,IC50,nM,,1900.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,uM,UO_0000065,,1.9
,13903573,[],CHEMBL3119571,Inhibition of human MDM2/p53 interaction by fluorescence polarization assay,B,,,BAO_0000190,BAO_0000224,protein format,Cl.O=C(c1cnccc1C(F)(F)F)N1CCCC(Oc2ccc(F)cc2)(C(=O)N2CCN(c3ccccn3)CC2)C1,,,CHEMBL3112574,Bioorg. Med. Chem. Lett.,2014,"{'bei': '9.37', 'le': '0.18', 'lle': '1.18', 'sei': '6.62'}",CHEMBL3112781,,CHEMBL3139260,5.22,False,http://www.openphacts.org/units/Nanomolar,1963359,=,1,True,=,,IC50,nM,,6000.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,uM,UO_0000065,,6.0
,13903574,[],CHEMBL3119571,Inhibition of human MDM2/p53 interaction by fluorescence polarization assay,B,,,BAO_0000190,BAO_0000224,protein format,Cl.O=C(c1cnccc1C(F)(F)F)N1CCCC(Oc2ccc(Cl)cc2)(C(=O)N2CCN(c3ccccn3)CC2)C1,,,CHEMBL3112574,Bioorg. Med. Chem. Lett.,2014,"{'bei': '9.01', 'le': '0.18', 'lle': '0.62', 'sei': '6.56'}",CHEMBL3112780,,CHEMBL3139631,5.17,False,http://www.openphacts.org/units/Nanomolar,1963358,=,1,True,=,,IC50,nM,,6700.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,uM,UO_0000065,,6.7
,13903575,[],CHEMBL3119571,Inhibition of human MDM2/p53 interaction by fluorescence polarization assay,B,,,BAO_0000190,BAO_0000224,protein format,Cl.O=C(c1cnccc1C(F)(F)F)N1CCCC(Oc2cccc(Cl)c2)(C(=O)N2CCN(c3ccccn3)CC2)C1,,,CHEMBL3112574,Bioorg. Med. Chem. Lett.,2014,"{'bei': '9.21', 'le': '0.18', 'lle': '0.73', 'sei': '6.70'}",CHEMBL3112779,,CHEMBL3139628,5.28,False,http://www.openphacts.org/units/Nanomolar,1963357,=,1,True,=,,IC50,nM,,5200.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,uM,UO_0000065,,5.2
,13903576,[],CHEMBL3119571,Inhibition of human MDM2/p53 interaction by fluorescence polarization assay,B,,,BAO_0000190,BAO_0000224,protein format,Cl.O=C(c1cnccc1C(F)(F)F)N1CCCC(Oc2ccccc2Cl)(C(=O)N2CCN(c3ccccn3)CC2)C1,,,CHEMBL3112574,Bioorg. Med. Chem. Lett.,2014,"{'bei': '8.15', 'le': '0.16', 'lle': '0.13', 'sei': '5.93'}",CHEMBL3112828,,CHEMBL3139381,4.68,False,http://www.openphacts.org/units/Nanomolar,1963407,=,1,True,=,,IC50,nM,,21000.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,uM,UO_0000065,,21.0
,13966493,[],CHEMBL3136838,Inhibition of 6His-tagged MDM2 (1 to 118) interaction to FITC-tagged p53 (17 to 26) (unknown origin) after 30 mins by fluorescence polarization assay,B,,,BAO_0000190,BAO_0000224,protein format,COc1ccc(C2=N[C@@H](c3ccc(Cl)cc3)[C@@H](c3ccc(Cl)cc3)N2C(=O)N2CCNC(=O)C2)c(OC(C)C)c1,,,CHEMBL3132806,MedChemComm,2013,"{'bei': '10.88', 'le': '0.22', 'lle': '0.43', 'sei': '7.58'}",CHEMBL191334,NUTLIN-3,CHEMBL191334,6.32,False,http://www.openphacts.org/units/Nanomolar,1976118,=,1,True,=,,IC50,nM,,474.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,uM,UO_0000065,,0.474
,13966494,[],CHEMBL3136838,Inhibition of 6His-tagged MDM2 (1 to 118) interaction to FITC-tagged p53 (17 to 26) (unknown origin) after 30 mins by fluorescence polarization assay,B,,,BAO_0000190,BAO_0000224,protein format,COc1ccc(C(=O)O)cc1-c1cc(-c2cccc(OC)c2OC)n(Cc2ccccc2)n1,Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL3132806,MedChemComm,2013,,CHEMBL3134185,,CHEMBL3134185,,False,http://www.openphacts.org/units/Nanomolar,1976117,=,1,True,=,,IC50,nM,,1018000.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,uM,UO_0000065,,1018.0
,13966495,[],CHEMBL3136838,Inhibition of 6His-tagged MDM2 (1 to 118) interaction to FITC-tagged p53 (17 to 26) (unknown origin) after 30 mins by fluorescence polarization assay,B,,,BAO_0000190,BAO_0000224,protein format,COc1ccc(CC(=O)O)cc1-c1cc(-c2cccc(OC)c2OC)n(Cc2ccccc2)n1,Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL3132806,MedChemComm,2013,,CHEMBL3134184,,CHEMBL3134184,,False,http://www.openphacts.org/units/Nanomolar,1976116,=,1,True,=,,IC50,nM,,967300.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,uM,UO_0000065,,967.3
,13966496,[],CHEMBL3136838,Inhibition of 6His-tagged MDM2 (1 to 118) interaction to FITC-tagged p53 (17 to 26) (unknown origin) after 30 mins by fluorescence polarization assay,B,,,BAO_0000190,BAO_0000224,protein format,COc1ccc(CC(=O)O)cc1-c1cc(-c2cccc(OC)c2OC)n(CCc2ccccc2)n1,Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL3132806,MedChemComm,2013,,CHEMBL3134183,,CHEMBL3134183,,False,http://www.openphacts.org/units/Nanomolar,1976115,=,1,True,=,,IC50,nM,,726800.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,uM,UO_0000065,,726.8
,13966497,[],CHEMBL3136838,Inhibition of 6His-tagged MDM2 (1 to 118) interaction to FITC-tagged p53 (17 to 26) (unknown origin) after 30 mins by fluorescence polarization assay,B,,,BAO_0000190,BAO_0000224,protein format,COc1ccc(CC(=O)O)cc1-c1cc(-c2ccc(F)cc2)n(Cc2ccccc2)n1,Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL3132806,MedChemComm,2013,,CHEMBL3134182,,CHEMBL3134182,,False,http://www.openphacts.org/units/Nanomolar,1976114,=,1,True,=,,IC50,nM,,594700.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,uM,UO_0000065,,594.7
,13966498,[],CHEMBL3136838,Inhibition of 6His-tagged MDM2 (1 to 118) interaction to FITC-tagged p53 (17 to 26) (unknown origin) after 30 mins by fluorescence polarization assay,B,,,BAO_0000190,BAO_0000224,protein format,COc1ccc(CCC(=O)O)cc1-c1cc(-c2cccc(OC)c2OC)n(Cc2ccccc2)n1,Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL3132806,MedChemComm,2013,,CHEMBL3134181,,CHEMBL3134181,,False,http://www.openphacts.org/units/Nanomolar,1976113,=,1,True,=,,IC50,nM,,449200.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,uM,UO_0000065,,449.2
,13966499,[],CHEMBL3136838,Inhibition of 6His-tagged MDM2 (1 to 118) interaction to FITC-tagged p53 (17 to 26) (unknown origin) after 30 mins by fluorescence polarization assay,B,,,BAO_0000190,BAO_0000224,protein format,COc1ccc(CCC(=O)O)cc1-c1cc(-c2cccc(OC)c2OC)n(CCc2ccccc2)n1,Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL3132806,MedChemComm,2013,,CHEMBL3134180,,CHEMBL3134180,,False,http://www.openphacts.org/units/Nanomolar,1976112,=,1,True,=,,IC50,nM,,436500.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,uM,UO_0000065,,436.5
,13966500,[],CHEMBL3136838,Inhibition of 6His-tagged MDM2 (1 to 118) interaction to FITC-tagged p53 (17 to 26) (unknown origin) after 30 mins by fluorescence polarization assay,B,,,BAO_0000190,BAO_0000224,protein format,CCOc1ccccc1-c1cc(-c2cc(CCC(=O)O)ccc2OC)nn1Cc1ccccc1,Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL3132806,MedChemComm,2013,,CHEMBL3134179,,CHEMBL3134179,,False,http://www.openphacts.org/units/Nanomolar,1976111,=,1,True,=,,IC50,nM,,388100.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,uM,UO_0000065,,388.1
,13966501,[],CHEMBL3136838,Inhibition of 6His-tagged MDM2 (1 to 118) interaction to FITC-tagged p53 (17 to 26) (unknown origin) after 30 mins by fluorescence polarization assay,B,,,BAO_0000190,BAO_0000224,protein format,CCOc1ccc(CCC(=O)O)cc1-c1cc(-c2cccc(OC)c2OC)n(Cc2ccccc2)n1,Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL3132806,MedChemComm,2013,,CHEMBL3134178,,CHEMBL3134178,,False,http://www.openphacts.org/units/Nanomolar,1976110,=,1,True,=,,IC50,nM,,352700.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,uM,UO_0000065,,352.7
,13966502,[],CHEMBL3136838,Inhibition of 6His-tagged MDM2 (1 to 118) interaction to FITC-tagged p53 (17 to 26) (unknown origin) after 30 mins by fluorescence polarization assay,B,,,BAO_0000190,BAO_0000224,protein format,CCOc1ccc(CC(=O)O)cc1-c1cc(-c2cccc(OC)c2OC)n(Cc2ccccc2)n1,Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL3132806,MedChemComm,2013,,CHEMBL3134177,,CHEMBL3134177,,False,http://www.openphacts.org/units/Nanomolar,1976109,=,1,True,=,,IC50,nM,,348200.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,uM,UO_0000065,,348.2
,13966503,[],CHEMBL3136838,Inhibition of 6His-tagged MDM2 (1 to 118) interaction to FITC-tagged p53 (17 to 26) (unknown origin) after 30 mins by fluorescence polarization assay,B,,,BAO_0000190,BAO_0000224,protein format,CCOc1ccccc1-c1cc(-c2ccc(C(=O)O)cc2)nn1Cc1ccccc1,Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL3132806,MedChemComm,2013,,CHEMBL3134176,,CHEMBL3134176,,False,http://www.openphacts.org/units/Nanomolar,1976108,=,1,True,=,,IC50,nM,,346400.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,uM,UO_0000065,,346.4
,13966504,[],CHEMBL3136838,Inhibition of 6His-tagged MDM2 (1 to 118) interaction to FITC-tagged p53 (17 to 26) (unknown origin) after 30 mins by fluorescence polarization assay,B,,,BAO_0000190,BAO_0000224,protein format,CCOc1ccccc1-c1cc(-c2cc(CC(=O)O)ccc2OC)nn1CCc1ccccc1,Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL3132806,MedChemComm,2013,,CHEMBL3134175,,CHEMBL3134175,,False,http://www.openphacts.org/units/Nanomolar,1976107,=,1,True,=,,IC50,nM,,339200.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,uM,UO_0000065,,339.2
,13966505,[],CHEMBL3136838,Inhibition of 6His-tagged MDM2 (1 to 118) interaction to FITC-tagged p53 (17 to 26) (unknown origin) after 30 mins by fluorescence polarization assay,B,,,BAO_0000190,BAO_0000224,protein format,CCCOc1ccc(CC(=O)O)cc1-c1cc(-c2cccc(OC)c2OC)n(Cc2ccccc2)n1,Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL3132806,MedChemComm,2013,,CHEMBL3134174,,CHEMBL3134174,,False,http://www.openphacts.org/units/Nanomolar,1976106,=,1,True,=,,IC50,nM,,328600.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,uM,UO_0000065,,328.6
,13966506,[],CHEMBL3136838,Inhibition of 6His-tagged MDM2 (1 to 118) interaction to FITC-tagged p53 (17 to 26) (unknown origin) after 30 mins by fluorescence polarization assay,B,,,BAO_0000190,BAO_0000224,protein format,CCOc1ccc(C(=O)O)cc1-c1cc(-c2cccc(OC)c2OC)n(Cc2ccccc2)n1,Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL3132806,MedChemComm,2013,,CHEMBL3134173,,CHEMBL3134173,,False,http://www.openphacts.org/units/Nanomolar,1976105,=,1,True,=,,IC50,nM,,294500.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,uM,UO_0000065,,294.5
,13966507,[],CHEMBL3136838,Inhibition of 6His-tagged MDM2 (1 to 118) interaction to FITC-tagged p53 (17 to 26) (unknown origin) after 30 mins by fluorescence polarization assay,B,,,BAO_0000190,BAO_0000224,protein format,CCOc1ccccc1-c1cc(-c2cc(CC(=O)O)ccc2OC)nn1Cc1ccccc1,Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL3132806,MedChemComm,2013,,CHEMBL3134172,,CHEMBL3134172,,False,http://www.openphacts.org/units/Nanomolar,1976104,=,1,True,=,,IC50,nM,,287600.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,uM,UO_0000065,,287.6
,13966508,[],CHEMBL3136838,Inhibition of 6His-tagged MDM2 (1 to 118) interaction to FITC-tagged p53 (17 to 26) (unknown origin) after 30 mins by fluorescence polarization assay,B,,,BAO_0000190,BAO_0000224,protein format,CCOc1ccccc1-c1cc(-c2cc(CCC(=O)O)ccc2OC)nn1CCc1ccccc1,Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL3132806,MedChemComm,2013,,CHEMBL3134171,,CHEMBL3134171,,False,http://www.openphacts.org/units/Nanomolar,1976103,=,1,True,=,,IC50,nM,,258400.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,uM,UO_0000065,,258.4
,13966509,[],CHEMBL3136838,Inhibition of 6His-tagged MDM2 (1 to 118) interaction to FITC-tagged p53 (17 to 26) (unknown origin) after 30 mins by fluorescence polarization assay,B,,,BAO_0000190,BAO_0000224,protein format,CCOc1ccccc1-c1cc(-c2cc(CC(=O)O)ccc2OCc2cccc(Cl)c2)nn1CCc1ccccc1,Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL3132806,MedChemComm,2013,,CHEMBL3134170,,CHEMBL3134170,,False,http://www.openphacts.org/units/Nanomolar,1976102,=,1,True,=,,IC50,nM,,248800.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,uM,UO_0000065,,248.8
,13966510,[],CHEMBL3136838,Inhibition of 6His-tagged MDM2 (1 to 118) interaction to FITC-tagged p53 (17 to 26) (unknown origin) after 30 mins by fluorescence polarization assay,B,,,BAO_0000190,BAO_0000224,protein format,CCOc1ccccc1-c1cc(-c2cc(C(=O)O)ccc2OC)nn1Cc1ccccc1,Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL3132806,MedChemComm,2013,,CHEMBL3134169,,CHEMBL3134169,,False,http://www.openphacts.org/units/Nanomolar,1976101,=,1,True,=,,IC50,nM,,238000.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,uM,UO_0000065,,238.0
,13966511,[],CHEMBL3136838,Inhibition of 6His-tagged MDM2 (1 to 118) interaction to FITC-tagged p53 (17 to 26) (unknown origin) after 30 mins by fluorescence polarization assay,B,,,BAO_0000190,BAO_0000224,protein format,CCOc1ccccc1-c1cc(-c2cc(C(=O)O)ccc2OC)nn1CCc1ccccc1,Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL3132806,MedChemComm,2013,,CHEMBL3134168,,CHEMBL3134168,,False,http://www.openphacts.org/units/Nanomolar,1976100,=,1,True,=,,IC50,nM,,232500.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,uM,UO_0000065,,232.5
,13966512,[],CHEMBL3136838,Inhibition of 6His-tagged MDM2 (1 to 118) interaction to FITC-tagged p53 (17 to 26) (unknown origin) after 30 mins by fluorescence polarization assay,B,,,BAO_0000190,BAO_0000224,protein format,COc1ccc(C(=O)O)cc1-c1cc(-c2cccc(OC)c2OC)n(CCc2ccccc2)n1,Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL3132806,MedChemComm,2013,,CHEMBL3134218,,CHEMBL3134218,,False,http://www.openphacts.org/units/Nanomolar,1976152,=,1,True,=,,IC50,nM,,185600.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,uM,UO_0000065,,185.6
,13966513,[],CHEMBL3136838,Inhibition of 6His-tagged MDM2 (1 to 118) interaction to FITC-tagged p53 (17 to 26) (unknown origin) after 30 mins by fluorescence polarization assay,B,,,BAO_0000190,BAO_0000224,protein format,O=C(O)Cc1ccc(OCc2ccccc2Cl)c(-c2cc(-c3ccc(F)cc3)n(Cc3ccccc3)n2)c1,Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL3132806,MedChemComm,2013,,CHEMBL3134217,,CHEMBL3134217,,False,http://www.openphacts.org/units/Nanomolar,1976151,=,1,True,=,,IC50,nM,,129800.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,uM,UO_0000065,,129.8
,13966514,[],CHEMBL3136838,Inhibition of 6His-tagged MDM2 (1 to 118) interaction to FITC-tagged p53 (17 to 26) (unknown origin) after 30 mins by fluorescence polarization assay,B,,,BAO_0000190,BAO_0000224,protein format,O=C(O)c1ccc(-c2cc(-c3ccc(F)cc3)n(CCc3ccccc3)n2)cc1,Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL3132806,MedChemComm,2013,,CHEMBL3134216,,CHEMBL3134216,,False,http://www.openphacts.org/units/Nanomolar,1976150,=,1,True,=,,IC50,nM,,127900.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,uM,UO_0000065,,127.9
,13966515,[],CHEMBL3136838,Inhibition of 6His-tagged MDM2 (1 to 118) interaction to FITC-tagged p53 (17 to 26) (unknown origin) after 30 mins by fluorescence polarization assay,B,,,BAO_0000190,BAO_0000224,protein format,COc1cccc(-c2cc(-c3cc(CC(=O)O)ccc3OCC(C)C)nn2Cc2ccccc2)c1OC,Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL3132806,MedChemComm,2013,,CHEMBL3134215,,CHEMBL3134215,,False,http://www.openphacts.org/units/Nanomolar,1976149,=,1,True,=,,IC50,nM,,120000.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,uM,UO_0000065,,120.0
,13966516,[],CHEMBL3136838,Inhibition of 6His-tagged MDM2 (1 to 118) interaction to FITC-tagged p53 (17 to 26) (unknown origin) after 30 mins by fluorescence polarization assay,B,,,BAO_0000190,BAO_0000224,protein format,CCCCOc1ccc(CC(=O)O)cc1-c1cc(-c2cccc(OC)c2OC)n(Cc2ccccc2)n1,Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL3132806,MedChemComm,2013,,CHEMBL3134214,,CHEMBL3134214,,False,http://www.openphacts.org/units/Nanomolar,1976148,=,1,True,=,,IC50,nM,,117700.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,uM,UO_0000065,,117.7
,13966517,[],CHEMBL3136838,Inhibition of 6His-tagged MDM2 (1 to 118) interaction to FITC-tagged p53 (17 to 26) (unknown origin) after 30 mins by fluorescence polarization assay,B,,,BAO_0000190,BAO_0000224,protein format,CCCCOc1ccc(CC(=O)O)cc1-c1cc(-c2cccc(OC)c2OC)n(CCc2ccccc2)n1,Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL3132806,MedChemComm,2013,,CHEMBL3134213,,CHEMBL3134213,,False,http://www.openphacts.org/units/Nanomolar,1976147,=,1,True,=,,IC50,nM,,115600.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,uM,UO_0000065,,115.6
,13966518,[],CHEMBL3136838,Inhibition of 6His-tagged MDM2 (1 to 118) interaction to FITC-tagged p53 (17 to 26) (unknown origin) after 30 mins by fluorescence polarization assay,B,,,BAO_0000190,BAO_0000224,protein format,CCOc1ccc(C(=O)O)cc1-c1cc(-c2ccccc2OCC)n(Cc2ccccc2)n1,Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL3132806,MedChemComm,2013,,CHEMBL3134212,,CHEMBL3134212,,False,http://www.openphacts.org/units/Nanomolar,1976146,=,1,True,=,,IC50,nM,,111100.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,uM,UO_0000065,,111.1
,13966519,[],CHEMBL3136838,Inhibition of 6His-tagged MDM2 (1 to 118) interaction to FITC-tagged p53 (17 to 26) (unknown origin) after 30 mins by fluorescence polarization assay,B,,,BAO_0000190,BAO_0000224,protein format,CCOc1ccc(CCC(=O)O)cc1-c1cc(-c2ccccc2OCC)n(CCc2ccccc2)n1,Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL3132806,MedChemComm,2013,,CHEMBL3134211,,CHEMBL3134211,,False,http://www.openphacts.org/units/Nanomolar,1976145,=,1,True,=,,IC50,nM,,105400.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,uM,UO_0000065,,105.4
,13966520,[],CHEMBL3136838,Inhibition of 6His-tagged MDM2 (1 to 118) interaction to FITC-tagged p53 (17 to 26) (unknown origin) after 30 mins by fluorescence polarization assay,B,,,BAO_0000190,BAO_0000224,protein format,CCOc1ccc(CC(=O)O)cc1-c1cc(-c2ccccc2OCC)n(CCc2ccccc2)n1,Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL3132806,MedChemComm,2013,,CHEMBL3134210,,CHEMBL3134210,,False,http://www.openphacts.org/units/Nanomolar,1976144,=,1,True,=,,IC50,nM,,102400.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,uM,UO_0000065,,102.4
,13966521,[],CHEMBL3136838,Inhibition of 6His-tagged MDM2 (1 to 118) interaction to FITC-tagged p53 (17 to 26) (unknown origin) after 30 mins by fluorescence polarization assay,B,,,BAO_0000190,BAO_0000224,protein format,CCOc1ccc(CCC(=O)O)cc1-c1cc(-c2ccc(F)cc2)n(Cc2ccccc2)n1,Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL3132806,MedChemComm,2013,,CHEMBL3134209,,CHEMBL3134209,,False,http://www.openphacts.org/units/Nanomolar,1976143,=,1,True,=,,IC50,nM,,100800.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,uM,UO_0000065,,100.8
,13966522,[],CHEMBL3136838,Inhibition of 6His-tagged MDM2 (1 to 118) interaction to FITC-tagged p53 (17 to 26) (unknown origin) after 30 mins by fluorescence polarization assay,B,,,BAO_0000190,BAO_0000224,protein format,CCOc1ccccc1-c1cc(-c2ccc(C(=O)O)cc2)nn1CCc1ccccc1,,,CHEMBL3132806,MedChemComm,2013,"{'bei': '9.79', 'le': '0.18', 'lle': '-1.52', 'sei': '6.28'}",CHEMBL3134208,,CHEMBL3134208,4.04,False,http://www.openphacts.org/units/Nanomolar,1976142,=,1,True,=,,IC50,nM,,91220.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,uM,UO_0000065,,91.22
,13966523,[],CHEMBL3136838,Inhibition of 6His-tagged MDM2 (1 to 118) interaction to FITC-tagged p53 (17 to 26) (unknown origin) after 30 mins by fluorescence polarization assay,B,,,BAO_0000190,BAO_0000224,protein format,COc1ccc(CCC(=O)O)cc1-c1cc(-c2ccc(Cl)cc2)n(Cc2ccccc2)n1,,,CHEMBL3132806,MedChemComm,2013,"{'bei': '9.09', 'le': '0.17', 'lle': '-1.88', 'sei': '6.31'}",CHEMBL3134207,,CHEMBL3134207,4.06,False,http://www.openphacts.org/units/Nanomolar,1976141,=,1,True,=,,IC50,nM,,86630.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,uM,UO_0000065,,86.63
,13966524,[],CHEMBL3136838,Inhibition of 6His-tagged MDM2 (1 to 118) interaction to FITC-tagged p53 (17 to 26) (unknown origin) after 30 mins by fluorescence polarization assay,B,,,BAO_0000190,BAO_0000224,protein format,CCCOc1ccc(C(=O)O)cc1-c1cc(-c2cccc(OC)c2OC)n(Cc2ccccc2)n1,,,CHEMBL3132806,MedChemComm,2013,"{'bei': '8.68', 'le': '0.16', 'lle': '-1.67', 'sei': '4.95'}",CHEMBL3134206,,CHEMBL3134206,4.10,False,http://www.openphacts.org/units/Nanomolar,1976140,=,1,True,=,,IC50,nM,,79270.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,uM,UO_0000065,,79.27
,13966525,[],CHEMBL3136838,Inhibition of 6His-tagged MDM2 (1 to 118) interaction to FITC-tagged p53 (17 to 26) (unknown origin) after 30 mins by fluorescence polarization assay,B,,,BAO_0000190,BAO_0000224,protein format,CCCOc1ccc(CC(=O)O)cc1-c1cc(-c2ccccc2OCC)n(CCc2ccccc2)n1,,,CHEMBL3132806,MedChemComm,2013,"{'bei': '8.55', 'le': '0.16', 'lle': '-2.13', 'sei': '5.63'}",CHEMBL3134205,,CHEMBL3134205,4.14,False,http://www.openphacts.org/units/Nanomolar,1976139,=,1,True,=,,IC50,nM,,71980.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,uM,UO_0000065,,71.98
,13966526,[],CHEMBL3136838,Inhibition of 6His-tagged MDM2 (1 to 118) interaction to FITC-tagged p53 (17 to 26) (unknown origin) after 30 mins by fluorescence polarization assay,B,,,BAO_0000190,BAO_0000224,protein format,CCCOc1ccc(C(=O)O)cc1-c1cc(-c2ccccc2OCC)n(Cc2ccccc2)n1,,,CHEMBL3132806,MedChemComm,2013,"{'bei': '9.12', 'le': '0.17', 'lle': '-1.99', 'sei': '5.66'}",CHEMBL3134204,,CHEMBL3134204,4.16,False,http://www.openphacts.org/units/Nanomolar,1976138,=,1,True,=,,IC50,nM,,68750.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,uM,UO_0000065,,68.75
,13966527,[],CHEMBL3136838,Inhibition of 6His-tagged MDM2 (1 to 118) interaction to FITC-tagged p53 (17 to 26) (unknown origin) after 30 mins by fluorescence polarization assay,B,,,BAO_0000190,BAO_0000224,protein format,COc1cccc(-c2cc(-c3cc(CC(=O)O)ccc3OCC(C)C)nn2CCc2ccccc2)c1OC,,,CHEMBL3132806,MedChemComm,2013,"{'bei': '8.09', 'le': '0.15', 'lle': '-1.97', 'sei': '5.03'}",CHEMBL3134203,,CHEMBL3134203,4.17,False,http://www.openphacts.org/units/Nanomolar,1976137,=,1,True,=,,IC50,nM,,68320.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,uM,UO_0000065,,68.32
,13966528,[],CHEMBL3136838,Inhibition of 6His-tagged MDM2 (1 to 118) interaction to FITC-tagged p53 (17 to 26) (unknown origin) after 30 mins by fluorescence polarization assay,B,,,BAO_0000190,BAO_0000224,protein format,CCCOc1ccc(CC(=O)O)cc1-c1cc(-c2cccc(OC)c2OC)n(CCc2ccccc2)n1,,,CHEMBL3132806,MedChemComm,2013,"{'bei': '8.42', 'le': '0.16', 'lle': '-1.67', 'sei': '5.09'}",CHEMBL3134202,,CHEMBL3134202,4.22,False,http://www.openphacts.org/units/Nanomolar,1976136,=,1,True,=,,IC50,nM,,60600.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,uM,UO_0000065,,60.6
,13966529,[],CHEMBL3136838,Inhibition of 6His-tagged MDM2 (1 to 118) interaction to FITC-tagged p53 (17 to 26) (unknown origin) after 30 mins by fluorescence polarization assay,B,,,BAO_0000190,BAO_0000224,protein format,CCOc1ccccc1-c1cc(-c2cc(CC(=O)O)ccc2OCc2cccc(Cl)c2)nn1Cc1ccccc1,,,CHEMBL3132806,MedChemComm,2013,"{'bei': '7.71', 'le': '0.15', 'lle': '-3.26', 'sei': '5.80'}",CHEMBL3134201,,CHEMBL3134201,4.26,False,http://www.openphacts.org/units/Nanomolar,1976135,=,1,True,=,,IC50,nM,,54390.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,uM,UO_0000065,,54.39
,13966530,[],CHEMBL3136838,Inhibition of 6His-tagged MDM2 (1 to 118) interaction to FITC-tagged p53 (17 to 26) (unknown origin) after 30 mins by fluorescence polarization assay,B,,,BAO_0000190,BAO_0000224,protein format,CCCCOc1ccc(CC(=O)O)cc1-c1cc(-c2ccccc2OCC)n(CCc2ccccc2)n1,,,CHEMBL3132806,MedChemComm,2013,"{'bei': '8.56', 'le': '0.16', 'lle': '-2.39', 'sei': '5.80'}",CHEMBL3134200,,CHEMBL3134200,4.27,False,http://www.openphacts.org/units/Nanomolar,1976134,=,1,True,=,,IC50,nM,,54060.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,uM,UO_0000065,,54.06
,13966531,[],CHEMBL3136838,Inhibition of 6His-tagged MDM2 (1 to 118) interaction to FITC-tagged p53 (17 to 26) (unknown origin) after 30 mins by fluorescence polarization assay,B,,,BAO_0000190,BAO_0000224,protein format,O=C(O)CCc1ccc(OCc2cccc(Cl)c2)c(-c2cc(-c3ccc(F)cc3)n(Cc3ccccc3)n2)c1,,,CHEMBL3132806,MedChemComm,2013,"{'bei': '7.92', 'le': '0.15', 'lle': '-3.36', 'sei': '6.66'}",CHEMBL3134199,,CHEMBL3134199,4.29,False,http://www.openphacts.org/units/Nanomolar,1976133,=,1,True,=,,IC50,nM,,51880.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,uM,UO_0000065,,51.88
,13966532,[],CHEMBL3136838,Inhibition of 6His-tagged MDM2 (1 to 118) interaction to FITC-tagged p53 (17 to 26) (unknown origin) after 30 mins by fluorescence polarization assay,B,,,BAO_0000190,BAO_0000224,protein format,CCOc1ccccc1-c1cc(-c2cc(CC(=O)O)ccc2OCC(C)C)nn1CCc1ccccc1,,,CHEMBL3132806,MedChemComm,2013,"{'bei': '8.65', 'le': '0.16', 'lle': '-2.21', 'sei': '5.86'}",CHEMBL3132875,,CHEMBL3132875,4.31,False,http://www.openphacts.org/units/Nanomolar,1976132,=,1,True,=,,IC50,nM,,48700.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,uM,UO_0000065,,48.7
,13966533,[],CHEMBL3136838,Inhibition of 6His-tagged MDM2 (1 to 118) interaction to FITC-tagged p53 (17 to 26) (unknown origin) after 30 mins by fluorescence polarization assay,B,,,BAO_0000190,BAO_0000224,protein format,O=C(O)CCc1ccc(OCc2cccc(Cl)c2)c(-c2cc(-c3ccc(F)cc3)n(CCc3ccccc3)n2)c1,,,CHEMBL3132806,MedChemComm,2013,"{'bei': '7.78', 'le': '0.15', 'lle': '-3.53', 'sei': '6.71'}",CHEMBL3134198,,CHEMBL3134198,4.32,False,http://www.openphacts.org/units/Nanomolar,1976131,=,1,True,=,,IC50,nM,,47830.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,uM,UO_0000065,,47.83
,13966534,[],CHEMBL3136838,Inhibition of 6His-tagged MDM2 (1 to 118) interaction to FITC-tagged p53 (17 to 26) (unknown origin) after 30 mins by fluorescence polarization assay,B,,,BAO_0000190,BAO_0000224,protein format,COc1ccc(CCC(=O)O)cc1-c1cc(-c2ccc(Cl)cc2)n(CCc2ccccc2)n1,,,CHEMBL3132806,MedChemComm,2013,"{'bei': '9.57', 'le': '0.18', 'lle': '-1.73', 'sei': '6.85'}",CHEMBL3134197,,CHEMBL3134197,4.41,False,http://www.openphacts.org/units/Nanomolar,1976130,=,1,True,=,,IC50,nM,,38870.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,uM,UO_0000065,,38.87
,13966535,[],CHEMBL3136838,Inhibition of 6His-tagged MDM2 (1 to 118) interaction to FITC-tagged p53 (17 to 26) (unknown origin) after 30 mins by fluorescence polarization assay,B,,,BAO_0000190,BAO_0000224,protein format,CCOc1ccc(CCC(=O)O)cc1-c1cc(-c2ccc(F)cc2)n(CCc2ccccc2)n1,,,CHEMBL3132806,MedChemComm,2013,"{'bei': '9.70', 'le': '0.18', 'lle': '-1.56', 'sei': '6.91'}",CHEMBL3134196,,CHEMBL3134196,4.45,False,http://www.openphacts.org/units/Nanomolar,1976129,=,1,True,=,,IC50,nM,,35780.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,uM,UO_0000065,,35.78
,13966536,[],CHEMBL3136838,Inhibition of 6His-tagged MDM2 (1 to 118) interaction to FITC-tagged p53 (17 to 26) (unknown origin) after 30 mins by fluorescence polarization assay,B,,,BAO_0000190,BAO_0000224,protein format,COc1cccc(-c2cc(-c3cc(CCC(=O)O)ccc3OCc3cccc(Cl)c3)nn2CCc2ccccc2)c1OC,,,CHEMBL3132806,MedChemComm,2013,"{'bei': '7.48', 'le': '0.14', 'lle': '-3.26', 'sei': '5.40'}",CHEMBL3134195,,CHEMBL3134195,4.47,False,http://www.openphacts.org/units/Nanomolar,1976128,=,1,True,=,,IC50,nM,,34020.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,uM,UO_0000065,,34.02
,13966537,[],CHEMBL3136838,Inhibition of 6His-tagged MDM2 (1 to 118) interaction to FITC-tagged p53 (17 to 26) (unknown origin) after 30 mins by fluorescence polarization assay,B,,,BAO_0000190,BAO_0000224,protein format,COc1cccc(-c2cc(-c3cc(CCC(=O)O)ccc3OCc3cccc(Cl)c3)nn2Cc2ccccc2)c1OC,,,CHEMBL3132806,MedChemComm,2013,"{'bei': '7.72', 'le': '0.15', 'lle': '-3.03', 'sei': '5.43'}",CHEMBL3134194,,CHEMBL3134194,4.50,False,http://www.openphacts.org/units/Nanomolar,1976127,=,1,True,=,,IC50,nM,,31620.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,uM,UO_0000065,,31.62
,13966538,[],CHEMBL3136838,Inhibition of 6His-tagged MDM2 (1 to 118) interaction to FITC-tagged p53 (17 to 26) (unknown origin) after 30 mins by fluorescence polarization assay,B,,,BAO_0000190,BAO_0000224,protein format,COc1ccc(CCC(=O)O)cc1-c1cc(-c2ccc(F)cc2)n(Cc2ccccc2)n1,,,CHEMBL3132806,MedChemComm,2013,"{'bei': '11.08', 'le': '0.20', 'lle': '-0.66', 'sei': '7.41'}",CHEMBL3134193,,CHEMBL3134193,4.77,False,http://www.openphacts.org/units/Nanomolar,1976126,=,1,True,=,,IC50,nM,,16980.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,uM,UO_0000065,,16.98
,13966539,[],CHEMBL3136838,Inhibition of 6His-tagged MDM2 (1 to 118) interaction to FITC-tagged p53 (17 to 26) (unknown origin) after 30 mins by fluorescence polarization assay,B,,,BAO_0000190,BAO_0000224,protein format,CCCCOc1ccc(C(=O)O)cc1-c1cc(-c2ccccc2OCC)n(CCc2ccccc2)n1,,,CHEMBL3132806,MedChemComm,2013,"{'bei': '9.86', 'le': '0.18', 'lle': '-1.96', 'sei': '6.49'}",CHEMBL3134192,,CHEMBL3134192,4.78,False,http://www.openphacts.org/units/Nanomolar,1976125,=,1,True,=,,IC50,nM,,16750.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,uM,UO_0000065,,16.75
,13966540,[],CHEMBL3136838,Inhibition of 6His-tagged MDM2 (1 to 118) interaction to FITC-tagged p53 (17 to 26) (unknown origin) after 30 mins by fluorescence polarization assay,B,,,BAO_0000190,BAO_0000224,protein format,CCOc1ccccc1-c1cc(-c2cc(C(=O)O)ccc2OCC(C)C)nn1CCc1ccccc1,,,CHEMBL3132806,MedChemComm,2013,"{'bei': '10.00', 'le': '0.18', 'lle': '-1.74', 'sei': '6.59'}",CHEMBL3134191,,CHEMBL3134191,4.85,False,http://www.openphacts.org/units/Nanomolar,1976124,=,1,True,=,,IC50,nM,,14190.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,uM,UO_0000065,,14.19
,13966541,[],CHEMBL3136838,Inhibition of 6His-tagged MDM2 (1 to 118) interaction to FITC-tagged p53 (17 to 26) (unknown origin) after 30 mins by fluorescence polarization assay,B,,,BAO_0000190,BAO_0000224,protein format,CCCCOc1ccc(C(=O)O)cc1-c1cc(-c2cccc(OC)c2OC)n(CCc2ccccc2)n1,,,CHEMBL3132806,MedChemComm,2013,"{'bei': '9.69', 'le': '0.18', 'lle': '-1.50', 'sei': '5.86'}",CHEMBL3134190,,CHEMBL3134190,4.85,False,http://www.openphacts.org/units/Nanomolar,1976123,=,1,True,=,,IC50,nM,,14150.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,uM,UO_0000065,,14.15
,13966542,[],CHEMBL3136838,Inhibition of 6His-tagged MDM2 (1 to 118) interaction to FITC-tagged p53 (17 to 26) (unknown origin) after 30 mins by fluorescence polarization assay,B,,,BAO_0000190,BAO_0000224,protein format,CCOc1ccc(C(=O)O)cc1-c1cc(-c2cccc(OC)c2OC)n(CCc2ccccc2)n1,,,CHEMBL3132806,MedChemComm,2013,"{'bei': '10.27', 'le': '0.19', 'lle': '-0.72', 'sei': '5.86'}",CHEMBL3134189,,CHEMBL3134189,4.85,False,http://www.openphacts.org/units/Nanomolar,1976122,=,1,True,=,,IC50,nM,,13980.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,uM,UO_0000065,,13.98
,13966543,[],CHEMBL3136838,Inhibition of 6His-tagged MDM2 (1 to 118) interaction to FITC-tagged p53 (17 to 26) (unknown origin) after 30 mins by fluorescence polarization assay,B,,,BAO_0000190,BAO_0000224,protein format,CCOc1ccc(C(=O)O)cc1-c1cc(-c2ccccc2OCC)n(CCc2ccccc2)n1,,,CHEMBL3132806,MedChemComm,2013,"{'bei': '10.89', 'le': '0.20', 'lle': '-0.99', 'sei': '6.76'}",CHEMBL3134188,,CHEMBL3134188,4.97,False,http://www.openphacts.org/units/Nanomolar,1976121,=,1,True,=,,IC50,nM,,10650.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,uM,UO_0000065,,10.65
,13966544,[],CHEMBL3136838,Inhibition of 6His-tagged MDM2 (1 to 118) interaction to FITC-tagged p53 (17 to 26) (unknown origin) after 30 mins by fluorescence polarization assay,B,,,BAO_0000190,BAO_0000224,protein format,COc1cccc(-c2cc(-c3cc(C(=O)O)ccc3OCC(C)C)nn2CCc2ccccc2)c1OC,,,CHEMBL3132806,MedChemComm,2013,"{'bei': '10.16', 'le': '0.19', 'lle': '-1.12', 'sei': '6.14'}",CHEMBL3134187,,CHEMBL3134187,5.08,False,http://www.openphacts.org/units/Nanomolar,1976120,=,1,True,=,,IC50,nM,,8220.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,uM,UO_0000065,,8.22
,13966545,[],CHEMBL3136838,Inhibition of 6His-tagged MDM2 (1 to 118) interaction to FITC-tagged p53 (17 to 26) (unknown origin) after 30 mins by fluorescence polarization assay,B,,,BAO_0000190,BAO_0000224,protein format,CCCOc1ccc(C(=O)O)cc1-c1cc(-c2cccc(OC)c2OC)n(CCc2ccccc2)n1,,,CHEMBL3132806,MedChemComm,2013,"{'bei': '10.65', 'le': '0.20', 'lle': '-0.78', 'sei': '6.26'}",CHEMBL3134186,,CHEMBL3134186,5.18,False,http://www.openphacts.org/units/Nanomolar,1976119,=,1,True,=,,IC50,nM,,6560.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,uM,UO_0000065,,6.56
,13968479,[],CHEMBL3136590,Inhibition of p53-MDM2 (1 to 118 residues) interaction (unknown origin) expressed in Escherichia coli BL-21 (DE3) assessed as inhibition of MDM2 binding by fluorescence polarization competitive binding assay,B,,,BAO_0000190,BAO_0000019,assay format,COc1ccc(C2=NC(c3ccc(Cl)cc3)C(c3ccc(Cl)cc3)N2C(=O)N2CCNC(=O)C2)c(OC(C)C)c1,,,CHEMBL3132800,MedChemComm,2013,"{'bei': '11.97', 'le': '0.24', 'lle': '1.07', 'sei': '8.34'}",CHEMBL211045,,CHEMBL211045,6.96,False,http://www.openphacts.org/units/Nanomolar,1974784,=,1,True,=,,IC50,nM,,110.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,uM,UO_0000065,,0.11
,13968480,[],CHEMBL3136590,Inhibition of p53-MDM2 (1 to 118 residues) interaction (unknown origin) expressed in Escherichia coli BL-21 (DE3) assessed as inhibition of MDM2 binding by fluorescence polarization competitive binding assay,B,,,BAO_0000190,BAO_0000019,assay format,Nc1sc(-c2ccc(Cl)cc2)c(-c2ccc(Cl)cc2)c1C(=O)Nc1ccccc1,,,CHEMBL3132800,MedChemComm,2013,,CHEMBL2385336,,CHEMBL2385336,,False,http://www.openphacts.org/units/Nanomolar,1974783,>,1,True,>,,IC50,nM,,50000.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,uM,UO_0000065,,50.0
,13968481,[],CHEMBL3136590,Inhibition of p53-MDM2 (1 to 118 residues) interaction (unknown origin) expressed in Escherichia coli BL-21 (DE3) assessed as inhibition of MDM2 binding by fluorescence polarization competitive binding assay,B,,,BAO_0000190,BAO_0000019,assay format,Nc1sc(-c2ccc(Cl)cc2)c(-c2ccc(Cl)cc2)c1C(=O)NC1CCCCC1,,,CHEMBL3132800,MedChemComm,2013,"{'bei': '13.57', 'le': '0.28', 'lle': '-0.98', 'sei': '10.97'}",CHEMBL2385521,,CHEMBL2385521,6.05,False,http://www.openphacts.org/units/Nanomolar,1974782,=,1,True,=,,IC50,nM,,900.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,uM,UO_0000065,,0.9
,13968482,[],CHEMBL3136590,Inhibition of p53-MDM2 (1 to 118 residues) interaction (unknown origin) expressed in Escherichia coli BL-21 (DE3) assessed as inhibition of MDM2 binding by fluorescence polarization competitive binding assay,B,,,BAO_0000190,BAO_0000019,assay format,Nc1sc(-c2ccc(Cl)cc2)c(-c2ccc(Cl)cc2)c1C(=O)NC1CC1,,,CHEMBL3132800,MedChemComm,2013,"{'bei': '14.09', 'le': '0.30', 'lle': '-0.18', 'sei': '10.31'}",CHEMBL2385518,,CHEMBL2385518,5.68,False,http://www.openphacts.org/units/Nanomolar,1974781,=,1,True,=,,IC50,nM,,2080.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,uM,UO_0000065,,2.08
,13968483,[],CHEMBL3136590,Inhibition of p53-MDM2 (1 to 118 residues) interaction (unknown origin) expressed in Escherichia coli BL-21 (DE3) assessed as inhibition of MDM2 binding by fluorescence polarization competitive binding assay,B,,,BAO_0000190,BAO_0000019,assay format,Nc1sc(-c2ccc(Cl)cc2)c(-c2ccc(Cl)cc2)c1C(=O)N1CCCC1,,,CHEMBL3132800,MedChemComm,2013,"{'bei': '13.29', 'le': '0.28', 'lle': '-0.66', 'sei': '11.97'}",CHEMBL2385523,,CHEMBL2385523,5.55,False,http://www.openphacts.org/units/Nanomolar,1974780,=,1,True,=,,IC50,nM,,2840.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,uM,UO_0000065,,2.84
,13968484,[],CHEMBL3136590,Inhibition of p53-MDM2 (1 to 118 residues) interaction (unknown origin) expressed in Escherichia coli BL-21 (DE3) assessed as inhibition of MDM2 binding by fluorescence polarization competitive binding assay,B,,,BAO_0000190,BAO_0000019,assay format,COC(=O)c1c(N)sc(-c2ccc(Cl)cc2)c1-c1ccc(Cl)cc1,,,CHEMBL3132800,MedChemComm,2013,"{'bei': '14.21', 'le': '0.31', 'lle': '-0.39', 'sei': '10.27'}",CHEMBL2385517,,CHEMBL2385517,5.37,False,http://www.openphacts.org/units/Nanomolar,1974779,=,1,True,=,,IC50,nM,,4230.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,uM,UO_0000065,,4.23
,14528322,[],CHEMBL3223357,Inhibition of p53 interaction to MDM2 (unknown origin) by surface plasmon resonance assay,B,,,BAO_0000190,BAO_0000224,protein format,CCOc1cc(OC)ccc1C1=N[C@@H](c2ccc(Br)cc2)[C@@H](c2ccc(Br)cc2)N1C(=O)N1CCN(CCO)CC1,,,CHEMBL3217437,MedChemComm,2011,"{'bei': '9.98', 'le': '0.23', 'lle': '0.96', 'sei': '8.81'}",CHEMBL407632,NUTLIN-2,CHEMBL407632,6.85,False,http://www.openphacts.org/units/Nanomolar,2075572,=,1,True,=,,IC50,nM,,140.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,uM,UO_0000065,,0.14
,14528329,[],CHEMBL3223361,Inhibition of p53 interaction to MDM2 (unknown origin),B,,,BAO_0000190,BAO_0000224,protein format,CC(C)(C)c1ncc(C2=N[C@@](C)(c3ccc(Cl)cc3)[C@@](C)(c3ccc(Cl)cc3)N2C(=O)N2CCN(CCOCCO)CC2)cn1,,,CHEMBL3217437,MedChemComm,2011,"{'bei': '11.49', 'le': '0.23', 'lle': '1.79', 'sei': '7.95'}",CHEMBL3220436,,CHEMBL3220436,7.51,False,http://www.openphacts.org/units/Nanomolar,2075577,=,1,True,=,,IC50,nM,,31.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,uM,UO_0000065,,0.031
,14528330,[],CHEMBL3223361,Inhibition of p53 interaction to MDM2 (unknown origin),B,,,BAO_0000190,BAO_0000224,protein format,COC(=O)c1cccc(S(=O)(=O)N2c3ccc(C(=O)N4CCN(C)CC4)c(=O)n3[C@@H](c3ccc(Cl)cc3)[C@H]2c2ccc(Cl)cc2)c1,,,CHEMBL3217437,MedChemComm,2011,"{'bei': '9.30', 'le': '0.19', 'lle': '1.47', 'sei': '5.80'}",CHEMBL3220437,,CHEMBL3220437,6.34,False,http://www.openphacts.org/units/Nanomolar,2075578,=,1,True,=,,IC50,nM,,460.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,uM,UO_0000065,,0.46
,14528332,[],CHEMBL3223361,Inhibition of p53 interaction to MDM2 (unknown origin),B,,,BAO_0000190,BAO_0000224,protein format,Cc1cccc([C@H]2N(CC(=O)O)C(=O)C[C@@H](c3cccc(Cl)c3)[C@]23C(=O)Nc2cc(Cl)ccc23)c1,,,CHEMBL3217437,MedChemComm,2011,"{'bei': '12.63', 'le': '0.25', 'lle': '1.10', 'sei': '7.42'}",CHEMBL3220685,,CHEMBL3220685,6.43,False,http://www.openphacts.org/units/Nanomolar,2075932,=,1,True,=,,IC50,nM,,370.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,uM,UO_0000065,,0.37
,14528333,[],CHEMBL3223361,Inhibition of p53 interaction to MDM2 (unknown origin),B,,,BAO_0000190,BAO_0000224,protein format,Cc1ccc(F)cc1[C@@H]1NC(=O)C[C@H](c2ccccc2OC(C)(C)C(=O)N2CCC(F)(F)CC2)[C@@]12C(=O)Nc1cc(Cl)ccc12,,,CHEMBL3217437,MedChemComm,2011,"{'bei': '11.35', 'le': '0.22', 'lle': '0.83', 'sei': '8.28'}",CHEMBL3220686,,CHEMBL3220686,7.27,False,http://www.openphacts.org/units/Nanomolar,2075933,=,1,True,=,,IC50,nM,,54.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,uM,UO_0000065,,0.054
,14528334,[],CHEMBL3223363,Inhibition of p53 interaction to GST-tagged MDM2 (unknown origin),B,,,BAO_0000190,BAO_0000224,protein format,CC(=O)N1CCC(Oc2ccc(I)cc2[C@@H]2NC(=O)C[C@H](c3cccc(Cl)c3)[C@@]23C(=O)Nc2cc(Cl)ccc23)CC1,,,CHEMBL3217437,MedChemComm,2011,"{'bei': '10.60', 'le': '0.25', 'lle': '1.25', 'sei': '8.51'}",CHEMBL3220687,,CHEMBL3220687,7.47,False,http://www.openphacts.org/units/Nanomolar,2075934,=,1,True,=,,IC50,nM,,34.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,uM,UO_0000065,,0.034
,14528335,[],CHEMBL3223361,Inhibition of p53 interaction to MDM2 (unknown origin),B,,,BAO_0000190,BAO_0000224,protein format,C=C(CC)[C@H]1N2CC(=O)N(CCCN(C)C)N=C2C[C@@H](c2cccc(Cl)c2)[C@]12C(=O)Nc1cc(Cl)ccc12,,,CHEMBL3217437,MedChemComm,2011,"{'bei': '12.62', 'le': '0.25', 'lle': '1.88', 'sei': '10.26'}",CHEMBL3220688,,CHEMBL3220688,7.00,False,http://www.openphacts.org/units/Nanomolar,2075935,=,1,True,=,,IC50,nM,,100.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,uM,UO_0000065,,0.1
,14528336,[],CHEMBL3223364,Inhibition of p53 interaction to MDM2 (unknown origin) by HTRF assay in presence of 0.02% bovine serum albumin,B,,,BAO_0000190,BAO_0000224,protein format,Cc1ccc(F)cc1[C@H]1NC(=O)C=C(c2cccc(Cl)c2)[C@]12C(=O)Nc1cc(Cl)ccc12,,,CHEMBL3217437,MedChemComm,2011,"{'bei': '15.36', 'le': '0.31', 'lle': '1.59', 'sei': '12.34'}",CHEMBL3220689,,CHEMBL3220689,7.18,False,http://www.openphacts.org/units/Nanomolar,2075936,=,1,True,=,,IC50,nM,,66.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,66.0
,14528337,[],CHEMBL3223361,Inhibition of p53 interaction to MDM2 (unknown origin),B,,,BAO_0000190,BAO_0000224,protein format,COc1cccc(C2(Cc3cccc(Cl)c3)C(=O)Nc3cc(Cl)ccc32)c1,,,CHEMBL3217437,MedChemComm,2011,"{'bei': '15.91', 'le': '0.32', 'lle': '0.86', 'sei': '16.53'}",CHEMBL3220690,,CHEMBL3220690,6.34,False,http://www.openphacts.org/units/Nanomolar,2075937,=,1,True,=,,IC50,nM,,460.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,uM,UO_0000065,,0.46
,14528338,[],CHEMBL3223364,Inhibition of p53 interaction to MDM2 (unknown origin) by HTRF assay in presence of 0.02% bovine serum albumin,B,,,BAO_0000190,BAO_0000224,protein format,CC(C)(C)C[C@@H]1N[C@@H](C(=O)NCCCCO)[C@@H](c2cccc(Cl)c2)[C@@]1(C#N)c1ccc(Cl)cc1,,,CHEMBL3217437,MedChemComm,2011,"{'bei': '12.96', 'le': '0.26', 'lle': '1.31', 'sei': '7.65'}",CHEMBL3220691,,CHEMBL3220691,6.51,False,http://www.openphacts.org/units/Nanomolar,2075938,=,1,True,=,,IC50,nM,,309.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,309.0
,14528339,[],CHEMBL3223364,Inhibition of p53 interaction to MDM2 (unknown origin) by HTRF assay in presence of 0.02% bovine serum albumin,B,,,BAO_0000190,BAO_0000224,protein format,CC(C)(C)C[C@@H]1N[C@@H](C(=O)NCC[C@H](O)CO)[C@@H](c2cc(F)cc(Cl)c2)[C@@]1(C#N)c1ccc(Cl)cc1F,,,CHEMBL3217437,MedChemComm,2011,"{'bei': '12.23', 'le': '0.25', 'lle': '2.33', 'sei': '6.44'}",CHEMBL3220692,,CHEMBL3220692,6.78,False,http://www.openphacts.org/units/Nanomolar,2075939,=,1,True,=,,IC50,nM,,165.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,165.0
,14528340,[],CHEMBL3223361,Inhibition of p53 interaction to MDM2 (unknown origin),B,,,BAO_0000190,BAO_0000224,protein format,CCOC(=O)[C@@]1(c2ccc(Cl)cc2)N=C(c2ccc(OC)cc2OC(C)C)N(C(=O)N2CCN(C(C)=O)CC2)[C@@H]1c1ccc(Cl)cc1,,,CHEMBL3217437,MedChemComm,2011,"{'bei': '10.50', 'le': '0.21', 'lle': '0.81', 'sei': '7.09'}",CHEMBL3220693,,CHEMBL3220693,7.16,False,http://www.openphacts.org/units/Nanomolar,2075940,=,1,True,=,,IC50,nM,,70.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,70.0
,14528343,[],CHEMBL3223361,Inhibition of p53 interaction to MDM2 (unknown origin),B,,,BAO_0000190,BAO_0000224,protein format,C[C@H](c1ccc(Cl)cc1)N1C(=O)c2cc(I)ccc2N(CCCCC(=O)O)C(=O)[C@H]1c1ccc(Cl)cc1,,,CHEMBL3217437,MedChemComm,2011,"{'bei': '12.28', 'le': '0.30', 'lle': '0.86', 'sei': '10.27'}",CHEMBL3220696,,CHEMBL3220696,8.00,False,http://www.openphacts.org/units/Nanomolar,2075943,=,1,True,=,,IC50,nM,,10.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,10.0
,14528344,[],CHEMBL3223361,Inhibition of p53 interaction to MDM2 (unknown origin),B,,,BAO_0000190,BAO_0000224,protein format,CC(C)C1=C(C(=O)N2C[C@H](F)C[C@H]2C(=O)N2CCNC3(CC3)C2)SC2=N[C@@](C)(c3ccc(Cl)nc3)[C@@H](c3ccc(Cl)c(F)c3)N21,,,CHEMBL3217437,MedChemComm,2011,"{'bei': '12.66', 'le': '0.26', 'lle': '2.88', 'sei': '10.54'}",CHEMBL3220697,,CHEMBL3220697,8.55,False,http://www.openphacts.org/units/Nanomolar,2075944,=,1,True,=,,IC50,nM,,2.8,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,2.8
,14528345,[],CHEMBL3223366,Inhibition of His-tagged p53 interaction to GST-tagged MDM2 (unknown origin),B,,,BAO_0000190,BAO_0000224,protein format,CC(C)C1=C(C(=O)N2CCC[C@H]2C(=O)N(C)C)SC2=N[C@@](C)(c3ccc(Cl)nc3)[C@@H](c3ccc(Cl)cc3)N21,,,CHEMBL3217437,MedChemComm,2011,"{'bei': '13.72', 'le': '0.28', 'lle': '2.14', 'sei': '11.36'}",CHEMBL3217786,,CHEMBL3217786,7.85,False,http://www.openphacts.org/units/Nanomolar,2075945,=,1,True,=,,IC50,nM,,14.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,uM,UO_0000065,,0.014
,14530479,[],CHEMBL3223361,Inhibition of p53 interaction to MDM2 (unknown origin),B,,,BAO_0000190,BAO_0000224,protein format,COc1cc(C(=O)N(C)[C@@H](Cc2c[nH]c3ccccc23)C(=O)N2CCN(c3ccc([N+](=O)[O-])cc3)CC2)c([N+](=O)[O-])cc1OC,,,CHEMBL3217437,MedChemComm,2011,"{'bei': '12.20', 'le': '0.23', 'lle': '3.49', 'sei': '4.58'}",CHEMBL3220698,,CHEMBL3220698,7.52,False,http://www.openphacts.org/units/Nanomolar,2075946,=,1,True,=,,IC50,nM,,30.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,uM,UO_0000065,,0.03
,14530480,[],CHEMBL3223361,Inhibition of p53 interaction to MDM2 (unknown origin),B,,,BAO_0000190,BAO_0000224,protein format,CCOC(=O)N1CCN(C(=O)[C@@]2(Sc3ccccc3)CC(=O)N(Cc3ccc(C#N)cc3)[C@@H]2c2c[nH]c3cc(Cl)ccc23)CC1,,,CHEMBL3217437,MedChemComm,2011,"{'bei': '9.34', 'le': '0.18', 'lle': '0.00', 'sei': '5.47'}",CHEMBL3220699,,CHEMBL3220699,6.00,False,http://www.openphacts.org/units/Nanomolar,2075947,=,1,True,=,,IC50,nM,,1000.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,uM,UO_0000065,,1.0
,14530483,[],CHEMBL3223361,Inhibition of p53 interaction to MDM2 (unknown origin),B,,,BAO_0000190,BAO_0000224,protein format,COc1cccc([C@]2(Cc3cccc(Cl)c3)C(=O)Nc3cc(Cl)ccc32)c1,,,CHEMBL3217437,MedChemComm,2011,"{'bei': '16.45', 'le': '0.33', 'lle': '1.07', 'sei': '17.10'}",CHEMBL3220704,,CHEMBL3220704,6.55,False,http://www.openphacts.org/units/Nanomolar,2075953,=,1,True,=,,IC50,nM,,280.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,uM,UO_0000065,,0.28
,14530485,[],CHEMBL3223361,Inhibition of p53 interaction to MDM2 (unknown origin),B,,,BAO_0000190,BAO_0000224,protein format,Cc1ccc(CN2C(=O)c3ccccc3C2(O[C@H]2C=C[C@@H](O)C2)c2ccc(Cl)cc2)cc1,,,CHEMBL3217437,MedChemComm,2011,"{'bei': '13.13', 'le': '0.25', 'lle': '0.64', 'sei': '11.76'}",CHEMBL1688256,,CHEMBL1688256,5.85,False,http://www.openphacts.org/units/Nanomolar,2075951,=,1,True,=,,IC50,nM,,1400.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,uM,UO_0000065,,1.4
,14530486,[],CHEMBL3223364,Inhibition of p53 interaction to MDM2 (unknown origin) by HTRF assay in presence of 0.02% bovine serum albumin,B,,,BAO_0000190,BAO_0000224,protein format,Cc1ccc(F)cc1[C@@H]1NC(=O)C[C@H](c2cc(Cl)cnc2CC(C)(C)C(=O)O)[C@@]12C(=O)Nc1cc(Cl)ccc12,,,CHEMBL3217437,MedChemComm,2011,"{'bei': '11.99', 'le': '0.24', 'lle': '1.12', 'sei': '6.31'}",CHEMBL3220703,,CHEMBL3220703,6.84,False,http://www.openphacts.org/units/Nanomolar,2075952,=,1,True,=,,IC50,nM,,145.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,uM,UO_0000065,,0.145
,14536263,[],CHEMBL3222408,Inhibition of Mdm2-p53 interaction in human PA-1 cells,B,,,BAO_0000190,BAO_0000219,cell-based format,O=C(O)[C@H]1c2ccccc2C(=O)N(Cc2ccc(Cl)cc2)[C@@H]1c1ccc(Cl)cc1,,,CHEMBL3217577,MedChemComm,2012,,CHEMBL3219399,,CHEMBL3219399,,False,http://www.openphacts.org/units/Nanomolar,2074227,>,1,True,>,,IC50,nM,,60000.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,uM,UO_0000065,,60.0
,14536264,[],CHEMBL3222408,Inhibition of Mdm2-p53 interaction in human PA-1 cells,B,,,BAO_0000190,BAO_0000219,cell-based format,COCCNC(=O)[C@H]1c2ccccc2C(=O)N(Cc2ccc(Cl)cc2)[C@@H]1c1ccc(Cl)cc1,,,CHEMBL3217577,MedChemComm,2012,"{'bei': '9.45', 'le': '0.19', 'lle': '-0.67', 'sei': '7.79'}",CHEMBL3219400,,CHEMBL3219400,4.57,False,http://www.openphacts.org/units/Nanomolar,2074228,=,1,True,=,,IC50,nM,,27100.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,uM,UO_0000065,,27.1
,14536265,[],CHEMBL3222408,Inhibition of Mdm2-p53 interaction in human PA-1 cells,B,,,BAO_0000190,BAO_0000219,cell-based format,CN1CCN(CCNC(=O)[C@H]2c3ccccc3C(=O)N(Cc3ccc(Cl)cc3)[C@@H]2c2c[nH]c3cc(Cl)ccc23)CC1,,,CHEMBL3217577,MedChemComm,2012,"{'bei': '8.81', 'le': '0.17', 'lle': '-0.12', 'sei': '7.26'}",CHEMBL3219401,,CHEMBL3219401,5.20,False,http://www.openphacts.org/units/Nanomolar,2074229,=,1,True,=,,IC50,nM,,6300.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,uM,UO_0000065,,6.3
,14536266,[],CHEMBL3222408,Inhibition of Mdm2-p53 interaction in human PA-1 cells,B,,,BAO_0000190,BAO_0000219,cell-based format,O=C1C(O)=C(c2ccccc2)C(c2ccc(Cl)cc2)N1Cc1ccc(Cl)cc1,,,CHEMBL3217577,MedChemComm,2012,"{'bei': '11.98', 'le': '0.24', 'lle': '-1.14', 'sei': '12.12'}",CHEMBL3219402,,CHEMBL3219402,4.91,False,http://www.openphacts.org/units/Nanomolar,2074230,=,1,True,=,,IC50,nM,,12200.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,uM,UO_0000065,,12.2
,14536267,[],CHEMBL3222408,Inhibition of Mdm2-p53 interaction in human PA-1 cells,B,,,BAO_0000190,BAO_0000219,cell-based format,COc1ccc(C2=N[C@@H](c3ccc(Cl)cc3)[C@@H](c3ccc(Cl)cc3)N2C(=O)N2CCNC(=O)C2)c(OC(C)C)c1,,,CHEMBL3217577,MedChemComm,2012,"{'bei': '9.18', 'le': '0.18', 'lle': '-0.55', 'sei': '6.39'}",CHEMBL191334,NUTLIN-3,CHEMBL191334,5.34,False,http://www.openphacts.org/units/Nanomolar,2074231,=,1,True,=,,IC50,nM,,4600.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,uM,UO_0000065,,4.6
,14977511,[],CHEMBL3372382,Inhibition of MDM2/P53 (unknown origin) protein interaction,B,,,BAO_0000190,BAO_0000224,protein format,CC(C)(C)C[C@@H]1N[C@@H](C(=O)NCC=N)[C@H](c2cccc(Cl)c2F)[C@]12C(=O)Nc1cc(Cl)ccc12,,,CHEMBL3351271,Bioorg. Med. Chem. Lett.,2015,"{'bei': '15.04', 'le': '0.31', 'lle': '2.95', 'sei': '8.08'}",CHEMBL3353231,,CHEMBL3353231,7.60,False,http://www.openphacts.org/units/Nanomolar,2241899,=,1,True,=,,IC50,nM,,25.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,25.0
,14977512,[],CHEMBL3372383,Inhibition of MDM2/P53 (unknown origin) protein interaction under serum free conditions by HTRF assay,B,,,BAO_0000190,BAO_0000224,protein format,CC[C@@H](CO)N1C(=O)[C@H](CC(=O)O)O[C@@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1,Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL3351271,Bioorg. Med. Chem. Lett.,2015,,CHEMBL2347393,,CHEMBL2347393,,False,http://www.openphacts.org/units/Nanomolar,2241900,=,1,True,=,,IC50,nM,,610000.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,mM,UO_0000065,,0.61
,14998193,[],CHEMBL3364003,Inhibition of p53-MDM2 (unknown origin) interaction using 0.02% BSA buffer after 1 hr by HTRF assay,B,,,BAO_0000190,BAO_0000224,protein format,COc1cc(C(=O)O)ccc1NC(=O)[C@@H]1N[C@@H](CC(C)(C)C)[C@](C#N)(c2ccc(Cl)cc2F)[C@H]1c1cccc(Cl)c1F,,,CHEMBL3352737,Bioorg. Med. Chem.,2014,"{'bei': '13.05', 'le': '0.26', 'lle': '1.11', 'sei': '7.22'}",CHEMBL2402737,IDASANUTLIN,CHEMBL2402737,8.05,False,http://www.openphacts.org/units/Nanomolar,2248560,=,1,True,=,,IC50,nM,,9.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,9.0
,14998206,[],CHEMBL3364003,Inhibition of p53-MDM2 (unknown origin) interaction using 0.02% BSA buffer after 1 hr by HTRF assay,B,,,BAO_0000190,BAO_0000224,protein format,COc1cc(C(N)=O)ccc1NC(=O)[C@@H]1N[C@@H](CC(C)(C)C)[C@@]2(C(=O)Nc3c2ccc(Cl)c3F)[C@H]1c1cccc(Cl)c1F,,,CHEMBL3352737,Bioorg. Med. Chem.,2014,"{'bei': '12.39', 'le': '0.25', 'lle': '2.05', 'sei': '6.38'}",CHEMBL3310323,,CHEMBL3310323,7.82,False,http://www.openphacts.org/units/Nanomolar,2248559,=,1,True,=,,IC50,nM,,15.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,15.0
,14998207,[],CHEMBL3364003,Inhibition of p53-MDM2 (unknown origin) interaction using 0.02% BSA buffer after 1 hr by HTRF assay,B,,,BAO_0000190,BAO_0000224,protein format,CC(C)(C)C[C@@H]1N[C@@H](C(=O)Nc2ccc(C(N)=O)cc2)[C@H](c2cccc(Cl)c2F)[C@]12C(=O)Nc1cc(Cl)c(F)cc12,,,CHEMBL3352737,Bioorg. Med. Chem.,2014,"{'bei': '13.67', 'le': '0.27', 'lle': '2.46', 'sei': '7.26'}",CHEMBL3310322,,CHEMBL3310322,8.22,False,http://www.openphacts.org/units/Nanomolar,2248558,=,1,True,=,,IC50,nM,,6.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,6.0
,14998208,[],CHEMBL3364003,Inhibition of p53-MDM2 (unknown origin) interaction using 0.02% BSA buffer after 1 hr by HTRF assay,B,,,BAO_0000190,BAO_0000224,protein format,COc1cc(C(N)=O)ccc1NC(=O)[C@@H]1N[C@@H](CC(C)(C)C)[C@@]2(C(=O)Nc3cc(Cl)cc(F)c32)[C@H]1c1cccc(Cl)c1F,,,CHEMBL3352737,Bioorg. Med. Chem.,2014,"{'bei': '13.14', 'le': '0.26', 'lle': '2.53', 'sei': '6.77'}",CHEMBL3310321,,CHEMBL3310321,8.30,False,http://www.openphacts.org/units/Nanomolar,2248557,=,1,True,=,,IC50,nM,,5.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,5.0
,14998209,[],CHEMBL3364003,Inhibition of p53-MDM2 (unknown origin) interaction using 0.02% BSA buffer after 1 hr by HTRF assay,B,,,BAO_0000190,BAO_0000224,protein format,COc1cc(OCCO)ccc1NC(=O)[C@@H]1N[C@@H](CC(C)(C)C)[C@@]2(C(=O)Nc3cc(Cl)ccc32)[C@H]1c1cccc(Cl)c1F,,,CHEMBL3352737,Bioorg. Med. Chem.,2014,"{'bei': '13.16', 'le': '0.26', 'lle': '2.40', 'sei': '7.62'}",CHEMBL3310320,,CHEMBL3310320,8.30,False,http://www.openphacts.org/units/Nanomolar,2248556,=,1,True,=,,IC50,nM,,5.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,5.0
,14998210,[],CHEMBL3364003,Inhibition of p53-MDM2 (unknown origin) interaction using 0.02% BSA buffer after 1 hr by HTRF assay,B,,,BAO_0000190,BAO_0000224,protein format,CC(C)(C)C[C@@H]1N[C@@H](C(=O)Nc2ccc(OCCO)cc2)[C@H](c2cccc(Cl)c2F)[C@]12C(=O)Nc1cc(Cl)ccc12,,,CHEMBL3352737,Bioorg. Med. Chem.,2014,"{'bei': '13.58', 'le': '0.27', 'lle': '2.26', 'sei': '8.18'}",CHEMBL3310319,,CHEMBL3310319,8.15,False,http://www.openphacts.org/units/Nanomolar,2246564,=,1,True,=,,IC50,nM,,7.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,7.0
,14998211,[],CHEMBL3364003,Inhibition of p53-MDM2 (unknown origin) interaction using 0.02% BSA buffer after 1 hr by HTRF assay,B,,,BAO_0000190,BAO_0000224,protein format,COc1cc(C(N)=O)ccc1-c1ccccc1NC(=O)[C@@H]1N[C@@H](CC(C)(C)C)[C@@]2(C(=O)Nc3cc(Cl)ccc32)[C@H]1c1cccc(Cl)c1F,,,CHEMBL3352737,Bioorg. Med. Chem.,2014,"{'bei': '12.04', 'le': '0.24', 'lle': '1.00', 'sei': '6.77'}",CHEMBL3310188,,CHEMBL3310188,8.30,False,http://www.openphacts.org/units/Nanomolar,2246563,=,1,True,=,,IC50,nM,,5.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,5.0
,14998212,[],CHEMBL3364003,Inhibition of p53-MDM2 (unknown origin) interaction using 0.02% BSA buffer after 1 hr by HTRF assay,B,,,BAO_0000190,BAO_0000224,protein format,CC(C)(C)C[C@@H]1N[C@@H](C(=O)Nc2ccc(C#N)cc2F)[C@H](c2cccc(Cl)c2F)[C@]12C(=O)Nc1cc(Cl)ccc12,,,CHEMBL3352737,Bioorg. Med. Chem.,2014,"{'bei': '13.98', 'le': '0.28', 'lle': '1.62', 'sei': '8.67'}",CHEMBL3310187,,CHEMBL3310187,8.15,False,http://www.openphacts.org/units/Nanomolar,2246562,=,1,True,=,,IC50,nM,,7.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,7.0
,14998213,[],CHEMBL3364003,Inhibition of p53-MDM2 (unknown origin) interaction using 0.02% BSA buffer after 1 hr by HTRF assay,B,,,BAO_0000190,BAO_0000224,protein format,COc1cc(NC(=O)[C@@H]2N[C@@H](CC(C)(C)C)[C@@]3(C(=O)Nc4cc(Cl)ccc43)[C@H]2c2cccc(Cl)c2F)ccc1C(N)=O,,,CHEMBL3352737,Bioorg. Med. Chem.,2014,"{'bei': '13.53', 'le': '0.27', 'lle': '2.67', 'sei': '6.77'}",CHEMBL3310186,,CHEMBL3310186,8.30,False,http://www.openphacts.org/units/Nanomolar,2246561,=,1,True,=,,IC50,nM,,5.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,5.0
,14998214,[],CHEMBL3364003,Inhibition of p53-MDM2 (unknown origin) interaction using 0.02% BSA buffer after 1 hr by HTRF assay,B,,,BAO_0000190,BAO_0000224,protein format,CC(C)(C)C[C@@H]1N[C@@H](C(=O)Nc2ccc(C(N)=O)cc2)[C@H](c2cccc(Cl)c2F)[C@]12C(=O)Nc1cc(Cl)ccc12,,,CHEMBL3352737,Bioorg. Med. Chem.,2014,"{'bei': '14.23', 'le': '0.28', 'lle': '2.68', 'sei': '7.33'}",CHEMBL3310185,,CHEMBL3310185,8.30,False,http://www.openphacts.org/units/Nanomolar,2246560,=,1,True,=,,IC50,nM,,5.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,5.0
,14998215,[],CHEMBL3364003,Inhibition of p53-MDM2 (unknown origin) interaction using 0.02% BSA buffer after 1 hr by HTRF assay,B,,,BAO_0000190,BAO_0000224,protein format,COc1cc(C(=O)O)ccc1NC(=O)[C@@H]1N[C@@H](CC(C)(C)C)[C@@]2(C(=O)Nc3cc(Cl)ccc32)[C@H]1c1cccc(Cl)c1F,,,CHEMBL3352737,Bioorg. Med. Chem.,2014,"{'bei': '13.51', 'le': '0.27', 'lle': '2.07', 'sei': '7.11'}",CHEMBL3310184,,CHEMBL3310184,8.30,False,http://www.openphacts.org/units/Nanomolar,2246559,=,1,True,=,,IC50,nM,,5.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,5.0
,14998216,[],CHEMBL3364003,Inhibition of p53-MDM2 (unknown origin) interaction using 0.02% BSA buffer after 1 hr by HTRF assay,B,,,BAO_0000190,BAO_0000224,protein format,COc1cc(NC(=O)[C@H]2N[C@H](CC(C)(C)C)[C@]3(C(=O)Nc4cc(Cl)ccc43)[C@@H]2c2cccc(Cl)c2F)ccc1C(=O)O,,,CHEMBL3352737,Bioorg. Med. Chem.,2014,"{'bei': '8.97', 'le': '0.18', 'lle': '-0.72', 'sei': '4.72'}",CHEMBL3310183,,CHEMBL3310183,5.51,False,http://www.openphacts.org/units/Nanomolar,2246558,=,1,True,=,,IC50,nM,,3089.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,3089.0
,14998217,[],CHEMBL3364003,Inhibition of p53-MDM2 (unknown origin) interaction using 0.02% BSA buffer after 1 hr by HTRF assay,B,,,BAO_0000190,BAO_0000224,protein format,COc1cc(NC(=O)[C@@H]2N[C@@H](CC(C)(C)C)[C@@]3(C(=O)Nc4cc(Cl)ccc43)[C@H]2c2cccc(Cl)c2F)ccc1C(=O)O,,,CHEMBL3352737,Bioorg. Med. Chem.,2014,"{'bei': '13.67', 'le': '0.27', 'lle': '2.17', 'sei': '7.19'}",CHEMBL3310182,,CHEMBL3310182,8.40,False,http://www.openphacts.org/units/Nanomolar,2246556,=,1,True,=,,IC50,nM,,4.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,4.0
,14998218,[],CHEMBL3364002,Inhibition of p53-MDM2 (unknown origin) interaction using 0.2% BSA buffer after 1 hr by HTRF assay,B,,,BAO_0000190,BAO_0000224,protein format,COc1cc(C(=O)O)ccc1NC(=O)[C@@H]1N[C@@H](CC(C)(C)C)[C@](C#N)(c2ccc(Cl)cc2F)[C@H]1c1cccc(Cl)c1F,,,CHEMBL3352737,Bioorg. Med. Chem.,2014,"{'bei': '12.98', 'le': '0.26', 'lle': '1.06', 'sei': '7.18'}",CHEMBL2402737,IDASANUTLIN,CHEMBL2402737,8.00,False,http://www.openphacts.org/units/Nanomolar,2248560,=,1,True,=,,IC50,nM,,10.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,10.0
,14998219,[],CHEMBL3364002,Inhibition of p53-MDM2 (unknown origin) interaction using 0.2% BSA buffer after 1 hr by HTRF assay,B,,,BAO_0000190,BAO_0000224,protein format,COc1cc(C(N)=O)ccc1NC(=O)[C@@H]1N[C@@H](CC(C)(C)C)[C@@]2(C(=O)Nc3c2ccc(Cl)c3F)[C@H]1c1cccc(Cl)c1F,,,CHEMBL3352737,Bioorg. Med. Chem.,2014,"{'bei': '12.26', 'le': '0.25', 'lle': '1.97', 'sei': '6.32'}",CHEMBL3310323,,CHEMBL3310323,7.75,False,http://www.openphacts.org/units/Nanomolar,2248559,=,1,True,=,,IC50,nM,,18.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,18.0
,14998220,[],CHEMBL3364002,Inhibition of p53-MDM2 (unknown origin) interaction using 0.2% BSA buffer after 1 hr by HTRF assay,B,,,BAO_0000190,BAO_0000224,protein format,CC(C)(C)C[C@@H]1N[C@@H](C(=O)Nc2ccc(C(N)=O)cc2)[C@H](c2cccc(Cl)c2F)[C@]12C(=O)Nc1cc(Cl)c(F)cc12,,,CHEMBL3352737,Bioorg. Med. Chem.,2014,"{'bei': '13.67', 'le': '0.27', 'lle': '2.46', 'sei': '7.26'}",CHEMBL3310322,,CHEMBL3310322,8.22,False,http://www.openphacts.org/units/Nanomolar,2248558,=,1,True,=,,IC50,nM,,6.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,6.0
,14998221,[],CHEMBL3364002,Inhibition of p53-MDM2 (unknown origin) interaction using 0.2% BSA buffer after 1 hr by HTRF assay,B,,,BAO_0000190,BAO_0000224,protein format,COc1cc(C(N)=O)ccc1NC(=O)[C@@H]1N[C@@H](CC(C)(C)C)[C@@]2(C(=O)Nc3cc(Cl)cc(F)c32)[C@H]1c1cccc(Cl)c1F,,,CHEMBL3352737,Bioorg. Med. Chem.,2014,"{'bei': '13.02', 'le': '0.26', 'lle': '2.45', 'sei': '6.71'}",CHEMBL3310321,,CHEMBL3310321,8.22,False,http://www.openphacts.org/units/Nanomolar,2248557,=,1,True,=,,IC50,nM,,6.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,6.0
,14998222,[],CHEMBL3364002,Inhibition of p53-MDM2 (unknown origin) interaction using 0.2% BSA buffer after 1 hr by HTRF assay,B,,,BAO_0000190,BAO_0000224,protein format,COc1cc(OCCO)ccc1NC(=O)[C@@H]1N[C@@H](CC(C)(C)C)[C@@]2(C(=O)Nc3cc(Cl)ccc32)[C@H]1c1cccc(Cl)c1F,,,CHEMBL3352737,Bioorg. Med. Chem.,2014,"{'bei': '13.16', 'le': '0.26', 'lle': '2.40', 'sei': '7.62'}",CHEMBL3310320,,CHEMBL3310320,8.30,False,http://www.openphacts.org/units/Nanomolar,2248556,=,1,True,=,,IC50,nM,,5.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,5.0
,14998223,[],CHEMBL3364002,Inhibition of p53-MDM2 (unknown origin) interaction using 0.2% BSA buffer after 1 hr by HTRF assay,B,,,BAO_0000190,BAO_0000224,protein format,CC(C)(C)C[C@@H]1N[C@@H](C(=O)Nc2ccc(OCCO)cc2)[C@H](c2cccc(Cl)c2F)[C@]12C(=O)Nc1cc(Cl)ccc12,,,CHEMBL3352737,Bioorg. Med. Chem.,2014,"{'bei': '13.48', 'le': '0.27', 'lle': '2.21', 'sei': '8.12'}",CHEMBL3310319,,CHEMBL3310319,8.10,False,http://www.openphacts.org/units/Nanomolar,2246564,=,1,True,=,,IC50,nM,,8.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,8.0
,14998224,[],CHEMBL3364002,Inhibition of p53-MDM2 (unknown origin) interaction using 0.2% BSA buffer after 1 hr by HTRF assay,B,,,BAO_0000190,BAO_0000224,protein format,COc1cc(C(N)=O)ccc1-c1ccccc1NC(=O)[C@@H]1N[C@@H](CC(C)(C)C)[C@@]2(C(=O)Nc3cc(Cl)ccc32)[C@H]1c1cccc(Cl)c1F,,,CHEMBL3352737,Bioorg. Med. Chem.,2014,"{'bei': '12.04', 'le': '0.24', 'lle': '1.00', 'sei': '6.77'}",CHEMBL3310188,,CHEMBL3310188,8.30,False,http://www.openphacts.org/units/Nanomolar,2246563,=,1,True,=,,IC50,nM,,5.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,5.0
,14998225,[],CHEMBL3364002,Inhibition of p53-MDM2 (unknown origin) interaction using 0.2% BSA buffer after 1 hr by HTRF assay,B,,,BAO_0000190,BAO_0000224,protein format,CC(C)(C)C[C@@H]1N[C@@H](C(=O)Nc2ccc(C#N)cc2F)[C@H](c2cccc(Cl)c2F)[C@]12C(=O)Nc1cc(Cl)ccc12,,,CHEMBL3352737,Bioorg. Med. Chem.,2014,"{'bei': '13.98', 'le': '0.28', 'lle': '1.62', 'sei': '8.67'}",CHEMBL3310187,,CHEMBL3310187,8.15,False,http://www.openphacts.org/units/Nanomolar,2246562,=,1,True,=,,IC50,nM,,7.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,7.0
,14998226,[],CHEMBL3364002,Inhibition of p53-MDM2 (unknown origin) interaction using 0.2% BSA buffer after 1 hr by HTRF assay,B,,,BAO_0000190,BAO_0000224,protein format,COc1cc(NC(=O)[C@@H]2N[C@@H](CC(C)(C)C)[C@@]3(C(=O)Nc4cc(Cl)ccc43)[C@H]2c2cccc(Cl)c2F)ccc1C(N)=O,,,CHEMBL3352737,Bioorg. Med. Chem.,2014,"{'bei': '13.53', 'le': '0.27', 'lle': '2.67', 'sei': '6.77'}",CHEMBL3310186,,CHEMBL3310186,8.30,False,http://www.openphacts.org/units/Nanomolar,2246561,=,1,True,=,,IC50,nM,,5.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,5.0
,14998227,[],CHEMBL3364002,Inhibition of p53-MDM2 (unknown origin) interaction using 0.2% BSA buffer after 1 hr by HTRF assay,B,,,BAO_0000190,BAO_0000224,protein format,CC(C)(C)C[C@@H]1N[C@@H](C(=O)Nc2ccc(C(N)=O)cc2)[C@H](c2cccc(Cl)c2F)[C@]12C(=O)Nc1cc(Cl)ccc12,,,CHEMBL3352737,Bioorg. Med. Chem.,2014,"{'bei': '14.23', 'le': '0.28', 'lle': '2.68', 'sei': '7.33'}",CHEMBL3310185,,CHEMBL3310185,8.30,False,http://www.openphacts.org/units/Nanomolar,2246560,=,1,True,=,,IC50,nM,,5.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,5.0
,14998228,[],CHEMBL3364002,Inhibition of p53-MDM2 (unknown origin) interaction using 0.2% BSA buffer after 1 hr by HTRF assay,B,,,BAO_0000190,BAO_0000224,protein format,COc1cc(C(=O)O)ccc1NC(=O)[C@@H]1N[C@@H](CC(C)(C)C)[C@@]2(C(=O)Nc3cc(Cl)ccc32)[C@H]1c1cccc(Cl)c1F,,,CHEMBL3352737,Bioorg. Med. Chem.,2014,"{'bei': '13.51', 'le': '0.27', 'lle': '2.07', 'sei': '7.11'}",CHEMBL3310184,,CHEMBL3310184,8.30,False,http://www.openphacts.org/units/Nanomolar,2246559,=,1,True,=,,IC50,nM,,5.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,5.0
,14998229,[],CHEMBL3364002,Inhibition of p53-MDM2 (unknown origin) interaction using 0.2% BSA buffer after 1 hr by HTRF assay,B,,,BAO_0000190,BAO_0000224,protein format,COc1cc(NC(=O)[C@H]2N[C@H](CC(C)(C)C)[C@]3(C(=O)Nc4cc(Cl)ccc43)[C@@H]2c2cccc(Cl)c2F)ccc1C(=O)O,,,CHEMBL3352737,Bioorg. Med. Chem.,2014,"{'bei': '8.83', 'le': '0.18', 'lle': '-0.80', 'sei': '4.65'}",CHEMBL3310183,,CHEMBL3310183,5.43,False,http://www.openphacts.org/units/Nanomolar,2246558,=,1,True,=,,IC50,nM,,3741.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,3741.0
,14998230,[],CHEMBL3364002,Inhibition of p53-MDM2 (unknown origin) interaction using 0.2% BSA buffer after 1 hr by HTRF assay,B,,,BAO_0000190,BAO_0000224,protein format,COc1cc(NC(=O)[C@@H]2N[C@@H](CC(C)(C)C)[C@@]3(C(=O)Nc4cc(Cl)ccc43)[C@H]2c2cccc(Cl)c2F)ccc1C(=O)O,,,CHEMBL3352737,Bioorg. Med. Chem.,2014,"{'bei': '13.67', 'le': '0.27', 'lle': '2.17', 'sei': '7.19'}",CHEMBL3310182,,CHEMBL3310182,8.40,False,http://www.openphacts.org/units/Nanomolar,2246556,=,1,True,=,,IC50,nM,,4.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,4.0
,14998280,[],CHEMBL3364002,Inhibition of p53-MDM2 (unknown origin) interaction using 0.2% BSA buffer after 1 hr by HTRF assay,B,,,BAO_0000190,BAO_0000224,protein format,CC(=O)N1CCCC([C@]2(Cc3cccc(Cl)c3)C(=O)Nc3cc(Cl)ccc32)C1,,,CHEMBL3352737,Bioorg. Med. Chem.,2014,"{'bei': '12.96', 'le': '0.26', 'lle': '0.73', 'sei': '10.95'}",CHEMBL3354604,,CHEMBL3354604,5.41,False,http://www.openphacts.org/units/Nanomolar,2246557,=,1,True,=,,IC50,nM,,3900.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,uM,UO_0000065,,3.9
,15132062,[],CHEMBL3363506,Inhibition of human MDM2 (1-188 aa) -p53 (1-83 aa) interaction expressed in Escherichia coli after 18 hrs by HTRF assay in presence of 15% human serum,B,,,BAO_0000190,BAO_0000019,assay format,CCC(CC)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1,,,CHEMBL3351557,ACS Med. Chem. Lett.,2014,"{'bei': '15.70', 'le': '0.32', 'lle': '0.54', 'sei': '12.60'}",CHEMBL2177190,,CHEMBL2177190,7.26,False,http://www.openphacts.org/units/Nanomolar,2266161,=,1,True,=,,IC50,nM,,55.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,uM,UO_0000065,,0.055
,15132063,[],CHEMBL3363506,Inhibition of human MDM2 (1-188 aa) -p53 (1-83 aa) interaction expressed in Escherichia coli after 18 hrs by HTRF assay in presence of 15% human serum,B,,,BAO_0000190,BAO_0000019,assay format,C[C@]1(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@@H](c2ccc(Cl)cc2)N(c2ccccc2)C1=O,,,CHEMBL3351557,ACS Med. Chem. Lett.,2014,"{'bei': '15.50', 'le': '0.31', 'lle': '0.52', 'sei': '12.60'}",CHEMBL3329619,,CHEMBL3329619,7.26,False,http://www.openphacts.org/units/Nanomolar,2266160,=,1,True,=,,IC50,nM,,55.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,uM,UO_0000065,,0.055
,15132064,[],CHEMBL3363506,Inhibition of human MDM2 (1-188 aa) -p53 (1-83 aa) interaction expressed in Escherichia coli after 18 hrs by HTRF assay in presence of 15% human serum,B,,,BAO_0000190,BAO_0000019,assay format,C[C@]1(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@@H](c2ccc(Cl)cc2)N(c2ccccn2)C1=O,,,CHEMBL3351557,ACS Med. Chem. Lett.,2014,"{'bei': '14.73', 'le': '0.30', 'lle': '0.78', 'sei': '9.81'}",CHEMBL3329618,,CHEMBL3329618,6.91,False,http://www.openphacts.org/units/Nanomolar,2266159,=,1,True,=,,IC50,nM,,122.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,uM,UO_0000065,,0.122
,15132065,[],CHEMBL3363506,Inhibition of human MDM2 (1-188 aa) -p53 (1-83 aa) interaction expressed in Escherichia coli after 18 hrs by HTRF assay in presence of 15% human serum,B,,,BAO_0000190,BAO_0000019,assay format,CC[C@@H](c1ncccc1C)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1,,,CHEMBL3351557,ACS Med. Chem. Lett.,2014,"{'bei': '12.82', 'le': '0.26', 'lle': '-0.65', 'sei': '9.56'}",CHEMBL3329617,,CHEMBL3329617,6.74,False,http://www.openphacts.org/units/Nanomolar,2266158,=,1,True,=,,IC50,nM,,183.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,uM,UO_0000065,,0.183
,15132066,[],CHEMBL3363506,Inhibition of human MDM2 (1-188 aa) -p53 (1-83 aa) interaction expressed in Escherichia coli after 18 hrs by HTRF assay in presence of 15% human serum,B,,,BAO_0000190,BAO_0000019,assay format,CC[C@@H](c1cc(C)ccn1)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1,,,CHEMBL3351557,ACS Med. Chem. Lett.,2014,"{'bei': '13.74', 'le': '0.27', 'lle': '-0.17', 'sei': '10.24'}",CHEMBL3329616,,CHEMBL3329616,7.22,False,http://www.openphacts.org/units/Nanomolar,2266157,=,1,True,=,,IC50,nM,,60.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,uM,UO_0000065,,0.06
,15132067,[],CHEMBL3363506,Inhibition of human MDM2 (1-188 aa) -p53 (1-83 aa) interaction expressed in Escherichia coli after 18 hrs by HTRF assay in presence of 15% human serum,B,,,BAO_0000190,BAO_0000019,assay format,CC[C@@H](c1ccc(C)cn1)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1,,,CHEMBL3351557,ACS Med. Chem. Lett.,2014,"{'bei': '13.15', 'le': '0.26', 'lle': '-0.48', 'sei': '9.80'}",CHEMBL3329615,,CHEMBL3329615,6.91,False,http://www.openphacts.org/units/Nanomolar,2266156,=,1,True,=,,IC50,nM,,123.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,uM,UO_0000065,,0.123
,15132068,[],CHEMBL3363506,Inhibition of human MDM2 (1-188 aa) -p53 (1-83 aa) interaction expressed in Escherichia coli after 18 hrs by HTRF assay in presence of 15% human serum,B,,,BAO_0000190,BAO_0000019,assay format,CC[C@@H](c1cccc(C2CC2)n1)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1,,,CHEMBL3351557,ACS Med. Chem. Lett.,2014,"{'bei': '12.04', 'le': '0.24', 'lle': '-1.32', 'sei': '9.42'}",CHEMBL3329614,,CHEMBL3329614,6.64,False,http://www.openphacts.org/units/Nanomolar,2266155,=,1,True,=,,IC50,nM,,228.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,uM,UO_0000065,,0.228
,15132069,[],CHEMBL3363506,Inhibition of human MDM2 (1-188 aa) -p53 (1-83 aa) interaction expressed in Escherichia coli after 18 hrs by HTRF assay in presence of 15% human serum,B,,,BAO_0000190,BAO_0000019,assay format,CC[C@@H](c1cccc(Cl)n1)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1,,,CHEMBL3351557,ACS Med. Chem. Lett.,2014,"{'bei': '13.99', 'le': '0.29', 'lle': '-0.09', 'sei': '10.83'}",CHEMBL3329613,,CHEMBL3329613,7.64,False,http://www.openphacts.org/units/Nanomolar,2266154,=,1,True,=,,IC50,nM,,23.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,uM,UO_0000065,,0.023
,15132070,[],CHEMBL3363506,Inhibition of human MDM2 (1-188 aa) -p53 (1-83 aa) interaction expressed in Escherichia coli after 18 hrs by HTRF assay in presence of 15% human serum,B,,,BAO_0000190,BAO_0000019,assay format,CC[C@@H](c1cccc(C)n1)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1,,,CHEMBL3351557,ACS Med. Chem. Lett.,2014,"{'bei': '14.26', 'le': '0.28', 'lle': '0.10', 'sei': '10.63'}",CHEMBL3329224,,CHEMBL3329224,7.50,False,http://www.openphacts.org/units/Nanomolar,2266153,=,1,True,=,,IC50,nM,,32.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,uM,UO_0000065,,0.032
,15132071,[],CHEMBL3363506,Inhibition of human MDM2 (1-188 aa) -p53 (1-83 aa) interaction expressed in Escherichia coli after 18 hrs by HTRF assay in presence of 15% human serum,B,,,BAO_0000190,BAO_0000019,assay format,CCC[C@@H](c1ccccn1)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1,,,CHEMBL3351557,ACS Med. Chem. Lett.,2014,"{'bei': '13.39', 'le': '0.27', 'lle': '-0.43', 'sei': '9.98'}",CHEMBL3329612,,CHEMBL3329612,7.04,False,http://www.openphacts.org/units/Nanomolar,2266152,=,1,True,=,,IC50,nM,,92.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,uM,UO_0000065,,0.092
,15132072,[],CHEMBL3363506,Inhibition of human MDM2 (1-188 aa) -p53 (1-83 aa) interaction expressed in Escherichia coli after 18 hrs by HTRF assay in presence of 15% human serum,B,,,BAO_0000190,BAO_0000019,assay format,C[C@]1(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@@H](c2ccc(Cl)cc2)N([C@H](c2ccccn2)C2CC2)C1=O,,,CHEMBL3351557,ACS Med. Chem. Lett.,2014,"{'bei': '14.75', 'le': '0.29', 'lle': '0.64', 'sei': '10.95'}",CHEMBL3329611,,CHEMBL3329611,7.72,False,http://www.openphacts.org/units/Nanomolar,2266151,=,1,True,=,,IC50,nM,,19.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,uM,UO_0000065,,0.019
,15132073,[],CHEMBL3363506,Inhibition of human MDM2 (1-188 aa) -p53 (1-83 aa) interaction expressed in Escherichia coli after 18 hrs by HTRF assay in presence of 15% human serum,B,,,BAO_0000190,BAO_0000019,assay format,CC(C)[C@@H](c1ccccn1)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1,,,CHEMBL3351557,ACS Med. Chem. Lett.,2014,"{'bei': '14.47', 'le': '0.29', 'lle': '0.28', 'sei': '10.78'}",CHEMBL3329610,,CHEMBL3329610,7.60,False,http://www.openphacts.org/units/Nanomolar,2266150,=,1,True,=,,IC50,nM,,25.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,uM,UO_0000065,,0.025
,15132074,[],CHEMBL3363506,Inhibition of human MDM2 (1-188 aa) -p53 (1-83 aa) interaction expressed in Escherichia coli after 18 hrs by HTRF assay in presence of 15% human serum,B,,,BAO_0000190,BAO_0000019,assay format,C[C@@H](c1ccccn1)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1,,,CHEMBL3351557,ACS Med. Chem. Lett.,2014,"{'bei': '14.49', 'le': '0.29', 'lle': '0.52', 'sei': '10.22'}",CHEMBL3329609,,CHEMBL3329609,7.21,False,http://www.openphacts.org/units/Nanomolar,2266149,=,1,True,=,,IC50,nM,,62.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,uM,UO_0000065,,0.062
,15132075,[],CHEMBL3363506,Inhibition of human MDM2 (1-188 aa) -p53 (1-83 aa) interaction expressed in Escherichia coli after 18 hrs by HTRF assay in presence of 15% human serum,B,,,BAO_0000190,BAO_0000019,assay format,CC[C@@H](c1cccnc1)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1,,,CHEMBL3351557,ACS Med. Chem. Lett.,2014,"{'bei': '13.82', 'le': '0.28', 'lle': '-0.01', 'sei': '10.03'}",CHEMBL3329608,,CHEMBL3329608,7.07,False,http://www.openphacts.org/units/Nanomolar,2266148,=,1,True,=,,IC50,nM,,85.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,uM,UO_0000065,,0.085
,15132076,[],CHEMBL3363506,Inhibition of human MDM2 (1-188 aa) -p53 (1-83 aa) interaction expressed in Escherichia coli after 18 hrs by HTRF assay in presence of 15% human serum,B,,,BAO_0000190,BAO_0000019,assay format,CC[C@@H](c1ccncc1)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1,,,CHEMBL3351557,ACS Med. Chem. Lett.,2014,"{'bei': '14.68', 'le': '0.29', 'lle': '0.43', 'sei': '10.65'}",CHEMBL3329607,,CHEMBL3329607,7.51,False,http://www.openphacts.org/units/Nanomolar,2266147,=,1,True,=,,IC50,nM,,31.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,uM,UO_0000065,,0.031
,15132077,[],CHEMBL3363506,Inhibition of human MDM2 (1-188 aa) -p53 (1-83 aa) interaction expressed in Escherichia coli after 18 hrs by HTRF assay in presence of 15% human serum,B,,,BAO_0000190,BAO_0000019,assay format,CC[C@@H](c1ncccn1)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1,,,CHEMBL3351557,ACS Med. Chem. Lett.,2014,"{'bei': '14.25', 'le': '0.28', 'lle': '0.83', 'sei': '8.76'}",CHEMBL3329606,,CHEMBL3329606,7.30,False,http://www.openphacts.org/units/Nanomolar,2266146,=,1,True,=,,IC50,nM,,50.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,uM,UO_0000065,,0.05
,15132078,[],CHEMBL3363506,Inhibition of human MDM2 (1-188 aa) -p53 (1-83 aa) interaction expressed in Escherichia coli after 18 hrs by HTRF assay in presence of 15% human serum,B,,,BAO_0000190,BAO_0000019,assay format,CC[C@@H](c1ccccn1)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1,,,CHEMBL3351557,ACS Med. Chem. Lett.,2014,"{'bei': '14.77', 'le': '0.29', 'lle': '0.47', 'sei': '10.71'}",CHEMBL3329605,,CHEMBL3329605,7.55,False,http://www.openphacts.org/units/Nanomolar,2266145,=,1,True,=,,IC50,nM,,28.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,uM,UO_0000065,,0.028
,15132079,[],CHEMBL3363506,Inhibition of human MDM2 (1-188 aa) -p53 (1-83 aa) interaction expressed in Escherichia coli after 18 hrs by HTRF assay in presence of 15% human serum,B,,,BAO_0000190,BAO_0000019,assay format,CC[C@@H](c1nccs1)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1,,,CHEMBL3351557,ACS Med. Chem. Lett.,2014,"{'bei': '13.88', 'le': '0.29', 'lle': '0.04', 'sei': '10.19'}",CHEMBL3329604,,CHEMBL3329604,7.18,False,http://www.openphacts.org/units/Nanomolar,2266144,=,1,True,=,,IC50,nM,,66.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,uM,UO_0000065,,0.066
,15132080,[],CHEMBL3363506,Inhibition of human MDM2 (1-188 aa) -p53 (1-83 aa) interaction expressed in Escherichia coli after 18 hrs by HTRF assay in presence of 15% human serum,B,,,BAO_0000190,BAO_0000019,assay format,CC[C@@H](c1cnco1)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1,,,CHEMBL3351557,ACS Med. Chem. Lett.,2014,"{'bei': '14.85', 'le': '0.30', 'lle': '0.77', 'sei': '8.90'}",CHEMBL3329603,,CHEMBL3329603,7.44,False,http://www.openphacts.org/units/Nanomolar,2266143,=,1,True,=,,IC50,nM,,36.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,uM,UO_0000065,,0.036
,15132081,[],CHEMBL3363506,Inhibition of human MDM2 (1-188 aa) -p53 (1-83 aa) interaction expressed in Escherichia coli after 18 hrs by HTRF assay in presence of 15% human serum,B,,,BAO_0000190,BAO_0000019,assay format,CC[C@@H]([C@@H]1CCCO1)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1,,,CHEMBL3351557,ACS Med. Chem. Lett.,2014,"{'bei': '15.26', 'le': '0.31', 'lle': '1.21', 'sei': '11.52'}",CHEMBL3329602,,CHEMBL3329602,7.70,False,http://www.openphacts.org/units/Nanomolar,2266142,=,1,True,=,,IC50,nM,,20.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,uM,UO_0000065,,0.02
,15132082,[],CHEMBL3363506,Inhibition of human MDM2 (1-188 aa) -p53 (1-83 aa) interaction expressed in Escherichia coli after 18 hrs by HTRF assay in presence of 15% human serum,B,,,BAO_0000190,BAO_0000019,assay format,CC[C@@H]([C@H](C)OC)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1,,,CHEMBL3351557,ACS Med. Chem. Lett.,2014,"{'bei': '15.83', 'le': '0.32', 'lle': '1.45', 'sei': '11.66'}",CHEMBL3329601,,CHEMBL3329601,7.80,False,http://www.openphacts.org/units/Nanomolar,2266141,=,1,True,=,,IC50,nM,,16.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,uM,UO_0000065,,0.016
,15132083,[],CHEMBL3363506,Inhibition of human MDM2 (1-188 aa) -p53 (1-83 aa) interaction expressed in Escherichia coli after 18 hrs by HTRF assay in presence of 15% human serum,B,,,BAO_0000190,BAO_0000019,assay format,CC[C@@H]([C@H](C)O)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1,,,CHEMBL3351557,ACS Med. Chem. Lett.,2014,"{'bei': '17.19', 'le': '0.35', 'lle': '2.53', 'sei': '10.56'}",CHEMBL2059435,,CHEMBL2059435,8.22,False,http://www.openphacts.org/units/Nanomolar,2266140,=,1,True,=,,IC50,nM,,6.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,uM,UO_0000065,,0.006
,15132084,[],CHEMBL3363505,Inhibition of human MDM2 (1-188 aa) -p53 (1-83 aa) interaction expressed in Escherichia coli after 18 hrs by HTRF assay,B,,,BAO_0000190,BAO_0000019,assay format,CC(C)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1,,,CHEMBL3351557,ACS Med. Chem. Lett.,2014,"{'bei': '18.52', 'le': '0.38', 'lle': '2.11', 'sei': '13.97'}",CHEMBL3329620,,CHEMBL3329620,8.05,False,http://www.openphacts.org/units/Nanomolar,2266162,=,1,True,=,,IC50,nM,,9.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,uM,UO_0000065,,0.009
,15132085,[],CHEMBL3363505,Inhibition of human MDM2 (1-188 aa) -p53 (1-83 aa) interaction expressed in Escherichia coli after 18 hrs by HTRF assay,B,,,BAO_0000190,BAO_0000019,assay format,CCC(CC)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1,,,CHEMBL3351557,ACS Med. Chem. Lett.,2014,"{'bei': '18.43', 'le': '0.38', 'lle': '1.80', 'sei': '14.79'}",CHEMBL2177190,,CHEMBL2177190,8.52,False,http://www.openphacts.org/units/Nanomolar,2266161,=,1,True,=,,IC50,nM,,3.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,uM,UO_0000065,,0.003
,15132086,[],CHEMBL3363505,Inhibition of human MDM2 (1-188 aa) -p53 (1-83 aa) interaction expressed in Escherichia coli after 18 hrs by HTRF assay,B,,,BAO_0000190,BAO_0000019,assay format,C[C@]1(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@@H](c2ccc(Cl)cc2)N(c2ccccc2)C1=O,,,CHEMBL3351557,ACS Med. Chem. Lett.,2014,"{'bei': '17.93', 'le': '0.36', 'lle': '1.66', 'sei': '14.58'}",CHEMBL3329619,,CHEMBL3329619,8.40,False,http://www.openphacts.org/units/Nanomolar,2266160,=,1,True,=,,IC50,nM,,4.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,uM,UO_0000065,,0.004
,15132087,[],CHEMBL3363505,Inhibition of human MDM2 (1-188 aa) -p53 (1-83 aa) interaction expressed in Escherichia coli after 18 hrs by HTRF assay,B,,,BAO_0000190,BAO_0000019,assay format,C[C@]1(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@@H](c2ccc(Cl)cc2)N(c2ccccn2)C1=O,,,CHEMBL3351557,ACS Med. Chem. Lett.,2014,"{'bei': '16.80', 'le': '0.34', 'lle': '1.76', 'sei': '11.19'}",CHEMBL3329618,,CHEMBL3329618,7.89,False,http://www.openphacts.org/units/Nanomolar,2266159,=,1,True,=,,IC50,nM,,13.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,uM,UO_0000065,,0.013
,15132088,[],CHEMBL3363505,Inhibition of human MDM2 (1-188 aa) -p53 (1-83 aa) interaction expressed in Escherichia coli after 18 hrs by HTRF assay,B,,,BAO_0000190,BAO_0000019,assay format,CC[C@@H](c1ncccc1C)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1,,,CHEMBL3351557,ACS Med. Chem. Lett.,2014,"{'bei': '15.80', 'le': '0.31', 'lle': '0.91', 'sei': '11.77'}",CHEMBL3329617,,CHEMBL3329617,8.30,False,http://www.openphacts.org/units/Nanomolar,2266158,=,1,True,=,,IC50,nM,,5.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,uM,UO_0000065,,0.005
,15132089,[],CHEMBL3363505,Inhibition of human MDM2 (1-188 aa) -p53 (1-83 aa) interaction expressed in Escherichia coli after 18 hrs by HTRF assay,B,,,BAO_0000190,BAO_0000019,assay format,CC[C@@H](c1cc(C)ccn1)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1,,,CHEMBL3351557,ACS Med. Chem. Lett.,2014,"{'bei': '16.22', 'le': '0.32', 'lle': '1.13', 'sei': '12.09'}",CHEMBL3329616,,CHEMBL3329616,8.52,False,http://www.openphacts.org/units/Nanomolar,2266157,=,1,True,=,,IC50,nM,,3.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,uM,UO_0000065,,0.003
,15132090,[],CHEMBL3363505,Inhibition of human MDM2 (1-188 aa) -p53 (1-83 aa) interaction expressed in Escherichia coli after 18 hrs by HTRF assay,B,,,BAO_0000190,BAO_0000019,assay format,CC[C@@H](c1ccc(C)cn1)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1,,,CHEMBL3351557,ACS Med. Chem. Lett.,2014,"{'bei': '15.52', 'le': '0.31', 'lle': '0.76', 'sei': '11.57'}",CHEMBL3329615,,CHEMBL3329615,8.15,False,http://www.openphacts.org/units/Nanomolar,2266156,=,1,True,=,,IC50,nM,,7.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,uM,UO_0000065,,0.007
,15132091,[],CHEMBL3363505,Inhibition of human MDM2 (1-188 aa) -p53 (1-83 aa) interaction expressed in Escherichia coli after 18 hrs by HTRF assay,B,,,BAO_0000190,BAO_0000019,assay format,CC[C@@H](c1cccc(C2CC2)n1)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1,,,CHEMBL3351557,ACS Med. Chem. Lett.,2014,"{'bei': '15.05', 'le': '0.30', 'lle': '0.34', 'sei': '11.77'}",CHEMBL3329614,,CHEMBL3329614,8.30,False,http://www.openphacts.org/units/Nanomolar,2266155,=,1,True,=,,IC50,nM,,5.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,uM,UO_0000065,,0.005
,15132092,[],CHEMBL3363505,Inhibition of human MDM2 (1-188 aa) -p53 (1-83 aa) interaction expressed in Escherichia coli after 18 hrs by HTRF assay,B,,,BAO_0000190,BAO_0000019,assay format,CC[C@@H](c1cccc(Cl)n1)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1,,,CHEMBL3351557,ACS Med. Chem. Lett.,2014,"{'bei': '16.77', 'le': '0.35', 'lle': '1.42', 'sei': '12.99'}",CHEMBL3329613,,CHEMBL3329613,9.15,False,http://www.openphacts.org/units/Nanomolar,2266154,=,1,True,=,,IC50,nM,,0.7,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,uM,UO_0000065,,0.0007
,15132093,[],CHEMBL3363505,Inhibition of human MDM2 (1-188 aa) -p53 (1-83 aa) interaction expressed in Escherichia coli after 18 hrs by HTRF assay,B,,,BAO_0000190,BAO_0000019,assay format,CC[C@@H](c1cccc(C)n1)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1,,,CHEMBL3351557,ACS Med. Chem. Lett.,2014,"{'bei': '16.55', 'le': '0.33', 'lle': '1.31', 'sei': '12.34'}",CHEMBL3329224,,CHEMBL3329224,8.70,False,http://www.openphacts.org/units/Nanomolar,2266153,=,1,True,=,,IC50,nM,,2.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,uM,UO_0000065,,0.002
,15132094,[],CHEMBL3363505,Inhibition of human MDM2 (1-188 aa) -p53 (1-83 aa) interaction expressed in Escherichia coli after 18 hrs by HTRF assay,B,,,BAO_0000190,BAO_0000019,assay format,CCC[C@@H](c1ccccn1)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1,,,CHEMBL3351557,ACS Med. Chem. Lett.,2014,"{'bei': '15.65', 'le': '0.31', 'lle': '0.75', 'sei': '11.66'}",CHEMBL3329612,,CHEMBL3329612,8.22,False,http://www.openphacts.org/units/Nanomolar,2266152,=,1,True,=,,IC50,nM,,6.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,uM,UO_0000065,,0.006
,15132095,[],CHEMBL3363505,Inhibition of human MDM2 (1-188 aa) -p53 (1-83 aa) interaction expressed in Escherichia coli after 18 hrs by HTRF assay,B,,,BAO_0000190,BAO_0000019,assay format,C[C@]1(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@@H](c2ccc(Cl)cc2)N([C@H](c2ccccn2)C2CC2)C1=O,,,CHEMBL3351557,ACS Med. Chem. Lett.,2014,"{'bei': '16.62', 'le': '0.33', 'lle': '1.62', 'sei': '12.34'}",CHEMBL3329611,,CHEMBL3329611,8.70,False,http://www.openphacts.org/units/Nanomolar,2266151,=,1,True,=,,IC50,nM,,2.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,uM,UO_0000065,,0.002
,15132096,[],CHEMBL3363505,Inhibition of human MDM2 (1-188 aa) -p53 (1-83 aa) interaction expressed in Escherichia coli after 18 hrs by HTRF assay,B,,,BAO_0000190,BAO_0000019,assay format,CC(C)[C@@H](c1ccccn1)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1,,,CHEMBL3351557,ACS Med. Chem. Lett.,2014,"{'bei': '16.55', 'le': '0.33', 'lle': '1.38', 'sei': '12.34'}",CHEMBL3329610,,CHEMBL3329610,8.70,False,http://www.openphacts.org/units/Nanomolar,2266150,=,1,True,=,,IC50,nM,,2.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,uM,UO_0000065,,0.002
,15132097,[],CHEMBL3363505,Inhibition of human MDM2 (1-188 aa) -p53 (1-83 aa) interaction expressed in Escherichia coli after 18 hrs by HTRF assay,B,,,BAO_0000190,BAO_0000019,assay format,C[C@@H](c1ccccn1)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1,,,CHEMBL3351557,ACS Med. Chem. Lett.,2014,"{'bei': '16.08', 'le': '0.32', 'lle': '1.31', 'sei': '11.35'}",CHEMBL3329609,,CHEMBL3329609,8.00,False,http://www.openphacts.org/units/Nanomolar,2266149,=,1,True,=,,IC50,nM,,10.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,uM,UO_0000065,,0.01
,15132098,[],CHEMBL3363505,Inhibition of human MDM2 (1-188 aa) -p53 (1-83 aa) interaction expressed in Escherichia coli after 18 hrs by HTRF assay,B,,,BAO_0000190,BAO_0000019,assay format,CC[C@@H](c1cccnc1)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1,,,CHEMBL3351557,ACS Med. Chem. Lett.,2014,"{'bei': '17.25', 'le': '0.34', 'lle': '1.74', 'sei': '12.52'}",CHEMBL3329608,,CHEMBL3329608,8.82,False,http://www.openphacts.org/units/Nanomolar,2266148,=,1,True,=,,IC50,nM,,1.5,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,uM,UO_0000065,,0.0015
,15132099,[],CHEMBL3363505,Inhibition of human MDM2 (1-188 aa) -p53 (1-83 aa) interaction expressed in Escherichia coli after 18 hrs by HTRF assay,B,,,BAO_0000190,BAO_0000019,assay format,CC[C@@H](c1ccncc1)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1,,,CHEMBL3351557,ACS Med. Chem. Lett.,2014,"{'bei': '15.73', 'le': '0.31', 'lle': '0.97', 'sei': '11.41'}",CHEMBL3329607,,CHEMBL3329607,8.05,False,http://www.openphacts.org/units/Nanomolar,2266147,=,1,True,=,,IC50,nM,,9.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,uM,UO_0000065,,0.009
,15132100,[],CHEMBL3363505,Inhibition of human MDM2 (1-188 aa) -p53 (1-83 aa) interaction expressed in Escherichia coli after 18 hrs by HTRF assay,B,,,BAO_0000190,BAO_0000019,assay format,CC[C@@H](c1ncccn1)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1,,,CHEMBL3351557,ACS Med. Chem. Lett.,2014,"{'bei': '15.91', 'le': '0.32', 'lle': '1.68', 'sei': '9.78'}",CHEMBL3329606,,CHEMBL3329606,8.15,False,http://www.openphacts.org/units/Nanomolar,2266146,=,1,True,=,,IC50,nM,,7.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,uM,UO_0000065,,0.007
,15132101,[],CHEMBL3363505,Inhibition of human MDM2 (1-188 aa) -p53 (1-83 aa) interaction expressed in Escherichia coli after 18 hrs by HTRF assay,B,,,BAO_0000190,BAO_0000019,assay format,CC[C@@H](c1ccccn1)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1,,,CHEMBL3351557,ACS Med. Chem. Lett.,2014,"{'bei': '16.66', 'le': '0.33', 'lle': '1.44', 'sei': '12.09'}",CHEMBL3329605,,CHEMBL3329605,8.52,False,http://www.openphacts.org/units/Nanomolar,2266145,=,1,True,=,,IC50,nM,,3.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,uM,UO_0000065,,0.003
,15132102,[],CHEMBL3363505,Inhibition of human MDM2 (1-188 aa) -p53 (1-83 aa) interaction expressed in Escherichia coli after 18 hrs by HTRF assay,B,,,BAO_0000190,BAO_0000019,assay format,CC[C@@H](c1nccs1)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1,,,CHEMBL3351557,ACS Med. Chem. Lett.,2014,"{'bei': '15.89', 'le': '0.33', 'lle': '1.08', 'sei': '11.66'}",CHEMBL3329604,,CHEMBL3329604,8.22,False,http://www.openphacts.org/units/Nanomolar,2266144,=,1,True,=,,IC50,nM,,6.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,uM,UO_0000065,,0.006
,15132103,[],CHEMBL3363505,Inhibition of human MDM2 (1-188 aa) -p53 (1-83 aa) interaction expressed in Escherichia coli after 18 hrs by HTRF assay,B,,,BAO_0000190,BAO_0000019,assay format,CC[C@@H](c1cnco1)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1,,,CHEMBL3351557,ACS Med. Chem. Lett.,2014,"{'bei': '16.15', 'le': '0.33', 'lle': '1.43', 'sei': '9.68'}",CHEMBL3329603,,CHEMBL3329603,8.10,False,http://www.openphacts.org/units/Nanomolar,2266143,=,1,True,=,,IC50,nM,,8.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,uM,UO_0000065,,0.008
,15132104,[],CHEMBL3363505,Inhibition of human MDM2 (1-188 aa) -p53 (1-83 aa) interaction expressed in Escherichia coli after 18 hrs by HTRF assay,B,,,BAO_0000190,BAO_0000019,assay format,CC[C@@H]([C@@H]1CCCO1)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1,,,CHEMBL3351557,ACS Med. Chem. Lett.,2014,"{'bei': '17.84', 'le': '0.36', 'lle': '2.51', 'sei': '13.46'}",CHEMBL3329602,,CHEMBL3329602,9.00,False,http://www.openphacts.org/units/Nanomolar,2266142,=,1,True,=,,IC50,nM,,1.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,uM,UO_0000065,,0.001
,15132105,[],CHEMBL3363505,Inhibition of human MDM2 (1-188 aa) -p53 (1-83 aa) interaction expressed in Escherichia coli after 18 hrs by HTRF assay,B,,,BAO_0000190,BAO_0000019,assay format,CC[C@@H]([C@H](C)OC)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1,,,CHEMBL3351557,ACS Med. Chem. Lett.,2014,"{'bei': '17.67', 'le': '0.36', 'lle': '2.35', 'sei': '13.01'}",CHEMBL3329601,,CHEMBL3329601,8.70,False,http://www.openphacts.org/units/Nanomolar,2266141,=,1,True,=,,IC50,nM,,2.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,uM,UO_0000065,,0.002
,15132106,[],CHEMBL3363505,Inhibition of human MDM2 (1-188 aa) -p53 (1-83 aa) interaction expressed in Escherichia coli after 18 hrs by HTRF assay,B,,,BAO_0000190,BAO_0000019,assay format,CC[C@@H]([C@H](C)O)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1,,,CHEMBL3351557,ACS Med. Chem. Lett.,2014,"{'bei': '18.81', 'le': '0.38', 'lle': '3.31', 'sei': '11.56'}",CHEMBL2059435,,CHEMBL2059435,9.00,False,http://www.openphacts.org/units/Nanomolar,2266140,=,1,True,=,,IC50,nM,,1.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,uM,UO_0000065,,0.001
,15132107,[],CHEMBL3363506,Inhibition of human MDM2 (1-188 aa) -p53 (1-83 aa) interaction expressed in Escherichia coli after 18 hrs by HTRF assay in presence of 15% human serum,B,,,BAO_0000190,BAO_0000019,assay format,CC(C)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1,,,CHEMBL3351557,ACS Med. Chem. Lett.,2014,"{'bei': '15.94', 'le': '0.33', 'lle': '0.98', 'sei': '12.02'}",CHEMBL3329620,,CHEMBL3329620,6.92,False,http://www.openphacts.org/units/Nanomolar,2266162,=,1,True,=,,IC50,nM,,119.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,uM,UO_0000065,,0.119
,15667319,[],CHEMBL3602283,Inhibition of MDM2/p53 interaction (unknown origin) using biotinylated MDM2 and Cy5-p53 (18 to 26 amino acids) by TR-FRET assay,B,,,BAO_0000190,BAO_0000224,protein format,COc1ccc(C2=N[C@@H](c3ccc(Cl)cc3)[C@@H](c3ccc(Cl)cc3)N2C(=O)N2CCNC(=O)C2)c(OC(C)C)c1,,,CHEMBL3600357,J. Med. Chem.,2015,"{'bei': '14.42', 'le': '0.29', 'lle': '2.50', 'sei': '10.05'}",CHEMBL191334,NUTLIN-3,CHEMBL191334,8.39,False,http://www.openphacts.org/units/Nanomolar,2492877,=,1,True,=,,IC50,nM,,4.1,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,uM,UO_0000065,,0.0041
,15667320,[],CHEMBL3602283,Inhibition of MDM2/p53 interaction (unknown origin) using biotinylated MDM2 and Cy5-p53 (18 to 26 amino acids) by TR-FRET assay,B,,,BAO_0000190,BAO_0000224,protein format,COc1cc2c(cc1OC(C)C)[C@H](c1ccc(Cl)cc1)N(c1ccc(N(C)C[C@H]3CC[C@H](N4CCN(C)C(=O)C4)CC3)cc1)C(=O)C2,,,CHEMBL3600357,J. Med. Chem.,2015,"{'bei': '13.30', 'le': '0.25', 'lle': '2.19', 'sei': '13.38'}",CHEMBL3601398,CGM-097,CHEMBL3601398,8.77,False,http://www.openphacts.org/units/Nanomolar,2492871,=,1,True,=,,IC50,nM,,1.7,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,uM,UO_0000065,,0.0017
,15667321,[],CHEMBL3602283,Inhibition of MDM2/p53 interaction (unknown origin) using biotinylated MDM2 and Cy5-p53 (18 to 26 amino acids) by TR-FRET assay,B,,,BAO_0000190,BAO_0000224,protein format,COc1cc2c(cc1OC(C)C)[C@H](c1ccc(Cl)cc1)N(c1cnc(N(C)C[C@H]3CC[C@H](N4CCN(C)C(=O)C4)CC3)cn1)C(=O)C2,,,CHEMBL3600357,J. Med. Chem.,2015,"{'bei': '12.28', 'le': '0.24', 'lle': '2.75', 'sei': '8.89'}",CHEMBL3601403,,CHEMBL3601403,8.12,False,http://www.openphacts.org/units/Nanomolar,2492876,=,1,True,=,,IC50,nM,,7.6,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,uM,UO_0000065,,0.0076
,15667322,[],CHEMBL3602283,Inhibition of MDM2/p53 interaction (unknown origin) using biotinylated MDM2 and Cy5-p53 (18 to 26 amino acids) by TR-FRET assay,B,,,BAO_0000190,BAO_0000224,protein format,COc1cc2c(cc1OC(C)C)[C@H](c1ccc(Cl)cc1)N(c1ccc(N(C)C[C@H]3CC[C@H](N4CCN(C)C(=O)C4)CC3)cn1)C(=O)C2,,,CHEMBL3600357,J. Med. Chem.,2015,"{'bei': '13.18', 'le': '0.25', 'lle': '2.72', 'sei': '11.09'}",CHEMBL3601402,,CHEMBL3601402,8.70,False,http://www.openphacts.org/units/Nanomolar,2492875,=,1,True,=,,IC50,nM,,2.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,uM,UO_0000065,,0.002
,15667323,[],CHEMBL3602283,Inhibition of MDM2/p53 interaction (unknown origin) using biotinylated MDM2 and Cy5-p53 (18 to 26 amino acids) by TR-FRET assay,B,,,BAO_0000190,BAO_0000224,protein format,COc1cc2c(cc1OC(C)C)[C@H](c1ccc(Cl)cc1)N(c1ccc(N(C)C[C@H]3CC[C@H](N4CCN(C)C(=O)C4)CC3)nc1)C(=O)C2,,,CHEMBL3600357,J. Med. Chem.,2015,"{'bei': '13.03', 'le': '0.25', 'lle': '2.62', 'sei': '10.97'}",CHEMBL3601401,,CHEMBL3601401,8.60,False,http://www.openphacts.org/units/Nanomolar,2492874,=,1,True,=,,IC50,nM,,2.5,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,uM,UO_0000065,,0.0025
,15667324,[],CHEMBL3602283,Inhibition of MDM2/p53 interaction (unknown origin) using biotinylated MDM2 and Cy5-p53 (18 to 26 amino acids) by TR-FRET assay,B,,,BAO_0000190,BAO_0000224,protein format,COc1cc2c(cc1OC(C)C)[C@H](c1ccc(Cl)cc1)N(c1ccc(N(C)C[C@H]3CC[C@H](N4CC(=O)N(C)C4)CC3)nc1)C(=O)C2,,,CHEMBL3600357,J. Med. Chem.,2015,"{'bei': '12.29', 'le': '0.24', 'lle': '2.00', 'sei': '10.13'}",CHEMBL3601400,,CHEMBL3601400,7.94,False,http://www.openphacts.org/units/Nanomolar,2492873,=,1,True,=,,IC50,nM,,11.4,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,uM,UO_0000065,,0.0114
,15667325,[],CHEMBL3602283,Inhibition of MDM2/p53 interaction (unknown origin) using biotinylated MDM2 and Cy5-p53 (18 to 26 amino acids) by TR-FRET assay,B,,,BAO_0000190,BAO_0000224,protein format,COc1cc2c(cc1OC(C)C)[C@H](c1ccc(Cl)cc1)N(c1ccc(N(C)C[C@H]3CC[C@H](N(C)C)CC3)nc1)C(=O)C2,,,CHEMBL3600357,J. Med. Chem.,2015,"{'bei': '14.88', 'le': '0.29', 'lle': '2.03', 'sei': '15.13'}",CHEMBL3601399,,CHEMBL3601399,8.80,False,http://www.openphacts.org/units/Nanomolar,2492872,=,1,True,=,,IC50,nM,,1.6,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,uM,UO_0000065,,0.0016
,15667326,[],CHEMBL3602283,Inhibition of MDM2/p53 interaction (unknown origin) using biotinylated MDM2 and Cy5-p53 (18 to 26 amino acids) by TR-FRET assay,B,,,BAO_0000190,BAO_0000224,protein format,COc1cc2c(cc1OC(C)C)[C@H](c1ccc(Cl)cc1)N(c1ccc(N(C)C[C@H]3CC[C@H](N4CCNC(=O)C4)CC3)cc1)C(=O)C2,,,CHEMBL3600357,J. Med. Chem.,2015,"{'bei': '13.63', 'le': '0.26', 'lle': '2.56', 'sei': '11.83'}",CHEMBL3601397,,CHEMBL3601397,8.80,False,http://www.openphacts.org/units/Nanomolar,2492870,=,1,True,=,,IC50,nM,,1.6,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,uM,UO_0000065,,0.0016
,15667327,[],CHEMBL3602283,Inhibition of MDM2/p53 interaction (unknown origin) using biotinylated MDM2 and Cy5-p53 (18 to 26 amino acids) by TR-FRET assay,B,,,BAO_0000190,BAO_0000224,protein format,COc1cc2c(cc1OC(C)C)[C@H](c1ccc(Cl)cc1)N(c1ccc(N(C)C[C@H]3CC[C@H](N4CNC(=O)C4)CC3)cc1)C(=O)C2,,,CHEMBL3600357,J. Med. Chem.,2015,"{'bei': '13.89', 'le': '0.27', 'lle': '2.57', 'sei': '11.79'}",CHEMBL3601396,,CHEMBL3601396,8.77,False,http://www.openphacts.org/units/Nanomolar,2492869,=,1,True,=,,IC50,nM,,1.7,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,uM,UO_0000065,,0.0017
,15667328,[],CHEMBL3602283,Inhibition of MDM2/p53 interaction (unknown origin) using biotinylated MDM2 and Cy5-p53 (18 to 26 amino acids) by TR-FRET assay,B,,,BAO_0000190,BAO_0000224,protein format,CCC(=O)N[C@H]1CC[C@H](CN(C)c2ccc(N3C(=O)Cc4cc(OC)c(O[C@H](C)CC)cc4[C@@H]3c3ccc(Cl)cc3)cc2)CC1,,,CHEMBL3600357,J. Med. Chem.,2015,"{'bei': '12.18', 'le': '0.23', 'lle': '-0.03', 'sei': '10.83'}",CHEMBL3601324,,CHEMBL3601324,7.70,False,http://www.openphacts.org/units/Nanomolar,2492790,=,1,True,=,,IC50,nM,,20.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,uM,UO_0000065,,0.02
,15667329,[],CHEMBL3602283,Inhibition of MDM2/p53 interaction (unknown origin) using biotinylated MDM2 and Cy5-p53 (18 to 26 amino acids) by TR-FRET assay,B,,,BAO_0000190,BAO_0000224,protein format,COc1cc2c(cc1OC(C)C)[C@H](c1ccc(Cl)cc1)N(c1ccc(N(C)C[C@H]3CC[C@H](N(C)C)CC3)cc1)C(=O)C2,,,CHEMBL3600357,J. Med. Chem.,2015,"{'bei': '15.18', 'le': '0.29', 'lle': '1.59', 'sei': '19.80'}",CHEMBL3601323,,CHEMBL3601323,8.96,False,http://www.openphacts.org/units/Nanomolar,2492789,=,1,True,=,,IC50,nM,,1.1,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,uM,UO_0000065,,0.0011
,15667330,[],CHEMBL3602283,Inhibition of MDM2/p53 interaction (unknown origin) using biotinylated MDM2 and Cy5-p53 (18 to 26 amino acids) by TR-FRET assay,B,,,BAO_0000190,BAO_0000224,protein format,CC[C@@H](C)Oc1cc2c(cc1OC)CC(=O)N(c1ccc(N(C)C[C@H]3CC[C@H](N(C)C)CC3)cc1)[C@H]2c1ccc(Cl)cc1,,,CHEMBL3600357,J. Med. Chem.,2015,"{'bei': '14.43', 'le': '0.28', 'lle': '0.96', 'sei': '19.27'}",CHEMBL3601322,,CHEMBL3601322,8.72,False,http://www.openphacts.org/units/Nanomolar,2492788,=,1,True,=,,IC50,nM,,1.9,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,uM,UO_0000065,,0.0019
,15667331,[],CHEMBL3602283,Inhibition of MDM2/p53 interaction (unknown origin) using biotinylated MDM2 and Cy5-p53 (18 to 26 amino acids) by TR-FRET assay,B,,,BAO_0000190,BAO_0000224,protein format,CC[C@@H](C)Oc1cc2c(cc1OC)CC(=O)N(c1ccc(N(C)C[C@H]3CC[C@H](N(C)C)CC3)cc1)C2c1ccc(Cl)cc1,,,CHEMBL3600357,J. Med. Chem.,2015,"{'bei': '14.11', 'le': '0.27', 'lle': '0.76', 'sei': '18.84'}",CHEMBL3601321,,CHEMBL3601321,8.52,False,http://www.openphacts.org/units/Nanomolar,2492787,=,1,True,=,,IC50,nM,,3.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,uM,UO_0000065,,0.003
,15667635,[],CHEMBL3602283,Inhibition of MDM2/p53 interaction (unknown origin) using biotinylated MDM2 and Cy5-p53 (18 to 26 amino acids) by TR-FRET assay,B,,,BAO_0000190,BAO_0000224,protein format,CC[C@@H](C)Oc1cc2c(cc1OC)CC(=O)N(c1ccc(N(C)C[C@H]3CC[C@H](N)CC3)cc1)C2c1ccc(Cl)cc1,,,CHEMBL3600357,J. Med. Chem.,2015,"{'bei': '14.79', 'le': '0.28', 'lle': '1.36', 'sei': '12.53'}",CHEMBL3601320,,CHEMBL3601320,8.52,False,http://www.openphacts.org/units/Nanomolar,2492786,=,1,True,=,,IC50,nM,,3.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,uM,UO_0000065,,0.003
,15667636,[],CHEMBL3602283,Inhibition of MDM2/p53 interaction (unknown origin) using biotinylated MDM2 and Cy5-p53 (18 to 26 amino acids) by TR-FRET assay,B,,,BAO_0000190,BAO_0000224,protein format,CC[C@@H](C)Oc1cc2c(cc1OC)CC(=O)N(c1ccc(N(C)CC3CCNCC3)cc1)C2c1ccc(Cl)cc1,,,CHEMBL3600357,J. Med. Chem.,2015,"{'bei': '14.94', 'le': '0.29', 'lle': '1.76', 'sei': '15.54'}",CHEMBL3601319,,CHEMBL3601319,8.40,False,http://www.openphacts.org/units/Nanomolar,2492785,=,1,True,=,,IC50,nM,,4.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,uM,UO_0000065,,0.004
,15667637,[],CHEMBL3602283,Inhibition of MDM2/p53 interaction (unknown origin) using biotinylated MDM2 and Cy5-p53 (18 to 26 amino acids) by TR-FRET assay,B,,,BAO_0000190,BAO_0000224,protein format,CC[C@@H](C)Oc1cc2c(cc1OC)CC(=O)N(c1ccc(N(C)Cc3ccncc3)cc1)[C@@H]2c1ccc(Cl)cc1,,,CHEMBL3600357,J. Med. Chem.,2015,"{'bei': '10.67', 'le': '0.20', 'lle': '-1.31', 'sei': '10.80'}",CHEMBL3601318,,CHEMBL3601318,5.93,False,http://www.openphacts.org/units/Nanomolar,2492784,=,1,True,=,,IC50,nM,,1171.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,uM,UO_0000065,,1.171
,15667638,[],CHEMBL3602283,Inhibition of MDM2/p53 interaction (unknown origin) using biotinylated MDM2 and Cy5-p53 (18 to 26 amino acids) by TR-FRET assay,B,,,BAO_0000190,BAO_0000224,protein format,CC[C@@H](C)Oc1cc2c(cc1OC)CC(=O)N(c1ccc(N(C)Cc3ccncc3)cc1)[C@H]2c1ccc(Cl)cc1,,,CHEMBL3600357,J. Med. Chem.,2015,"{'bei': '15.53', 'le': '0.29', 'lle': '1.40', 'sei': '15.73'}",CHEMBL3601317,,CHEMBL3601317,8.64,False,http://www.openphacts.org/units/Nanomolar,2492783,=,1,True,=,,IC50,nM,,2.3,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,uM,UO_0000065,,0.0023
,15667639,[],CHEMBL3602283,Inhibition of MDM2/p53 interaction (unknown origin) using biotinylated MDM2 and Cy5-p53 (18 to 26 amino acids) by TR-FRET assay,B,,,BAO_0000190,BAO_0000224,protein format,CC[C@@H](C)Oc1cc2c(cc1OC)CC(=O)N(c1ccc(N(C)Cc3ccncc3)cc1)C2c1ccc(Cl)cc1,,,CHEMBL3600357,J. Med. Chem.,2015,"{'bei': '14.56', 'le': '0.28', 'lle': '0.86', 'sei': '14.75'}",CHEMBL3601316,,CHEMBL3601316,8.10,False,http://www.openphacts.org/units/Nanomolar,2492782,=,1,True,=,,IC50,nM,,8.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,uM,UO_0000065,,0.008
,15667673,[],CHEMBL3603534,Inhibition of MDM2/p53 interaction (unknown origin) assessed as p53 nuclear translocation by GRIP p53 translocation assay,B,,,BAO_0000190,BAO_0000224,protein format,COc1cc2c(cc1OC(C)C)[C@H](c1ccc(Cl)cc1)N(c1ccc(N(C)C[C@H]3CC[C@H](N4CCN(C)C(=O)C4)CC3)cc1)C(=O)C2,,,CHEMBL3600357,J. Med. Chem.,2015,"{'bei': '10.09', 'le': '0.19', 'lle': '0.07', 'sei': '10.14'}",CHEMBL3601398,CGM-097,CHEMBL3601398,6.65,False,http://www.openphacts.org/units/Nanomolar,2492871,=,1,True,=,,IC50,nM,,224.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,224.0
,15680180,[],CHEMBL3607773,Inhibition of p53-MDM2 interaction (unknown origin) by TR-FRET assay,B,,,BAO_0000190,BAO_0000224,protein format,COc1ccc(C2=N[C@@H](c3ccc(Cl)cc3)[C@@H](c3ccc(Cl)cc3)N2C(=O)N2CCNC(=O)C2)c(OC(C)C)c1,,,CHEMBL3603835,Bioorg. Med. Chem. Lett.,2015,"{'bei': '13.76', 'le': '0.27', 'lle': '2.11', 'sei': '9.58'}",CHEMBL191334,NUTLIN-3,CHEMBL191334,8.00,False,http://www.openphacts.org/units/Nanomolar,2494632,=,1,True,=,,IC50,nM,,10.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,uM,UO_0000065,,0.01
,15680181,[],CHEMBL3607773,Inhibition of p53-MDM2 interaction (unknown origin) by TR-FRET assay,B,,,BAO_0000190,BAO_0000224,protein format,CC[C@@H](C)Oc1cc2c(cc1OC)CC(=O)N(c1ccc(N(C)Cc3ccncc3)cc1)[C@H]2c1ccc(Cl)cc1,,,CHEMBL3603835,Bioorg. Med. Chem. Lett.,2015,"{'bei': '15.53', 'le': '0.29', 'lle': '1.40', 'sei': '15.73'}",CHEMBL3601317,,CHEMBL3601317,8.64,False,http://www.openphacts.org/units/Nanomolar,2494631,=,1,True,=,,IC50,nM,,2.3,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,uM,UO_0000065,,0.0023
,15680182,[],CHEMBL3607773,Inhibition of p53-MDM2 interaction (unknown origin) by TR-FRET assay,B,,,BAO_0000190,BAO_0000224,protein format,CC[C@@H](C)Oc1cc2c(cc1OC)CC(=O)N(c1ccc(N(C)Cc3ccncc3)cc1)[C@@H]2c1ccc(Cl)cc1,,,CHEMBL3603835,Bioorg. Med. Chem. Lett.,2015,"{'bei': '10.65', 'le': '0.20', 'lle': '-1.32', 'sei': '10.78'}",CHEMBL3601318,,CHEMBL3601318,5.92,False,http://www.openphacts.org/units/Nanomolar,2494630,=,1,True,=,,IC50,nM,,1200.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,uM,UO_0000065,,1.2
,15680183,[],CHEMBL3607773,Inhibition of p53-MDM2 interaction (unknown origin) by TR-FRET assay,B,,,BAO_0000190,BAO_0000224,protein format,CC[C@@H](C)Oc1cc2c(cc1OC)CC(=O)N(c1ccc(N(C)Cc3ccncc3)cc1)C2c1ccc(Cl)cc1,,,CHEMBL3603835,Bioorg. Med. Chem. Lett.,2015,"{'bei': '14.56', 'le': '0.28', 'lle': '0.86', 'sei': '14.75'}",CHEMBL3601316,,CHEMBL3601316,8.10,False,http://www.openphacts.org/units/Nanomolar,2494629,=,1,True,=,,IC50,nM,,8.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,uM,UO_0000065,,0.008
,15680184,[],CHEMBL3607773,Inhibition of p53-MDM2 interaction (unknown origin) by TR-FRET assay,B,,,BAO_0000190,BAO_0000224,protein format,CC[C@@H](C)Oc1cc2c(cc1OC)CC(=O)N(c1ccc(N(C)Cc3cccnc3)cc1)C2c1ccc(Cl)cc1,,,CHEMBL3603835,Bioorg. Med. Chem. Lett.,2015,"{'bei': '14.07', 'le': '0.27', 'lle': '0.58', 'sei': '14.25'}",CHEMBL3604664,,CHEMBL3604664,7.82,False,http://www.openphacts.org/units/Nanomolar,2494628,=,1,True,=,,IC50,nM,,15.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,uM,UO_0000065,,0.015
,15680185,[],CHEMBL3607773,Inhibition of p53-MDM2 interaction (unknown origin) by TR-FRET assay,B,,,BAO_0000190,BAO_0000224,protein format,CC[C@@H](C)Oc1cc2c(cc1OC)CC(=O)N(c1ccc(N(C)Cc3ccc(F)cc3)cc1)C2c1ccc(Cl)cc1,,,CHEMBL3603835,Bioorg. Med. Chem. Lett.,2015,"{'bei': '12.08', 'le': '0.23', 'lle': '-1.06', 'sei': '16.47'}",CHEMBL3604663,,CHEMBL3604663,6.92,False,http://www.openphacts.org/units/Nanomolar,2494627,=,1,True,=,,IC50,nM,,120.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,uM,UO_0000065,,0.12
,15680186,[],CHEMBL3607773,Inhibition of p53-MDM2 interaction (unknown origin) by TR-FRET assay,B,,,BAO_0000190,BAO_0000224,protein format,CC[C@@H](C)Oc1cc2c(cc1OC)CC(=O)N(c1ccc(N(C)Cc3cccc(F)c3)cc1)C2c1ccc(Cl)cc1,,,CHEMBL3603835,Bioorg. Med. Chem. Lett.,2015,"{'bei': '11.81', 'le': '0.23', 'lle': '-1.21', 'sei': '16.11'}",CHEMBL3604662,,CHEMBL3604662,6.77,False,http://www.openphacts.org/units/Nanomolar,2494626,=,1,True,=,,IC50,nM,,170.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,uM,UO_0000065,,0.17
,15680187,[],CHEMBL3607773,Inhibition of p53-MDM2 interaction (unknown origin) by TR-FRET assay,B,,,BAO_0000190,BAO_0000224,protein format,CC[C@@H](C)Oc1cc2c(cc1OC)CC(=O)N(c1ccc(N(C)C)cc1)C2c1ccc(Cl)cc1,,,CHEMBL3603835,Bioorg. Med. Chem. Lett.,2015,"{'bei': '14.45', 'le': '0.28', 'lle': '0.65', 'sei': '16.47'}",CHEMBL3604661,,CHEMBL3604661,6.92,False,http://www.openphacts.org/units/Nanomolar,2494625,=,1,True,=,,IC50,nM,,120.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,uM,UO_0000065,,0.12
,15680188,[],CHEMBL3607773,Inhibition of p53-MDM2 interaction (unknown origin) by TR-FRET assay,B,,,BAO_0000190,BAO_0000224,protein format,CCOc1cc2c(cc1OCC)C(c1ccc(Cl)cc1)N(c1ccc(C)cc1OCc1nn[nH]n1)C(=O)C2,,,CHEMBL3603835,Bioorg. Med. Chem. Lett.,2015,"{'bei': '12.02', 'le': '0.23', 'lle': '1.20', 'sei': '6.27'}",CHEMBL3604660,,CHEMBL3604660,6.42,False,http://www.openphacts.org/units/Nanomolar,2494624,=,1,True,=,,IC50,nM,,380.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,uM,UO_0000065,,0.38
,15680189,[],CHEMBL3607773,Inhibition of p53-MDM2 interaction (unknown origin) by TR-FRET assay,B,,,BAO_0000190,BAO_0000224,protein format,CCOc1cc2c(cc1OCC)C(c1ccc(Cl)cc1)N(c1cccc(Cl)c1)C(=O)C2,,,CHEMBL3603835,Bioorg. Med. Chem. Lett.,2015,"{'bei': '12.83', 'le': '0.26', 'lle': '-0.62', 'sei': '15.10'}",CHEMBL3603849,,CHEMBL3603849,5.85,False,http://www.openphacts.org/units/Nanomolar,2494623,=,1,True,=,,IC50,nM,,1400.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,uM,UO_0000065,,1.4
,15680190,[],CHEMBL3607773,Inhibition of p53-MDM2 interaction (unknown origin) by TR-FRET assay,B,,,BAO_0000190,BAO_0000224,protein format,CCOc1cc2c(cc1OCC)C(c1ccc(Cl)cc1)N(c1ccc(Cl)cc1)C(=O)C2,,,CHEMBL3603835,Bioorg. Med. Chem. Lett.,2015,"{'bei': '13.15', 'le': '0.26', 'lle': '-0.47', 'sei': '15.48'}",CHEMBL3604659,,CHEMBL3604659,6.00,False,http://www.openphacts.org/units/Nanomolar,2494622,=,1,True,=,,IC50,nM,,1000.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,uM,UO_0000065,,1.0
,15680191,[],CHEMBL3607773,Inhibition of p53-MDM2 interaction (unknown origin) by TR-FRET assay,B,,,BAO_0000190,BAO_0000224,protein format,CCOc1cc2c(cc1OCC)C(c1ccc(Cl)cc1)N(c1ccc(OC)cc1)C(=O)C2,,,CHEMBL3603835,Bioorg. Med. Chem. Lett.,2015,"{'bei': '13.87', 'le': '0.27', 'lle': '0.45', 'sei': '13.06'}",CHEMBL3604658,,CHEMBL3604658,6.27,False,http://www.openphacts.org/units/Nanomolar,2494621,=,1,True,=,,IC50,nM,,540.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,uM,UO_0000065,,0.54
,16437886,[],CHEMBL3754930,Inhibition of p53-HDM2 (unknown origin) interaction,B,,,BAO_0000190,BAO_0000224,protein format,CC(C)CCN(CC(=O)N(CCS(N)(=O)=O)CC(=O)N(CC(N)=O)Cc1ccc([N+](=O)[O-])cc1)C(=O)CN(CCCP(=O)(O)O)C(=O)CN(Cc1ccc([N+](=O)[O-])cc1)C(=O)CN(CCc1c[nH]c2ccccc12)C(=O)CN(CCCCP(=O)(O)O)C(=O)CN(Cc1ccc([N+](=O)[O-])cc1)C(=O)CN(CCc1ccccc1)C(=O)CNCc1ccc([N+](=O)[O-])cc1,,,CHEMBL3751840,Bioorg. Med. Chem. Lett.,2016,"{'bei': '2.86', 'le': None, 'lle': None, 'sei': None}",CHEMBL3754362,,CHEMBL3754362,5.18,False,http://www.openphacts.org/units/Nanomolar,2745099,=,1,True,=,,IC50,nM,,6600.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,uM,UO_0000065,,6.6
,16437887,[],CHEMBL3754930,Inhibition of p53-HDM2 (unknown origin) interaction,B,,,BAO_0000190,BAO_0000224,protein format,CC(C)C[C@@H]1NC(=O)[C@H](Cc2c[nH]c3ccc(Cl)cc23)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@@H]2CCCN2C(=O)[C@H]2CCCN2C(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](CC(=O)O)NC1=O,,,CHEMBL3751840,Bioorg. Med. Chem. Lett.,2016,"{'bei': '4.96', 'le': None, 'lle': None, 'sei': None}",CHEMBL3752931,,CHEMBL3752931,6.85,False,http://www.openphacts.org/units/Nanomolar,2745095,=,1,True,=,,IC50,nM,,140.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,uM,UO_0000065,,0.14
,16504584,[],CHEMBL3778678,Inhibition of Flag-tagged p53/GST-tagged Mdm2 (unknown origin) expressed in Escherichia coli BL21 after 1 hr by ELISA microplate reader method,B,,,BAO_0000190,BAO_0000019,assay format,COc1ccc(C2=N[C@@H](c3ccc(Cl)cc3)[C@@H](c3ccc(Cl)cc3)N2C(=O)N2CCNC(=O)C2)c(OC(C)C)c1,,,CHEMBL3774315,Bioorg. Med. Chem.,2016,"{'bei': '10.84', 'le': '0.22', 'lle': '0.41', 'sei': '7.55'}",CHEMBL191334,NUTLIN-3,CHEMBL191334,6.30,False,http://www.openphacts.org/units/Nanomolar,2762893,=,1,True,=,,IC50,nM,,500.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,uM,UO_0000065,,0.5
,16504585,[],CHEMBL3778678,Inhibition of Flag-tagged p53/GST-tagged Mdm2 (unknown origin) expressed in Escherichia coli BL21 after 1 hr by ELISA microplate reader method,B,,,BAO_0000190,BAO_0000019,assay format,O=C(Nc1ccccc1S)c1ccc(Cl)nc1,,,CHEMBL3774315,Bioorg. Med. Chem.,2016,"{'bei': '18.19', 'le': '0.39', 'lle': '1.54', 'sei': '11.47'}",CHEMBL3775281,,CHEMBL3775281,4.82,False,http://www.openphacts.org/units/Nanomolar,2762892,=,1,True,=,,IC50,nM,,15300.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,uM,UO_0000065,,15.3
,16504586,[],CHEMBL3778678,Inhibition of Flag-tagged p53/GST-tagged Mdm2 (unknown origin) expressed in Escherichia coli BL21 after 1 hr by ELISA microplate reader method,B,,,BAO_0000190,BAO_0000019,assay format,O=C(Nc1ccccc1S)c1ccc(Cl)cc1,,,CHEMBL3774315,Bioorg. Med. Chem.,2016,"{'bei': '17.95', 'le': '0.38', 'lle': '0.86', 'sei': '16.27'}",CHEMBL3775808,,CHEMBL3775808,4.74,False,http://www.openphacts.org/units/Nanomolar,2762891,=,1,True,=,,IC50,nM,,18400.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,uM,UO_0000065,,18.4
,16504587,[],CHEMBL3778678,Inhibition of Flag-tagged p53/GST-tagged Mdm2 (unknown origin) expressed in Escherichia coli BL21 after 1 hr by ELISA microplate reader method,B,,,BAO_0000190,BAO_0000019,assay format,CC(C)C(=O)Sc1ccccc1NC(=O)c1ccccc1,,,CHEMBL3774315,Bioorg. Med. Chem.,2016,"{'bei': '16.15', 'le': '0.31', 'lle': '0.63', 'sei': '10.47'}",CHEMBL3775936,,CHEMBL3775936,4.84,False,http://www.openphacts.org/units/Nanomolar,2762890,=,1,True,=,,IC50,nM,,14600.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,uM,UO_0000065,,14.6
,16504588,[],CHEMBL3778678,Inhibition of Flag-tagged p53/GST-tagged Mdm2 (unknown origin) expressed in Escherichia coli BL21 after 1 hr by ELISA microplate reader method,B,,,BAO_0000190,BAO_0000019,assay format,O=C(Nc1ccccc1S)c1ccccc1,,,CHEMBL3774315,Bioorg. Med. Chem.,2016,,CHEMBL3774514,,CHEMBL3774514,,False,http://www.openphacts.org/units/Nanomolar,2762889,>,1,True,>,,IC50,nM,,25000.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,uM,UO_0000065,,25.0
,16504589,[],CHEMBL3778678,Inhibition of Flag-tagged p53/GST-tagged Mdm2 (unknown origin) expressed in Escherichia coli BL21 after 1 hr by ELISA microplate reader method,B,,,BAO_0000190,BAO_0000019,assay format,CCCCCCCC(=O)Nc1ccccc1S,,,CHEMBL3774315,Bioorg. Med. Chem.,2016,,CHEMBL3775136,,CHEMBL3775136,,False,http://www.openphacts.org/units/Nanomolar,2762888,>,1,True,>,,IC50,nM,,25000.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,uM,UO_0000065,,25.0
,16505466,[],CHEMBL3778678,Inhibition of Flag-tagged p53/GST-tagged Mdm2 (unknown origin) expressed in Escherichia coli BL21 after 1 hr by ELISA microplate reader method,B,,,BAO_0000190,BAO_0000019,assay format,CC(C)C(=O)Nc1ccccc1OC(=O)C(C)C,,,CHEMBL3774315,Bioorg. Med. Chem.,2016,,CHEMBL3775883,,CHEMBL3775883,,False,http://www.openphacts.org/units/Nanomolar,2762887,>,1,True,>,,IC50,nM,,25000.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,uM,UO_0000065,,25.0
,16505467,[],CHEMBL3778678,Inhibition of Flag-tagged p53/GST-tagged Mdm2 (unknown origin) expressed in Escherichia coli BL21 after 1 hr by ELISA microplate reader method,B,,,BAO_0000190,BAO_0000019,assay format,CC(C)C(=O)Nc1ccccc1O,,,CHEMBL3774315,Bioorg. Med. Chem.,2016,,CHEMBL3774671,,CHEMBL3774671,,False,http://www.openphacts.org/units/Nanomolar,2762886,>,1,True,>,,IC50,nM,,25000.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,uM,UO_0000065,,25.0
,16505468,[],CHEMBL3778678,Inhibition of Flag-tagged p53/GST-tagged Mdm2 (unknown origin) expressed in Escherichia coli BL21 after 1 hr by ELISA microplate reader method,B,,,BAO_0000190,BAO_0000019,assay format,CC(C)C(=O)Nc1ccccc1SC(=O)C(C)C,,,CHEMBL3774315,Bioorg. Med. Chem.,2016,"{'bei': '18.40', 'le': '0.37', 'lle': '1.32', 'sei': '10.58'}",CHEMBL3774508,,CHEMBL3774508,4.88,False,http://www.openphacts.org/units/Nanomolar,2762885,=,1,True,=,,IC50,nM,,13100.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,uM,UO_0000065,,13.1
,16505469,[],CHEMBL3778678,Inhibition of Flag-tagged p53/GST-tagged Mdm2 (unknown origin) expressed in Escherichia coli BL21 after 1 hr by ELISA microplate reader method,B,,,BAO_0000190,BAO_0000019,assay format,CC(C)C(=O)Nc1ccccc1S,,,CHEMBL3774315,Bioorg. Med. Chem.,2016,,CHEMBL3775815,,CHEMBL3775815,,False,http://www.openphacts.org/units/Nanomolar,2762884,>,1,True,>,,IC50,nM,,25000.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,uM,UO_0000065,,25.0
,16585130,[],CHEMBL3807696,Inhibition of human recombinant His-tagged MDM2 (1 to 118 residues) interaction with FAM-tagged p53-based peptide (unknown origin) incubated for 15 mins by fluorescence polarization assay,B,,,BAO_0000190,BAO_0000224,protein format,COc1ccccc1N1CCN(C(=O)C2(Oc3ccc(C(F)(F)F)cc3)CCCN(C(=O)c3cnccc3C(F)(F)F)C2)CC1,,,CHEMBL3804796,ACS Med. Chem. Lett.,2016,"{'bei': '9.77', 'le': '0.19', 'lle': '0.69', 'sei': '8.27'}",CHEMBL3139619,,CHEMBL3139619,6.22,False,http://www.openphacts.org/units/Nanomolar,2777173,=,1,True,=,,IC50,nM,,600.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,uM,UO_0000065,,0.6
,16585131,[],CHEMBL3807696,Inhibition of human recombinant His-tagged MDM2 (1 to 118 residues) interaction with FAM-tagged p53-based peptide (unknown origin) incubated for 15 mins by fluorescence polarization assay,B,,,BAO_0000190,BAO_0000224,protein format,COCCOc1ccccc1N1CCN(C(=O)[C@]2(Oc3ccc(C(F)(F)F)cc3)CCCN(C(=O)c3cnccc3C(F)(F)F)[C@@H]2CCO)CC1,,,CHEMBL3804796,ACS Med. Chem. Lett.,2016,"{'bei': '10.51', 'le': '0.20', 'lle': '2.32', 'sei': '7.28'}",CHEMBL3305317,,CHEMBL3305317,7.62,False,http://www.openphacts.org/units/Nanomolar,2777174,=,1,True,=,,IC50,nM,,24.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,uM,UO_0000065,,0.024
,16585132,[],CHEMBL3807696,Inhibition of human recombinant His-tagged MDM2 (1 to 118 residues) interaction with FAM-tagged p53-based peptide (unknown origin) incubated for 15 mins by fluorescence polarization assay,B,,,BAO_0000190,BAO_0000224,protein format,CCC[C@@H]1N(C(=O)c2cnccc2C(F)(F)F)CCC[C@]1(Oc1ccc(C(F)(F)F)cc1)C(=O)N1CCN(c2ccccc2OCCO)CC1,,,CHEMBL3804796,ACS Med. Chem. Lett.,2016,"{'bei': '10.44', 'le': '0.20', 'lle': '1.34', 'sei': '7.75'}",CHEMBL4299674,,CHEMBL4299674,7.40,False,http://www.openphacts.org/units/Nanomolar,2777175,=,1,True,=,,IC50,nM,,40.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,uM,UO_0000065,,0.04
,16585133,[],CHEMBL3807696,Inhibition of human recombinant His-tagged MDM2 (1 to 118 residues) interaction with FAM-tagged p53-based peptide (unknown origin) incubated for 15 mins by fluorescence polarization assay,B,,,BAO_0000190,BAO_0000224,protein format,CCC[C@H]1N(C(=O)c2cnccc2C(F)(F)F)CCC[C@@]1(Oc1cccs1)C(=O)N1CCN(c2ccccc2OCCO)CC1,,,CHEMBL3804796,ACS Med. Chem. Lett.,2016,"{'bei': '8.56', 'le': '0.17', 'lle': '0.44', 'sei': '5.80'}",CHEMBL3806304,,CHEMBL3806304,5.54,False,http://www.openphacts.org/units/Nanomolar,2777176,=,1,True,=,,IC50,nM,,2900.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,uM,UO_0000065,,2.9
,16585134,[],CHEMBL3807696,Inhibition of human recombinant His-tagged MDM2 (1 to 118 residues) interaction with FAM-tagged p53-based peptide (unknown origin) incubated for 15 mins by fluorescence polarization assay,B,,,BAO_0000190,BAO_0000224,protein format,CCC[C@H]1N(C(=O)c2cnccc2C(F)(F)F)CCC[C@@]1(Oc1cc(I)cs1)C(=O)N1CCN(c2ccccc2OCCO)CC1,,,CHEMBL3804796,ACS Med. Chem. Lett.,2016,"{'bei': '9.12', 'le': '0.21', 'lle': '1.34', 'sei': '7.38'}",CHEMBL3805162,,CHEMBL3805162,7.05,False,http://www.openphacts.org/units/Nanomolar,2777177,=,1,True,=,,IC50,nM,,90.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,uM,UO_0000065,,0.09
,16585135,[],CHEMBL3807696,Inhibition of human recombinant His-tagged MDM2 (1 to 118 residues) interaction with FAM-tagged p53-based peptide (unknown origin) incubated for 15 mins by fluorescence polarization assay,B,,,BAO_0000190,BAO_0000224,protein format,CCC[C@@H]1N(C(=O)c2cnccc2C(F)(F)F)CCC[C@]1(Oc1cc(C(F)(F)F)cs1)C(=O)N1CCN(c2ccccc2OCCO)CC1,,,CHEMBL3804796,ACS Med. Chem. Lett.,2016,"{'bei': '9.47', 'le': '0.19', 'lle': '0.65', 'sei': '7.09'}",CHEMBL4299661,,CHEMBL4299661,6.77,False,http://www.openphacts.org/units/Nanomolar,2777178,=,1,True,=,,IC50,nM,,170.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,uM,UO_0000065,,0.17
,16585136,[],CHEMBL3807696,Inhibition of human recombinant His-tagged MDM2 (1 to 118 residues) interaction with FAM-tagged p53-based peptide (unknown origin) incubated for 15 mins by fluorescence polarization assay,B,,,BAO_0000190,BAO_0000224,protein format,C=CC[C@H]1N(C(=O)c2cnccc2C(F)(F)F)CCC[C@@]1(Oc1cc(C2CC2)cs1)C(=O)N1CCN(c2ccccc2OCCCC(=O)O)CC1,,,CHEMBL3804796,ACS Med. Chem. Lett.,2016,"{'bei': '7.51', 'le': '0.15', 'lle': '-1.17', 'sei': '4.85'}",CHEMBL3805828,,CHEMBL3805828,5.46,False,http://www.openphacts.org/units/Nanomolar,2777179,=,1,True,=,,IC50,nM,,3500.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,uM,UO_0000065,,3.5
,16585137,[],CHEMBL3807696,Inhibition of human recombinant His-tagged MDM2 (1 to 118 residues) interaction with FAM-tagged p53-based peptide (unknown origin) incubated for 15 mins by fluorescence polarization assay,B,,,BAO_0000190,BAO_0000224,protein format,CCC[C@@H]1N(C(=O)c2cnccc2C(F)(F)F)CCC[C@]1(Oc1nc(C(F)(F)F)cs1)C(=O)N1CCN(c2ccccc2OCCO)CC1,,,CHEMBL3804796,ACS Med. Chem. Lett.,2016,"{'bei': '8.33', 'le': '0.17', 'lle': '0.44', 'sei': '5.50'}",CHEMBL4299636,,CHEMBL4299636,5.96,False,http://www.openphacts.org/units/Nanomolar,2777180,=,1,True,=,,IC50,nM,,1100.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,uM,UO_0000065,,1.1
,16585138,[],CHEMBL3807696,Inhibition of human recombinant His-tagged MDM2 (1 to 118 residues) interaction with FAM-tagged p53-based peptide (unknown origin) incubated for 15 mins by fluorescence polarization assay,B,,,BAO_0000190,BAO_0000224,protein format,CCC[C@@H]1N(C(=O)c2cnccc2C(F)(F)F)CCC[C@]1(Oc1cc(C(F)(F)F)n(C)n1)C(=O)N1CCN(c2ccccc2OCCO)CC1,,,CHEMBL3804796,ACS Med. Chem. Lett.,2016,"{'bei': '7.30', 'le': '0.14', 'lle': '0.40', 'sei': '4.59'}",CHEMBL4299637,,CHEMBL4299637,5.20,False,http://www.openphacts.org/units/Nanomolar,2777181,=,1,True,=,,IC50,nM,,6300.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,uM,UO_0000065,,6.3
,16585139,[],CHEMBL3807696,Inhibition of human recombinant His-tagged MDM2 (1 to 118 residues) interaction with FAM-tagged p53-based peptide (unknown origin) incubated for 15 mins by fluorescence polarization assay,B,,,BAO_0000190,BAO_0000224,protein format,CCC[C@@H]1N(C(=O)c2cnccc2C(F)(F)F)CCC[C@]1(Oc1csc(C(F)(F)F)c1)C(=O)N1CCN(c2ccccc2OCCO)CC1,,,CHEMBL3804796,ACS Med. Chem. Lett.,2016,"{'bei': '10.95', 'le': '0.22', 'lle': '1.70', 'sei': '8.20'}",CHEMBL4299638,,CHEMBL4299638,7.82,False,http://www.openphacts.org/units/Nanomolar,2777182,=,1,True,=,,IC50,nM,,15.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,uM,UO_0000065,,0.015
,16585140,[],CHEMBL3807696,Inhibition of human recombinant His-tagged MDM2 (1 to 118 residues) interaction with FAM-tagged p53-based peptide (unknown origin) incubated for 15 mins by fluorescence polarization assay,B,,,BAO_0000190,BAO_0000224,protein format,CCC[C@@H]1N(C(=O)c2cnccc2C(F)(F)F)CCC[C@]1(Oc1csc(C(F)(F)C(F)(F)F)c1)C(=O)N1CCN(c2ccccc2OCCO)CC1,,,CHEMBL3804796,ACS Med. Chem. Lett.,2016,"{'bei': '9.94', 'le': '0.20', 'lle': '0.84', 'sei': '7.97'}",CHEMBL4299646,,CHEMBL4299646,7.60,False,http://www.openphacts.org/units/Nanomolar,2777183,=,1,True,=,,IC50,nM,,25.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,uM,UO_0000065,,0.025
,16585141,[],CHEMBL3807696,Inhibition of human recombinant His-tagged MDM2 (1 to 118 residues) interaction with FAM-tagged p53-based peptide (unknown origin) incubated for 15 mins by fluorescence polarization assay,B,,,BAO_0000190,BAO_0000224,protein format,CCC[C@H]1N(C(=O)c2cnccc2C(F)(F)F)CCC[C@@]1(Oc1csc(C(F)(F)F)c1C)C(=O)N1CCN(c2ccccc2OCCO)CC1,,,CHEMBL3804796,ACS Med. Chem. Lett.,2016,"{'bei': '9.93', 'le': '0.20', 'lle': '0.81', 'sei': '7.58'}",CHEMBL3805082,,CHEMBL3805082,7.24,False,http://www.openphacts.org/units/Nanomolar,2777184,=,1,True,=,,IC50,nM,,58.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,uM,UO_0000065,,0.058
,16585142,[],CHEMBL3807696,Inhibition of human recombinant His-tagged MDM2 (1 to 118 residues) interaction with FAM-tagged p53-based peptide (unknown origin) incubated for 15 mins by fluorescence polarization assay,B,,,BAO_0000190,BAO_0000224,protein format,CCC[C@H]1N(C(=O)c2cnccc2C(F)(F)F)CCC[C@@]1(Oc1csc(C(F)(F)F)c1Cl)C(=O)N1CCN(c2ccccc2OCCO)CC1,,,CHEMBL3804796,ACS Med. Chem. Lett.,2016,"{'bei': '9.19', 'le': '0.19', 'lle': '0.11', 'sei': '7.22'}",CHEMBL3805987,,CHEMBL3805987,6.89,False,http://www.openphacts.org/units/Nanomolar,2777240,=,1,True,=,,IC50,nM,,130.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,uM,UO_0000065,,0.13
,16585143,[],CHEMBL3807696,Inhibition of human recombinant His-tagged MDM2 (1 to 118 residues) interaction with FAM-tagged p53-based peptide (unknown origin) incubated for 15 mins by fluorescence polarization assay,B,,,BAO_0000190,BAO_0000224,protein format,CCC[C@H]1N(C(=O)c2cnccc2C(F)(F)F)CCC[C@@]1(Oc1cc(C(F)(F)F)sc1C)C(=O)N1CCN(c2ccccc2OCCO)CC1,,,CHEMBL3804796,ACS Med. Chem. Lett.,2016,"{'bei': '8.68', 'le': '0.17', 'lle': '-0.10', 'sei': '6.63'}",CHEMBL3805382,,CHEMBL3805382,6.33,False,http://www.openphacts.org/units/Nanomolar,2777241,=,1,True,=,,IC50,nM,,470.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,uM,UO_0000065,,0.47
,16585144,[],CHEMBL3807696,Inhibition of human recombinant His-tagged MDM2 (1 to 118 residues) interaction with FAM-tagged p53-based peptide (unknown origin) incubated for 15 mins by fluorescence polarization assay,B,,,BAO_0000190,BAO_0000224,protein format,CCC[C@H]1N(C(=O)c2cnccc2C(F)(F)F)CCC[C@@]1(Oc1csc(C(F)(F)F)c1)C(=O)N1CCN(c2ccccc2OC(C)(C)CO)CC1,,,CHEMBL3804796,ACS Med. Chem. Lett.,2016,"{'bei': '10.23', 'le': '0.20', 'lle': '0.70', 'sei': '7.97'}",CHEMBL3805720,,CHEMBL3805720,7.60,False,http://www.openphacts.org/units/Nanomolar,2777242,=,1,True,=,,IC50,nM,,25.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,uM,UO_0000065,,0.025
,16585145,[],CHEMBL3807696,Inhibition of human recombinant His-tagged MDM2 (1 to 118 residues) interaction with FAM-tagged p53-based peptide (unknown origin) incubated for 15 mins by fluorescence polarization assay,B,,,BAO_0000190,BAO_0000224,protein format,CCC[C@H]1N(C(=O)c2cnccc2C(F)(F)F)CCC[C@@]1(Oc1csc(C(F)(F)F)c1)C(=O)N1CCN(c2ccccc2OCC(C)(C)O)CC1,,,CHEMBL3804796,ACS Med. Chem. Lett.,2016,"{'bei': '10.28', 'le': '0.20', 'lle': '0.74', 'sei': '8.00'}",CHEMBL3805484,,CHEMBL3805484,7.64,False,http://www.openphacts.org/units/Nanomolar,2777243,=,1,True,=,,IC50,nM,,23.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,uM,UO_0000065,,0.023
,16585146,[],CHEMBL3807696,Inhibition of human recombinant His-tagged MDM2 (1 to 118 residues) interaction with FAM-tagged p53-based peptide (unknown origin) incubated for 15 mins by fluorescence polarization assay,B,,,BAO_0000190,BAO_0000224,protein format,CCC[C@H]1N(C(=O)c2cnccc2C(F)(F)F)CCC[C@@]1(Oc1csc(C(F)(F)F)c1)C(=O)N1CCN(c2ccccc2OCC(=O)O)CC1,,,CHEMBL3804796,ACS Med. Chem. Lett.,2016,"{'bei': '11.94', 'le': '0.24', 'lle': '2.48', 'sei': '7.73'}",CHEMBL3806040,,CHEMBL3806040,8.70,False,http://www.openphacts.org/units/Nanomolar,2777244,=,1,True,=,,IC50,nM,,2.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,uM,UO_0000065,,0.002
,16585147,[],CHEMBL3807696,Inhibition of human recombinant His-tagged MDM2 (1 to 118 residues) interaction with FAM-tagged p53-based peptide (unknown origin) incubated for 15 mins by fluorescence polarization assay,B,,,BAO_0000190,BAO_0000224,protein format,CCC[C@@H]1N(C(=O)c2cnccc2C(F)(F)F)CCC[C@]1(Oc1csc(C(F)(F)F)c1)C(=O)N1CCN(c2ccccc2OCC(=O)NC)CC1,,,CHEMBL3804796,ACS Med. Chem. Lett.,2016,"{'bei': '11.32', 'le': '0.22', 'lle': '2.52', 'sei': '8.05'}",CHEMBL4299668,,CHEMBL4299668,8.40,False,http://www.openphacts.org/units/Nanomolar,2777245,=,1,True,=,,IC50,nM,,4.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,uM,UO_0000065,,0.004
,16585148,[],CHEMBL3807696,Inhibition of human recombinant His-tagged MDM2 (1 to 118 residues) interaction with FAM-tagged p53-based peptide (unknown origin) incubated for 15 mins by fluorescence polarization assay,B,,,BAO_0000190,BAO_0000224,protein format,CCC[C@H]1N(C(=O)c2cnccc2C(F)(F)F)CCC[C@@]1(Oc1csc(C(F)(F)F)c1)C(=O)N1CCN(c2ccccc2OC(C)(C)C(=O)O)CC1,,,CHEMBL3804796,ACS Med. Chem. Lett.,2016,"{'bei': '10.52', 'le': '0.21', 'lle': '0.97', 'sei': '7.07'}",CHEMBL3805499,,CHEMBL3805499,7.96,False,http://www.openphacts.org/units/Nanomolar,2777246,=,1,True,=,,IC50,nM,,11.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,uM,UO_0000065,,0.011
,16585149,[],CHEMBL3807696,Inhibition of human recombinant His-tagged MDM2 (1 to 118 residues) interaction with FAM-tagged p53-based peptide (unknown origin) incubated for 15 mins by fluorescence polarization assay,B,,,BAO_0000190,BAO_0000224,protein format,CCC[C@H]1N(C(=O)c2cnccc2C(F)(F)F)CCC[C@@]1(Oc1csc(C(F)(F)F)c1)C(=O)N1CCN(c2ccccc2OCC(C)(C)C(=O)O)CC1,,,CHEMBL3804796,ACS Med. Chem. Lett.,2016,"{'bei': '10.90', 'le': '0.22', 'lle': '1.16', 'sei': '7.46'}",CHEMBL3805140,,CHEMBL3805140,8.40,False,http://www.openphacts.org/units/Nanomolar,2777247,=,1,True,=,,IC50,nM,,4.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,uM,UO_0000065,,0.004
,16585150,[],CHEMBL3807696,Inhibition of human recombinant His-tagged MDM2 (1 to 118 residues) interaction with FAM-tagged p53-based peptide (unknown origin) incubated for 15 mins by fluorescence polarization assay,B,,,BAO_0000190,BAO_0000224,protein format,CCC[C@H]1N(C(=O)c2cnccc2C(F)(F)F)CCC[C@@]1(Oc1csc(C(F)(F)F)c1)C(=O)N1CCN(c2ccccc2OCCCC(=O)O)CC1,,,CHEMBL3804796,ACS Med. Chem. Lett.,2016,"{'bei': '10.78', 'le': '0.21', 'lle': '1.15', 'sei': '7.25'}",CHEMBL3805372,,CHEMBL3805372,8.15,False,http://www.openphacts.org/units/Nanomolar,2777248,=,1,True,=,,IC50,nM,,7.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,uM,UO_0000065,,0.007
,16585151,[],CHEMBL3807696,Inhibition of human recombinant His-tagged MDM2 (1 to 118 residues) interaction with FAM-tagged p53-based peptide (unknown origin) incubated for 15 mins by fluorescence polarization assay,B,,,BAO_0000190,BAO_0000224,protein format,CCC[C@@H]1N(C(=O)c2cnccc2C(F)(F)F)CCC[C@]1(Oc1csc(C(F)(F)F)c1)C(=O)N1CCN(c2ccccc2OCCC(C)(C)C(=O)O)CC1,,,CHEMBL3804796,ACS Med. Chem. Lett.,2016,"{'bei': '10.19', 'le': '0.20', 'lle': '0.37', 'sei': '7.11'}",CHEMBL4299644,,CHEMBL4299644,8.00,False,http://www.openphacts.org/units/Nanomolar,2777249,=,1,True,=,,IC50,nM,,10.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,uM,UO_0000065,,0.01
,16585152,[],CHEMBL3807696,Inhibition of human recombinant His-tagged MDM2 (1 to 118 residues) interaction with FAM-tagged p53-based peptide (unknown origin) incubated for 15 mins by fluorescence polarization assay,B,,,BAO_0000190,BAO_0000224,protein format,CCC[C@@H]1N(C(=O)c2cnccc2C(F)(F)F)CCC[C@]1(Oc1csc(C(F)(F)F)c1)C(=O)N1CCN(c2ccccc2OCC2(CC(=O)O)CC2)CC1,,,CHEMBL3804796,ACS Med. Chem. Lett.,2016,"{'bei': '9.56', 'le': '0.19', 'lle': '0.09', 'sei': '6.65'}",CHEMBL4299645,,CHEMBL4299645,7.48,False,http://www.openphacts.org/units/Nanomolar,2777250,=,1,True,=,,IC50,nM,,33.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,uM,UO_0000065,,0.033
,16585153,[],CHEMBL3807696,Inhibition of human recombinant His-tagged MDM2 (1 to 118 residues) interaction with FAM-tagged p53-based peptide (unknown origin) incubated for 15 mins by fluorescence polarization assay,B,,,BAO_0000190,BAO_0000224,protein format,CCC[C@H]1N(C(=O)c2cnccc2C(F)(F)F)CCC[C@@]1(Oc1csc(C(F)(F)F)c1)C(=O)N1CCN(c2ccccc2OCCCCC(=O)O)CC1,,,CHEMBL3804796,ACS Med. Chem. Lett.,2016,"{'bei': '10.58', 'le': '0.21', 'lle': '0.76', 'sei': '7.25'}",CHEMBL3805870,,CHEMBL3805870,8.15,False,http://www.openphacts.org/units/Nanomolar,2777251,=,1,True,=,,IC50,nM,,7.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,uM,UO_0000065,,0.007
,16585154,[],CHEMBL3807696,Inhibition of human recombinant His-tagged MDM2 (1 to 118 residues) interaction with FAM-tagged p53-based peptide (unknown origin) incubated for 15 mins by fluorescence polarization assay,B,,,BAO_0000190,BAO_0000224,protein format,COc1ccc(C2=N[C@@H](c3ccc(Cl)cc3)[C@@H](c3ccc(Cl)cc3)N2C(=O)N2CCNC(=O)C2)c(OC(C)C)c1,,,CHEMBL3804796,ACS Med. Chem. Lett.,2016,"{'bei': '12.30', 'le': '0.24', 'lle': '1.26', 'sei': '8.57'}",CHEMBL191334,NUTLIN-3,CHEMBL191334,7.16,False,http://www.openphacts.org/units/Nanomolar,2777252,=,1,True,=,,IC50,nM,,70.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,uM,UO_0000065,,0.07
378329,17751949,[],CHEMBL3888179,"Homogenous Time-Resolved Fluorescence Assay (HTRF1 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 2.5 nM GST-hMDM2 (aa 1-188), 5 nM biotinylated-p53 (aa 1-83), 1.8 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 200 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.",B,,,BAO_0000190,BAO_0000224,protein format,CC[C@@H](C(=O)OC(C)(C)C)N1C(=O)[C@@H](CC(=O)O)CC(c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1,,,CHEMBL3886611,,2016,"{'bei': '14.21', 'le': '0.29', 'lle': '1.14', 'sei': '8.82'}",CHEMBL4111829,,CHEMBL4111829,7.40,False,http://www.openphacts.org/units/Nanomolar,2869284,=,37,True,=,,IC50,nM,,40.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,40.0
378330,17751950,[],CHEMBL3888179,"Homogenous Time-Resolved Fluorescence Assay (HTRF1 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 2.5 nM GST-hMDM2 (aa 1-188), 5 nM biotinylated-p53 (aa 1-83), 1.8 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 200 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.",B,,,BAO_0000190,BAO_0000224,protein format,CC[C@@H](C(=O)OC(C)(C)C)N1C(=O)[C@H](CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1,,,CHEMBL3886611,,2016,"{'bei': '12.87', 'le': '0.26', 'lle': '0.44', 'sei': '7.98'}",CHEMBL3894269,,CHEMBL3894269,6.70,False,http://www.openphacts.org/units/Nanomolar,2869285,=,37,True,=,,IC50,nM,,200.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,200.0
378331,17751951,[],CHEMBL3888179,"Homogenous Time-Resolved Fluorescence Assay (HTRF1 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 2.5 nM GST-hMDM2 (aa 1-188), 5 nM biotinylated-p53 (aa 1-83), 1.8 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 200 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.",B,,,BAO_0000190,BAO_0000224,protein format,CCOC(=O)[C@H](CC)N1C(=O)[C@@H](CC(=O)O)C[C@H](c2cccc(Cl)c2)C1c1ccc(Cl)cc1,,,CHEMBL3886611,,2016,"{'bei': '14.67', 'le': '0.30', 'lle': '1.74', 'sei': '8.61'}",CHEMBL4113757,,CHEMBL4113757,7.22,False,http://www.openphacts.org/units/Nanomolar,2869286,=,37,True,=,,IC50,nM,,60.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,60.0
378332,17751952,[],CHEMBL3888179,"Homogenous Time-Resolved Fluorescence Assay (HTRF1 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 2.5 nM GST-hMDM2 (aa 1-188), 5 nM biotinylated-p53 (aa 1-83), 1.8 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 200 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.",B,,,BAO_0000190,BAO_0000224,protein format,CCOC(=O)[C@H](CC(C)C)N1C(=O)[C@@H](CC(=O)O)C[C@H](c2cccc(Cl)c2)C1c1ccc(Cl)cc1,,,CHEMBL3886611,,2016,"{'bei': '12.91', 'le': '0.26', 'lle': '0.60', 'sei': '8.01'}",CHEMBL4113886,,CHEMBL4113886,6.72,False,http://www.openphacts.org/units/Nanomolar,2869287,=,37,True,=,,IC50,nM,,190.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,190.0
378333,17751953,[],CHEMBL3888179,"Homogenous Time-Resolved Fluorescence Assay (HTRF1 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 2.5 nM GST-hMDM2 (aa 1-188), 5 nM biotinylated-p53 (aa 1-83), 1.8 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 200 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.",B,,,BAO_0000190,BAO_0000224,protein format,CCC[C@@H](C(=O)OCC)N1C(=O)[C@@H](CC(=O)O)C[C@H](c2cccc(Cl)c2)C1c1ccc(Cl)cc1,,,CHEMBL3886611,,2016,"{'bei': '12.97', 'le': '0.26', 'lle': '0.70', 'sei': '7.83'}",CHEMBL4106846,,CHEMBL4106846,6.57,False,http://www.openphacts.org/units/Nanomolar,2869288,=,37,True,=,,IC50,nM,,270.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,270.0
378334,17751954,[],CHEMBL3888179,"Homogenous Time-Resolved Fluorescence Assay (HTRF1 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 2.5 nM GST-hMDM2 (aa 1-188), 5 nM biotinylated-p53 (aa 1-83), 1.8 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 200 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.",B,,,BAO_0000190,BAO_0000224,protein format,CCOC(=O)[C@H](C1CC1)N1C(=O)[C@@H](CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1,,,CHEMBL3886611,,2016,"{'bei': '14.67', 'le': '0.30', 'lle': '1.92', 'sei': '8.82'}",CHEMBL4114861,,CHEMBL4114861,7.40,False,http://www.openphacts.org/units/Nanomolar,2869289,=,37,True,=,,IC50,nM,,40.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,40.0
378335,17751955,[],CHEMBL3888179,"Homogenous Time-Resolved Fluorescence Assay (HTRF1 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 2.5 nM GST-hMDM2 (aa 1-188), 5 nM biotinylated-p53 (aa 1-83), 1.8 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 200 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.",B,,,BAO_0000190,BAO_0000224,protein format,CC[C@@H](CO)N1C(=O)[C@@H](CC(=O)O)C[C@H](c2cccc(Cl)c2)C1c1ccc(Cl)cc1,,,CHEMBL3886611,,2016,"{'bei': '16.21', 'le': '0.33', 'lle': '2.39', 'sei': '9.38'}",CHEMBL4114823,,CHEMBL4114823,7.30,False,http://www.openphacts.org/units/Nanomolar,2869290,=,37,True,=,,IC50,nM,,50.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,50.0
378336,17751956,[],CHEMBL3888179,"Homogenous Time-Resolved Fluorescence Assay (HTRF1 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 2.5 nM GST-hMDM2 (aa 1-188), 5 nM biotinylated-p53 (aa 1-83), 1.8 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 200 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.",B,,,BAO_0000190,BAO_0000224,protein format,O=C(O)C[C@H]1C[C@H](c2cccc(Cl)c2)[C@@H](c2ccc(Cl)cc2)N([C@H](CO)C2CC2)C1=O,,,CHEMBL3886611,,2016,"{'bei': '16.00', 'le': '0.33', 'lle': '2.49', 'sei': '9.50'}",CHEMBL4115504,,CHEMBL4115504,7.40,False,http://www.openphacts.org/units/Nanomolar,2869291,=,37,True,=,,IC50,nM,,40.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,40.0
378337,17751957,[],CHEMBL3888179,"Homogenous Time-Resolved Fluorescence Assay (HTRF1 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 2.5 nM GST-hMDM2 (aa 1-188), 5 nM biotinylated-p53 (aa 1-83), 1.8 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 200 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.",B,,,BAO_0000190,BAO_0000224,protein format,CC[C@@H](COCC1CC1)N1C(=O)[C@@H](CC(=O)O)C[C@H](c2cccc(Cl)c2)C1c1ccc(Cl)cc1,,,CHEMBL3886611,,2016,"{'bei': '14.91', 'le': '0.30', 'lle': '1.17', 'sei': '11.26'}",CHEMBL4109794,,CHEMBL4109794,7.52,False,http://www.openphacts.org/units/Nanomolar,2869292,=,37,True,=,,IC50,nM,,30.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,30.0
378338,17751958,[],CHEMBL3888179,"Homogenous Time-Resolved Fluorescence Assay (HTRF1 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 2.5 nM GST-hMDM2 (aa 1-188), 5 nM biotinylated-p53 (aa 1-83), 1.8 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 200 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.",B,,,BAO_0000190,BAO_0000224,protein format,CC[C@@H](COC)N1C(=O)[C@@H](CC(=O)O)C[C@H](c2cccc(Cl)c2)C1c1ccc(Cl)cc1,,,CHEMBL3886611,,2016,"{'bei': '15.41', 'le': '0.32', 'lle': '1.58', 'sei': '10.70'}",CHEMBL4112950,,CHEMBL4112950,7.16,False,http://www.openphacts.org/units/Nanomolar,2869293,=,37,True,=,,IC50,nM,,70.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,70.0
378339,17751959,[],CHEMBL3888179,"Homogenous Time-Resolved Fluorescence Assay (HTRF1 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 2.5 nM GST-hMDM2 (aa 1-188), 5 nM biotinylated-p53 (aa 1-83), 1.8 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 200 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.",B,,,BAO_0000190,BAO_0000224,protein format,CC[C@@H](COCCOC)N1C(=O)[C@@H](CC(=O)O)C[C@H](c2cccc(Cl)c2)C1c1ccc(Cl)cc1,,,CHEMBL3886611,,2016,"{'bei': '13.86', 'le': '0.28', 'lle': '1.47', 'sei': '9.26'}",CHEMBL4107352,,CHEMBL4107352,7.05,False,http://www.openphacts.org/units/Nanomolar,2869294,=,37,True,=,,IC50,nM,,90.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,90.0
378340,17751960,[],CHEMBL3888179,"Homogenous Time-Resolved Fluorescence Assay (HTRF1 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 2.5 nM GST-hMDM2 (aa 1-188), 5 nM biotinylated-p53 (aa 1-83), 1.8 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 200 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.",B,,,BAO_0000190,BAO_0000224,protein format,CC[C@@H](COCC1(C#N)CC1)N1C(=O)[C@@H](CC(=O)O)C[C@H](c2cccc(Cl)c2)C1c1ccc(Cl)cc1,,,CHEMBL3886611,,2016,"{'bei': '13.97', 'le': '0.28', 'lle': '1.16', 'sei': '8.16'}",CHEMBL4112735,,CHEMBL4112735,7.40,False,http://www.openphacts.org/units/Nanomolar,2869295,=,37,True,=,,IC50,nM,,40.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,40.0
378341,17751961,[],CHEMBL3888179,"Homogenous Time-Resolved Fluorescence Assay (HTRF1 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 2.5 nM GST-hMDM2 (aa 1-188), 5 nM biotinylated-p53 (aa 1-83), 1.8 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 200 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.",B,,,BAO_0000190,BAO_0000224,protein format,CC[C@@H](COCC1CC1)N1C(=O)[C@H](CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1,,,CHEMBL3886611,,2016,"{'bei': '13.79', 'le': '0.28', 'lle': '0.61', 'sei': '10.41'}",CHEMBL3891817,,CHEMBL3891817,6.96,False,http://www.openphacts.org/units/Nanomolar,2869296,=,37,True,=,,IC50,nM,,110.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,110.0
378342,17751962,[],CHEMBL3888179,"Homogenous Time-Resolved Fluorescence Assay (HTRF1 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 2.5 nM GST-hMDM2 (aa 1-188), 5 nM biotinylated-p53 (aa 1-83), 1.8 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 200 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.",B,,,BAO_0000190,BAO_0000224,protein format,CC[C@@H](COC)N1C(=O)[C@H](CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1,,,CHEMBL3886611,,2016,"{'bei': '14.08', 'le': '0.29', 'lle': '0.97', 'sei': '9.78'}",CHEMBL3966670,,CHEMBL3966670,6.54,False,http://www.openphacts.org/units/Nanomolar,2869297,=,37,True,=,,IC50,nM,,290.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,290.0
378343,17751963,[],CHEMBL3888179,"Homogenous Time-Resolved Fluorescence Assay (HTRF1 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 2.5 nM GST-hMDM2 (aa 1-188), 5 nM biotinylated-p53 (aa 1-83), 1.8 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 200 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.",B,,,BAO_0000190,BAO_0000224,protein format,CC[C@@H](COCCOC)N1C(=O)[C@H](CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1,,,CHEMBL3886611,,2016,"{'bei': '13.02', 'le': '0.27', 'lle': '1.04', 'sei': '8.70'}",CHEMBL3967626,,CHEMBL3967626,6.62,False,http://www.openphacts.org/units/Nanomolar,2869298,=,37,True,=,,IC50,nM,,240.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,240.0
378344,17751964,[],CHEMBL3888179,"Homogenous Time-Resolved Fluorescence Assay (HTRF1 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 2.5 nM GST-hMDM2 (aa 1-188), 5 nM biotinylated-p53 (aa 1-83), 1.8 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 200 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.",B,,,BAO_0000190,BAO_0000224,protein format,CC[C@@H](COCC1(C(N)=O)CC1)N1C(=O)[C@@H](CC(=O)O)C[C@H](c2cccc(Cl)c2)C1c1ccc(Cl)cc1,,,CHEMBL3886611,,2016,"{'bei': '13.07', 'le': '0.26', 'lle': '1.95', 'sei': '6.51'}",CHEMBL4111792,,CHEMBL4111792,7.16,False,http://www.openphacts.org/units/Nanomolar,2869299,=,37,True,=,,IC50,nM,,70.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,70.0
378345,17751965,[],CHEMBL3888179,"Homogenous Time-Resolved Fluorescence Assay (HTRF1 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 2.5 nM GST-hMDM2 (aa 1-188), 5 nM biotinylated-p53 (aa 1-83), 1.8 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 200 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.",B,,,BAO_0000190,BAO_0000224,protein format,CC[C@@H](COCC1(C(N)=O)CC1)N1C(=O)[C@H](CC(=O)O)C[C@H](c2cccc(Cl)c2)C1c1ccc(Cl)cc1,,,CHEMBL3886611,,2016,"{'bei': '12.09', 'le': '0.24', 'lle': '1.42', 'sei': '6.02'}",CHEMBL3976132,,CHEMBL3976132,6.62,False,http://www.openphacts.org/units/Nanomolar,2869300,=,37,True,=,,IC50,nM,,240.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,240.0
378346,17751966,[],CHEMBL3888179,"Homogenous Time-Resolved Fluorescence Assay (HTRF1 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 2.5 nM GST-hMDM2 (aa 1-188), 5 nM biotinylated-p53 (aa 1-83), 1.8 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 200 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.",B,,,BAO_0000190,BAO_0000224,protein format,CC[C@@H](COCC(C)(C)O)N1C(=O)[C@H](CC(=O)O)C[C@H](c2cccc(Cl)c2)C1c1ccc(Cl)cc1,,,CHEMBL3886611,,2016,"{'bei': '13.32', 'le': '0.27', 'lle': '1.25', 'sei': '7.99'}",CHEMBL3895079,,CHEMBL3895079,6.96,False,http://www.openphacts.org/units/Nanomolar,2869301,=,37,True,=,,IC50,nM,,110.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,110.0
378347,17751967,[],CHEMBL3888179,"Homogenous Time-Resolved Fluorescence Assay (HTRF1 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 2.5 nM GST-hMDM2 (aa 1-188), 5 nM biotinylated-p53 (aa 1-83), 1.8 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 200 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.",B,,,BAO_0000190,BAO_0000224,protein format,CC[C@@H](C(O)C(F)(F)F)N1C(=O)[C@@H](CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1,,,CHEMBL3886611,,2016,"{'bei': '15.43', 'le': '0.32', 'lle': '2.16', 'sei': '10.28'}",CHEMBL4108586,,CHEMBL4108586,8.00,False,http://www.openphacts.org/units/Nanomolar,2869302,=,37,True,=,,IC50,nM,,10.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,10.0
378348,17751968,[],CHEMBL3888179,"Homogenous Time-Resolved Fluorescence Assay (HTRF1 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 2.5 nM GST-hMDM2 (aa 1-188), 5 nM biotinylated-p53 (aa 1-83), 1.8 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 200 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.",B,,,BAO_0000190,BAO_0000224,protein format,CC[C@@H](C(O)C(F)(F)F)N1C(=O)[C@@H](CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1,,,CHEMBL3886611,,2016,"{'bei': '13.80', 'le': '0.29', 'lle': '1.31', 'sei': '9.19'}",CHEMBL4108586,,CHEMBL4108586,7.16,False,http://www.openphacts.org/units/Nanomolar,2869302,=,37,True,=,,IC50,nM,,70.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,70.0
378349,17751969,[],CHEMBL3888179,"Homogenous Time-Resolved Fluorescence Assay (HTRF1 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 2.5 nM GST-hMDM2 (aa 1-188), 5 nM biotinylated-p53 (aa 1-83), 1.8 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 200 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.",B,,,BAO_0000190,BAO_0000224,protein format,CC[C@@H](CN1CCOCC1)N1C(=O)[C@@H](CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1,,,CHEMBL3886611,,2016,"{'bei': '13.77', 'le': '0.28', 'lle': '1.90', 'sei': '10.21'}",CHEMBL4109809,,CHEMBL4109809,7.16,False,http://www.openphacts.org/units/Nanomolar,2869303,=,37,True,=,,IC50,nM,,70.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,70.0
378350,17751970,[],CHEMBL3888179,"Homogenous Time-Resolved Fluorescence Assay (HTRF1 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 2.5 nM GST-hMDM2 (aa 1-188), 5 nM biotinylated-p53 (aa 1-83), 1.8 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 200 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.",B,,,BAO_0000190,BAO_0000224,protein format,CCNC[C@@H](CC)N1C(=O)[C@@H](CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1,,,CHEMBL3886611,,2016,"{'bei': '13.22', 'le': '0.27', 'lle': '0.78', 'sei': '9.06'}",CHEMBL3915542,,CHEMBL3915542,6.31,False,http://www.openphacts.org/units/Nanomolar,2869304,=,37,True,=,,IC50,nM,,490.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,490.0
378351,17751971,[],CHEMBL3888179,"Homogenous Time-Resolved Fluorescence Assay (HTRF1 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 2.5 nM GST-hMDM2 (aa 1-188), 5 nM biotinylated-p53 (aa 1-83), 1.8 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 200 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.",B,,,BAO_0000190,BAO_0000224,protein format,CC[C@@H](CNCC(F)(F)F)N1C(=O)[C@@H](CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1,,,CHEMBL3886611,,2016,"{'bei': '12.74', 'le': '0.26', 'lle': '0.70', 'sei': '9.72'}",CHEMBL3977218,,CHEMBL3977218,6.77,False,http://www.openphacts.org/units/Nanomolar,2869305,=,37,True,=,,IC50,nM,,170.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,170.0
378352,17751972,[],CHEMBL3888179,"Homogenous Time-Resolved Fluorescence Assay (HTRF1 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 2.5 nM GST-hMDM2 (aa 1-188), 5 nM biotinylated-p53 (aa 1-83), 1.8 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 200 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.",B,,,BAO_0000190,BAO_0000224,protein format,CC[C@@H](CN1CCCC1)N1C(=O)[C@@H](CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1,,,CHEMBL3886611,,2016,"{'bei': '12.40', 'le': '0.25', 'lle': '0.22', 'sei': '10.26'}",CHEMBL3906565,,CHEMBL3906565,6.24,False,http://www.openphacts.org/units/Nanomolar,2869306,=,37,True,=,,IC50,nM,,570.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,570.0
378353,17751973,[],CHEMBL3888179,"Homogenous Time-Resolved Fluorescence Assay (HTRF1 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 2.5 nM GST-hMDM2 (aa 1-188), 5 nM biotinylated-p53 (aa 1-83), 1.8 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 200 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.",B,,,BAO_0000190,BAO_0000224,protein format,CC[C@H](CN1CCCC1=O)N1C(=O)[C@@H](CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1,,,CHEMBL3886611,,2016,"{'bei': '13.25', 'le': '0.27', 'lle': '1.31', 'sei': '8.80'}",CHEMBL3967086,,CHEMBL3967086,6.85,False,http://www.openphacts.org/units/Nanomolar,2869307,=,37,True,=,,IC50,nM,,140.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,140.0
378354,17751974,[],CHEMBL3888179,"Homogenous Time-Resolved Fluorescence Assay (HTRF1 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 2.5 nM GST-hMDM2 (aa 1-188), 5 nM biotinylated-p53 (aa 1-83), 1.8 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 200 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.",B,,,BAO_0000190,BAO_0000224,protein format,CC[C@@H](CN1CCS(=O)(=O)CC1)N1C(=O)[C@@H](CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1,,,CHEMBL3886611,,2016,"{'bei': '12.13', 'le': '0.25', 'lle': '2.24', 'sei': '7.25'}",CHEMBL3901116,,CHEMBL3901116,6.89,False,http://www.openphacts.org/units/Nanomolar,2869308,=,37,True,=,,IC50,nM,,130.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,130.0
378355,17751975,[],CHEMBL3888179,"Homogenous Time-Resolved Fluorescence Assay (HTRF1 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 2.5 nM GST-hMDM2 (aa 1-188), 5 nM biotinylated-p53 (aa 1-83), 1.8 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 200 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.",B,,,BAO_0000190,BAO_0000224,protein format,CC[C@@H](CNc1nccs1)N1C(=O)[C@@H](CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1,,,CHEMBL3886611,,2016,"{'bei': '13.15', 'le': '0.27', 'lle': '0.51', 'sei': '8.48'}",CHEMBL3961139,,CHEMBL3961139,7.00,False,http://www.openphacts.org/units/Nanomolar,2869309,=,37,True,=,,IC50,nM,,100.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,100.0
378356,17751976,[],CHEMBL3888179,"Homogenous Time-Resolved Fluorescence Assay (HTRF1 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 2.5 nM GST-hMDM2 (aa 1-188), 5 nM biotinylated-p53 (aa 1-83), 1.8 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 200 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.",B,,,BAO_0000190,BAO_0000224,protein format,CC[C@@H](CNC(C)=O)N1C(=O)[C@@H](CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1,,,CHEMBL3886611,,2016,"{'bei': '13.72', 'le': '0.28', 'lle': '1.68', 'sei': '7.78'}",CHEMBL4106464,,CHEMBL4106464,6.75,False,http://www.openphacts.org/units/Nanomolar,2869310,=,37,True,=,,IC50,nM,,180.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,180.0
378357,17751977,[],CHEMBL3888179,"Homogenous Time-Resolved Fluorescence Assay (HTRF1 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 2.5 nM GST-hMDM2 (aa 1-188), 5 nM biotinylated-p53 (aa 1-83), 1.8 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 200 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.",B,,,BAO_0000190,BAO_0000224,protein format,CC[C@@H](CNS(C)(=O)=O)N1C(=O)[C@@H](CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1,,,CHEMBL3886611,,2016,"{'bei': '14.26', 'le': '0.30', 'lle': '3.05', 'sei': '7.25'}",CHEMBL4111743,,CHEMBL4111743,7.52,False,http://www.openphacts.org/units/Nanomolar,2869311,=,37,True,=,,IC50,nM,,30.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,30.0
378358,17751978,[],CHEMBL3888179,"Homogenous Time-Resolved Fluorescence Assay (HTRF1 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 2.5 nM GST-hMDM2 (aa 1-188), 5 nM biotinylated-p53 (aa 1-83), 1.8 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 200 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.",B,,,BAO_0000190,BAO_0000224,protein format,CC[C@@H](CCC#N)N1C(=O)[C@@H](CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1,,,CHEMBL3886611,,2016,"{'bei': '15.89', 'le': '0.32', 'lle': '1.30', 'sei': '9.24'}",CHEMBL4110652,,CHEMBL4110652,7.52,False,http://www.openphacts.org/units/Nanomolar,2869312,=,37,True,=,,IC50,nM,,30.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,30.0
378359,17751979,[],CHEMBL3888179,"Homogenous Time-Resolved Fluorescence Assay (HTRF1 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 2.5 nM GST-hMDM2 (aa 1-188), 5 nM biotinylated-p53 (aa 1-83), 1.8 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 200 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.",B,,,BAO_0000190,BAO_0000224,protein format,CC[C@@H](CCS(C)(=O)=O)N1C(=O)[C@@H](CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1,,,CHEMBL3886611,,2016,"{'bei': '13.87', 'le': '0.29', 'lle': '1.95', 'sei': '7.96'}",CHEMBL4113641,,CHEMBL4113641,7.30,False,http://www.openphacts.org/units/Nanomolar,2869313,=,37,True,=,,IC50,nM,,50.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,50.0
378360,17751980,[],CHEMBL3888179,"Homogenous Time-Resolved Fluorescence Assay (HTRF1 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 2.5 nM GST-hMDM2 (aa 1-188), 5 nM biotinylated-p53 (aa 1-83), 1.8 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 200 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.",B,,,BAO_0000190,BAO_0000224,protein format,CC[C@@H](CCc1ccccn1)N1C(=O)[C@@H](CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1,,,CHEMBL3886611,,2016,"{'bei': '13.41', 'le': '0.27', 'lle': '0.10', 'sei': '9.99'}",CHEMBL4115223,,CHEMBL4115223,7.05,False,http://www.openphacts.org/units/Nanomolar,2869314,=,37,True,=,,IC50,nM,,90.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,90.0
378361,17751981,[],CHEMBL3888179,"Homogenous Time-Resolved Fluorescence Assay (HTRF1 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 2.5 nM GST-hMDM2 (aa 1-188), 5 nM biotinylated-p53 (aa 1-83), 1.8 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 200 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.",B,,,BAO_0000190,BAO_0000224,protein format,CCNC(=O)[C@H](CC)N1C(=O)[C@@H](CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1,,,CHEMBL3886611,,2016,"{'bei': '13.00', 'le': '0.26', 'lle': '1.33', 'sei': '7.37'}",CHEMBL4113910,,CHEMBL4113910,6.39,False,http://www.openphacts.org/units/Nanomolar,2869315,=,37,True,=,,IC50,nM,,410.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,410.0
378362,17751982,[],CHEMBL3888179,"Homogenous Time-Resolved Fluorescence Assay (HTRF1 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 2.5 nM GST-hMDM2 (aa 1-188), 5 nM biotinylated-p53 (aa 1-83), 1.8 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 200 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.",B,,,BAO_0000190,BAO_0000224,protein format,CC[C@@H](c1nnc(C)o1)N1C(=O)[C@@H](CC(=O)O)CC(c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1,,,CHEMBL3886611,,2016,"{'bei': '12.24', 'le': '0.25', 'lle': '0.17', 'sei': '6.37'}",CHEMBL4113762,,CHEMBL4113762,6.15,False,http://www.openphacts.org/units/Nanomolar,2869316,=,37,True,=,,IC50,nM,,710.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,710.0
378363,17751983,[],CHEMBL3888179,"Homogenous Time-Resolved Fluorescence Assay (HTRF1 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 2.5 nM GST-hMDM2 (aa 1-188), 5 nM biotinylated-p53 (aa 1-83), 1.8 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 200 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.",B,,,BAO_0000190,BAO_0000224,protein format,O=C(O)C[C@H]1CC(c2cccc(Cl)c2)[C@@H](c2ccc(Cl)cc2)N(CC2CC2)C1=O,,,CHEMBL3886611,,2016,"{'bei': '15.78', 'le': '0.32', 'lle': '1.27', 'sei': '11.85'}",CHEMBL4113368,,CHEMBL4113368,6.82,False,http://www.openphacts.org/units/Nanomolar,2869317,=,37,True,=,,IC50,nM,,150.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,150.0
378364,17751984,[],CHEMBL3888179,"Homogenous Time-Resolved Fluorescence Assay (HTRF1 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 2.5 nM GST-hMDM2 (aa 1-188), 5 nM biotinylated-p53 (aa 1-83), 1.8 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 200 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.",B,,,BAO_0000190,BAO_0000224,protein format,CC[C@@H](CNc1nccs1)N1C(=O)[C@@H](CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1,,,CHEMBL3886611,,2016,"{'bei': '10.08', 'le': '0.21', 'lle': '-1.12', 'sei': '6.50'}",CHEMBL3961139,,CHEMBL3961139,5.37,False,http://www.openphacts.org/units/Nanomolar,2869309,=,37,True,=,,IC50,nM,,4300.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,4300.0
378365,17751985,[],CHEMBL3888179,"Homogenous Time-Resolved Fluorescence Assay (HTRF1 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 2.5 nM GST-hMDM2 (aa 1-188), 5 nM biotinylated-p53 (aa 1-83), 1.8 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 200 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.",B,,,BAO_0000190,BAO_0000224,protein format,CCC(CC)CN1C(=O)[C@@H](CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1,,,CHEMBL3886611,,2016,"{'bei': '15.62', 'le': '0.32', 'lle': '0.64', 'sei': '12.54'}",CHEMBL3907720,,CHEMBL3907720,7.22,False,http://www.openphacts.org/units/Nanomolar,2869318,=,37,True,=,,IC50,nM,,60.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,60.0
378366,17751986,[],CHEMBL3888179,"Homogenous Time-Resolved Fluorescence Assay (HTRF1 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 2.5 nM GST-hMDM2 (aa 1-188), 5 nM biotinylated-p53 (aa 1-83), 1.8 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 200 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.",B,,,BAO_0000190,BAO_0000224,protein format,O=C(O)C[C@H]1C[C@H](c2cccc(Cl)c2)[C@@H](c2ccc(Cl)cc2)N(CC2CCCC2)C1=O,,,CHEMBL3886611,,2016,"{'bei': '14.60', 'le': '0.30', 'lle': '0.39', 'sei': '11.67'}",CHEMBL3978255,,CHEMBL3978255,6.72,False,http://www.openphacts.org/units/Nanomolar,2869319,=,37,True,=,,IC50,nM,,190.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,190.0
378367,17751987,[],CHEMBL3888179,"Homogenous Time-Resolved Fluorescence Assay (HTRF1 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 2.5 nM GST-hMDM2 (aa 1-188), 5 nM biotinylated-p53 (aa 1-83), 1.8 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 200 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.",B,,,BAO_0000190,BAO_0000224,protein format,CC1(C)CCCC1CN1C(=O)[C@@H](CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1,,,CHEMBL3886611,,2016,"{'bei': '13.35', 'le': '0.27', 'lle': '-0.45', 'sei': '11.32'}",CHEMBL3935760,,CHEMBL3935760,6.52,False,http://www.openphacts.org/units/Nanomolar,2869320,=,37,True,=,,IC50,nM,,300.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,300.0
378368,17751988,[],CHEMBL3888179,"Homogenous Time-Resolved Fluorescence Assay (HTRF1 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 2.5 nM GST-hMDM2 (aa 1-188), 5 nM biotinylated-p53 (aa 1-83), 1.8 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 200 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.",B,,,BAO_0000190,BAO_0000224,protein format,O=C(O)C[C@H]1C[C@H](c2cccc(Cl)c2)[C@@H](c2ccc(Cl)cc2)N(CC2CCCCC2)C1=O,,,CHEMBL3886611,,2016,"{'bei': '14.27', 'le': '0.29', 'lle': '0.05', 'sei': '11.75'}",CHEMBL3904258,,CHEMBL3904258,6.77,False,http://www.openphacts.org/units/Nanomolar,2869321,=,37,True,=,,IC50,nM,,170.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,170.0
378369,17751989,[],CHEMBL3888179,"Homogenous Time-Resolved Fluorescence Assay (HTRF1 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 2.5 nM GST-hMDM2 (aa 1-188), 5 nM biotinylated-p53 (aa 1-83), 1.8 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 200 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.",B,,,BAO_0000190,BAO_0000224,protein format,O=C(O)C[C@@H]1CC(c2cccc(Cl)c2)[C@@H](c2ccc(Cl)cc2)N(CC2CC2)C1=O,,,CHEMBL3886611,,2016,"{'bei': '15.02', 'le': '0.31', 'lle': '0.94', 'sei': '11.27'}",CHEMBL3905949,,CHEMBL3905949,6.50,False,http://www.openphacts.org/units/Nanomolar,2869322,=,37,True,=,,IC50,nM,,320.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,320.0
378370,17751990,[],CHEMBL3888179,"Homogenous Time-Resolved Fluorescence Assay (HTRF1 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 2.5 nM GST-hMDM2 (aa 1-188), 5 nM biotinylated-p53 (aa 1-83), 1.8 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 200 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.",B,,,BAO_0000190,BAO_0000224,protein format,CCCN1C(=O)[C@H](CC(=O)O)CC(c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1,,,CHEMBL3886611,,2016,"{'bei': '15.20', 'le': '0.31', 'lle': '0.84', 'sei': '11.09'}",CHEMBL3933945,,CHEMBL3933945,6.39,False,http://www.openphacts.org/units/Nanomolar,2869323,=,37,True,=,,IC50,nM,,410.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,410.0
378371,17751991,[],CHEMBL3888179,"Homogenous Time-Resolved Fluorescence Assay (HTRF1 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 2.5 nM GST-hMDM2 (aa 1-188), 5 nM biotinylated-p53 (aa 1-83), 1.8 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 200 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.",B,,,BAO_0000190,BAO_0000224,protein format,O=C(O)C[C@@H]1CC(c2cccc(Cl)c2)[C@@H](c2ccc(Cl)cc2)N(CC2CCC2)C1=O,,,CHEMBL3886611,,2016,"{'bei': '12.78', 'le': '0.26', 'lle': '-0.23', 'sei': '9.90'}",CHEMBL3918513,,CHEMBL3918513,5.71,False,http://www.openphacts.org/units/Nanomolar,2869324,=,37,True,=,,IC50,nM,,1970.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,1970.0
378372,17751992,[],CHEMBL3888179,"Homogenous Time-Resolved Fluorescence Assay (HTRF1 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 2.5 nM GST-hMDM2 (aa 1-188), 5 nM biotinylated-p53 (aa 1-83), 1.8 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 200 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.",B,,,BAO_0000190,BAO_0000224,protein format,CC(C)CN1C(=O)[C@H](CC(=O)O)CC(c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1,,,CHEMBL3886611,,2016,"{'bei': '14.61', 'le': '0.30', 'lle': '0.55', 'sei': '11.02'}",CHEMBL3942905,,CHEMBL3942905,6.35,False,http://www.openphacts.org/units/Nanomolar,2869325,=,37,True,=,,IC50,nM,,450.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,450.0
378373,17751993,[],CHEMBL3888179,"Homogenous Time-Resolved Fluorescence Assay (HTRF1 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 2.5 nM GST-hMDM2 (aa 1-188), 5 nM biotinylated-p53 (aa 1-83), 1.8 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 200 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.",B,,,BAO_0000190,BAO_0000224,protein format,O=C(O)C[C@@H]1CC(c2cccc(Cl)c2)[C@@H](c2ccc(Cl)cc2)N(CC2CCCC2)C1=O,,,CHEMBL3886611,,2016,"{'bei': '13.60', 'le': '0.28', 'lle': '-0.07', 'sei': '10.87'}",CHEMBL3891537,,CHEMBL3891537,6.26,False,http://www.openphacts.org/units/Nanomolar,2869326,=,37,True,=,,IC50,nM,,550.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,550.0
378374,17751994,[],CHEMBL3888179,"Homogenous Time-Resolved Fluorescence Assay (HTRF1 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 2.5 nM GST-hMDM2 (aa 1-188), 5 nM biotinylated-p53 (aa 1-83), 1.8 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 200 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.",B,,,BAO_0000190,BAO_0000224,protein format,CCC(CC)N1C(=O)[C@H](CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1,,,CHEMBL3886611,,2016,"{'bei': '14.65', 'le': '0.30', 'lle': '0.24', 'sei': '11.40'}",CHEMBL3919602,,CHEMBL3919602,6.57,False,http://www.openphacts.org/units/Nanomolar,2869327,=,37,True,=,,IC50,nM,,270.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,270.0
378375,17751995,[],CHEMBL3888179,"Homogenous Time-Resolved Fluorescence Assay (HTRF1 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 2.5 nM GST-hMDM2 (aa 1-188), 5 nM biotinylated-p53 (aa 1-83), 1.8 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 200 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.",B,,,BAO_0000190,BAO_0000224,protein format,COC(=O)C[C@H]1C[C@H](c2cccc(Cl)c2)[C@@H](c2ccc(Cl)cc2)N(CC2CC2)C1=O,,,CHEMBL3886611,,2016,"{'bei': '12.19', 'le': '0.25', 'lle': '-0.20', 'sei': '11.67'}",CHEMBL2177182,,CHEMBL2177182,5.44,False,http://www.openphacts.org/units/Nanomolar,2869328,=,37,True,=,,IC50,nM,,3630.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,3630.0
378376,17751996,[],CHEMBL3888179,"Homogenous Time-Resolved Fluorescence Assay (HTRF1 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 2.5 nM GST-hMDM2 (aa 1-188), 5 nM biotinylated-p53 (aa 1-83), 1.8 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 200 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.",B,,,BAO_0000190,BAO_0000224,protein format,NC(=O)C[C@H]1C[C@H](c2cccc(Cl)c2)[C@@H](c2ccc(Cl)cc2)N(CC2CC2)C1=O,,,CHEMBL3886611,,2016,"{'bei': '13.59', 'le': '0.28', 'lle': '0.91', 'sei': '9.25'}",CHEMBL2177183,,CHEMBL2177183,5.86,False,http://www.openphacts.org/units/Nanomolar,2869329,=,37,True,=,,IC50,nM,,1370.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,1370.0
378377,17751997,[],CHEMBL3888179,"Homogenous Time-Resolved Fluorescence Assay (HTRF1 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 2.5 nM GST-hMDM2 (aa 1-188), 5 nM biotinylated-p53 (aa 1-83), 1.8 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 200 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.",B,,,BAO_0000190,BAO_0000224,protein format,CCOC(=O)CNC(=O)C[C@H]1C[C@H](c2cccc(Cl)c2)[C@@H](c2ccc(Cl)cc2)N(CC2CC2)C1=O,,,CHEMBL3886611,,2016,"{'bei': '10.87', 'le': '0.22', 'lle': '0.47', 'sei': '7.43'}",CHEMBL4106930,,CHEMBL4106930,5.62,False,http://www.openphacts.org/units/Nanomolar,2869330,=,37,True,=,,IC50,nM,,2380.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,2380.0
378378,17751998,[],CHEMBL3888179,"Homogenous Time-Resolved Fluorescence Assay (HTRF1 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 2.5 nM GST-hMDM2 (aa 1-188), 5 nM biotinylated-p53 (aa 1-83), 1.8 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 200 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.",B,,,BAO_0000190,BAO_0000224,protein format,O=C(O)CNC(=O)C[C@H]1C[C@H](c2cccc(Cl)c2)[C@@H](c2ccc(Cl)cc2)N(CC2CC2)C1=O,,,CHEMBL3886611,,2016,"{'bei': '12.43', 'le': '0.25', 'lle': '1.41', 'sei': '7.01'}",CHEMBL4106454,,CHEMBL4106454,6.08,False,http://www.openphacts.org/units/Nanomolar,2869331,=,37,True,=,,IC50,nM,,830.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,830.0
378379,17751999,[],CHEMBL3888179,"Homogenous Time-Resolved Fluorescence Assay (HTRF1 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 2.5 nM GST-hMDM2 (aa 1-188), 5 nM biotinylated-p53 (aa 1-83), 1.8 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 200 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.",B,,,BAO_0000190,BAO_0000224,protein format,NNC(=O)C[C@H]1C[C@H](c2cccc(Cl)c2)[C@@H](c2ccc(Cl)cc2)N(CC2CC2)C1=O,,,CHEMBL3886611,,2016,"{'bei': '12.35', 'le': '0.25', 'lle': '1.05', 'sei': '7.31'}",CHEMBL4108672,,CHEMBL4108672,5.51,False,http://www.openphacts.org/units/Nanomolar,2869332,=,37,True,=,,IC50,nM,,3060.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,3060.0
378380,17752000,[],CHEMBL3888179,"Homogenous Time-Resolved Fluorescence Assay (HTRF1 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 2.5 nM GST-hMDM2 (aa 1-188), 5 nM biotinylated-p53 (aa 1-83), 1.8 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 200 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.",B,,,BAO_0000190,BAO_0000224,protein format,O=C(C[C@H]1C[C@H](c2cccc(Cl)c2)[C@@H](c2ccc(Cl)cc2)N(CC2CC2)C1=O)NO,,,CHEMBL3886611,,2016,"{'bei': '12.90', 'le': '0.26', 'lle': '0.80', 'sei': '8.28'}",CHEMBL4109441,,CHEMBL4109441,5.77,False,http://www.openphacts.org/units/Nanomolar,2869333,=,37,True,=,,IC50,nM,,1700.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,1700.0
378381,17752001,[],CHEMBL3888179,"Homogenous Time-Resolved Fluorescence Assay (HTRF1 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 2.5 nM GST-hMDM2 (aa 1-188), 5 nM biotinylated-p53 (aa 1-83), 1.8 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 200 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.",B,,,BAO_0000190,BAO_0000224,protein format,CCOC(=O)[C@H](CC)N1C(=O)[C@@H](CC(=O)NS(C)(=O)=O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1,,,CHEMBL3886611,,2016,"{'bei': '12.09', 'le': '0.25', 'lle': '2.42', 'sei': '6.27'}",CHEMBL4109575,,CHEMBL4109575,6.89,False,http://www.openphacts.org/units/Nanomolar,2869334,=,37,True,=,,IC50,nM,,130.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,130.0
378382,17752002,[],CHEMBL3888179,"Homogenous Time-Resolved Fluorescence Assay (HTRF1 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 2.5 nM GST-hMDM2 (aa 1-188), 5 nM biotinylated-p53 (aa 1-83), 1.8 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 200 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.",B,,,BAO_0000190,BAO_0000224,protein format,CCOC(=O)[C@H](CC)N1C(=O)[C@@H](CC(=O)NCCCN2CCOCC2)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1,,,CHEMBL3886611,,2016,"{'bei': '9.18', 'le': '0.18', 'lle': '0.44', 'sei': '6.44'}",CHEMBL4109586,,CHEMBL4109586,5.68,False,http://www.openphacts.org/units/Nanomolar,2869335,=,37,True,=,,IC50,nM,,2090.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,2090.0
378383,17752003,[],CHEMBL3888179,"Homogenous Time-Resolved Fluorescence Assay (HTRF1 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 2.5 nM GST-hMDM2 (aa 1-188), 5 nM biotinylated-p53 (aa 1-83), 1.8 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 200 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.",B,,,BAO_0000190,BAO_0000224,protein format,O=C1[C@@H](Cc2nnn[nH]2)C[C@H](c2cccc(Cl)c2)[C@@H](c2ccc(Cl)cc2)N1CC1CC1,,,CHEMBL3886611,,2016,"{'bei': '15.44', 'le': '0.31', 'lle': '2.22', 'sei': '9.42'}",CHEMBL2177185,,CHEMBL2177185,7.05,False,http://www.openphacts.org/units/Nanomolar,2869336,=,37,True,=,,IC50,nM,,90.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,90.0
378384,17752004,[],CHEMBL3888179,"Homogenous Time-Resolved Fluorescence Assay (HTRF1 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 2.5 nM GST-hMDM2 (aa 1-188), 5 nM biotinylated-p53 (aa 1-83), 1.8 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 200 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.",B,,,BAO_0000190,BAO_0000224,protein format,CC[C@@H](C(=O)OC(C)(C)C)N1C(=O)[C@@H](Cc2nnco2)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1,,,CHEMBL3886611,,2016,"{'bei': '10.51', 'le': '0.21', 'lle': '-0.69', 'sei': '6.69'}",CHEMBL4109962,,CHEMBL4109962,5.72,False,http://www.openphacts.org/units/Nanomolar,2869337,=,37,True,=,,IC50,nM,,1890.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,1890.0
378385,17752005,[],CHEMBL3888179,"Homogenous Time-Resolved Fluorescence Assay (HTRF1 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 2.5 nM GST-hMDM2 (aa 1-188), 5 nM biotinylated-p53 (aa 1-83), 1.8 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 200 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.",B,,,BAO_0000190,BAO_0000224,protein format,Cc1nnc(C[C@H]2C[C@H](c3cccc(Cl)c3)[C@@H](c3ccc(Cl)cc3)N(CC3CC3)C2=O)o1,,,CHEMBL3886611,,2016,"{'bei': '12.32', 'le': '0.25', 'lle': '-0.21', 'sei': '9.79'}",CHEMBL4110956,,CHEMBL4110956,5.80,False,http://www.openphacts.org/units/Nanomolar,2869338,=,37,True,=,,IC50,nM,,1600.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,1600.0
378386,17752006,[],CHEMBL3888179,"Homogenous Time-Resolved Fluorescence Assay (HTRF1 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 2.5 nM GST-hMDM2 (aa 1-188), 5 nM biotinylated-p53 (aa 1-83), 1.8 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 200 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.",B,,,BAO_0000190,BAO_0000224,protein format,CS(=O)(=O)NC(=O)C[C@@H]1CC(c2cccc(Cl)c2)[C@@H](c2ccc(Cl)cc2)N(CC2CC2)C1=O,,,CHEMBL3886611,,2016,"{'bei': '12.08', 'le': '0.25', 'lle': '1.61', 'sei': '7.37'}",CHEMBL3894955,,CHEMBL3894955,6.16,False,http://www.openphacts.org/units/Nanomolar,2869339,=,37,True,=,,IC50,nM,,700.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,700.0
378387,17752007,[],CHEMBL3888179,"Homogenous Time-Resolved Fluorescence Assay (HTRF1 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 2.5 nM GST-hMDM2 (aa 1-188), 5 nM biotinylated-p53 (aa 1-83), 1.8 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 200 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.",B,,,BAO_0000190,BAO_0000224,protein format,NC(=O)C[C@@H]1C[C@H](c2cccc(Cl)c2)[C@@H](c2ccc(Cl)cc2)N(CC2CC2)C1=O,,,CHEMBL3886611,,2016,"{'bei': '14.05', 'le': '0.29', 'lle': '1.11', 'sei': '9.56'}",CHEMBL3947579,,CHEMBL3947579,6.06,False,http://www.openphacts.org/units/Nanomolar,2869340,=,37,True,=,,IC50,nM,,870.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,870.0
378388,17752008,[],CHEMBL3888179,"Homogenous Time-Resolved Fluorescence Assay (HTRF1 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 2.5 nM GST-hMDM2 (aa 1-188), 5 nM biotinylated-p53 (aa 1-83), 1.8 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 200 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.",B,,,BAO_0000190,BAO_0000224,protein format,O=C1[C@H](Cc2nnn[nH]2)C[C@H](c2cccc(Cl)c2)[C@@H](c2ccc(Cl)cc2)N1CC1CC1,,,CHEMBL3886611,,2016,"{'bei': '14.89', 'le': '0.30', 'lle': '1.97', 'sei': '9.09'}",CHEMBL3979952,,CHEMBL3979952,6.80,False,http://www.openphacts.org/units/Nanomolar,2869341,=,37,True,=,,IC50,nM,,160.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,160.0
378389,17752009,[],CHEMBL3888179,"Homogenous Time-Resolved Fluorescence Assay (HTRF1 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 2.5 nM GST-hMDM2 (aa 1-188), 5 nM biotinylated-p53 (aa 1-83), 1.8 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 200 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.",B,,,BAO_0000190,BAO_0000224,protein format,Cc1cc(C[C@@H]2C[C@H](c3cccc(Cl)c3)[C@@H](c3ccc(Cl)cc3)N(CC3CC3)C2=O)no1,,,CHEMBL3886611,,2016,"{'bei': '13.87', 'le': '0.28', 'lle': '-0.11', 'sei': '14.05'}",CHEMBL4108982,,CHEMBL4108982,6.51,False,http://www.openphacts.org/units/Nanomolar,2869342,=,37,True,=,,IC50,nM,,310.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,310.0
378390,17752010,[],CHEMBL3888179,"Homogenous Time-Resolved Fluorescence Assay (HTRF1 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 2.5 nM GST-hMDM2 (aa 1-188), 5 nM biotinylated-p53 (aa 1-83), 1.8 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 200 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.",B,,,BAO_0000190,BAO_0000224,protein format,O=C(O)C[C@H]1C[C@H](c2cccc(Cl)c2)[C@]2(C(=O)Nc3cc(Cl)ccc32)N(CC2CC2)C1=O,,,CHEMBL3886611,,2016,"{'bei': '14.88', 'le': '0.30', 'lle': '2.39', 'sei': '8.13'}",CHEMBL4109769,,CHEMBL4109769,7.05,False,http://www.openphacts.org/units/Nanomolar,2869343,=,37,True,=,,IC50,nM,,90.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,90.0
378391,17752011,[],CHEMBL3888179,"Homogenous Time-Resolved Fluorescence Assay (HTRF1 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 2.5 nM GST-hMDM2 (aa 1-188), 5 nM biotinylated-p53 (aa 1-83), 1.8 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 200 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.",B,,,BAO_0000190,BAO_0000224,protein format,O=C(O)C[C@H]1C[C@H](c2cccc(Cl)c2)[C@@H](c2ccc(Cl)s2)C(CC2CC2)C1=O,,,CHEMBL3886611,,2016,"{'bei': '14.56', 'le': '0.31', 'lle': '-0.03', 'sei': '11.71'}",CHEMBL4108877,,CHEMBL4108877,6.37,False,http://www.openphacts.org/units/Nanomolar,2869344,=,37,True,=,,IC50,nM,,430.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,430.0
378392,17752012,[],CHEMBL3888179,"Homogenous Time-Resolved Fluorescence Assay (HTRF1 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 2.5 nM GST-hMDM2 (aa 1-188), 5 nM biotinylated-p53 (aa 1-83), 1.8 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 200 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.",B,,,BAO_0000190,BAO_0000224,protein format,O=C(O)C[C@@H]1CC(c2cccc(Cl)c2)[C@@H](c2ccc(Cl)s2)N(CC2CC2)C1=O,,,CHEMBL3886611,,2016,"{'bei': '15.19', 'le': '0.32', 'lle': '1.05', 'sei': '11.56'}",CHEMBL3955799,,CHEMBL3955799,6.66,False,http://www.openphacts.org/units/Nanomolar,2869345,=,37,True,=,,IC50,nM,,220.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,220.0
378393,17752013,[],CHEMBL3888179,"Homogenous Time-Resolved Fluorescence Assay (HTRF1 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 2.5 nM GST-hMDM2 (aa 1-188), 5 nM biotinylated-p53 (aa 1-83), 1.8 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 200 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.",B,,,BAO_0000190,BAO_0000224,protein format,CCOC(=O)[C@H](CC)N1C(=O)[C@@](C)(CC(=O)O)CC(c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1,,,CHEMBL3886611,,2016,"{'bei': '15.20', 'le': '0.31', 'lle': '1.83', 'sei': '9.18'}",CHEMBL3926383,,CHEMBL3926383,7.70,False,http://www.openphacts.org/units/Nanomolar,2869346,=,37,True,=,,IC50,nM,,20.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,20.0
378394,17752014,[],CHEMBL3888179,"Homogenous Time-Resolved Fluorescence Assay (HTRF1 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 2.5 nM GST-hMDM2 (aa 1-188), 5 nM biotinylated-p53 (aa 1-83), 1.8 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 200 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.",B,,,BAO_0000190,BAO_0000224,protein format,CC[C@@H](C(=O)OC(C)(C)C)N1C(=O)[C@](C)(CC(=O)O)CC(c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1,,,CHEMBL3886611,,2016,"{'bei': '12.18', 'le': '0.25', 'lle': '-0.14', 'sei': '7.76'}",CHEMBL3953174,,CHEMBL3953174,6.51,False,http://www.openphacts.org/units/Nanomolar,2869347,=,37,True,=,,IC50,nM,,310.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,310.0
378395,17752015,[],CHEMBL3888179,"Homogenous Time-Resolved Fluorescence Assay (HTRF1 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 2.5 nM GST-hMDM2 (aa 1-188), 5 nM biotinylated-p53 (aa 1-83), 1.8 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 200 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.",B,,,BAO_0000190,BAO_0000224,protein format,CC[C@@H](C(=O)OC(C)(C)C)N1C(=O)[C@@](C)(CC(=O)O)CC(c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1,,,CHEMBL3886611,,2016,"{'bei': '14.40', 'le': '0.29', 'lle': '1.05', 'sei': '9.18'}",CHEMBL3964670,,CHEMBL3964670,7.70,False,http://www.openphacts.org/units/Nanomolar,2869348,=,37,True,=,,IC50,nM,,20.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,20.0
378396,17752016,[],CHEMBL3888179,"Homogenous Time-Resolved Fluorescence Assay (HTRF1 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 2.5 nM GST-hMDM2 (aa 1-188), 5 nM biotinylated-p53 (aa 1-83), 1.8 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 200 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.",B,,,BAO_0000190,BAO_0000224,protein format,CC[C@@H](COCC1CC1)N1C(=O)[C@@](C)(CC(=O)O)CC(c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1,,,CHEMBL3886611,,2016,"{'bei': '14.51', 'le': '0.29', 'lle': '0.78', 'sei': '11.26'}",CHEMBL3930864,,CHEMBL3930864,7.52,False,http://www.openphacts.org/units/Nanomolar,2869349,=,37,True,=,,IC50,nM,,30.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,30.0
378397,17752017,[],CHEMBL3888179,"Homogenous Time-Resolved Fluorescence Assay (HTRF1 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 2.5 nM GST-hMDM2 (aa 1-188), 5 nM biotinylated-p53 (aa 1-83), 1.8 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 200 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.",B,,,BAO_0000190,BAO_0000224,protein format,O=C(O)C[C@@]1(CCN2CCCC2)C[C@H](c2cccc(Cl)c2)[C@@H](c2ccc(Cl)cc2)N(CC2CC2)C1=O,,,CHEMBL3886611,,2016,"{'bei': '13.64', 'le': '0.27', 'lle': '0.81', 'sei': '11.87'}",CHEMBL4115245,,CHEMBL4115245,7.22,False,http://www.openphacts.org/units/Nanomolar,2869350,=,37,True,=,,IC50,nM,,60.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,60.0
378398,17752018,[],CHEMBL3888179,"Homogenous Time-Resolved Fluorescence Assay (HTRF1 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 2.5 nM GST-hMDM2 (aa 1-188), 5 nM biotinylated-p53 (aa 1-83), 1.8 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 200 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.",B,,,BAO_0000190,BAO_0000224,protein format,O=C(O)C[C@@]1(CCN2CCOCC2)C[C@H](c2cccc(Cl)c2)[C@@H](c2ccc(Cl)cc2)N(CC2CC2)C1=O,,,CHEMBL3886611,,2016,"{'bei': '12.62', 'le': '0.25', 'lle': '1.25', 'sei': '9.83'}",CHEMBL4112059,,CHEMBL4112059,6.89,False,http://www.openphacts.org/units/Nanomolar,2869351,=,37,True,=,,IC50,nM,,130.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,130.0
378399,17752019,[],CHEMBL3888179,"Homogenous Time-Resolved Fluorescence Assay (HTRF1 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 2.5 nM GST-hMDM2 (aa 1-188), 5 nM biotinylated-p53 (aa 1-83), 1.8 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 200 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.",B,,,BAO_0000190,BAO_0000224,protein format,CCC(CC)N1C(=O)[C@@](C)(CC(=O)O)CC(c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1,,,CHEMBL3886611,,2016,"{'bei': '16.65', 'le': '0.34', 'lle': '0.98', 'sei': '13.36'}",CHEMBL4111833,,CHEMBL4111833,7.70,False,http://www.openphacts.org/units/Nanomolar,2869352,=,37,True,=,,IC50,nM,,20.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,20.0
378400,17752020,[],CHEMBL3888179,"Homogenous Time-Resolved Fluorescence Assay (HTRF1 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 2.5 nM GST-hMDM2 (aa 1-188), 5 nM biotinylated-p53 (aa 1-83), 1.8 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 200 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.",B,,,BAO_0000190,BAO_0000224,protein format,C[C@]1(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@@H](c2ccc(Cl)cc2)N(CC2CC2)C1=O,,,CHEMBL3886611,,2016,"{'bei': '16.18', 'le': '0.33', 'lle': '1.28', 'sei': '12.54'}",CHEMBL3927443,,CHEMBL3927443,7.22,False,http://www.openphacts.org/units/Nanomolar,2869353,=,37,True,=,,IC50,nM,,60.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,60.0
378401,17752021,[],CHEMBL3888179,"Homogenous Time-Resolved Fluorescence Assay (HTRF1 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 2.5 nM GST-hMDM2 (aa 1-188), 5 nM biotinylated-p53 (aa 1-83), 1.8 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 200 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.",B,,,BAO_0000190,BAO_0000224,protein format,CC(C)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1,,,CHEMBL3886611,,2016,"{'bei': '17.32', 'le': '0.35', 'lle': '1.58', 'sei': '13.06'}",CHEMBL3329620,,CHEMBL3329620,7.52,False,http://www.openphacts.org/units/Nanomolar,2869354,=,37,True,=,,IC50,nM,,30.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,30.0
378402,17752022,[],CHEMBL3888179,"Homogenous Time-Resolved Fluorescence Assay (HTRF1 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 2.5 nM GST-hMDM2 (aa 1-188), 5 nM biotinylated-p53 (aa 1-83), 1.8 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 200 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.",B,,,BAO_0000190,BAO_0000224,protein format,C[C@]1(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@@H](c2ccc(Cl)cc2)N(C2CCC2)C1=O,,,CHEMBL3886611,,2016,"{'bei': '16.03', 'le': '0.33', 'lle': '1.07', 'sei': '12.42'}",CHEMBL3941435,,CHEMBL3941435,7.16,False,http://www.openphacts.org/units/Nanomolar,2869355,=,37,True,=,,IC50,nM,,70.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,70.0
378403,17752023,[],CHEMBL3888179,"Homogenous Time-Resolved Fluorescence Assay (HTRF1 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 2.5 nM GST-hMDM2 (aa 1-188), 5 nM biotinylated-p53 (aa 1-83), 1.8 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 200 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.",B,,,BAO_0000190,BAO_0000224,protein format,C[C@]1(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@@H](c2ccc(Cl)cc2)N(C2CCCC2)C1=O,,,CHEMBL3886611,,2016,"{'bei': '16.34', 'le': '0.33', 'lle': '1.05', 'sei': '13.06'}",CHEMBL3929164,,CHEMBL3929164,7.52,False,http://www.openphacts.org/units/Nanomolar,2869356,=,37,True,=,,IC50,nM,,30.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,30.0
378404,17752024,[],CHEMBL3888179,"Homogenous Time-Resolved Fluorescence Assay (HTRF1 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 2.5 nM GST-hMDM2 (aa 1-188), 5 nM biotinylated-p53 (aa 1-83), 1.8 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 200 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.",B,,,BAO_0000190,BAO_0000224,protein format,CCC(CC)N1C(=O)[C@@](C)(Cc2n[nH]c(=O)[nH]2)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1,,,CHEMBL3886611,,2016,"{'bei': '13.28', 'le': '0.27', 'lle': '0.76', 'sei': '8.13'}",CHEMBL4109978,,CHEMBL4109978,6.66,False,http://www.openphacts.org/units/Nanomolar,2869357,=,37,True,=,,IC50,nM,,220.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,220.0
378405,17752025,[],CHEMBL3888179,"Homogenous Time-Resolved Fluorescence Assay (HTRF1 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 2.5 nM GST-hMDM2 (aa 1-188), 5 nM biotinylated-p53 (aa 1-83), 1.8 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 200 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.",B,,,BAO_0000190,BAO_0000224,protein format,CCC(CC)N1C(=O)[C@@](C)(Cc2n[nH]c(=O)o2)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1,,,CHEMBL3886611,,2016,"{'bei': '13.11', 'le': '0.26', 'lle': '0.43', 'sei': '8.31'}",CHEMBL4114646,,CHEMBL4114646,6.58,False,http://www.openphacts.org/units/Nanomolar,2869358,=,37,True,=,,IC50,nM,,260.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,260.0
378406,17752026,[],CHEMBL3888179,"Homogenous Time-Resolved Fluorescence Assay (HTRF1 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 2.5 nM GST-hMDM2 (aa 1-188), 5 nM biotinylated-p53 (aa 1-83), 1.8 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 200 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.",B,,,BAO_0000190,BAO_0000224,protein format,CCC(CC)N1C(=O)[C@@](C)(CC(=O)NS(=O)(=O)C(F)(F)F)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1,,,CHEMBL3886611,,2016,"{'bei': '10.57', 'le': '0.23', 'lle': '-0.32', 'sei': '7.51'}",CHEMBL4109543,,CHEMBL4109543,6.28,False,http://www.openphacts.org/units/Nanomolar,2869359,=,37,True,=,,IC50,nM,,530.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,530.0
378407,17752027,[],CHEMBL3888179,"Homogenous Time-Resolved Fluorescence Assay (HTRF1 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 2.5 nM GST-hMDM2 (aa 1-188), 5 nM biotinylated-p53 (aa 1-83), 1.8 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 200 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.",B,,,BAO_0000190,BAO_0000224,protein format,CCC(CC)N1C(=O)[C@@](C)(Cc2cc(O)n[nH]2)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1,,,CHEMBL3886611,,2016,"{'bei': '12.46', 'le': '0.25', 'lle': '-0.68', 'sei': '9.01'}",CHEMBL4108935,,CHEMBL4108935,6.24,False,http://www.openphacts.org/units/Nanomolar,2869360,=,37,True,=,,IC50,nM,,580.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,580.0
378408,17752028,[],CHEMBL3888179,"Homogenous Time-Resolved Fluorescence Assay (HTRF1 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 2.5 nM GST-hMDM2 (aa 1-188), 5 nM biotinylated-p53 (aa 1-83), 1.8 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 200 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.",B,,,BAO_0000190,BAO_0000224,protein format,CCC(CC)N1C(=O)[C@@](C)(Cc2cc(O)no2)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1,,,CHEMBL3886611,,2016,"{'bei': '14.15', 'le': '0.29', 'lle': '-0.08', 'sei': '10.66'}",CHEMBL4110925,,CHEMBL4110925,7.10,False,http://www.openphacts.org/units/Nanomolar,2869361,=,37,True,=,,IC50,nM,,80.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,80.0
378409,17752029,[],CHEMBL3888179,"Homogenous Time-Resolved Fluorescence Assay (HTRF1 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 2.5 nM GST-hMDM2 (aa 1-188), 5 nM biotinylated-p53 (aa 1-83), 1.8 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 200 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.",B,,,BAO_0000190,BAO_0000224,protein format,CCC(CC)N1C(=O)[C@@](C)(CC2OC(=O)NC2=O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1,,,CHEMBL3886611,,2016,"{'bei': '12.19', 'le': '0.25', 'lle': '0.04', 'sei': '8.33'}",CHEMBL4108531,,CHEMBL4108531,6.31,False,http://www.openphacts.org/units/Nanomolar,2869362,=,37,True,=,,IC50,nM,,490.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,490.0
378410,17752030,[],CHEMBL3888179,"Homogenous Time-Resolved Fluorescence Assay (HTRF1 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 2.5 nM GST-hMDM2 (aa 1-188), 5 nM biotinylated-p53 (aa 1-83), 1.8 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 200 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.",B,,,BAO_0000190,BAO_0000224,protein format,CCC(CC)N1C(=O)[C@@](C)(Cc2noc(=O)[nH]2)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1,,,CHEMBL3886611,,2016,"{'bei': '15.32', 'le': '0.31', 'lle': '1.54', 'sei': '9.72'}",CHEMBL4107285,,CHEMBL4107285,7.70,False,http://www.openphacts.org/units/Nanomolar,2869363,=,37,True,=,,IC50,nM,,20.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,20.0
378411,17752031,[],CHEMBL3888179,"Homogenous Time-Resolved Fluorescence Assay (HTRF1 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 2.5 nM GST-hMDM2 (aa 1-188), 5 nM biotinylated-p53 (aa 1-83), 1.8 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 200 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.",B,,,BAO_0000190,BAO_0000224,protein format,CC(C)N1C(=O)[C@@](C)(Cc2noc(=O)[nH]2)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1,,,CHEMBL3886611,,2016,"{'bei': '15.86', 'le': '0.32', 'lle': '2.14', 'sei': '9.50'}",CHEMBL4114346,,CHEMBL4114346,7.52,False,http://www.openphacts.org/units/Nanomolar,2869364,=,37,True,=,,IC50,nM,,30.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,30.0
378412,17752032,[],CHEMBL3888179,"Homogenous Time-Resolved Fluorescence Assay (HTRF1 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 2.5 nM GST-hMDM2 (aa 1-188), 5 nM biotinylated-p53 (aa 1-83), 1.8 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 200 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.",B,,,BAO_0000190,BAO_0000224,protein format,CCC(CC)N1C(=O)[C@@](C)(Cc2nsc(=O)[nH]2)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1,,,CHEMBL3886611,,2016,"{'bei': '11.10', 'le': '0.23', 'lle': '-0.88', 'sei': '8.71'}",CHEMBL4112284,,CHEMBL4112284,5.75,False,http://www.openphacts.org/units/Nanomolar,2869365,=,37,True,=,,IC50,nM,,1760.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,1760.0
378413,17752033,[],CHEMBL3888179,"Homogenous Time-Resolved Fluorescence Assay (HTRF1 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 2.5 nM GST-hMDM2 (aa 1-188), 5 nM biotinylated-p53 (aa 1-83), 1.8 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 200 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.",B,,,BAO_0000190,BAO_0000224,protein format,CC(C)N1C(=O)[C@@](C)(Cc2nsc(=O)[nH]2)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1,,,CHEMBL3886611,,2016,"{'bei': '11.63', 'le': '0.24', 'lle': '-0.15', 'sei': '8.63'}",CHEMBL4114447,,CHEMBL4114447,5.70,False,http://www.openphacts.org/units/Nanomolar,2869366,=,37,True,=,,IC50,nM,,1980.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,1980.0
378414,17752034,[],CHEMBL3888179,"Homogenous Time-Resolved Fluorescence Assay (HTRF1 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 2.5 nM GST-hMDM2 (aa 1-188), 5 nM biotinylated-p53 (aa 1-83), 1.8 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 200 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.",B,,,BAO_0000190,BAO_0000224,protein format,CC(C)N1C(=O)[C@@](C)(Cc2nnn[nH]2)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1,,,CHEMBL3886611,,2016,"{'bei': '17.45', 'le': '0.35', 'lle': '2.78', 'sei': '10.70'}",CHEMBL4107290,,CHEMBL4107290,8.00,False,http://www.openphacts.org/units/Nanomolar,2869367,=,37,True,=,,IC50,nM,,10.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,10.0
378415,17752035,[],CHEMBL3888179,"Homogenous Time-Resolved Fluorescence Assay (HTRF1 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 2.5 nM GST-hMDM2 (aa 1-188), 5 nM biotinylated-p53 (aa 1-83), 1.8 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 200 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.",B,,,BAO_0000190,BAO_0000224,protein format,CCC(CC)N1C(=O)[C@@](CC)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1,,,CHEMBL3886611,,2016,"{'bei': '16.16', 'le': '0.33', 'lle': '0.59', 'sei': '13.36'}",CHEMBL4108954,,CHEMBL4108954,7.70,False,http://www.openphacts.org/units/Nanomolar,2869368,=,37,True,=,,IC50,nM,,20.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,20.0
378416,17752036,[],CHEMBL3888179,"Homogenous Time-Resolved Fluorescence Assay (HTRF1 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 2.5 nM GST-hMDM2 (aa 1-188), 5 nM biotinylated-p53 (aa 1-83), 1.8 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 200 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.",B,,,BAO_0000190,BAO_0000224,protein format,CCC(CC)N1C(=O)[C@@](C)(CS(C)(=O)=O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1,,,CHEMBL3886611,,2016,"{'bei': '12.24', 'le': '0.26', 'lle': '-0.21', 'sei': '11.16'}",CHEMBL4107240,,CHEMBL4107240,6.08,False,http://www.openphacts.org/units/Nanomolar,2869369,=,37,True,=,,IC50,nM,,840.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,840.0
378417,17752037,[],CHEMBL3888179,"Homogenous Time-Resolved Fluorescence Assay (HTRF1 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 2.5 nM GST-hMDM2 (aa 1-188), 5 nM biotinylated-p53 (aa 1-83), 1.8 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 200 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.",B,,,BAO_0000190,BAO_0000224,protein format,CC[C@@H](c1nc(C2CC2)no1)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1,,,CHEMBL3886611,,2016,"{'bei': '13.08', 'le': '0.26', 'lle': '0.16', 'sei': '7.35'}",CHEMBL4113210,,CHEMBL4113210,7.10,False,http://www.openphacts.org/units/Nanomolar,2869370,=,37,True,=,,IC50,nM,,80.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,80.0
378418,17752038,[],CHEMBL3888179,"Homogenous Time-Resolved Fluorescence Assay (HTRF1 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 2.5 nM GST-hMDM2 (aa 1-188), 5 nM biotinylated-p53 (aa 1-83), 1.8 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 200 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.",B,,,BAO_0000190,BAO_0000224,protein format,CC[C@H](c1nc(C2CC2)no1)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1,,,CHEMBL3886611,,2016,"{'bei': '13.64', 'le': '0.27', 'lle': '0.46', 'sei': '7.66'}",CHEMBL4112052,,CHEMBL4112052,7.40,False,http://www.openphacts.org/units/Nanomolar,2869371,=,37,True,=,,IC50,nM,,40.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,40.0
378419,17752039,[],CHEMBL3888179,"Homogenous Time-Resolved Fluorescence Assay (HTRF1 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 2.5 nM GST-hMDM2 (aa 1-188), 5 nM biotinylated-p53 (aa 1-83), 1.8 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 200 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.",B,,,BAO_0000190,BAO_0000224,protein format,CC[C@@H](CN1CCOCC1)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1,,,CHEMBL3886611,,2016,"{'bei': '15.00', 'le': '0.30', 'lle': '2.36', 'sei': '11.42'}",CHEMBL3894532,,CHEMBL3894532,8.00,False,http://www.openphacts.org/units/Nanomolar,2869372,=,37,True,=,,IC50,nM,,10.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,10.0
378420,17752040,[],CHEMBL3888179,"Homogenous Time-Resolved Fluorescence Assay (HTRF1 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 2.5 nM GST-hMDM2 (aa 1-188), 5 nM biotinylated-p53 (aa 1-83), 1.8 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 200 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.",B,,,BAO_0000190,BAO_0000224,protein format,CC[C@@H](CNCC(F)(F)F)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1,,,CHEMBL3886611,,2016,"{'bei': '13.56', 'le': '0.28', 'lle': '0.94', 'sei': '10.62'}",CHEMBL3919031,,CHEMBL3919031,7.40,False,http://www.openphacts.org/units/Nanomolar,2869373,=,37,True,=,,IC50,nM,,40.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,40.0
378421,17752041,[],CHEMBL3888179,"Homogenous Time-Resolved Fluorescence Assay (HTRF1 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 2.5 nM GST-hMDM2 (aa 1-188), 5 nM biotinylated-p53 (aa 1-83), 1.8 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 200 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.",B,,,BAO_0000190,BAO_0000224,protein format,CC[C@@H](CN1CCOC(C)(C)C1)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1,,,CHEMBL3886611,,2016,"{'bei': '14.25', 'le': '0.29', 'lle': '1.58', 'sei': '11.42'}",CHEMBL3980222,,CHEMBL3980222,8.00,False,http://www.openphacts.org/units/Nanomolar,2869374,=,37,True,=,,IC50,nM,,10.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,10.0
378422,17752042,[],CHEMBL3888179,"Homogenous Time-Resolved Fluorescence Assay (HTRF1 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 2.5 nM GST-hMDM2 (aa 1-188), 5 nM biotinylated-p53 (aa 1-83), 1.8 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 200 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.",B,,,BAO_0000190,BAO_0000224,protein format,CC[C@@H](CN1CC(C)OC(C)C1)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1,,,CHEMBL3886611,,2016,"{'bei': '14.25', 'le': '0.29', 'lle': '1.58', 'sei': '11.42'}",CHEMBL3910104,,CHEMBL3910104,8.00,False,http://www.openphacts.org/units/Nanomolar,2869375,=,37,True,=,,IC50,nM,,10.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,10.0
378423,17752043,[],CHEMBL3888179,"Homogenous Time-Resolved Fluorescence Assay (HTRF1 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 2.5 nM GST-hMDM2 (aa 1-188), 5 nM biotinylated-p53 (aa 1-83), 1.8 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 200 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.",B,,,BAO_0000190,BAO_0000224,protein format,CC[C@@H](CN1CCN(S(=O)(=O)C2CC2)CC1)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1,,,CHEMBL3886611,,2016,"{'bei': '11.82', 'le': '0.24', 'lle': '2.10', 'sei': '7.66'}",CHEMBL3972181,,CHEMBL3972181,7.52,False,http://www.openphacts.org/units/Nanomolar,2869376,=,37,True,=,,IC50,nM,,30.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,30.0
378424,17752044,[],CHEMBL3888179,"Homogenous Time-Resolved Fluorescence Assay (HTRF1 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 2.5 nM GST-hMDM2 (aa 1-188), 5 nM biotinylated-p53 (aa 1-83), 1.8 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 200 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.",B,,,BAO_0000190,BAO_0000224,protein format,CC[C@@H](CN1CCN(S(C)(=O)=O)CC1)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1,,,CHEMBL3886611,,2016,"{'bei': '12.61', 'le': '0.26', 'lle': '2.81', 'sei': '7.84'}",CHEMBL3904550,,CHEMBL3904550,7.70,False,http://www.openphacts.org/units/Nanomolar,2869377,=,37,True,=,,IC50,nM,,20.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,20.0
378425,17752045,[],CHEMBL3888179,"Homogenous Time-Resolved Fluorescence Assay (HTRF1 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 2.5 nM GST-hMDM2 (aa 1-188), 5 nM biotinylated-p53 (aa 1-83), 1.8 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 200 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.",B,,,BAO_0000190,BAO_0000224,protein format,CC[C@@H](CN1CCN(C(C)=O)CC1)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1,,,CHEMBL3886611,,2016,"{'bei': '13.92', 'le': '0.28', 'lle': '2.53', 'sei': '9.86'}",CHEMBL3966894,,CHEMBL3966894,8.00,False,http://www.openphacts.org/units/Nanomolar,2869378,=,37,True,=,,IC50,nM,,10.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,10.0
378426,17752046,[],CHEMBL3888179,"Homogenous Time-Resolved Fluorescence Assay (HTRF1 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 2.5 nM GST-hMDM2 (aa 1-188), 5 nM biotinylated-p53 (aa 1-83), 1.8 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 200 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.",B,,,BAO_0000190,BAO_0000224,protein format,CC[C@@H](CN1CCN(C(=O)C2CC2)CC1)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1,,,CHEMBL3886611,,2016,"{'bei': '13.32', 'le': '0.27', 'lle': '2.14', 'sei': '9.86'}",CHEMBL3895600,,CHEMBL3895600,8.00,False,http://www.openphacts.org/units/Nanomolar,2869379,=,37,True,=,,IC50,nM,,10.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,10.0
378427,17752047,[],CHEMBL3888179,"Homogenous Time-Resolved Fluorescence Assay (HTRF1 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 2.5 nM GST-hMDM2 (aa 1-188), 5 nM biotinylated-p53 (aa 1-83), 1.8 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 200 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.",B,,,BAO_0000190,BAO_0000224,protein format,CC[C@@H](CN1CCOCC1)N1C(=O)[C@@](C)(Cc2noc(=O)[nH]2)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1,,,CHEMBL3886611,,2016,"{'bei': '13.95', 'le': '0.28', 'lle': '2.91', 'sei': '8.73'}",CHEMBL3963943,,CHEMBL3963943,8.00,False,http://www.openphacts.org/units/Nanomolar,2869380,=,37,True,=,,IC50,nM,,10.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,10.0
378428,17752048,[],CHEMBL3888179,"Homogenous Time-Resolved Fluorescence Assay (HTRF1 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 2.5 nM GST-hMDM2 (aa 1-188), 5 nM biotinylated-p53 (aa 1-83), 1.8 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 200 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.",B,,,BAO_0000190,BAO_0000224,protein format,CC[C@@H](CN1CC(C)(C)OC1=O)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1,,,CHEMBL3886611,,2016,"{'bei': '13.71', 'le': '0.28', 'lle': '1.16', 'sei': '8.83'}",CHEMBL3926751,,CHEMBL3926751,7.70,False,http://www.openphacts.org/units/Nanomolar,2869381,=,37,True,=,,IC50,nM,,20.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,20.0
378429,17752049,[],CHEMBL3888179,"Homogenous Time-Resolved Fluorescence Assay (HTRF1 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 2.5 nM GST-hMDM2 (aa 1-188), 5 nM biotinylated-p53 (aa 1-83), 1.8 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 200 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.",B,,,BAO_0000190,BAO_0000224,protein format,CC[C@@H](C(=O)NC(C)(C)C)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1,,,CHEMBL3886611,,2016,"{'bei': '14.43', 'le': '0.29', 'lle': '1.48', 'sei': '8.88'}",CHEMBL4107660,,CHEMBL4107660,7.70,False,http://www.openphacts.org/units/Nanomolar,2869382,=,37,True,=,,IC50,nM,,20.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,20.0
378430,17752050,[],CHEMBL3888179,"Homogenous Time-Resolved Fluorescence Assay (HTRF1 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 2.5 nM GST-hMDM2 (aa 1-188), 5 nM biotinylated-p53 (aa 1-83), 1.8 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 200 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.",B,,,BAO_0000190,BAO_0000224,protein format,C[C@]1(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@@H](c2ccc(Cl)cc2)N([C@H]2CC[C@@H](O)[C@H]2O)C1=O,,,CHEMBL3886611,,2016,"{'bei': '14.83', 'le': '0.30', 'lle': '2.88', 'sei': '7.44'}",CHEMBL4114636,,CHEMBL4114636,7.30,False,http://www.openphacts.org/units/Nanomolar,2869383,=,37,True,=,,IC50,nM,,50.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,50.0
378431,17752051,[],CHEMBL3888179,"Homogenous Time-Resolved Fluorescence Assay (HTRF1 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 2.5 nM GST-hMDM2 (aa 1-188), 5 nM biotinylated-p53 (aa 1-83), 1.8 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 200 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.",B,,,BAO_0000190,BAO_0000224,protein format,C[C@]1(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@@H](c2ccc(Cl)cc2)N([C@@H]2CC[C@H](O)[C@@H]2O)C1=O,,,CHEMBL3886611,,2016,"{'bei': '13.31', 'le': '0.27', 'lle': '2.13', 'sei': '6.68'}",CHEMBL4111577,,CHEMBL4111577,6.55,False,http://www.openphacts.org/units/Nanomolar,2869384,=,37,True,=,,IC50,nM,,280.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,280.0
378432,17752052,[],CHEMBL3888179,"Homogenous Time-Resolved Fluorescence Assay (HTRF1 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 2.5 nM GST-hMDM2 (aa 1-188), 5 nM biotinylated-p53 (aa 1-83), 1.8 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 200 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.",B,,,BAO_0000190,BAO_0000224,protein format,C[C@]1(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@@H](c2ccc(Cl)cc2)N([C@H]2CCCN(CC(F)(F)F)C2)C1=O,,,CHEMBL3886611,,2016,"{'bei': '13.27', 'le': '0.27', 'lle': '0.84', 'sei': '12.16'}",CHEMBL3926199,,CHEMBL3926199,7.40,False,http://www.openphacts.org/units/Nanomolar,2869385,=,37,True,=,,IC50,nM,,40.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,40.0
378433,17752053,[],CHEMBL3888179,"Homogenous Time-Resolved Fluorescence Assay (HTRF1 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 2.5 nM GST-hMDM2 (aa 1-188), 5 nM biotinylated-p53 (aa 1-83), 1.8 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 200 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.",B,,,BAO_0000190,BAO_0000224,protein format,C[C@]1(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@@H](c2ccc(Cl)cc2)N([C@H]2CCCN(CC(F)(F)F)C2)C1=O,,,CHEMBL3886611,,2016,"{'bei': '10.70', 'le': '0.22', 'lle': '-0.60', 'sei': '9.80'}",CHEMBL3926199,,CHEMBL3926199,5.96,False,http://www.openphacts.org/units/Nanomolar,2869385,=,37,True,=,,IC50,nM,,1090.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,1090.0
378434,17752054,[],CHEMBL3888179,"Homogenous Time-Resolved Fluorescence Assay (HTRF1 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 2.5 nM GST-hMDM2 (aa 1-188), 5 nM biotinylated-p53 (aa 1-83), 1.8 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 200 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.",B,,,BAO_0000190,BAO_0000224,protein format,C[C@]1(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@@H](c2ccc(Cl)cc2)N(C2CC[C@@H](O)C2)C1=O,,,CHEMBL3886611,,2016,"{'bei': '14.11', 'le': '0.29', 'lle': '1.27', 'sei': '8.63'}",CHEMBL4107088,,CHEMBL4107088,6.72,False,http://www.openphacts.org/units/Nanomolar,2869386,=,37,True,=,,IC50,nM,,190.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,190.0
378435,17752055,[],CHEMBL3888179,"Homogenous Time-Resolved Fluorescence Assay (HTRF1 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 2.5 nM GST-hMDM2 (aa 1-188), 5 nM biotinylated-p53 (aa 1-83), 1.8 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 200 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.",B,,,BAO_0000190,BAO_0000224,protein format,C[C@]1(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@@H](c2ccc(Cl)cc2)N(C2CCCOC2)C1=O,,,CHEMBL3886611,,2016,"{'bei': '14.02', 'le': '0.29', 'lle': '0.97', 'sei': '9.99'}",CHEMBL4113463,,CHEMBL4113463,6.68,False,http://www.openphacts.org/units/Nanomolar,2869387,=,37,True,=,,IC50,nM,,210.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,210.0
378436,17752056,[],CHEMBL3888179,"Homogenous Time-Resolved Fluorescence Assay (HTRF1 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 2.5 nM GST-hMDM2 (aa 1-188), 5 nM biotinylated-p53 (aa 1-83), 1.8 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 200 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.",B,,,BAO_0000190,BAO_0000224,protein format,C[C@]1(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@@H](c2ccc(Cl)cc2)N(c2cnccn2)C1=O,,,CHEMBL3886611,,2016,"{'bei': '14.79', 'le': '0.30', 'lle': '1.43', 'sei': '8.34'}",CHEMBL4106459,,CHEMBL4106459,6.96,False,http://www.openphacts.org/units/Nanomolar,2869388,=,37,True,=,,IC50,nM,,110.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,110.0
378437,17752057,[],CHEMBL3888179,"Homogenous Time-Resolved Fluorescence Assay (HTRF1 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 2.5 nM GST-hMDM2 (aa 1-188), 5 nM biotinylated-p53 (aa 1-83), 1.8 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 200 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.",B,,,BAO_0000190,BAO_0000224,protein format,Cn1cc(N2C(=O)[C@@](C)(CC(=O)O)C[C@H](c3cccc(Cl)c3)[C@H]2c2ccc(Cl)cc2)cn1,,,CHEMBL3886611,,2016,"{'bei': '13.81', 'le': '0.28', 'lle': '1.05', 'sei': '8.65'}",CHEMBL4108550,,CHEMBL4108550,6.52,False,http://www.openphacts.org/units/Nanomolar,2869389,=,37,True,=,,IC50,nM,,300.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,300.0
378438,17752058,[],CHEMBL3888179,"Homogenous Time-Resolved Fluorescence Assay (HTRF1 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 2.5 nM GST-hMDM2 (aa 1-188), 5 nM biotinylated-p53 (aa 1-83), 1.8 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 200 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.",B,,,BAO_0000190,BAO_0000224,protein format,C[C@]1(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@@H](c2ccc(Cl)cc2)N(c2ccncn2)C1=O,,,CHEMBL3886611,,2016,"{'bei': '13.75', 'le': '0.28', 'lle': '0.94', 'sei': '7.76'}",CHEMBL4107967,,CHEMBL4107967,6.47,False,http://www.openphacts.org/units/Nanomolar,2869390,=,37,True,=,,IC50,nM,,340.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,340.0
378439,17752059,[],CHEMBL3888179,"Homogenous Time-Resolved Fluorescence Assay (HTRF1 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 2.5 nM GST-hMDM2 (aa 1-188), 5 nM biotinylated-p53 (aa 1-83), 1.8 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 200 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.",B,,,BAO_0000190,BAO_0000224,protein format,C[C@]1(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@@H](c2ccc(Cl)cc2)N(c2ccnc(Cl)n2)C1=O,,,CHEMBL3886611,,2016,"{'bei': '12.31', 'le': '0.26', 'lle': '0.03', 'sei': '7.45'}",CHEMBL4111096,,CHEMBL4111096,6.21,False,http://www.openphacts.org/units/Nanomolar,2869391,=,37,True,=,,IC50,nM,,610.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,610.0
378440,17752060,[],CHEMBL3888179,"Homogenous Time-Resolved Fluorescence Assay (HTRF1 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 2.5 nM GST-hMDM2 (aa 1-188), 5 nM biotinylated-p53 (aa 1-83), 1.8 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 200 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.",B,,,BAO_0000190,BAO_0000224,protein format,C[C@]1(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@@H](c2ccc(Cl)cc2)N(c2ncccn2)C1=O,,,CHEMBL3886611,,2016,"{'bei': '14.11', 'le': '0.28', 'lle': '1.11', 'sei': '7.96'}",CHEMBL4107479,,CHEMBL4107479,6.64,False,http://www.openphacts.org/units/Nanomolar,2869392,=,37,True,=,,IC50,nM,,230.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,230.0
378441,17752061,[],CHEMBL3888179,"Homogenous Time-Resolved Fluorescence Assay (HTRF1 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 2.5 nM GST-hMDM2 (aa 1-188), 5 nM biotinylated-p53 (aa 1-83), 1.8 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 200 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.",B,,,BAO_0000190,BAO_0000224,protein format,Cc1cccnc1N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1,,,CHEMBL3886611,,2016,"{'bei': '15.56', 'le': '0.31', 'lle': '1.08', 'sei': '10.67'}",CHEMBL4110794,,CHEMBL4110794,7.52,False,http://www.openphacts.org/units/Nanomolar,2869393,=,37,True,=,,IC50,nM,,30.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,30.0
378442,17752062,[],CHEMBL3888179,"Homogenous Time-Resolved Fluorescence Assay (HTRF1 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 2.5 nM GST-hMDM2 (aa 1-188), 5 nM biotinylated-p53 (aa 1-83), 1.8 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 200 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.",B,,,BAO_0000190,BAO_0000224,protein format,Cc1ccnc(N2C(=O)[C@@](C)(CC(=O)O)C[C@H](c3cccc(Cl)c3)[C@H]2c2ccc(Cl)cc2)c1,,,CHEMBL3886611,,2016,"{'bei': '15.56', 'le': '0.31', 'lle': '1.08', 'sei': '10.67'}",CHEMBL4112858,,CHEMBL4112858,7.52,False,http://www.openphacts.org/units/Nanomolar,2869394,=,37,True,=,,IC50,nM,,30.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,30.0
378443,17752063,[],CHEMBL3888179,"Homogenous Time-Resolved Fluorescence Assay (HTRF1 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 2.5 nM GST-hMDM2 (aa 1-188), 5 nM biotinylated-p53 (aa 1-83), 1.8 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 200 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.",B,,,BAO_0000190,BAO_0000224,protein format,C[C@]1(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@@H](c2ccc(Cl)cc2)N(C(C2CC2)C2CC2)C1=O,,,CHEMBL3886611,,2016,,CHEMBL4110280,,CHEMBL4110280,,False,http://www.openphacts.org/units/Nanomolar,2869395,<,37,True,<,,IC50,nM,,10.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,10.0
378444,17752064,[],CHEMBL3888179,"Homogenous Time-Resolved Fluorescence Assay (HTRF1 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 2.5 nM GST-hMDM2 (aa 1-188), 5 nM biotinylated-p53 (aa 1-83), 1.8 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 200 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.",B,,,BAO_0000190,BAO_0000224,protein format,C[C@@]1(CC(=O)O)C[C@H](c2cccc(Cl)c2)C(c2ccc(Cl)cc2)N(C(C2CC2)C2CC2)C1=O,,,CHEMBL3886611,,2016,"{'bei': '13.18', 'le': '0.27', 'lle': '-0.31', 'sei': '11.12'}",CHEMBL4114522,,CHEMBL4114522,6.41,False,http://www.openphacts.org/units/Nanomolar,2869396,=,37,True,=,,IC50,nM,,390.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,390.0
378445,17752065,[],CHEMBL3888179,"Homogenous Time-Resolved Fluorescence Assay (HTRF1 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 2.5 nM GST-hMDM2 (aa 1-188), 5 nM biotinylated-p53 (aa 1-83), 1.8 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 200 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.",B,,,BAO_0000190,BAO_0000224,protein format,CC(C)N1[C@H](c2ccc(Cl)cc2)[C@@H](c2cccc(Cl)c2)C[C@H](CC(=O)O)S1(=O)=O,,,CHEMBL3886611,,2016,"{'bei': '13.47', 'le': '0.29', 'lle': '1.04', 'sei': '8.23'}",CHEMBL4111242,,CHEMBL4111242,6.15,False,http://www.openphacts.org/units/Nanomolar,2869397,=,37,True,=,,IC50,nM,,710.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,710.0
378446,17752066,[],CHEMBL3888179,"Homogenous Time-Resolved Fluorescence Assay (HTRF1 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 2.5 nM GST-hMDM2 (aa 1-188), 5 nM biotinylated-p53 (aa 1-83), 1.8 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 200 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.",B,,,BAO_0000190,BAO_0000224,protein format,CC(C)N1[C@H](c2ccc(Cl)cc2)[C@@H](c2cccc(Cl)c2)C[C@@H](CC(=O)O)S1(=O)=O,,,CHEMBL3886611,,2016,"{'bei': '13.56', 'le': '0.29', 'lle': '1.08', 'sei': '8.28'}",CHEMBL3908460,,CHEMBL3908460,6.19,False,http://www.openphacts.org/units/Nanomolar,2869398,=,37,True,=,,IC50,nM,,650.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,650.0
378447,17752067,[],CHEMBL3888179,"Homogenous Time-Resolved Fluorescence Assay (HTRF1 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 2.5 nM GST-hMDM2 (aa 1-188), 5 nM biotinylated-p53 (aa 1-83), 1.8 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 200 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.",B,,,BAO_0000190,BAO_0000224,protein format,CC(C)N1[C@H](c2ccc(Cl)cc2)[C@@H](c2cccc(Cl)c2)C[C@](C)(CC(=O)O)S1(=O)=O,,,CHEMBL3886611,,2016,"{'bei': '14.71', 'le': '0.32', 'lle': '1.42', 'sei': '9.27'}",CHEMBL4111356,,CHEMBL4111356,6.92,False,http://www.openphacts.org/units/Nanomolar,2869399,=,37,True,=,,IC50,nM,,120.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,120.0
378448,17752068,[],CHEMBL3888179,"Homogenous Time-Resolved Fluorescence Assay (HTRF1 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 2.5 nM GST-hMDM2 (aa 1-188), 5 nM biotinylated-p53 (aa 1-83), 1.8 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 200 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.",B,,,BAO_0000190,BAO_0000224,protein format,CC(C)N1[C@H](c2ccc(Cl)cc2)[C@@H](c2cccc(Cl)c2)C[C@@](C)(CC(=O)O)S1(=O)=O,,,CHEMBL3886611,,2016,"{'bei': '13.29', 'le': '0.28', 'lle': '0.75', 'sei': '8.37'}",CHEMBL4113101,,CHEMBL4113101,6.25,False,http://www.openphacts.org/units/Nanomolar,2869400,=,37,True,=,,IC50,nM,,560.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,560.0
378449,17752069,[],CHEMBL3888179,"Homogenous Time-Resolved Fluorescence Assay (HTRF1 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 2.5 nM GST-hMDM2 (aa 1-188), 5 nM biotinylated-p53 (aa 1-83), 1.8 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 200 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.",B,,,BAO_0000190,BAO_0000224,protein format,CC[C@@H](CN1CCOCC1)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cn1,,,CHEMBL3886611,,2016,"{'bei': '13.66', 'le': '0.28', 'lle': '2.26', 'sei': '8.80'}",CHEMBL3940102,,CHEMBL3940102,7.30,False,http://www.openphacts.org/units/Nanomolar,2869401,=,37,True,=,,IC50,nM,,50.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,50.0
378450,17752070,[],CHEMBL3888179,"Homogenous Time-Resolved Fluorescence Assay (HTRF1 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 2.5 nM GST-hMDM2 (aa 1-188), 5 nM biotinylated-p53 (aa 1-83), 1.8 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 200 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.",B,,,BAO_0000190,BAO_0000224,protein format,CCC(CC)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cn1,,,CHEMBL3886611,,2016,"{'bei': '15.76', 'le': '0.32', 'lle': '1.18', 'sei': '10.36'}",CHEMBL4113137,,CHEMBL4113137,7.30,False,http://www.openphacts.org/units/Nanomolar,2869402,=,37,True,=,,IC50,nM,,50.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,50.0
378451,17752071,[],CHEMBL3888179,"Homogenous Time-Resolved Fluorescence Assay (HTRF1 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 2.5 nM GST-hMDM2 (aa 1-188), 5 nM biotinylated-p53 (aa 1-83), 1.8 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 200 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.",B,,,BAO_0000190,BAO_0000224,protein format,CCC(CC)N1C(=O)[C@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cn1,,,CHEMBL3886611,,2016,"{'bei': '13.03', 'le': '0.27', 'lle': '-0.08', 'sei': '8.56'}",CHEMBL4109214,,CHEMBL4109214,6.04,False,http://www.openphacts.org/units/Nanomolar,2869403,=,37,True,=,,IC50,nM,,920.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,920.0
378452,17752072,[],CHEMBL3888179,"Homogenous Time-Resolved Fluorescence Assay (HTRF1 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 2.5 nM GST-hMDM2 (aa 1-188), 5 nM biotinylated-p53 (aa 1-83), 1.8 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 200 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.",B,,,BAO_0000190,BAO_0000224,protein format,CC[C@@H](C(=O)OC(C)(C)C)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cn1,,,CHEMBL3886611,,2016,"{'bei': '14.38', 'le': '0.29', 'lle': '1.65', 'sei': '7.95'}",CHEMBL4112305,,CHEMBL4112305,7.70,False,http://www.openphacts.org/units/Nanomolar,2869404,=,37,True,=,,IC50,nM,,20.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,20.0
378453,17752073,[],CHEMBL3888179,"Homogenous Time-Resolved Fluorescence Assay (HTRF1 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 2.5 nM GST-hMDM2 (aa 1-188), 5 nM biotinylated-p53 (aa 1-83), 1.8 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 200 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.",B,,,BAO_0000190,BAO_0000224,protein format,CC[C@@H](C(=O)OC(C)(C)C)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cc(Cl)ccn2)[C@H]1c1ccc(Cl)cc1,,,CHEMBL3886611,,2016,"{'bei': '14.38', 'le': '0.29', 'lle': '1.65', 'sei': '7.95'}",CHEMBL4112050,,CHEMBL4112050,7.70,False,http://www.openphacts.org/units/Nanomolar,2869405,=,37,True,=,,IC50,nM,,20.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,20.0
378454,17752074,[],CHEMBL3888179,"Homogenous Time-Resolved Fluorescence Assay (HTRF1 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 2.5 nM GST-hMDM2 (aa 1-188), 5 nM biotinylated-p53 (aa 1-83), 1.8 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 200 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.",B,,,BAO_0000190,BAO_0000224,protein format,CC[C@@H](C(=O)OC(C)(C)C)N1C(=O)[C@@](C)(Cc2nnn[nH]2)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1,,,CHEMBL3886611,,2016,"{'bei': '14.32', 'le': '0.29', 'lle': '2.07', 'sei': '7.92'}",CHEMBL2177189,,CHEMBL2177189,8.00,False,http://www.openphacts.org/units/Nanomolar,2869406,=,37,True,=,,IC50,nM,,10.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,10.0
378455,17752075,[],CHEMBL3888179,"Homogenous Time-Resolved Fluorescence Assay (HTRF1 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 2.5 nM GST-hMDM2 (aa 1-188), 5 nM biotinylated-p53 (aa 1-83), 1.8 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 200 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.",B,,,BAO_0000190,BAO_0000224,protein format,CC[C@@H](CNS(C)(=O)=O)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1,,,CHEMBL3886611,,2016,"{'bei': '14.77', 'le': '0.31', 'lle': '3.14', 'sei': '7.71'}",CHEMBL3125710,,CHEMBL3125710,8.00,False,http://www.openphacts.org/units/Nanomolar,2869407,=,37,True,=,,IC50,nM,,10.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,10.0
378456,17752076,[],CHEMBL3888179,"Homogenous Time-Resolved Fluorescence Assay (HTRF1 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 2.5 nM GST-hMDM2 (aa 1-188), 5 nM biotinylated-p53 (aa 1-83), 1.8 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 200 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.",B,,,BAO_0000190,BAO_0000224,protein format,CC[C@@H](CC(C)=O)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1,,,CHEMBL3886611,,2016,"{'bei': '16.31', 'le': '0.33', 'lle': '1.71', 'sei': '10.71'}",CHEMBL3955489,,CHEMBL3955489,8.00,False,http://www.openphacts.org/units/Nanomolar,2869408,=,37,True,=,,IC50,nM,,10.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,10.0
378457,17752077,[],CHEMBL3888179,"Homogenous Time-Resolved Fluorescence Assay (HTRF1 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 2.5 nM GST-hMDM2 (aa 1-188), 5 nM biotinylated-p53 (aa 1-83), 1.8 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 200 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.",B,,,BAO_0000190,BAO_0000224,protein format,CC[C@@H](CC(C)(C)O)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1,,,CHEMBL3886611,,2016,"{'bei': '14.13', 'le': '0.29', 'lle': '0.68', 'sei': '9.19'}",CHEMBL3125704,,CHEMBL3125704,7.16,False,http://www.openphacts.org/units/Nanomolar,2869409,=,37,True,=,,IC50,nM,,70.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,70.0
378458,17752078,[],CHEMBL3888179,"Homogenous Time-Resolved Fluorescence Assay (HTRF1 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 2.5 nM GST-hMDM2 (aa 1-188), 5 nM biotinylated-p53 (aa 1-83), 1.8 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 200 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.",B,,,BAO_0000190,BAO_0000224,protein format,CC[C@@H](CC(C)(O)C(F)(F)F)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1,,,CHEMBL3886611,,2016,"{'bei': '12.35', 'le': '0.26', 'lle': '-0.09', 'sei': '8.89'}",CHEMBL3932275,,CHEMBL3932275,6.92,False,http://www.openphacts.org/units/Nanomolar,2869410,=,37,True,=,,IC50,nM,,120.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,120.0
378459,17752079,[],CHEMBL3888179,"Homogenous Time-Resolved Fluorescence Assay (HTRF1 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 2.5 nM GST-hMDM2 (aa 1-188), 5 nM biotinylated-p53 (aa 1-83), 1.8 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 200 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.",B,,,BAO_0000190,BAO_0000224,protein format,CC[C@@H](CC(C)(O)C(F)(F)F)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1,,,CHEMBL3886611,,2016,"{'bei': '14.27', 'le': '0.30', 'lle': '0.99', 'sei': '10.28'}",CHEMBL3932275,,CHEMBL3932275,8.00,False,http://www.openphacts.org/units/Nanomolar,2869410,=,37,True,=,,IC50,nM,,10.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,10.0
378460,17752080,[],CHEMBL3888179,"Homogenous Time-Resolved Fluorescence Assay (HTRF1 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 2.5 nM GST-hMDM2 (aa 1-188), 5 nM biotinylated-p53 (aa 1-83), 1.8 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 200 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.",B,,,BAO_0000190,BAO_0000224,protein format,CC[C@@H](CN(C)S(C)(=O)=O)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1,,,CHEMBL3886611,,2016,"{'bei': '14.40', 'le': '0.30', 'lle': '2.80', 'sei': '8.42'}",CHEMBL3954030,,CHEMBL3954030,8.00,False,http://www.openphacts.org/units/Nanomolar,2869411,=,37,True,=,,IC50,nM,,10.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,10.0
378461,17752081,[],CHEMBL3888179,"Homogenous Time-Resolved Fluorescence Assay (HTRF1 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 2.5 nM GST-hMDM2 (aa 1-188), 5 nM biotinylated-p53 (aa 1-83), 1.8 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 200 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.",B,,,BAO_0000190,BAO_0000224,protein format,CC[C@@H](CC(O)(C1CC1)C(F)(F)F)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1,,,CHEMBL3886611,,2016,"{'bei': '13.64', 'le': '0.28', 'lle': '0.60', 'sei': '10.28'}",CHEMBL3980672,,CHEMBL3980672,8.00,False,http://www.openphacts.org/units/Nanomolar,2869412,=,37,True,=,,IC50,nM,,10.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,10.0
378462,17752082,[],CHEMBL3888179,"Homogenous Time-Resolved Fluorescence Assay (HTRF1 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 2.5 nM GST-hMDM2 (aa 1-188), 5 nM biotinylated-p53 (aa 1-83), 1.8 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 200 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.",B,,,BAO_0000190,BAO_0000224,protein format,CC[C@@H](CCC(C)(C)O)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1,,,CHEMBL3886611,,2016,"{'bei': '15.37', 'le': '0.31', 'lle': '1.14', 'sei': '10.28'}",CHEMBL3125705,,CHEMBL3125705,8.00,False,http://www.openphacts.org/units/Nanomolar,2869413,=,37,True,=,,IC50,nM,,10.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,10.0
378463,17752083,[],CHEMBL3888179,"Homogenous Time-Resolved Fluorescence Assay (HTRF1 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 2.5 nM GST-hMDM2 (aa 1-188), 5 nM biotinylated-p53 (aa 1-83), 1.8 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 200 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.",B,,,BAO_0000190,BAO_0000224,protein format,CC[C@@H](CC(O)(O)C(F)(F)F)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1,,,CHEMBL3886611,,2016,"{'bei': '14.22', 'le': '0.30', 'lle': '2.06', 'sei': '8.16'}",CHEMBL3948736,,CHEMBL3948736,8.00,False,http://www.openphacts.org/units/Nanomolar,2869414,=,37,True,=,,IC50,nM,,10.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,10.0
378464,17752084,[],CHEMBL3888179,"Homogenous Time-Resolved Fluorescence Assay (HTRF1 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 2.5 nM GST-hMDM2 (aa 1-188), 5 nM biotinylated-p53 (aa 1-83), 1.8 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 200 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.",B,,,BAO_0000190,BAO_0000224,protein format,CC[C@@H](CCC(C)(O)C(F)(F)F)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1,,,CHEMBL3886611,,2016,"{'bei': '13.93', 'le': '0.29', 'lle': '0.60', 'sei': '10.28'}",CHEMBL3977905,,CHEMBL3977905,8.00,False,http://www.openphacts.org/units/Nanomolar,2869415,=,37,True,=,,IC50,nM,,10.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,10.0
378465,17752085,[],CHEMBL3888179,"Homogenous Time-Resolved Fluorescence Assay (HTRF1 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 2.5 nM GST-hMDM2 (aa 1-188), 5 nM biotinylated-p53 (aa 1-83), 1.8 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 200 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.",B,,,BAO_0000190,BAO_0000224,protein format,CC[C@@H](CCC(C)(O)C(F)(F)F)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)C1c1ccc(Cl)cc1,,,CHEMBL3886611,,2016,,CHEMBL3976926,,CHEMBL3976926,,False,http://www.openphacts.org/units/Nanomolar,2869416,<,37,True,<,,IC50,nM,,10.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,10.0
378466,17752086,[],CHEMBL3888179,"Homogenous Time-Resolved Fluorescence Assay (HTRF1 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 2.5 nM GST-hMDM2 (aa 1-188), 5 nM biotinylated-p53 (aa 1-83), 1.8 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 200 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.",B,,,BAO_0000190,BAO_0000224,protein format,CC[C@@H](CCCC(C)(C)O)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)C1c1ccc(Cl)cc1,,,CHEMBL3886611,,2016,"{'bei': '14.97', 'le': '0.30', 'lle': '0.75', 'sei': '10.28'}",CHEMBL3902756,,CHEMBL3902756,8.00,False,http://www.openphacts.org/units/Nanomolar,2869417,=,37,True,=,,IC50,nM,,10.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,10.0
378467,17752087,[],CHEMBL3888179,"Homogenous Time-Resolved Fluorescence Assay (HTRF1 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 2.5 nM GST-hMDM2 (aa 1-188), 5 nM biotinylated-p53 (aa 1-83), 1.8 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 200 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.",B,,,BAO_0000190,BAO_0000224,protein format,CC[C@@H](CN(C)S(=O)(=O)C1CC1)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)C1c1ccc(Cl)cc1,,,CHEMBL3886611,,2016,,CHEMBL3962770,,CHEMBL3962770,,False,http://www.openphacts.org/units/Nanomolar,2869418,<,37,True,<,,IC50,nM,,10.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,10.0
378468,17752088,[],CHEMBL3888179,"Homogenous Time-Resolved Fluorescence Assay (HTRF1 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 2.5 nM GST-hMDM2 (aa 1-188), 5 nM biotinylated-p53 (aa 1-83), 1.8 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 200 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.",B,,,BAO_0000190,BAO_0000224,protein format,CC[C@@H](CN(C1CC1)S(C)(=O)=O)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)C1c1ccc(Cl)cc1,,,CHEMBL3886611,,2016,"{'bei': '13.76', 'le': '0.29', 'lle': '2.27', 'sei': '8.42'}",CHEMBL3893802,,CHEMBL3893802,8.00,False,http://www.openphacts.org/units/Nanomolar,2869419,=,37,True,=,,IC50,nM,,10.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,10.0
378469,17752089,[],CHEMBL3888179,"Homogenous Time-Resolved Fluorescence Assay (HTRF1 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 2.5 nM GST-hMDM2 (aa 1-188), 5 nM biotinylated-p53 (aa 1-83), 1.8 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 200 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.",B,,,BAO_0000190,BAO_0000224,protein format,CC[C@@H](CC(O)C(F)(F)F)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)C1c1ccc(Cl)cc1,,,CHEMBL3886611,,2016,"{'bei': '13.77', 'le': '0.29', 'lle': '0.90', 'sei': '9.66'}",CHEMBL3892703,,CHEMBL3892703,7.52,False,http://www.openphacts.org/units/Nanomolar,2869420,=,37,True,=,,IC50,nM,,30.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,30.0
378470,17752090,[],CHEMBL3888179,"Homogenous Time-Resolved Fluorescence Assay (HTRF1 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 2.5 nM GST-hMDM2 (aa 1-188), 5 nM biotinylated-p53 (aa 1-83), 1.8 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 200 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.",B,,,BAO_0000190,BAO_0000224,protein format,CC[C@@H](CC(O)C(F)(F)F)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)C1c1ccc(Cl)cc1,,,CHEMBL3886611,,2016,"{'bei': '13.54', 'le': '0.28', 'lle': '0.78', 'sei': '9.50'}",CHEMBL3892703,,CHEMBL3892703,7.40,False,http://www.openphacts.org/units/Nanomolar,2869420,=,37,True,=,,IC50,nM,,40.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,40.0
378471,17752091,[],CHEMBL3888179,"Homogenous Time-Resolved Fluorescence Assay (HTRF1 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 2.5 nM GST-hMDM2 (aa 1-188), 5 nM biotinylated-p53 (aa 1-83), 1.8 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 200 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.",B,,,BAO_0000190,BAO_0000224,protein format,CC[C@@H](CC(C)O)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)C1c1ccc(Cl)cc1,,,CHEMBL3886611,,2016,"{'bei': '16.25', 'le': '0.33', 'lle': '1.92', 'sei': '10.28'}",CHEMBL3952928,,CHEMBL3952928,8.00,False,http://www.openphacts.org/units/Nanomolar,2869421,=,37,True,=,,IC50,nM,,10.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,10.0
378472,17752092,[],CHEMBL3888179,"Homogenous Time-Resolved Fluorescence Assay (HTRF1 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 2.5 nM GST-hMDM2 (aa 1-188), 5 nM biotinylated-p53 (aa 1-83), 1.8 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 200 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.",B,,,BAO_0000190,BAO_0000224,protein format,CC[C@@H](CC(C)O)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)C1c1ccc(Cl)cc1,,,CHEMBL3886611,,2016,"{'bei': '16.25', 'le': '0.33', 'lle': '1.92', 'sei': '10.28'}",CHEMBL3952928,,CHEMBL3952928,8.00,False,http://www.openphacts.org/units/Nanomolar,2869421,=,37,True,=,,IC50,nM,,10.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,10.0
378473,17752093,[],CHEMBL3888179,"Homogenous Time-Resolved Fluorescence Assay (HTRF1 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 2.5 nM GST-hMDM2 (aa 1-188), 5 nM biotinylated-p53 (aa 1-83), 1.8 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 200 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.",B,,,BAO_0000190,BAO_0000224,protein format,CC[C@@H](CN(CC(F)(F)F)S(C)(=O)=O)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)C1c1ccc(Cl)cc1,,,CHEMBL3886611,,2016,"{'bei': '12.83', 'le': '0.27', 'lle': '1.87', 'sei': '8.42'}",CHEMBL3961625,,CHEMBL3961625,8.00,False,http://www.openphacts.org/units/Nanomolar,2869422,=,37,True,=,,IC50,nM,,10.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,10.0
378474,17752094,[],CHEMBL3888179,"Homogenous Time-Resolved Fluorescence Assay (HTRF1 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 2.5 nM GST-hMDM2 (aa 1-188), 5 nM biotinylated-p53 (aa 1-83), 1.8 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 200 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.",B,,,BAO_0000190,BAO_0000224,protein format,CCC(CN1CCCS1(=O)=O)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1,,,CHEMBL3886611,,2016,,CHEMBL4115408,,CHEMBL4115408,,False,http://www.openphacts.org/units/Nanomolar,2869423,<,37,True,<,,IC50,nM,,10.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,10.0
378475,17752095,[],CHEMBL3888179,"Homogenous Time-Resolved Fluorescence Assay (HTRF1 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 2.5 nM GST-hMDM2 (aa 1-188), 5 nM biotinylated-p53 (aa 1-83), 1.8 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 200 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.",B,,,BAO_0000190,BAO_0000224,protein format,CCC([C@H](C)C(C)(C)O)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1,,,CHEMBL3886611,,2016,"{'bei': '14.21', 'le': '0.29', 'lle': '0.68', 'sei': '9.50'}",CHEMBL3969208,,CHEMBL3969208,7.40,False,http://www.openphacts.org/units/Nanomolar,2869424,=,37,True,=,,IC50,nM,,40.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,40.0
378476,17752096,[],CHEMBL3888179,"Homogenous Time-Resolved Fluorescence Assay (HTRF1 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 2.5 nM GST-hMDM2 (aa 1-188), 5 nM biotinylated-p53 (aa 1-83), 1.8 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 200 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.",B,,,BAO_0000190,BAO_0000224,protein format,CCC(CC(C)(C)C#N)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1,,,CHEMBL3886611,,2016,"{'bei': '15.52', 'le': '0.31', 'lle': '0.75', 'sei': '9.83'}",CHEMBL4108719,,CHEMBL4108719,8.00,False,http://www.openphacts.org/units/Nanomolar,2869425,=,37,True,=,,IC50,nM,,10.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,10.0
378477,17752097,[],CHEMBL3888179,"Homogenous Time-Resolved Fluorescence Assay (HTRF1 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 2.5 nM GST-hMDM2 (aa 1-188), 5 nM biotinylated-p53 (aa 1-83), 1.8 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 200 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.",B,,,BAO_0000190,BAO_0000224,protein format,CC[C@@H](C(C)=O)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1,,,CHEMBL3886611,,2016,"{'bei': '16.16', 'le': '0.33', 'lle': '1.80', 'sei': '10.31'}",CHEMBL4110761,,CHEMBL4110761,7.70,False,http://www.openphacts.org/units/Nanomolar,2869426,=,37,True,=,,IC50,nM,,20.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,20.0
378478,17752098,[],CHEMBL3888179,"Homogenous Time-Resolved Fluorescence Assay (HTRF1 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 2.5 nM GST-hMDM2 (aa 1-188), 5 nM biotinylated-p53 (aa 1-83), 1.8 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 200 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.",B,,,BAO_0000190,BAO_0000224,protein format,CC[C@@H]([C@H](C)O)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1,,,CHEMBL3886611,,2016,"{'bei': '16.72', 'le': '0.34', 'lle': '2.31', 'sei': '10.28'}",CHEMBL2059435,,CHEMBL2059435,8.00,False,http://www.openphacts.org/units/Nanomolar,2869427,=,37,True,=,,IC50,nM,,10.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,10.0
378479,17752099,[],CHEMBL3888179,"Homogenous Time-Resolved Fluorescence Assay (HTRF1 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 2.5 nM GST-hMDM2 (aa 1-188), 5 nM biotinylated-p53 (aa 1-83), 1.8 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 200 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.",B,,,BAO_0000190,BAO_0000224,protein format,CC[C@@H]([C@@H](C)O)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1,,,CHEMBL3886611,,2016,"{'bei': '16.72', 'le': '0.34', 'lle': '2.31', 'sei': '10.28'}",CHEMBL4112746,,CHEMBL4112746,8.00,False,http://www.openphacts.org/units/Nanomolar,2869428,=,37,True,=,,IC50,nM,,10.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,10.0
378480,17752100,[],CHEMBL3888179,"Homogenous Time-Resolved Fluorescence Assay (HTRF1 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 2.5 nM GST-hMDM2 (aa 1-188), 5 nM biotinylated-p53 (aa 1-83), 1.8 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 200 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.",B,,,BAO_0000190,BAO_0000224,protein format,CC[C@H](N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1)C(C)(C)O,,,CHEMBL3886611,,2016,"{'bei': '16.25', 'le': '0.33', 'lle': '1.92', 'sei': '10.28'}",CHEMBL3125703,,CHEMBL3125703,8.00,False,http://www.openphacts.org/units/Nanomolar,2869429,=,37,True,=,,IC50,nM,,10.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,10.0
378481,17752101,[],CHEMBL3888179,"Homogenous Time-Resolved Fluorescence Assay (HTRF1 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 2.5 nM GST-hMDM2 (aa 1-188), 5 nM biotinylated-p53 (aa 1-83), 1.8 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 200 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.",B,,,BAO_0000190,BAO_0000224,protein format,CC[C@@H]([C@H](O)CC)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1,,,CHEMBL3886611,,2016,"{'bei': '16.25', 'le': '0.33', 'lle': '1.92', 'sei': '10.28'}",CHEMBL4115158,,CHEMBL4115158,8.00,False,http://www.openphacts.org/units/Nanomolar,2869430,=,37,True,=,,IC50,nM,,10.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,10.0
378482,17752102,[],CHEMBL3888179,"Homogenous Time-Resolved Fluorescence Assay (HTRF1 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 2.5 nM GST-hMDM2 (aa 1-188), 5 nM biotinylated-p53 (aa 1-83), 1.8 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 200 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.",B,,,BAO_0000190,BAO_0000224,protein format,CC[C@@H](CCO)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1,,,CHEMBL3886611,,2016,"{'bei': '16.72', 'le': '0.34', 'lle': '2.31', 'sei': '10.28'}",CHEMBL3980413,,CHEMBL3980413,8.00,False,http://www.openphacts.org/units/Nanomolar,2869431,=,37,True,=,,IC50,nM,,10.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,10.0
378483,17752103,[],CHEMBL3888179,"Homogenous Time-Resolved Fluorescence Assay (HTRF1 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 2.5 nM GST-hMDM2 (aa 1-188), 5 nM biotinylated-p53 (aa 1-83), 1.8 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 200 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.",B,,,BAO_0000190,BAO_0000224,protein format,CC[C@H](N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1)C(C)(O)C(F)(F)F,,,CHEMBL3886611,,2016,"{'bei': '14.64', 'le': '0.30', 'lle': '1.38', 'sei': '10.28'}",CHEMBL4108551,,CHEMBL4108551,8.00,False,http://www.openphacts.org/units/Nanomolar,2869432,=,37,True,=,,IC50,nM,,10.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,10.0
378484,17752104,[],CHEMBL3888179,"Homogenous Time-Resolved Fluorescence Assay (HTRF1 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 2.5 nM GST-hMDM2 (aa 1-188), 5 nM biotinylated-p53 (aa 1-83), 1.8 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 200 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.",B,,,BAO_0000190,BAO_0000224,protein format,CCC(CN(C)S(C)(=O)=O)N1C(=O)[C@@](C)(CC(N)=O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1,,,CHEMBL3886611,,2016,"{'bei': '12.62', 'le': '0.27', 'lle': '2.40', 'sei': '6.95'}",CHEMBL4110424,,CHEMBL4110424,7.00,False,http://www.openphacts.org/units/Nanomolar,2869433,=,37,True,=,,IC50,nM,,100.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,100.0
378485,17752105,[],CHEMBL3888179,"Homogenous Time-Resolved Fluorescence Assay (HTRF1 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 2.5 nM GST-hMDM2 (aa 1-188), 5 nM biotinylated-p53 (aa 1-83), 1.8 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 200 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.",B,,,BAO_0000190,BAO_0000224,protein format,CC[C@@H](C(=O)NCC(C)(C)C)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1,,,CHEMBL3886611,,2016,"{'bei': '14.06', 'le': '0.28', 'lle': '1.23', 'sei': '8.88'}",CHEMBL4107867,,CHEMBL4107867,7.70,False,http://www.openphacts.org/units/Nanomolar,2869434,=,37,True,=,,IC50,nM,,20.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,20.0
378486,17752106,[],CHEMBL3888179,"Homogenous Time-Resolved Fluorescence Assay (HTRF1 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 2.5 nM GST-hMDM2 (aa 1-188), 5 nM biotinylated-p53 (aa 1-83), 1.8 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 200 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.",B,,,BAO_0000190,BAO_0000224,protein format,CC[C@@H](C1=NC(C)(C)CO1)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1,,,CHEMBL3886611,,2016,"{'bei': '13.92', 'le': '0.28', 'lle': '0.88', 'sei': '9.34'}",CHEMBL4111736,,CHEMBL4111736,7.40,False,http://www.openphacts.org/units/Nanomolar,2869435,=,37,True,=,,IC50,nM,,40.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,40.0
378487,17752107,[],CHEMBL3888179,"Homogenous Time-Resolved Fluorescence Assay (HTRF1 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 2.5 nM GST-hMDM2 (aa 1-188), 5 nM biotinylated-p53 (aa 1-83), 1.8 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 200 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.",B,,,BAO_0000190,BAO_0000224,protein format,CC[C@@H](CN(CC(F)(F)F)C(C)=O)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1,,,CHEMBL3886611,,2016,"{'bei': '12.81', 'le': '0.26', 'lle': '0.80', 'sei': '9.65'}",CHEMBL3904755,,CHEMBL3904755,7.52,False,http://www.openphacts.org/units/Nanomolar,2869436,=,37,True,=,,IC50,nM,,30.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,30.0
378488,17752108,[],CHEMBL3888179,"Homogenous Time-Resolved Fluorescence Assay (HTRF1 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 2.5 nM GST-hMDM2 (aa 1-188), 5 nM biotinylated-p53 (aa 1-83), 1.8 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 200 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.",B,,,BAO_0000190,BAO_0000224,protein format,CC[C@@H](CO)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1,,,CHEMBL3886611,,2016,"{'bei': '16.58', 'le': '0.34', 'lle': '2.40', 'sei': '9.89'}",CHEMBL2177191,,CHEMBL2177191,7.70,False,http://www.openphacts.org/units/Nanomolar,2869437,=,37,True,=,,IC50,nM,,20.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,20.0
378489,17752109,[],CHEMBL3888179,"Homogenous Time-Resolved Fluorescence Assay (HTRF1 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 2.5 nM GST-hMDM2 (aa 1-188), 5 nM biotinylated-p53 (aa 1-83), 1.8 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 200 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.",B,,,BAO_0000190,BAO_0000224,protein format,CC[C@@H](CCS(=O)(=O)CC)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)C1c1ccc(Cl)cc1,,,CHEMBL3886611,,2016,"{'bei': '14.43', 'le': '0.30', 'lle': '1.86', 'sei': '8.72'}",CHEMBL3921531,,CHEMBL3921531,8.00,False,http://www.openphacts.org/units/Nanomolar,2869438,=,37,True,=,,IC50,nM,,10.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,10.0
378490,17752110,[],CHEMBL3888179,"Homogenous Time-Resolved Fluorescence Assay (HTRF1 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 2.5 nM GST-hMDM2 (aa 1-188), 5 nM biotinylated-p53 (aa 1-83), 1.8 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 200 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.",B,,,BAO_0000190,BAO_0000224,protein format,CC[C@@H](CCS(=O)(=O)C(C)C)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)C1c1ccc(Cl)cc1,,,CHEMBL3886611,,2016,"{'bei': '14.07', 'le': '0.30', 'lle': '1.48', 'sei': '8.72'}",CHEMBL3957985,,CHEMBL3957985,8.00,False,http://www.openphacts.org/units/Nanomolar,2869439,=,37,True,=,,IC50,nM,,10.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,10.0
378491,17752111,[],CHEMBL3888179,"Homogenous Time-Resolved Fluorescence Assay (HTRF1 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 2.5 nM GST-hMDM2 (aa 1-188), 5 nM biotinylated-p53 (aa 1-83), 1.8 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 200 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.",B,,,BAO_0000190,BAO_0000224,protein format,CC[C@@H](CCS(=O)(=O)CC1CC1)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)C1c1ccc(Cl)cc1,,,CHEMBL3886611,,2016,"{'bei': '12.74', 'le': '0.27', 'lle': '0.87', 'sei': '8.06'}",CHEMBL3919318,,CHEMBL3919318,7.40,False,http://www.openphacts.org/units/Nanomolar,2869440,=,37,True,=,,IC50,nM,,40.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,40.0
378492,17752112,[],CHEMBL3888179,"Homogenous Time-Resolved Fluorescence Assay (HTRF1 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 2.5 nM GST-hMDM2 (aa 1-188), 5 nM biotinylated-p53 (aa 1-83), 1.8 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 200 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.",B,,,BAO_0000190,BAO_0000224,protein format,CC[C@@H](CN1CCCC1=O)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1,,,CHEMBL3886611,,2016,"{'bei': '14.49', 'le': '0.29', 'lle': '1.77', 'sei': '9.88'}",CHEMBL3899355,,CHEMBL3899355,7.70,False,http://www.openphacts.org/units/Nanomolar,2869441,=,37,True,=,,IC50,nM,,20.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,20.0
378493,17752113,[],CHEMBL3888179,"Homogenous Time-Resolved Fluorescence Assay (HTRF1 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 2.5 nM GST-hMDM2 (aa 1-188), 5 nM biotinylated-p53 (aa 1-83), 1.8 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 200 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.",B,,,BAO_0000190,BAO_0000224,protein format,CC[C@@H](CN1C[C@H]2C[C@@H]1CO2)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1,,,CHEMBL3886611,,2016,"{'bei': '13.12', 'le': '0.26', 'lle': '1.37', 'sei': '10.21'}",CHEMBL3926559,,CHEMBL3926559,7.16,False,http://www.openphacts.org/units/Nanomolar,2869442,=,37,True,=,,IC50,nM,,70.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,70.0
378494,17752114,[],CHEMBL3888179,"Homogenous Time-Resolved Fluorescence Assay (HTRF1 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 2.5 nM GST-hMDM2 (aa 1-188), 5 nM biotinylated-p53 (aa 1-83), 1.8 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 200 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.",B,,,BAO_0000190,BAO_0000224,protein format,CC[C@@H](CN1CCOCC1C)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1,,,CHEMBL3886611,,2016,"{'bei': '14.61', 'le': '0.30', 'lle': '1.97', 'sei': '11.42'}",CHEMBL3962786,,CHEMBL3962786,8.00,False,http://www.openphacts.org/units/Nanomolar,2869443,=,37,True,=,,IC50,nM,,10.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,10.0
378495,17752115,[],CHEMBL3888179,"Homogenous Time-Resolved Fluorescence Assay (HTRF1 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 2.5 nM GST-hMDM2 (aa 1-188), 5 nM biotinylated-p53 (aa 1-83), 1.8 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 200 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.",B,,,BAO_0000190,BAO_0000224,protein format,CC[C@@H](CN1CCS(=O)(=O)CC1)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1,,,CHEMBL3886611,,2016,"{'bei': '13.24', 'le': '0.28', 'lle': '2.66', 'sei': '8.11'}",CHEMBL3963132,,CHEMBL3963132,7.70,False,http://www.openphacts.org/units/Nanomolar,2869444,=,37,True,=,,IC50,nM,,20.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,20.0
378496,17752116,[],CHEMBL3888179,"Homogenous Time-Resolved Fluorescence Assay (HTRF1 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 2.5 nM GST-hMDM2 (aa 1-188), 5 nM biotinylated-p53 (aa 1-83), 1.8 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 200 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.",B,,,BAO_0000190,BAO_0000224,protein format,CC[C@@H](CN1CC(F)(F)C1)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1,,,CHEMBL3886611,,2016,"{'bei': '13.95', 'le': '0.29', 'lle': '1.26', 'sei': '12.36'}",CHEMBL3950605,,CHEMBL3950605,7.52,False,http://www.openphacts.org/units/Nanomolar,2869445,=,37,True,=,,IC50,nM,,30.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,30.0
378497,17752117,[],CHEMBL3888179,"Homogenous Time-Resolved Fluorescence Assay (HTRF1 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 2.5 nM GST-hMDM2 (aa 1-188), 5 nM biotinylated-p53 (aa 1-83), 1.8 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 200 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.",B,,,BAO_0000190,BAO_0000224,protein format,CC[C@@H](CN1CC2CCC(C1)O2)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1,,,CHEMBL3886611,,2016,"{'bei': '13.44', 'le': '0.27', 'lle': '1.35', 'sei': '10.73'}",CHEMBL3938040,,CHEMBL3938040,7.52,False,http://www.openphacts.org/units/Nanomolar,2869446,=,37,True,=,,IC50,nM,,30.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,30.0
378498,17752118,[],CHEMBL3888179,"Homogenous Time-Resolved Fluorescence Assay (HTRF1 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 2.5 nM GST-hMDM2 (aa 1-188), 5 nM biotinylated-p53 (aa 1-83), 1.8 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 200 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.",B,,,BAO_0000190,BAO_0000224,protein format,CC[C@@H](CN1CCOCC1(C)C)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1,,,CHEMBL3886611,,2016,"{'bei': '13.71', 'le': '0.28', 'lle': '1.28', 'sei': '10.99'}",CHEMBL3941874,,CHEMBL3941874,7.70,False,http://www.openphacts.org/units/Nanomolar,2869447,=,37,True,=,,IC50,nM,,20.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,20.0
378499,17752119,[],CHEMBL3888179,"Homogenous Time-Resolved Fluorescence Assay (HTRF1 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 2.5 nM GST-hMDM2 (aa 1-188), 5 nM biotinylated-p53 (aa 1-83), 1.8 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 200 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.",B,,,BAO_0000190,BAO_0000224,protein format,CC[C@@H](CN1CC(O)(C(F)(F)F)C1)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1,,,CHEMBL3886611,,2016,"{'bei': '12.59', 'le': '0.26', 'lle': '1.48', 'sei': '9.12'}",CHEMBL3964874,,CHEMBL3964874,7.40,False,http://www.openphacts.org/units/Nanomolar,2869448,=,37,True,=,,IC50,nM,,40.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,40.0
378500,17752120,[],CHEMBL3888179,"Homogenous Time-Resolved Fluorescence Assay (HTRF1 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 2.5 nM GST-hMDM2 (aa 1-188), 5 nM biotinylated-p53 (aa 1-83), 1.8 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 200 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.",B,,,BAO_0000190,BAO_0000224,protein format,CC[C@@H](CN(C)C1COC1)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1,,,CHEMBL3886611,,2016,"{'bei': '14.10', 'le': '0.29', 'lle': '1.88', 'sei': '10.73'}",CHEMBL3977225,,CHEMBL3977225,7.52,False,http://www.openphacts.org/units/Nanomolar,2869449,=,37,True,=,,IC50,nM,,30.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,30.0
378501,17752121,[],CHEMBL3888179,"Homogenous Time-Resolved Fluorescence Assay (HTRF1 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 2.5 nM GST-hMDM2 (aa 1-188), 5 nM biotinylated-p53 (aa 1-83), 1.8 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 200 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.",B,,,BAO_0000190,BAO_0000224,protein format,CC[C@@H](CN1CCOC1=O)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1,,,CHEMBL3886611,,2016,"{'bei': '14.10', 'le': '0.29', 'lle': '1.76', 'sei': '8.63'}",CHEMBL3966228,,CHEMBL3966228,7.52,False,http://www.openphacts.org/units/Nanomolar,2869450,=,37,True,=,,IC50,nM,,30.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,30.0
378502,17752122,[],CHEMBL3888179,"Homogenous Time-Resolved Fluorescence Assay (HTRF1 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 2.5 nM GST-hMDM2 (aa 1-188), 5 nM biotinylated-p53 (aa 1-83), 1.8 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 200 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.",B,,,BAO_0000190,BAO_0000224,protein format,CC[C@@H](Cn1ccccc1=O)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1,,,CHEMBL3886611,,2016,"{'bei': '13.11', 'le': '0.26', 'lle': '0.93', 'sei': '8.91'}",CHEMBL3927464,,CHEMBL3927464,7.10,False,http://www.openphacts.org/units/Nanomolar,2869451,=,37,True,=,,IC50,nM,,80.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,80.0
378503,17752123,[],CHEMBL3888179,"Homogenous Time-Resolved Fluorescence Assay (HTRF1 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 2.5 nM GST-hMDM2 (aa 1-188), 5 nM biotinylated-p53 (aa 1-83), 1.8 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 200 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.",B,,,BAO_0000190,BAO_0000224,protein format,CC[C@@H](Cn1cc(C(F)(F)F)ccc1=O)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1,,,CHEMBL3886611,,2016,"{'bei': '12.34', 'le': '0.25', 'lle': '0.33', 'sei': '9.45'}",CHEMBL3951659,,CHEMBL3951659,7.52,False,http://www.openphacts.org/units/Nanomolar,2869452,=,37,True,=,,IC50,nM,,30.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,30.0
378504,17752124,[],CHEMBL3888179,"Homogenous Time-Resolved Fluorescence Assay (HTRF1 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 2.5 nM GST-hMDM2 (aa 1-188), 5 nM biotinylated-p53 (aa 1-83), 1.8 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 200 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.",B,,,BAO_0000190,BAO_0000224,protein format,C=CC[C@@]1(C)C[C@H](c2cccc(Cl)c2)[C@@H](c2ccc(Cl)cc2)N([C@@H](CC)COc2cccnc2)C1=O,,,CHEMBL3886611,,2016,"{'bei': '14.37', 'le': '0.29', 'lle': '-0.37', 'sei': '17.73'}",CHEMBL3913666,,CHEMBL3913666,7.52,False,http://www.openphacts.org/units/Nanomolar,2869453,=,37,True,=,,IC50,nM,,30.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,30.0
378505,17752125,[],CHEMBL3888179,"Homogenous Time-Resolved Fluorescence Assay (HTRF1 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 2.5 nM GST-hMDM2 (aa 1-188), 5 nM biotinylated-p53 (aa 1-83), 1.8 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 200 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.",B,,,BAO_0000190,BAO_0000224,protein format,CC[C@@H](C1CCCO1)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1,,,CHEMBL3886611,,2016,"{'bei': '15.26', 'le': '0.31', 'lle': '1.21', 'sei': '11.52'}",CHEMBL4114935,,CHEMBL4114935,7.70,False,http://www.openphacts.org/units/Nanomolar,2869454,=,37,True,=,,IC50,nM,,20.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,20.0
378506,17752126,[],CHEMBL3888179,"Homogenous Time-Resolved Fluorescence Assay (HTRF1 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 2.5 nM GST-hMDM2 (aa 1-188), 5 nM biotinylated-p53 (aa 1-83), 1.8 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 200 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.",B,,,BAO_0000190,BAO_0000224,protein format,CC[C@@H](C1CCCO1)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1,,,CHEMBL3886611,,2016,"{'bei': '15.86', 'le': '0.32', 'lle': '1.51', 'sei': '11.97'}",CHEMBL4114935,,CHEMBL4114935,8.00,False,http://www.openphacts.org/units/Nanomolar,2869454,=,37,True,=,,IC50,nM,,10.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,10.0
378507,17752127,[],CHEMBL3888179,"Homogenous Time-Resolved Fluorescence Assay (HTRF1 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 2.5 nM GST-hMDM2 (aa 1-188), 5 nM biotinylated-p53 (aa 1-83), 1.8 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 200 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.",B,,,BAO_0000190,BAO_0000224,protein format,CC[C@@H](C1CCC(=O)O1)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1,,,CHEMBL3886611,,2016,"{'bei': '14.85', 'le': '0.30', 'lle': '1.68', 'sei': '9.18'}",CHEMBL3899788,,CHEMBL3899788,7.70,False,http://www.openphacts.org/units/Nanomolar,2869455,=,37,True,=,,IC50,nM,,20.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,20.0
378508,17752128,[],CHEMBL3888179,"Homogenous Time-Resolved Fluorescence Assay (HTRF1 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 2.5 nM GST-hMDM2 (aa 1-188), 5 nM biotinylated-p53 (aa 1-83), 1.8 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 200 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.",B,,,BAO_0000190,BAO_0000224,protein format,CC[C@H](c1nc2ccccc2s1)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1,,,CHEMBL3886611,,2016,"{'bei': '12.41', 'le': '0.25', 'lle': '-1.24', 'sei': '9.99'}",CHEMBL4107897,,CHEMBL4107897,7.05,False,http://www.openphacts.org/units/Nanomolar,2869456,=,37,True,=,,IC50,nM,,90.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,90.0
378509,17752129,[],CHEMBL3888179,"Homogenous Time-Resolved Fluorescence Assay (HTRF1 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 2.5 nM GST-hMDM2 (aa 1-188), 5 nM biotinylated-p53 (aa 1-83), 1.8 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 200 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.",B,,,BAO_0000190,BAO_0000224,protein format,CC[C@@H](c1nc2ccccc2s1)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1,,,CHEMBL3886611,,2016,"{'bei': '12.61', 'le': '0.26', 'lle': '-1.14', 'sei': '10.15'}",CHEMBL4115598,,CHEMBL4115598,7.16,False,http://www.openphacts.org/units/Nanomolar,2869457,=,37,True,=,,IC50,nM,,70.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,70.0
378510,17752130,[],CHEMBL3888179,"Homogenous Time-Resolved Fluorescence Assay (HTRF1 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 2.5 nM GST-hMDM2 (aa 1-188), 5 nM biotinylated-p53 (aa 1-83), 1.8 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 200 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.",B,,,BAO_0000190,BAO_0000224,protein format,CC[C@@H](c1cc(C)no1)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1,,,CHEMBL3886611,,2016,"{'bei': '14.35', 'le': '0.29', 'lle': '0.42', 'sei': '8.84'}",CHEMBL3959723,,CHEMBL3959723,7.40,False,http://www.openphacts.org/units/Nanomolar,2869458,=,37,True,=,,IC50,nM,,40.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,40.0
378511,17752131,[],CHEMBL3888179,"Homogenous Time-Resolved Fluorescence Assay (HTRF1 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 2.5 nM GST-hMDM2 (aa 1-188), 5 nM biotinylated-p53 (aa 1-83), 1.8 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 200 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.",B,,,BAO_0000190,BAO_0000224,protein format,CC[C@@H](c1ccccn1)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1,,,CHEMBL3886611,,2016,"{'bei': '14.71', 'le': '0.29', 'lle': '0.44', 'sei': '10.67'}",CHEMBL3329605,,CHEMBL3329605,7.52,False,http://www.openphacts.org/units/Nanomolar,2869459,=,37,True,=,,IC50,nM,,30.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,30.0
378512,17752132,[],CHEMBL3888179,"Homogenous Time-Resolved Fluorescence Assay (HTRF1 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 2.5 nM GST-hMDM2 (aa 1-188), 5 nM biotinylated-p53 (aa 1-83), 1.8 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 200 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.",B,,,BAO_0000190,BAO_0000224,protein format,CCC[C@@H](c1ccccn1)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1,,,CHEMBL3886611,,2016,"{'bei': '13.51', 'le': '0.27', 'lle': '-0.37', 'sei': '10.07'}",CHEMBL3329612,,CHEMBL3329612,7.10,False,http://www.openphacts.org/units/Nanomolar,2869460,=,37,True,=,,IC50,nM,,80.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,80.0
378513,17752133,[],CHEMBL3888179,"Homogenous Time-Resolved Fluorescence Assay (HTRF1 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 2.5 nM GST-hMDM2 (aa 1-188), 5 nM biotinylated-p53 (aa 1-83), 1.8 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 200 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.",B,,,BAO_0000190,BAO_0000224,protein format,C[C@]1(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@@H](c2ccc(Cl)cc2)N([C@@H](CC2CC2)c2ccccn2)C1=O,,,CHEMBL3886611,,2016,"{'bei': '13.20', 'le': '0.26', 'lle': '-0.37', 'sei': '10.07'}",CHEMBL3938935,,CHEMBL3938935,7.10,False,http://www.openphacts.org/units/Nanomolar,2869461,=,37,True,=,,IC50,nM,,80.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,80.0
378514,17752134,[],CHEMBL3888179,"Homogenous Time-Resolved Fluorescence Assay (HTRF1 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 2.5 nM GST-hMDM2 (aa 1-188), 5 nM biotinylated-p53 (aa 1-83), 1.8 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 200 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.",B,,,BAO_0000190,BAO_0000224,protein format,CC[C@@H](c1cccnc1)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1,,,CHEMBL3886611,,2016,"{'bei': '13.88', 'le': '0.28', 'lle': '0.02', 'sei': '10.07'}",CHEMBL3329608,,CHEMBL3329608,7.10,False,http://www.openphacts.org/units/Nanomolar,2869462,=,37,True,=,,IC50,nM,,80.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,80.0
378515,17752135,[],CHEMBL3888179,"Homogenous Time-Resolved Fluorescence Assay (HTRF1 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 2.5 nM GST-hMDM2 (aa 1-188), 5 nM biotinylated-p53 (aa 1-83), 1.8 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 200 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.",B,,,BAO_0000190,BAO_0000224,protein format,CC[C@@H](c1cnccn1)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1,,,CHEMBL3886611,,2016,"{'bei': '14.25', 'le': '0.28', 'lle': '0.83', 'sei': '8.76'}",CHEMBL3895235,,CHEMBL3895235,7.30,False,http://www.openphacts.org/units/Nanomolar,2869463,=,37,True,=,,IC50,nM,,50.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,50.0
378516,17752136,[],CHEMBL3888179,"Homogenous Time-Resolved Fluorescence Assay (HTRF1 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 2.5 nM GST-hMDM2 (aa 1-188), 5 nM biotinylated-p53 (aa 1-83), 1.8 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 200 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.",B,,,BAO_0000190,BAO_0000224,protein format,CC[C@@H](c1ncccn1)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1,,,CHEMBL3886611,,2016,"{'bei': '14.09', 'le': '0.28', 'lle': '0.75', 'sei': '8.66'}",CHEMBL3329606,,CHEMBL3329606,7.22,False,http://www.openphacts.org/units/Nanomolar,2869464,=,37,True,=,,IC50,nM,,60.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,60.0
378517,17752137,[],CHEMBL3888179,"Homogenous Time-Resolved Fluorescence Assay (HTRF1 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 2.5 nM GST-hMDM2 (aa 1-188), 5 nM biotinylated-p53 (aa 1-83), 1.8 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 200 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.",B,,,BAO_0000190,BAO_0000224,protein format,CC[C@@H](c1cccc(C)n1)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1,,,CHEMBL3886611,,2016,"{'bei': '15.22', 'le': '0.30', 'lle': '0.61', 'sei': '11.35'}",CHEMBL3329224,,CHEMBL3329224,8.00,False,http://www.openphacts.org/units/Nanomolar,2869465,=,37,True,=,,IC50,nM,,10.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,10.0
378518,17752138,[],CHEMBL3888179,"Homogenous Time-Resolved Fluorescence Assay (HTRF1 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 2.5 nM GST-hMDM2 (aa 1-188), 5 nM biotinylated-p53 (aa 1-83), 1.8 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 200 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.",B,,,BAO_0000190,BAO_0000224,protein format,CC[C@@H](c1ccncc1)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1,,,CHEMBL3886611,,2016,"{'bei': '14.46', 'le': '0.29', 'lle': '0.32', 'sei': '10.49'}",CHEMBL3329607,,CHEMBL3329607,7.40,False,http://www.openphacts.org/units/Nanomolar,2869466,=,37,True,=,,IC50,nM,,40.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,40.0
378519,17752139,[],CHEMBL3888179,"Homogenous Time-Resolved Fluorescence Assay (HTRF1 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 2.5 nM GST-hMDM2 (aa 1-188), 5 nM biotinylated-p53 (aa 1-83), 1.8 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 200 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.",B,,,BAO_0000190,BAO_0000224,protein format,CC[C@@H](c1nccs1)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1,,,CHEMBL3886611,,2016,"{'bei': '14.11', 'le': '0.29', 'lle': '0.16', 'sei': '10.36'}",CHEMBL3329604,,CHEMBL3329604,7.30,False,http://www.openphacts.org/units/Nanomolar,2869467,=,37,True,=,,IC50,nM,,50.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,50.0
378520,17752140,[],CHEMBL3888179,"Homogenous Time-Resolved Fluorescence Assay (HTRF1 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 2.5 nM GST-hMDM2 (aa 1-188), 5 nM biotinylated-p53 (aa 1-83), 1.8 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 200 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.",B,,,BAO_0000190,BAO_0000224,protein format,CC[C@H](c1cccc(C(C)(C)O)n1)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1,,,CHEMBL3886611,,2016,"{'bei': '13.52', 'le': '0.27', 'lle': '0.39', 'sei': '8.49'}",CHEMBL4111092,,CHEMBL4111092,7.70,False,http://www.openphacts.org/units/Nanomolar,2869468,=,37,True,=,,IC50,nM,,20.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,20.0
378521,17752141,[],CHEMBL3888179,"Homogenous Time-Resolved Fluorescence Assay (HTRF1 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 2.5 nM GST-hMDM2 (aa 1-188), 5 nM biotinylated-p53 (aa 1-83), 1.8 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 200 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.",B,,,BAO_0000190,BAO_0000224,protein format,CC[C@H](c1cccc(C2CC2)n1)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1,,,CHEMBL3886611,,2016,"{'bei': '13.64', 'le': '0.27', 'lle': '-0.44', 'sei': '10.67'}",CHEMBL4114388,,CHEMBL4114388,7.52,False,http://www.openphacts.org/units/Nanomolar,2869469,=,37,True,=,,IC50,nM,,30.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,30.0
378522,17752142,[],CHEMBL3888179,"Homogenous Time-Resolved Fluorescence Assay (HTRF1 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 2.5 nM GST-hMDM2 (aa 1-188), 5 nM biotinylated-p53 (aa 1-83), 1.8 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 200 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.",B,,,BAO_0000190,BAO_0000224,protein format,C[C@]1(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@@H](c2ccc(Cl)cc2)N([C@@H](CC(F)(F)F)c2ccccn2)C1=O,,,CHEMBL3886611,,2016,"{'bei': '13.30', 'le': '0.27', 'lle': '-0.10', 'sei': '10.67'}",CHEMBL4109848,,CHEMBL4109848,7.52,False,http://www.openphacts.org/units/Nanomolar,2869470,=,37,True,=,,IC50,nM,,30.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,30.0
378523,17752143,[],CHEMBL3888179,"Homogenous Time-Resolved Fluorescence Assay (HTRF1 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 2.5 nM GST-hMDM2 (aa 1-188), 5 nM biotinylated-p53 (aa 1-83), 1.8 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 200 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.",B,,,BAO_0000190,BAO_0000224,protein format,C[C@]1(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@@H](c2ccc(Cl)cc2)N([C@@H](CC(F)F)c2ccccn2)C1=O,,,CHEMBL3886611,,2016,"{'bei': '13.51', 'le': '0.27', 'lle': '0.08', 'sei': '10.49'}",CHEMBL4110711,,CHEMBL4110711,7.40,False,http://www.openphacts.org/units/Nanomolar,2869471,=,37,True,=,,IC50,nM,,40.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,40.0
378524,17752144,[],CHEMBL3888179,"Homogenous Time-Resolved Fluorescence Assay (HTRF1 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 2.5 nM GST-hMDM2 (aa 1-188), 5 nM biotinylated-p53 (aa 1-83), 1.8 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 200 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.",B,,,BAO_0000190,BAO_0000224,protein format,CC(C)[C@@H](c1ccccn1)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1,,,CHEMBL3886611,,2016,"{'bei': '14.32', 'le': '0.29', 'lle': '0.20', 'sei': '10.67'}",CHEMBL3329610,,CHEMBL3329610,7.52,False,http://www.openphacts.org/units/Nanomolar,2869472,=,37,True,=,,IC50,nM,,30.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,30.0
378525,17752145,[],CHEMBL3888179,"Homogenous Time-Resolved Fluorescence Assay (HTRF1 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 2.5 nM GST-hMDM2 (aa 1-188), 5 nM biotinylated-p53 (aa 1-83), 1.8 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 200 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.",B,,,BAO_0000190,BAO_0000224,protein format,CCC(CC)N1C(=O)[C@@](C)(Cc2nnn[nH]2)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1,,,CHEMBL3886611,,2016,"{'bei': '15.83', 'le': '0.32', 'lle': '1.70', 'sei': '10.30'}",CHEMBL4109795,,CHEMBL4109795,7.70,False,http://www.openphacts.org/units/Nanomolar,2869473,=,37,True,=,,IC50,nM,,20.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,20.0
378526,17752146,[],CHEMBL3888179,"Homogenous Time-Resolved Fluorescence Assay (HTRF1 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 2.5 nM GST-hMDM2 (aa 1-188), 5 nM biotinylated-p53 (aa 1-83), 1.8 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 200 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.",B,,,BAO_0000190,BAO_0000224,protein format,CC(C)(C)OC(=O)[C@H](C1CC1)N1C(=O)[C@@H](CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1,,,CHEMBL3886611,,2016,"{'bei': '14.13', 'le': '0.29', 'lle': '1.26', 'sei': '8.97'}",CHEMBL4114226,,CHEMBL4114226,7.52,False,http://www.openphacts.org/units/Nanomolar,2869474,=,37,True,=,,IC50,nM,,30.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,30.0
378527,17752147,[],CHEMBL3888179,"Homogenous Time-Resolved Fluorescence Assay (HTRF1 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 2.5 nM GST-hMDM2 (aa 1-188), 5 nM biotinylated-p53 (aa 1-83), 1.8 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 200 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.",B,,,BAO_0000190,BAO_0000224,protein format,CCOC(=O)[C@H](C1CC1)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)C1c1ccc(Cl)cc1,,,CHEMBL3886611,,2016,"{'bei': '15.43', 'le': '0.31', 'lle': '2.13', 'sei': '9.53'}",CHEMBL4107995,,CHEMBL4107995,8.00,False,http://www.openphacts.org/units/Nanomolar,2869475,=,37,True,=,,IC50,nM,,10.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,10.0
378528,17752148,[],CHEMBL3888179,"Homogenous Time-Resolved Fluorescence Assay (HTRF1 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 2.5 nM GST-hMDM2 (aa 1-188), 5 nM biotinylated-p53 (aa 1-83), 1.8 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 200 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.",B,,,BAO_0000190,BAO_0000224,protein format,C[C@]1(CC(=O)O)C[C@H](c2cccc(Cl)c2)C(c2ccc(Cl)cc2)N([C@H](CO)C2CC2)C1=O,,,CHEMBL3886611,,2016,"{'bei': '16.79', 'le': '0.34', 'lle': '2.70', 'sei': '10.28'}",CHEMBL4108086,,CHEMBL4108086,8.00,False,http://www.openphacts.org/units/Nanomolar,2869476,=,37,True,=,,IC50,nM,,10.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,10.0
378529,17752149,[],CHEMBL3888179,"Homogenous Time-Resolved Fluorescence Assay (HTRF1 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 2.5 nM GST-hMDM2 (aa 1-188), 5 nM biotinylated-p53 (aa 1-83), 1.8 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 200 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.",B,,,BAO_0000190,BAO_0000224,protein format,CC[C@@H](O)[C@H](C1CC1)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)C1c1ccc(Cl)cc1,,,CHEMBL3886611,,2016,"{'bei': '14.32', 'le': '0.29', 'lle': '1.14', 'sei': '9.28'}",CHEMBL4109136,,CHEMBL4109136,7.22,False,http://www.openphacts.org/units/Nanomolar,2869477,=,37,True,=,,IC50,nM,,60.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,60.0
378530,17752150,[],CHEMBL3888179,"Homogenous Time-Resolved Fluorescence Assay (HTRF1 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 2.5 nM GST-hMDM2 (aa 1-188), 5 nM biotinylated-p53 (aa 1-83), 1.8 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 200 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.",B,,,BAO_0000190,BAO_0000224,protein format,CN(C[C@H](C1CC1)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1)S(=O)(=O)C1CC1,,,CHEMBL3886611,,2016,,CHEMBL3125517,,CHEMBL3125517,,False,http://www.openphacts.org/units/Nanomolar,2869478,<,37,True,<,,IC50,nM,,10.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,10.0
378531,17752151,[],CHEMBL3888179,"Homogenous Time-Resolved Fluorescence Assay (HTRF1 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 2.5 nM GST-hMDM2 (aa 1-188), 5 nM biotinylated-p53 (aa 1-83), 1.8 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 200 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.",B,,,BAO_0000190,BAO_0000224,protein format,C[C@H](O)[C@H](C1CC1)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1,,,CHEMBL3886611,,2016,"{'bei': '14.47', 'le': '0.29', 'lle': '1.41', 'sei': '9.12'}",CHEMBL3975518,,CHEMBL3975518,7.10,False,http://www.openphacts.org/units/Nanomolar,2869479,=,37,True,=,,IC50,nM,,80.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,80.0
378532,17752152,[],CHEMBL3888179,"Homogenous Time-Resolved Fluorescence Assay (HTRF1 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 2.5 nM GST-hMDM2 (aa 1-188), 5 nM biotinylated-p53 (aa 1-83), 1.8 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 200 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.",B,,,BAO_0000190,BAO_0000224,protein format,C[C@]1(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@@H](c2ccc(Cl)cc2)N([C@@H](c2ccccn2)C2CC2)C1=O,,,CHEMBL3886611,,2016,"{'bei': '14.71', 'le': '0.29', 'lle': '0.62', 'sei': '10.92'}",CHEMBL4108893,,CHEMBL4108893,7.70,False,http://www.openphacts.org/units/Nanomolar,2869480,=,37,True,=,,IC50,nM,,20.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,20.0
378533,17752153,[],CHEMBL3888179,"Homogenous Time-Resolved Fluorescence Assay (HTRF1 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 2.5 nM GST-hMDM2 (aa 1-188), 5 nM biotinylated-p53 (aa 1-83), 1.8 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 200 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.",B,,,BAO_0000190,BAO_0000224,protein format,CCN(CC)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1,,,CHEMBL3886611,,2016,"{'bei': '17.26', 'le': '0.35', 'lle': '2.21', 'sei': '13.15'}",CHEMBL4109614,,CHEMBL4109614,8.00,False,http://www.openphacts.org/units/Nanomolar,2869481,=,37,True,=,,IC50,nM,,10.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,10.0
378534,17752154,[],CHEMBL3888179,"Homogenous Time-Resolved Fluorescence Assay (HTRF1 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 2.5 nM GST-hMDM2 (aa 1-188), 5 nM biotinylated-p53 (aa 1-83), 1.8 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 200 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.",B,,,BAO_0000190,BAO_0000224,protein format,CN(C)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1,,,CHEMBL3886611,,2016,"{'bei': '17.68', 'le': '0.36', 'lle': '2.69', 'sei': '12.65'}",CHEMBL4108536,,CHEMBL4108536,7.70,False,http://www.openphacts.org/units/Nanomolar,2869482,=,37,True,=,,IC50,nM,,20.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,20.0
378535,17752155,[],CHEMBL3888180,"Homogenous Time-Resolved Fluorescence Assay (HTRF2 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 0.2 nM GST-hMDM2 (aa 1-188), 0.5 nM biotinylated-p53 (aa 1-83), 0.18 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 100 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.",B,,,BAO_0000190,BAO_0000224,protein format,CC[C@@H](C(=O)OC(C)(C)C)N1C(=O)[C@@H](CC(=O)O)CC(c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1,,,CHEMBL3886611,,2016,"{'bei': '16.14', 'le': '0.33', 'lle': '2.14', 'sei': '10.01'}",CHEMBL4111829,,CHEMBL4111829,8.40,False,http://www.openphacts.org/units/Nanomolar,2869284,=,37,True,=,,IC50,nM,,4.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,4.0
378536,17752156,[],CHEMBL3888180,"Homogenous Time-Resolved Fluorescence Assay (HTRF2 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 0.2 nM GST-hMDM2 (aa 1-188), 0.5 nM biotinylated-p53 (aa 1-83), 0.18 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 100 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.",B,,,BAO_0000190,BAO_0000224,protein format,CCOC(=O)[C@H](CC)N1C(=O)[C@@H](CC(=O)O)C[C@H](c2cccc(Cl)c2)C1c1ccc(Cl)cc1,,,CHEMBL3886611,,2016,"{'bei': '16.25', 'le': '0.33', 'lle': '2.52', 'sei': '9.53'}",CHEMBL4113757,,CHEMBL4113757,8.00,False,http://www.openphacts.org/units/Nanomolar,2869286,=,37,True,=,,IC50,nM,,10.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,10.0
378537,17752157,[],CHEMBL3888180,"Homogenous Time-Resolved Fluorescence Assay (HTRF2 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 0.2 nM GST-hMDM2 (aa 1-188), 0.5 nM biotinylated-p53 (aa 1-83), 0.18 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 100 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.",B,,,BAO_0000190,BAO_0000224,protein format,CC[C@@H](CCC#N)N1C(=O)[C@@H](CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1,,,CHEMBL3886611,,2016,"{'bei': '17.74', 'le': '0.36', 'lle': '2.18', 'sei': '10.32'}",CHEMBL4110652,,CHEMBL4110652,8.40,False,http://www.openphacts.org/units/Nanomolar,2869312,=,37,True,=,,IC50,nM,,4.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,4.0
378538,17752158,[],CHEMBL3888180,"Homogenous Time-Resolved Fluorescence Assay (HTRF2 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 0.2 nM GST-hMDM2 (aa 1-188), 0.5 nM biotinylated-p53 (aa 1-83), 0.18 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 100 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.",B,,,BAO_0000190,BAO_0000224,protein format,O=C(O)C[C@H]1CC(c2cccc(Cl)c2)[C@@H](c2ccc(Cl)cc2)N(CC2CC2)C1=O,,,CHEMBL3886611,,2016,"{'bei': '17.40', 'le': '0.35', 'lle': '1.97', 'sei': '13.06'}",CHEMBL4113368,,CHEMBL4113368,7.52,False,http://www.openphacts.org/units/Nanomolar,2869317,=,37,True,=,,IC50,nM,,30.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,30.0
378539,17752159,[],CHEMBL3888180,"Homogenous Time-Resolved Fluorescence Assay (HTRF2 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 0.2 nM GST-hMDM2 (aa 1-188), 0.5 nM biotinylated-p53 (aa 1-83), 0.18 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 100 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.",B,,,BAO_0000190,BAO_0000224,protein format,CCOC(=O)[C@H](CC)N1C(=O)[C@@](C)(CC(=O)O)CC(c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1,,,CHEMBL3886611,,2016,"{'bei': '16.83', 'le': '0.34', 'lle': '2.65', 'sei': '10.16'}",CHEMBL3926383,,CHEMBL3926383,8.52,False,http://www.openphacts.org/units/Nanomolar,2869346,=,37,True,=,,IC50,nM,,3.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,3.0
378540,17752160,[],CHEMBL3888180,"Homogenous Time-Resolved Fluorescence Assay (HTRF2 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 0.2 nM GST-hMDM2 (aa 1-188), 0.5 nM biotinylated-p53 (aa 1-83), 0.18 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 100 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.",B,,,BAO_0000190,BAO_0000224,protein format,CC[C@@H](C(=O)OC(C)(C)C)N1C(=O)[C@@](C)(CC(=O)O)CC(c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1,,,CHEMBL3886611,,2016,"{'bei': '16.28', 'le': '0.33', 'lle': '2.05', 'sei': '10.37'}",CHEMBL3964670,,CHEMBL3964670,8.70,False,http://www.openphacts.org/units/Nanomolar,2869348,=,37,True,=,,IC50,nM,,2.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,2.0
378541,17752161,[],CHEMBL3888180,"Homogenous Time-Resolved Fluorescence Assay (HTRF2 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 0.2 nM GST-hMDM2 (aa 1-188), 0.5 nM biotinylated-p53 (aa 1-83), 0.18 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 100 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.",B,,,BAO_0000190,BAO_0000224,protein format,CC[C@@H](COCC1CC1)N1C(=O)[C@@](C)(CC(=O)O)CC(c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1,,,CHEMBL3886611,,2016,"{'bei': '16.78', 'le': '0.34', 'lle': '1.96', 'sei': '13.01'}",CHEMBL3930864,,CHEMBL3930864,8.70,False,http://www.openphacts.org/units/Nanomolar,2869349,=,37,True,=,,IC50,nM,,2.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,2.0
378542,17752162,[],CHEMBL3888180,"Homogenous Time-Resolved Fluorescence Assay (HTRF2 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 0.2 nM GST-hMDM2 (aa 1-188), 0.5 nM biotinylated-p53 (aa 1-83), 0.18 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 100 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.",B,,,BAO_0000190,BAO_0000224,protein format,CCC(CC)N1C(=O)[C@@](C)(CC(=O)O)CC(c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1,,,CHEMBL3886611,,2016,"{'bei': '18.43', 'le': '0.38', 'lle': '1.80', 'sei': '14.79'}",CHEMBL4111833,,CHEMBL4111833,8.52,False,http://www.openphacts.org/units/Nanomolar,2869352,=,37,True,=,,IC50,nM,,3.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,3.0
378543,17752163,[],CHEMBL3888180,"Homogenous Time-Resolved Fluorescence Assay (HTRF2 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 0.2 nM GST-hMDM2 (aa 1-188), 0.5 nM biotinylated-p53 (aa 1-83), 0.18 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 100 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.",B,,,BAO_0000190,BAO_0000224,protein format,CC(C)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1,,,CHEMBL3886611,,2016,"{'bei': '18.93', 'le': '0.39', 'lle': '2.28', 'sei': '14.27'}",CHEMBL3329620,,CHEMBL3329620,8.22,False,http://www.openphacts.org/units/Nanomolar,2869354,=,37,True,=,,IC50,nM,,6.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,6.0
378544,17752164,[],CHEMBL3888180,"Homogenous Time-Resolved Fluorescence Assay (HTRF2 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 0.2 nM GST-hMDM2 (aa 1-188), 0.5 nM biotinylated-p53 (aa 1-83), 0.18 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 100 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.",B,,,BAO_0000190,BAO_0000224,protein format,C[C@]1(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@@H](c2ccc(Cl)cc2)N(C2CCCC2)C1=O,,,CHEMBL3886611,,2016,"{'bei': '18.03', 'le': '0.37', 'lle': '1.83', 'sei': '14.41'}",CHEMBL3929164,,CHEMBL3929164,8.30,False,http://www.openphacts.org/units/Nanomolar,2869356,=,37,True,=,,IC50,nM,,5.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,5.0
378545,17752165,[],CHEMBL3888180,"Homogenous Time-Resolved Fluorescence Assay (HTRF2 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 0.2 nM GST-hMDM2 (aa 1-188), 0.5 nM biotinylated-p53 (aa 1-83), 0.18 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 100 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.",B,,,BAO_0000190,BAO_0000224,protein format,CC[C@@H](CN1CCOCC1)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1,,,CHEMBL3886611,,2016,"{'bei': '15.74', 'le': '0.32', 'lle': '2.76', 'sei': '11.98'}",CHEMBL3894532,,CHEMBL3894532,8.40,False,http://www.openphacts.org/units/Nanomolar,2869372,=,37,True,=,,IC50,nM,,4.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,4.0
378546,17752166,[],CHEMBL3888180,"Homogenous Time-Resolved Fluorescence Assay (HTRF2 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 0.2 nM GST-hMDM2 (aa 1-188), 0.5 nM biotinylated-p53 (aa 1-83), 0.18 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 100 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.",B,,,BAO_0000190,BAO_0000224,protein format,CC[C@@H](CN1CCOC(C)(C)C1)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1,,,CHEMBL3886611,,2016,"{'bei': '15.18', 'le': '0.31', 'lle': '2.10', 'sei': '12.16'}",CHEMBL3980222,,CHEMBL3980222,8.52,False,http://www.openphacts.org/units/Nanomolar,2869374,=,37,True,=,,IC50,nM,,3.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,3.0
378547,17752167,[],CHEMBL3888180,"Homogenous Time-Resolved Fluorescence Assay (HTRF2 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 0.2 nM GST-hMDM2 (aa 1-188), 0.5 nM biotinylated-p53 (aa 1-83), 0.18 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 100 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.",B,,,BAO_0000190,BAO_0000224,protein format,CC[C@@H](CN1CCN(S(=O)(=O)C2CC2)CC1)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1,,,CHEMBL3886611,,2016,"{'bei': '12.64', 'le': '0.26', 'lle': '2.63', 'sei': '8.19'}",CHEMBL3972181,,CHEMBL3972181,8.05,False,http://www.openphacts.org/units/Nanomolar,2869376,=,37,True,=,,IC50,nM,,9.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,9.0
378548,17752168,[],CHEMBL3888180,"Homogenous Time-Resolved Fluorescence Assay (HTRF2 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 0.2 nM GST-hMDM2 (aa 1-188), 0.5 nM biotinylated-p53 (aa 1-83), 0.18 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 100 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.",B,,,BAO_0000190,BAO_0000224,protein format,CC[C@@H](CN1CCN(S(C)(=O)=O)CC1)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1,,,CHEMBL3886611,,2016,"{'bei': '13.26', 'le': '0.28', 'lle': '3.21', 'sei': '8.24'}",CHEMBL3904550,,CHEMBL3904550,8.10,False,http://www.openphacts.org/units/Nanomolar,2869377,=,37,True,=,,IC50,nM,,8.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,8.0
378549,17752169,[],CHEMBL3888180,"Homogenous Time-Resolved Fluorescence Assay (HTRF2 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 0.2 nM GST-hMDM2 (aa 1-188), 0.5 nM biotinylated-p53 (aa 1-83), 0.18 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 100 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.",B,,,BAO_0000190,BAO_0000224,protein format,CC[C@@H](CN1CCN(C(C)=O)CC1)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1,,,CHEMBL3886611,,2016,"{'bei': '15.14', 'le': '0.30', 'lle': '3.23', 'sei': '10.72'}",CHEMBL3966894,,CHEMBL3966894,8.70,False,http://www.openphacts.org/units/Nanomolar,2869378,=,37,True,=,,IC50,nM,,2.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,2.0
378550,17752170,[],CHEMBL3888180,"Homogenous Time-Resolved Fluorescence Assay (HTRF2 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 0.2 nM GST-hMDM2 (aa 1-188), 0.5 nM biotinylated-p53 (aa 1-83), 0.18 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 100 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.",B,,,BAO_0000190,BAO_0000224,protein format,CC[C@@H](CN1CCN(C(=O)C2CC2)CC1)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1,,,CHEMBL3886611,,2016,"{'bei': '13.98', 'le': '0.28', 'lle': '2.54', 'sei': '10.35'}",CHEMBL3895600,,CHEMBL3895600,8.40,False,http://www.openphacts.org/units/Nanomolar,2869379,=,37,True,=,,IC50,nM,,4.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,4.0
378551,17752171,[],CHEMBL3888180,"Homogenous Time-Resolved Fluorescence Assay (HTRF2 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 0.2 nM GST-hMDM2 (aa 1-188), 0.5 nM biotinylated-p53 (aa 1-83), 0.18 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 100 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.",B,,,BAO_0000190,BAO_0000224,protein format,CC[C@@H](CN1CCOCC1)N1C(=O)[C@@](C)(Cc2noc(=O)[nH]2)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1,,,CHEMBL3886611,,2016,"{'bei': '15.17', 'le': '0.30', 'lle': '3.61', 'sei': '9.49'}",CHEMBL3963943,,CHEMBL3963943,8.70,False,http://www.openphacts.org/units/Nanomolar,2869380,=,37,True,=,,IC50,nM,,2.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,2.0
378552,17752172,[],CHEMBL3888180,"Homogenous Time-Resolved Fluorescence Assay (HTRF2 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 0.2 nM GST-hMDM2 (aa 1-188), 0.5 nM biotinylated-p53 (aa 1-83), 0.18 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 100 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.",B,,,BAO_0000190,BAO_0000224,protein format,CC[C@@H](C(=O)NC(C)(C)C)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1,,,CHEMBL3886611,,2016,"{'bei': '15.41', 'le': '0.31', 'lle': '2.00', 'sei': '9.48'}",CHEMBL4107660,,CHEMBL4107660,8.22,False,http://www.openphacts.org/units/Nanomolar,2869382,=,37,True,=,,IC50,nM,,6.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,6.0
378553,17752173,[],CHEMBL3888180,"Homogenous Time-Resolved Fluorescence Assay (HTRF2 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 0.2 nM GST-hMDM2 (aa 1-188), 0.5 nM biotinylated-p53 (aa 1-83), 0.18 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 100 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.",B,,,BAO_0000190,BAO_0000224,protein format,C[C@]1(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@@H](c2ccc(Cl)cc2)N(C(C2CC2)C2CC2)C1=O,,,CHEMBL3886611,,2016,"{'bei': '18.50', 'le': '0.37', 'lle': '2.28', 'sei': '15.62'}",CHEMBL4110280,,CHEMBL4110280,9.00,False,http://www.openphacts.org/units/Nanomolar,2869395,=,37,True,=,,IC50,nM,,1.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,1.0
378554,17752174,[],CHEMBL3888180,"Homogenous Time-Resolved Fluorescence Assay (HTRF2 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 0.2 nM GST-hMDM2 (aa 1-188), 0.5 nM biotinylated-p53 (aa 1-83), 0.18 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 100 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.",B,,,BAO_0000190,BAO_0000224,protein format,CCC(CC)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cn1,,,CHEMBL3886611,,2016,"{'bei': '17.17', 'le': '0.35', 'lle': '1.84', 'sei': '11.29'}",CHEMBL4113137,,CHEMBL4113137,7.96,False,http://www.openphacts.org/units/Nanomolar,2869402,=,37,True,=,,IC50,nM,,11.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,11.0
378555,17752175,[],CHEMBL3888180,"Homogenous Time-Resolved Fluorescence Assay (HTRF2 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 0.2 nM GST-hMDM2 (aa 1-188), 0.5 nM biotinylated-p53 (aa 1-83), 0.18 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 100 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.",B,,,BAO_0000190,BAO_0000224,protein format,CC[C@@H](C(=O)OC(C)(C)C)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cc(Cl)ccn2)[C@H]1c1ccc(Cl)cc1,,,CHEMBL3886611,,2016,"{'bei': '15.50', 'le': '0.31', 'lle': '2.25', 'sei': '8.58'}",CHEMBL4112050,,CHEMBL4112050,8.30,False,http://www.openphacts.org/units/Nanomolar,2869405,=,37,True,=,,IC50,nM,,5.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,5.0
378556,17752176,[],CHEMBL3888180,"Homogenous Time-Resolved Fluorescence Assay (HTRF2 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 0.2 nM GST-hMDM2 (aa 1-188), 0.5 nM biotinylated-p53 (aa 1-83), 0.18 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 100 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.",B,,,BAO_0000190,BAO_0000224,protein format,CCC(CN(C)S(=O)(=O)C1CC1)N1C(=O)[C@H](CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1,,,CHEMBL3886611,,2016,"{'bei': '13.96', 'le': '0.29', 'lle': '2.58', 'sei': '8.34'}",CHEMBL3922286,,CHEMBL3922286,7.92,False,http://www.openphacts.org/units/Nanomolar,2869483,=,37,True,=,,IC50,nM,,12.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,12.0
378557,17752177,[],CHEMBL3888180,"Homogenous Time-Resolved Fluorescence Assay (HTRF2 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 0.2 nM GST-hMDM2 (aa 1-188), 0.5 nM biotinylated-p53 (aa 1-83), 0.18 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 100 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.",B,,,BAO_0000190,BAO_0000224,protein format,CC[C@@H](CN(C)S(=O)(=O)C1CC1)N1C(=O)[C@H](C(C)C(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1,,,CHEMBL3886611,,2016,"{'bei': '13.24', 'le': '0.28', 'lle': '2.11', 'sei': '8.11'}",CHEMBL3944731,,CHEMBL3944731,7.70,False,http://www.openphacts.org/units/Nanomolar,2869484,=,37,True,=,,IC50,nM,,20.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,20.0
378558,17752178,[],CHEMBL3888180,"Homogenous Time-Resolved Fluorescence Assay (HTRF2 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 0.2 nM GST-hMDM2 (aa 1-188), 0.5 nM biotinylated-p53 (aa 1-83), 0.18 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 100 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.",B,,,BAO_0000190,BAO_0000224,protein format,CC[C@@H](C(=O)OC(C)(C)C)N1C(=O)[C@@](C)(Cc2nnn[nH]2)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1,,,CHEMBL3886611,,2016,"{'bei': '16.11', 'le': '0.32', 'lle': '3.07', 'sei': '8.90'}",CHEMBL2177189,,CHEMBL2177189,9.00,False,http://www.openphacts.org/units/Nanomolar,2869406,=,37,True,=,,IC50,nM,,1.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,1.0
378559,17752179,[],CHEMBL3888180,"Homogenous Time-Resolved Fluorescence Assay (HTRF2 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 0.2 nM GST-hMDM2 (aa 1-188), 0.5 nM biotinylated-p53 (aa 1-83), 0.18 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 100 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.",B,,,BAO_0000190,BAO_0000224,protein format,CC[C@@H](CNS(C)(=O)=O)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1,,,CHEMBL3886611,,2016,"{'bei': '16.62', 'le': '0.35', 'lle': '4.14', 'sei': '8.67'}",CHEMBL3125710,,CHEMBL3125710,9.00,False,http://www.openphacts.org/units/Nanomolar,2869407,=,37,True,=,,IC50,nM,,1.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,1.0
378560,17752180,[],CHEMBL3888180,"Homogenous Time-Resolved Fluorescence Assay (HTRF2 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 0.2 nM GST-hMDM2 (aa 1-188), 0.5 nM biotinylated-p53 (aa 1-83), 0.18 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 100 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.",B,,,BAO_0000190,BAO_0000224,protein format,CC[C@@H](CC(C)=O)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1,,,CHEMBL3886611,,2016,"{'bei': '17.38', 'le': '0.35', 'lle': '2.23', 'sei': '11.41'}",CHEMBL3955489,,CHEMBL3955489,8.52,False,http://www.openphacts.org/units/Nanomolar,2869408,=,37,True,=,,IC50,nM,,3.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,3.0
378561,17752181,[],CHEMBL3888180,"Homogenous Time-Resolved Fluorescence Assay (HTRF2 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 0.2 nM GST-hMDM2 (aa 1-188), 0.5 nM biotinylated-p53 (aa 1-83), 0.18 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 100 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.",B,,,BAO_0000190,BAO_0000224,protein format,CC[C@@H](CC(C)(O)C(F)(F)F)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1,,,CHEMBL3886611,,2016,"{'bei': '12.77', 'le': '0.26', 'lle': '0.14', 'sei': '9.19'}",CHEMBL3932275,,CHEMBL3932275,7.16,False,http://www.openphacts.org/units/Nanomolar,2869410,=,37,True,=,,IC50,nM,,70.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,70.0
378562,17752182,[],CHEMBL3888180,"Homogenous Time-Resolved Fluorescence Assay (HTRF2 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 0.2 nM GST-hMDM2 (aa 1-188), 0.5 nM biotinylated-p53 (aa 1-83), 0.18 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 100 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.",B,,,BAO_0000190,BAO_0000224,protein format,CC[C@@H](CC(C)(O)C(F)(F)F)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1,,,CHEMBL3886611,,2016,"{'bei': '15.52', 'le': '0.32', 'lle': '1.69', 'sei': '11.18'}",CHEMBL3932275,,CHEMBL3932275,8.70,False,http://www.openphacts.org/units/Nanomolar,2869410,=,37,True,=,,IC50,nM,,2.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,2.0
378563,17752183,[],CHEMBL3888180,"Homogenous Time-Resolved Fluorescence Assay (HTRF2 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 0.2 nM GST-hMDM2 (aa 1-188), 0.5 nM biotinylated-p53 (aa 1-83), 0.18 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 100 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.",B,,,BAO_0000190,BAO_0000224,protein format,CC[C@@H](CN(C)S(C)(=O)=O)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1,,,CHEMBL3886611,,2016,"{'bei': '15.66', 'le': '0.33', 'lle': '3.50', 'sei': '9.16'}",CHEMBL3954030,,CHEMBL3954030,8.70,False,http://www.openphacts.org/units/Nanomolar,2869411,=,37,True,=,,IC50,nM,,2.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,2.0
378564,17752184,[],CHEMBL3888180,"Homogenous Time-Resolved Fluorescence Assay (HTRF2 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 0.2 nM GST-hMDM2 (aa 1-188), 0.5 nM biotinylated-p53 (aa 1-83), 0.18 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 100 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.",B,,,BAO_0000190,BAO_0000224,protein format,CC[C@@H](CCC(C)(C)O)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1,,,CHEMBL3886611,,2016,"{'bei': '17.29', 'le': '0.35', 'lle': '2.14', 'sei': '11.56'}",CHEMBL3125705,,CHEMBL3125705,9.00,False,http://www.openphacts.org/units/Nanomolar,2869413,=,37,True,=,,IC50,nM,,1.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,1.0
378565,17752185,[],CHEMBL3888180,"Homogenous Time-Resolved Fluorescence Assay (HTRF2 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 0.2 nM GST-hMDM2 (aa 1-188), 0.5 nM biotinylated-p53 (aa 1-83), 0.18 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 100 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.",B,,,BAO_0000190,BAO_0000224,protein format,CC[C@@H](CC(O)(O)C(F)(F)F)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1,,,CHEMBL3886611,,2016,"{'bei': '15.47', 'le': '0.32', 'lle': '2.76', 'sei': '8.87'}",CHEMBL3948736,,CHEMBL3948736,8.70,False,http://www.openphacts.org/units/Nanomolar,2869414,=,37,True,=,,IC50,nM,,2.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,2.0
378566,17752186,[],CHEMBL3888180,"Homogenous Time-Resolved Fluorescence Assay (HTRF2 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 0.2 nM GST-hMDM2 (aa 1-188), 0.5 nM biotinylated-p53 (aa 1-83), 0.18 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 100 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.",B,,,BAO_0000190,BAO_0000224,protein format,CC[C@@H](CCC(C)(O)C(F)(F)F)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1,,,CHEMBL3886611,,2016,"{'bei': '15.14', 'le': '0.31', 'lle': '1.30', 'sei': '11.18'}",CHEMBL3977905,,CHEMBL3977905,8.70,False,http://www.openphacts.org/units/Nanomolar,2869415,=,37,True,=,,IC50,nM,,2.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,2.0
378567,17752187,[],CHEMBL3888180,"Homogenous Time-Resolved Fluorescence Assay (HTRF2 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 0.2 nM GST-hMDM2 (aa 1-188), 0.5 nM biotinylated-p53 (aa 1-83), 0.18 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 100 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.",B,,,BAO_0000190,BAO_0000224,protein format,CC[C@@H](CCC(C)(O)C(F)(F)F)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)C1c1ccc(Cl)cc1,,,CHEMBL3886611,,2016,"{'bei': '15.67', 'le': '0.32', 'lle': '1.60', 'sei': '11.56'}",CHEMBL3976926,,CHEMBL3976926,9.00,False,http://www.openphacts.org/units/Nanomolar,2869416,=,37,True,=,,IC50,nM,,1.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,1.0
378568,17752188,[],CHEMBL3888180,"Homogenous Time-Resolved Fluorescence Assay (HTRF2 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 0.2 nM GST-hMDM2 (aa 1-188), 0.5 nM biotinylated-p53 (aa 1-83), 0.18 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 100 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.",B,,,BAO_0000190,BAO_0000224,protein format,CC[C@@H](CCCC(C)(C)O)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)C1c1ccc(Cl)cc1,,,CHEMBL3886611,,2016,"{'bei': '15.71', 'le': '0.32', 'lle': '1.15', 'sei': '10.79'}",CHEMBL3902756,,CHEMBL3902756,8.40,False,http://www.openphacts.org/units/Nanomolar,2869417,=,37,True,=,,IC50,nM,,4.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,4.0
378569,17752189,[],CHEMBL3888180,"Homogenous Time-Resolved Fluorescence Assay (HTRF2 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 0.2 nM GST-hMDM2 (aa 1-188), 0.5 nM biotinylated-p53 (aa 1-83), 0.18 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 100 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.",B,,,BAO_0000190,BAO_0000224,protein format,CC[C@@H](CN(C)S(=O)(=O)C1CC1)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)C1c1ccc(Cl)cc1,,,CHEMBL3886611,,2016,"{'bei': '15.48', 'le': '0.32', 'lle': '3.27', 'sei': '9.47'}",CHEMBL3962770,,CHEMBL3962770,9.00,False,http://www.openphacts.org/units/Nanomolar,2869418,=,37,True,=,,IC50,nM,,1.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,1.0
378570,17752190,[],CHEMBL3888180,"Homogenous Time-Resolved Fluorescence Assay (HTRF2 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 0.2 nM GST-hMDM2 (aa 1-188), 0.5 nM biotinylated-p53 (aa 1-83), 0.18 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 100 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.",B,,,BAO_0000190,BAO_0000224,protein format,CC[C@@H](CN(C1CC1)S(C)(=O)=O)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)C1c1ccc(Cl)cc1,,,CHEMBL3886611,,2016,"{'bei': '15.48', 'le': '0.32', 'lle': '3.27', 'sei': '9.47'}",CHEMBL3893802,,CHEMBL3893802,9.00,False,http://www.openphacts.org/units/Nanomolar,2869419,=,37,True,=,,IC50,nM,,1.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,1.0
378571,17752191,[],CHEMBL3888180,"Homogenous Time-Resolved Fluorescence Assay (HTRF2 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 0.2 nM GST-hMDM2 (aa 1-188), 0.5 nM biotinylated-p53 (aa 1-83), 0.18 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 100 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.",B,,,BAO_0000190,BAO_0000224,protein format,CC[C@@H](CC(O)C(F)(F)F)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)C1c1ccc(Cl)cc1,,,CHEMBL3886611,,2016,"{'bei': '14.13', 'le': '0.29', 'lle': '1.10', 'sei': '9.92'}",CHEMBL3892703,,CHEMBL3892703,7.72,False,http://www.openphacts.org/units/Nanomolar,2869420,=,37,True,=,,IC50,nM,,19.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,19.0
378572,17752192,[],CHEMBL3888180,"Homogenous Time-Resolved Fluorescence Assay (HTRF2 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 0.2 nM GST-hMDM2 (aa 1-188), 0.5 nM biotinylated-p53 (aa 1-83), 0.18 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 100 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.",B,,,BAO_0000190,BAO_0000224,protein format,CC[C@@H](CC(O)C(F)(F)F)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)C1c1ccc(Cl)cc1,,,CHEMBL3886611,,2016,"{'bei': '14.37', 'le': '0.30', 'lle': '1.23', 'sei': '10.09'}",CHEMBL3892703,,CHEMBL3892703,7.85,False,http://www.openphacts.org/units/Nanomolar,2869420,=,37,True,=,,IC50,nM,,14.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,14.0
378573,17752193,[],CHEMBL3888180,"Homogenous Time-Resolved Fluorescence Assay (HTRF2 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 0.2 nM GST-hMDM2 (aa 1-188), 0.5 nM biotinylated-p53 (aa 1-83), 0.18 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 100 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.",B,,,BAO_0000190,BAO_0000224,protein format,CC[C@@H](CC(C)O)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)C1c1ccc(Cl)cc1,,,CHEMBL3886611,,2016,"{'bei': '17.05', 'le': '0.35', 'lle': '2.32', 'sei': '10.79'}",CHEMBL3952928,,CHEMBL3952928,8.40,False,http://www.openphacts.org/units/Nanomolar,2869421,=,37,True,=,,IC50,nM,,4.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,4.0
378574,17752194,[],CHEMBL3888180,"Homogenous Time-Resolved Fluorescence Assay (HTRF2 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 0.2 nM GST-hMDM2 (aa 1-188), 0.5 nM biotinylated-p53 (aa 1-83), 0.18 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 100 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.",B,,,BAO_0000190,BAO_0000224,protein format,CC[C@@H](CC(C)O)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)C1c1ccc(Cl)cc1,,,CHEMBL3886611,,2016,"{'bei': '17.05', 'le': '0.35', 'lle': '2.32', 'sei': '10.79'}",CHEMBL3952928,,CHEMBL3952928,8.40,False,http://www.openphacts.org/units/Nanomolar,2869421,=,37,True,=,,IC50,nM,,4.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,4.0
378575,17752195,[],CHEMBL3888180,"Homogenous Time-Resolved Fluorescence Assay (HTRF2 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 0.2 nM GST-hMDM2 (aa 1-188), 0.5 nM biotinylated-p53 (aa 1-83), 0.18 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 100 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.",B,,,BAO_0000190,BAO_0000224,protein format,CC[C@@H](CN(CC(F)(F)F)S(C)(=O)=O)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)C1c1ccc(Cl)cc1,,,CHEMBL3886611,,2016,"{'bei': '13.95', 'le': '0.30', 'lle': '2.57', 'sei': '9.16'}",CHEMBL3961625,,CHEMBL3961625,8.70,False,http://www.openphacts.org/units/Nanomolar,2869422,=,37,True,=,,IC50,nM,,2.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,2.0
378576,17752196,[],CHEMBL3888180,"Homogenous Time-Resolved Fluorescence Assay (HTRF2 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 0.2 nM GST-hMDM2 (aa 1-188), 0.5 nM biotinylated-p53 (aa 1-83), 0.18 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 100 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.",B,,,BAO_0000190,BAO_0000224,protein format,CCC(CN1CCCS1(=O)=O)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1,,,CHEMBL3886611,,2016,"{'bei': '15.86', 'le': '0.33', 'lle': '3.65', 'sei': '9.47'}",CHEMBL4115408,,CHEMBL4115408,9.00,False,http://www.openphacts.org/units/Nanomolar,2869423,=,37,True,=,,IC50,nM,,1.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,1.0
378577,17752197,[],CHEMBL3888180,"Homogenous Time-Resolved Fluorescence Assay (HTRF2 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 0.2 nM GST-hMDM2 (aa 1-188), 0.5 nM biotinylated-p53 (aa 1-83), 0.18 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 100 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.",B,,,BAO_0000190,BAO_0000224,protein format,CCC([C@H](C)C(C)(C)O)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1,,,CHEMBL3886611,,2016,"{'bei': '15.80', 'le': '0.32', 'lle': '1.50', 'sei': '10.56'}",CHEMBL3969208,,CHEMBL3969208,8.22,False,http://www.openphacts.org/units/Nanomolar,2869424,=,37,True,=,,IC50,nM,,6.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,6.0
378578,17752198,[],CHEMBL3888180,"Homogenous Time-Resolved Fluorescence Assay (HTRF2 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 0.2 nM GST-hMDM2 (aa 1-188), 0.5 nM biotinylated-p53 (aa 1-83), 0.18 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 100 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.",B,,,BAO_0000190,BAO_0000224,protein format,CCC(CC(C)(C)C#N)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1,,,CHEMBL3886611,,2016,"{'bei': '16.88', 'le': '0.34', 'lle': '1.45', 'sei': '10.69'}",CHEMBL4108719,,CHEMBL4108719,8.70,False,http://www.openphacts.org/units/Nanomolar,2869425,=,37,True,=,,IC50,nM,,2.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,2.0
378579,17752199,[],CHEMBL3888180,"Homogenous Time-Resolved Fluorescence Assay (HTRF2 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 0.2 nM GST-hMDM2 (aa 1-188), 0.5 nM biotinylated-p53 (aa 1-83), 0.18 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 100 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.",B,,,BAO_0000190,BAO_0000224,protein format,CC[C@@H](C(C)=O)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1,,,CHEMBL3886611,,2016,"{'bei': '17.26', 'le': '0.35', 'lle': '2.32', 'sei': '11.01'}",CHEMBL4110761,,CHEMBL4110761,8.22,False,http://www.openphacts.org/units/Nanomolar,2869426,=,37,True,=,,IC50,nM,,6.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,6.0
378580,17752200,[],CHEMBL3888180,"Homogenous Time-Resolved Fluorescence Assay (HTRF2 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 0.2 nM GST-hMDM2 (aa 1-188), 0.5 nM biotinylated-p53 (aa 1-83), 0.18 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 100 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.",B,,,BAO_0000190,BAO_0000224,protein format,CC[C@@H]([C@H](C)O)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1,,,CHEMBL3886611,,2016,"{'bei': '18.81', 'le': '0.38', 'lle': '3.31', 'sei': '11.56'}",CHEMBL2059435,,CHEMBL2059435,9.00,False,http://www.openphacts.org/units/Nanomolar,2869427,=,37,True,=,,IC50,nM,,1.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,1.0
378581,17752201,[],CHEMBL3888180,"Homogenous Time-Resolved Fluorescence Assay (HTRF2 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 0.2 nM GST-hMDM2 (aa 1-188), 0.5 nM biotinylated-p53 (aa 1-83), 0.18 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 100 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.",B,,,BAO_0000190,BAO_0000224,protein format,CC[C@@H]([C@H](C)CO)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1,,,CHEMBL3886611,,2016,"{'bei': '17.67', 'le': '0.36', 'lle': '2.76', 'sei': '11.18'}",CHEMBL4108869,,CHEMBL4108869,8.70,False,http://www.openphacts.org/units/Nanomolar,2869485,=,37,True,=,,IC50,nM,,2.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,2.0
378582,17752202,[],CHEMBL3888180,"Homogenous Time-Resolved Fluorescence Assay (HTRF2 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 0.2 nM GST-hMDM2 (aa 1-188), 0.5 nM biotinylated-p53 (aa 1-83), 0.18 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 100 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.",B,,,BAO_0000190,BAO_0000224,protein format,CC[C@@H]([C@@H](C)O)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1,,,CHEMBL3886611,,2016,"{'bei': '18.18', 'le': '0.37', 'lle': '3.01', 'sei': '11.18'}",CHEMBL4112746,,CHEMBL4112746,8.70,False,http://www.openphacts.org/units/Nanomolar,2869428,=,37,True,=,,IC50,nM,,2.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,2.0
378583,17752203,[],CHEMBL3888180,"Homogenous Time-Resolved Fluorescence Assay (HTRF2 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 0.2 nM GST-hMDM2 (aa 1-188), 0.5 nM biotinylated-p53 (aa 1-83), 0.18 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 100 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.",B,,,BAO_0000190,BAO_0000224,protein format,CC[C@H]([C@H](C)O)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1,,,CHEMBL3886611,,2016,"{'bei': '16.64', 'le': '0.34', 'lle': '2.27', 'sei': '10.22'}",CHEMBL3960530,,CHEMBL3960530,7.96,False,http://www.openphacts.org/units/Nanomolar,2869486,=,37,True,=,,IC50,nM,,11.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,11.0
378584,17752204,[],CHEMBL3888180,"Homogenous Time-Resolved Fluorescence Assay (HTRF2 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 0.2 nM GST-hMDM2 (aa 1-188), 0.5 nM biotinylated-p53 (aa 1-83), 0.18 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 100 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.",B,,,BAO_0000190,BAO_0000224,protein format,CC[C@H](N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1)C(C)(C)O,,,CHEMBL3886611,,2016,"{'bei': '17.67', 'le': '0.36', 'lle': '2.62', 'sei': '11.18'}",CHEMBL3125703,,CHEMBL3125703,8.70,False,http://www.openphacts.org/units/Nanomolar,2869429,=,37,True,=,,IC50,nM,,2.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,2.0
378585,17752205,[],CHEMBL3888180,"Homogenous Time-Resolved Fluorescence Assay (HTRF2 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 0.2 nM GST-hMDM2 (aa 1-188), 0.5 nM biotinylated-p53 (aa 1-83), 0.18 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 100 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.",B,,,BAO_0000190,BAO_0000224,protein format,CC[C@@H](CCO)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1,,,CHEMBL3886611,,2016,"{'bei': '18.18', 'le': '0.37', 'lle': '3.01', 'sei': '11.18'}",CHEMBL3980413,,CHEMBL3980413,8.70,False,http://www.openphacts.org/units/Nanomolar,2869431,=,37,True,=,,IC50,nM,,2.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,2.0
378586,17752206,[],CHEMBL3888180,"Homogenous Time-Resolved Fluorescence Assay (HTRF2 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 0.2 nM GST-hMDM2 (aa 1-188), 0.5 nM biotinylated-p53 (aa 1-83), 0.18 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 100 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.",B,,,BAO_0000190,BAO_0000224,protein format,CCC(CN(C)S(=O)(=O)C1CC1)N1C(=O)[C@@](C)(CC(=O)NS(C)(=O)=O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1,,,CHEMBL3886611,,2016,"{'bei': '12.48', 'le': '0.27', 'lle': '3.49', 'sei': '6.80'}",CHEMBL4108608,,CHEMBL4108608,8.22,False,http://www.openphacts.org/units/Nanomolar,2869487,=,37,True,=,,IC50,nM,,6.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,6.0
378587,17752207,[],CHEMBL3888180,"Homogenous Time-Resolved Fluorescence Assay (HTRF2 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 0.2 nM GST-hMDM2 (aa 1-188), 0.5 nM biotinylated-p53 (aa 1-83), 0.18 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 100 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.",B,,,BAO_0000190,BAO_0000224,protein format,CC[C@@H](CN(C)S(=O)(=O)C1CC1)N1C(=O)[C@@](C)(CC(=O)NCCCO)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1,,,CHEMBL3886611,,2016,"{'bei': '11.39', 'le': '0.24', 'lle': '2.13', 'sei': '6.80'}",CHEMBL3967671,,CHEMBL3967671,7.28,False,http://www.openphacts.org/units/Nanomolar,2869488,=,37,True,=,,IC50,nM,,53.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,53.0
378588,17752208,[],CHEMBL3888180,"Homogenous Time-Resolved Fluorescence Assay (HTRF2 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 0.2 nM GST-hMDM2 (aa 1-188), 0.5 nM biotinylated-p53 (aa 1-83), 0.18 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 100 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.",B,,,BAO_0000190,BAO_0000224,protein format,CC[C@@H](CN(C)S(=O)(=O)C1CC1)N1C(=O)[C@@](C)(CC(=O)NCCO)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1,,,CHEMBL3886611,,2016,"{'bei': '11.70', 'le': '0.24', 'lle': '2.55', 'sei': '6.83'}",CHEMBL3941572,,CHEMBL3941572,7.31,False,http://www.openphacts.org/units/Nanomolar,2869489,=,37,True,=,,IC50,nM,,49.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,49.0
378589,17752209,[],CHEMBL3888180,"Homogenous Time-Resolved Fluorescence Assay (HTRF2 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 0.2 nM GST-hMDM2 (aa 1-188), 0.5 nM biotinylated-p53 (aa 1-83), 0.18 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 100 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.",B,,,BAO_0000190,BAO_0000224,protein format,CC[C@@H](CN(C)S(=O)(=O)C1CC1)N1C(=O)[C@@](C)(CC(=O)NO)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1,,,CHEMBL3886611,,2016,"{'bei': '12.71', 'le': '0.27', 'lle': '2.43', 'sei': '7.09'}",CHEMBL3979336,,CHEMBL3979336,7.58,False,http://www.openphacts.org/units/Nanomolar,2869490,=,37,True,=,,IC50,nM,,26.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,26.0
378590,17752210,[],CHEMBL3888180,"Homogenous Time-Resolved Fluorescence Assay (HTRF2 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 0.2 nM GST-hMDM2 (aa 1-188), 0.5 nM biotinylated-p53 (aa 1-83), 0.18 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 100 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.",B,,,BAO_0000190,BAO_0000224,protein format,CC[C@@H](CN(C)S(=O)(=O)C1CC1)N1C(=O)[C@@](C)(CC(=O)NOC)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1,,,CHEMBL3886611,,2016,"{'bei': '12.05', 'le': '0.25', 'lle': '2.03', 'sei': '7.66'}",CHEMBL3950302,,CHEMBL3950302,7.36,False,http://www.openphacts.org/units/Nanomolar,2869491,=,37,True,=,,IC50,nM,,44.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,44.0
378591,17752211,[],CHEMBL3888180,"Homogenous Time-Resolved Fluorescence Assay (HTRF2 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 0.2 nM GST-hMDM2 (aa 1-188), 0.5 nM biotinylated-p53 (aa 1-83), 0.18 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 100 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.",B,,,BAO_0000190,BAO_0000224,protein format,CC[C@@H](CN(C)S(=O)(=O)C1CC1)N1C(=O)[C@@](C)(CC(=O)NC[C@@H](O)CO)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1,,,CHEMBL3886611,,2016,"{'bei': '10.99', 'le': '0.23', 'lle': '3.07', 'sei': '5.65'}",CHEMBL3973418,,CHEMBL3973418,7.19,False,http://www.openphacts.org/units/Nanomolar,2869492,=,37,True,=,,IC50,nM,,64.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,64.0
378592,17752212,[],CHEMBL3888180,"Homogenous Time-Resolved Fluorescence Assay (HTRF2 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 0.2 nM GST-hMDM2 (aa 1-188), 0.5 nM biotinylated-p53 (aa 1-83), 0.18 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 100 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.",B,,,BAO_0000190,BAO_0000224,protein format,CC[C@@H](CN(C)S(=O)(=O)C1CC1)N1C(=O)[C@@](C)(CC(=O)NC[C@H](O)CO)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1,,,CHEMBL3886611,,2016,"{'bei': '11.05', 'le': '0.23', 'lle': '3.12', 'sei': '5.69'}",CHEMBL3905833,,CHEMBL3905833,7.24,False,http://www.openphacts.org/units/Nanomolar,2869493,=,37,True,=,,IC50,nM,,58.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,58.0
378593,17752213,[],CHEMBL3888180,"Homogenous Time-Resolved Fluorescence Assay (HTRF2 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 0.2 nM GST-hMDM2 (aa 1-188), 0.5 nM biotinylated-p53 (aa 1-83), 0.18 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 100 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.",B,,,BAO_0000190,BAO_0000224,protein format,CC[C@@H](CN(C)S(=O)(=O)C1CC1)N1C(=O)[C@@](C)(CC(=O)NC#N)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1,,,CHEMBL3886611,,2016,"{'bei': '14.36', 'le': '0.30', 'lle': '3.45', 'sei': '7.87'}",CHEMBL3968058,,CHEMBL3968058,8.70,False,http://www.openphacts.org/units/Nanomolar,2869494,=,37,True,=,,IC50,nM,,2.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,2.0
378594,17752214,[],CHEMBL3888180,"Homogenous Time-Resolved Fluorescence Assay (HTRF2 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 0.2 nM GST-hMDM2 (aa 1-188), 0.5 nM biotinylated-p53 (aa 1-83), 0.18 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 100 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.",B,,,BAO_0000190,BAO_0000224,protein format,CC[C@@H](CN(C)S(=O)(=O)C1CC1)N1C(=O)[C@@](C)(CC(=O)NCCN(C)C)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1,,,CHEMBL3886611,,2016,"{'bei': '10.70', 'le': '0.22', 'lle': '1.64', 'sei': '7.75'}",CHEMBL3896895,,CHEMBL3896895,6.97,False,http://www.openphacts.org/units/Nanomolar,2869495,=,37,True,=,,IC50,nM,,106.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,106.0
378595,17752215,[],CHEMBL3888180,"Homogenous Time-Resolved Fluorescence Assay (HTRF2 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 0.2 nM GST-hMDM2 (aa 1-188), 0.5 nM biotinylated-p53 (aa 1-83), 0.18 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 100 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.",B,,,BAO_0000190,BAO_0000224,protein format,CC[C@@H](CN(C)S(=O)(=O)C1CC1)N1C(=O)[C@@](C)(CC(=O)NCCC(O)CO)C[C@H](c2cccc(Cl)c2)C1c1ccc(Cl)cc1,,,CHEMBL3886611,,2016,"{'bei': '11.30', 'le': '0.23', 'lle': '3.04', 'sei': '5.94'}",CHEMBL3967015,,CHEMBL3967015,7.55,False,http://www.openphacts.org/units/Nanomolar,2869496,=,37,True,=,,IC50,nM,,28.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,28.0
378596,17752216,[],CHEMBL3888180,"Homogenous Time-Resolved Fluorescence Assay (HTRF2 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 0.2 nM GST-hMDM2 (aa 1-188), 0.5 nM biotinylated-p53 (aa 1-83), 0.18 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 100 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.",B,,,BAO_0000190,BAO_0000224,protein format,CC[C@@H](CNS(=O)(=O)C1CC1)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)C1c1ccc(Cl)cc1,,,CHEMBL3886611,,2016,"{'bei': '15.86', 'le': '0.33', 'lle': '3.61', 'sei': '8.67'}",CHEMBL3892226,,CHEMBL3892226,9.00,False,http://www.openphacts.org/units/Nanomolar,2869497,=,37,True,=,,IC50,nM,,1.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,1.0
378597,17752217,[],CHEMBL3888180,"Homogenous Time-Resolved Fluorescence Assay (HTRF2 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 0.2 nM GST-hMDM2 (aa 1-188), 0.5 nM biotinylated-p53 (aa 1-83), 0.18 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 100 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.",B,,,BAO_0000190,BAO_0000224,protein format,CC[C@@H](CN(C)S(=O)(=O)C1CC1)N1C(=O)[C@@](C)(C(C)C(=O)O)C[C@H](c2cccc(Cl)c2)C1c1ccc(Cl)cc1,,,CHEMBL3886611,,2016,"{'bei': '13.14', 'le': '0.27', 'lle': '1.84', 'sei': '8.24'}",CHEMBL3981404,,CHEMBL3981404,7.82,False,http://www.openphacts.org/units/Nanomolar,2869498,=,37,True,=,,IC50,nM,,15.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,15.0
378598,17752218,[],CHEMBL3888180,"Homogenous Time-Resolved Fluorescence Assay (HTRF2 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 0.2 nM GST-hMDM2 (aa 1-188), 0.5 nM biotinylated-p53 (aa 1-83), 0.18 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 100 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.",B,,,BAO_0000190,BAO_0000224,protein format,CC[C@@H](C(C)NS(=O)(=O)C1CC1)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)C1c1ccc(Cl)cc1,,,CHEMBL3886611,,2016,"{'bei': '14.96', 'le': '0.31', 'lle': '2.92', 'sei': '8.38'}",CHEMBL4113117,,CHEMBL4113117,8.70,False,http://www.openphacts.org/units/Nanomolar,2869499,=,37,True,=,,IC50,nM,,2.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,2.0
378599,17752219,[],CHEMBL3888180,"Homogenous Time-Resolved Fluorescence Assay (HTRF2 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 0.2 nM GST-hMDM2 (aa 1-188), 0.5 nM biotinylated-p53 (aa 1-83), 0.18 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 100 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.",B,,,BAO_0000190,BAO_0000224,protein format,CC[C@@H](C(C)NS(=O)(=O)C1CC1)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)C1c1ccc(Cl)cc1,,,CHEMBL3886611,,2016,"{'bei': '15.48', 'le': '0.32', 'lle': '3.22', 'sei': '8.67'}",CHEMBL4113117,,CHEMBL4113117,9.00,False,http://www.openphacts.org/units/Nanomolar,2869499,=,37,True,=,,IC50,nM,,1.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,1.0
378600,17752220,[],CHEMBL3888180,"Homogenous Time-Resolved Fluorescence Assay (HTRF2 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 0.2 nM GST-hMDM2 (aa 1-188), 0.5 nM biotinylated-p53 (aa 1-83), 0.18 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 100 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.",B,,,BAO_0000190,BAO_0000224,protein format,CC[C@@H](C(C)NS(=O)(=O)C(C)C)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)C1c1ccc(Cl)cc1,,,CHEMBL3886611,,2016,"{'bei': '14.60', 'le': '0.31', 'lle': '2.49', 'sei': '8.21'}",CHEMBL4111025,,CHEMBL4111025,8.52,False,http://www.openphacts.org/units/Nanomolar,2869500,=,37,True,=,,IC50,nM,,3.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,3.0
378601,17752221,[],CHEMBL3888180,"Homogenous Time-Resolved Fluorescence Assay (HTRF2 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 0.2 nM GST-hMDM2 (aa 1-188), 0.5 nM biotinylated-p53 (aa 1-83), 0.18 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 100 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.",B,,,BAO_0000190,BAO_0000224,protein format,CC[C@@H](C(=O)N(C)S(=O)(=O)C1CC1)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1,,,CHEMBL3886611,,2016,"{'bei': '12.22', 'le': '0.25', 'lle': '2.02', 'sei': '6.49'}",CHEMBL4107560,,CHEMBL4107560,7.28,False,http://www.openphacts.org/units/Nanomolar,2869501,=,37,True,=,,IC50,nM,,53.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,53.0
378602,17752222,[],CHEMBL3888180,"Homogenous Time-Resolved Fluorescence Assay (HTRF2 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 0.2 nM GST-hMDM2 (aa 1-188), 0.5 nM biotinylated-p53 (aa 1-83), 0.18 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 100 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.",B,,,BAO_0000190,BAO_0000224,protein format,CC[C@@H](C(=O)NCC(C)(C)C)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1,,,CHEMBL3886611,,2016,"{'bei': '15.02', 'le': '0.30', 'lle': '1.75', 'sei': '9.48'}",CHEMBL4107867,,CHEMBL4107867,8.22,False,http://www.openphacts.org/units/Nanomolar,2869434,=,37,True,=,,IC50,nM,,6.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,6.0
378603,17752223,[],CHEMBL3888180,"Homogenous Time-Resolved Fluorescence Assay (HTRF2 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 0.2 nM GST-hMDM2 (aa 1-188), 0.5 nM biotinylated-p53 (aa 1-83), 0.18 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 100 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.",B,,,BAO_0000190,BAO_0000224,protein format,CC[C@@H](CN(CC(F)(F)F)C(C)=O)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1,,,CHEMBL3886611,,2016,"{'bei': '13.78', 'le': '0.28', 'lle': '1.38', 'sei': '10.39'}",CHEMBL3904755,,CHEMBL3904755,8.10,False,http://www.openphacts.org/units/Nanomolar,2869436,=,37,True,=,,IC50,nM,,8.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,8.0
378604,17752224,[],CHEMBL3888180,"Homogenous Time-Resolved Fluorescence Assay (HTRF2 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 0.2 nM GST-hMDM2 (aa 1-188), 0.5 nM biotinylated-p53 (aa 1-83), 0.18 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 100 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.",B,,,BAO_0000190,BAO_0000224,protein format,CC[C@@H](CNS(=O)(=O)C(C)(C)C)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1,,,CHEMBL3886611,,2016,"{'bei': '14.91', 'le': '0.31', 'lle': '2.67', 'sei': '8.38'}",CHEMBL3125513,,CHEMBL3125513,8.70,False,http://www.openphacts.org/units/Nanomolar,2869502,=,37,True,=,,IC50,nM,,2.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,2.0
378605,17752225,[],CHEMBL3888180,"Homogenous Time-Resolved Fluorescence Assay (HTRF2 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 0.2 nM GST-hMDM2 (aa 1-188), 0.5 nM biotinylated-p53 (aa 1-83), 0.18 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 100 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.",B,,,BAO_0000190,BAO_0000224,protein format,CC[C@@H](CN(C)S(=O)(=O)C(C)(C)C)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1,,,CHEMBL3886611,,2016,"{'bei': '14.05', 'le': '0.29', 'lle': '2.03', 'sei': '8.84'}",CHEMBL3125515,,CHEMBL3125515,8.40,False,http://www.openphacts.org/units/Nanomolar,2869503,=,37,True,=,,IC50,nM,,4.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,4.0
378606,17752226,[],CHEMBL3888180,"Homogenous Time-Resolved Fluorescence Assay (HTRF2 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 0.2 nM GST-hMDM2 (aa 1-188), 0.5 nM biotinylated-p53 (aa 1-83), 0.18 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 100 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.",B,,,BAO_0000190,BAO_0000224,protein format,CC[C@@H](CNS(=O)(=O)C(C)C)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1,,,CHEMBL3886611,,2016,"{'bei': '14.96', 'le': '0.31', 'lle': '2.88', 'sei': '8.21'}",CHEMBL3955779,,CHEMBL3955779,8.52,False,http://www.openphacts.org/units/Nanomolar,2869504,=,37,True,=,,IC50,nM,,3.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,3.0
378607,17752227,[],CHEMBL3888180,"Homogenous Time-Resolved Fluorescence Assay (HTRF2 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 0.2 nM GST-hMDM2 (aa 1-188), 0.5 nM biotinylated-p53 (aa 1-83), 0.18 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 100 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.",B,,,BAO_0000190,BAO_0000224,protein format,CC[C@@H](CN(CC)S(=O)(=O)C(C)C)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1,,,CHEMBL3886611,,2016,"{'bei': '13.20', 'le': '0.28', 'lle': '1.52', 'sei': '8.30'}",CHEMBL3947547,,CHEMBL3947547,7.89,False,http://www.openphacts.org/units/Nanomolar,2869505,=,37,True,=,,IC50,nM,,13.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,13.0
378608,17752228,[],CHEMBL3888180,"Homogenous Time-Resolved Fluorescence Assay (HTRF2 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 0.2 nM GST-hMDM2 (aa 1-188), 0.5 nM biotinylated-p53 (aa 1-83), 0.18 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 100 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.",B,,,BAO_0000190,BAO_0000224,protein format,CC[C@@H](CO)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1,,,CHEMBL3886611,,2016,"{'bei': '18.73', 'le': '0.38', 'lle': '3.40', 'sei': '11.18'}",CHEMBL2177191,,CHEMBL2177191,8.70,False,http://www.openphacts.org/units/Nanomolar,2869437,=,37,True,=,,IC50,nM,,2.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,2.0
378609,17752229,[],CHEMBL3888180,"Homogenous Time-Resolved Fluorescence Assay (HTRF2 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 0.2 nM GST-hMDM2 (aa 1-188), 0.5 nM biotinylated-p53 (aa 1-83), 0.18 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 100 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.",B,,,BAO_0000190,BAO_0000224,protein format,CC[C@@H](CNS(=O)(=O)C(F)(F)F)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1,,,CHEMBL3886611,,2016,"{'bei': '13.69', 'le': '0.29', 'lle': '2.40', 'sei': '7.86'}",CHEMBL3947049,,CHEMBL3947049,8.15,False,http://www.openphacts.org/units/Nanomolar,2869506,=,37,True,=,,IC50,nM,,7.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,7.0
378610,17752230,[],CHEMBL3888180,"Homogenous Time-Resolved Fluorescence Assay (HTRF2 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 0.2 nM GST-hMDM2 (aa 1-188), 0.5 nM biotinylated-p53 (aa 1-83), 0.18 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 100 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.",B,,,BAO_0000190,BAO_0000224,protein format,CC[C@@H](CNS(=O)(=O)c1ccc(Cl)cc1)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1,,,CHEMBL3886611,,2016,"{'bei': '13.36', 'le': '0.28', 'lle': '1.58', 'sei': '8.21'}",CHEMBL3919843,,CHEMBL3919843,8.52,False,http://www.openphacts.org/units/Nanomolar,2869507,=,37,True,=,,IC50,nM,,3.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,3.0
378611,17752231,[],CHEMBL3888180,"Homogenous Time-Resolved Fluorescence Assay (HTRF2 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 0.2 nM GST-hMDM2 (aa 1-188), 0.5 nM biotinylated-p53 (aa 1-83), 0.18 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 100 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.",B,,,BAO_0000190,BAO_0000224,protein format,CC[C@@H](CNS(=O)(=O)c1ccc(C)cc1)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1,,,CHEMBL3886611,,2016,"{'bei': '14.57', 'le': '0.30', 'lle': '2.40', 'sei': '8.67'}",CHEMBL3960885,,CHEMBL3960885,9.00,False,http://www.openphacts.org/units/Nanomolar,2869508,=,37,True,=,,IC50,nM,,1.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,1.0
378612,17752232,[],CHEMBL3888180,"Homogenous Time-Resolved Fluorescence Assay (HTRF2 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 0.2 nM GST-hMDM2 (aa 1-188), 0.5 nM biotinylated-p53 (aa 1-83), 0.18 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 100 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.",B,,,BAO_0000190,BAO_0000224,protein format,CC[C@@H](CNS(=O)(=O)c1ccccc1Cl)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1,,,CHEMBL3886611,,2016,"{'bei': '13.36', 'le': '0.28', 'lle': '1.58', 'sei': '8.21'}",CHEMBL3902491,,CHEMBL3902491,8.52,False,http://www.openphacts.org/units/Nanomolar,2869509,=,37,True,=,,IC50,nM,,3.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,3.0
378613,17752233,[],CHEMBL3888180,"Homogenous Time-Resolved Fluorescence Assay (HTRF2 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 0.2 nM GST-hMDM2 (aa 1-188), 0.5 nM biotinylated-p53 (aa 1-83), 0.18 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 100 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.",B,,,BAO_0000190,BAO_0000224,protein format,CC[C@@H](CNS(=O)(=O)c1ccccc1C)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1,,,CHEMBL3886611,,2016,"{'bei': '13.44', 'le': '0.28', 'lle': '1.70', 'sei': '8.00'}",CHEMBL3891284,,CHEMBL3891284,8.30,False,http://www.openphacts.org/units/Nanomolar,2869510,=,37,True,=,,IC50,nM,,5.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,5.0
378614,17752234,[],CHEMBL3888180,"Homogenous Time-Resolved Fluorescence Assay (HTRF2 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 0.2 nM GST-hMDM2 (aa 1-188), 0.5 nM biotinylated-p53 (aa 1-83), 0.18 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 100 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.",B,,,BAO_0000190,BAO_0000224,protein format,CC[C@@H](CNS(=O)(=O)c1ccc(OC)cc1)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1,,,CHEMBL3886611,,2016,"{'bei': '14.20', 'le': '0.29', 'lle': '2.70', 'sei': '7.96'}",CHEMBL3919357,,CHEMBL3919357,9.00,False,http://www.openphacts.org/units/Nanomolar,2869511,=,37,True,=,,IC50,nM,,1.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,1.0
378615,17752235,[],CHEMBL3888180,"Homogenous Time-Resolved Fluorescence Assay (HTRF2 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 0.2 nM GST-hMDM2 (aa 1-188), 0.5 nM biotinylated-p53 (aa 1-83), 0.18 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 100 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.",B,,,BAO_0000190,BAO_0000224,protein format,CC[C@@H](CNS(=O)(=O)c1ccccc1)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1,,,CHEMBL3886611,,2016,"{'bei': '14.91', 'le': '0.31', 'lle': '2.71', 'sei': '8.67'}",CHEMBL3974584,,CHEMBL3974584,9.00,False,http://www.openphacts.org/units/Nanomolar,2869512,=,37,True,=,,IC50,nM,,1.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,1.0
378616,17752236,[],CHEMBL3888180,"Homogenous Time-Resolved Fluorescence Assay (HTRF2 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 0.2 nM GST-hMDM2 (aa 1-188), 0.5 nM biotinylated-p53 (aa 1-83), 0.18 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 100 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.",B,,,BAO_0000190,BAO_0000224,protein format,CC[C@@H](CNS(=O)(=O)C1(C)CC1)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1,,,CHEMBL3886611,,2016,"{'bei': '15.48', 'le': '0.32', 'lle': '3.22', 'sei': '8.67'}",CHEMBL3896807,,CHEMBL3896807,9.00,False,http://www.openphacts.org/units/Nanomolar,2869513,=,37,True,=,,IC50,nM,,1.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,1.0
378617,17752237,[],CHEMBL3888180,"Homogenous Time-Resolved Fluorescence Assay (HTRF2 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 0.2 nM GST-hMDM2 (aa 1-188), 0.5 nM biotinylated-p53 (aa 1-83), 0.18 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 100 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.",B,,,BAO_0000190,BAO_0000224,protein format,CC[C@@H](CN1Cc2ccccc2S1(=O)=O)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1,,,CHEMBL3886611,,2016,"{'bei': '13.48', 'le': '0.28', 'lle': '1.79', 'sei': '8.74'}",CHEMBL3975667,,CHEMBL3975667,8.30,False,http://www.openphacts.org/units/Nanomolar,2869514,=,37,True,=,,IC50,nM,,5.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,5.0
378618,17752238,[],CHEMBL3888180,"Homogenous Time-Resolved Fluorescence Assay (HTRF2 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 0.2 nM GST-hMDM2 (aa 1-188), 0.5 nM biotinylated-p53 (aa 1-83), 0.18 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 100 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.",B,,,BAO_0000190,BAO_0000224,protein format,CC[C@@H](CN1C(C)(C)c2ccccc2S1(=O)=O)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1,,,CHEMBL3886611,,2016,"{'bei': '13.52', 'le': '0.28', 'lle': '1.45', 'sei': '9.16'}",CHEMBL3904865,,CHEMBL3904865,8.70,False,http://www.openphacts.org/units/Nanomolar,2869515,=,37,True,=,,IC50,nM,,2.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,2.0
378619,17752239,[],CHEMBL3888180,"Homogenous Time-Resolved Fluorescence Assay (HTRF2 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 0.2 nM GST-hMDM2 (aa 1-188), 0.5 nM biotinylated-p53 (aa 1-83), 0.18 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 100 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.",B,,,BAO_0000190,BAO_0000224,protein format,CC[C@@H](CNS(=O)(=O)c1cccnc1)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1,,,CHEMBL3886611,,2016,,CHEMBL3980529,,CHEMBL3980529,,False,http://www.openphacts.org/units/Nanomolar,2869516,<,37,True,<,,IC50,nM,,1.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,1.0
378620,17752240,[],CHEMBL3888180,"Homogenous Time-Resolved Fluorescence Assay (HTRF2 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 0.2 nM GST-hMDM2 (aa 1-188), 0.5 nM biotinylated-p53 (aa 1-83), 0.18 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 100 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.",B,,,BAO_0000190,BAO_0000224,protein format,CC[C@@H](CNS(=O)(=O)c1ccc(C#N)cc1)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1,,,CHEMBL3886611,,2016,,CHEMBL3913854,,CHEMBL3913854,,False,http://www.openphacts.org/units/Nanomolar,2869517,<,37,True,<,,IC50,nM,,1.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,1.0
378621,17752241,[],CHEMBL3888180,"Homogenous Time-Resolved Fluorescence Assay (HTRF2 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 0.2 nM GST-hMDM2 (aa 1-188), 0.5 nM biotinylated-p53 (aa 1-83), 0.18 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 100 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.",B,,,BAO_0000190,BAO_0000224,protein format,CC[C@@H](CNS(=O)(=O)c1cccc(C#N)c1)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1,,,CHEMBL3886611,,2016,,CHEMBL3899019,,CHEMBL3899019,,False,http://www.openphacts.org/units/Nanomolar,2869518,<,37,True,<,,IC50,nM,,1.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,1.0
378622,17752242,[],CHEMBL3888180,"Homogenous Time-Resolved Fluorescence Assay (HTRF2 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 0.2 nM GST-hMDM2 (aa 1-188), 0.5 nM biotinylated-p53 (aa 1-83), 0.18 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 100 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.",B,,,BAO_0000190,BAO_0000224,protein format,CC[C@@H](CNS(=O)(=O)c1ccccn1)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1,,,CHEMBL3886611,,2016,"{'bei': '14.89', 'le': '0.31', 'lle': '3.32', 'sei': '7.71'}",CHEMBL3927069,,CHEMBL3927069,9.00,False,http://www.openphacts.org/units/Nanomolar,2869519,=,37,True,=,,IC50,nM,,1.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,1.0
378623,17752243,[],CHEMBL3888180,"Homogenous Time-Resolved Fluorescence Assay (HTRF2 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 0.2 nM GST-hMDM2 (aa 1-188), 0.5 nM biotinylated-p53 (aa 1-83), 0.18 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 100 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.",B,,,BAO_0000190,BAO_0000224,protein format,CC[C@@H](CN(C)S(=O)(=O)C1(C)CC1)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1,,,CHEMBL3886611,,2016,"{'bei': '15.11', 'le': '0.32', 'lle': '2.88', 'sei': '9.47'}",CHEMBL3945887,,CHEMBL3945887,9.00,False,http://www.openphacts.org/units/Nanomolar,2869520,=,37,True,=,,IC50,nM,,1.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,1.0
378624,17752244,[],CHEMBL3888180,"Homogenous Time-Resolved Fluorescence Assay (HTRF2 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 0.2 nM GST-hMDM2 (aa 1-188), 0.5 nM biotinylated-p53 (aa 1-83), 0.18 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 100 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.",B,,,BAO_0000190,BAO_0000224,protein format,CC[C@@H](CN(C)S(=O)(=O)C1CC1)N1C(=O)[C@](C)(CCC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1,,,CHEMBL3886611,,2016,"{'bei': '12.35', 'le': '0.26', 'lle': '1.24', 'sei': '7.74'}",CHEMBL3935901,,CHEMBL3935901,7.36,False,http://www.openphacts.org/units/Nanomolar,2869521,=,37,True,=,,IC50,nM,,44.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,44.0
378625,17752245,[],CHEMBL3888180,"Homogenous Time-Resolved Fluorescence Assay (HTRF2 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 0.2 nM GST-hMDM2 (aa 1-188), 0.5 nM biotinylated-p53 (aa 1-83), 0.18 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 100 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.",B,,,BAO_0000190,BAO_0000224,protein format,CC[C@@H](CN(C)S(=O)(=O)C1CC1)N1C(=O)[C@@](CC)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1,,,CHEMBL3886611,,2016,"{'bei': '14.61', 'le': '0.30', 'lle': '2.58', 'sei': '9.16'}",CHEMBL3940783,,CHEMBL3940783,8.70,False,http://www.openphacts.org/units/Nanomolar,2869522,=,37,True,=,,IC50,nM,,2.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,2.0
378626,17752246,[],CHEMBL3888180,"Homogenous Time-Resolved Fluorescence Assay (HTRF2 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 0.2 nM GST-hMDM2 (aa 1-188), 0.5 nM biotinylated-p53 (aa 1-83), 0.18 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 100 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.",B,,,BAO_0000190,BAO_0000224,protein format,CC[C@@H](CN(C)S(=O)(=O)C1CC1)N1C(=O)[C@](CC(=O)O)(OC)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1,,,CHEMBL3886611,,2016,"{'bei': '15.06', 'le': '0.32', 'lle': '3.89', 'sei': '8.64'}",CHEMBL3948246,,CHEMBL3948246,9.00,False,http://www.openphacts.org/units/Nanomolar,2869523,=,37,True,=,,IC50,nM,,1.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,1.0
378627,17752247,[],CHEMBL3888180,"Homogenous Time-Resolved Fluorescence Assay (HTRF2 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 0.2 nM GST-hMDM2 (aa 1-188), 0.5 nM biotinylated-p53 (aa 1-83), 0.18 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 100 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.",B,,,BAO_0000190,BAO_0000224,protein format,CCC(C(=O)CC(C)C)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1,,,CHEMBL3886611,,2016,"{'bei': '16.78', 'le': '0.34', 'lle': '1.77', 'sei': '11.65'}",CHEMBL4107468,,CHEMBL4107468,8.70,False,http://www.openphacts.org/units/Nanomolar,2869524,=,37,True,=,,IC50,nM,,2.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,2.0
378628,17752248,[],CHEMBL3888180,"Homogenous Time-Resolved Fluorescence Assay (HTRF2 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 0.2 nM GST-hMDM2 (aa 1-188), 0.5 nM biotinylated-p53 (aa 1-83), 0.18 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 100 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.",B,,,BAO_0000190,BAO_0000224,protein format,CC[C@@H](CCS(=O)(=O)CC)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)C1c1ccc(Cl)cc1,,,CHEMBL3886611,,2016,"{'bei': '16.23', 'le': '0.34', 'lle': '2.86', 'sei': '9.81'}",CHEMBL3921531,,CHEMBL3921531,9.00,False,http://www.openphacts.org/units/Nanomolar,2869438,=,37,True,=,,IC50,nM,,1.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,1.0
378629,17752249,[],CHEMBL3888180,"Homogenous Time-Resolved Fluorescence Assay (HTRF2 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 0.2 nM GST-hMDM2 (aa 1-188), 0.5 nM biotinylated-p53 (aa 1-83), 0.18 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 100 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.",B,,,BAO_0000190,BAO_0000224,protein format,CC[C@@H](CCS(=O)(=O)C(C)C)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)C1c1ccc(Cl)cc1,,,CHEMBL3886611,,2016,"{'bei': '14.99', 'le': '0.31', 'lle': '2.00', 'sei': '9.29'}",CHEMBL3957985,,CHEMBL3957985,8.52,False,http://www.openphacts.org/units/Nanomolar,2869439,=,37,True,=,,IC50,nM,,3.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,3.0
378630,17752250,[],CHEMBL3888180,"Homogenous Time-Resolved Fluorescence Assay (HTRF2 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 0.2 nM GST-hMDM2 (aa 1-188), 0.5 nM biotinylated-p53 (aa 1-83), 0.18 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 100 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.",B,,,BAO_0000190,BAO_0000224,protein format,CC[C@@H](CCS(=O)(=O)CC1CC1)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)C1c1ccc(Cl)cc1,,,CHEMBL3886611,,2016,"{'bei': '13.86', 'le': '0.29', 'lle': '1.52', 'sei': '8.77'}",CHEMBL3919318,,CHEMBL3919318,8.05,False,http://www.openphacts.org/units/Nanomolar,2869440,=,37,True,=,,IC50,nM,,9.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,9.0
378631,17752251,[],CHEMBL3888180,"Homogenous Time-Resolved Fluorescence Assay (HTRF2 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 0.2 nM GST-hMDM2 (aa 1-188), 0.5 nM biotinylated-p53 (aa 1-83), 0.18 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 100 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.",B,,,BAO_0000190,BAO_0000224,protein format,CC[C@@H](CN1CCCC1=O)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1,,,CHEMBL3886611,,2016,"{'bei': '15.34', 'le': '0.31', 'lle': '2.22', 'sei': '10.47'}",CHEMBL3899355,,CHEMBL3899355,8.15,False,http://www.openphacts.org/units/Nanomolar,2869441,=,37,True,=,,IC50,nM,,7.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,7.0
378632,17752252,[],CHEMBL3888180,"Homogenous Time-Resolved Fluorescence Assay (HTRF2 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 0.2 nM GST-hMDM2 (aa 1-188), 0.5 nM biotinylated-p53 (aa 1-83), 0.18 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 100 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.",B,,,BAO_0000190,BAO_0000224,protein format,CC[C@@H](CN1C[C@H]2C[C@@H]1CO2)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1,,,CHEMBL3886611,,2016,"{'bei': '14.75', 'le': '0.30', 'lle': '2.27', 'sei': '11.48'}",CHEMBL3926559,,CHEMBL3926559,8.05,False,http://www.openphacts.org/units/Nanomolar,2869442,=,37,True,=,,IC50,nM,,9.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,9.0
378633,17752253,[],CHEMBL3888180,"Homogenous Time-Resolved Fluorescence Assay (HTRF2 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 0.2 nM GST-hMDM2 (aa 1-188), 0.5 nM biotinylated-p53 (aa 1-83), 0.18 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 100 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.",B,,,BAO_0000190,BAO_0000224,protein format,CC[C@@H](CN1CCOCC1C)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1,,,CHEMBL3886611,,2016,"{'bei': '15.89', 'le': '0.32', 'lle': '2.67', 'sei': '12.41'}",CHEMBL3962786,,CHEMBL3962786,8.70,False,http://www.openphacts.org/units/Nanomolar,2869443,=,37,True,=,,IC50,nM,,2.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,2.0
378634,17752254,[],CHEMBL3888180,"Homogenous Time-Resolved Fluorescence Assay (HTRF2 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 0.2 nM GST-hMDM2 (aa 1-188), 0.5 nM biotinylated-p53 (aa 1-83), 0.18 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 100 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.",B,,,BAO_0000190,BAO_0000224,protein format,CC[C@@H](CN1CCS(=O)(=O)CC1)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1,,,CHEMBL3886611,,2016,"{'bei': '14.44', 'le': '0.30', 'lle': '3.36', 'sei': '8.84'}",CHEMBL3963132,,CHEMBL3963132,8.40,False,http://www.openphacts.org/units/Nanomolar,2869444,=,37,True,=,,IC50,nM,,4.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,4.0
378635,17752255,[],CHEMBL3888180,"Homogenous Time-Resolved Fluorescence Assay (HTRF2 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 0.2 nM GST-hMDM2 (aa 1-188), 0.5 nM biotinylated-p53 (aa 1-83), 0.18 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 100 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.",B,,,BAO_0000190,BAO_0000224,protein format,CC[C@@H](CN1CC(F)(F)C1)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1,,,CHEMBL3886611,,2016,"{'bei': '15.39', 'le': '0.31', 'lle': '2.04', 'sei': '13.64'}",CHEMBL3950605,,CHEMBL3950605,8.30,False,http://www.openphacts.org/units/Nanomolar,2869445,=,37,True,=,,IC50,nM,,5.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,5.0
378636,17752256,[],CHEMBL3888180,"Homogenous Time-Resolved Fluorescence Assay (HTRF2 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 0.2 nM GST-hMDM2 (aa 1-188), 0.5 nM biotinylated-p53 (aa 1-83), 0.18 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 100 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.",B,,,BAO_0000190,BAO_0000224,protein format,CC[C@@H](CN1CCOCC1(C)C)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1,,,CHEMBL3886611,,2016,"{'bei': '15.18', 'le': '0.31', 'lle': '2.10', 'sei': '12.16'}",CHEMBL3941874,,CHEMBL3941874,8.52,False,http://www.openphacts.org/units/Nanomolar,2869447,=,37,True,=,,IC50,nM,,3.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,3.0
378637,17752257,[],CHEMBL3888180,"Homogenous Time-Resolved Fluorescence Assay (HTRF2 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 0.2 nM GST-hMDM2 (aa 1-188), 0.5 nM biotinylated-p53 (aa 1-83), 0.18 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 100 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.",B,,,BAO_0000190,BAO_0000224,protein format,CC[C@@H](CN1CC(O)(C(F)(F)F)C1)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1,,,CHEMBL3886611,,2016,"{'bei': '14.00', 'le': '0.29', 'lle': '2.30', 'sei': '10.14'}",CHEMBL3964874,,CHEMBL3964874,8.22,False,http://www.openphacts.org/units/Nanomolar,2869448,=,37,True,=,,IC50,nM,,6.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,6.0
378638,17752258,[],CHEMBL3888180,"Homogenous Time-Resolved Fluorescence Assay (HTRF2 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 0.2 nM GST-hMDM2 (aa 1-188), 0.5 nM biotinylated-p53 (aa 1-83), 0.18 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 100 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.",B,,,BAO_0000190,BAO_0000224,protein format,CC[C@@H](CN(C)C1COC1)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1,,,CHEMBL3886611,,2016,"{'bei': '15.98', 'le': '0.32', 'lle': '2.88', 'sei': '12.16'}",CHEMBL3977225,,CHEMBL3977225,8.52,False,http://www.openphacts.org/units/Nanomolar,2869449,=,37,True,=,,IC50,nM,,3.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,3.0
378639,17752259,[],CHEMBL3888180,"Homogenous Time-Resolved Fluorescence Assay (HTRF2 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 0.2 nM GST-hMDM2 (aa 1-188), 0.5 nM biotinylated-p53 (aa 1-83), 0.18 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 100 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.",B,,,BAO_0000190,BAO_0000224,protein format,CC[C@@H](CN1CCOC1=O)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1,,,CHEMBL3886611,,2016,"{'bei': '15.56', 'le': '0.31', 'lle': '2.54', 'sei': '9.52'}",CHEMBL3966228,,CHEMBL3966228,8.30,False,http://www.openphacts.org/units/Nanomolar,2869450,=,37,True,=,,IC50,nM,,5.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,5.0
378640,17752260,[],CHEMBL3888180,"Homogenous Time-Resolved Fluorescence Assay (HTRF2 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 0.2 nM GST-hMDM2 (aa 1-188), 0.5 nM biotinylated-p53 (aa 1-83), 0.18 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 100 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.",B,,,BAO_0000190,BAO_0000224,protein format,CC[C@@H](Cn1ccccc1=O)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1,,,CHEMBL3886611,,2016,"{'bei': '14.26', 'le': '0.29', 'lle': '1.55', 'sei': '9.70'}",CHEMBL3927464,,CHEMBL3927464,7.72,False,http://www.openphacts.org/units/Nanomolar,2869451,=,37,True,=,,IC50,nM,,19.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,19.0
378641,17752261,[],CHEMBL3888180,"Homogenous Time-Resolved Fluorescence Assay (HTRF2 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 0.2 nM GST-hMDM2 (aa 1-188), 0.5 nM biotinylated-p53 (aa 1-83), 0.18 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 100 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.",B,,,BAO_0000190,BAO_0000224,protein format,CC[C@@H](Cn1cc(C(F)(F)F)ccc1=O)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1,,,CHEMBL3886611,,2016,"{'bei': '13.00', 'le': '0.26', 'lle': '0.73', 'sei': '9.95'}",CHEMBL3951659,,CHEMBL3951659,7.92,False,http://www.openphacts.org/units/Nanomolar,2869452,=,37,True,=,,IC50,nM,,12.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,12.0
378642,17752262,[],CHEMBL3888180,"Homogenous Time-Resolved Fluorescence Assay (HTRF2 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 0.2 nM GST-hMDM2 (aa 1-188), 0.5 nM biotinylated-p53 (aa 1-83), 0.18 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 100 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.",B,,,BAO_0000190,BAO_0000224,protein format,CC[C@@H](C1CCCO1)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1,,,CHEMBL3886611,,2016,"{'bei': '16.90', 'le': '0.34', 'lle': '2.03', 'sei': '12.75'}",CHEMBL4114935,,CHEMBL4114935,8.52,False,http://www.openphacts.org/units/Nanomolar,2869454,=,37,True,=,,IC50,nM,,3.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,3.0
378643,17752263,[],CHEMBL3888180,"Homogenous Time-Resolved Fluorescence Assay (HTRF2 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 0.2 nM GST-hMDM2 (aa 1-188), 0.5 nM biotinylated-p53 (aa 1-83), 0.18 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 100 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.",B,,,BAO_0000190,BAO_0000224,protein format,CC[C@@H](C1CCCO1)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1,,,CHEMBL3886611,,2016,"{'bei': '17.84', 'le': '0.36', 'lle': '2.51', 'sei': '13.46'}",CHEMBL4114935,,CHEMBL4114935,9.00,False,http://www.openphacts.org/units/Nanomolar,2869454,=,37,True,=,,IC50,nM,,1.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,1.0
378644,17752264,[],CHEMBL3888180,"Homogenous Time-Resolved Fluorescence Assay (HTRF2 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 0.2 nM GST-hMDM2 (aa 1-188), 0.5 nM biotinylated-p53 (aa 1-83), 0.18 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 100 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.",B,,,BAO_0000190,BAO_0000224,protein format,CC[C@@H](C1CCC(=O)O1)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1,,,CHEMBL3886611,,2016,"{'bei': '16.20', 'le': '0.33', 'lle': '2.38', 'sei': '10.01'}",CHEMBL3899788,,CHEMBL3899788,8.40,False,http://www.openphacts.org/units/Nanomolar,2869455,=,37,True,=,,IC50,nM,,4.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,4.0
378645,17752265,[],CHEMBL3888180,"Homogenous Time-Resolved Fluorescence Assay (HTRF2 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 0.2 nM GST-hMDM2 (aa 1-188), 0.5 nM biotinylated-p53 (aa 1-83), 0.18 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 100 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.",B,,,BAO_0000190,BAO_0000224,protein format,CC[C@@H](C1CCCCO1)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1,,,CHEMBL3886611,,2016,"{'bei': '17.36', 'le': '0.35', 'lle': '2.12', 'sei': '13.46'}",CHEMBL3924685,,CHEMBL3924685,9.00,False,http://www.openphacts.org/units/Nanomolar,2869525,=,37,True,=,,IC50,nM,,1.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,1.0
378646,17752266,[],CHEMBL3888180,"Homogenous Time-Resolved Fluorescence Assay (HTRF2 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 0.2 nM GST-hMDM2 (aa 1-188), 0.5 nM biotinylated-p53 (aa 1-83), 0.18 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 100 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.",B,,,BAO_0000190,BAO_0000224,protein format,CC[C@@H](C1CCCCO1)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1,,,CHEMBL3886611,,2016,"{'bei': '16.78', 'le': '0.34', 'lle': '1.82', 'sei': '13.01'}",CHEMBL3924685,,CHEMBL3924685,8.70,False,http://www.openphacts.org/units/Nanomolar,2869525,=,37,True,=,,IC50,nM,,2.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,2.0
378647,17752267,[],CHEMBL3888180,"Homogenous Time-Resolved Fluorescence Assay (HTRF2 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 0.2 nM GST-hMDM2 (aa 1-188), 0.5 nM biotinylated-p53 (aa 1-83), 0.18 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 100 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.",B,,,BAO_0000190,BAO_0000224,protein format,CC[C@@H](c1cccc(Cl)n1)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1,,,CHEMBL3886611,,2016,"{'bei': '16.49', 'le': '0.34', 'lle': '1.27', 'sei': '12.77'}",CHEMBL3329613,,CHEMBL3329613,9.00,False,http://www.openphacts.org/units/Nanomolar,2869526,=,37,True,=,,IC50,nM,,1.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,1.0
378648,17752268,[],CHEMBL3888180,"Homogenous Time-Resolved Fluorescence Assay (HTRF2 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 0.2 nM GST-hMDM2 (aa 1-188), 0.5 nM biotinylated-p53 (aa 1-83), 0.18 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 100 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.",B,,,BAO_0000190,BAO_0000224,protein format,CC[C@@H](c1ccccn1)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1,,,CHEMBL3886611,,2016,"{'bei': '15.64', 'le': '0.31', 'lle': '0.92', 'sei': '11.35'}",CHEMBL3329605,,CHEMBL3329605,8.00,False,http://www.openphacts.org/units/Nanomolar,2869459,=,37,True,=,,IC50,nM,,10.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,10.0
378649,17752269,[],CHEMBL3888180,"Homogenous Time-Resolved Fluorescence Assay (HTRF2 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 0.2 nM GST-hMDM2 (aa 1-188), 0.5 nM biotinylated-p53 (aa 1-83), 0.18 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 100 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.",B,,,BAO_0000190,BAO_0000224,protein format,CC[C@@H](c1cnccn1)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1,,,CHEMBL3886611,,2016,"{'bei': '15.53', 'le': '0.31', 'lle': '1.49', 'sei': '9.54'}",CHEMBL3895235,,CHEMBL3895235,7.96,False,http://www.openphacts.org/units/Nanomolar,2869463,=,37,True,=,,IC50,nM,,11.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,11.0
378650,17752270,[],CHEMBL3888180,"Homogenous Time-Resolved Fluorescence Assay (HTRF2 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 0.2 nM GST-hMDM2 (aa 1-188), 0.5 nM biotinylated-p53 (aa 1-83), 0.18 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 100 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.",B,,,BAO_0000190,BAO_0000224,protein format,CC[C@@H](c1ccncc1)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1,,,CHEMBL3886611,,2016,"{'bei': '15.73', 'le': '0.31', 'lle': '0.97', 'sei': '11.41'}",CHEMBL3329607,,CHEMBL3329607,8.05,False,http://www.openphacts.org/units/Nanomolar,2869466,=,37,True,=,,IC50,nM,,9.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,9.0
378651,17752271,[],CHEMBL3888180,"Homogenous Time-Resolved Fluorescence Assay (HTRF2 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 0.2 nM GST-hMDM2 (aa 1-188), 0.5 nM biotinylated-p53 (aa 1-83), 0.18 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 100 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.",B,,,BAO_0000190,BAO_0000224,protein format,CC[C@@H](c1cccc(C(F)(F)F)n1)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1,,,CHEMBL3886611,,2016,"{'bei': '15.53', 'le': '0.32', 'lle': '0.90', 'sei': '12.77'}",CHEMBL3932633,,CHEMBL3932633,9.00,False,http://www.openphacts.org/units/Nanomolar,2869527,=,37,True,=,,IC50,nM,,1.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,1.0
378652,17752272,[],CHEMBL3888180,"Homogenous Time-Resolved Fluorescence Assay (HTRF2 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 0.2 nM GST-hMDM2 (aa 1-188), 0.5 nM biotinylated-p53 (aa 1-83), 0.18 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 100 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.",B,,,BAO_0000190,BAO_0000224,protein format,CC[C@H](c1cccc(C(C)(C)O)n1)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1,,,CHEMBL3886611,,2016,"{'bei': '14.96', 'le': '0.30', 'lle': '1.21', 'sei': '9.39'}",CHEMBL4111092,,CHEMBL4111092,8.52,False,http://www.openphacts.org/units/Nanomolar,2869468,=,37,True,=,,IC50,nM,,3.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,3.0
378653,17752273,[],CHEMBL3888180,"Homogenous Time-Resolved Fluorescence Assay (HTRF2 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 0.2 nM GST-hMDM2 (aa 1-188), 0.5 nM biotinylated-p53 (aa 1-83), 0.18 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 100 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.",B,,,BAO_0000190,BAO_0000224,protein format,CC(C)[C@@H](c1ccccn1)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1,,,CHEMBL3886611,,2016,"{'bei': '15.31', 'le': '0.31', 'lle': '0.73', 'sei': '11.41'}",CHEMBL3329610,,CHEMBL3329610,8.05,False,http://www.openphacts.org/units/Nanomolar,2869472,=,37,True,=,,IC50,nM,,9.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,9.0
378654,17752274,[],CHEMBL3888180,"Homogenous Time-Resolved Fluorescence Assay (HTRF2 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 0.2 nM GST-hMDM2 (aa 1-188), 0.5 nM biotinylated-p53 (aa 1-83), 0.18 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 100 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.",B,,,BAO_0000190,BAO_0000224,protein format,CCC(CC)N1C(=O)[C@@](C)(Cc2nnn[nH]2)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1,,,CHEMBL3886611,,2016,"{'bei': '17.52', 'le': '0.35', 'lle': '2.52', 'sei': '11.40'}",CHEMBL4109795,,CHEMBL4109795,8.52,False,http://www.openphacts.org/units/Nanomolar,2869473,=,37,True,=,,IC50,nM,,3.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,3.0
378655,17752275,[],CHEMBL3888180,"Homogenous Time-Resolved Fluorescence Assay (HTRF2 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 0.2 nM GST-hMDM2 (aa 1-188), 0.5 nM biotinylated-p53 (aa 1-83), 0.18 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 100 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.",B,,,BAO_0000190,BAO_0000224,protein format,CC[C@@H]([C@H](C)O)N1C(=O)[C@@](C)(C[C@@H](O)CO)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1,,,CHEMBL3886611,,2016,"{'bei': '14.16', 'le': '0.29', 'lle': '2.04', 'sei': '8.64'}",CHEMBL3967652,,CHEMBL3967652,7.00,False,http://www.openphacts.org/units/Nanomolar,2869528,=,37,True,=,,IC50,nM,,100.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,100.0
378656,17752276,[],CHEMBL3888180,"Homogenous Time-Resolved Fluorescence Assay (HTRF2 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 0.2 nM GST-hMDM2 (aa 1-188), 0.5 nM biotinylated-p53 (aa 1-83), 0.18 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 100 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.",B,,,BAO_0000190,BAO_0000224,protein format,CC[C@@H]([C@H](C)O)N1C(=O)[C@@](C)(C[C@H](O)CO)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1,,,CHEMBL3886611,,2016,"{'bei': '13.01', 'le': '0.27', 'lle': '1.47', 'sei': '7.94'}",CHEMBL3941170,,CHEMBL3941170,6.43,False,http://www.openphacts.org/units/Nanomolar,2869529,=,37,True,=,,IC50,nM,,371.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,371.0
378657,17752277,[],CHEMBL3888180,"Homogenous Time-Resolved Fluorescence Assay (HTRF2 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 0.2 nM GST-hMDM2 (aa 1-188), 0.5 nM biotinylated-p53 (aa 1-83), 0.18 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 100 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.",B,,,BAO_0000190,BAO_0000224,protein format,CC[C@@H](CO)N1C(=O)[C@@](C)(C2CC2C(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1,,,CHEMBL3886611,,2016,"{'bei': '14.27', 'le': '0.29', 'lle': '1.45', 'sei': '8.99'}",CHEMBL3958840,,CHEMBL3958840,7.00,False,http://www.openphacts.org/units/Nanomolar,2869530,=,37,True,=,,IC50,nM,,100.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,100.0
378658,17752278,[],CHEMBL3888180,"Homogenous Time-Resolved Fluorescence Assay (HTRF2 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 0.2 nM GST-hMDM2 (aa 1-188), 0.5 nM biotinylated-p53 (aa 1-83), 0.18 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 100 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.",B,,,BAO_0000190,BAO_0000224,protein format,CC(C)(C)OC(=O)[C@H](C1CC1)N1C(=O)[C@@H](CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1,,,CHEMBL3886611,,2016,"{'bei': '15.44', 'le': '0.31', 'lle': '1.96', 'sei': '9.80'}",CHEMBL4114226,,CHEMBL4114226,8.22,False,http://www.openphacts.org/units/Nanomolar,2869474,=,37,True,=,,IC50,nM,,6.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,6.0
378659,17752279,[],CHEMBL3888180,"Homogenous Time-Resolved Fluorescence Assay (HTRF2 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 0.2 nM GST-hMDM2 (aa 1-188), 0.5 nM biotinylated-p53 (aa 1-83), 0.18 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 100 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.",B,,,BAO_0000190,BAO_0000224,protein format,CCOC(=O)[C@H](C1CC1)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)C1c1ccc(Cl)cc1,,,CHEMBL3886611,,2016,"{'bei': '17.36', 'le': '0.35', 'lle': '3.13', 'sei': '10.73'}",CHEMBL4107995,,CHEMBL4107995,9.00,False,http://www.openphacts.org/units/Nanomolar,2869475,=,37,True,=,,IC50,nM,,1.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,1.0
378660,17752280,[],CHEMBL3888180,"Homogenous Time-Resolved Fluorescence Assay (HTRF2 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 0.2 nM GST-hMDM2 (aa 1-188), 0.5 nM biotinylated-p53 (aa 1-83), 0.18 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 100 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.",B,,,BAO_0000190,BAO_0000224,protein format,C[C@]1(CC(=O)O)C[C@H](c2cccc(Cl)c2)C(c2ccc(Cl)cc2)N([C@H](CO)C2CC2)C1=O,,,CHEMBL3886611,,2016,"{'bei': '18.89', 'le': '0.38', 'lle': '3.70', 'sei': '11.56'}",CHEMBL4108086,,CHEMBL4108086,9.00,False,http://www.openphacts.org/units/Nanomolar,2869476,=,37,True,=,,IC50,nM,,1.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,1.0
378661,17752281,[],CHEMBL3888180,"Homogenous Time-Resolved Fluorescence Assay (HTRF2 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 0.2 nM GST-hMDM2 (aa 1-188), 0.5 nM biotinylated-p53 (aa 1-83), 0.18 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 100 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.",B,,,BAO_0000190,BAO_0000224,protein format,CC[C@]1(CC(=O)O)C[C@H](c2cccc(Cl)c2)C(c2ccc(Cl)cc2)N([C@H](CN(C)S(=O)(=O)C2CC2)C2CC2)C1=O,,,CHEMBL3886611,,2016,"{'bei': '14.81', 'le': '0.31', 'lle': '2.88', 'sei': '9.47'}",CHEMBL4107164,,CHEMBL4107164,9.00,False,http://www.openphacts.org/units/Nanomolar,2869531,=,37,True,=,,IC50,nM,,1.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,1.0
378662,17752282,[],CHEMBL3888180,"Homogenous Time-Resolved Fluorescence Assay (HTRF2 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 0.2 nM GST-hMDM2 (aa 1-188), 0.5 nM biotinylated-p53 (aa 1-83), 0.18 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 100 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.",B,,,BAO_0000190,BAO_0000224,protein format,CC[C@]1(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@@H](c2ccc(Cl)cc2)N([C@H](CNS(=O)(=O)C2CC2)C2CC2)C1=O,,,CHEMBL3886611,,2016,,CHEMBL4111967,,CHEMBL4111967,,False,http://www.openphacts.org/units/Nanomolar,2869532,<,37,True,<,,IC50,nM,,1.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,1.0
378663,17752283,[],CHEMBL3888180,"Homogenous Time-Resolved Fluorescence Assay (HTRF2 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 0.2 nM GST-hMDM2 (aa 1-188), 0.5 nM biotinylated-p53 (aa 1-83), 0.18 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 100 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.",B,,,BAO_0000190,BAO_0000224,protein format,CC[C@]1(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@@H](c2ccc(Cl)cc2)N([C@H](CNS(=O)(=O)CC)C2CC2)C1=O,,,CHEMBL3886611,,2016,,CHEMBL4112490,,CHEMBL4112490,,False,http://www.openphacts.org/units/Nanomolar,2869533,<,37,True,<,,IC50,nM,,1.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,1.0
378664,17752284,[],CHEMBL3888180,"Homogenous Time-Resolved Fluorescence Assay (HTRF2 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 0.2 nM GST-hMDM2 (aa 1-188), 0.5 nM biotinylated-p53 (aa 1-83), 0.18 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 100 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.",B,,,BAO_0000190,BAO_0000224,protein format,CN(C[C@H](C1CC1)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1)S(=O)(=O)C1CC1,,,CHEMBL3886611,,2016,,CHEMBL3125517,,CHEMBL3125517,,False,http://www.openphacts.org/units/Nanomolar,2869478,<,37,True,<,,IC50,nM,,1.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,1.0
378665,17752285,[],CHEMBL3888180,"Homogenous Time-Resolved Fluorescence Assay (HTRF2 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 0.2 nM GST-hMDM2 (aa 1-188), 0.5 nM biotinylated-p53 (aa 1-83), 0.18 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 100 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.",B,,,BAO_0000190,BAO_0000224,protein format,C[C@@H](O)[C@H](C1CC1)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1,,,CHEMBL3886611,,2016,"{'bei': '18.35', 'le': '0.37', 'lle': '3.31', 'sei': '11.56'}",CHEMBL4111710,,CHEMBL4111710,9.00,False,http://www.openphacts.org/units/Nanomolar,2869534,=,37,True,=,,IC50,nM,,1.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,1.0
378666,17752286,[],CHEMBL3888180,"Homogenous Time-Resolved Fluorescence Assay (HTRF2 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 0.2 nM GST-hMDM2 (aa 1-188), 0.5 nM biotinylated-p53 (aa 1-83), 0.18 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 100 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.",B,,,BAO_0000190,BAO_0000224,protein format,C[C@H](O)[C@H](C1CC1)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1,,,CHEMBL3886611,,2016,"{'bei': '17.74', 'le': '0.36', 'lle': '3.01', 'sei': '11.18'}",CHEMBL3975518,,CHEMBL3975518,8.70,False,http://www.openphacts.org/units/Nanomolar,2869479,=,37,True,=,,IC50,nM,,2.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,2.0
378667,17752287,[],CHEMBL3888180,"Homogenous Time-Resolved Fluorescence Assay (HTRF2 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 0.2 nM GST-hMDM2 (aa 1-188), 0.5 nM biotinylated-p53 (aa 1-83), 0.18 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 100 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.",B,,,BAO_0000190,BAO_0000224,protein format,CC(C)S(=O)(=O)NC[C@H](C1CC1)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1,,,CHEMBL3886611,,2016,"{'bei': '14.96', 'le': '0.31', 'lle': '3.06', 'sei': '8.38'}",CHEMBL4108117,,CHEMBL4108117,8.70,False,http://www.openphacts.org/units/Nanomolar,2869535,=,37,True,=,,IC50,nM,,2.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,2.0
378668,17752288,[],CHEMBL3888180,"Homogenous Time-Resolved Fluorescence Assay (HTRF2 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 0.2 nM GST-hMDM2 (aa 1-188), 0.5 nM biotinylated-p53 (aa 1-83), 0.18 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 100 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.",B,,,BAO_0000190,BAO_0000224,protein format,CN(C[C@@H](C1CC1)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1)S(=O)(=O)C1CC1,,,CHEMBL3886611,,2016,"{'bei': '13.74', 'le': '0.29', 'lle': '2.42', 'sei': '8.59'}",CHEMBL4114852,,CHEMBL4114852,8.15,False,http://www.openphacts.org/units/Nanomolar,2869536,=,37,True,=,,IC50,nM,,7.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,7.0
378669,17752289,[],CHEMBL3888180,"Homogenous Time-Resolved Fluorescence Assay (HTRF2 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 0.2 nM GST-hMDM2 (aa 1-188), 0.5 nM biotinylated-p53 (aa 1-83), 0.18 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 100 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.",B,,,BAO_0000190,BAO_0000224,protein format,CC(C)[C@@H]([C@H](C)O)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1,,,CHEMBL3886611,,2016,"{'bei': '18.28', 'le': '0.37', 'lle': '3.06', 'sei': '11.56'}",CHEMBL3983226,,CHEMBL3983226,9.00,False,http://www.openphacts.org/units/Nanomolar,2869537,=,37,True,=,,IC50,nM,,1.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,1.0
378670,17752290,[],CHEMBL3888180,"Homogenous Time-Resolved Fluorescence Assay (HTRF2 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 0.2 nM GST-hMDM2 (aa 1-188), 0.5 nM biotinylated-p53 (aa 1-83), 0.18 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 100 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.",B,,,BAO_0000190,BAO_0000224,protein format,C[C@]1(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@@H](c2ccc(Cl)cc2)N([C@@H](c2ccccn2)C2CC2)C1=O,,,CHEMBL3886611,,2016,"{'bei': '16.28', 'le': '0.32', 'lle': '1.44', 'sei': '12.09'}",CHEMBL4108893,,CHEMBL4108893,8.52,False,http://www.openphacts.org/units/Nanomolar,2869480,=,37,True,=,,IC50,nM,,3.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,3.0
378671,17752291,[],CHEMBL3888180,"Homogenous Time-Resolved Fluorescence Assay (HTRF2 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 0.2 nM GST-hMDM2 (aa 1-188), 0.5 nM biotinylated-p53 (aa 1-83), 0.18 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 100 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.",B,,,BAO_0000190,BAO_0000224,protein format,C[C@]1(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@@H](c2ccc(Cl)cc2)N([C@H](CNS(=O)(=O)c2cccs2)C2CC2)C1=O,,,CHEMBL3886611,,2016,"{'bei': '15.60', 'le': '0.33', 'lle': '3.35', 'sei': '9.35'}",CHEMBL4111986,,CHEMBL4111986,9.70,False,http://www.openphacts.org/units/Nanomolar,2869538,=,37,True,=,,IC50,nM,,0.2,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,0.2
378672,17752292,[],CHEMBL3888180,"Homogenous Time-Resolved Fluorescence Assay (HTRF2 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 0.2 nM GST-hMDM2 (aa 1-188), 0.5 nM biotinylated-p53 (aa 1-83), 0.18 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 100 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.",B,,,BAO_0000190,BAO_0000224,protein format,CN(C[C@H](C1CC1)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1)S(=O)(=O)c1cccs1,,,CHEMBL3886611,,2016,"{'bei': '14.98', 'le': '0.32', 'lle': '2.83', 'sei': '10.03'}",CHEMBL4115203,,CHEMBL4115203,9.52,False,http://www.openphacts.org/units/Nanomolar,2869539,=,37,True,=,,IC50,nM,,0.3,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,0.3
378673,17752293,[],CHEMBL3888180,"Homogenous Time-Resolved Fluorescence Assay (HTRF2 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 0.2 nM GST-hMDM2 (aa 1-188), 0.5 nM biotinylated-p53 (aa 1-83), 0.18 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 100 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.",B,,,BAO_0000190,BAO_0000224,protein format,C[C@]1(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@@H](c2ccc(Cl)cc2)N([C@H](CNS(=O)(=O)c2ccc(Cl)s2)C2CC2)C1=O,,,CHEMBL3886611,,2016,"{'bei': '14.18', 'le': '0.31', 'lle': '2.30', 'sei': '8.96'}",CHEMBL4111867,,CHEMBL4111867,9.30,False,http://www.openphacts.org/units/Nanomolar,2869540,=,37,True,=,,IC50,nM,,0.5,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,0.5
378674,17752294,[],CHEMBL3888180,"Homogenous Time-Resolved Fluorescence Assay (HTRF2 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 0.2 nM GST-hMDM2 (aa 1-188), 0.5 nM biotinylated-p53 (aa 1-83), 0.18 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 100 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.",B,,,BAO_0000190,BAO_0000224,protein format,CN(C[C@H](C1CC1)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1)S(=O)(=O)c1ccc(Cl)s1,,,CHEMBL3886611,,2016,"{'bei': '13.88', 'le': '0.30', 'lle': '1.95', 'sei': '9.79'}",CHEMBL4110001,,CHEMBL4110001,9.30,False,http://www.openphacts.org/units/Nanomolar,2869541,=,37,True,=,,IC50,nM,,0.5,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,0.5
378675,17752295,[],CHEMBL3888180,"Homogenous Time-Resolved Fluorescence Assay (HTRF2 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 0.2 nM GST-hMDM2 (aa 1-188), 0.5 nM biotinylated-p53 (aa 1-83), 0.18 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 100 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.",B,,,BAO_0000190,BAO_0000224,protein format,CC(C)(C)S(=O)(=O)N(C[C@H](C1CC1)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1)C(F)F,,,CHEMBL3886611,,2016,"{'bei': '14.75', 'le': '0.31', 'lle': '2.56', 'sei': '10.03'}",CHEMBL4113321,,CHEMBL4113321,9.52,False,http://www.openphacts.org/units/Nanomolar,2869542,=,37,True,=,,IC50,nM,,0.3,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,0.3
378676,17752296,[],CHEMBL3888180,"Homogenous Time-Resolved Fluorescence Assay (HTRF2 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 0.2 nM GST-hMDM2 (aa 1-188), 0.5 nM biotinylated-p53 (aa 1-83), 0.18 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 100 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.",B,,,BAO_0000190,BAO_0000224,protein format,CCS(=O)(=O)N(C[C@H](C1CC1)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1)C(F)F,,,CHEMBL3886611,,2016,"{'bei': '16.19', 'le': '0.34', 'lle': '3.82', 'sei': '10.53'}",CHEMBL3965232,,CHEMBL3965232,10.00,False,http://www.openphacts.org/units/Nanomolar,2869543,=,37,True,=,,IC50,nM,,0.1,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,0.1
378677,17752297,[],CHEMBL3888180,"Homogenous Time-Resolved Fluorescence Assay (HTRF2 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 0.2 nM GST-hMDM2 (aa 1-188), 0.5 nM biotinylated-p53 (aa 1-83), 0.18 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 100 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.",B,,,BAO_0000190,BAO_0000224,protein format,C[C@]1(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@@H](c2ccc(Cl)cc2)N([C@H](CN(C(F)F)S(=O)(=O)C2CC2)C2CC2)C1=O,,,CHEMBL3886611,,2016,"{'bei': '15.88', 'le': '0.33', 'lle': '3.67', 'sei': '10.53'}",CHEMBL3963590,,CHEMBL3963590,10.00,False,http://www.openphacts.org/units/Nanomolar,2869544,=,37,True,=,,IC50,nM,,0.1,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,0.1
378678,17752298,[],CHEMBL3888180,"Homogenous Time-Resolved Fluorescence Assay (HTRF2 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 0.2 nM GST-hMDM2 (aa 1-188), 0.5 nM biotinylated-p53 (aa 1-83), 0.18 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 100 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.",B,,,BAO_0000190,BAO_0000224,protein format,C[C@]1(C2(C(=O)O)CC2)C[C@H](c2cccc(Cl)c2)[C@@H](c2ccc(Cl)cc2)N([C@H](CNS(=O)(=O)C2CC2)C2CC2)C1=O,,,CHEMBL3886611,,2016,"{'bei': '13.64', 'le': '0.28', 'lle': '2.48', 'sei': '7.96'}",CHEMBL4108351,,CHEMBL4108351,8.26,False,http://www.openphacts.org/units/Nanomolar,2869545,=,37,True,=,,IC50,nM,,5.5,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,5.5
378679,17752299,[],CHEMBL3888180,"Homogenous Time-Resolved Fluorescence Assay (HTRF2 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 0.2 nM GST-hMDM2 (aa 1-188), 0.5 nM biotinylated-p53 (aa 1-83), 0.18 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 100 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.",B,,,BAO_0000190,BAO_0000224,protein format,CCS(=O)(=O)N(C[C@H](C1CC1)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1)c1ccccc1F,,,CHEMBL3886611,,2016,"{'bei': '15.11', 'le': '0.31', 'lle': '2.69', 'sei': '10.53'}",CHEMBL4112633,,CHEMBL4112633,10.00,False,http://www.openphacts.org/units/Nanomolar,2869546,=,37,True,=,,IC50,nM,,0.1,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,0.1
378680,17752300,[],CHEMBL3888180,"Homogenous Time-Resolved Fluorescence Assay (HTRF2 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 0.2 nM GST-hMDM2 (aa 1-188), 0.5 nM biotinylated-p53 (aa 1-83), 0.18 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 100 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.",B,,,BAO_0000190,BAO_0000224,protein format,C[C@]1(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@@H](c2ccc(Cl)cc2)N([C@H](CN(c2ccccc2F)S(C)(=O)=O)C2CC2)C1=O,,,CHEMBL3886611,,2016,"{'bei': '14.98', 'le': '0.31', 'lle': '2.78', 'sei': '10.21'}",CHEMBL4112795,,CHEMBL4112795,9.70,False,http://www.openphacts.org/units/Nanomolar,2869547,=,37,True,=,,IC50,nM,,0.2,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,0.2
378681,17752301,[],CHEMBL3888180,"Homogenous Time-Resolved Fluorescence Assay (HTRF2 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 0.2 nM GST-hMDM2 (aa 1-188), 0.5 nM biotinylated-p53 (aa 1-83), 0.18 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 100 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.",B,,,BAO_0000190,BAO_0000224,protein format,C[C@]1(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@@H](c2ccc(Cl)cc2)N([C@H](CN(c2ccccc2)S(=O)(=O)C2CC2)C2CC2)C1=O,,,CHEMBL3886611,,2016,"{'bei': '14.79', 'le': '0.30', 'lle': '2.39', 'sei': '10.21'}",CHEMBL4112350,,CHEMBL4112350,9.70,False,http://www.openphacts.org/units/Nanomolar,2869548,=,37,True,=,,IC50,nM,,0.2,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,0.2
378682,17752302,[],CHEMBL3888180,"Homogenous Time-Resolved Fluorescence Assay (HTRF2 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 0.2 nM GST-hMDM2 (aa 1-188), 0.5 nM biotinylated-p53 (aa 1-83), 0.18 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 100 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.",B,,,BAO_0000190,BAO_0000224,protein format,CCS(=O)(=O)N(C[C@H](C1CC1)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1)c1ccccc1,,,CHEMBL3886611,,2016,"{'bei': '14.80', 'le': '0.30', 'lle': '2.35', 'sei': '10.03'}",CHEMBL4111883,,CHEMBL4111883,9.52,False,http://www.openphacts.org/units/Nanomolar,2869549,=,37,True,=,,IC50,nM,,0.3,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,0.3
378683,17752303,[],CHEMBL3888180,"Homogenous Time-Resolved Fluorescence Assay (HTRF2 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 0.2 nM GST-hMDM2 (aa 1-188), 0.5 nM biotinylated-p53 (aa 1-83), 0.18 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 100 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.",B,,,BAO_0000190,BAO_0000224,protein format,CCS(=O)(=O)NC[C@H](C1CC1)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1,,,CHEMBL3886611,,2016,"{'bei': '16.39', 'le': '0.34', 'lle': '4.05', 'sei': '8.96'}",CHEMBL4106856,,CHEMBL4106856,9.30,False,http://www.openphacts.org/units/Nanomolar,2869550,=,37,True,=,,IC50,nM,,0.5,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,0.5
378684,17752304,[],CHEMBL3888180,"Homogenous Time-Resolved Fluorescence Assay (HTRF2 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 0.2 nM GST-hMDM2 (aa 1-188), 0.5 nM biotinylated-p53 (aa 1-83), 0.18 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 100 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.",B,,,BAO_0000190,BAO_0000224,protein format,CCS(=O)(=O)N(C[C@H](C1CC1)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1)c1cccc(F)c1,,,CHEMBL3886611,,2016,"{'bei': '14.66', 'le': '0.30', 'lle': '2.39', 'sei': '10.21'}",CHEMBL4111346,,CHEMBL4111346,9.70,False,http://www.openphacts.org/units/Nanomolar,2869551,=,37,True,=,,IC50,nM,,0.2,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,0.2
378685,17752305,[],CHEMBL3888180,"Homogenous Time-Resolved Fluorescence Assay (HTRF2 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 0.2 nM GST-hMDM2 (aa 1-188), 0.5 nM biotinylated-p53 (aa 1-83), 0.18 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 100 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.",B,,,BAO_0000190,BAO_0000224,protein format,[C-]#[N+]c1ccccc1N(C[C@H](C1CC1)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1)S(C)(=O)=O,,,CHEMBL3886611,,2016,"{'bei': '14.82', 'le': '0.30', 'lle': '2.37', 'sei': '9.76'}",CHEMBL4107929,,CHEMBL4107929,9.70,False,http://www.openphacts.org/units/Nanomolar,2869552,=,37,True,=,,IC50,nM,,0.2,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,0.2
378686,17752306,[],CHEMBL3888180,"Homogenous Time-Resolved Fluorescence Assay (HTRF2 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 0.2 nM GST-hMDM2 (aa 1-188), 0.5 nM biotinylated-p53 (aa 1-83), 0.18 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 100 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.",B,,,BAO_0000190,BAO_0000224,protein format,CCCS(=O)(=O)NC[C@H](C1CC1)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1,,,CHEMBL3886611,,2016,"{'bei': '15.99', 'le': '0.33', 'lle': '3.66', 'sei': '8.96'}",CHEMBL4107558,,CHEMBL4107558,9.30,False,http://www.openphacts.org/units/Nanomolar,2869553,=,37,True,=,,IC50,nM,,0.5,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,0.5
378687,17752307,[],CHEMBL3888180,"Homogenous Time-Resolved Fluorescence Assay (HTRF2 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 0.2 nM GST-hMDM2 (aa 1-188), 0.5 nM biotinylated-p53 (aa 1-83), 0.18 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 100 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.",B,,,BAO_0000190,BAO_0000224,protein format,C[C@]1(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@@H](c2ccc(Cl)cc2)N([C@H](CN(c2ccccc2)S(C)(=O)=O)C2CC2)C1=O,,,CHEMBL3886611,,2016,"{'bei': '14.65', 'le': '0.30', 'lle': '2.44', 'sei': '9.71'}",CHEMBL4109383,,CHEMBL4109383,9.22,False,http://www.openphacts.org/units/Nanomolar,2869554,=,37,True,=,,IC50,nM,,0.6,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,0.6
378688,17752308,[],CHEMBL3888180,"Homogenous Time-Resolved Fluorescence Assay (HTRF2 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 0.2 nM GST-hMDM2 (aa 1-188), 0.5 nM biotinylated-p53 (aa 1-83), 0.18 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 100 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.",B,,,BAO_0000190,BAO_0000224,protein format,[C-]#[N+]c1cccc(N(C[C@H](C2CC2)N2C(=O)[C@@](C)(CC(=O)O)C[C@H](c3cccc(Cl)c3)[C@H]2c2ccc(Cl)cc2)S(C)(=O)=O)c1,,,CHEMBL3886611,,2016,"{'bei': '14.55', 'le': '0.30', 'lle': '2.19', 'sei': '9.59'}",CHEMBL4107158,,CHEMBL4107158,9.52,False,http://www.openphacts.org/units/Nanomolar,2869555,=,37,True,=,,IC50,nM,,0.3,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,0.3
378689,17752309,[],CHEMBL3888180,"Homogenous Time-Resolved Fluorescence Assay (HTRF2 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 0.2 nM GST-hMDM2 (aa 1-188), 0.5 nM biotinylated-p53 (aa 1-83), 0.18 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 100 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.",B,,,BAO_0000190,BAO_0000224,protein format,C[C@]1(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@@H](c2ccc(Cl)cc2)N([C@H](CN(c2cccnc2)S(C)(=O)=O)C2CC2)C1=O,,,CHEMBL3886611,,2016,"{'bei': '15.38', 'le': '0.32', 'lle': '3.53', 'sei': '8.99'}",CHEMBL4111149,,CHEMBL4111149,9.70,False,http://www.openphacts.org/units/Nanomolar,2869556,=,37,True,=,,IC50,nM,,0.2,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,0.2
378690,17752310,[],CHEMBL3888180,"Homogenous Time-Resolved Fluorescence Assay (HTRF2 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 0.2 nM GST-hMDM2 (aa 1-188), 0.5 nM biotinylated-p53 (aa 1-83), 0.18 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 100 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.",B,,,BAO_0000190,BAO_0000224,protein format,C[C@]1(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@@H](c2ccc(Cl)cc2)N([C@H](CN(Cc2cccs2)S(C)(=O)=O)C2CC2)C1=O,,,CHEMBL3886611,,2016,"{'bei': '14.09', 'le': '0.30', 'lle': '2.32', 'sei': '9.64'}",CHEMBL4112224,,CHEMBL4112224,9.15,False,http://www.openphacts.org/units/Nanomolar,2869557,=,37,True,=,,IC50,nM,,0.7,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,0.7
378691,17752311,[],CHEMBL3888180,"Homogenous Time-Resolved Fluorescence Assay (HTRF2 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 0.2 nM GST-hMDM2 (aa 1-188), 0.5 nM biotinylated-p53 (aa 1-83), 0.18 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 100 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.",B,,,BAO_0000190,BAO_0000224,protein format,COc1cccc(CN(C[C@H](C2CC2)N2C(=O)[C@@](C)(CC(=O)O)C[C@H](c3cccc(Cl)c3)[C@H]2c2ccc(Cl)cc2)S(C)(=O)=O)c1,,,CHEMBL3886611,,2016,"{'bei': '13.10', 'le': '0.27', 'lle': '2.04', 'sei': '8.47'}",CHEMBL4112010,,CHEMBL4112010,8.82,False,http://www.openphacts.org/units/Nanomolar,2869558,=,37,True,=,,IC50,nM,,1.5,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,1.5
378692,17752312,[],CHEMBL3888180,"Homogenous Time-Resolved Fluorescence Assay (HTRF2 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 0.2 nM GST-hMDM2 (aa 1-188), 0.5 nM biotinylated-p53 (aa 1-83), 0.18 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 100 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.",B,,,BAO_0000190,BAO_0000224,protein format,C[C@]1(CC(=O)O)C[C@H](c2cccc(Cl)c2)C(c2ccc(Cl)cc2)N([C@H](CNS(=O)(=O)Cc2ccccc2)C2CC2)C1=O,,,CHEMBL3886611,,2016,"{'bei': '14.45', 'le': '0.30', 'lle': '2.67', 'sei': '8.77'}",CHEMBL4115516,,CHEMBL4115516,9.10,False,http://www.openphacts.org/units/Nanomolar,2869559,=,37,True,=,,IC50,nM,,0.8,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,0.8
378693,17752313,[],CHEMBL3888180,"Homogenous Time-Resolved Fluorescence Assay (HTRF2 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 0.2 nM GST-hMDM2 (aa 1-188), 0.5 nM biotinylated-p53 (aa 1-83), 0.18 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 100 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.",B,,,BAO_0000190,BAO_0000224,protein format,C[C@]1(CC(=O)O)C[C@H](c2cccc(Cl)c2)C(c2ccc(Cl)cc2)N([C@H](CNS(=O)(=O)Cc2ccccn2)C2CC2)C1=O,,,CHEMBL3886611,,2016,"{'bei': '14.62', 'le': '0.30', 'lle': '3.40', 'sei': '7.90'}",CHEMBL4114867,,CHEMBL4114867,9.22,False,http://www.openphacts.org/units/Nanomolar,2869560,=,37,True,=,,IC50,nM,,0.6,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,0.6
378694,17752314,[],CHEMBL3888180,"Homogenous Time-Resolved Fluorescence Assay (HTRF2 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 0.2 nM GST-hMDM2 (aa 1-188), 0.5 nM biotinylated-p53 (aa 1-83), 0.18 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 100 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.",B,,,BAO_0000190,BAO_0000224,protein format,C[C@]1(CC(=O)O)C[C@H](c2cccc(Cl)c2)C(c2ccc(Cl)cc2)N([C@H](CNS(=O)(=O)Cc2cccnc2)C2CC2)C1=O,,,CHEMBL3886611,,2016,"{'bei': '15.10', 'le': '0.31', 'lle': '3.70', 'sei': '8.16'}",CHEMBL4107542,,CHEMBL4107542,9.52,False,http://www.openphacts.org/units/Nanomolar,2869561,=,37,True,=,,IC50,nM,,0.3,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,0.3
378695,17752315,[],CHEMBL3888180,"Homogenous Time-Resolved Fluorescence Assay (HTRF2 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 0.2 nM GST-hMDM2 (aa 1-188), 0.5 nM biotinylated-p53 (aa 1-83), 0.18 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 100 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.",B,,,BAO_0000190,BAO_0000224,protein format,C[C@]1(CC(=O)O)C[C@H](c2cccc(Cl)c2)C(c2ccc(Cl)cc2)N([C@H](CN(c2ccccn2)S(C)(=O)=O)C2CC2)C1=O,,,CHEMBL3886611,,2016,"{'bei': '12.48', 'le': '0.26', 'lle': '1.70', 'sei': '7.29'}",CHEMBL4110271,,CHEMBL4110271,7.87,False,http://www.openphacts.org/units/Nanomolar,2869562,=,37,True,=,,IC50,nM,,13.5,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,13.5
378696,17752316,[],CHEMBL3888180,"Homogenous Time-Resolved Fluorescence Assay (HTRF2 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 0.2 nM GST-hMDM2 (aa 1-188), 0.5 nM biotinylated-p53 (aa 1-83), 0.18 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 100 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.",B,,,BAO_0000190,BAO_0000224,protein format,C[C@]1(CC(=O)O)C[C@H](c2cccc(Cl)c2)C(c2ccc(Cl)cc2)N([C@H](CNS(C)(=O)=O)C2CC2)C1=O,,,CHEMBL3886611,,2016,"{'bei': '17.20', 'le': '0.36', 'lle': '4.66', 'sei': '9.18'}",CHEMBL4110212,,CHEMBL4110212,9.52,False,http://www.openphacts.org/units/Nanomolar,2869563,=,37,True,=,,IC50,nM,,0.3,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,0.3
378697,17752317,[],CHEMBL3888180,"Homogenous Time-Resolved Fluorescence Assay (HTRF2 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 0.2 nM GST-hMDM2 (aa 1-188), 0.5 nM biotinylated-p53 (aa 1-83), 0.18 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 100 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.",B,,,BAO_0000190,BAO_0000224,protein format,CC[C@]1(CC(=O)O)C[C@H](c2cccc(Cl)c2)C(c2ccc(Cl)cc2)N([C@H](CNS(=O)(=O)C(C)C)C2CC2)C1=O,,,CHEMBL3886611,,2016,"{'bei': '15.19', 'le': '0.32', 'lle': '3.02', 'sei': '8.72'}",CHEMBL4112786,,CHEMBL4112786,9.05,False,http://www.openphacts.org/units/Nanomolar,2869564,=,37,True,=,,IC50,nM,,0.9,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,0.9
378698,17752318,[],CHEMBL3888180,"Homogenous Time-Resolved Fluorescence Assay (HTRF2 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 0.2 nM GST-hMDM2 (aa 1-188), 0.5 nM biotinylated-p53 (aa 1-83), 0.18 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 100 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.",B,,,BAO_0000190,BAO_0000224,protein format,CC[C@]1(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@@H](c2ccc(Cl)cc2)N([C@H](CNS(=O)(=O)C2CCC2)C2CC2)C1=O,,,CHEMBL3886611,,2016,"{'bei': '14.97', 'le': '0.31', 'lle': '2.93', 'sei': '8.77'}",CHEMBL4112149,,CHEMBL4112149,9.10,False,http://www.openphacts.org/units/Nanomolar,2869565,=,37,True,=,,IC50,nM,,0.8,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,0.8
378699,17752319,[],CHEMBL3888180,"Homogenous Time-Resolved Fluorescence Assay (HTRF2 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 0.2 nM GST-hMDM2 (aa 1-188), 0.5 nM biotinylated-p53 (aa 1-83), 0.18 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 100 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.",B,,,BAO_0000190,BAO_0000224,protein format,CC[C@]1(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@@H](c2ccc(Cl)cc2)N([C@H](CNS(=O)(=O)C2CCCC2)C2CC2)C1=O,,,CHEMBL3886611,,2016,"{'bei': '14.73', 'le': '0.30', 'lle': '2.59', 'sei': '8.82'}",CHEMBL4109111,,CHEMBL4109111,9.15,False,http://www.openphacts.org/units/Nanomolar,2869566,=,37,True,=,,IC50,nM,,0.7,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,0.7
378700,17752320,[],CHEMBL3888180,"Homogenous Time-Resolved Fluorescence Assay (HTRF2 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 0.2 nM GST-hMDM2 (aa 1-188), 0.5 nM biotinylated-p53 (aa 1-83), 0.18 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 100 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.",B,,,BAO_0000190,BAO_0000224,protein format,CC(C)[C@@H](CN(C)S(=O)(=O)C1CC1)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1,,,CHEMBL3886611,,2016,"{'bei': '14.68', 'le': '0.31', 'lle': '2.76', 'sei': '9.21'}",CHEMBL3125518,,CHEMBL3125518,8.74,False,http://www.openphacts.org/units/Nanomolar,2869567,=,37,True,=,,IC50,nM,,1.8,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,1.8
378701,17752321,[],CHEMBL3888180,"Homogenous Time-Resolved Fluorescence Assay (HTRF2 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 0.2 nM GST-hMDM2 (aa 1-188), 0.5 nM biotinylated-p53 (aa 1-83), 0.18 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 100 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.",B,,,BAO_0000190,BAO_0000224,protein format,CC(C)[C@@H](CNS(=O)(=O)C1CC1)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1,,,CHEMBL3886611,,2016,"{'bei': '14.37', 'le': '0.30', 'lle': '2.72', 'sei': '8.05'}",CHEMBL4113936,,CHEMBL4113936,8.36,False,http://www.openphacts.org/units/Nanomolar,2869568,=,37,True,=,,IC50,nM,,4.4,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,4.4
378702,17752322,[],CHEMBL3888180,"Homogenous Time-Resolved Fluorescence Assay (HTRF2 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 0.2 nM GST-hMDM2 (aa 1-188), 0.5 nM biotinylated-p53 (aa 1-83), 0.18 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 100 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.",B,,,BAO_0000190,BAO_0000224,protein format,CCS(=O)(=O)NC[C@H](C(C)C)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1,,,CHEMBL3886611,,2016,"{'bei': '13.68', 'le': '0.29', 'lle': '2.29', 'sei': '7.51'}",CHEMBL4108939,,CHEMBL4108939,7.79,False,http://www.openphacts.org/units/Nanomolar,2869569,=,37,True,=,,IC50,nM,,16.1,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,16.1
378703,17752323,[],CHEMBL3888180,"Homogenous Time-Resolved Fluorescence Assay (HTRF2 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 0.2 nM GST-hMDM2 (aa 1-188), 0.5 nM biotinylated-p53 (aa 1-83), 0.18 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 100 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.",B,,,BAO_0000190,BAO_0000224,protein format,CC[C@@H](CNS(=O)(=O)C1CCC1)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1,,,CHEMBL3886611,,2016,"{'bei': '15.28', 'le': '0.32', 'lle': '3.11', 'sei': '8.56'}",CHEMBL3961423,,CHEMBL3961423,8.89,False,http://www.openphacts.org/units/Nanomolar,2869570,=,37,True,=,,IC50,nM,,1.3,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,1.3
378704,17752324,[],CHEMBL3888180,"Homogenous Time-Resolved Fluorescence Assay (HTRF2 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 0.2 nM GST-hMDM2 (aa 1-188), 0.5 nM biotinylated-p53 (aa 1-83), 0.18 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 100 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.",B,,,BAO_0000190,BAO_0000224,protein format,CC[C@@H](CN(CC)S(=O)(=O)C1CCC1)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1,,,CHEMBL3886611,,2016,"{'bei': '13.12', 'le': '0.27', 'lle': '1.49', 'sei': '8.42'}",CHEMBL3960491,,CHEMBL3960491,8.00,False,http://www.openphacts.org/units/Nanomolar,2869571,=,37,True,=,,IC50,nM,,10.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,10.0
378705,17752325,[],CHEMBL3888180,"Homogenous Time-Resolved Fluorescence Assay (HTRF2 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 0.2 nM GST-hMDM2 (aa 1-188), 0.5 nM biotinylated-p53 (aa 1-83), 0.18 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 100 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.",B,,,BAO_0000190,BAO_0000224,protein format,CC[C@@H](CS(C)(=O)=O)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1,,,CHEMBL3886611,,2016,"{'bei': '18.09', 'le': '0.38', 'lle': '4.17', 'sei': '10.38'}",CHEMBL3125522,,CHEMBL3125522,9.52,False,http://www.openphacts.org/units/Nanomolar,2869572,=,37,True,=,,IC50,nM,,0.3,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,0.3
378706,17752326,[],CHEMBL3888180,"Homogenous Time-Resolved Fluorescence Assay (HTRF2 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 0.2 nM GST-hMDM2 (aa 1-188), 0.5 nM biotinylated-p53 (aa 1-83), 0.18 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 100 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.",B,,,BAO_0000190,BAO_0000224,protein format,CCCS(=O)(=O)C[C@H](CC)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1,,,CHEMBL3886611,,2016,"{'bei': '16.95', 'le': '0.36', 'lle': '3.26', 'sei': '10.24'}",CHEMBL3968648,,CHEMBL3968648,9.40,False,http://www.openphacts.org/units/Nanomolar,2869573,=,37,True,=,,IC50,nM,,0.4,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,0.4
378707,17752327,[],CHEMBL3888180,"Homogenous Time-Resolved Fluorescence Assay (HTRF2 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 0.2 nM GST-hMDM2 (aa 1-188), 0.5 nM biotinylated-p53 (aa 1-83), 0.18 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 100 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.",B,,,BAO_0000190,BAO_0000224,protein format,CC[C@@H](CS(=O)(=O)CC(C)C)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1,,,CHEMBL3886611,,2016,"{'bei': '16.36', 'le': '0.34', 'lle': '2.92', 'sei': '10.14'}",CHEMBL3942755,,CHEMBL3942755,9.30,False,http://www.openphacts.org/units/Nanomolar,2869574,=,37,True,=,,IC50,nM,,0.5,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,0.5
378708,17752328,[],CHEMBL3888180,"Homogenous Time-Resolved Fluorescence Assay (HTRF2 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 0.2 nM GST-hMDM2 (aa 1-188), 0.5 nM biotinylated-p53 (aa 1-83), 0.18 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 100 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.",B,,,BAO_0000190,BAO_0000224,protein format,CC[C@@H](CS(=O)(=O)CC1CC1)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1,,,CHEMBL3886611,,2016,"{'bei': '16.81', 'le': '0.35', 'lle': '3.38', 'sei': '10.38'}",CHEMBL3125528,,CHEMBL3125528,9.52,False,http://www.openphacts.org/units/Nanomolar,2869575,=,37,True,=,,IC50,nM,,0.3,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,0.3
378709,17752329,[],CHEMBL3888180,"Homogenous Time-Resolved Fluorescence Assay (HTRF2 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 0.2 nM GST-hMDM2 (aa 1-188), 0.5 nM biotinylated-p53 (aa 1-83), 0.18 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 100 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.",B,,,BAO_0000190,BAO_0000224,protein format,CC[C@@H](CS(=O)(=O)CC1CCC1)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1,,,CHEMBL3886611,,2016,"{'bei': '16.02', 'le': '0.33', 'lle': '2.77', 'sei': '10.14'}",CHEMBL3984400,,CHEMBL3984400,9.30,False,http://www.openphacts.org/units/Nanomolar,2869576,=,37,True,=,,IC50,nM,,0.5,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,0.5
378710,17752330,[],CHEMBL3888180,"Homogenous Time-Resolved Fluorescence Assay (HTRF2 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 0.2 nM GST-hMDM2 (aa 1-188), 0.5 nM biotinylated-p53 (aa 1-83), 0.18 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 100 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.",B,,,BAO_0000190,BAO_0000224,protein format,CC[C@@H](CS(=O)(=O)C1CCCC1)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1,,,CHEMBL3886611,,2016,"{'bei': '16.40', 'le': '0.34', 'lle': '2.85', 'sei': '10.38'}",CHEMBL3125530,,CHEMBL3125530,9.52,False,http://www.openphacts.org/units/Nanomolar,2869577,=,37,True,=,,IC50,nM,,0.3,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,0.3
378711,17752331,[],CHEMBL3888180,"Homogenous Time-Resolved Fluorescence Assay (HTRF2 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 0.2 nM GST-hMDM2 (aa 1-188), 0.5 nM biotinylated-p53 (aa 1-83), 0.18 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 100 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.",B,,,BAO_0000190,BAO_0000224,protein format,CC[C@@H](CS(=O)(=O)C1COC1)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1,,,CHEMBL3886611,,2016,"{'bei': '16.75', 'le': '0.35', 'lle': '4.40', 'sei': '9.43'}",CHEMBL3125531,,CHEMBL3125531,9.52,False,http://www.openphacts.org/units/Nanomolar,2869578,=,37,True,=,,IC50,nM,,0.3,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,0.3
378712,17752332,[],CHEMBL3888180,"Homogenous Time-Resolved Fluorescence Assay (HTRF2 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 0.2 nM GST-hMDM2 (aa 1-188), 0.5 nM biotinylated-p53 (aa 1-83), 0.18 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 100 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.",B,,,BAO_0000190,BAO_0000224,protein format,CC[C@@H](CS(=O)(=O)CC1(C)COC1)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1,,,CHEMBL3886611,,2016,"{'bei': '16.76', 'le': '0.35', 'lle': '4.24', 'sei': '9.90'}",CHEMBL3915847,,CHEMBL3915847,10.00,False,http://www.openphacts.org/units/Nanomolar,2869579,=,37,True,=,,IC50,nM,,0.1,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,0.1
378713,17752333,[],CHEMBL3888180,"Homogenous Time-Resolved Fluorescence Assay (HTRF2 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 0.2 nM GST-hMDM2 (aa 1-188), 0.5 nM biotinylated-p53 (aa 1-83), 0.18 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 100 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.",B,,,BAO_0000190,BAO_0000224,protein format,CC[C@@H](CS(=O)(=O)C1CCOCC1)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1,,,CHEMBL3886611,,2016,"{'bei': '16.26', 'le': '0.34', 'lle': '3.80', 'sei': '9.60'}",CHEMBL3893885,,CHEMBL3893885,9.70,False,http://www.openphacts.org/units/Nanomolar,2869580,=,37,True,=,,IC50,nM,,0.2,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,0.2
378714,17752334,[],CHEMBL3888180,"Homogenous Time-Resolved Fluorescence Assay (HTRF2 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 0.2 nM GST-hMDM2 (aa 1-188), 0.5 nM biotinylated-p53 (aa 1-83), 0.18 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 100 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.",B,,,BAO_0000190,BAO_0000224,protein format,CC[C@@H](CS(=O)(=O)CC(C)(C)O)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1,,,CHEMBL3886611,,2016,"{'bei': '16.59', 'le': '0.35', 'lle': '4.20', 'sei': '8.66'}",CHEMBL3958379,,CHEMBL3958379,9.70,False,http://www.openphacts.org/units/Nanomolar,2869581,=,37,True,=,,IC50,nM,,0.2,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,0.2
378715,17752335,[],CHEMBL3888180,"Homogenous Time-Resolved Fluorescence Assay (HTRF2 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 0.2 nM GST-hMDM2 (aa 1-188), 0.5 nM biotinylated-p53 (aa 1-83), 0.18 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 100 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.",B,,,BAO_0000190,BAO_0000224,protein format,CC[C@@H](CS(=O)(=O)[C@H](C)CC)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1,,,CHEMBL3886611,,2016,"{'bei': '17.59', 'le': '0.37', 'lle': '3.48', 'sei': '10.90'}",CHEMBL3983607,,CHEMBL3983607,10.00,False,http://www.openphacts.org/units/Nanomolar,2869582,=,37,True,=,,IC50,nM,,0.1,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,0.1
378716,17752336,[],CHEMBL3888180,"Homogenous Time-Resolved Fluorescence Assay (HTRF2 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 0.2 nM GST-hMDM2 (aa 1-188), 0.5 nM biotinylated-p53 (aa 1-83), 0.18 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 100 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.",B,,,BAO_0000190,BAO_0000224,protein format,CC[C@@H](CS(=O)(=O)[C@H](C)CC)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1,,,CHEMBL3886611,,2016,"{'bei': '13.98', 'le': '0.29', 'lle': '1.43', 'sei': '8.67'}",CHEMBL3983607,,CHEMBL3983607,7.95,False,http://www.openphacts.org/units/Nanomolar,2869582,=,37,True,=,,IC50,nM,,11.2,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,11.2
378717,17752337,[],CHEMBL3888180,"Homogenous Time-Resolved Fluorescence Assay (HTRF2 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 0.2 nM GST-hMDM2 (aa 1-188), 0.5 nM biotinylated-p53 (aa 1-83), 0.18 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 100 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.",B,,,BAO_0000190,BAO_0000224,protein format,C[C@]1(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@@H](c2ccc(Cl)cc2)N([C@H](CS(=O)(=O)C2CCCC2)C2CC2)C1=O,,,CHEMBL3886611,,2016,"{'bei': '16.37', 'le': '0.34', 'lle': '3.03', 'sei': '10.57'}",CHEMBL3959436,,CHEMBL3959436,9.70,False,http://www.openphacts.org/units/Nanomolar,2869583,=,37,True,=,,IC50,nM,,0.2,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,0.2
378718,17752338,[],CHEMBL3888180,"Homogenous Time-Resolved Fluorescence Assay (HTRF2 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 0.2 nM GST-hMDM2 (aa 1-188), 0.5 nM biotinylated-p53 (aa 1-83), 0.18 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 100 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.",B,,,BAO_0000190,BAO_0000224,protein format,CC1(CS(=O)(=O)C[C@H](C2CC2)N2C(=O)[C@@](C)(CC(=O)O)C[C@H](c3cccc(Cl)c3)[C@H]2c2ccc(Cl)cc2)COC1,,,CHEMBL3886611,,2016,"{'bei': '16.43', 'le': '0.34', 'lle': '4.24', 'sei': '9.90'}",CHEMBL3986408,,CHEMBL3986408,10.00,False,http://www.openphacts.org/units/Nanomolar,2869584,=,37,True,=,,IC50,nM,,0.1,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,0.1
378719,17752339,[],CHEMBL3888180,"Homogenous Time-Resolved Fluorescence Assay (HTRF2 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 0.2 nM GST-hMDM2 (aa 1-188), 0.5 nM biotinylated-p53 (aa 1-83), 0.18 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 100 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.",B,,,BAO_0000190,BAO_0000224,protein format,C[C@]1(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@@H](c2ccc(Cl)cc2)N([C@H](CS(=O)(=O)c2ccccc2)C2CC2)C1=O,,,CHEMBL3886611,,2016,"{'bei': '14.74', 'le': '0.30', 'lle': '2.07', 'sei': '9.65'}",CHEMBL3970501,,CHEMBL3970501,8.85,False,http://www.openphacts.org/units/Nanomolar,2869585,=,37,True,=,,IC50,nM,,1.4,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,1.4
378720,17752340,[],CHEMBL3888180,"Homogenous Time-Resolved Fluorescence Assay (HTRF2 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 0.2 nM GST-hMDM2 (aa 1-188), 0.5 nM biotinylated-p53 (aa 1-83), 0.18 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 100 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.",B,,,BAO_0000190,BAO_0000224,protein format,Cc1ccccc1S(=O)(=O)C[C@H](C1CC1)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1,,,CHEMBL3886611,,2016,"{'bei': '13.89', 'le': '0.28', 'lle': '1.45', 'sei': '9.31'}",CHEMBL3940186,,CHEMBL3940186,8.54,False,http://www.openphacts.org/units/Nanomolar,2869586,=,37,True,=,,IC50,nM,,2.9,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,2.9
378721,17752341,[],CHEMBL3888180,"Homogenous Time-Resolved Fluorescence Assay (HTRF2 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 0.2 nM GST-hMDM2 (aa 1-188), 0.5 nM biotinylated-p53 (aa 1-83), 0.18 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 100 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.",B,,,BAO_0000190,BAO_0000224,protein format,C[C@]1(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@@H](c2ccc(Cl)cc2)N([C@H](CS(=O)(=O)c2ccccc2Cl)C2CC2)C1=O,,,CHEMBL3886611,,2016,"{'bei': '14.05', 'le': '0.30', 'lle': '1.48', 'sei': '9.72'}",CHEMBL3968189,,CHEMBL3968189,8.92,False,http://www.openphacts.org/units/Nanomolar,2869587,=,37,True,=,,IC50,nM,,1.2,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,1.2
378722,17752342,[],CHEMBL3888180,"Homogenous Time-Resolved Fluorescence Assay (HTRF2 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 0.2 nM GST-hMDM2 (aa 1-188), 0.5 nM biotinylated-p53 (aa 1-83), 0.18 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 100 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.",B,,,BAO_0000190,BAO_0000224,protein format,C[C@]1(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@@H](c2ccc(Cl)cc2)N([C@H](CS(=O)(=O)c2ccc(Cl)cc2)C2CC2)C1=O,,,CHEMBL3886611,,2016,"{'bei': '13.44', 'le': '0.28', 'lle': '1.10', 'sei': '9.31'}",CHEMBL3982594,,CHEMBL3982594,8.54,False,http://www.openphacts.org/units/Nanomolar,2869588,=,37,True,=,,IC50,nM,,2.9,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,2.9
378723,17752343,[],CHEMBL3888180,"Homogenous Time-Resolved Fluorescence Assay (HTRF2 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 0.2 nM GST-hMDM2 (aa 1-188), 0.5 nM biotinylated-p53 (aa 1-83), 0.18 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 100 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.",B,,,BAO_0000190,BAO_0000224,protein format,C[C@]1(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@@H](c2ccc(Cl)cc2)N([C@H](CS(=O)(=O)c2ccc(F)cc2)C2CC2)C1=O,,,CHEMBL3886611,,2016,"{'bei': '13.94', 'le': '0.29', 'lle': '1.70', 'sei': '9.39'}",CHEMBL3950450,,CHEMBL3950450,8.62,False,http://www.openphacts.org/units/Nanomolar,2869589,=,37,True,=,,IC50,nM,,2.4,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,2.4
378724,17752344,[],CHEMBL3888180,"Homogenous Time-Resolved Fluorescence Assay (HTRF2 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 0.2 nM GST-hMDM2 (aa 1-188), 0.5 nM biotinylated-p53 (aa 1-83), 0.18 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 100 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.",B,,,BAO_0000190,BAO_0000224,protein format,C[C@]1(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@@H](c2ccc(Cl)cc2)N([C@H](CS(=O)(=O)c2ccncc2)C2CC2)C1=O,,,CHEMBL3886611,,2016,"{'bei': '15.46', 'le': '0.32', 'lle': '3.12', 'sei': '8.89'}",CHEMBL3974607,,CHEMBL3974607,9.30,False,http://www.openphacts.org/units/Nanomolar,2869590,=,37,True,=,,IC50,nM,,0.5,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,0.5
378725,17752345,[],CHEMBL3888180,"Homogenous Time-Resolved Fluorescence Assay (HTRF2 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 0.2 nM GST-hMDM2 (aa 1-188), 0.5 nM biotinylated-p53 (aa 1-83), 0.18 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 100 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.",B,,,BAO_0000190,BAO_0000224,protein format,C[C@]1(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@@H](c2ccc(Cl)cc2)N([C@H](CS(=O)(=O)c2ccc(F)cc2Cl)C2CC2)C1=O,,,CHEMBL3886611,,2016,"{'bei': '13.61', 'le': '0.29', 'lle': '1.31', 'sei': '9.69'}",CHEMBL3897481,,CHEMBL3897481,8.89,False,http://www.openphacts.org/units/Nanomolar,2869591,=,37,True,=,,IC50,nM,,1.3,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,1.3
378726,17752346,[],CHEMBL3888180,"Homogenous Time-Resolved Fluorescence Assay (HTRF2 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 0.2 nM GST-hMDM2 (aa 1-188), 0.5 nM biotinylated-p53 (aa 1-83), 0.18 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 100 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.",B,,,BAO_0000190,BAO_0000224,protein format,C[C@]1(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@@H](c2ccc(Cl)cc2)N([C@H](CS(=O)(=O)CC2CC2)C2CC2)C1=O,,,CHEMBL3886611,,2016,"{'bei': '17.28', 'le': '0.36', 'lle': '3.86', 'sei': '10.90'}",CHEMBL3899040,,CHEMBL3899040,10.00,False,http://www.openphacts.org/units/Nanomolar,2869592,=,37,True,=,,IC50,nM,,0.1,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,0.1
378727,17752347,[],CHEMBL3888180,"Homogenous Time-Resolved Fluorescence Assay (HTRF2 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 0.2 nM GST-hMDM2 (aa 1-188), 0.5 nM biotinylated-p53 (aa 1-83), 0.18 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 100 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.",B,,,BAO_0000190,BAO_0000224,protein format,C[C@]1(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@@H](c2ccc(Cl)cc2)N([C@H](CS(=O)(=O)CC(F)(F)F)C2CC2)C1=O,,,CHEMBL3886611,,2016,"{'bei': '15.99', 'le': '0.34', 'lle': '3.41', 'sei': '10.57'}",CHEMBL3897931,,CHEMBL3897931,9.70,False,http://www.openphacts.org/units/Nanomolar,2869593,=,37,True,=,,IC50,nM,,0.2,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,0.2
378728,17752348,[],CHEMBL3888180,"Homogenous Time-Resolved Fluorescence Assay (HTRF2 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 0.2 nM GST-hMDM2 (aa 1-188), 0.5 nM biotinylated-p53 (aa 1-83), 0.18 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 100 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.",B,,,BAO_0000190,BAO_0000224,protein format,C[C@]1(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@@H](c2ccc(Cl)cc2)N([C@H](CS(=O)(=O)C(F)(F)F)C2CC2)C1=O,,,CHEMBL3886611,,2016,"{'bei': '16.07', 'le': '0.34', 'lle': '3.28', 'sei': '10.38'}",CHEMBL4108486,,CHEMBL4108486,9.52,False,http://www.openphacts.org/units/Nanomolar,2869594,=,37,True,=,,IC50,nM,,0.3,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,0.3
378729,17752349,[],CHEMBL3888180,"Homogenous Time-Resolved Fluorescence Assay (HTRF2 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 0.2 nM GST-hMDM2 (aa 1-188), 0.5 nM biotinylated-p53 (aa 1-83), 0.18 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 100 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.",B,,,BAO_0000190,BAO_0000224,protein format,CC[C@]1(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@@H](c2ccc(Cl)cc2)N([C@H](CS(=O)(=O)c2ccccc2)C2CC2)C1=O,,,CHEMBL3886611,,2016,"{'bei': '14.31', 'le': '0.29', 'lle': '1.63', 'sei': '9.59'}",CHEMBL3959155,,CHEMBL3959155,8.80,False,http://www.openphacts.org/units/Nanomolar,2869595,=,37,True,=,,IC50,nM,,1.6,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,1.6
378730,17752350,[],CHEMBL3888180,"Homogenous Time-Resolved Fluorescence Assay (HTRF2 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 0.2 nM GST-hMDM2 (aa 1-188), 0.5 nM biotinylated-p53 (aa 1-83), 0.18 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 100 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.",B,,,BAO_0000190,BAO_0000224,protein format,CC[C@]1(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@@H](c2ccc(Cl)cc2)N([C@H](CS(=O)(=O)c2ccccc2Cl)C2CC2)C1=O,,,CHEMBL3886611,,2016,"{'bei': '14.48', 'le': '0.31', 'lle': '1.57', 'sei': '10.24'}",CHEMBL3892453,,CHEMBL3892453,9.40,False,http://www.openphacts.org/units/Nanomolar,2869596,=,37,True,=,,IC50,nM,,0.4,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,0.4
378731,17752351,[],CHEMBL3888180,"Homogenous Time-Resolved Fluorescence Assay (HTRF2 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 0.2 nM GST-hMDM2 (aa 1-188), 0.5 nM biotinylated-p53 (aa 1-83), 0.18 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 100 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.",B,,,BAO_0000190,BAO_0000224,protein format,CC[C@]1(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@@H](c2ccc(Cl)cc2)N([C@H](CS(=O)(=O)c2ccccc2F)C2CC2)C1=O,,,CHEMBL3886611,,2016,"{'bei': '14.86', 'le': '0.31', 'lle': '2.09', 'sei': '10.24'}",CHEMBL3986817,,CHEMBL3986817,9.40,False,http://www.openphacts.org/units/Nanomolar,2869597,=,37,True,=,,IC50,nM,,0.4,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,0.4
378732,17752352,[],CHEMBL3888180,"Homogenous Time-Resolved Fluorescence Assay (HTRF2 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 0.2 nM GST-hMDM2 (aa 1-188), 0.5 nM biotinylated-p53 (aa 1-83), 0.18 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 100 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.",B,,,BAO_0000190,BAO_0000224,protein format,CC[C@]1(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@@H](c2ccc(Cl)cc2)N([C@H](CS(=O)(=O)c2cccc(F)c2)C2CC2)C1=O,,,CHEMBL3886611,,2016,"{'bei': '14.00', 'le': '0.29', 'lle': '1.54', 'sei': '9.65'}",CHEMBL3920713,,CHEMBL3920713,8.85,False,http://www.openphacts.org/units/Nanomolar,2869598,=,37,True,=,,IC50,nM,,1.4,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,1.4
378733,17752353,[],CHEMBL3888180,"Homogenous Time-Resolved Fluorescence Assay (HTRF2 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 0.2 nM GST-hMDM2 (aa 1-188), 0.5 nM biotinylated-p53 (aa 1-83), 0.18 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 100 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.",B,,,BAO_0000190,BAO_0000224,protein format,CC[C@]1(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@@H](c2ccc(Cl)cc2)N([C@H](CS(=O)(=O)c2ccc(F)cc2)C2CC2)C1=O,,,CHEMBL3886611,,2016,"{'bei': '13.90', 'le': '0.29', 'lle': '1.49', 'sei': '9.59'}",CHEMBL3951924,,CHEMBL3951924,8.80,False,http://www.openphacts.org/units/Nanomolar,2869599,=,37,True,=,,IC50,nM,,1.6,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,1.6
378734,17752354,[],CHEMBL3888180,"Homogenous Time-Resolved Fluorescence Assay (HTRF2 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 0.2 nM GST-hMDM2 (aa 1-188), 0.5 nM biotinylated-p53 (aa 1-83), 0.18 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 100 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.",B,,,BAO_0000190,BAO_0000224,protein format,CCCS(=O)(=O)C[C@H](C1CC1)N1C(=O)[C@@](CC)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1,,,CHEMBL3886611,,2016,"{'bei': '16.71', 'le': '0.35', 'lle': '3.17', 'sei': '10.57'}",CHEMBL3915213,,CHEMBL3915213,9.70,False,http://www.openphacts.org/units/Nanomolar,2869600,=,37,True,=,,IC50,nM,,0.2,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,0.2
378735,17752355,[],CHEMBL3888180,"Homogenous Time-Resolved Fluorescence Assay (HTRF2 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 0.2 nM GST-hMDM2 (aa 1-188), 0.5 nM biotinylated-p53 (aa 1-83), 0.18 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 100 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.",B,,,BAO_0000190,BAO_0000224,protein format,CCCCS(=O)(=O)C[C@H](C1CC1)N1C(=O)[C@@](CC)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1,,,CHEMBL3886611,,2016,"{'bei': '16.31', 'le': '0.34', 'lle': '2.78', 'sei': '10.57'}",CHEMBL3943183,,CHEMBL3943183,9.70,False,http://www.openphacts.org/units/Nanomolar,2869601,=,37,True,=,,IC50,nM,,0.2,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,0.2
378736,17752356,[],CHEMBL3888180,"Homogenous Time-Resolved Fluorescence Assay (HTRF2 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 0.2 nM GST-hMDM2 (aa 1-188), 0.5 nM biotinylated-p53 (aa 1-83), 0.18 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 100 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.",B,,,BAO_0000190,BAO_0000224,protein format,CC[C@]1(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@@H](c2ccc(Cl)cc2)N([C@H](CS(=O)(=O)CCC(C)C)C2CC2)C1=O,,,CHEMBL3886611,,2016,"{'bei': '15.65', 'le': '0.33', 'lle': '2.36', 'sei': '10.38'}",CHEMBL3942141,,CHEMBL3942141,9.52,False,http://www.openphacts.org/units/Nanomolar,2869602,=,37,True,=,,IC50,nM,,0.3,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,0.3
378737,17752357,[],CHEMBL3888180,"Homogenous Time-Resolved Fluorescence Assay (HTRF2 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 0.2 nM GST-hMDM2 (aa 1-188), 0.5 nM biotinylated-p53 (aa 1-83), 0.18 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 100 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.",B,,,BAO_0000190,BAO_0000224,protein format,CC[C@]1(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@@H](c2ccc(Cl)cc2)N([C@H](CS(=O)(=O)C2CCCC2)C2CC2)C1=O,,,CHEMBL3886611,,2016,"{'bei': '15.99', 'le': '0.33', 'lle': '2.64', 'sei': '10.57'}",CHEMBL3968199,,CHEMBL3968199,9.70,False,http://www.openphacts.org/units/Nanomolar,2869603,=,37,True,=,,IC50,nM,,0.2,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,0.2
378738,17752358,[],CHEMBL3888180,"Homogenous Time-Resolved Fluorescence Assay (HTRF2 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 0.2 nM GST-hMDM2 (aa 1-188), 0.5 nM biotinylated-p53 (aa 1-83), 0.18 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 100 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.",B,,,BAO_0000190,BAO_0000224,protein format,CC[C@]1(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@@H](c2ccc(Cl)cc2)N([C@H](CS(=O)(=O)C2CCCCC2)C2CC2)C1=O,,,CHEMBL3886611,,2016,"{'bei': '16.11', 'le': '0.33', 'lle': '2.55', 'sei': '10.90'}",CHEMBL3929623,,CHEMBL3929623,10.00,False,http://www.openphacts.org/units/Nanomolar,2869604,=,37,True,=,,IC50,nM,,0.1,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,0.1
378739,17752359,[],CHEMBL3888180,"Homogenous Time-Resolved Fluorescence Assay (HTRF2 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 0.2 nM GST-hMDM2 (aa 1-188), 0.5 nM biotinylated-p53 (aa 1-83), 0.18 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 100 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.",B,,,BAO_0000190,BAO_0000224,protein format,CC[C@]1(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@@H](c2ccc(Cl)cc2)N([C@H](CS(C)(=O)=O)C2CC2)C1=O,,,CHEMBL3886611,,2016,"{'bei': '17.24', 'le': '0.36', 'lle': '3.78', 'sei': '10.38'}",CHEMBL3916712,,CHEMBL3916712,9.52,False,http://www.openphacts.org/units/Nanomolar,2869605,=,37,True,=,,IC50,nM,,0.3,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,0.3
378740,17752360,[],CHEMBL3888180,"Homogenous Time-Resolved Fluorescence Assay (HTRF2 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 0.2 nM GST-hMDM2 (aa 1-188), 0.5 nM biotinylated-p53 (aa 1-83), 0.18 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 100 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.",B,,,BAO_0000190,BAO_0000224,protein format,CC(C)[C@@H](CS(=O)(=O)CC(F)(F)F)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1,,,CHEMBL3886611,,2016,"{'bei': '14.37', 'le': '0.31', 'lle': '2.21', 'sei': '9.53'}",CHEMBL3957184,,CHEMBL3957184,8.74,False,http://www.openphacts.org/units/Nanomolar,2869606,=,37,True,=,,IC50,nM,,1.8,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,1.8
378741,17752361,[],CHEMBL3888180,"Homogenous Time-Resolved Fluorescence Assay (HTRF2 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 0.2 nM GST-hMDM2 (aa 1-188), 0.5 nM biotinylated-p53 (aa 1-83), 0.18 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 100 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.",B,,,BAO_0000190,BAO_0000224,protein format,CC(C)[C@@H](CS(=O)(=O)C(C)(C)C)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1,,,CHEMBL3886611,,2016,"{'bei': '15.83', 'le': '0.33', 'lle': '2.45', 'sei': '10.05'}",CHEMBL3125535,,CHEMBL3125535,9.22,False,http://www.openphacts.org/units/Nanomolar,2869607,=,37,True,=,,IC50,nM,,0.6,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,0.6
378742,17752362,[],CHEMBL3888180,"Homogenous Time-Resolved Fluorescence Assay (HTRF2 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 0.2 nM GST-hMDM2 (aa 1-188), 0.5 nM biotinylated-p53 (aa 1-83), 0.18 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 100 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.",B,,,BAO_0000190,BAO_0000224,protein format,CC(C)[C@@H](CS(C)(=O)=O)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1,,,CHEMBL3886611,,2016,"{'bei': '17.62', 'le': '0.37', 'lle': '3.92', 'sei': '10.38'}",CHEMBL3125700,,CHEMBL3125700,9.52,False,http://www.openphacts.org/units/Nanomolar,2869608,=,37,True,=,,IC50,nM,,0.3,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,0.3
378743,17752363,[],CHEMBL3888180,"Homogenous Time-Resolved Fluorescence Assay (HTRF2 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 0.2 nM GST-hMDM2 (aa 1-188), 0.5 nM biotinylated-p53 (aa 1-83), 0.18 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 100 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.",B,,,BAO_0000190,BAO_0000224,protein format,CC[C@@H](CS(=O)(=O)CC)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1,,,CHEMBL3886611,,2016,"{'bei': '17.62', 'le': '0.37', 'lle': '3.78', 'sei': '10.38'}",CHEMBL3125524,,CHEMBL3125524,9.52,False,http://www.openphacts.org/units/Nanomolar,2869609,=,37,True,=,,IC50,nM,,0.3,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,0.3
378744,17752364,[],CHEMBL3888180,"Homogenous Time-Resolved Fluorescence Assay (HTRF2 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 0.2 nM GST-hMDM2 (aa 1-188), 0.5 nM biotinylated-p53 (aa 1-83), 0.18 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 100 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.",B,,,BAO_0000190,BAO_0000224,protein format,CC[C@@H](CS(=O)(=O)C1CC1)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1,,,CHEMBL3886611,,2016,"{'bei': '17.55', 'le': '0.37', 'lle': '3.81', 'sei': '10.57'}",CHEMBL3125525,,CHEMBL3125525,9.70,False,http://www.openphacts.org/units/Nanomolar,2869610,=,37,True,=,,IC50,nM,,0.2,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,0.2
378745,17752365,[],CHEMBL3888180,"Homogenous Time-Resolved Fluorescence Assay (HTRF2 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 0.2 nM GST-hMDM2 (aa 1-188), 0.5 nM biotinylated-p53 (aa 1-83), 0.18 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 100 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.",B,,,BAO_0000190,BAO_0000224,protein format,CC[C@@H](CS(=O)(=O)C(C)C)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1,,,CHEMBL3886611,,2016,"{'bei': '17.49', 'le': '0.37', 'lle': '3.57', 'sei': '10.57'}",CHEMBL3125526,,CHEMBL3125526,9.70,False,http://www.openphacts.org/units/Nanomolar,2869611,=,37,True,=,,IC50,nM,,0.2,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,0.2
378746,17752366,[],CHEMBL3888180,"Homogenous Time-Resolved Fluorescence Assay (HTRF2 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 0.2 nM GST-hMDM2 (aa 1-188), 0.5 nM biotinylated-p53 (aa 1-83), 0.18 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 100 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.",B,,,BAO_0000190,BAO_0000224,protein format,CC[C@@H](CS(=O)(=O)C(C)(C)C)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1,,,CHEMBL3886611,,2016,"{'bei': '17.59', 'le': '0.37', 'lle': '3.48', 'sei': '10.90'}",CHEMBL3125527,,CHEMBL3125527,10.00,False,http://www.openphacts.org/units/Nanomolar,2869612,=,37,True,=,,IC50,nM,,0.1,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,0.1
378747,17752367,[],CHEMBL3888180,"Homogenous Time-Resolved Fluorescence Assay (HTRF2 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 0.2 nM GST-hMDM2 (aa 1-188), 0.5 nM biotinylated-p53 (aa 1-83), 0.18 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 100 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.",B,,,BAO_0000190,BAO_0000224,protein format,CC[C@@H](CS(=O)(=O)C1CCC1)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1,,,CHEMBL3886611,,2016,"{'bei': '17.12', 'le': '0.36', 'lle': '3.42', 'sei': '10.57'}",CHEMBL3125529,,CHEMBL3125529,9.70,False,http://www.openphacts.org/units/Nanomolar,2869613,=,37,True,=,,IC50,nM,,0.2,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,0.2
378748,17752368,[],CHEMBL3888180,"Homogenous Time-Resolved Fluorescence Assay (HTRF2 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 0.2 nM GST-hMDM2 (aa 1-188), 0.5 nM biotinylated-p53 (aa 1-83), 0.18 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 100 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.",B,,,BAO_0000190,BAO_0000224,protein format,CCC(CS(=O)(=O)CC)N1C(=O)[C@@](CC)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1,,,CHEMBL3886611,,2016,"{'bei': '16.95', 'le': '0.36', 'lle': '3.26', 'sei': '10.24'}",CHEMBL4110659,,CHEMBL4110659,9.40,False,http://www.openphacts.org/units/Nanomolar,2869614,=,37,True,=,,IC50,nM,,0.4,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,0.4
378749,17752369,[],CHEMBL3888180,"Homogenous Time-Resolved Fluorescence Assay (HTRF2 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 0.2 nM GST-hMDM2 (aa 1-188), 0.5 nM biotinylated-p53 (aa 1-83), 0.18 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 100 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.",B,,,BAO_0000190,BAO_0000224,protein format,CC[C@@H](CS(=O)(=O)C(C)C)N1C(=O)[C@@](CC)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1,,,CHEMBL3886611,,2016,"{'bei': '17.06', 'le': '0.36', 'lle': '3.18', 'sei': '10.57'}",CHEMBL3944399,,CHEMBL3944399,9.70,False,http://www.openphacts.org/units/Nanomolar,2869615,=,37,True,=,,IC50,nM,,0.2,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,0.2
378750,17752370,[],CHEMBL3888180,"Homogenous Time-Resolved Fluorescence Assay (HTRF2 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 0.2 nM GST-hMDM2 (aa 1-188), 0.5 nM biotinylated-p53 (aa 1-83), 0.18 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 100 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.",B,,,BAO_0000190,BAO_0000224,protein format,CC[C@@H](CS(=O)(=O)C(C)(C)C)N1C(=O)[C@@](CC)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1,,,CHEMBL3886611,,2016,"{'bei': '17.16', 'le': '0.36', 'lle': '3.09', 'sei': '10.90'}",CHEMBL3952401,,CHEMBL3952401,10.00,False,http://www.openphacts.org/units/Nanomolar,2869616,=,37,True,=,,IC50,nM,,0.1,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,0.1
378751,17752371,[],CHEMBL3888180,"Homogenous Time-Resolved Fluorescence Assay (HTRF2 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 0.2 nM GST-hMDM2 (aa 1-188), 0.5 nM biotinylated-p53 (aa 1-83), 0.18 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 100 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.",B,,,BAO_0000190,BAO_0000224,protein format,CC[C@@H](CS(=O)(=O)C1CCC1)N1C(=O)[C@@](CC)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1,,,CHEMBL3886611,,2016,"{'bei': '16.40', 'le': '0.34', 'lle': '2.85', 'sei': '10.38'}",CHEMBL3905634,,CHEMBL3905634,9.52,False,http://www.openphacts.org/units/Nanomolar,2869617,=,37,True,=,,IC50,nM,,0.3,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,0.3
378752,17752372,[],CHEMBL3888180,"Homogenous Time-Resolved Fluorescence Assay (HTRF2 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 0.2 nM GST-hMDM2 (aa 1-188), 0.5 nM biotinylated-p53 (aa 1-83), 0.18 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 100 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.",B,,,BAO_0000190,BAO_0000224,protein format,CC[C@@H](CS(=O)(=O)C1CC1)N1C(=O)[C@@](CC)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1,,,CHEMBL3886611,,2016,"{'bei': '16.81', 'le': '0.35', 'lle': '3.24', 'sei': '10.38'}",CHEMBL3961096,,CHEMBL3961096,9.52,False,http://www.openphacts.org/units/Nanomolar,2869618,=,37,True,=,,IC50,nM,,0.3,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,0.3
378753,17752373,[],CHEMBL3888180,"Homogenous Time-Resolved Fluorescence Assay (HTRF2 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 0.2 nM GST-hMDM2 (aa 1-188), 0.5 nM biotinylated-p53 (aa 1-83), 0.18 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 100 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.",B,,,BAO_0000190,BAO_0000224,protein format,CCS(=O)(=O)C[C@H](C1CC1)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1,,,CHEMBL3886611,,2016,"{'bei': '18.10', 'le': '0.38', 'lle': '4.26', 'sei': '10.90'}",CHEMBL4106749,,CHEMBL4106749,10.00,False,http://www.openphacts.org/units/Nanomolar,2869619,=,37,True,=,,IC50,nM,,0.1,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,0.1
378754,17752374,[],CHEMBL3888180,"Homogenous Time-Resolved Fluorescence Assay (HTRF2 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 0.2 nM GST-hMDM2 (aa 1-188), 0.5 nM biotinylated-p53 (aa 1-83), 0.18 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 100 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.",B,,,BAO_0000190,BAO_0000224,protein format,CC(C)S(=O)(=O)C[C@H](C1CC1)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1,,,CHEMBL3886611,,2016,"{'bei': '17.65', 'le': '0.37', 'lle': '3.87', 'sei': '10.90'}",CHEMBL3125697,,CHEMBL3125697,10.00,False,http://www.openphacts.org/units/Nanomolar,2869620,=,37,True,=,,IC50,nM,,0.1,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,0.1
378755,17752375,[],CHEMBL3888180,"Homogenous Time-Resolved Fluorescence Assay (HTRF2 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 0.2 nM GST-hMDM2 (aa 1-188), 0.5 nM biotinylated-p53 (aa 1-83), 0.18 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 100 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.",B,,,BAO_0000190,BAO_0000224,protein format,CC(C)(C)S(=O)(=O)C[C@H](C1CC1)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1,,,CHEMBL3886611,,2016,"{'bei': '17.22', 'le': '0.36', 'lle': '3.48', 'sei': '10.90'}",CHEMBL3125537,,CHEMBL3125537,10.00,False,http://www.openphacts.org/units/Nanomolar,2869621,=,37,True,=,,IC50,nM,,0.1,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,0.1
378756,17752376,[],CHEMBL3888180,"Homogenous Time-Resolved Fluorescence Assay (HTRF2 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 0.2 nM GST-hMDM2 (aa 1-188), 0.5 nM biotinylated-p53 (aa 1-83), 0.18 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 100 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.",B,,,BAO_0000190,BAO_0000224,protein format,C[C@]1(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@@H](c2ccc(Cl)cc2)N([C@H](CS(=O)(=O)C2CCC2)C2CC2)C1=O,,,CHEMBL3886611,,2016,"{'bei': '16.76', 'le': '0.35', 'lle': '3.42', 'sei': '10.57'}",CHEMBL3968680,,CHEMBL3968680,9.70,False,http://www.openphacts.org/units/Nanomolar,2869622,=,37,True,=,,IC50,nM,,0.2,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,0.2
378757,17752377,[],CHEMBL3888180,"Homogenous Time-Resolved Fluorescence Assay (HTRF2 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 0.2 nM GST-hMDM2 (aa 1-188), 0.5 nM biotinylated-p53 (aa 1-83), 0.18 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 100 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.",B,,,BAO_0000190,BAO_0000224,protein format,C[C@]1(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@@H](c2ccc(Cl)cc2)N([C@H](CS(=O)(=O)C2CC2)C2CC2)C1=O,,,CHEMBL3886611,,2016,"{'bei': '17.71', 'le': '0.37', 'lle': '4.11', 'sei': '10.90'}",CHEMBL3894720,,CHEMBL3894720,10.00,False,http://www.openphacts.org/units/Nanomolar,2869623,=,37,True,=,,IC50,nM,,0.1,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,0.1
378758,17752378,[],CHEMBL3888180,"Homogenous Time-Resolved Fluorescence Assay (HTRF2 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 0.2 nM GST-hMDM2 (aa 1-188), 0.5 nM biotinylated-p53 (aa 1-83), 0.18 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 100 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.",B,,,BAO_0000190,BAO_0000224,protein format,C[C@]1(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@@H](c2ccc(Cl)cc2)N([C@H](CS(C)(=O)=O)C2CC2)C1=O,,,CHEMBL3886611,,2016,"{'bei': '18.57', 'le': '0.39', 'lle': '4.65', 'sei': '10.90'}",CHEMBL3125701,,CHEMBL3125701,10.00,False,http://www.openphacts.org/units/Nanomolar,2869624,=,37,True,=,,IC50,nM,,0.1,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,0.1
378759,17752379,[],CHEMBL3888180,"Homogenous Time-Resolved Fluorescence Assay (HTRF2 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 0.2 nM GST-hMDM2 (aa 1-188), 0.5 nM biotinylated-p53 (aa 1-83), 0.18 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 100 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.",B,,,BAO_0000190,BAO_0000224,protein format,CCC(C)(C)S(=O)(=O)C[C@H](C1CC1)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1,,,CHEMBL3886611,,2016,"{'bei': '15.51', 'le': '0.32', 'lle': '2.31', 'sei': '10.05'}",CHEMBL3977180,,CHEMBL3977180,9.22,False,http://www.openphacts.org/units/Nanomolar,2869625,=,37,True,=,,IC50,nM,,0.6,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,0.6
378760,17752380,[],CHEMBL3888180,"Homogenous Time-Resolved Fluorescence Assay (HTRF2 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 0.2 nM GST-hMDM2 (aa 1-188), 0.5 nM biotinylated-p53 (aa 1-83), 0.18 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 100 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.",B,,,BAO_0000190,BAO_0000224,protein format,C[C@]1(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@@H](c2ccc(Cl)cc2)N([C@H](CS(=O)(=O)c2ccc(F)cc2F)C2CC2)C1=O,,,CHEMBL3886611,,2016,"{'bei': '14.21', 'le': '0.29', 'lle': '1.99', 'sei': '9.86'}",CHEMBL3929489,,CHEMBL3929489,9.05,False,http://www.openphacts.org/units/Nanomolar,2869626,=,37,True,=,,IC50,nM,,0.9,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,0.9
378761,17752381,[],CHEMBL3888180,"Homogenous Time-Resolved Fluorescence Assay (HTRF2 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 0.2 nM GST-hMDM2 (aa 1-188), 0.5 nM biotinylated-p53 (aa 1-83), 0.18 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 100 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.",B,,,BAO_0000190,BAO_0000224,protein format,CC[C@]1(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@@H](c2ccc(Cl)cc2)N([C@H](CS(=O)(=O)CC)C2CC2)C1=O,,,CHEMBL3886611,,2016,"{'bei': '17.12', 'le': '0.36', 'lle': '3.56', 'sei': '10.57'}",CHEMBL4111158,,CHEMBL4111158,9.70,False,http://www.openphacts.org/units/Nanomolar,2869627,=,37,True,=,,IC50,nM,,0.2,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,0.2
378762,17752382,[],CHEMBL3888180,"Homogenous Time-Resolved Fluorescence Assay (HTRF2 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 0.2 nM GST-hMDM2 (aa 1-188), 0.5 nM biotinylated-p53 (aa 1-83), 0.18 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 100 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.",B,,,BAO_0000190,BAO_0000224,protein format,CC[C@]1(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@@H](c2ccc(Cl)cc2)N([C@H](CS(=O)(=O)C(C)C)C2CC2)C1=O,,,CHEMBL3886611,,2016,"{'bei': '17.22', 'le': '0.36', 'lle': '3.48', 'sei': '10.90'}",CHEMBL3956221,,CHEMBL3956221,10.00,False,http://www.openphacts.org/units/Nanomolar,2869628,=,37,True,=,,IC50,nM,,0.1,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,0.1
378763,17752383,[],CHEMBL3888180,"Homogenous Time-Resolved Fluorescence Assay (HTRF2 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 0.2 nM GST-hMDM2 (aa 1-188), 0.5 nM biotinylated-p53 (aa 1-83), 0.18 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 100 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.",B,,,BAO_0000190,BAO_0000224,protein format,CC[C@]1(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@@H](c2ccc(Cl)cc2)N([C@H](CS(=O)(=O)C(C)(C)C)C2CC2)C1=O,,,CHEMBL3886611,,2016,"{'bei': '16.31', 'le': '0.34', 'lle': '2.79', 'sei': '10.57'}",CHEMBL3925866,,CHEMBL3925866,9.70,False,http://www.openphacts.org/units/Nanomolar,2869629,=,37,True,=,,IC50,nM,,0.2,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,0.2
378764,17752384,[],CHEMBL3888180,"Homogenous Time-Resolved Fluorescence Assay (HTRF2 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 0.2 nM GST-hMDM2 (aa 1-188), 0.5 nM biotinylated-p53 (aa 1-83), 0.18 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 100 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.",B,,,BAO_0000190,BAO_0000224,protein format,CC[C@]1(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@@H](c2ccc(Cl)cc2)N([C@H](CS(=O)(=O)C2CC2)C2CC2)C1=O,,,CHEMBL3886611,,2016,"{'bei': '16.46', 'le': '0.34', 'lle': '3.24', 'sei': '10.38'}",CHEMBL3953498,,CHEMBL3953498,9.52,False,http://www.openphacts.org/units/Nanomolar,2869630,=,37,True,=,,IC50,nM,,0.3,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,0.3
378765,17752385,[],CHEMBL3888180,"Homogenous Time-Resolved Fluorescence Assay (HTRF2 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 0.2 nM GST-hMDM2 (aa 1-188), 0.5 nM biotinylated-p53 (aa 1-83), 0.18 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 100 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.",B,,,BAO_0000190,BAO_0000224,protein format,CCS(=O)(=O)C[C@H](C(C)C)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1,,,CHEMBL3886611,,2016,"{'bei': '16.77', 'le': '0.35', 'lle': '3.31', 'sei': '10.14'}",CHEMBL4110053,,CHEMBL4110053,9.30,False,http://www.openphacts.org/units/Nanomolar,2869631,=,37,True,=,,IC50,nM,,0.5,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,0.5
378766,17752386,[],CHEMBL3888180,"Homogenous Time-Resolved Fluorescence Assay (HTRF2 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 0.2 nM GST-hMDM2 (aa 1-188), 0.5 nM biotinylated-p53 (aa 1-83), 0.18 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 100 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.",B,,,BAO_0000190,BAO_0000224,protein format,CC(C)[C@@H](CS(=O)(=O)C(C)C)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1,,,CHEMBL3886611,,2016,"{'bei': '15.83', 'le': '0.33', 'lle': '2.62', 'sei': '9.81'}",CHEMBL3125702,AMG-232,CHEMBL3125702,9.00,False,http://www.openphacts.org/units/Nanomolar,2869632,=,37,True,=,,IC50,nM,,1.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,1.0
378767,17752387,[],CHEMBL3888180,"Homogenous Time-Resolved Fluorescence Assay (HTRF2 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 0.2 nM GST-hMDM2 (aa 1-188), 0.5 nM biotinylated-p53 (aa 1-83), 0.18 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 100 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.",B,,,BAO_0000190,BAO_0000224,protein format,CC(C)(C)[C@@H](CS(C)(=O)=O)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1,,,CHEMBL3886611,,2016,"{'bei': '17.49', 'le': '0.37', 'lle': '3.71', 'sei': '10.57'}",CHEMBL4108590,,CHEMBL4108590,9.70,False,http://www.openphacts.org/units/Nanomolar,2869633,=,37,True,=,,IC50,nM,,0.2,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,0.2
378768,17752388,[],CHEMBL3888180,"Homogenous Time-Resolved Fluorescence Assay (HTRF2 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 0.2 nM GST-hMDM2 (aa 1-188), 0.5 nM biotinylated-p53 (aa 1-83), 0.18 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 100 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.",B,,,BAO_0000190,BAO_0000224,protein format,CCS(=O)(=O)C[C@@H](N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1)C(C)(C)C,,,CHEMBL3886611,,2016,"{'bei': '16.75', 'le': '0.35', 'lle': '3.14', 'sei': '10.38'}",CHEMBL4115157,,CHEMBL4115157,9.52,False,http://www.openphacts.org/units/Nanomolar,2869634,=,37,True,=,,IC50,nM,,0.3,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,0.3
378769,17752389,[],CHEMBL3888180,"Homogenous Time-Resolved Fluorescence Assay (HTRF2 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 0.2 nM GST-hMDM2 (aa 1-188), 0.5 nM biotinylated-p53 (aa 1-83), 0.18 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 100 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.",B,,,BAO_0000190,BAO_0000224,protein format,CC(C)S(=O)(=O)C[C@@H](N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1)C(C)(C)C,,,CHEMBL3886611,,2016,"{'bei': '15.61', 'le': '0.33', 'lle': '2.33', 'sei': '9.91'}",CHEMBL3125540,,CHEMBL3125540,9.10,False,http://www.openphacts.org/units/Nanomolar,2869635,=,37,True,=,,IC50,nM,,0.8,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,0.8
378770,17752390,[],CHEMBL3888180,"Homogenous Time-Resolved Fluorescence Assay (HTRF2 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 0.2 nM GST-hMDM2 (aa 1-188), 0.5 nM biotinylated-p53 (aa 1-83), 0.18 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 100 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.",B,,,BAO_0000190,BAO_0000224,protein format,CCC(CC)S(=O)(=O)C[C@H](C1CC1)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1,,,CHEMBL3886611,,2016,"{'bei': '16.82', 'le': '0.35', 'lle': '3.09', 'sei': '10.90'}",CHEMBL4112965,,CHEMBL4112965,10.00,False,http://www.openphacts.org/units/Nanomolar,2869636,=,37,True,=,,IC50,nM,,0.1,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,0.1
378771,17752391,[],CHEMBL3888180,"Homogenous Time-Resolved Fluorescence Assay (HTRF2 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 0.2 nM GST-hMDM2 (aa 1-188), 0.5 nM biotinylated-p53 (aa 1-83), 0.18 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 100 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.",B,,,BAO_0000190,BAO_0000224,protein format,CC[C@@H](C[S@@+]([O-])C(C)C)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1,,,CHEMBL3886611,,2016,"{'bei': '15.94', 'le': '0.33', 'lle': '2.12', 'sei': '11.50'}",CHEMBL3924621,,CHEMBL3924621,8.59,False,http://www.openphacts.org/units/Nanomolar,2869637,=,37,True,=,,IC50,nM,,2.6,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,2.6
378772,17752392,[],CHEMBL3888180,"Homogenous Time-Resolved Fluorescence Assay (HTRF2 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 0.2 nM GST-hMDM2 (aa 1-188), 0.5 nM biotinylated-p53 (aa 1-83), 0.18 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 100 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.",B,,,BAO_0000190,BAO_0000224,protein format,CC[C@@H](C[S@@+]([O-])C(C)C)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1,,,CHEMBL3886611,,2016,"{'bei': '16.19', 'le': '0.34', 'lle': '2.25', 'sei': '11.68'}",CHEMBL3924621,,CHEMBL3924621,8.72,False,http://www.openphacts.org/units/Nanomolar,2869637,=,37,True,=,,IC50,nM,,1.9,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,1.9
378773,17752393,[],CHEMBL3888180,"Homogenous Time-Resolved Fluorescence Assay (HTRF2 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 0.2 nM GST-hMDM2 (aa 1-188), 0.5 nM biotinylated-p53 (aa 1-83), 0.18 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 100 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.",B,,,BAO_0000190,BAO_0000224,protein format,CC[C@@H]([C@@H](C)S(C)(=O)=O)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1,,,CHEMBL3886611,,2016,"{'bei': '17.06', 'le': '0.36', 'lle': '3.48', 'sei': '10.05'}",CHEMBL4112794,,CHEMBL4112794,9.22,False,http://www.openphacts.org/units/Nanomolar,2869638,=,37,True,=,,IC50,nM,,0.6,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,0.6
378774,17752394,[],CHEMBL3888180,"Homogenous Time-Resolved Fluorescence Assay (HTRF2 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 0.2 nM GST-hMDM2 (aa 1-188), 0.5 nM biotinylated-p53 (aa 1-83), 0.18 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 100 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.",B,,,BAO_0000190,BAO_0000224,protein format,CC[C@@H]([C@@H](C)S(=O)(=O)CC)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1,,,CHEMBL3886611,,2016,"{'bei': '16.95', 'le': '0.36', 'lle': '3.27', 'sei': '10.24'}",CHEMBL4113035,,CHEMBL4113035,9.40,False,http://www.openphacts.org/units/Nanomolar,2869639,=,37,True,=,,IC50,nM,,0.4,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,0.4
378775,17752395,[],CHEMBL3888180,"Homogenous Time-Resolved Fluorescence Assay (HTRF2 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 0.2 nM GST-hMDM2 (aa 1-188), 0.5 nM biotinylated-p53 (aa 1-83), 0.18 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 100 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.",B,,,BAO_0000190,BAO_0000224,protein format,CC[C@@H]([C@H](C)S(=O)(=O)CC)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1,,,CHEMBL3886611,,2016,"{'bei': '18.03', 'le': '0.38', 'lle': '3.87', 'sei': '10.90'}",CHEMBL3958045,,CHEMBL3958045,10.00,False,http://www.openphacts.org/units/Nanomolar,2869640,=,37,True,=,,IC50,nM,,0.1,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,0.1
378776,17752396,[],CHEMBL3888180,"Homogenous Time-Resolved Fluorescence Assay (HTRF2 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 0.2 nM GST-hMDM2 (aa 1-188), 0.5 nM biotinylated-p53 (aa 1-83), 0.18 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 100 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.",B,,,BAO_0000190,BAO_0000224,protein format,CC[C@@H](CS(=O)(=O)NC1COC1)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1,,,CHEMBL3886611,,2016,"{'bei': '16.62', 'le': '0.35', 'lle': '5.07', 'sei': '8.58'}",CHEMBL3934002,,CHEMBL3934002,9.70,False,http://www.openphacts.org/units/Nanomolar,2869641,=,37,True,=,,IC50,nM,,0.2,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,0.2
378777,17752397,[],CHEMBL3888180,"Homogenous Time-Resolved Fluorescence Assay (HTRF2 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 0.2 nM GST-hMDM2 (aa 1-188), 0.5 nM biotinylated-p53 (aa 1-83), 0.18 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 100 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.",B,,,BAO_0000190,BAO_0000224,protein format,CC[C@@H](CS(=O)(=O)NCC1(C)COC1)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1,,,CHEMBL3886611,,2016,"{'bei': '15.86', 'le': '0.33', 'lle': '4.43', 'sei': '8.58'}",CHEMBL3978594,,CHEMBL3978594,9.70,False,http://www.openphacts.org/units/Nanomolar,2869642,=,37,True,=,,IC50,nM,,0.2,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,0.2
378778,17752398,[],CHEMBL3888180,"Homogenous Time-Resolved Fluorescence Assay (HTRF2 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 0.2 nM GST-hMDM2 (aa 1-188), 0.5 nM biotinylated-p53 (aa 1-83), 0.18 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 100 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.",B,,,BAO_0000190,BAO_0000224,protein format,CC[C@@H](CS(=O)(=O)NCC1COC1)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1,,,CHEMBL3886611,,2016,"{'bei': '16.23', 'le': '0.34', 'lle': '4.82', 'sei': '8.58'}",CHEMBL3949514,,CHEMBL3949514,9.70,False,http://www.openphacts.org/units/Nanomolar,2869643,=,37,True,=,,IC50,nM,,0.2,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,0.2
378779,17752399,[],CHEMBL3888180,"Homogenous Time-Resolved Fluorescence Assay (HTRF2 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 0.2 nM GST-hMDM2 (aa 1-188), 0.5 nM biotinylated-p53 (aa 1-83), 0.18 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 100 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.",B,,,BAO_0000190,BAO_0000224,protein format,CC(C)(C)NS(=O)(=O)C[C@H](C1CC1)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)C1c1ccc(Cl)cc1,,,CHEMBL3886611,,2016,"{'bei': '16.79', 'le': '0.35', 'lle': '3.97', 'sei': '9.64'}",CHEMBL4114145,,CHEMBL4114145,10.00,False,http://www.openphacts.org/units/Nanomolar,2869644,=,37,True,=,,IC50,nM,,0.1,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,0.1
378780,17752400,[],CHEMBL3888180,"Homogenous Time-Resolved Fluorescence Assay (HTRF2 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 0.2 nM GST-hMDM2 (aa 1-188), 0.5 nM biotinylated-p53 (aa 1-83), 0.18 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 100 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.",B,,,BAO_0000190,BAO_0000224,protein format,CNS(=O)(=O)C[C@H](C1CC1)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1,,,CHEMBL3886611,,2016,"{'bei': '16.26', 'le': '0.34', 'lle': '4.14', 'sei': '8.67'}",CHEMBL3318755,,CHEMBL3318755,9.00,False,http://www.openphacts.org/units/Nanomolar,2869645,=,37,True,=,,IC50,nM,,1.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,1.0
378781,17752401,[],CHEMBL3888180,"Homogenous Time-Resolved Fluorescence Assay (HTRF2 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 0.2 nM GST-hMDM2 (aa 1-188), 0.5 nM biotinylated-p53 (aa 1-83), 0.18 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 100 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.",B,,,BAO_0000190,BAO_0000224,protein format,CN(C)S(=O)(=O)C[C@H](C1CC1)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1,,,CHEMBL3886611,,2016,"{'bei': '17.09', 'le': '0.36', 'lle': '4.50', 'sei': '10.21'}",CHEMBL3125519,,CHEMBL3125519,9.70,False,http://www.openphacts.org/units/Nanomolar,2869646,=,37,True,=,,IC50,nM,,0.2,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,0.2
378782,17752402,[],CHEMBL3888180,"Homogenous Time-Resolved Fluorescence Assay (HTRF2 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 0.2 nM GST-hMDM2 (aa 1-188), 0.5 nM biotinylated-p53 (aa 1-83), 0.18 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 100 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.",B,,,BAO_0000190,BAO_0000224,protein format,CC(C)NS(=O)(=O)C[C@H](C1CC1)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1,,,CHEMBL3886611,,2016,"{'bei': '17.20', 'le': '0.36', 'lle': '4.36', 'sei': '9.64'}",CHEMBL3318760,,CHEMBL3318760,10.00,False,http://www.openphacts.org/units/Nanomolar,2869647,=,37,True,=,,IC50,nM,,0.1,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,0.1
378783,17752403,[],CHEMBL3888180,"Homogenous Time-Resolved Fluorescence Assay (HTRF2 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 0.2 nM GST-hMDM2 (aa 1-188), 0.5 nM biotinylated-p53 (aa 1-83), 0.18 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 100 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.",B,,,BAO_0000190,BAO_0000224,protein format,C[C@]1(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@@H](c2ccc(Cl)cc2)N([C@H](CS(=O)(=O)N2CCOCC2)C2CC2)C1=O,,,CHEMBL3886611,,2016,"{'bei': '16.41', 'le': '0.34', 'lle': '5.03', 'sei': '9.60'}",CHEMBL3318767,,CHEMBL3318767,10.00,False,http://www.openphacts.org/units/Nanomolar,2869648,=,37,True,=,,IC50,nM,,0.1,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,0.1
378784,17752404,[],CHEMBL3888180,"Homogenous Time-Resolved Fluorescence Assay (HTRF2 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 0.2 nM GST-hMDM2 (aa 1-188), 0.5 nM biotinylated-p53 (aa 1-83), 0.18 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 100 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.",B,,,BAO_0000190,BAO_0000224,protein format,C[C@]1(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@@H](c2ccc(Cl)cc2)N([C@H](CS(=O)(=O)N2CCCCC2)C2CC2)C1=O,,,CHEMBL3886611,,2016,"{'bei': '15.18', 'le': '0.31', 'lle': '3.09', 'sei': '9.71'}",CHEMBL3318766,,CHEMBL3318766,9.22,False,http://www.openphacts.org/units/Nanomolar,2869649,=,37,True,=,,IC50,nM,,0.6,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,0.6
378785,17752405,[],CHEMBL3888180,"Homogenous Time-Resolved Fluorescence Assay (HTRF2 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 0.2 nM GST-hMDM2 (aa 1-188), 0.5 nM biotinylated-p53 (aa 1-83), 0.18 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 100 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.",B,,,BAO_0000190,BAO_0000224,protein format,C[C@]1(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@@H](c2ccc(Cl)cc2)N([C@H](CS(=O)(=O)N2CCCC2)C2CC2)C1=O,,,CHEMBL3886611,,2016,"{'bei': '16.85', 'le': '0.35', 'lle': '4.26', 'sei': '10.53'}",CHEMBL3125521,,CHEMBL3125521,10.00,False,http://www.openphacts.org/units/Nanomolar,2869650,=,37,True,=,,IC50,nM,,0.1,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,0.1
378786,17752406,[],CHEMBL3888180,"Homogenous Time-Resolved Fluorescence Assay (HTRF2 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 0.2 nM GST-hMDM2 (aa 1-188), 0.5 nM biotinylated-p53 (aa 1-83), 0.18 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 100 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.",B,,,BAO_0000190,BAO_0000224,protein format,C[C@]1(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@@H](c2ccc(Cl)cc2)N([C@H](CS(=O)(=O)N2CCC2)C2CC2)C1=O,,,CHEMBL3886611,,2016,"{'bei': '16.74', 'le': '0.35', 'lle': '4.35', 'sei': '10.21'}",CHEMBL3125520,,CHEMBL3125520,9.70,False,http://www.openphacts.org/units/Nanomolar,2869651,=,37,True,=,,IC50,nM,,0.2,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,0.2
378787,17752407,[],CHEMBL3888180,"Homogenous Time-Resolved Fluorescence Assay (HTRF2 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 0.2 nM GST-hMDM2 (aa 1-188), 0.5 nM biotinylated-p53 (aa 1-83), 0.18 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 100 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.",B,,,BAO_0000190,BAO_0000224,protein format,CN(C)S(=O)(=O)NC[C@H](C1CC1)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1,,,CHEMBL3886611,,2016,"{'bei': '15.97', 'le': '0.33', 'lle': '4.59', 'sei': '8.69'}",CHEMBL4114394,,CHEMBL4114394,9.30,False,http://www.openphacts.org/units/Nanomolar,2869652,=,37,True,=,,IC50,nM,,0.5,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,0.5
378788,17752408,[],CHEMBL3888180,"Homogenous Time-Resolved Fluorescence Assay (HTRF2 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 0.2 nM GST-hMDM2 (aa 1-188), 0.5 nM biotinylated-p53 (aa 1-83), 0.18 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 100 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.",B,,,BAO_0000190,BAO_0000224,protein format,CN(C)S(=O)(=O)N(C)C[C@H](C1CC1)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1,,,CHEMBL3886611,,2016,"{'bei': '15.59', 'le': '0.33', 'lle': '4.25', 'sei': '9.47'}",CHEMBL4109313,,CHEMBL4109313,9.30,False,http://www.openphacts.org/units/Nanomolar,2869653,=,37,True,=,,IC50,nM,,0.5,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,0.5
378789,17752409,[],CHEMBL3888180,"Homogenous Time-Resolved Fluorescence Assay (HTRF2 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 0.2 nM GST-hMDM2 (aa 1-188), 0.5 nM biotinylated-p53 (aa 1-83), 0.18 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 100 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.",B,,,BAO_0000190,BAO_0000224,protein format,CN1C(=O)N(C[C@H](C2CC2)N2C(=O)[C@@](C)(CC(=O)O)C[C@H](c3cccc(Cl)c3)[C@H]2c2ccc(Cl)cc2)C(=O)C1(C)C,,,CHEMBL3886611,,2016,"{'bei': '14.56', 'le': '0.29', 'lle': '2.76', 'sei': '8.90'}",CHEMBL3896849,,CHEMBL3896849,8.74,False,http://www.openphacts.org/units/Nanomolar,2869654,=,37,True,=,,IC50,nM,,1.8,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,1.8
378790,17752410,[],CHEMBL3888180,"Homogenous Time-Resolved Fluorescence Assay (HTRF2 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 0.2 nM GST-hMDM2 (aa 1-188), 0.5 nM biotinylated-p53 (aa 1-83), 0.18 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 100 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.",B,,,BAO_0000190,BAO_0000224,protein format,CC1(C)NC(=O)N(C[C@H](C2CC2)N2C(=O)[C@@](C)(CC(=O)O)C[C@H](c3cccc(Cl)c3)[C@H]2c2ccc(Cl)cc2)C1=O,,,CHEMBL3886611,,2016,"{'bei': '13.90', 'le': '0.28', 'lle': '2.51', 'sei': '7.62'}",CHEMBL3971528,,CHEMBL3971528,8.15,False,http://www.openphacts.org/units/Nanomolar,2869655,=,37,True,=,,IC50,nM,,7.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,7.0
378791,17752411,[],CHEMBL3888180,"Homogenous Time-Resolved Fluorescence Assay (HTRF2 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 0.2 nM GST-hMDM2 (aa 1-188), 0.5 nM biotinylated-p53 (aa 1-83), 0.18 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 100 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.",B,,,BAO_0000190,BAO_0000224,protein format,C[C@]1(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@@H](c2ccc(Cl)cc2)N([C@H](Cn2c(=O)[nH]c3ccccc32)C2CC2)C1=O,,,CHEMBL3886611,,2016,"{'bei': '14.94', 'le': '0.29', 'lle': '2.20', 'sei': '9.28'}",CHEMBL3962217,,CHEMBL3962217,8.85,False,http://www.openphacts.org/units/Nanomolar,2869656,=,37,True,=,,IC50,nM,,1.4,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,1.4
378792,17752412,[],CHEMBL3888180,"Homogenous Time-Resolved Fluorescence Assay (HTRF2 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 0.2 nM GST-hMDM2 (aa 1-188), 0.5 nM biotinylated-p53 (aa 1-83), 0.18 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 100 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.",B,,,BAO_0000190,BAO_0000224,protein format,C=CC[C@@]1(C)C[C@H](c2ccc(F)c(Cl)c2)[C@@H](c2ccc(Cl)cc2)N(C(C)C)C1=O,,,CHEMBL3886611,,2016,"{'bei': '19.11', 'le': '0.39', 'lle': '1.12', 'sei': '40.87'}",CHEMBL4112399,,CHEMBL4112399,8.30,False,http://www.openphacts.org/units/Nanomolar,2869657,=,37,True,=,,IC50,nM,,5.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,5.0
378793,17752413,[],CHEMBL3888180,"Homogenous Time-Resolved Fluorescence Assay (HTRF2 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 0.2 nM GST-hMDM2 (aa 1-188), 0.5 nM biotinylated-p53 (aa 1-83), 0.18 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 100 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.",B,,,BAO_0000190,BAO_0000224,protein format,CC(C)N1C(=O)[C@](C)(CC(=O)O)C[C@H](c2cc(F)cc(Cl)c2)[C@H]1c1ccc(Cl)cc1,,,CHEMBL3886611,,2016,"{'bei': '15.28', 'le': '0.31', 'lle': '0.83', 'sei': '11.99'}",CHEMBL4111372,,CHEMBL4111372,6.91,False,http://www.openphacts.org/units/Nanomolar,2869658,=,37,True,=,,IC50,nM,,123.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,123.0
378794,17752414,[],CHEMBL3888180,"Homogenous Time-Resolved Fluorescence Assay (HTRF2 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 0.2 nM GST-hMDM2 (aa 1-188), 0.5 nM biotinylated-p53 (aa 1-83), 0.18 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 100 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.",B,,,BAO_0000190,BAO_0000224,protein format,CC[C@@H](CNS(=O)(=O)CC)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cc(F)cc(Cl)c2)[C@H]1c1ccc(Cl)cc1,,,CHEMBL3886611,,2016,"{'bei': '15.96', 'le': '0.34', 'lle': '3.76', 'sei': '8.82'}",CHEMBL3941277,,CHEMBL3941277,9.15,False,http://www.openphacts.org/units/Nanomolar,2869659,=,37,True,=,,IC50,nM,,0.7,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,0.7
378795,17752415,[],CHEMBL3888180,"Homogenous Time-Resolved Fluorescence Assay (HTRF2 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 0.2 nM GST-hMDM2 (aa 1-188), 0.5 nM biotinylated-p53 (aa 1-83), 0.18 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 100 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.",B,,,BAO_0000190,BAO_0000224,protein format,CC[C@@H](CN(C)S(=O)(=O)CC)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cc(F)cc(Cl)c2)[C@H]1c1ccc(Cl)cc1,,,CHEMBL3886611,,2016,"{'bei': '16.00', 'le': '0.34', 'lle': '3.67', 'sei': '9.89'}",CHEMBL3965712,,CHEMBL3965712,9.40,False,http://www.openphacts.org/units/Nanomolar,2869660,=,37,True,=,,IC50,nM,,0.4,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,0.4
378796,17752416,[],CHEMBL3888180,"Homogenous Time-Resolved Fluorescence Assay (HTRF2 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 0.2 nM GST-hMDM2 (aa 1-188), 0.5 nM biotinylated-p53 (aa 1-83), 0.18 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 100 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.",B,,,BAO_0000190,BAO_0000224,protein format,CC[C@@H](CS(C)(=O)=O)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cc(F)cc(Cl)c2)[C@H]1c1ccc(Cl)cc1,,,CHEMBL3886611,,2016,"{'bei': '17.08', 'le': '0.36', 'lle': '3.81', 'sei': '10.14'}",CHEMBL3935799,,CHEMBL3935799,9.30,False,http://www.openphacts.org/units/Nanomolar,2869661,=,37,True,=,,IC50,nM,,0.5,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,0.5
378797,17752417,[],CHEMBL3888180,"Homogenous Time-Resolved Fluorescence Assay (HTRF2 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 0.2 nM GST-hMDM2 (aa 1-188), 0.5 nM biotinylated-p53 (aa 1-83), 0.18 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 100 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.",B,,,BAO_0000190,BAO_0000224,protein format,CC[C@@H](CS(=O)(=O)CC)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cc(F)cc(Cl)c2)[C@H]1c1ccc(Cl)cc1,,,CHEMBL3886611,,2016,"{'bei': '17.37', 'le': '0.37', 'lle': '3.82', 'sei': '10.57'}",CHEMBL3897410,,CHEMBL3897410,9.70,False,http://www.openphacts.org/units/Nanomolar,2869662,=,37,True,=,,IC50,nM,,0.2,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,0.2
378798,17752418,[],CHEMBL3888180,"Homogenous Time-Resolved Fluorescence Assay (HTRF2 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 0.2 nM GST-hMDM2 (aa 1-188), 0.5 nM biotinylated-p53 (aa 1-83), 0.18 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 100 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.",B,,,BAO_0000190,BAO_0000224,protein format,CC[C@@H](CS(=O)(=O)C1CC1)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cc(F)cc(Cl)c2)[C@H]1c1ccc(Cl)cc1,,,CHEMBL3886611,,2016,"{'bei': '17.00', 'le': '0.36', 'lle': '3.67', 'sei': '10.57'}",CHEMBL3972089,,CHEMBL3972089,9.70,False,http://www.openphacts.org/units/Nanomolar,2869663,=,37,True,=,,IC50,nM,,0.2,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,0.2
378799,17752419,[],CHEMBL3888180,"Homogenous Time-Resolved Fluorescence Assay (HTRF2 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 0.2 nM GST-hMDM2 (aa 1-188), 0.5 nM biotinylated-p53 (aa 1-83), 0.18 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 100 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.",B,,,BAO_0000190,BAO_0000224,protein format,CC[C@@H](CS(=O)(=O)C(C)(C)C)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cc(F)cc(Cl)c2)[C@H]1c1ccc(Cl)cc1,,,CHEMBL3886611,,2016,"{'bei': '17.05', 'le': '0.36', 'lle': '3.34', 'sei': '10.90'}",CHEMBL3904145,,CHEMBL3904145,10.00,False,http://www.openphacts.org/units/Nanomolar,2869664,=,37,True,=,,IC50,nM,,0.1,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,0.1
378800,17752420,[],CHEMBL3888180,"Homogenous Time-Resolved Fluorescence Assay (HTRF2 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 0.2 nM GST-hMDM2 (aa 1-188), 0.5 nM biotinylated-p53 (aa 1-83), 0.18 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 100 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.",B,,,BAO_0000190,BAO_0000224,protein format,CC[C@@H](CS(=O)(=O)C(C)C)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cc(F)cc(Cl)c2)[C@H]1c1ccc(Cl)cc1,,,CHEMBL3886611,,2016,"{'bei': '17.47', 'le': '0.37', 'lle': '3.73', 'sei': '10.90'}",CHEMBL3909721,,CHEMBL3909721,10.00,False,http://www.openphacts.org/units/Nanomolar,2869665,=,37,True,=,,IC50,nM,,0.1,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,0.1
378801,17752421,[],CHEMBL3888180,"Homogenous Time-Resolved Fluorescence Assay (HTRF2 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 0.2 nM GST-hMDM2 (aa 1-188), 0.5 nM biotinylated-p53 (aa 1-83), 0.18 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 100 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.",B,,,BAO_0000190,BAO_0000224,protein format,CC[C@@H](CS(=O)(=O)C1CC1)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cncc(Cl)c2)[C@H]1c1ccc(Cl)cc1,,,CHEMBL3886611,,2016,"{'bei': '15.21', 'le': '0.32', 'lle': '3.14', 'sei': '8.05'}",CHEMBL3932147,,CHEMBL3932147,8.42,False,http://www.openphacts.org/units/Nanomolar,2869666,=,37,True,=,,IC50,nM,,3.8,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,3.8
378802,17752422,[],CHEMBL3888180,"Homogenous Time-Resolved Fluorescence Assay (HTRF2 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 0.2 nM GST-hMDM2 (aa 1-188), 0.5 nM biotinylated-p53 (aa 1-83), 0.18 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 100 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.",B,,,BAO_0000190,BAO_0000224,protein format,CC[C@@H](CS(=O)(=O)C(C)(C)C)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cncc(Cl)c2)[C@H]1c1ccc(Cl)cc1,,,CHEMBL3886611,,2016,"{'bei': '15.49', 'le': '0.33', 'lle': '2.90', 'sei': '8.43'}",CHEMBL3941159,,CHEMBL3941159,8.82,False,http://www.openphacts.org/units/Nanomolar,2869667,=,37,True,=,,IC50,nM,,1.5,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,1.5
378803,17752423,[],CHEMBL3888180,"Homogenous Time-Resolved Fluorescence Assay (HTRF2 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 0.2 nM GST-hMDM2 (aa 1-188), 0.5 nM biotinylated-p53 (aa 1-83), 0.18 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 100 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.",B,,,BAO_0000190,BAO_0000224,protein format,CC[C@@H](CNS(=O)(=O)C1CC1)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cncc(Cl)c2)[C@H]1c1ccc(Cl)cc1,,,CHEMBL3886611,,2016,"{'bei': '14.66', 'le': '0.31', 'lle': '3.55', 'sei': '7.15'}",CHEMBL3918643,,CHEMBL3918643,8.34,False,http://www.openphacts.org/units/Nanomolar,2869668,=,37,True,=,,IC50,nM,,4.6,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,4.6
378804,17752424,[],CHEMBL3888180,"Homogenous Time-Resolved Fluorescence Assay (HTRF2 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 0.2 nM GST-hMDM2 (aa 1-188), 0.5 nM biotinylated-p53 (aa 1-83), 0.18 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 100 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.",B,,,BAO_0000190,BAO_0000224,protein format,CC[C@@H](CN(C)S(=O)(=O)C1CC1)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cncc(Cl)c2)[C@H]1c1ccc(Cl)cc1,,,CHEMBL3886611,,2016,"{'bei': '14.42', 'le': '0.30', 'lle': '3.27', 'sei': '7.78'}",CHEMBL3946498,,CHEMBL3946498,8.40,False,http://www.openphacts.org/units/Nanomolar,2869669,=,37,True,=,,IC50,nM,,4.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,4.0
378805,17752425,[],CHEMBL3888180,"Homogenous Time-Resolved Fluorescence Assay (HTRF2 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 0.2 nM GST-hMDM2 (aa 1-188), 0.5 nM biotinylated-p53 (aa 1-83), 0.18 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 100 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.",B,,,BAO_0000190,BAO_0000224,protein format,CC[C@@H](CS(=O)(=O)CC)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cn1,,,CHEMBL3886611,,2016,"{'bei': '16.70', 'le': '0.35', 'lle': '3.91', 'sei': '8.64'}",CHEMBL3931077,,CHEMBL3931077,9.05,False,http://www.openphacts.org/units/Nanomolar,2869670,=,37,True,=,,IC50,nM,,0.9,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,0.9
378806,17752426,[],CHEMBL3888180,"Homogenous Time-Resolved Fluorescence Assay (HTRF2 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 0.2 nM GST-hMDM2 (aa 1-188), 0.5 nM biotinylated-p53 (aa 1-83), 0.18 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 100 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.",B,,,BAO_0000190,BAO_0000224,protein format,CC[C@@H](CN(C)S(=O)(=O)C1CC1)N1C(=O)[C@@](CCN2CCOCC2)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1,,,CHEMBL3886611,,2016,"{'bei': '12.42', 'le': '0.26', 'lle': '3.02', 'sei': '7.87'}",CHEMBL3984190,,CHEMBL3984190,8.46,False,http://www.openphacts.org/units/Nanomolar,2869671,=,37,True,=,,IC50,nM,,3.5,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,3.5
378807,17752427,[],CHEMBL3888180,"Homogenous Time-Resolved Fluorescence Assay (HTRF2 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 0.2 nM GST-hMDM2 (aa 1-188), 0.5 nM biotinylated-p53 (aa 1-83), 0.18 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 100 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.",B,,,BAO_0000190,BAO_0000224,protein format,CC[C@@H](CN(C)S(=O)(=O)C1CC1)N1C(=O)[C@@](CCN2CCCC2)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1,,,CHEMBL3886611,,2016,"{'bei': '12.92', 'le': '0.27', 'lle': '2.39', 'sei': '8.74'}",CHEMBL3895410,,CHEMBL3895410,8.59,False,http://www.openphacts.org/units/Nanomolar,2869672,=,37,True,=,,IC50,nM,,2.6,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,2.6
378808,17752428,[],CHEMBL3888180,"Homogenous Time-Resolved Fluorescence Assay (HTRF2 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 0.2 nM GST-hMDM2 (aa 1-188), 0.5 nM biotinylated-p53 (aa 1-83), 0.18 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 100 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.",B,,,BAO_0000190,BAO_0000224,protein format,CCC(CN(C)S(=O)(=O)C1CC1)N1C(=O)[C@@](CCN2CCS(=O)(=O)CC2)(CC(N)=O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1,,,CHEMBL3886611,,2016,"{'bei': '12.37', 'le': '0.26', 'lle': '4.76', 'sei': '6.51'}",CHEMBL4109170,,CHEMBL4109170,9.00,False,http://www.openphacts.org/units/Nanomolar,2869673,=,37,True,=,,IC50,nM,,1.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,1.0
378809,17752429,[],CHEMBL3888180,"Homogenous Time-Resolved Fluorescence Assay (HTRF2 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 0.2 nM GST-hMDM2 (aa 1-188), 0.5 nM biotinylated-p53 (aa 1-83), 0.18 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 100 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.",B,,,BAO_0000190,BAO_0000224,protein format,CCC(CN(C)S(=O)(=O)C1CC1)N1C(=O)[C@@]2(C[C@H](c3cccc(Cl)c3)C1c1ccc(Cl)cc1)C[C@H]2C(=O)O,,,CHEMBL3886611,,2016,"{'bei': '13.15', 'le': '0.27', 'lle': '2.28', 'sei': '8.03'}",CHEMBL4114575,,CHEMBL4114575,7.62,False,http://www.openphacts.org/units/Nanomolar,2869674,=,37,True,=,,IC50,nM,,23.8,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,23.8
378810,17752430,[],CHEMBL3888180,"Homogenous Time-Resolved Fluorescence Assay (HTRF2 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 0.2 nM GST-hMDM2 (aa 1-188), 0.5 nM biotinylated-p53 (aa 1-83), 0.18 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 100 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.",B,,,BAO_0000190,BAO_0000224,protein format,CC[C@@H]([C@H](O)CO)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1,,,CHEMBL3886611,,2016,"{'bei': '18.20', 'le': '0.37', 'lle': '4.34', 'sei': '9.18'}",CHEMBL4110667,,CHEMBL4110667,9.00,False,http://www.openphacts.org/units/Nanomolar,2869675,=,37,True,=,,IC50,nM,,1.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,1.0
378811,17752431,[],CHEMBL3888180,"Homogenous Time-Resolved Fluorescence Assay (HTRF2 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 0.2 nM GST-hMDM2 (aa 1-188), 0.5 nM biotinylated-p53 (aa 1-83), 0.18 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 100 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.",B,,,BAO_0000190,BAO_0000224,protein format,CC[C@@H]([C@H](O)CO)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1,,,CHEMBL3886611,,2016,"{'bei': '17.33', 'le': '0.35', 'lle': '3.91', 'sei': '8.74'}",CHEMBL4110667,,CHEMBL4110667,8.57,False,http://www.openphacts.org/units/Nanomolar,2869675,=,37,True,=,,IC50,nM,,2.7,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,2.7
378812,17752432,[],CHEMBL3888180,"Homogenous Time-Resolved Fluorescence Assay (HTRF2 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 0.2 nM GST-hMDM2 (aa 1-188), 0.5 nM biotinylated-p53 (aa 1-83), 0.18 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 100 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.",B,,,BAO_0000190,BAO_0000224,protein format,CC[C@@H]([C@H](O)C1CC1)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1,,,CHEMBL3886611,,2016,"{'bei': '17.62', 'le': '0.36', 'lle': '2.81', 'sei': '11.42'}",CHEMBL4110335,,CHEMBL4110335,8.89,False,http://www.openphacts.org/units/Nanomolar,2869676,=,37,True,=,,IC50,nM,,1.3,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,1.3
378813,17752433,[],CHEMBL3888180,"Homogenous Time-Resolved Fluorescence Assay (HTRF2 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 0.2 nM GST-hMDM2 (aa 1-188), 0.5 nM biotinylated-p53 (aa 1-83), 0.18 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 100 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.",B,,,BAO_0000190,BAO_0000224,protein format,CC(C)N1C(=O)[C@H](CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@@]1(C)c1ccc(Cl)cc1,,,CHEMBL3886611,,2016,"{'bei': '17.81', 'le': '0.36', 'lle': '2.02', 'sei': '13.43'}",CHEMBL3958512,,CHEMBL3958512,7.74,False,http://www.openphacts.org/units/Nanomolar,2869677,=,37,True,=,,IC50,nM,,18.3,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,18.3
378814,17752434,[],CHEMBL3888180,"Homogenous Time-Resolved Fluorescence Assay (HTRF2 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 0.2 nM GST-hMDM2 (aa 1-188), 0.5 nM biotinylated-p53 (aa 1-83), 0.18 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 100 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.",B,,,BAO_0000190,BAO_0000224,protein format,CC(C)N1C(=O)[C@@H](CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@@]1(C)c1ccc(Cl)cc1,,,CHEMBL3886611,,2016,"{'bei': '19.50', 'le': '0.40', 'lle': '2.75', 'sei': '14.70'}",CHEMBL4110489,,CHEMBL4110489,8.47,False,http://www.openphacts.org/units/Nanomolar,2869678,=,37,True,=,,IC50,nM,,3.4,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,3.4
378815,17752435,[],CHEMBL3888180,"Homogenous Time-Resolved Fluorescence Assay (HTRF2 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 0.2 nM GST-hMDM2 (aa 1-188), 0.5 nM biotinylated-p53 (aa 1-83), 0.18 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 100 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.",B,,,BAO_0000190,BAO_0000224,protein format,CC[C@@H](CN1CCCS1(=O)=O)N1C(=O)[C@H](Cc2cccc(OC)n2)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1,,,CHEMBL3886611,,2016,"{'bei': '11.21', 'le': '0.23', 'lle': '0.78', 'sei': '8.66'}",CHEMBL4110607,,CHEMBL4110607,6.91,False,http://www.openphacts.org/units/Nanomolar,2869679,=,37,True,=,,IC50,nM,,123.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,123.0
378816,17752436,[],CHEMBL3888180,"Homogenous Time-Resolved Fluorescence Assay (HTRF2 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 0.2 nM GST-hMDM2 (aa 1-188), 0.5 nM biotinylated-p53 (aa 1-83), 0.18 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 100 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.",B,,,BAO_0000190,BAO_0000224,protein format,CC[C@@H](CN1CCCS1(=O)=O)N1C(=O)[C@@H](Cc2cccc(OC)n2)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1,,,CHEMBL3886611,,2016,"{'bei': '10.89', 'le': '0.22', 'lle': '0.58', 'sei': '8.41'}",CHEMBL3975725,,CHEMBL3975725,6.71,False,http://www.openphacts.org/units/Nanomolar,2869680,=,37,True,=,,IC50,nM,,194.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,194.0
378817,17752437,[],CHEMBL3888180,"Homogenous Time-Resolved Fluorescence Assay (HTRF2 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 0.2 nM GST-hMDM2 (aa 1-188), 0.5 nM biotinylated-p53 (aa 1-83), 0.18 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 100 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.",B,,,BAO_0000190,BAO_0000224,protein format,CC[C@@H](CN1CCCS1(=O)=O)N1C(=O)[C@H](Cc2cccc(O)n2)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1,,,CHEMBL3886611,,2016,"{'bei': '11.59', 'le': '0.24', 'lle': '1.16', 'sei': '7.69'}",CHEMBL4107265,,CHEMBL4107265,6.98,False,http://www.openphacts.org/units/Nanomolar,2869681,=,37,True,=,,IC50,nM,,104.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,104.0
378818,17752438,[],CHEMBL3888180,"Homogenous Time-Resolved Fluorescence Assay (HTRF2 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 0.2 nM GST-hMDM2 (aa 1-188), 0.5 nM biotinylated-p53 (aa 1-83), 0.18 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 100 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.",B,,,BAO_0000190,BAO_0000224,protein format,CC[C@@H](CN1CCCS1(=O)=O)N1C(=O)[C@@H](Cc2cccc(O)n2)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1,,,CHEMBL3886611,,2016,"{'bei': '12.67', 'le': '0.26', 'lle': '1.82', 'sei': '8.41'}",CHEMBL3970638,,CHEMBL3970638,7.64,False,http://www.openphacts.org/units/Nanomolar,2869682,=,37,True,=,,IC50,nM,,23.1,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,23.1
378819,17752439,[],CHEMBL3888180,"Homogenous Time-Resolved Fluorescence Assay (HTRF2 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 0.2 nM GST-hMDM2 (aa 1-188), 0.5 nM biotinylated-p53 (aa 1-83), 0.18 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 100 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.",B,,,BAO_0000190,BAO_0000224,protein format,CC[C@@H](CN1CCCS1(=O)=O)N1C(=O)[C@](C)(Cc2cccc(OC)n2)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1,,,CHEMBL3886611,,2016,"{'bei': '10.92', 'le': '0.22', 'lle': '0.37', 'sei': '8.63'}",CHEMBL3932076,,CHEMBL3932076,6.89,False,http://www.openphacts.org/units/Nanomolar,2869683,=,37,True,=,,IC50,nM,,130.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,130.0
378820,17752440,[],CHEMBL3888180,"Homogenous Time-Resolved Fluorescence Assay (HTRF2 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 0.2 nM GST-hMDM2 (aa 1-188), 0.5 nM biotinylated-p53 (aa 1-83), 0.18 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 100 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.",B,,,BAO_0000190,BAO_0000224,protein format,CC[C@@H](CN1CCCS1(=O)=O)N1C(=O)[C@@](C)(Cc2cccc(OC)n2)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1,,,CHEMBL3886611,,2016,"{'bei': '10.40', 'le': '0.21', 'lle': '0.04', 'sei': '8.22'}",CHEMBL3959586,,CHEMBL3959586,6.56,False,http://www.openphacts.org/units/Nanomolar,2869684,=,37,True,=,,IC50,nM,,275.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,275.0
378821,17752441,[],CHEMBL3888180,"Homogenous Time-Resolved Fluorescence Assay (HTRF2 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 0.2 nM GST-hMDM2 (aa 1-188), 0.5 nM biotinylated-p53 (aa 1-83), 0.18 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 100 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.",B,,,BAO_0000190,BAO_0000224,protein format,CC[C@@H](CN1CCCS1(=O)=O)N1C(=O)[C@](C)(Cc2cccc(O)n2)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1,,,CHEMBL3886611,,2016,"{'bei': '11.80', 'le': '0.24', 'lle': '1.07', 'sei': '8.02'}",CHEMBL3923124,,CHEMBL3923124,7.28,False,http://www.openphacts.org/units/Nanomolar,2869685,=,37,True,=,,IC50,nM,,52.6,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,52.6
378822,17752442,[],CHEMBL3888180,"Homogenous Time-Resolved Fluorescence Assay (HTRF2 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 0.2 nM GST-hMDM2 (aa 1-188), 0.5 nM biotinylated-p53 (aa 1-83), 0.18 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 100 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.",B,,,BAO_0000190,BAO_0000224,protein format,CC[C@@H](CN1CCCS1(=O)=O)N1C(=O)[C@@](C)(Cc2cccc(O)n2)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1,,,CHEMBL3886611,,2016,"{'bei': '11.23', 'le': '0.23', 'lle': '0.71', 'sei': '7.63'}",CHEMBL3947440,,CHEMBL3947440,6.92,False,http://www.openphacts.org/units/Nanomolar,2869686,=,37,True,=,,IC50,nM,,119.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,119.0
378823,17752443,[],CHEMBL3888180,"Homogenous Time-Resolved Fluorescence Assay (HTRF2 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 0.2 nM GST-hMDM2 (aa 1-188), 0.5 nM biotinylated-p53 (aa 1-83), 0.18 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 100 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.",B,,,BAO_0000190,BAO_0000224,protein format,CCS(=O)(=O)C[C@H](C1CC1)N1C(=O)[C@@](C)(CC(=O)CO)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1,,,CHEMBL3886611,,2016,"{'bei': '14.80', 'le': '0.31', 'lle': '3.17', 'sei': '9.14'}",CHEMBL4111077,,CHEMBL4111077,8.39,False,http://www.openphacts.org/units/Nanomolar,2869687,=,37,True,=,,IC50,nM,,4.1,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,4.1
378824,17752444,[],CHEMBL3888180,"Homogenous Time-Resolved Fluorescence Assay (HTRF2 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 0.2 nM GST-hMDM2 (aa 1-188), 0.5 nM biotinylated-p53 (aa 1-83), 0.18 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 100 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.",B,,,BAO_0000190,BAO_0000224,protein format,CCN(CC)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1,,,CHEMBL3886611,,2016,"{'bei': '18.60', 'le': '0.38', 'lle': '2.83', 'sei': '14.17'}",CHEMBL4109614,,CHEMBL4109614,8.62,False,http://www.openphacts.org/units/Nanomolar,2869481,=,37,True,=,,IC50,nM,,2.4,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,2.4
378825,17752445,[],CHEMBL3888180,"Homogenous Time-Resolved Fluorescence Assay (HTRF2 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 0.2 nM GST-hMDM2 (aa 1-188), 0.5 nM biotinylated-p53 (aa 1-83), 0.18 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 100 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.",B,,,BAO_0000190,BAO_0000224,protein format,CC[C@H]1[C@H](C)O[C@]23OC(=O)C[C@@]2(C)C[C@H](c2cccc(Cl)c2)[C@@H](c2ccc(Cl)cc2)N13,,,CHEMBL3886611,,2016,"{'bei': '18.99', 'le': '0.39', 'lle': '2.41', 'sei': '22.56'}",CHEMBL3891247,,CHEMBL3891247,8.74,False,http://www.openphacts.org/units/Nanomolar,2869688,=,37,True,=,,IC50,nM,,1.8,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,1.8
411591,17776407,[],CHEMBL3888633,"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: Assay 1: The test is performed in white 384-well plates (Greiner Bio-One, reference 781207) in a total volume of 60 L by adding 1 L of compounds tested at different concentrations diluted in 100% DMSO (1.7% final DMSO concentration) in reaction buffer (PBS, 125 mM NaCl, 0.001% Novexin (consists of carbohydrate polymers), designed to increase the solubility and stability of proteins; Expedeon Ltd., Cambridgeshire, United Kingdom), 0.01% Gelatin, 0.01% 0.2%, Pluronic F-127 (block copolymer from ethylenoxide and propyleneoxide), 1 mM DTT). After addition of 1.25 nM MDM2-biotinylated or 2.5 nM MDM4-biotinylated (internal preparations), and 0.625 nM Europium labeled streptavidin (Perkin Elmer), the solution is pre-incubated for 15 minutes at room temperature, then 10 nM Cy5-p53 peptide (internal preparation) is added before an incubation at room temperature for 15 minutes prior to reading the plate. For measurement of samples, a Victor II microplate reader (Perkin Elmer) is used with the following settings: Excitation 340 nm, Emission Donor 620 nm and Emission Acceptor 665 nm.",B,,,BAO_0000190,BAO_0000224,protein format,COc1ccccc1-c1cc2c(n1C(C)C)C(c1ccc(Cl)cc1C)N(c1cccc(Cl)c1F)C2=O,,,CHEMBL3886789,,2016,"{'bei': '15.33', 'le': '0.30', 'lle': '-0.23', 'sei': '23.27'}",CHEMBL3971119,,CHEMBL3971119,8.02,False,http://www.openphacts.org/units/Nanomolar,2885837,=,37,True,=,,IC50,nM,,9.5,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,9.5
411592,17776408,[],CHEMBL3888633,"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: Assay 1: The test is performed in white 384-well plates (Greiner Bio-One, reference 781207) in a total volume of 60 L by adding 1 L of compounds tested at different concentrations diluted in 100% DMSO (1.7% final DMSO concentration) in reaction buffer (PBS, 125 mM NaCl, 0.001% Novexin (consists of carbohydrate polymers), designed to increase the solubility and stability of proteins; Expedeon Ltd., Cambridgeshire, United Kingdom), 0.01% Gelatin, 0.01% 0.2%, Pluronic F-127 (block copolymer from ethylenoxide and propyleneoxide), 1 mM DTT). After addition of 1.25 nM MDM2-biotinylated or 2.5 nM MDM4-biotinylated (internal preparations), and 0.625 nM Europium labeled streptavidin (Perkin Elmer), the solution is pre-incubated for 15 minutes at room temperature, then 10 nM Cy5-p53 peptide (internal preparation) is added before an incubation at room temperature for 15 minutes prior to reading the plate. For measurement of samples, a Victor II microplate reader (Perkin Elmer) is used with the following settings: Excitation 340 nm, Emission Donor 620 nm and Emission Acceptor 665 nm.",B,,,BAO_0000190,BAO_0000224,protein format,CNC(=O)c1ccc(OC)c(-c2cc3c(n2C(C)C)C(c2ccc(Cl)cc2C)N(c2cccc(Cl)c2F)C3=O)c1,,,CHEMBL3886789,,2016,"{'bei': '14.71', 'le': '0.29', 'lle': '0.93', 'sei': '13.43'}",CHEMBL3896443,,CHEMBL3896443,8.54,False,http://www.openphacts.org/units/Nanomolar,2885838,=,37,True,=,,IC50,nM,,2.9,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,2.9
411593,17776409,[],CHEMBL3888633,"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: Assay 1: The test is performed in white 384-well plates (Greiner Bio-One, reference 781207) in a total volume of 60 L by adding 1 L of compounds tested at different concentrations diluted in 100% DMSO (1.7% final DMSO concentration) in reaction buffer (PBS, 125 mM NaCl, 0.001% Novexin (consists of carbohydrate polymers), designed to increase the solubility and stability of proteins; Expedeon Ltd., Cambridgeshire, United Kingdom), 0.01% Gelatin, 0.01% 0.2%, Pluronic F-127 (block copolymer from ethylenoxide and propyleneoxide), 1 mM DTT). After addition of 1.25 nM MDM2-biotinylated or 2.5 nM MDM4-biotinylated (internal preparations), and 0.625 nM Europium labeled streptavidin (Perkin Elmer), the solution is pre-incubated for 15 minutes at room temperature, then 10 nM Cy5-p53 peptide (internal preparation) is added before an incubation at room temperature for 15 minutes prior to reading the plate. For measurement of samples, a Victor II microplate reader (Perkin Elmer) is used with the following settings: Excitation 340 nm, Emission Donor 620 nm and Emission Acceptor 665 nm.",B,,,BAO_0000190,BAO_0000224,protein format,COc1ccc(F)cc1-c1cc2c(n1C(C)C)C(c1ccc(Cl)cc1C)N(c1cccc(Cl)c1F)C2=O,,,CHEMBL3886789,,2016,"{'bei': '15.19', 'le': '0.30', 'lle': '-0.17', 'sei': '23.85'}",CHEMBL3909154,,CHEMBL3909154,8.22,False,http://www.openphacts.org/units/Nanomolar,2885839,=,37,True,=,,IC50,nM,,6.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,6.0
411594,17776410,[],CHEMBL3888633,"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: Assay 1: The test is performed in white 384-well plates (Greiner Bio-One, reference 781207) in a total volume of 60 L by adding 1 L of compounds tested at different concentrations diluted in 100% DMSO (1.7% final DMSO concentration) in reaction buffer (PBS, 125 mM NaCl, 0.001% Novexin (consists of carbohydrate polymers), designed to increase the solubility and stability of proteins; Expedeon Ltd., Cambridgeshire, United Kingdom), 0.01% Gelatin, 0.01% 0.2%, Pluronic F-127 (block copolymer from ethylenoxide and propyleneoxide), 1 mM DTT). After addition of 1.25 nM MDM2-biotinylated or 2.5 nM MDM4-biotinylated (internal preparations), and 0.625 nM Europium labeled streptavidin (Perkin Elmer), the solution is pre-incubated for 15 minutes at room temperature, then 10 nM Cy5-p53 peptide (internal preparation) is added before an incubation at room temperature for 15 minutes prior to reading the plate. For measurement of samples, a Victor II microplate reader (Perkin Elmer) is used with the following settings: Excitation 340 nm, Emission Donor 620 nm and Emission Acceptor 665 nm.",B,,,BAO_0000190,BAO_0000224,protein format,CNC(=O)c1ccc(OC)c(-c2cc3c(n2C(C)C)[C@H](c2ccc(Cl)cc2C)N(c2cccc(Cl)c2F)C3=O)c1,,,CHEMBL3886789,,2016,"{'bei': '15.89', 'le': '0.31', 'lle': '1.61', 'sei': '14.51'}",CHEMBL3919782,,CHEMBL3919782,9.22,False,http://www.openphacts.org/units/Nanomolar,2885840,=,37,True,=,,IC50,nM,,0.6,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,0.6
411595,17776411,[],CHEMBL3888633,"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: Assay 1: The test is performed in white 384-well plates (Greiner Bio-One, reference 781207) in a total volume of 60 L by adding 1 L of compounds tested at different concentrations diluted in 100% DMSO (1.7% final DMSO concentration) in reaction buffer (PBS, 125 mM NaCl, 0.001% Novexin (consists of carbohydrate polymers), designed to increase the solubility and stability of proteins; Expedeon Ltd., Cambridgeshire, United Kingdom), 0.01% Gelatin, 0.01% 0.2%, Pluronic F-127 (block copolymer from ethylenoxide and propyleneoxide), 1 mM DTT). After addition of 1.25 nM MDM2-biotinylated or 2.5 nM MDM4-biotinylated (internal preparations), and 0.625 nM Europium labeled streptavidin (Perkin Elmer), the solution is pre-incubated for 15 minutes at room temperature, then 10 nM Cy5-p53 peptide (internal preparation) is added before an incubation at room temperature for 15 minutes prior to reading the plate. For measurement of samples, a Victor II microplate reader (Perkin Elmer) is used with the following settings: Excitation 340 nm, Emission Donor 620 nm and Emission Acceptor 665 nm.",B,,,BAO_0000190,BAO_0000224,protein format,COc1ccccc1-c1cc2c(n1C(C)C)C(c1ccc(Cl)cc1)N(c1cc(Cl)ccc1C)C2=O,,,CHEMBL3886789,,2016,"{'bei': '18.24', 'le': '0.36', 'lle': '1.11', 'sei': '26.75'}",CHEMBL3985044,,CHEMBL3985044,9.22,False,http://www.openphacts.org/units/Nanomolar,2885841,=,37,True,=,,IC50,nM,,0.6,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,0.6
411596,17776412,[],CHEMBL3888633,"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: Assay 1: The test is performed in white 384-well plates (Greiner Bio-One, reference 781207) in a total volume of 60 L by adding 1 L of compounds tested at different concentrations diluted in 100% DMSO (1.7% final DMSO concentration) in reaction buffer (PBS, 125 mM NaCl, 0.001% Novexin (consists of carbohydrate polymers), designed to increase the solubility and stability of proteins; Expedeon Ltd., Cambridgeshire, United Kingdom), 0.01% Gelatin, 0.01% 0.2%, Pluronic F-127 (block copolymer from ethylenoxide and propyleneoxide), 1 mM DTT). After addition of 1.25 nM MDM2-biotinylated or 2.5 nM MDM4-biotinylated (internal preparations), and 0.625 nM Europium labeled streptavidin (Perkin Elmer), the solution is pre-incubated for 15 minutes at room temperature, then 10 nM Cy5-p53 peptide (internal preparation) is added before an incubation at room temperature for 15 minutes prior to reading the plate. For measurement of samples, a Victor II microplate reader (Perkin Elmer) is used with the following settings: Excitation 340 nm, Emission Donor 620 nm and Emission Acceptor 665 nm.",B,,,BAO_0000190,BAO_0000224,protein format,CNC(=O)c1ccc(OC)c(-c2cc3c(n2C(C)C)C(c2ccc(Cl)cc2)N(c2cc(Cl)ccc2C)C3=O)c1,,,CHEMBL3886789,,2016,"{'bei': '16.08', 'le': '0.32', 'lle': '1.58', 'sei': '14.23'}",CHEMBL3925236,,CHEMBL3925236,9.05,False,http://www.openphacts.org/units/Nanomolar,2885842,=,37,True,=,,IC50,nM,,0.9,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,0.9
411597,17776413,[],CHEMBL3888633,"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: Assay 1: The test is performed in white 384-well plates (Greiner Bio-One, reference 781207) in a total volume of 60 L by adding 1 L of compounds tested at different concentrations diluted in 100% DMSO (1.7% final DMSO concentration) in reaction buffer (PBS, 125 mM NaCl, 0.001% Novexin (consists of carbohydrate polymers), designed to increase the solubility and stability of proteins; Expedeon Ltd., Cambridgeshire, United Kingdom), 0.01% Gelatin, 0.01% 0.2%, Pluronic F-127 (block copolymer from ethylenoxide and propyleneoxide), 1 mM DTT). After addition of 1.25 nM MDM2-biotinylated or 2.5 nM MDM4-biotinylated (internal preparations), and 0.625 nM Europium labeled streptavidin (Perkin Elmer), the solution is pre-incubated for 15 minutes at room temperature, then 10 nM Cy5-p53 peptide (internal preparation) is added before an incubation at room temperature for 15 minutes prior to reading the plate. For measurement of samples, a Victor II microplate reader (Perkin Elmer) is used with the following settings: Excitation 340 nm, Emission Donor 620 nm and Emission Acceptor 665 nm.",B,,,BAO_0000190,BAO_0000224,protein format,CNC(=O)c1ccc(OC)c(-c2cc3c(n2C(C)C)[C@H](c2ccc(Cl)cc2C)N(c2cc(Cl)ccc2C)C3=O)c1,,,CHEMBL3886789,,2016,"{'bei': '16.13', 'le': '0.32', 'lle': '1.52', 'sei': '14.63'}",CHEMBL3937629,,CHEMBL3937629,9.30,False,http://www.openphacts.org/units/Nanomolar,2885843,=,37,True,=,,IC50,nM,,0.5,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,0.5
411598,17776414,[],CHEMBL3888633,"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: Assay 1: The test is performed in white 384-well plates (Greiner Bio-One, reference 781207) in a total volume of 60 L by adding 1 L of compounds tested at different concentrations diluted in 100% DMSO (1.7% final DMSO concentration) in reaction buffer (PBS, 125 mM NaCl, 0.001% Novexin (consists of carbohydrate polymers), designed to increase the solubility and stability of proteins; Expedeon Ltd., Cambridgeshire, United Kingdom), 0.01% Gelatin, 0.01% 0.2%, Pluronic F-127 (block copolymer from ethylenoxide and propyleneoxide), 1 mM DTT). After addition of 1.25 nM MDM2-biotinylated or 2.5 nM MDM4-biotinylated (internal preparations), and 0.625 nM Europium labeled streptavidin (Perkin Elmer), the solution is pre-incubated for 15 minutes at room temperature, then 10 nM Cy5-p53 peptide (internal preparation) is added before an incubation at room temperature for 15 minutes prior to reading the plate. For measurement of samples, a Victor II microplate reader (Perkin Elmer) is used with the following settings: Excitation 340 nm, Emission Donor 620 nm and Emission Acceptor 665 nm.",B,,,BAO_0000190,BAO_0000224,protein format,COc1ccc(C(=O)NOCCO)cc1-c1cc2c(n1C(C)C)C(c1ccc(Cl)cc1)N(c1cc(Cl)ccc1C)C2=O,,,CHEMBL3886789,,2016,"{'bei': '14.72', 'le': '0.29', 'lle': '2.20', 'sei': '9.63'}",CHEMBL3895665,,CHEMBL3895665,8.96,False,http://www.openphacts.org/units/Nanomolar,2885844,=,37,True,=,,IC50,nM,,1.1,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,1.1
411599,17776415,[],CHEMBL3888633,"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: Assay 1: The test is performed in white 384-well plates (Greiner Bio-One, reference 781207) in a total volume of 60 L by adding 1 L of compounds tested at different concentrations diluted in 100% DMSO (1.7% final DMSO concentration) in reaction buffer (PBS, 125 mM NaCl, 0.001% Novexin (consists of carbohydrate polymers), designed to increase the solubility and stability of proteins; Expedeon Ltd., Cambridgeshire, United Kingdom), 0.01% Gelatin, 0.01% 0.2%, Pluronic F-127 (block copolymer from ethylenoxide and propyleneoxide), 1 mM DTT). After addition of 1.25 nM MDM2-biotinylated or 2.5 nM MDM4-biotinylated (internal preparations), and 0.625 nM Europium labeled streptavidin (Perkin Elmer), the solution is pre-incubated for 15 minutes at room temperature, then 10 nM Cy5-p53 peptide (internal preparation) is added before an incubation at room temperature for 15 minutes prior to reading the plate. For measurement of samples, a Victor II microplate reader (Perkin Elmer) is used with the following settings: Excitation 340 nm, Emission Donor 620 nm and Emission Acceptor 665 nm.",B,,,BAO_0000190,BAO_0000224,protein format,COc1ccc(C(=O)O)cc1-c1cc2c(n1C(C)C)C(c1ccc(Cl)cc1)N([C@H]1CC[C@H](O)CC1)C2=O,,,CHEMBL3886789,,2016,"{'bei': '15.12', 'le': '0.29', 'lle': '1.97', 'sei': '8.60'}",CHEMBL3894034,,CHEMBL3894034,7.91,False,http://www.openphacts.org/units/Nanomolar,2885845,=,37,True,=,,IC50,nM,,12.3,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,12.3
411600,17776416,[],CHEMBL3888633,"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: Assay 1: The test is performed in white 384-well plates (Greiner Bio-One, reference 781207) in a total volume of 60 L by adding 1 L of compounds tested at different concentrations diluted in 100% DMSO (1.7% final DMSO concentration) in reaction buffer (PBS, 125 mM NaCl, 0.001% Novexin (consists of carbohydrate polymers), designed to increase the solubility and stability of proteins; Expedeon Ltd., Cambridgeshire, United Kingdom), 0.01% Gelatin, 0.01% 0.2%, Pluronic F-127 (block copolymer from ethylenoxide and propyleneoxide), 1 mM DTT). After addition of 1.25 nM MDM2-biotinylated or 2.5 nM MDM4-biotinylated (internal preparations), and 0.625 nM Europium labeled streptavidin (Perkin Elmer), the solution is pre-incubated for 15 minutes at room temperature, then 10 nM Cy5-p53 peptide (internal preparation) is added before an incubation at room temperature for 15 minutes prior to reading the plate. For measurement of samples, a Victor II microplate reader (Perkin Elmer) is used with the following settings: Excitation 340 nm, Emission Donor 620 nm and Emission Acceptor 665 nm.",B,,,BAO_0000190,BAO_0000224,protein format,COc1nc(N)ncc1-c1cc2c(n1C(C)C)C(c1ccc(Cl)cc1)N([C@H]1CC[C@H](O)CC1)C2=O,,,CHEMBL3886789,,2016,"{'bei': '15.93', 'le': '0.31', 'lle': '3.28', 'sei': '7.42'}",CHEMBL3895110,,CHEMBL3895110,7.90,False,http://www.openphacts.org/units/Nanomolar,2885846,=,37,True,=,,IC50,nM,,12.6,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,12.6
411601,17776417,[],CHEMBL3888633,"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: Assay 1: The test is performed in white 384-well plates (Greiner Bio-One, reference 781207) in a total volume of 60 L by adding 1 L of compounds tested at different concentrations diluted in 100% DMSO (1.7% final DMSO concentration) in reaction buffer (PBS, 125 mM NaCl, 0.001% Novexin (consists of carbohydrate polymers), designed to increase the solubility and stability of proteins; Expedeon Ltd., Cambridgeshire, United Kingdom), 0.01% Gelatin, 0.01% 0.2%, Pluronic F-127 (block copolymer from ethylenoxide and propyleneoxide), 1 mM DTT). After addition of 1.25 nM MDM2-biotinylated or 2.5 nM MDM4-biotinylated (internal preparations), and 0.625 nM Europium labeled streptavidin (Perkin Elmer), the solution is pre-incubated for 15 minutes at room temperature, then 10 nM Cy5-p53 peptide (internal preparation) is added before an incubation at room temperature for 15 minutes prior to reading the plate. For measurement of samples, a Victor II microplate reader (Perkin Elmer) is used with the following settings: Excitation 340 nm, Emission Donor 620 nm and Emission Acceptor 665 nm.",B,,,BAO_0000190,BAO_0000224,protein format,COc1nc(N)ncc1-c1cc2c(n1C(C)C)C(c1ccc(Cl)cc1)N(C1CCOCC1)C2=O,,,CHEMBL3886789,,2016,"{'bei': '16.74', 'le': '0.32', 'lle': '3.58', 'sei': '8.45'}",CHEMBL3916949,,CHEMBL3916949,8.07,False,http://www.openphacts.org/units/Nanomolar,2885847,=,37,True,=,,IC50,nM,,8.5,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,8.5
411602,17776418,[],CHEMBL3888633,"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: Assay 1: The test is performed in white 384-well plates (Greiner Bio-One, reference 781207) in a total volume of 60 L by adding 1 L of compounds tested at different concentrations diluted in 100% DMSO (1.7% final DMSO concentration) in reaction buffer (PBS, 125 mM NaCl, 0.001% Novexin (consists of carbohydrate polymers), designed to increase the solubility and stability of proteins; Expedeon Ltd., Cambridgeshire, United Kingdom), 0.01% Gelatin, 0.01% 0.2%, Pluronic F-127 (block copolymer from ethylenoxide and propyleneoxide), 1 mM DTT). After addition of 1.25 nM MDM2-biotinylated or 2.5 nM MDM4-biotinylated (internal preparations), and 0.625 nM Europium labeled streptavidin (Perkin Elmer), the solution is pre-incubated for 15 minutes at room temperature, then 10 nM Cy5-p53 peptide (internal preparation) is added before an incubation at room temperature for 15 minutes prior to reading the plate. For measurement of samples, a Victor II microplate reader (Perkin Elmer) is used with the following settings: Excitation 340 nm, Emission Donor 620 nm and Emission Acceptor 665 nm.",B,,,BAO_0000190,BAO_0000224,protein format,COc1ccccc1-c1cc2c(n1C(C)C)C(c1ccc(Cl)cc1C)N([C@H]1CC[C@H](O)CC1)C2=O,,,CHEMBL3886789,,2016,"{'bei': '15.35', 'le': '0.30', 'lle': '1.01', 'sei': '13.84'}",CHEMBL3931174,,CHEMBL3931174,7.57,False,http://www.openphacts.org/units/Nanomolar,2885848,=,37,True,=,,IC50,nM,,27.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,27.0
411603,17776419,[],CHEMBL3888633,"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: Assay 1: The test is performed in white 384-well plates (Greiner Bio-One, reference 781207) in a total volume of 60 L by adding 1 L of compounds tested at different concentrations diluted in 100% DMSO (1.7% final DMSO concentration) in reaction buffer (PBS, 125 mM NaCl, 0.001% Novexin (consists of carbohydrate polymers), designed to increase the solubility and stability of proteins; Expedeon Ltd., Cambridgeshire, United Kingdom), 0.01% Gelatin, 0.01% 0.2%, Pluronic F-127 (block copolymer from ethylenoxide and propyleneoxide), 1 mM DTT). After addition of 1.25 nM MDM2-biotinylated or 2.5 nM MDM4-biotinylated (internal preparations), and 0.625 nM Europium labeled streptavidin (Perkin Elmer), the solution is pre-incubated for 15 minutes at room temperature, then 10 nM Cy5-p53 peptide (internal preparation) is added before an incubation at room temperature for 15 minutes prior to reading the plate. For measurement of samples, a Victor II microplate reader (Perkin Elmer) is used with the following settings: Excitation 340 nm, Emission Donor 620 nm and Emission Acceptor 665 nm.",B,,,BAO_0000190,BAO_0000224,protein format,CNC(=O)c1ccc(OC)c(-c2cc3c(n2C(C)C)C(c2ccc(Cl)cc2C)N([C@H]2CC[C@H](O)CC2)C3=O)c1,,,CHEMBL3886789,,2016,"{'bei': '14.35', 'le': '0.28', 'lle': '1.99', 'sei': '9.42'}",CHEMBL3906706,,CHEMBL3906706,7.90,False,http://www.openphacts.org/units/Nanomolar,2885849,=,37,True,=,,IC50,nM,,12.7,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,12.7
411604,17776420,[],CHEMBL3888633,"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: Assay 1: The test is performed in white 384-well plates (Greiner Bio-One, reference 781207) in a total volume of 60 L by adding 1 L of compounds tested at different concentrations diluted in 100% DMSO (1.7% final DMSO concentration) in reaction buffer (PBS, 125 mM NaCl, 0.001% Novexin (consists of carbohydrate polymers), designed to increase the solubility and stability of proteins; Expedeon Ltd., Cambridgeshire, United Kingdom), 0.01% Gelatin, 0.01% 0.2%, Pluronic F-127 (block copolymer from ethylenoxide and propyleneoxide), 1 mM DTT). After addition of 1.25 nM MDM2-biotinylated or 2.5 nM MDM4-biotinylated (internal preparations), and 0.625 nM Europium labeled streptavidin (Perkin Elmer), the solution is pre-incubated for 15 minutes at room temperature, then 10 nM Cy5-p53 peptide (internal preparation) is added before an incubation at room temperature for 15 minutes prior to reading the plate. For measurement of samples, a Victor II microplate reader (Perkin Elmer) is used with the following settings: Excitation 340 nm, Emission Donor 620 nm and Emission Acceptor 665 nm.",B,,,BAO_0000190,BAO_0000224,protein format,COc1ncc(-c2cc3c(n2C(C)C)C(c2ccc(Cl)cc2C)N([C@H]2CC[C@H](O)CC2)C3=O)c(OC)n1,,,CHEMBL3886789,,2016,"{'bei': '14.63', 'le': '0.28', 'lle': '2.33', 'sei': '8.57'}",CHEMBL3937960,,CHEMBL3937960,7.68,False,http://www.openphacts.org/units/Nanomolar,2885850,=,37,True,=,,IC50,nM,,20.7,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,20.7
411605,17776421,[],CHEMBL3888633,"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: Assay 1: The test is performed in white 384-well plates (Greiner Bio-One, reference 781207) in a total volume of 60 L by adding 1 L of compounds tested at different concentrations diluted in 100% DMSO (1.7% final DMSO concentration) in reaction buffer (PBS, 125 mM NaCl, 0.001% Novexin (consists of carbohydrate polymers), designed to increase the solubility and stability of proteins; Expedeon Ltd., Cambridgeshire, United Kingdom), 0.01% Gelatin, 0.01% 0.2%, Pluronic F-127 (block copolymer from ethylenoxide and propyleneoxide), 1 mM DTT). After addition of 1.25 nM MDM2-biotinylated or 2.5 nM MDM4-biotinylated (internal preparations), and 0.625 nM Europium labeled streptavidin (Perkin Elmer), the solution is pre-incubated for 15 minutes at room temperature, then 10 nM Cy5-p53 peptide (internal preparation) is added before an incubation at room temperature for 15 minutes prior to reading the plate. For measurement of samples, a Victor II microplate reader (Perkin Elmer) is used with the following settings: Excitation 340 nm, Emission Donor 620 nm and Emission Acceptor 665 nm.",B,,,BAO_0000190,BAO_0000224,protein format,COc1ncc(-c2cc3c(n2C(C)C)C(c2ccc(Cl)cc2C)N(C2CCOCC2)C3=O)c(OC)n1,,,CHEMBL3886789,,2016,"{'bei': '15.64', 'le': '0.30', 'lle': '2.76', 'sei': '10.15'}",CHEMBL3920354,,CHEMBL3920354,7.99,False,http://www.openphacts.org/units/Nanomolar,2885851,=,37,True,=,,IC50,nM,,10.2,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,10.2
411606,17776422,[],CHEMBL3888633,"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: Assay 1: The test is performed in white 384-well plates (Greiner Bio-One, reference 781207) in a total volume of 60 L by adding 1 L of compounds tested at different concentrations diluted in 100% DMSO (1.7% final DMSO concentration) in reaction buffer (PBS, 125 mM NaCl, 0.001% Novexin (consists of carbohydrate polymers), designed to increase the solubility and stability of proteins; Expedeon Ltd., Cambridgeshire, United Kingdom), 0.01% Gelatin, 0.01% 0.2%, Pluronic F-127 (block copolymer from ethylenoxide and propyleneoxide), 1 mM DTT). After addition of 1.25 nM MDM2-biotinylated or 2.5 nM MDM4-biotinylated (internal preparations), and 0.625 nM Europium labeled streptavidin (Perkin Elmer), the solution is pre-incubated for 15 minutes at room temperature, then 10 nM Cy5-p53 peptide (internal preparation) is added before an incubation at room temperature for 15 minutes prior to reading the plate. For measurement of samples, a Victor II microplate reader (Perkin Elmer) is used with the following settings: Excitation 340 nm, Emission Donor 620 nm and Emission Acceptor 665 nm.",B,,,BAO_0000190,BAO_0000224,protein format,CNC(=O)N1CCC(N2C(=O)c3cc(-c4cnc(OC)nc4OC)n(C(C)C)c3C2c2ccc(Cl)cc2)CC1,,,CHEMBL3886789,,2016,"{'bei': '15.41', 'le': '0.30', 'lle': '3.97', 'sei': '8.37'}",CHEMBL3906442,,CHEMBL3906442,8.52,False,http://www.openphacts.org/units/Nanomolar,2885852,=,37,True,=,,IC50,nM,,3.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,3.0
411607,17776423,[],CHEMBL3888633,"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: Assay 1: The test is performed in white 384-well plates (Greiner Bio-One, reference 781207) in a total volume of 60 L by adding 1 L of compounds tested at different concentrations diluted in 100% DMSO (1.7% final DMSO concentration) in reaction buffer (PBS, 125 mM NaCl, 0.001% Novexin (consists of carbohydrate polymers), designed to increase the solubility and stability of proteins; Expedeon Ltd., Cambridgeshire, United Kingdom), 0.01% Gelatin, 0.01% 0.2%, Pluronic F-127 (block copolymer from ethylenoxide and propyleneoxide), 1 mM DTT). After addition of 1.25 nM MDM2-biotinylated or 2.5 nM MDM4-biotinylated (internal preparations), and 0.625 nM Europium labeled streptavidin (Perkin Elmer), the solution is pre-incubated for 15 minutes at room temperature, then 10 nM Cy5-p53 peptide (internal preparation) is added before an incubation at room temperature for 15 minutes prior to reading the plate. For measurement of samples, a Victor II microplate reader (Perkin Elmer) is used with the following settings: Excitation 340 nm, Emission Donor 620 nm and Emission Acceptor 665 nm.",B,,,BAO_0000190,BAO_0000224,protein format,COc1nc(N)ncc1-c1cc2c(n1C(C)C)C(c1ccc(Cl)cc1)N(C1CCC(=O)N(C)C1)C2=O,,,CHEMBL3886789,,2016,"{'bei': '16.66', 'le': '0.32', 'lle': '4.54', 'sei': '7.96'}",CHEMBL3980916,,CHEMBL3980916,8.48,False,http://www.openphacts.org/units/Nanomolar,2885853,=,37,True,=,,IC50,nM,,3.3,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,3.3
411608,17776424,[],CHEMBL3888633,"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: Assay 1: The test is performed in white 384-well plates (Greiner Bio-One, reference 781207) in a total volume of 60 L by adding 1 L of compounds tested at different concentrations diluted in 100% DMSO (1.7% final DMSO concentration) in reaction buffer (PBS, 125 mM NaCl, 0.001% Novexin (consists of carbohydrate polymers), designed to increase the solubility and stability of proteins; Expedeon Ltd., Cambridgeshire, United Kingdom), 0.01% Gelatin, 0.01% 0.2%, Pluronic F-127 (block copolymer from ethylenoxide and propyleneoxide), 1 mM DTT). After addition of 1.25 nM MDM2-biotinylated or 2.5 nM MDM4-biotinylated (internal preparations), and 0.625 nM Europium labeled streptavidin (Perkin Elmer), the solution is pre-incubated for 15 minutes at room temperature, then 10 nM Cy5-p53 peptide (internal preparation) is added before an incubation at room temperature for 15 minutes prior to reading the plate. For measurement of samples, a Victor II microplate reader (Perkin Elmer) is used with the following settings: Excitation 340 nm, Emission Donor 620 nm and Emission Acceptor 665 nm.",B,,,BAO_0000190,BAO_0000224,protein format,COc1ncc(-c2cc3c(n2C(C)C)[C@H](c2ccc(Cl)cc2)N(c2cc(Cl)c(=O)n(C)c2)C3=O)c(OC)n1,,,CHEMBL3886789,,2016,"{'bei': '16.63', 'le': '0.33', 'lle': '3.92', 'sei': '10.08'}",CHEMBL3895404,,CHEMBL3895404,9.22,False,http://www.openphacts.org/units/Nanomolar,2885854,=,37,True,=,,IC50,nM,,0.6,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,0.6
411609,17776425,[],CHEMBL3888633,"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: Assay 1: The test is performed in white 384-well plates (Greiner Bio-One, reference 781207) in a total volume of 60 L by adding 1 L of compounds tested at different concentrations diluted in 100% DMSO (1.7% final DMSO concentration) in reaction buffer (PBS, 125 mM NaCl, 0.001% Novexin (consists of carbohydrate polymers), designed to increase the solubility and stability of proteins; Expedeon Ltd., Cambridgeshire, United Kingdom), 0.01% Gelatin, 0.01% 0.2%, Pluronic F-127 (block copolymer from ethylenoxide and propyleneoxide), 1 mM DTT). After addition of 1.25 nM MDM2-biotinylated or 2.5 nM MDM4-biotinylated (internal preparations), and 0.625 nM Europium labeled streptavidin (Perkin Elmer), the solution is pre-incubated for 15 minutes at room temperature, then 10 nM Cy5-p53 peptide (internal preparation) is added before an incubation at room temperature for 15 minutes prior to reading the plate. For measurement of samples, a Victor II microplate reader (Perkin Elmer) is used with the following settings: Excitation 340 nm, Emission Donor 620 nm and Emission Acceptor 665 nm.",B,,,BAO_0000190,BAO_0000224,protein format,COc1nc(N(C)C)ncc1-c1cc2c(n1C(C)C)[C@H](c1ccc(C#N)cc1)N(c1cc(Cl)c[nH]c1=O)C2=O,,,CHEMBL3886789,,2016,"{'bei': '16.72', 'le': '0.32', 'lle': '4.54', 'sei': '7.57'}",CHEMBL3924973,,CHEMBL3924973,9.10,False,http://www.openphacts.org/units/Nanomolar,2885855,=,37,True,=,,IC50,nM,,0.8,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,0.8
411610,17776426,[],CHEMBL3888633,"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: Assay 1: The test is performed in white 384-well plates (Greiner Bio-One, reference 781207) in a total volume of 60 L by adding 1 L of compounds tested at different concentrations diluted in 100% DMSO (1.7% final DMSO concentration) in reaction buffer (PBS, 125 mM NaCl, 0.001% Novexin (consists of carbohydrate polymers), designed to increase the solubility and stability of proteins; Expedeon Ltd., Cambridgeshire, United Kingdom), 0.01% Gelatin, 0.01% 0.2%, Pluronic F-127 (block copolymer from ethylenoxide and propyleneoxide), 1 mM DTT). After addition of 1.25 nM MDM2-biotinylated or 2.5 nM MDM4-biotinylated (internal preparations), and 0.625 nM Europium labeled streptavidin (Perkin Elmer), the solution is pre-incubated for 15 minutes at room temperature, then 10 nM Cy5-p53 peptide (internal preparation) is added before an incubation at room temperature for 15 minutes prior to reading the plate. For measurement of samples, a Victor II microplate reader (Perkin Elmer) is used with the following settings: Excitation 340 nm, Emission Donor 620 nm and Emission Acceptor 665 nm.",B,,,BAO_0000190,BAO_0000224,protein format,COc1ncc(-c2cc3c(n2C2CC2)C(c2ccc(Cl)cc2)N(c2cc(C)c(=O)n(C)c2)C3=O)c(OC)n1,,,CHEMBL3886789,,2016,"{'bei': '14.06', 'le': '0.27', 'lle': '2.77', 'sei': '8.17'}",CHEMBL3895294,,CHEMBL3895294,7.48,False,http://www.openphacts.org/units/Nanomolar,2885856,=,37,True,=,,IC50,nM,,33.3,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,33.3
411611,17776427,[],CHEMBL3888633,"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: Assay 1: The test is performed in white 384-well plates (Greiner Bio-One, reference 781207) in a total volume of 60 L by adding 1 L of compounds tested at different concentrations diluted in 100% DMSO (1.7% final DMSO concentration) in reaction buffer (PBS, 125 mM NaCl, 0.001% Novexin (consists of carbohydrate polymers), designed to increase the solubility and stability of proteins; Expedeon Ltd., Cambridgeshire, United Kingdom), 0.01% Gelatin, 0.01% 0.2%, Pluronic F-127 (block copolymer from ethylenoxide and propyleneoxide), 1 mM DTT). After addition of 1.25 nM MDM2-biotinylated or 2.5 nM MDM4-biotinylated (internal preparations), and 0.625 nM Europium labeled streptavidin (Perkin Elmer), the solution is pre-incubated for 15 minutes at room temperature, then 10 nM Cy5-p53 peptide (internal preparation) is added before an incubation at room temperature for 15 minutes prior to reading the plate. For measurement of samples, a Victor II microplate reader (Perkin Elmer) is used with the following settings: Excitation 340 nm, Emission Donor 620 nm and Emission Acceptor 665 nm.",B,,,BAO_0000190,BAO_0000224,protein format,COc1ncc(-c2cc3c(n2C2CC2)C(c2ccc(Cl)cc2)N(c2cc(C)c(=O)n(C)c2)C3=O)cn1,,,CHEMBL3886789,,2016,"{'bei': '10.77', 'le': '0.21', 'lle': '0.71', 'sei': '6.57'}",CHEMBL3923259,,CHEMBL3923259,5.41,False,http://www.openphacts.org/units/Nanomolar,2885857,=,37,True,=,,IC50,nM,,3916.8,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,3916.8
411612,17776428,[],CHEMBL3888633,"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: Assay 1: The test is performed in white 384-well plates (Greiner Bio-One, reference 781207) in a total volume of 60 L by adding 1 L of compounds tested at different concentrations diluted in 100% DMSO (1.7% final DMSO concentration) in reaction buffer (PBS, 125 mM NaCl, 0.001% Novexin (consists of carbohydrate polymers), designed to increase the solubility and stability of proteins; Expedeon Ltd., Cambridgeshire, United Kingdom), 0.01% Gelatin, 0.01% 0.2%, Pluronic F-127 (block copolymer from ethylenoxide and propyleneoxide), 1 mM DTT). After addition of 1.25 nM MDM2-biotinylated or 2.5 nM MDM4-biotinylated (internal preparations), and 0.625 nM Europium labeled streptavidin (Perkin Elmer), the solution is pre-incubated for 15 minutes at room temperature, then 10 nM Cy5-p53 peptide (internal preparation) is added before an incubation at room temperature for 15 minutes prior to reading the plate. For measurement of samples, a Victor II microplate reader (Perkin Elmer) is used with the following settings: Excitation 340 nm, Emission Donor 620 nm and Emission Acceptor 665 nm.",B,,,BAO_0000190,BAO_0000224,protein format,Cc1cc(N2C(=O)c3cc(-c4ccn(C)c(=O)c4)n(C4CC4)c3C2c2ccc(Cl)cc2)cn(C)c1=O,,,CHEMBL3886789,,2016,"{'bei': '11.36', 'le': '0.22', 'lle': '1.09', 'sei': '8.22'}",CHEMBL3900710,,CHEMBL3900710,5.69,False,http://www.openphacts.org/units/Nanomolar,2885858,=,37,True,=,,IC50,nM,,2044.3,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,2044.3
411635,17776451,[],CHEMBL3888635,"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: Assay 2: The test is performed in white 384-well plates (Greiner Bio-One, reference 781207) in a total volume of 60 L by adding 1 L of compounds tested at different concentrations diluted in 100% DMSO (1.7% final DMSO concentration) in reaction buffer (PBS, 125 mM NaCl, 0.001% Novexin (consists of carbohydrate polymers), designed to increase the solubility and stability of proteins; Expedeon Ltd., Cambridgeshire, United Kingdom), 0.01% Gelatin, 0.01% 0.2%, Pluronic F-127 (block copolymer from ethylenoxide and propyleneoxide), 1 mM DTT). After addition of 1.25 nM MDM2-biotinylated or 2.5 nM MDM4-biotinylated (internal preparations), and 0.625 nM Europium labeled streptavidin (Perkin Elmer), the solution is pre-incubated for 15 minutes at room temperature, then 10 nM Cy5-p53 peptide (internal preparation) is added before an incubation at room temperature for 15 minutes prior to reading the plate. For measurement of samples, a Victor II microplate reader (Perkin Elmer) is used with the following settings: Excitation 340 nm, Emission Donor 620 nm and Emission Acceptor 665 nm. For selected compounds displaying IC50s between 0.05 and 5 nM on MDM2, a slightly modified assay is used with the following adaptations: 0.1 nM MDM2, 0.1 nM Europium labeled streptavidin and Tecan genios Pro is used as a microplate reader for the fluorescence measurements (p53-MDM2 Assay 2).",B,,,BAO_0000190,BAO_0000224,protein format,CNC(=O)c1ccc(OC)c(-c2cc3c(n2C(C)C)C(c2ccc(Cl)cc2C)N(c2cccc(Cl)c2F)C3=O)c1,,,CHEMBL3886789,,2016,"{'bei': '15.71', 'le': '0.31', 'lle': '1.51', 'sei': '14.35'}",CHEMBL3896443,,CHEMBL3896443,9.12,False,http://www.openphacts.org/units/Nanomolar,2885838,=,37,True,=,,IC50,nM,,0.757,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,0.757
411636,17776452,[],CHEMBL3888635,"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: Assay 2: The test is performed in white 384-well plates (Greiner Bio-One, reference 781207) in a total volume of 60 L by adding 1 L of compounds tested at different concentrations diluted in 100% DMSO (1.7% final DMSO concentration) in reaction buffer (PBS, 125 mM NaCl, 0.001% Novexin (consists of carbohydrate polymers), designed to increase the solubility and stability of proteins; Expedeon Ltd., Cambridgeshire, United Kingdom), 0.01% Gelatin, 0.01% 0.2%, Pluronic F-127 (block copolymer from ethylenoxide and propyleneoxide), 1 mM DTT). After addition of 1.25 nM MDM2-biotinylated or 2.5 nM MDM4-biotinylated (internal preparations), and 0.625 nM Europium labeled streptavidin (Perkin Elmer), the solution is pre-incubated for 15 minutes at room temperature, then 10 nM Cy5-p53 peptide (internal preparation) is added before an incubation at room temperature for 15 minutes prior to reading the plate. For measurement of samples, a Victor II microplate reader (Perkin Elmer) is used with the following settings: Excitation 340 nm, Emission Donor 620 nm and Emission Acceptor 665 nm. For selected compounds displaying IC50s between 0.05 and 5 nM on MDM2, a slightly modified assay is used with the following adaptations: 0.1 nM MDM2, 0.1 nM Europium labeled streptavidin and Tecan genios Pro is used as a microplate reader for the fluorescence measurements (p53-MDM2 Assay 2).",B,,,BAO_0000190,BAO_0000224,protein format,COc1ccc(CO)cc1-c1cc2c(n1C(C)C)C(c1ccc(Cl)cc1C)N(c1cccc(Cl)c1F)C2=O,,,CHEMBL3886789,,2016,"{'bei': '17.24', 'le': '0.34', 'lle': '1.80', 'sei': '17.45'}",CHEMBL3961756,,CHEMBL3961756,9.54,False,http://www.openphacts.org/units/Nanomolar,2885859,=,37,True,=,,IC50,nM,,0.286,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,0.286
411637,17776453,[],CHEMBL3888635,"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: Assay 2: The test is performed in white 384-well plates (Greiner Bio-One, reference 781207) in a total volume of 60 L by adding 1 L of compounds tested at different concentrations diluted in 100% DMSO (1.7% final DMSO concentration) in reaction buffer (PBS, 125 mM NaCl, 0.001% Novexin (consists of carbohydrate polymers), designed to increase the solubility and stability of proteins; Expedeon Ltd., Cambridgeshire, United Kingdom), 0.01% Gelatin, 0.01% 0.2%, Pluronic F-127 (block copolymer from ethylenoxide and propyleneoxide), 1 mM DTT). After addition of 1.25 nM MDM2-biotinylated or 2.5 nM MDM4-biotinylated (internal preparations), and 0.625 nM Europium labeled streptavidin (Perkin Elmer), the solution is pre-incubated for 15 minutes at room temperature, then 10 nM Cy5-p53 peptide (internal preparation) is added before an incubation at room temperature for 15 minutes prior to reading the plate. For measurement of samples, a Victor II microplate reader (Perkin Elmer) is used with the following settings: Excitation 340 nm, Emission Donor 620 nm and Emission Acceptor 665 nm. For selected compounds displaying IC50s between 0.05 and 5 nM on MDM2, a slightly modified assay is used with the following adaptations: 0.1 nM MDM2, 0.1 nM Europium labeled streptavidin and Tecan genios Pro is used as a microplate reader for the fluorescence measurements (p53-MDM2 Assay 2).",B,,,BAO_0000190,BAO_0000224,protein format,COc1ncccc1-c1cc2c(n1C(C)C)C(c1ccc(Cl)cc1C)N(c1cccc(Cl)c1F)C2=O,,,CHEMBL3886789,,2016,"{'bei': '16.72', 'le': '0.33', 'lle': '1.13', 'sei': '18.52'}",CHEMBL3901714,,CHEMBL3901714,8.77,False,http://www.openphacts.org/units/Nanomolar,2885860,=,37,True,=,,IC50,nM,,1.696,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,1.696
411638,17776454,[],CHEMBL3888635,"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: Assay 2: The test is performed in white 384-well plates (Greiner Bio-One, reference 781207) in a total volume of 60 L by adding 1 L of compounds tested at different concentrations diluted in 100% DMSO (1.7% final DMSO concentration) in reaction buffer (PBS, 125 mM NaCl, 0.001% Novexin (consists of carbohydrate polymers), designed to increase the solubility and stability of proteins; Expedeon Ltd., Cambridgeshire, United Kingdom), 0.01% Gelatin, 0.01% 0.2%, Pluronic F-127 (block copolymer from ethylenoxide and propyleneoxide), 1 mM DTT). After addition of 1.25 nM MDM2-biotinylated or 2.5 nM MDM4-biotinylated (internal preparations), and 0.625 nM Europium labeled streptavidin (Perkin Elmer), the solution is pre-incubated for 15 minutes at room temperature, then 10 nM Cy5-p53 peptide (internal preparation) is added before an incubation at room temperature for 15 minutes prior to reading the plate. For measurement of samples, a Victor II microplate reader (Perkin Elmer) is used with the following settings: Excitation 340 nm, Emission Donor 620 nm and Emission Acceptor 665 nm. For selected compounds displaying IC50s between 0.05 and 5 nM on MDM2, a slightly modified assay is used with the following adaptations: 0.1 nM MDM2, 0.1 nM Europium labeled streptavidin and Tecan genios Pro is used as a microplate reader for the fluorescence measurements (p53-MDM2 Assay 2).",B,,,BAO_0000190,BAO_0000224,protein format,COc1ccncc1-c1cc2c(n1C(C)C)C(c1ccc(Cl)cc1C)N(c1cccc(Cl)c1F)C2=O,,,CHEMBL3886789,,2016,"{'bei': '18.62', 'le': '0.37', 'lle': '2.12', 'sei': '20.62'}",CHEMBL3975972,,CHEMBL3975972,9.76,False,http://www.openphacts.org/units/Nanomolar,2885861,=,37,True,=,,IC50,nM,,0.172,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,0.172
411639,17776455,[],CHEMBL3888635,"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: Assay 2: The test is performed in white 384-well plates (Greiner Bio-One, reference 781207) in a total volume of 60 L by adding 1 L of compounds tested at different concentrations diluted in 100% DMSO (1.7% final DMSO concentration) in reaction buffer (PBS, 125 mM NaCl, 0.001% Novexin (consists of carbohydrate polymers), designed to increase the solubility and stability of proteins; Expedeon Ltd., Cambridgeshire, United Kingdom), 0.01% Gelatin, 0.01% 0.2%, Pluronic F-127 (block copolymer from ethylenoxide and propyleneoxide), 1 mM DTT). After addition of 1.25 nM MDM2-biotinylated or 2.5 nM MDM4-biotinylated (internal preparations), and 0.625 nM Europium labeled streptavidin (Perkin Elmer), the solution is pre-incubated for 15 minutes at room temperature, then 10 nM Cy5-p53 peptide (internal preparation) is added before an incubation at room temperature for 15 minutes prior to reading the plate. For measurement of samples, a Victor II microplate reader (Perkin Elmer) is used with the following settings: Excitation 340 nm, Emission Donor 620 nm and Emission Acceptor 665 nm. For selected compounds displaying IC50s between 0.05 and 5 nM on MDM2, a slightly modified assay is used with the following adaptations: 0.1 nM MDM2, 0.1 nM Europium labeled streptavidin and Tecan genios Pro is used as a microplate reader for the fluorescence measurements (p53-MDM2 Assay 2).",B,,,BAO_0000190,BAO_0000224,protein format,CNC(=O)c1ccc(OC)c(-c2cc3c(n2C(C)C)[C@H](c2ccc(Cl)cc2C)N(c2cccc(Cl)c2F)C3=O)c1,,,CHEMBL3886789,,2016,"{'bei': '17.10', 'le': '0.34', 'lle': '2.31', 'sei': '15.61'}",CHEMBL3919782,,CHEMBL3919782,9.92,False,http://www.openphacts.org/units/Nanomolar,2885840,=,37,True,=,,IC50,nM,,0.119,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,0.119
411640,17776456,[],CHEMBL3888635,"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: Assay 2: The test is performed in white 384-well plates (Greiner Bio-One, reference 781207) in a total volume of 60 L by adding 1 L of compounds tested at different concentrations diluted in 100% DMSO (1.7% final DMSO concentration) in reaction buffer (PBS, 125 mM NaCl, 0.001% Novexin (consists of carbohydrate polymers), designed to increase the solubility and stability of proteins; Expedeon Ltd., Cambridgeshire, United Kingdom), 0.01% Gelatin, 0.01% 0.2%, Pluronic F-127 (block copolymer from ethylenoxide and propyleneoxide), 1 mM DTT). After addition of 1.25 nM MDM2-biotinylated or 2.5 nM MDM4-biotinylated (internal preparations), and 0.625 nM Europium labeled streptavidin (Perkin Elmer), the solution is pre-incubated for 15 minutes at room temperature, then 10 nM Cy5-p53 peptide (internal preparation) is added before an incubation at room temperature for 15 minutes prior to reading the plate. For measurement of samples, a Victor II microplate reader (Perkin Elmer) is used with the following settings: Excitation 340 nm, Emission Donor 620 nm and Emission Acceptor 665 nm. For selected compounds displaying IC50s between 0.05 and 5 nM on MDM2, a slightly modified assay is used with the following adaptations: 0.1 nM MDM2, 0.1 nM Europium labeled streptavidin and Tecan genios Pro is used as a microplate reader for the fluorescence measurements (p53-MDM2 Assay 2).",B,,,BAO_0000190,BAO_0000224,protein format,CNC(=O)c1ccc(OC)c(-c2cc3c(n2C(C)C)[C@@H](c2ccc(Cl)cc2C)N(c2cccc(Cl)c2F)C3=O)c1,,,CHEMBL3886789,,2016,"{'bei': '12.59', 'le': '0.25', 'lle': '-0.30', 'sei': '11.50'}",CHEMBL4113211,,CHEMBL4113211,7.31,False,http://www.openphacts.org/units/Nanomolar,2885862,=,37,True,=,,IC50,nM,,49.03,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,49.027
411641,17776457,[],CHEMBL3888635,"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: Assay 2: The test is performed in white 384-well plates (Greiner Bio-One, reference 781207) in a total volume of 60 L by adding 1 L of compounds tested at different concentrations diluted in 100% DMSO (1.7% final DMSO concentration) in reaction buffer (PBS, 125 mM NaCl, 0.001% Novexin (consists of carbohydrate polymers), designed to increase the solubility and stability of proteins; Expedeon Ltd., Cambridgeshire, United Kingdom), 0.01% Gelatin, 0.01% 0.2%, Pluronic F-127 (block copolymer from ethylenoxide and propyleneoxide), 1 mM DTT). After addition of 1.25 nM MDM2-biotinylated or 2.5 nM MDM4-biotinylated (internal preparations), and 0.625 nM Europium labeled streptavidin (Perkin Elmer), the solution is pre-incubated for 15 minutes at room temperature, then 10 nM Cy5-p53 peptide (internal preparation) is added before an incubation at room temperature for 15 minutes prior to reading the plate. For measurement of samples, a Victor II microplate reader (Perkin Elmer) is used with the following settings: Excitation 340 nm, Emission Donor 620 nm and Emission Acceptor 665 nm. For selected compounds displaying IC50s between 0.05 and 5 nM on MDM2, a slightly modified assay is used with the following adaptations: 0.1 nM MDM2, 0.1 nM Europium labeled streptavidin and Tecan genios Pro is used as a microplate reader for the fluorescence measurements (p53-MDM2 Assay 2).",B,,,BAO_0000190,BAO_0000224,protein format,COc1ccccc1-c1cc2c(n1C(C)C)C(c1ccc(Cl)cc1)N(c1cc(Cl)ccc1C)C2=O,,,CHEMBL3886789,,2016,"{'bei': '18.85', 'le': '0.37', 'lle': '1.42', 'sei': '27.63'}",CHEMBL3985044,,CHEMBL3985044,9.53,False,http://www.openphacts.org/units/Nanomolar,2885841,=,37,True,=,,IC50,nM,,0.298,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,0.298
411642,17776458,[],CHEMBL3888635,"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: Assay 2: The test is performed in white 384-well plates (Greiner Bio-One, reference 781207) in a total volume of 60 L by adding 1 L of compounds tested at different concentrations diluted in 100% DMSO (1.7% final DMSO concentration) in reaction buffer (PBS, 125 mM NaCl, 0.001% Novexin (consists of carbohydrate polymers), designed to increase the solubility and stability of proteins; Expedeon Ltd., Cambridgeshire, United Kingdom), 0.01% Gelatin, 0.01% 0.2%, Pluronic F-127 (block copolymer from ethylenoxide and propyleneoxide), 1 mM DTT). After addition of 1.25 nM MDM2-biotinylated or 2.5 nM MDM4-biotinylated (internal preparations), and 0.625 nM Europium labeled streptavidin (Perkin Elmer), the solution is pre-incubated for 15 minutes at room temperature, then 10 nM Cy5-p53 peptide (internal preparation) is added before an incubation at room temperature for 15 minutes prior to reading the plate. For measurement of samples, a Victor II microplate reader (Perkin Elmer) is used with the following settings: Excitation 340 nm, Emission Donor 620 nm and Emission Acceptor 665 nm. For selected compounds displaying IC50s between 0.05 and 5 nM on MDM2, a slightly modified assay is used with the following adaptations: 0.1 nM MDM2, 0.1 nM Europium labeled streptavidin and Tecan genios Pro is used as a microplate reader for the fluorescence measurements (p53-MDM2 Assay 2).",B,,,BAO_0000190,BAO_0000224,protein format,CNC(=O)c1ccc(OC)c(-c2cc3c(n2C(C)C)C(c2ccc(Cl)cc2)N(c2cc(Cl)ccc2C)C3=O)c1,,,CHEMBL3886789,,2016,"{'bei': '17.66', 'le': '0.35', 'lle': '2.47', 'sei': '15.63'}",CHEMBL3925236,,CHEMBL3925236,9.94,False,http://www.openphacts.org/units/Nanomolar,2885842,=,37,True,=,,IC50,nM,,0.116,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,0.116
411643,17776459,[],CHEMBL3888635,"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: Assay 2: The test is performed in white 384-well plates (Greiner Bio-One, reference 781207) in a total volume of 60 L by adding 1 L of compounds tested at different concentrations diluted in 100% DMSO (1.7% final DMSO concentration) in reaction buffer (PBS, 125 mM NaCl, 0.001% Novexin (consists of carbohydrate polymers), designed to increase the solubility and stability of proteins; Expedeon Ltd., Cambridgeshire, United Kingdom), 0.01% Gelatin, 0.01% 0.2%, Pluronic F-127 (block copolymer from ethylenoxide and propyleneoxide), 1 mM DTT). After addition of 1.25 nM MDM2-biotinylated or 2.5 nM MDM4-biotinylated (internal preparations), and 0.625 nM Europium labeled streptavidin (Perkin Elmer), the solution is pre-incubated for 15 minutes at room temperature, then 10 nM Cy5-p53 peptide (internal preparation) is added before an incubation at room temperature for 15 minutes prior to reading the plate. For measurement of samples, a Victor II microplate reader (Perkin Elmer) is used with the following settings: Excitation 340 nm, Emission Donor 620 nm and Emission Acceptor 665 nm. For selected compounds displaying IC50s between 0.05 and 5 nM on MDM2, a slightly modified assay is used with the following adaptations: 0.1 nM MDM2, 0.1 nM Europium labeled streptavidin and Tecan genios Pro is used as a microplate reader for the fluorescence measurements (p53-MDM2 Assay 2).",B,,,BAO_0000190,BAO_0000224,protein format,COc1ccc(CO)cc1-c1cc2c(n1C(C)C)C(c1ccc(Cl)cc1)N(c1cc(Cl)ccc1C)C2=O,,,CHEMBL3886789,,2016,"{'bei': '18.58', 'le': '0.37', 'lle': '2.35', 'sei': '18.18'}",CHEMBL3926314,,CHEMBL3926314,9.95,False,http://www.openphacts.org/units/Nanomolar,2885863,=,37,True,=,,IC50,nM,,0.113,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,0.113
411644,17776460,[],CHEMBL3888635,"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: Assay 2: The test is performed in white 384-well plates (Greiner Bio-One, reference 781207) in a total volume of 60 L by adding 1 L of compounds tested at different concentrations diluted in 100% DMSO (1.7% final DMSO concentration) in reaction buffer (PBS, 125 mM NaCl, 0.001% Novexin (consists of carbohydrate polymers), designed to increase the solubility and stability of proteins; Expedeon Ltd., Cambridgeshire, United Kingdom), 0.01% Gelatin, 0.01% 0.2%, Pluronic F-127 (block copolymer from ethylenoxide and propyleneoxide), 1 mM DTT). After addition of 1.25 nM MDM2-biotinylated or 2.5 nM MDM4-biotinylated (internal preparations), and 0.625 nM Europium labeled streptavidin (Perkin Elmer), the solution is pre-incubated for 15 minutes at room temperature, then 10 nM Cy5-p53 peptide (internal preparation) is added before an incubation at room temperature for 15 minutes prior to reading the plate. For measurement of samples, a Victor II microplate reader (Perkin Elmer) is used with the following settings: Excitation 340 nm, Emission Donor 620 nm and Emission Acceptor 665 nm. For selected compounds displaying IC50s between 0.05 and 5 nM on MDM2, a slightly modified assay is used with the following adaptations: 0.1 nM MDM2, 0.1 nM Europium labeled streptavidin and Tecan genios Pro is used as a microplate reader for the fluorescence measurements (p53-MDM2 Assay 2).",B,,,BAO_0000190,BAO_0000224,protein format,COc1ncccc1-c1cc2c(n1C(C)C)C(c1ccc(Cl)cc1)N(c1cc(Cl)ccc1C)C2=O,,,CHEMBL3886789,,2016,"{'bei': '18.38', 'le': '0.36', 'lle': '1.81', 'sei': '19.66'}",CHEMBL3898237,,CHEMBL3898237,9.31,False,http://www.openphacts.org/units/Nanomolar,2885864,=,37,True,=,,IC50,nM,,0.49,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,0.49
411645,17776461,[],CHEMBL3888635,"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: Assay 2: The test is performed in white 384-well plates (Greiner Bio-One, reference 781207) in a total volume of 60 L by adding 1 L of compounds tested at different concentrations diluted in 100% DMSO (1.7% final DMSO concentration) in reaction buffer (PBS, 125 mM NaCl, 0.001% Novexin (consists of carbohydrate polymers), designed to increase the solubility and stability of proteins; Expedeon Ltd., Cambridgeshire, United Kingdom), 0.01% Gelatin, 0.01% 0.2%, Pluronic F-127 (block copolymer from ethylenoxide and propyleneoxide), 1 mM DTT). After addition of 1.25 nM MDM2-biotinylated or 2.5 nM MDM4-biotinylated (internal preparations), and 0.625 nM Europium labeled streptavidin (Perkin Elmer), the solution is pre-incubated for 15 minutes at room temperature, then 10 nM Cy5-p53 peptide (internal preparation) is added before an incubation at room temperature for 15 minutes prior to reading the plate. For measurement of samples, a Victor II microplate reader (Perkin Elmer) is used with the following settings: Excitation 340 nm, Emission Donor 620 nm and Emission Acceptor 665 nm. For selected compounds displaying IC50s between 0.05 and 5 nM on MDM2, a slightly modified assay is used with the following adaptations: 0.1 nM MDM2, 0.1 nM Europium labeled streptavidin and Tecan genios Pro is used as a microplate reader for the fluorescence measurements (p53-MDM2 Assay 2).",B,,,BAO_0000190,BAO_0000224,protein format,COc1ccncc1-c1cc2c(n1C(C)C)C(c1ccc(Cl)cc1)N(c1cc(Cl)ccc1C)C2=O,,,CHEMBL3886789,,2016,"{'bei': '19.26', 'le': '0.38', 'lle': '2.25', 'sei': '20.60'}",CHEMBL3917871,,CHEMBL3917871,9.75,False,http://www.openphacts.org/units/Nanomolar,2885865,=,37,True,=,,IC50,nM,,0.176,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,0.176
411646,17776462,[],CHEMBL3888635,"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: Assay 2: The test is performed in white 384-well plates (Greiner Bio-One, reference 781207) in a total volume of 60 L by adding 1 L of compounds tested at different concentrations diluted in 100% DMSO (1.7% final DMSO concentration) in reaction buffer (PBS, 125 mM NaCl, 0.001% Novexin (consists of carbohydrate polymers), designed to increase the solubility and stability of proteins; Expedeon Ltd., Cambridgeshire, United Kingdom), 0.01% Gelatin, 0.01% 0.2%, Pluronic F-127 (block copolymer from ethylenoxide and propyleneoxide), 1 mM DTT). After addition of 1.25 nM MDM2-biotinylated or 2.5 nM MDM4-biotinylated (internal preparations), and 0.625 nM Europium labeled streptavidin (Perkin Elmer), the solution is pre-incubated for 15 minutes at room temperature, then 10 nM Cy5-p53 peptide (internal preparation) is added before an incubation at room temperature for 15 minutes prior to reading the plate. For measurement of samples, a Victor II microplate reader (Perkin Elmer) is used with the following settings: Excitation 340 nm, Emission Donor 620 nm and Emission Acceptor 665 nm. For selected compounds displaying IC50s between 0.05 and 5 nM on MDM2, a slightly modified assay is used with the following adaptations: 0.1 nM MDM2, 0.1 nM Europium labeled streptavidin and Tecan genios Pro is used as a microplate reader for the fluorescence measurements (p53-MDM2 Assay 2).",B,,,BAO_0000190,BAO_0000224,protein format,COc1ncc(-c2cc3c(n2C(C)C)C(c2ccc(Cl)cc2)N(c2cc(Cl)ccc2C)C3=O)c(OC)n1,,,CHEMBL3886789,,2016,"{'bei': '18.92', 'le': '0.38', 'lle': '3.26', 'sei': '14.63'}",CHEMBL3945756,,CHEMBL3945756,10.17,False,http://www.openphacts.org/units/Nanomolar,2885866,=,37,True,=,,IC50,nM,,0.068,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,0.068
411647,17776463,[],CHEMBL3888635,"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: Assay 2: The test is performed in white 384-well plates (Greiner Bio-One, reference 781207) in a total volume of 60 L by adding 1 L of compounds tested at different concentrations diluted in 100% DMSO (1.7% final DMSO concentration) in reaction buffer (PBS, 125 mM NaCl, 0.001% Novexin (consists of carbohydrate polymers), designed to increase the solubility and stability of proteins; Expedeon Ltd., Cambridgeshire, United Kingdom), 0.01% Gelatin, 0.01% 0.2%, Pluronic F-127 (block copolymer from ethylenoxide and propyleneoxide), 1 mM DTT). After addition of 1.25 nM MDM2-biotinylated or 2.5 nM MDM4-biotinylated (internal preparations), and 0.625 nM Europium labeled streptavidin (Perkin Elmer), the solution is pre-incubated for 15 minutes at room temperature, then 10 nM Cy5-p53 peptide (internal preparation) is added before an incubation at room temperature for 15 minutes prior to reading the plate. For measurement of samples, a Victor II microplate reader (Perkin Elmer) is used with the following settings: Excitation 340 nm, Emission Donor 620 nm and Emission Acceptor 665 nm. For selected compounds displaying IC50s between 0.05 and 5 nM on MDM2, a slightly modified assay is used with the following adaptations: 0.1 nM MDM2, 0.1 nM Europium labeled streptavidin and Tecan genios Pro is used as a microplate reader for the fluorescence measurements (p53-MDM2 Assay 2).",B,,,BAO_0000190,BAO_0000224,protein format,COc1ccc(C(=O)N(C)C)cc1-c1cc2c(n1C(C)C)C(c1ccc(Cl)cc1)N(c1cc(Cl)ccc1C)C2=O,,,CHEMBL3886789,,2016,"{'bei': '17.13', 'le': '0.34', 'lle': '2.07', 'sei': '18.03'}",CHEMBL3923310,,CHEMBL3923310,9.88,False,http://www.openphacts.org/units/Nanomolar,2885867,=,37,True,=,,IC50,nM,,0.133,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,0.133
411648,17776464,[],CHEMBL3888635,"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: Assay 2: The test is performed in white 384-well plates (Greiner Bio-One, reference 781207) in a total volume of 60 L by adding 1 L of compounds tested at different concentrations diluted in 100% DMSO (1.7% final DMSO concentration) in reaction buffer (PBS, 125 mM NaCl, 0.001% Novexin (consists of carbohydrate polymers), designed to increase the solubility and stability of proteins; Expedeon Ltd., Cambridgeshire, United Kingdom), 0.01% Gelatin, 0.01% 0.2%, Pluronic F-127 (block copolymer from ethylenoxide and propyleneoxide), 1 mM DTT). After addition of 1.25 nM MDM2-biotinylated or 2.5 nM MDM4-biotinylated (internal preparations), and 0.625 nM Europium labeled streptavidin (Perkin Elmer), the solution is pre-incubated for 15 minutes at room temperature, then 10 nM Cy5-p53 peptide (internal preparation) is added before an incubation at room temperature for 15 minutes prior to reading the plate. For measurement of samples, a Victor II microplate reader (Perkin Elmer) is used with the following settings: Excitation 340 nm, Emission Donor 620 nm and Emission Acceptor 665 nm. For selected compounds displaying IC50s between 0.05 and 5 nM on MDM2, a slightly modified assay is used with the following adaptations: 0.1 nM MDM2, 0.1 nM Europium labeled streptavidin and Tecan genios Pro is used as a microplate reader for the fluorescence measurements (p53-MDM2 Assay 2).",B,,,BAO_0000190,BAO_0000224,protein format,COc1ncncc1-c1cc2c(n1C(C)C)C(c1ccc(Cl)cc1)N(c1cc(Cl)ccc1C)C2=O,,,CHEMBL3886789,,2016,"{'bei': '18.74', 'le': '0.37', 'lle': '2.61', 'sei': '15.79'}",CHEMBL3954470,,CHEMBL3954470,9.51,False,http://www.openphacts.org/units/Nanomolar,2885868,=,37,True,=,,IC50,nM,,0.308,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,0.308
411649,17776465,[],CHEMBL3888635,"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: Assay 2: The test is performed in white 384-well plates (Greiner Bio-One, reference 781207) in a total volume of 60 L by adding 1 L of compounds tested at different concentrations diluted in 100% DMSO (1.7% final DMSO concentration) in reaction buffer (PBS, 125 mM NaCl, 0.001% Novexin (consists of carbohydrate polymers), designed to increase the solubility and stability of proteins; Expedeon Ltd., Cambridgeshire, United Kingdom), 0.01% Gelatin, 0.01% 0.2%, Pluronic F-127 (block copolymer from ethylenoxide and propyleneoxide), 1 mM DTT). After addition of 1.25 nM MDM2-biotinylated or 2.5 nM MDM4-biotinylated (internal preparations), and 0.625 nM Europium labeled streptavidin (Perkin Elmer), the solution is pre-incubated for 15 minutes at room temperature, then 10 nM Cy5-p53 peptide (internal preparation) is added before an incubation at room temperature for 15 minutes prior to reading the plate. For measurement of samples, a Victor II microplate reader (Perkin Elmer) is used with the following settings: Excitation 340 nm, Emission Donor 620 nm and Emission Acceptor 665 nm. For selected compounds displaying IC50s between 0.05 and 5 nM on MDM2, a slightly modified assay is used with the following adaptations: 0.1 nM MDM2, 0.1 nM Europium labeled streptavidin and Tecan genios Pro is used as a microplate reader for the fluorescence measurements (p53-MDM2 Assay 2).",B,,,BAO_0000190,BAO_0000224,protein format,COc1ccc(C#N)cc1-c1cc2c(n1C(C)C)C(c1ccc(Cl)cc1)N(c1cc(Cl)ccc1C)C2=O,,,CHEMBL3886789,,2016,"{'bei': '18.01', 'le': '0.35', 'lle': '1.57', 'sei': '16.39'}",CHEMBL3932259,,CHEMBL3932259,9.55,False,http://www.openphacts.org/units/Nanomolar,2885869,=,37,True,=,,IC50,nM,,0.281,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,0.281
411650,17776466,[],CHEMBL3888635,"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: Assay 2: The test is performed in white 384-well plates (Greiner Bio-One, reference 781207) in a total volume of 60 L by adding 1 L of compounds tested at different concentrations diluted in 100% DMSO (1.7% final DMSO concentration) in reaction buffer (PBS, 125 mM NaCl, 0.001% Novexin (consists of carbohydrate polymers), designed to increase the solubility and stability of proteins; Expedeon Ltd., Cambridgeshire, United Kingdom), 0.01% Gelatin, 0.01% 0.2%, Pluronic F-127 (block copolymer from ethylenoxide and propyleneoxide), 1 mM DTT). After addition of 1.25 nM MDM2-biotinylated or 2.5 nM MDM4-biotinylated (internal preparations), and 0.625 nM Europium labeled streptavidin (Perkin Elmer), the solution is pre-incubated for 15 minutes at room temperature, then 10 nM Cy5-p53 peptide (internal preparation) is added before an incubation at room temperature for 15 minutes prior to reading the plate. For measurement of samples, a Victor II microplate reader (Perkin Elmer) is used with the following settings: Excitation 340 nm, Emission Donor 620 nm and Emission Acceptor 665 nm. For selected compounds displaying IC50s between 0.05 and 5 nM on MDM2, a slightly modified assay is used with the following adaptations: 0.1 nM MDM2, 0.1 nM Europium labeled streptavidin and Tecan genios Pro is used as a microplate reader for the fluorescence measurements (p53-MDM2 Assay 2).",B,,,BAO_0000190,BAO_0000224,protein format,CNC(=O)c1ccc(OC)c(-c2cc3c(n2C(C)C)[C@H](c2ccc(Cl)cc2)N(c2cc(Cl)ccc2C)C3=O)c1,,,CHEMBL3886789,,2016,"{'bei': '17.82', 'le': '0.35', 'lle': '2.55', 'sei': '15.77'}",CHEMBL3916664,,CHEMBL3916664,10.02,False,http://www.openphacts.org/units/Nanomolar,2885870,=,37,True,=,,IC50,nM,,0.095,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,0.095
411651,17776467,[],CHEMBL3888635,"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: Assay 2: The test is performed in white 384-well plates (Greiner Bio-One, reference 781207) in a total volume of 60 L by adding 1 L of compounds tested at different concentrations diluted in 100% DMSO (1.7% final DMSO concentration) in reaction buffer (PBS, 125 mM NaCl, 0.001% Novexin (consists of carbohydrate polymers), designed to increase the solubility and stability of proteins; Expedeon Ltd., Cambridgeshire, United Kingdom), 0.01% Gelatin, 0.01% 0.2%, Pluronic F-127 (block copolymer from ethylenoxide and propyleneoxide), 1 mM DTT). After addition of 1.25 nM MDM2-biotinylated or 2.5 nM MDM4-biotinylated (internal preparations), and 0.625 nM Europium labeled streptavidin (Perkin Elmer), the solution is pre-incubated for 15 minutes at room temperature, then 10 nM Cy5-p53 peptide (internal preparation) is added before an incubation at room temperature for 15 minutes prior to reading the plate. For measurement of samples, a Victor II microplate reader (Perkin Elmer) is used with the following settings: Excitation 340 nm, Emission Donor 620 nm and Emission Acceptor 665 nm. For selected compounds displaying IC50s between 0.05 and 5 nM on MDM2, a slightly modified assay is used with the following adaptations: 0.1 nM MDM2, 0.1 nM Europium labeled streptavidin and Tecan genios Pro is used as a microplate reader for the fluorescence measurements (p53-MDM2 Assay 2).",B,,,BAO_0000190,BAO_0000224,protein format,CNC(=O)c1ccc(OC)c(-c2cc3c(n2C(C)C)[C@@H](c2ccc(Cl)cc2)N(c2cc(Cl)ccc2C)C3=O)c1,,,CHEMBL3886789,,2016,"{'bei': '11.99', 'le': '0.24', 'lle': '-0.73', 'sei': '10.61'}",CHEMBL4107457,,CHEMBL4107457,6.74,False,http://www.openphacts.org/units/Nanomolar,2885871,=,37,True,=,,IC50,nM,,180.52,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,180.517
411652,17776468,[],CHEMBL3888635,"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: Assay 2: The test is performed in white 384-well plates (Greiner Bio-One, reference 781207) in a total volume of 60 L by adding 1 L of compounds tested at different concentrations diluted in 100% DMSO (1.7% final DMSO concentration) in reaction buffer (PBS, 125 mM NaCl, 0.001% Novexin (consists of carbohydrate polymers), designed to increase the solubility and stability of proteins; Expedeon Ltd., Cambridgeshire, United Kingdom), 0.01% Gelatin, 0.01% 0.2%, Pluronic F-127 (block copolymer from ethylenoxide and propyleneoxide), 1 mM DTT). After addition of 1.25 nM MDM2-biotinylated or 2.5 nM MDM4-biotinylated (internal preparations), and 0.625 nM Europium labeled streptavidin (Perkin Elmer), the solution is pre-incubated for 15 minutes at room temperature, then 10 nM Cy5-p53 peptide (internal preparation) is added before an incubation at room temperature for 15 minutes prior to reading the plate. For measurement of samples, a Victor II microplate reader (Perkin Elmer) is used with the following settings: Excitation 340 nm, Emission Donor 620 nm and Emission Acceptor 665 nm. For selected compounds displaying IC50s between 0.05 and 5 nM on MDM2, a slightly modified assay is used with the following adaptations: 0.1 nM MDM2, 0.1 nM Europium labeled streptavidin and Tecan genios Pro is used as a microplate reader for the fluorescence measurements (p53-MDM2 Assay 2).",B,,,BAO_0000190,BAO_0000224,protein format,COc1ccc(C(=O)N(C)C)cc1-c1cc2c(n1C(C)C)[C@H](c1ccc(Cl)cc1)N(c1cc(Cl)ccc1C)C2=O,,,CHEMBL3886789,,2016,"{'bei': '17.56', 'le': '0.35', 'lle': '2.31', 'sei': '18.48'}",CHEMBL3916525,,CHEMBL3916525,10.12,False,http://www.openphacts.org/units/Nanomolar,2885872,=,37,True,=,,IC50,nM,,0.075,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,0.075
411653,17776469,[],CHEMBL3888635,"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: Assay 2: The test is performed in white 384-well plates (Greiner Bio-One, reference 781207) in a total volume of 60 L by adding 1 L of compounds tested at different concentrations diluted in 100% DMSO (1.7% final DMSO concentration) in reaction buffer (PBS, 125 mM NaCl, 0.001% Novexin (consists of carbohydrate polymers), designed to increase the solubility and stability of proteins; Expedeon Ltd., Cambridgeshire, United Kingdom), 0.01% Gelatin, 0.01% 0.2%, Pluronic F-127 (block copolymer from ethylenoxide and propyleneoxide), 1 mM DTT). After addition of 1.25 nM MDM2-biotinylated or 2.5 nM MDM4-biotinylated (internal preparations), and 0.625 nM Europium labeled streptavidin (Perkin Elmer), the solution is pre-incubated for 15 minutes at room temperature, then 10 nM Cy5-p53 peptide (internal preparation) is added before an incubation at room temperature for 15 minutes prior to reading the plate. For measurement of samples, a Victor II microplate reader (Perkin Elmer) is used with the following settings: Excitation 340 nm, Emission Donor 620 nm and Emission Acceptor 665 nm. For selected compounds displaying IC50s between 0.05 and 5 nM on MDM2, a slightly modified assay is used with the following adaptations: 0.1 nM MDM2, 0.1 nM Europium labeled streptavidin and Tecan genios Pro is used as a microplate reader for the fluorescence measurements (p53-MDM2 Assay 2).",B,,,BAO_0000190,BAO_0000224,protein format,COc1ccc(C(=O)N(C)C)cc1-c1cc2c(n1C(C)C)[C@@H](c1ccc(Cl)cc1)N(c1cc(Cl)ccc1C)C2=O,,,CHEMBL3886789,,2016,"{'bei': '10.77', 'le': '0.21', 'lle': '-1.60', 'sei': '11.33'}",CHEMBL4107315,,CHEMBL4107315,6.21,False,http://www.openphacts.org/units/Nanomolar,2885873,=,37,True,=,,IC50,nM,,620.83,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,620.83
411654,17776470,[],CHEMBL3888635,"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: Assay 2: The test is performed in white 384-well plates (Greiner Bio-One, reference 781207) in a total volume of 60 L by adding 1 L of compounds tested at different concentrations diluted in 100% DMSO (1.7% final DMSO concentration) in reaction buffer (PBS, 125 mM NaCl, 0.001% Novexin (consists of carbohydrate polymers), designed to increase the solubility and stability of proteins; Expedeon Ltd., Cambridgeshire, United Kingdom), 0.01% Gelatin, 0.01% 0.2%, Pluronic F-127 (block copolymer from ethylenoxide and propyleneoxide), 1 mM DTT). After addition of 1.25 nM MDM2-biotinylated or 2.5 nM MDM4-biotinylated (internal preparations), and 0.625 nM Europium labeled streptavidin (Perkin Elmer), the solution is pre-incubated for 15 minutes at room temperature, then 10 nM Cy5-p53 peptide (internal preparation) is added before an incubation at room temperature for 15 minutes prior to reading the plate. For measurement of samples, a Victor II microplate reader (Perkin Elmer) is used with the following settings: Excitation 340 nm, Emission Donor 620 nm and Emission Acceptor 665 nm. For selected compounds displaying IC50s between 0.05 and 5 nM on MDM2, a slightly modified assay is used with the following adaptations: 0.1 nM MDM2, 0.1 nM Europium labeled streptavidin and Tecan genios Pro is used as a microplate reader for the fluorescence measurements (p53-MDM2 Assay 2).",B,,,BAO_0000190,BAO_0000224,protein format,COc1ccc(-c2cc3c(n2C(C)C)C(c2ccc(Cl)cc2)N(c2cc(Cl)ccc2C)C3=O)c(OC)n1,,,CHEMBL3886789,,2016,"{'bei': '17.69', 'le': '0.35', 'lle': '1.98', 'sei': '16.77'}",CHEMBL3953300,,CHEMBL3953300,9.49,False,http://www.openphacts.org/units/Nanomolar,2885874,=,37,True,=,,IC50,nM,,0.323,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,0.323
411655,17776471,[],CHEMBL3888635,"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: Assay 2: The test is performed in white 384-well plates (Greiner Bio-One, reference 781207) in a total volume of 60 L by adding 1 L of compounds tested at different concentrations diluted in 100% DMSO (1.7% final DMSO concentration) in reaction buffer (PBS, 125 mM NaCl, 0.001% Novexin (consists of carbohydrate polymers), designed to increase the solubility and stability of proteins; Expedeon Ltd., Cambridgeshire, United Kingdom), 0.01% Gelatin, 0.01% 0.2%, Pluronic F-127 (block copolymer from ethylenoxide and propyleneoxide), 1 mM DTT). After addition of 1.25 nM MDM2-biotinylated or 2.5 nM MDM4-biotinylated (internal preparations), and 0.625 nM Europium labeled streptavidin (Perkin Elmer), the solution is pre-incubated for 15 minutes at room temperature, then 10 nM Cy5-p53 peptide (internal preparation) is added before an incubation at room temperature for 15 minutes prior to reading the plate. For measurement of samples, a Victor II microplate reader (Perkin Elmer) is used with the following settings: Excitation 340 nm, Emission Donor 620 nm and Emission Acceptor 665 nm. For selected compounds displaying IC50s between 0.05 and 5 nM on MDM2, a slightly modified assay is used with the following adaptations: 0.1 nM MDM2, 0.1 nM Europium labeled streptavidin and Tecan genios Pro is used as a microplate reader for the fluorescence measurements (p53-MDM2 Assay 2).",B,,,BAO_0000190,BAO_0000224,protein format,COc1ncc(-c2cc3c(n2C(C)C)[C@H](c2ccc(Cl)cc2)N(c2cc(Cl)ccc2C)C3=O)c(OC)n1,,,CHEMBL3886789,,2016,"{'bei': '18.95', 'le': '0.38', 'lle': '3.28', 'sei': '14.66'}",CHEMBL3901716,,CHEMBL3901716,10.19,False,http://www.openphacts.org/units/Nanomolar,2885875,=,37,True,=,,IC50,nM,,0.065,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,0.065
411656,17776472,[],CHEMBL3888635,"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: Assay 2: The test is performed in white 384-well plates (Greiner Bio-One, reference 781207) in a total volume of 60 L by adding 1 L of compounds tested at different concentrations diluted in 100% DMSO (1.7% final DMSO concentration) in reaction buffer (PBS, 125 mM NaCl, 0.001% Novexin (consists of carbohydrate polymers), designed to increase the solubility and stability of proteins; Expedeon Ltd., Cambridgeshire, United Kingdom), 0.01% Gelatin, 0.01% 0.2%, Pluronic F-127 (block copolymer from ethylenoxide and propyleneoxide), 1 mM DTT). After addition of 1.25 nM MDM2-biotinylated or 2.5 nM MDM4-biotinylated (internal preparations), and 0.625 nM Europium labeled streptavidin (Perkin Elmer), the solution is pre-incubated for 15 minutes at room temperature, then 10 nM Cy5-p53 peptide (internal preparation) is added before an incubation at room temperature for 15 minutes prior to reading the plate. For measurement of samples, a Victor II microplate reader (Perkin Elmer) is used with the following settings: Excitation 340 nm, Emission Donor 620 nm and Emission Acceptor 665 nm. For selected compounds displaying IC50s between 0.05 and 5 nM on MDM2, a slightly modified assay is used with the following adaptations: 0.1 nM MDM2, 0.1 nM Europium labeled streptavidin and Tecan genios Pro is used as a microplate reader for the fluorescence measurements (p53-MDM2 Assay 2).",B,,,BAO_0000190,BAO_0000224,protein format,COc1ncc(-c2cc3c(n2C(C)C)[C@@H](c2ccc(Cl)cc2)N(c2cc(Cl)ccc2C)C3=O)c(OC)n1,,,CHEMBL3886789,,2016,"{'bei': '14.01', 'le': '0.28', 'lle': '0.62', 'sei': '10.84'}",CHEMBL4114597,,CHEMBL4114597,7.53,False,http://www.openphacts.org/units/Nanomolar,2885876,=,37,True,=,,IC50,nM,,29.59,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,29.593
411657,17776473,[],CHEMBL3888635,"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: Assay 2: The test is performed in white 384-well plates (Greiner Bio-One, reference 781207) in a total volume of 60 L by adding 1 L of compounds tested at different concentrations diluted in 100% DMSO (1.7% final DMSO concentration) in reaction buffer (PBS, 125 mM NaCl, 0.001% Novexin (consists of carbohydrate polymers), designed to increase the solubility and stability of proteins; Expedeon Ltd., Cambridgeshire, United Kingdom), 0.01% Gelatin, 0.01% 0.2%, Pluronic F-127 (block copolymer from ethylenoxide and propyleneoxide), 1 mM DTT). After addition of 1.25 nM MDM2-biotinylated or 2.5 nM MDM4-biotinylated (internal preparations), and 0.625 nM Europium labeled streptavidin (Perkin Elmer), the solution is pre-incubated for 15 minutes at room temperature, then 10 nM Cy5-p53 peptide (internal preparation) is added before an incubation at room temperature for 15 minutes prior to reading the plate. For measurement of samples, a Victor II microplate reader (Perkin Elmer) is used with the following settings: Excitation 340 nm, Emission Donor 620 nm and Emission Acceptor 665 nm. For selected compounds displaying IC50s between 0.05 and 5 nM on MDM2, a slightly modified assay is used with the following adaptations: 0.1 nM MDM2, 0.1 nM Europium labeled streptavidin and Tecan genios Pro is used as a microplate reader for the fluorescence measurements (p53-MDM2 Assay 2).",B,,,BAO_0000190,BAO_0000224,protein format,COc1nc(N)ncc1-c1cc2c(n1C(C)C)C(c1ccc(Cl)cc1)N(c1cc(Cl)ccc1C)C2=O,,,CHEMBL3886789,,2016,"{'bei': '18.34', 'le': '0.36', 'lle': '3.10', 'sei': '11.10'}",CHEMBL3945261,,CHEMBL3945261,9.58,False,http://www.openphacts.org/units/Nanomolar,2885877,=,37,True,=,,IC50,nM,,0.263,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,0.263
411658,17776474,[],CHEMBL3888635,"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: Assay 2: The test is performed in white 384-well plates (Greiner Bio-One, reference 781207) in a total volume of 60 L by adding 1 L of compounds tested at different concentrations diluted in 100% DMSO (1.7% final DMSO concentration) in reaction buffer (PBS, 125 mM NaCl, 0.001% Novexin (consists of carbohydrate polymers), designed to increase the solubility and stability of proteins; Expedeon Ltd., Cambridgeshire, United Kingdom), 0.01% Gelatin, 0.01% 0.2%, Pluronic F-127 (block copolymer from ethylenoxide and propyleneoxide), 1 mM DTT). After addition of 1.25 nM MDM2-biotinylated or 2.5 nM MDM4-biotinylated (internal preparations), and 0.625 nM Europium labeled streptavidin (Perkin Elmer), the solution is pre-incubated for 15 minutes at room temperature, then 10 nM Cy5-p53 peptide (internal preparation) is added before an incubation at room temperature for 15 minutes prior to reading the plate. For measurement of samples, a Victor II microplate reader (Perkin Elmer) is used with the following settings: Excitation 340 nm, Emission Donor 620 nm and Emission Acceptor 665 nm. For selected compounds displaying IC50s between 0.05 and 5 nM on MDM2, a slightly modified assay is used with the following adaptations: 0.1 nM MDM2, 0.1 nM Europium labeled streptavidin and Tecan genios Pro is used as a microplate reader for the fluorescence measurements (p53-MDM2 Assay 2).",B,,,BAO_0000190,BAO_0000224,protein format,CNc1ncc(-c2cc3c(n2C(C)C)C(c2ccc(Cl)cc2)N(c2cc(Cl)ccc2C)C3=O)c(OC)n1,,,CHEMBL3886789,,2016,"{'bei': '18.10', 'le': '0.36', 'lle': '2.77', 'sei': '13.43'}",CHEMBL3917376,,CHEMBL3917376,9.71,False,http://www.openphacts.org/units/Nanomolar,2885878,=,37,True,=,,IC50,nM,,0.195,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,0.195
411659,17776475,[],CHEMBL3888635,"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: Assay 2: The test is performed in white 384-well plates (Greiner Bio-One, reference 781207) in a total volume of 60 L by adding 1 L of compounds tested at different concentrations diluted in 100% DMSO (1.7% final DMSO concentration) in reaction buffer (PBS, 125 mM NaCl, 0.001% Novexin (consists of carbohydrate polymers), designed to increase the solubility and stability of proteins; Expedeon Ltd., Cambridgeshire, United Kingdom), 0.01% Gelatin, 0.01% 0.2%, Pluronic F-127 (block copolymer from ethylenoxide and propyleneoxide), 1 mM DTT). After addition of 1.25 nM MDM2-biotinylated or 2.5 nM MDM4-biotinylated (internal preparations), and 0.625 nM Europium labeled streptavidin (Perkin Elmer), the solution is pre-incubated for 15 minutes at room temperature, then 10 nM Cy5-p53 peptide (internal preparation) is added before an incubation at room temperature for 15 minutes prior to reading the plate. For measurement of samples, a Victor II microplate reader (Perkin Elmer) is used with the following settings: Excitation 340 nm, Emission Donor 620 nm and Emission Acceptor 665 nm. For selected compounds displaying IC50s between 0.05 and 5 nM on MDM2, a slightly modified assay is used with the following adaptations: 0.1 nM MDM2, 0.1 nM Europium labeled streptavidin and Tecan genios Pro is used as a microplate reader for the fluorescence measurements (p53-MDM2 Assay 2).",B,,,BAO_0000190,BAO_0000224,protein format,COc1nc(N(C)C)ncc1-c1cc2c(n1C(C)C)C(c1ccc(Cl)cc1)N(c1cc(Cl)ccc1C)C2=O,,,CHEMBL3886789,,2016,"{'bei': '17.53', 'le': '0.35', 'lle': '2.68', 'sei': '15.20'}",CHEMBL3939933,,CHEMBL3939933,9.65,False,http://www.openphacts.org/units/Nanomolar,2885879,=,37,True,=,,IC50,nM,,0.225,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,0.225
411660,17776476,[],CHEMBL3888635,"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: Assay 2: The test is performed in white 384-well plates (Greiner Bio-One, reference 781207) in a total volume of 60 L by adding 1 L of compounds tested at different concentrations diluted in 100% DMSO (1.7% final DMSO concentration) in reaction buffer (PBS, 125 mM NaCl, 0.001% Novexin (consists of carbohydrate polymers), designed to increase the solubility and stability of proteins; Expedeon Ltd., Cambridgeshire, United Kingdom), 0.01% Gelatin, 0.01% 0.2%, Pluronic F-127 (block copolymer from ethylenoxide and propyleneoxide), 1 mM DTT). After addition of 1.25 nM MDM2-biotinylated or 2.5 nM MDM4-biotinylated (internal preparations), and 0.625 nM Europium labeled streptavidin (Perkin Elmer), the solution is pre-incubated for 15 minutes at room temperature, then 10 nM Cy5-p53 peptide (internal preparation) is added before an incubation at room temperature for 15 minutes prior to reading the plate. For measurement of samples, a Victor II microplate reader (Perkin Elmer) is used with the following settings: Excitation 340 nm, Emission Donor 620 nm and Emission Acceptor 665 nm. For selected compounds displaying IC50s between 0.05 and 5 nM on MDM2, a slightly modified assay is used with the following adaptations: 0.1 nM MDM2, 0.1 nM Europium labeled streptavidin and Tecan genios Pro is used as a microplate reader for the fluorescence measurements (p53-MDM2 Assay 2).",B,,,BAO_0000190,BAO_0000224,protein format,COc1ccc(C(=O)N2CCOCC2)cc1-c1cc2c(n1C(C)C)C(c1ccc(Cl)cc1)N(c1cc(Cl)ccc1C)C2=O,,,CHEMBL3886789,,2016,"{'bei': '16.13', 'le': '0.32', 'lle': '2.39', 'sei': '15.58'}",CHEMBL3908421,,CHEMBL3908421,9.97,False,http://www.openphacts.org/units/Nanomolar,2885880,=,37,True,=,,IC50,nM,,0.106,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,0.106
411661,17776477,[],CHEMBL3888635,"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: Assay 2: The test is performed in white 384-well plates (Greiner Bio-One, reference 781207) in a total volume of 60 L by adding 1 L of compounds tested at different concentrations diluted in 100% DMSO (1.7% final DMSO concentration) in reaction buffer (PBS, 125 mM NaCl, 0.001% Novexin (consists of carbohydrate polymers), designed to increase the solubility and stability of proteins; Expedeon Ltd., Cambridgeshire, United Kingdom), 0.01% Gelatin, 0.01% 0.2%, Pluronic F-127 (block copolymer from ethylenoxide and propyleneoxide), 1 mM DTT). After addition of 1.25 nM MDM2-biotinylated or 2.5 nM MDM4-biotinylated (internal preparations), and 0.625 nM Europium labeled streptavidin (Perkin Elmer), the solution is pre-incubated for 15 minutes at room temperature, then 10 nM Cy5-p53 peptide (internal preparation) is added before an incubation at room temperature for 15 minutes prior to reading the plate. For measurement of samples, a Victor II microplate reader (Perkin Elmer) is used with the following settings: Excitation 340 nm, Emission Donor 620 nm and Emission Acceptor 665 nm. For selected compounds displaying IC50s between 0.05 and 5 nM on MDM2, a slightly modified assay is used with the following adaptations: 0.1 nM MDM2, 0.1 nM Europium labeled streptavidin and Tecan genios Pro is used as a microplate reader for the fluorescence measurements (p53-MDM2 Assay 2).",B,,,BAO_0000190,BAO_0000224,protein format,Cc1ccc(Cl)cc1N1C(=O)c2cc(-c3ccccc3O)n(C(C)C)c2C1c1ccc(Cl)cc1,,,CHEMBL3886789,,2016,"{'bei': '19.36', 'le': '0.38', 'lle': '1.70', 'sei': '20.92'}",CHEMBL3930918,,CHEMBL3930918,9.51,False,http://www.openphacts.org/units/Nanomolar,2885881,=,37,True,=,,IC50,nM,,0.306,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,0.306
411662,17776478,[],CHEMBL3888635,"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: Assay 2: The test is performed in white 384-well plates (Greiner Bio-One, reference 781207) in a total volume of 60 L by adding 1 L of compounds tested at different concentrations diluted in 100% DMSO (1.7% final DMSO concentration) in reaction buffer (PBS, 125 mM NaCl, 0.001% Novexin (consists of carbohydrate polymers), designed to increase the solubility and stability of proteins; Expedeon Ltd., Cambridgeshire, United Kingdom), 0.01% Gelatin, 0.01% 0.2%, Pluronic F-127 (block copolymer from ethylenoxide and propyleneoxide), 1 mM DTT). After addition of 1.25 nM MDM2-biotinylated or 2.5 nM MDM4-biotinylated (internal preparations), and 0.625 nM Europium labeled streptavidin (Perkin Elmer), the solution is pre-incubated for 15 minutes at room temperature, then 10 nM Cy5-p53 peptide (internal preparation) is added before an incubation at room temperature for 15 minutes prior to reading the plate. For measurement of samples, a Victor II microplate reader (Perkin Elmer) is used with the following settings: Excitation 340 nm, Emission Donor 620 nm and Emission Acceptor 665 nm. For selected compounds displaying IC50s between 0.05 and 5 nM on MDM2, a slightly modified assay is used with the following adaptations: 0.1 nM MDM2, 0.1 nM Europium labeled streptavidin and Tecan genios Pro is used as a microplate reader for the fluorescence measurements (p53-MDM2 Assay 2).",B,,,BAO_0000190,BAO_0000224,protein format,COc1ccccc1-c1cc2c(n1C(C)C)C(c1ccc(Cl)cc1C)N(c1cc(Cl)ccc1C)C2=O,,,CHEMBL3886789,,2016,"{'bei': '18.14', 'le': '0.36', 'lle': '1.00', 'sei': '27.34'}",CHEMBL3902934,,CHEMBL3902934,9.43,False,http://www.openphacts.org/units/Nanomolar,2885882,=,37,True,=,,IC50,nM,,0.376,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,0.376
411663,17776479,[],CHEMBL3888635,"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: Assay 2: The test is performed in white 384-well plates (Greiner Bio-One, reference 781207) in a total volume of 60 L by adding 1 L of compounds tested at different concentrations diluted in 100% DMSO (1.7% final DMSO concentration) in reaction buffer (PBS, 125 mM NaCl, 0.001% Novexin (consists of carbohydrate polymers), designed to increase the solubility and stability of proteins; Expedeon Ltd., Cambridgeshire, United Kingdom), 0.01% Gelatin, 0.01% 0.2%, Pluronic F-127 (block copolymer from ethylenoxide and propyleneoxide), 1 mM DTT). After addition of 1.25 nM MDM2-biotinylated or 2.5 nM MDM4-biotinylated (internal preparations), and 0.625 nM Europium labeled streptavidin (Perkin Elmer), the solution is pre-incubated for 15 minutes at room temperature, then 10 nM Cy5-p53 peptide (internal preparation) is added before an incubation at room temperature for 15 minutes prior to reading the plate. For measurement of samples, a Victor II microplate reader (Perkin Elmer) is used with the following settings: Excitation 340 nm, Emission Donor 620 nm and Emission Acceptor 665 nm. For selected compounds displaying IC50s between 0.05 and 5 nM on MDM2, a slightly modified assay is used with the following adaptations: 0.1 nM MDM2, 0.1 nM Europium labeled streptavidin and Tecan genios Pro is used as a microplate reader for the fluorescence measurements (p53-MDM2 Assay 2).",B,,,BAO_0000190,BAO_0000224,protein format,CNC(=O)c1ccc(OC)c(-c2cc3c(n2C(C)C)C(c2ccc(Cl)cc2C)N(c2cc(Cl)ccc2C)C3=O)c1,,,CHEMBL3886789,,2016,"{'bei': '16.89', 'le': '0.33', 'lle': '1.96', 'sei': '15.31'}",CHEMBL3961529,,CHEMBL3961529,9.73,False,http://www.openphacts.org/units/Nanomolar,2885883,=,37,True,=,,IC50,nM,,0.184,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,0.184
411664,17776480,[],CHEMBL3888635,"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: Assay 2: The test is performed in white 384-well plates (Greiner Bio-One, reference 781207) in a total volume of 60 L by adding 1 L of compounds tested at different concentrations diluted in 100% DMSO (1.7% final DMSO concentration) in reaction buffer (PBS, 125 mM NaCl, 0.001% Novexin (consists of carbohydrate polymers), designed to increase the solubility and stability of proteins; Expedeon Ltd., Cambridgeshire, United Kingdom), 0.01% Gelatin, 0.01% 0.2%, Pluronic F-127 (block copolymer from ethylenoxide and propyleneoxide), 1 mM DTT). After addition of 1.25 nM MDM2-biotinylated or 2.5 nM MDM4-biotinylated (internal preparations), and 0.625 nM Europium labeled streptavidin (Perkin Elmer), the solution is pre-incubated for 15 minutes at room temperature, then 10 nM Cy5-p53 peptide (internal preparation) is added before an incubation at room temperature for 15 minutes prior to reading the plate. For measurement of samples, a Victor II microplate reader (Perkin Elmer) is used with the following settings: Excitation 340 nm, Emission Donor 620 nm and Emission Acceptor 665 nm. For selected compounds displaying IC50s between 0.05 and 5 nM on MDM2, a slightly modified assay is used with the following adaptations: 0.1 nM MDM2, 0.1 nM Europium labeled streptavidin and Tecan genios Pro is used as a microplate reader for the fluorescence measurements (p53-MDM2 Assay 2).",B,,,BAO_0000190,BAO_0000224,protein format,CNC(=O)c1ccc(OC)c(-c2cc3c(n2C(C)C)[C@H](c2ccc(Cl)cc2C)N(c2cc(Cl)ccc2C)C3=O)c1,,,CHEMBL3886789,,2016,"{'bei': '17.39', 'le': '0.34', 'lle': '2.25', 'sei': '15.77'}",CHEMBL3937629,,CHEMBL3937629,10.03,False,http://www.openphacts.org/units/Nanomolar,2885843,=,37,True,=,,IC50,nM,,0.094,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,0.094
411665,17776481,[],CHEMBL3888635,"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: Assay 2: The test is performed in white 384-well plates (Greiner Bio-One, reference 781207) in a total volume of 60 L by adding 1 L of compounds tested at different concentrations diluted in 100% DMSO (1.7% final DMSO concentration) in reaction buffer (PBS, 125 mM NaCl, 0.001% Novexin (consists of carbohydrate polymers), designed to increase the solubility and stability of proteins; Expedeon Ltd., Cambridgeshire, United Kingdom), 0.01% Gelatin, 0.01% 0.2%, Pluronic F-127 (block copolymer from ethylenoxide and propyleneoxide), 1 mM DTT). After addition of 1.25 nM MDM2-biotinylated or 2.5 nM MDM4-biotinylated (internal preparations), and 0.625 nM Europium labeled streptavidin (Perkin Elmer), the solution is pre-incubated for 15 minutes at room temperature, then 10 nM Cy5-p53 peptide (internal preparation) is added before an incubation at room temperature for 15 minutes prior to reading the plate. For measurement of samples, a Victor II microplate reader (Perkin Elmer) is used with the following settings: Excitation 340 nm, Emission Donor 620 nm and Emission Acceptor 665 nm. For selected compounds displaying IC50s between 0.05 and 5 nM on MDM2, a slightly modified assay is used with the following adaptations: 0.1 nM MDM2, 0.1 nM Europium labeled streptavidin and Tecan genios Pro is used as a microplate reader for the fluorescence measurements (p53-MDM2 Assay 2).",B,,,BAO_0000190,BAO_0000224,protein format,CNC(=O)c1ccc(OC)c(-c2cc3c(n2C(C)C)[C@@H](c2ccc(Cl)cc2C)N(c2cc(Cl)ccc2C)C3=O)c1,,,CHEMBL3886789,,2016,"{'bei': '12.75', 'le': '0.25', 'lle': '-0.43', 'sei': '11.56'}",CHEMBL4110748,,CHEMBL4110748,7.35,False,http://www.openphacts.org/units/Nanomolar,2885884,=,37,True,=,,IC50,nM,,44.56,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,44.56
411666,17776482,[],CHEMBL3888635,"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: Assay 2: The test is performed in white 384-well plates (Greiner Bio-One, reference 781207) in a total volume of 60 L by adding 1 L of compounds tested at different concentrations diluted in 100% DMSO (1.7% final DMSO concentration) in reaction buffer (PBS, 125 mM NaCl, 0.001% Novexin (consists of carbohydrate polymers), designed to increase the solubility and stability of proteins; Expedeon Ltd., Cambridgeshire, United Kingdom), 0.01% Gelatin, 0.01% 0.2%, Pluronic F-127 (block copolymer from ethylenoxide and propyleneoxide), 1 mM DTT). After addition of 1.25 nM MDM2-biotinylated or 2.5 nM MDM4-biotinylated (internal preparations), and 0.625 nM Europium labeled streptavidin (Perkin Elmer), the solution is pre-incubated for 15 minutes at room temperature, then 10 nM Cy5-p53 peptide (internal preparation) is added before an incubation at room temperature for 15 minutes prior to reading the plate. For measurement of samples, a Victor II microplate reader (Perkin Elmer) is used with the following settings: Excitation 340 nm, Emission Donor 620 nm and Emission Acceptor 665 nm. For selected compounds displaying IC50s between 0.05 and 5 nM on MDM2, a slightly modified assay is used with the following adaptations: 0.1 nM MDM2, 0.1 nM Europium labeled streptavidin and Tecan genios Pro is used as a microplate reader for the fluorescence measurements (p53-MDM2 Assay 2).",B,,,BAO_0000190,BAO_0000224,protein format,COc1ccc(-c2nnn[nH]2)cc1-c1cc2c(n1C(C)C)C(c1ccc(Cl)cc1)N(c1cc(Cl)ccc1C)C2=O,,,CHEMBL3886789,,2016,"{'bei': '16.96', 'le': '0.33', 'lle': '2.44', 'sei': '10.94'}",CHEMBL3955553,,CHEMBL3955553,9.73,False,http://www.openphacts.org/units/Nanomolar,2885885,=,37,True,=,,IC50,nM,,0.188,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,0.188
411667,17776483,[],CHEMBL3888635,"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: Assay 2: The test is performed in white 384-well plates (Greiner Bio-One, reference 781207) in a total volume of 60 L by adding 1 L of compounds tested at different concentrations diluted in 100% DMSO (1.7% final DMSO concentration) in reaction buffer (PBS, 125 mM NaCl, 0.001% Novexin (consists of carbohydrate polymers), designed to increase the solubility and stability of proteins; Expedeon Ltd., Cambridgeshire, United Kingdom), 0.01% Gelatin, 0.01% 0.2%, Pluronic F-127 (block copolymer from ethylenoxide and propyleneoxide), 1 mM DTT). After addition of 1.25 nM MDM2-biotinylated or 2.5 nM MDM4-biotinylated (internal preparations), and 0.625 nM Europium labeled streptavidin (Perkin Elmer), the solution is pre-incubated for 15 minutes at room temperature, then 10 nM Cy5-p53 peptide (internal preparation) is added before an incubation at room temperature for 15 minutes prior to reading the plate. For measurement of samples, a Victor II microplate reader (Perkin Elmer) is used with the following settings: Excitation 340 nm, Emission Donor 620 nm and Emission Acceptor 665 nm. For selected compounds displaying IC50s between 0.05 and 5 nM on MDM2, a slightly modified assay is used with the following adaptations: 0.1 nM MDM2, 0.1 nM Europium labeled streptavidin and Tecan genios Pro is used as a microplate reader for the fluorescence measurements (p53-MDM2 Assay 2).",B,,,BAO_0000190,BAO_0000224,protein format,COc1ccc(C(=O)O)cc1-c1cc2c(n1C(C)C)C(c1ccc(Cl)cc1)N(c1cc(Cl)ccc1C)C2=O,,,CHEMBL3886789,,2016,"{'bei': '17.79', 'le': '0.35', 'lle': '1.96', 'sei': '13.62'}",CHEMBL3959598,,CHEMBL3959598,9.77,False,http://www.openphacts.org/units/Nanomolar,2885886,=,37,True,=,,IC50,nM,,0.169,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,0.169
411668,17776484,[],CHEMBL3888635,"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: Assay 2: The test is performed in white 384-well plates (Greiner Bio-One, reference 781207) in a total volume of 60 L by adding 1 L of compounds tested at different concentrations diluted in 100% DMSO (1.7% final DMSO concentration) in reaction buffer (PBS, 125 mM NaCl, 0.001% Novexin (consists of carbohydrate polymers), designed to increase the solubility and stability of proteins; Expedeon Ltd., Cambridgeshire, United Kingdom), 0.01% Gelatin, 0.01% 0.2%, Pluronic F-127 (block copolymer from ethylenoxide and propyleneoxide), 1 mM DTT). After addition of 1.25 nM MDM2-biotinylated or 2.5 nM MDM4-biotinylated (internal preparations), and 0.625 nM Europium labeled streptavidin (Perkin Elmer), the solution is pre-incubated for 15 minutes at room temperature, then 10 nM Cy5-p53 peptide (internal preparation) is added before an incubation at room temperature for 15 minutes prior to reading the plate. For measurement of samples, a Victor II microplate reader (Perkin Elmer) is used with the following settings: Excitation 340 nm, Emission Donor 620 nm and Emission Acceptor 665 nm. For selected compounds displaying IC50s between 0.05 and 5 nM on MDM2, a slightly modified assay is used with the following adaptations: 0.1 nM MDM2, 0.1 nM Europium labeled streptavidin and Tecan genios Pro is used as a microplate reader for the fluorescence measurements (p53-MDM2 Assay 2).",B,,,BAO_0000190,BAO_0000224,protein format,COc1ccc(C(=O)NCCS(C)(=O)=O)cc1-c1cc2c(n1C(C)C)C(c1ccc(Cl)cc1)N(c1cc(Cl)ccc1C)C2=O,,,CHEMBL3886789,,2016,"{'bei': '15.18', 'le': '0.31', 'lle': '3.06', 'sei': '10.17'}",CHEMBL3902132,,CHEMBL3902132,9.94,False,http://www.openphacts.org/units/Nanomolar,2885887,=,37,True,=,,IC50,nM,,0.115,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,0.115
411669,17776485,[],CHEMBL3888635,"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: Assay 2: The test is performed in white 384-well plates (Greiner Bio-One, reference 781207) in a total volume of 60 L by adding 1 L of compounds tested at different concentrations diluted in 100% DMSO (1.7% final DMSO concentration) in reaction buffer (PBS, 125 mM NaCl, 0.001% Novexin (consists of carbohydrate polymers), designed to increase the solubility and stability of proteins; Expedeon Ltd., Cambridgeshire, United Kingdom), 0.01% Gelatin, 0.01% 0.2%, Pluronic F-127 (block copolymer from ethylenoxide and propyleneoxide), 1 mM DTT). After addition of 1.25 nM MDM2-biotinylated or 2.5 nM MDM4-biotinylated (internal preparations), and 0.625 nM Europium labeled streptavidin (Perkin Elmer), the solution is pre-incubated for 15 minutes at room temperature, then 10 nM Cy5-p53 peptide (internal preparation) is added before an incubation at room temperature for 15 minutes prior to reading the plate. For measurement of samples, a Victor II microplate reader (Perkin Elmer) is used with the following settings: Excitation 340 nm, Emission Donor 620 nm and Emission Acceptor 665 nm. For selected compounds displaying IC50s between 0.05 and 5 nM on MDM2, a slightly modified assay is used with the following adaptations: 0.1 nM MDM2, 0.1 nM Europium labeled streptavidin and Tecan genios Pro is used as a microplate reader for the fluorescence measurements (p53-MDM2 Assay 2).",B,,,BAO_0000190,BAO_0000224,protein format,COc1ccc(C(=O)NOCCO)cc1-c1cc2c(n1C(C)C)C(c1ccc(Cl)cc1)N(c1cc(Cl)ccc1C)C2=O,,,CHEMBL3886789,,2016,"{'bei': '16.27', 'le': '0.32', 'lle': '3.14', 'sei': '10.65'}",CHEMBL3895665,,CHEMBL3895665,9.90,False,http://www.openphacts.org/units/Nanomolar,2885844,=,37,True,=,,IC50,nM,,0.125,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,0.125
411670,17776486,[],CHEMBL3888635,"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: Assay 2: The test is performed in white 384-well plates (Greiner Bio-One, reference 781207) in a total volume of 60 L by adding 1 L of compounds tested at different concentrations diluted in 100% DMSO (1.7% final DMSO concentration) in reaction buffer (PBS, 125 mM NaCl, 0.001% Novexin (consists of carbohydrate polymers), designed to increase the solubility and stability of proteins; Expedeon Ltd., Cambridgeshire, United Kingdom), 0.01% Gelatin, 0.01% 0.2%, Pluronic F-127 (block copolymer from ethylenoxide and propyleneoxide), 1 mM DTT). After addition of 1.25 nM MDM2-biotinylated or 2.5 nM MDM4-biotinylated (internal preparations), and 0.625 nM Europium labeled streptavidin (Perkin Elmer), the solution is pre-incubated for 15 minutes at room temperature, then 10 nM Cy5-p53 peptide (internal preparation) is added before an incubation at room temperature for 15 minutes prior to reading the plate. For measurement of samples, a Victor II microplate reader (Perkin Elmer) is used with the following settings: Excitation 340 nm, Emission Donor 620 nm and Emission Acceptor 665 nm. For selected compounds displaying IC50s between 0.05 and 5 nM on MDM2, a slightly modified assay is used with the following adaptations: 0.1 nM MDM2, 0.1 nM Europium labeled streptavidin and Tecan genios Pro is used as a microplate reader for the fluorescence measurements (p53-MDM2 Assay 2).",B,,,BAO_0000190,BAO_0000224,protein format,COc1ccc(-c2cc3c(n2C(C)C)C(c2ccc(Cl)cc2)N(c2cc(Cl)ccc2C)C3=O)c(OC)c1,,,CHEMBL3886789,,2016,"{'bei': '17.47', 'le': '0.35', 'lle': '1.23', 'sei': '21.40'}",CHEMBL3931214,,CHEMBL3931214,9.35,False,http://www.openphacts.org/units/Nanomolar,2885888,=,37,True,=,,IC50,nM,,0.444,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,0.444
411671,17776487,[],CHEMBL3888635,"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: Assay 2: The test is performed in white 384-well plates (Greiner Bio-One, reference 781207) in a total volume of 60 L by adding 1 L of compounds tested at different concentrations diluted in 100% DMSO (1.7% final DMSO concentration) in reaction buffer (PBS, 125 mM NaCl, 0.001% Novexin (consists of carbohydrate polymers), designed to increase the solubility and stability of proteins; Expedeon Ltd., Cambridgeshire, United Kingdom), 0.01% Gelatin, 0.01% 0.2%, Pluronic F-127 (block copolymer from ethylenoxide and propyleneoxide), 1 mM DTT). After addition of 1.25 nM MDM2-biotinylated or 2.5 nM MDM4-biotinylated (internal preparations), and 0.625 nM Europium labeled streptavidin (Perkin Elmer), the solution is pre-incubated for 15 minutes at room temperature, then 10 nM Cy5-p53 peptide (internal preparation) is added before an incubation at room temperature for 15 minutes prior to reading the plate. For measurement of samples, a Victor II microplate reader (Perkin Elmer) is used with the following settings: Excitation 340 nm, Emission Donor 620 nm and Emission Acceptor 665 nm. For selected compounds displaying IC50s between 0.05 and 5 nM on MDM2, a slightly modified assay is used with the following adaptations: 0.1 nM MDM2, 0.1 nM Europium labeled streptavidin and Tecan genios Pro is used as a microplate reader for the fluorescence measurements (p53-MDM2 Assay 2).",B,,,BAO_0000190,BAO_0000224,protein format,COc1nc(N)ncc1-c1cc2c(n1C(C)C)C(c1ccc(C#N)cc1)N(c1ccc(F)c(Cl)c1)C2=O,,,CHEMBL3886789,,2016,"{'bei': '17.90', 'le': '0.34', 'lle': '3.72', 'sei': '8.41'}",CHEMBL3894270,,CHEMBL3894270,9.26,False,http://www.openphacts.org/units/Nanomolar,2885889,=,37,True,=,,IC50,nM,,0.556,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,0.556
411672,17776488,[],CHEMBL3888635,"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: Assay 2: The test is performed in white 384-well plates (Greiner Bio-One, reference 781207) in a total volume of 60 L by adding 1 L of compounds tested at different concentrations diluted in 100% DMSO (1.7% final DMSO concentration) in reaction buffer (PBS, 125 mM NaCl, 0.001% Novexin (consists of carbohydrate polymers), designed to increase the solubility and stability of proteins; Expedeon Ltd., Cambridgeshire, United Kingdom), 0.01% Gelatin, 0.01% 0.2%, Pluronic F-127 (block copolymer from ethylenoxide and propyleneoxide), 1 mM DTT). After addition of 1.25 nM MDM2-biotinylated or 2.5 nM MDM4-biotinylated (internal preparations), and 0.625 nM Europium labeled streptavidin (Perkin Elmer), the solution is pre-incubated for 15 minutes at room temperature, then 10 nM Cy5-p53 peptide (internal preparation) is added before an incubation at room temperature for 15 minutes prior to reading the plate. For measurement of samples, a Victor II microplate reader (Perkin Elmer) is used with the following settings: Excitation 340 nm, Emission Donor 620 nm and Emission Acceptor 665 nm. For selected compounds displaying IC50s between 0.05 and 5 nM on MDM2, a slightly modified assay is used with the following adaptations: 0.1 nM MDM2, 0.1 nM Europium labeled streptavidin and Tecan genios Pro is used as a microplate reader for the fluorescence measurements (p53-MDM2 Assay 2).",B,,,BAO_0000190,BAO_0000224,protein format,COc1ncc(-c2cc3c(n2C(C)C)C(c2ccc(C#N)cc2)N(c2ccc(F)c(Cl)c2)C3=O)c(OC)n1,,,CHEMBL3886789,,2016,"{'bei': '17.52', 'le': '0.33', 'lle': '3.36', 'sei': '9.99'}",CHEMBL3891121,,CHEMBL3891121,9.32,False,http://www.openphacts.org/units/Nanomolar,2885890,=,37,True,=,,IC50,nM,,0.478,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,0.478
411673,17776489,[],CHEMBL3888635,"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: Assay 2: The test is performed in white 384-well plates (Greiner Bio-One, reference 781207) in a total volume of 60 L by adding 1 L of compounds tested at different concentrations diluted in 100% DMSO (1.7% final DMSO concentration) in reaction buffer (PBS, 125 mM NaCl, 0.001% Novexin (consists of carbohydrate polymers), designed to increase the solubility and stability of proteins; Expedeon Ltd., Cambridgeshire, United Kingdom), 0.01% Gelatin, 0.01% 0.2%, Pluronic F-127 (block copolymer from ethylenoxide and propyleneoxide), 1 mM DTT). After addition of 1.25 nM MDM2-biotinylated or 2.5 nM MDM4-biotinylated (internal preparations), and 0.625 nM Europium labeled streptavidin (Perkin Elmer), the solution is pre-incubated for 15 minutes at room temperature, then 10 nM Cy5-p53 peptide (internal preparation) is added before an incubation at room temperature for 15 minutes prior to reading the plate. For measurement of samples, a Victor II microplate reader (Perkin Elmer) is used with the following settings: Excitation 340 nm, Emission Donor 620 nm and Emission Acceptor 665 nm. For selected compounds displaying IC50s between 0.05 and 5 nM on MDM2, a slightly modified assay is used with the following adaptations: 0.1 nM MDM2, 0.1 nM Europium labeled streptavidin and Tecan genios Pro is used as a microplate reader for the fluorescence measurements (p53-MDM2 Assay 2).",B,,,BAO_0000190,BAO_0000224,protein format,COc1nc(N)ncc1-c1cc2c(n1C(C)C)C(c1ccc(C#N)cc1)N(c1cccc(Cl)c1F)C2=O,,,CHEMBL3886789,,2016,"{'bei': '18.29', 'le': '0.35', 'lle': '3.93', 'sei': '8.59'}",CHEMBL3976234,,CHEMBL3976234,9.46,False,http://www.openphacts.org/units/Nanomolar,2885891,=,37,True,=,,IC50,nM,,0.349,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,0.349
411674,17776490,[],CHEMBL3888635,"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: Assay 2: The test is performed in white 384-well plates (Greiner Bio-One, reference 781207) in a total volume of 60 L by adding 1 L of compounds tested at different concentrations diluted in 100% DMSO (1.7% final DMSO concentration) in reaction buffer (PBS, 125 mM NaCl, 0.001% Novexin (consists of carbohydrate polymers), designed to increase the solubility and stability of proteins; Expedeon Ltd., Cambridgeshire, United Kingdom), 0.01% Gelatin, 0.01% 0.2%, Pluronic F-127 (block copolymer from ethylenoxide and propyleneoxide), 1 mM DTT). After addition of 1.25 nM MDM2-biotinylated or 2.5 nM MDM4-biotinylated (internal preparations), and 0.625 nM Europium labeled streptavidin (Perkin Elmer), the solution is pre-incubated for 15 minutes at room temperature, then 10 nM Cy5-p53 peptide (internal preparation) is added before an incubation at room temperature for 15 minutes prior to reading the plate. For measurement of samples, a Victor II microplate reader (Perkin Elmer) is used with the following settings: Excitation 340 nm, Emission Donor 620 nm and Emission Acceptor 665 nm. For selected compounds displaying IC50s between 0.05 and 5 nM on MDM2, a slightly modified assay is used with the following adaptations: 0.1 nM MDM2, 0.1 nM Europium labeled streptavidin and Tecan genios Pro is used as a microplate reader for the fluorescence measurements (p53-MDM2 Assay 2).",B,,,BAO_0000190,BAO_0000224,protein format,COc1ncc(-c2cc3c(n2C(C)C)C(c2ccc(C#N)cc2)N(c2cccc(Cl)c2F)C3=O)c(OC)n1,,,CHEMBL3886789,,2016,"{'bei': '18.06', 'le': '0.35', 'lle': '3.65', 'sei': '10.30'}",CHEMBL3909112,,CHEMBL3909112,9.61,False,http://www.openphacts.org/units/Nanomolar,2885892,=,37,True,=,,IC50,nM,,0.246,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,0.246
411675,17776491,[],CHEMBL3888635,"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: Assay 2: The test is performed in white 384-well plates (Greiner Bio-One, reference 781207) in a total volume of 60 L by adding 1 L of compounds tested at different concentrations diluted in 100% DMSO (1.7% final DMSO concentration) in reaction buffer (PBS, 125 mM NaCl, 0.001% Novexin (consists of carbohydrate polymers), designed to increase the solubility and stability of proteins; Expedeon Ltd., Cambridgeshire, United Kingdom), 0.01% Gelatin, 0.01% 0.2%, Pluronic F-127 (block copolymer from ethylenoxide and propyleneoxide), 1 mM DTT). After addition of 1.25 nM MDM2-biotinylated or 2.5 nM MDM4-biotinylated (internal preparations), and 0.625 nM Europium labeled streptavidin (Perkin Elmer), the solution is pre-incubated for 15 minutes at room temperature, then 10 nM Cy5-p53 peptide (internal preparation) is added before an incubation at room temperature for 15 minutes prior to reading the plate. For measurement of samples, a Victor II microplate reader (Perkin Elmer) is used with the following settings: Excitation 340 nm, Emission Donor 620 nm and Emission Acceptor 665 nm. For selected compounds displaying IC50s between 0.05 and 5 nM on MDM2, a slightly modified assay is used with the following adaptations: 0.1 nM MDM2, 0.1 nM Europium labeled streptavidin and Tecan genios Pro is used as a microplate reader for the fluorescence measurements (p53-MDM2 Assay 2).",B,,,BAO_0000190,BAO_0000224,protein format,COc1nc(N)ncc1-c1cc2c(n1C(C)C)C(c1ccc(C#N)cc1)N(c1cc(Cl)ccc1C)C2=O,,,CHEMBL3886789,,2016,"{'bei': '18.32', 'le': '0.35', 'lle': '3.70', 'sei': '8.54'}",CHEMBL3892910,,CHEMBL3892910,9.40,False,http://www.openphacts.org/units/Nanomolar,2885893,=,37,True,=,,IC50,nM,,0.401,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,0.401
411676,17776492,[],CHEMBL3888635,"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: Assay 2: The test is performed in white 384-well plates (Greiner Bio-One, reference 781207) in a total volume of 60 L by adding 1 L of compounds tested at different concentrations diluted in 100% DMSO (1.7% final DMSO concentration) in reaction buffer (PBS, 125 mM NaCl, 0.001% Novexin (consists of carbohydrate polymers), designed to increase the solubility and stability of proteins; Expedeon Ltd., Cambridgeshire, United Kingdom), 0.01% Gelatin, 0.01% 0.2%, Pluronic F-127 (block copolymer from ethylenoxide and propyleneoxide), 1 mM DTT). After addition of 1.25 nM MDM2-biotinylated or 2.5 nM MDM4-biotinylated (internal preparations), and 0.625 nM Europium labeled streptavidin (Perkin Elmer), the solution is pre-incubated for 15 minutes at room temperature, then 10 nM Cy5-p53 peptide (internal preparation) is added before an incubation at room temperature for 15 minutes prior to reading the plate. For measurement of samples, a Victor II microplate reader (Perkin Elmer) is used with the following settings: Excitation 340 nm, Emission Donor 620 nm and Emission Acceptor 665 nm. For selected compounds displaying IC50s between 0.05 and 5 nM on MDM2, a slightly modified assay is used with the following adaptations: 0.1 nM MDM2, 0.1 nM Europium labeled streptavidin and Tecan genios Pro is used as a microplate reader for the fluorescence measurements (p53-MDM2 Assay 2).",B,,,BAO_0000190,BAO_0000224,protein format,COc1ncc(-c2cc3c(n2C(C)C)C(c2ccc(C#N)cc2)N(c2cc(Cl)ccc2C)C3=O)c(OC)n1,,,CHEMBL3886789,,2016,"{'bei': '18.52', 'le': '0.35', 'lle': '3.65', 'sei': '10.48'}",CHEMBL3902052,,CHEMBL3902052,9.78,False,http://www.openphacts.org/units/Nanomolar,2885894,=,37,True,=,,IC50,nM,,0.167,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,0.167
411677,17776493,[],CHEMBL3888635,"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: Assay 2: The test is performed in white 384-well plates (Greiner Bio-One, reference 781207) in a total volume of 60 L by adding 1 L of compounds tested at different concentrations diluted in 100% DMSO (1.7% final DMSO concentration) in reaction buffer (PBS, 125 mM NaCl, 0.001% Novexin (consists of carbohydrate polymers), designed to increase the solubility and stability of proteins; Expedeon Ltd., Cambridgeshire, United Kingdom), 0.01% Gelatin, 0.01% 0.2%, Pluronic F-127 (block copolymer from ethylenoxide and propyleneoxide), 1 mM DTT). After addition of 1.25 nM MDM2-biotinylated or 2.5 nM MDM4-biotinylated (internal preparations), and 0.625 nM Europium labeled streptavidin (Perkin Elmer), the solution is pre-incubated for 15 minutes at room temperature, then 10 nM Cy5-p53 peptide (internal preparation) is added before an incubation at room temperature for 15 minutes prior to reading the plate. For measurement of samples, a Victor II microplate reader (Perkin Elmer) is used with the following settings: Excitation 340 nm, Emission Donor 620 nm and Emission Acceptor 665 nm. For selected compounds displaying IC50s between 0.05 and 5 nM on MDM2, a slightly modified assay is used with the following adaptations: 0.1 nM MDM2, 0.1 nM Europium labeled streptavidin and Tecan genios Pro is used as a microplate reader for the fluorescence measurements (p53-MDM2 Assay 2).",B,,,BAO_0000190,BAO_0000224,protein format,CCn1c(-c2cnc(OC)nc2OC)cc2c1C(c1ccc(Cl)cc1)N(c1cc(Cl)ccc1C)C2=O,,,CHEMBL3886789,,2016,"{'bei': '13.48', 'le': '0.27', 'lle': '0.71', 'sei': '10.16'}",CHEMBL3901889,,CHEMBL3901889,7.06,False,http://www.openphacts.org/units/Nanomolar,2885895,=,37,True,=,,IC50,nM,,87.63,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,87.626
411678,17776494,[],CHEMBL3888635,"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: Assay 2: The test is performed in white 384-well plates (Greiner Bio-One, reference 781207) in a total volume of 60 L by adding 1 L of compounds tested at different concentrations diluted in 100% DMSO (1.7% final DMSO concentration) in reaction buffer (PBS, 125 mM NaCl, 0.001% Novexin (consists of carbohydrate polymers), designed to increase the solubility and stability of proteins; Expedeon Ltd., Cambridgeshire, United Kingdom), 0.01% Gelatin, 0.01% 0.2%, Pluronic F-127 (block copolymer from ethylenoxide and propyleneoxide), 1 mM DTT). After addition of 1.25 nM MDM2-biotinylated or 2.5 nM MDM4-biotinylated (internal preparations), and 0.625 nM Europium labeled streptavidin (Perkin Elmer), the solution is pre-incubated for 15 minutes at room temperature, then 10 nM Cy5-p53 peptide (internal preparation) is added before an incubation at room temperature for 15 minutes prior to reading the plate. For measurement of samples, a Victor II microplate reader (Perkin Elmer) is used with the following settings: Excitation 340 nm, Emission Donor 620 nm and Emission Acceptor 665 nm. For selected compounds displaying IC50s between 0.05 and 5 nM on MDM2, a slightly modified assay is used with the following adaptations: 0.1 nM MDM2, 0.1 nM Europium labeled streptavidin and Tecan genios Pro is used as a microplate reader for the fluorescence measurements (p53-MDM2 Assay 2).",B,,,BAO_0000190,BAO_0000224,protein format,COc1ccccc1-c1cc2c(n1C(C)C)C(c1ccc(Cl)cc1)N(c1cc(Cl)c(=O)n(C)c1)C2=O,,,CHEMBL3886789,,2016,"{'bei': '18.55', 'le': '0.37', 'lle': '3.19', 'sei': '17.16'}",CHEMBL3969509,,CHEMBL3969509,9.69,False,http://www.openphacts.org/units/Nanomolar,2885896,=,37,True,=,,IC50,nM,,0.203,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,0.203
411679,17776495,[],CHEMBL3888635,"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: Assay 2: The test is performed in white 384-well plates (Greiner Bio-One, reference 781207) in a total volume of 60 L by adding 1 L of compounds tested at different concentrations diluted in 100% DMSO (1.7% final DMSO concentration) in reaction buffer (PBS, 125 mM NaCl, 0.001% Novexin (consists of carbohydrate polymers), designed to increase the solubility and stability of proteins; Expedeon Ltd., Cambridgeshire, United Kingdom), 0.01% Gelatin, 0.01% 0.2%, Pluronic F-127 (block copolymer from ethylenoxide and propyleneoxide), 1 mM DTT). After addition of 1.25 nM MDM2-biotinylated or 2.5 nM MDM4-biotinylated (internal preparations), and 0.625 nM Europium labeled streptavidin (Perkin Elmer), the solution is pre-incubated for 15 minutes at room temperature, then 10 nM Cy5-p53 peptide (internal preparation) is added before an incubation at room temperature for 15 minutes prior to reading the plate. For measurement of samples, a Victor II microplate reader (Perkin Elmer) is used with the following settings: Excitation 340 nm, Emission Donor 620 nm and Emission Acceptor 665 nm. For selected compounds displaying IC50s between 0.05 and 5 nM on MDM2, a slightly modified assay is used with the following adaptations: 0.1 nM MDM2, 0.1 nM Europium labeled streptavidin and Tecan genios Pro is used as a microplate reader for the fluorescence measurements (p53-MDM2 Assay 2).",B,,,BAO_0000190,BAO_0000224,protein format,COc1ccc(C(=O)N2CCOCC2)cc1-c1cc2c(n1C(C)C)C(c1ccc(Cl)cc1)N(c1cc(Cl)c(=O)n(C)c1)C2=O,,,CHEMBL3886789,,2016,"{'bei': '15.46', 'le': '0.30', 'lle': '3.85', 'sei': '11.42'}",CHEMBL3901604,,CHEMBL3901604,9.82,False,http://www.openphacts.org/units/Nanomolar,2885897,=,37,True,=,,IC50,nM,,0.15,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,0.15
411680,17776496,[],CHEMBL3888635,"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: Assay 2: The test is performed in white 384-well plates (Greiner Bio-One, reference 781207) in a total volume of 60 L by adding 1 L of compounds tested at different concentrations diluted in 100% DMSO (1.7% final DMSO concentration) in reaction buffer (PBS, 125 mM NaCl, 0.001% Novexin (consists of carbohydrate polymers), designed to increase the solubility and stability of proteins; Expedeon Ltd., Cambridgeshire, United Kingdom), 0.01% Gelatin, 0.01% 0.2%, Pluronic F-127 (block copolymer from ethylenoxide and propyleneoxide), 1 mM DTT). After addition of 1.25 nM MDM2-biotinylated or 2.5 nM MDM4-biotinylated (internal preparations), and 0.625 nM Europium labeled streptavidin (Perkin Elmer), the solution is pre-incubated for 15 minutes at room temperature, then 10 nM Cy5-p53 peptide (internal preparation) is added before an incubation at room temperature for 15 minutes prior to reading the plate. For measurement of samples, a Victor II microplate reader (Perkin Elmer) is used with the following settings: Excitation 340 nm, Emission Donor 620 nm and Emission Acceptor 665 nm. For selected compounds displaying IC50s between 0.05 and 5 nM on MDM2, a slightly modified assay is used with the following adaptations: 0.1 nM MDM2, 0.1 nM Europium labeled streptavidin and Tecan genios Pro is used as a microplate reader for the fluorescence measurements (p53-MDM2 Assay 2).",B,,,BAO_0000190,BAO_0000224,protein format,COc1ncc(-c2cc3c(n2C(C)C)C(c2ccc(Cl)cc2)N(c2cc(Cl)c(=O)n(C)c2)C3=O)c(OC)n1,,,CHEMBL3886789,,2016,"{'bei': '17.54', 'le': '0.35', 'lle': '4.43', 'sei': '10.63'}",CHEMBL3926268,,CHEMBL3926268,9.73,False,http://www.openphacts.org/units/Nanomolar,2885898,=,37,True,=,,IC50,nM,,0.188,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,0.188
411681,17776497,[],CHEMBL3888635,"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: Assay 2: The test is performed in white 384-well plates (Greiner Bio-One, reference 781207) in a total volume of 60 L by adding 1 L of compounds tested at different concentrations diluted in 100% DMSO (1.7% final DMSO concentration) in reaction buffer (PBS, 125 mM NaCl, 0.001% Novexin (consists of carbohydrate polymers), designed to increase the solubility and stability of proteins; Expedeon Ltd., Cambridgeshire, United Kingdom), 0.01% Gelatin, 0.01% 0.2%, Pluronic F-127 (block copolymer from ethylenoxide and propyleneoxide), 1 mM DTT). After addition of 1.25 nM MDM2-biotinylated or 2.5 nM MDM4-biotinylated (internal preparations), and 0.625 nM Europium labeled streptavidin (Perkin Elmer), the solution is pre-incubated for 15 minutes at room temperature, then 10 nM Cy5-p53 peptide (internal preparation) is added before an incubation at room temperature for 15 minutes prior to reading the plate. For measurement of samples, a Victor II microplate reader (Perkin Elmer) is used with the following settings: Excitation 340 nm, Emission Donor 620 nm and Emission Acceptor 665 nm. For selected compounds displaying IC50s between 0.05 and 5 nM on MDM2, a slightly modified assay is used with the following adaptations: 0.1 nM MDM2, 0.1 nM Europium labeled streptavidin and Tecan genios Pro is used as a microplate reader for the fluorescence measurements (p53-MDM2 Assay 2).",B,,,BAO_0000190,BAO_0000224,protein format,CNC(=O)c1ccc(OC)c(-c2cc3c(n2C(C)C)C(c2ccc(Cl)cc2)N(c2cc(Cl)c(=O)n(C)c2)C3=O)c1,,,CHEMBL3886789,,2016,"{'bei': '17.02', 'le': '0.34', 'lle': '4.00', 'sei': '11.53'}",CHEMBL3916320,,CHEMBL3916320,9.86,False,http://www.openphacts.org/units/Nanomolar,2885899,=,37,True,=,,IC50,nM,,0.137,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,0.137
411682,17776498,[],CHEMBL3888635,"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: Assay 2: The test is performed in white 384-well plates (Greiner Bio-One, reference 781207) in a total volume of 60 L by adding 1 L of compounds tested at different concentrations diluted in 100% DMSO (1.7% final DMSO concentration) in reaction buffer (PBS, 125 mM NaCl, 0.001% Novexin (consists of carbohydrate polymers), designed to increase the solubility and stability of proteins; Expedeon Ltd., Cambridgeshire, United Kingdom), 0.01% Gelatin, 0.01% 0.2%, Pluronic F-127 (block copolymer from ethylenoxide and propyleneoxide), 1 mM DTT). After addition of 1.25 nM MDM2-biotinylated or 2.5 nM MDM4-biotinylated (internal preparations), and 0.625 nM Europium labeled streptavidin (Perkin Elmer), the solution is pre-incubated for 15 minutes at room temperature, then 10 nM Cy5-p53 peptide (internal preparation) is added before an incubation at room temperature for 15 minutes prior to reading the plate. For measurement of samples, a Victor II microplate reader (Perkin Elmer) is used with the following settings: Excitation 340 nm, Emission Donor 620 nm and Emission Acceptor 665 nm. For selected compounds displaying IC50s between 0.05 and 5 nM on MDM2, a slightly modified assay is used with the following adaptations: 0.1 nM MDM2, 0.1 nM Europium labeled streptavidin and Tecan genios Pro is used as a microplate reader for the fluorescence measurements (p53-MDM2 Assay 2).",B,,,BAO_0000190,BAO_0000224,protein format,COc1ccc(C(=O)O)cc1-c1cc2c(n1C(C)C)C(c1ccc(Cl)cc1)N(c1cc(Cl)c(=O)n(C)c1)C2=O,,,CHEMBL3886789,,2016,"{'bei': '17.00', 'le': '0.34', 'lle': '3.43', 'sei': '10.27'}",CHEMBL3903599,,CHEMBL3903599,9.63,False,http://www.openphacts.org/units/Nanomolar,2885900,=,37,True,=,,IC50,nM,,0.234,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,0.234
411683,17776499,[],CHEMBL3888635,"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: Assay 2: The test is performed in white 384-well plates (Greiner Bio-One, reference 781207) in a total volume of 60 L by adding 1 L of compounds tested at different concentrations diluted in 100% DMSO (1.7% final DMSO concentration) in reaction buffer (PBS, 125 mM NaCl, 0.001% Novexin (consists of carbohydrate polymers), designed to increase the solubility and stability of proteins; Expedeon Ltd., Cambridgeshire, United Kingdom), 0.01% Gelatin, 0.01% 0.2%, Pluronic F-127 (block copolymer from ethylenoxide and propyleneoxide), 1 mM DTT). After addition of 1.25 nM MDM2-biotinylated or 2.5 nM MDM4-biotinylated (internal preparations), and 0.625 nM Europium labeled streptavidin (Perkin Elmer), the solution is pre-incubated for 15 minutes at room temperature, then 10 nM Cy5-p53 peptide (internal preparation) is added before an incubation at room temperature for 15 minutes prior to reading the plate. For measurement of samples, a Victor II microplate reader (Perkin Elmer) is used with the following settings: Excitation 340 nm, Emission Donor 620 nm and Emission Acceptor 665 nm. For selected compounds displaying IC50s between 0.05 and 5 nM on MDM2, a slightly modified assay is used with the following adaptations: 0.1 nM MDM2, 0.1 nM Europium labeled streptavidin and Tecan genios Pro is used as a microplate reader for the fluorescence measurements (p53-MDM2 Assay 2).",B,,,BAO_0000190,BAO_0000224,protein format,COc1nc(N)ncc1-c1cc2c(n1C(C)C)C(c1ccc(Cl)cc1)N(c1cc(Cl)c(=O)n(C)c1)C2=O,,,CHEMBL3886789,,2016,"{'bei': '17.31', 'le': '0.34', 'lle': '4.47', 'sei': '8.62'}",CHEMBL3983005,,CHEMBL3983005,9.34,False,http://www.openphacts.org/units/Nanomolar,2885901,=,37,True,=,,IC50,nM,,0.461,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,0.461
411684,17776500,[],CHEMBL3888635,"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: Assay 2: The test is performed in white 384-well plates (Greiner Bio-One, reference 781207) in a total volume of 60 L by adding 1 L of compounds tested at different concentrations diluted in 100% DMSO (1.7% final DMSO concentration) in reaction buffer (PBS, 125 mM NaCl, 0.001% Novexin (consists of carbohydrate polymers), designed to increase the solubility and stability of proteins; Expedeon Ltd., Cambridgeshire, United Kingdom), 0.01% Gelatin, 0.01% 0.2%, Pluronic F-127 (block copolymer from ethylenoxide and propyleneoxide), 1 mM DTT). After addition of 1.25 nM MDM2-biotinylated or 2.5 nM MDM4-biotinylated (internal preparations), and 0.625 nM Europium labeled streptavidin (Perkin Elmer), the solution is pre-incubated for 15 minutes at room temperature, then 10 nM Cy5-p53 peptide (internal preparation) is added before an incubation at room temperature for 15 minutes prior to reading the plate. For measurement of samples, a Victor II microplate reader (Perkin Elmer) is used with the following settings: Excitation 340 nm, Emission Donor 620 nm and Emission Acceptor 665 nm. For selected compounds displaying IC50s between 0.05 and 5 nM on MDM2, a slightly modified assay is used with the following adaptations: 0.1 nM MDM2, 0.1 nM Europium labeled streptavidin and Tecan genios Pro is used as a microplate reader for the fluorescence measurements (p53-MDM2 Assay 2).",B,,,BAO_0000190,BAO_0000224,protein format,COc1nc(N(C)C)ncc1-c1cc2c(n1C(C)C)C(c1ccc(Cl)cc1)N(c1cc(Cl)c(=O)n(C)c1)C2=O,,,CHEMBL3886789,,2016,"{'bei': '17.38', 'le': '0.35', 'lle': '4.50', 'sei': '11.54'}",CHEMBL3954342,,CHEMBL3954342,9.86,False,http://www.openphacts.org/units/Nanomolar,2885902,=,37,True,=,,IC50,nM,,0.137,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,0.137
411685,17776501,[],CHEMBL3888635,"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: Assay 2: The test is performed in white 384-well plates (Greiner Bio-One, reference 781207) in a total volume of 60 L by adding 1 L of compounds tested at different concentrations diluted in 100% DMSO (1.7% final DMSO concentration) in reaction buffer (PBS, 125 mM NaCl, 0.001% Novexin (consists of carbohydrate polymers), designed to increase the solubility and stability of proteins; Expedeon Ltd., Cambridgeshire, United Kingdom), 0.01% Gelatin, 0.01% 0.2%, Pluronic F-127 (block copolymer from ethylenoxide and propyleneoxide), 1 mM DTT). After addition of 1.25 nM MDM2-biotinylated or 2.5 nM MDM4-biotinylated (internal preparations), and 0.625 nM Europium labeled streptavidin (Perkin Elmer), the solution is pre-incubated for 15 minutes at room temperature, then 10 nM Cy5-p53 peptide (internal preparation) is added before an incubation at room temperature for 15 minutes prior to reading the plate. For measurement of samples, a Victor II microplate reader (Perkin Elmer) is used with the following settings: Excitation 340 nm, Emission Donor 620 nm and Emission Acceptor 665 nm. For selected compounds displaying IC50s between 0.05 and 5 nM on MDM2, a slightly modified assay is used with the following adaptations: 0.1 nM MDM2, 0.1 nM Europium labeled streptavidin and Tecan genios Pro is used as a microplate reader for the fluorescence measurements (p53-MDM2 Assay 2).",B,,,BAO_0000190,BAO_0000224,protein format,CNC(=O)c1ccc(OC)c(-c2cc3c(n2C(C)C)C(c2ccc(Cl)cc2)N(c2ccc(F)c(Cl)c2)C3=O)c1,,,CHEMBL3886789,,2016,"{'bei': '16.75', 'le': '0.33', 'lle': '2.19', 'sei': '14.93'}",CHEMBL3902175,,CHEMBL3902175,9.49,False,http://www.openphacts.org/units/Nanomolar,2885903,=,37,True,=,,IC50,nM,,0.323,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,0.323
411686,17776502,[],CHEMBL3888635,"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: Assay 2: The test is performed in white 384-well plates (Greiner Bio-One, reference 781207) in a total volume of 60 L by adding 1 L of compounds tested at different concentrations diluted in 100% DMSO (1.7% final DMSO concentration) in reaction buffer (PBS, 125 mM NaCl, 0.001% Novexin (consists of carbohydrate polymers), designed to increase the solubility and stability of proteins; Expedeon Ltd., Cambridgeshire, United Kingdom), 0.01% Gelatin, 0.01% 0.2%, Pluronic F-127 (block copolymer from ethylenoxide and propyleneoxide), 1 mM DTT). After addition of 1.25 nM MDM2-biotinylated or 2.5 nM MDM4-biotinylated (internal preparations), and 0.625 nM Europium labeled streptavidin (Perkin Elmer), the solution is pre-incubated for 15 minutes at room temperature, then 10 nM Cy5-p53 peptide (internal preparation) is added before an incubation at room temperature for 15 minutes prior to reading the plate. For measurement of samples, a Victor II microplate reader (Perkin Elmer) is used with the following settings: Excitation 340 nm, Emission Donor 620 nm and Emission Acceptor 665 nm. For selected compounds displaying IC50s between 0.05 and 5 nM on MDM2, a slightly modified assay is used with the following adaptations: 0.1 nM MDM2, 0.1 nM Europium labeled streptavidin and Tecan genios Pro is used as a microplate reader for the fluorescence measurements (p53-MDM2 Assay 2).",B,,,BAO_0000190,BAO_0000224,protein format,COc1ncc(-c2cc3c(n2C(C)C)C(c2ccc(Cl)cc2)N(c2ccc(F)c(Cl)c2)C3=O)c(OC)n1,,,CHEMBL3886789,,2016,"{'bei': '17.68', 'le': '0.35', 'lle': '2.83', 'sei': '13.78'}",CHEMBL3900501,,CHEMBL3900501,9.57,False,http://www.openphacts.org/units/Nanomolar,2885904,=,37,True,=,,IC50,nM,,0.267,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,0.267
411687,17776503,[],CHEMBL3888635,"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: Assay 2: The test is performed in white 384-well plates (Greiner Bio-One, reference 781207) in a total volume of 60 L by adding 1 L of compounds tested at different concentrations diluted in 100% DMSO (1.7% final DMSO concentration) in reaction buffer (PBS, 125 mM NaCl, 0.001% Novexin (consists of carbohydrate polymers), designed to increase the solubility and stability of proteins; Expedeon Ltd., Cambridgeshire, United Kingdom), 0.01% Gelatin, 0.01% 0.2%, Pluronic F-127 (block copolymer from ethylenoxide and propyleneoxide), 1 mM DTT). After addition of 1.25 nM MDM2-biotinylated or 2.5 nM MDM4-biotinylated (internal preparations), and 0.625 nM Europium labeled streptavidin (Perkin Elmer), the solution is pre-incubated for 15 minutes at room temperature, then 10 nM Cy5-p53 peptide (internal preparation) is added before an incubation at room temperature for 15 minutes prior to reading the plate. For measurement of samples, a Victor II microplate reader (Perkin Elmer) is used with the following settings: Excitation 340 nm, Emission Donor 620 nm and Emission Acceptor 665 nm. For selected compounds displaying IC50s between 0.05 and 5 nM on MDM2, a slightly modified assay is used with the following adaptations: 0.1 nM MDM2, 0.1 nM Europium labeled streptavidin and Tecan genios Pro is used as a microplate reader for the fluorescence measurements (p53-MDM2 Assay 2).",B,,,BAO_0000190,BAO_0000224,protein format,COc1ccc(C(=O)N2CCOCC2)cc1-c1cc2c(n1C(C)C)C(c1ccc(Cl)cc1)N(c1ccc(F)c(Cl)c1)C2=O,,,CHEMBL3886789,,2016,"{'bei': '15.33', 'le': '0.30', 'lle': '2.13', 'sei': '14.91'}",CHEMBL3962088,,CHEMBL3962088,9.54,False,http://www.openphacts.org/units/Nanomolar,2885905,=,37,True,=,,IC50,nM,,0.287,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,0.287
411688,17776504,[],CHEMBL3888635,"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: Assay 2: The test is performed in white 384-well plates (Greiner Bio-One, reference 781207) in a total volume of 60 L by adding 1 L of compounds tested at different concentrations diluted in 100% DMSO (1.7% final DMSO concentration) in reaction buffer (PBS, 125 mM NaCl, 0.001% Novexin (consists of carbohydrate polymers), designed to increase the solubility and stability of proteins; Expedeon Ltd., Cambridgeshire, United Kingdom), 0.01% Gelatin, 0.01% 0.2%, Pluronic F-127 (block copolymer from ethylenoxide and propyleneoxide), 1 mM DTT). After addition of 1.25 nM MDM2-biotinylated or 2.5 nM MDM4-biotinylated (internal preparations), and 0.625 nM Europium labeled streptavidin (Perkin Elmer), the solution is pre-incubated for 15 minutes at room temperature, then 10 nM Cy5-p53 peptide (internal preparation) is added before an incubation at room temperature for 15 minutes prior to reading the plate. For measurement of samples, a Victor II microplate reader (Perkin Elmer) is used with the following settings: Excitation 340 nm, Emission Donor 620 nm and Emission Acceptor 665 nm. For selected compounds displaying IC50s between 0.05 and 5 nM on MDM2, a slightly modified assay is used with the following adaptations: 0.1 nM MDM2, 0.1 nM Europium labeled streptavidin and Tecan genios Pro is used as a microplate reader for the fluorescence measurements (p53-MDM2 Assay 2).",B,,,BAO_0000190,BAO_0000224,protein format,COc1ccc(C(=O)O)cc1-c1cc2c(n1C(C)C)C(c1ccc(Cl)cc1)N(c1ccc(F)c(Cl)c1)C2=O,,,CHEMBL3886789,,2016,"{'bei': '17.08', 'le': '0.34', 'lle': '1.81', 'sei': '13.17'}",CHEMBL3928665,,CHEMBL3928665,9.46,False,http://www.openphacts.org/units/Nanomolar,2885906,=,37,True,=,,IC50,nM,,0.351,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,0.351
411689,17776505,[],CHEMBL3888635,"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: Assay 2: The test is performed in white 384-well plates (Greiner Bio-One, reference 781207) in a total volume of 60 L by adding 1 L of compounds tested at different concentrations diluted in 100% DMSO (1.7% final DMSO concentration) in reaction buffer (PBS, 125 mM NaCl, 0.001% Novexin (consists of carbohydrate polymers), designed to increase the solubility and stability of proteins; Expedeon Ltd., Cambridgeshire, United Kingdom), 0.01% Gelatin, 0.01% 0.2%, Pluronic F-127 (block copolymer from ethylenoxide and propyleneoxide), 1 mM DTT). After addition of 1.25 nM MDM2-biotinylated or 2.5 nM MDM4-biotinylated (internal preparations), and 0.625 nM Europium labeled streptavidin (Perkin Elmer), the solution is pre-incubated for 15 minutes at room temperature, then 10 nM Cy5-p53 peptide (internal preparation) is added before an incubation at room temperature for 15 minutes prior to reading the plate. For measurement of samples, a Victor II microplate reader (Perkin Elmer) is used with the following settings: Excitation 340 nm, Emission Donor 620 nm and Emission Acceptor 665 nm. For selected compounds displaying IC50s between 0.05 and 5 nM on MDM2, a slightly modified assay is used with the following adaptations: 0.1 nM MDM2, 0.1 nM Europium labeled streptavidin and Tecan genios Pro is used as a microplate reader for the fluorescence measurements (p53-MDM2 Assay 2).",B,,,BAO_0000190,BAO_0000224,protein format,COc1nc(N(C)C)ncc1-c1cc2c(n1C(C)C)C(c1ccc(Cl)cc1)N(c1ccc(F)c(Cl)c1)C2=O,,,CHEMBL3886789,,2016,"{'bei': '16.84', 'le': '0.34', 'lle': '2.54', 'sei': '14.71'}",CHEMBL3932419,,CHEMBL3932419,9.34,False,http://www.openphacts.org/units/Nanomolar,2885907,=,37,True,=,,IC50,nM,,0.458,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,0.458
411690,17776506,[],CHEMBL3888635,"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: Assay 2: The test is performed in white 384-well plates (Greiner Bio-One, reference 781207) in a total volume of 60 L by adding 1 L of compounds tested at different concentrations diluted in 100% DMSO (1.7% final DMSO concentration) in reaction buffer (PBS, 125 mM NaCl, 0.001% Novexin (consists of carbohydrate polymers), designed to increase the solubility and stability of proteins; Expedeon Ltd., Cambridgeshire, United Kingdom), 0.01% Gelatin, 0.01% 0.2%, Pluronic F-127 (block copolymer from ethylenoxide and propyleneoxide), 1 mM DTT). After addition of 1.25 nM MDM2-biotinylated or 2.5 nM MDM4-biotinylated (internal preparations), and 0.625 nM Europium labeled streptavidin (Perkin Elmer), the solution is pre-incubated for 15 minutes at room temperature, then 10 nM Cy5-p53 peptide (internal preparation) is added before an incubation at room temperature for 15 minutes prior to reading the plate. For measurement of samples, a Victor II microplate reader (Perkin Elmer) is used with the following settings: Excitation 340 nm, Emission Donor 620 nm and Emission Acceptor 665 nm. For selected compounds displaying IC50s between 0.05 and 5 nM on MDM2, a slightly modified assay is used with the following adaptations: 0.1 nM MDM2, 0.1 nM Europium labeled streptavidin and Tecan genios Pro is used as a microplate reader for the fluorescence measurements (p53-MDM2 Assay 2).",B,,,BAO_0000190,BAO_0000224,protein format,COc1ccccc1-c1c(C#N)c2c(n1C(C)C)C(c1ccc(Cl)cc1)N(c1cc(Cl)ccc1C)C2=O,,,CHEMBL3886789,,2016,"{'bei': '18.45', 'le': '0.36', 'lle': '1.81', 'sei': '16.80'}",CHEMBL3907629,,CHEMBL3907629,9.79,False,http://www.openphacts.org/units/Nanomolar,2885908,=,37,True,=,,IC50,nM,,0.163,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,0.163
411691,17776507,[],CHEMBL3888635,"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: Assay 2: The test is performed in white 384-well plates (Greiner Bio-One, reference 781207) in a total volume of 60 L by adding 1 L of compounds tested at different concentrations diluted in 100% DMSO (1.7% final DMSO concentration) in reaction buffer (PBS, 125 mM NaCl, 0.001% Novexin (consists of carbohydrate polymers), designed to increase the solubility and stability of proteins; Expedeon Ltd., Cambridgeshire, United Kingdom), 0.01% Gelatin, 0.01% 0.2%, Pluronic F-127 (block copolymer from ethylenoxide and propyleneoxide), 1 mM DTT). After addition of 1.25 nM MDM2-biotinylated or 2.5 nM MDM4-biotinylated (internal preparations), and 0.625 nM Europium labeled streptavidin (Perkin Elmer), the solution is pre-incubated for 15 minutes at room temperature, then 10 nM Cy5-p53 peptide (internal preparation) is added before an incubation at room temperature for 15 minutes prior to reading the plate. For measurement of samples, a Victor II microplate reader (Perkin Elmer) is used with the following settings: Excitation 340 nm, Emission Donor 620 nm and Emission Acceptor 665 nm. For selected compounds displaying IC50s between 0.05 and 5 nM on MDM2, a slightly modified assay is used with the following adaptations: 0.1 nM MDM2, 0.1 nM Europium labeled streptavidin and Tecan genios Pro is used as a microplate reader for the fluorescence measurements (p53-MDM2 Assay 2).",B,,,BAO_0000190,BAO_0000224,protein format,COc1ccc(CC(=O)O)cc1-c1cc2c(n1C(C)C)C(c1ccc(Cl)cc1)N(c1cc(Cl)ccc1C)C2=O,,,CHEMBL3886789,,2016,"{'bei': '17.41', 'le': '0.34', 'lle': '2.07', 'sei': '13.67'}",CHEMBL3978167,,CHEMBL3978167,9.81,False,http://www.openphacts.org/units/Nanomolar,2885909,=,37,True,=,,IC50,nM,,0.155,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,0.155
411692,17776508,[],CHEMBL3888635,"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: Assay 2: The test is performed in white 384-well plates (Greiner Bio-One, reference 781207) in a total volume of 60 L by adding 1 L of compounds tested at different concentrations diluted in 100% DMSO (1.7% final DMSO concentration) in reaction buffer (PBS, 125 mM NaCl, 0.001% Novexin (consists of carbohydrate polymers), designed to increase the solubility and stability of proteins; Expedeon Ltd., Cambridgeshire, United Kingdom), 0.01% Gelatin, 0.01% 0.2%, Pluronic F-127 (block copolymer from ethylenoxide and propyleneoxide), 1 mM DTT). After addition of 1.25 nM MDM2-biotinylated or 2.5 nM MDM4-biotinylated (internal preparations), and 0.625 nM Europium labeled streptavidin (Perkin Elmer), the solution is pre-incubated for 15 minutes at room temperature, then 10 nM Cy5-p53 peptide (internal preparation) is added before an incubation at room temperature for 15 minutes prior to reading the plate. For measurement of samples, a Victor II microplate reader (Perkin Elmer) is used with the following settings: Excitation 340 nm, Emission Donor 620 nm and Emission Acceptor 665 nm. For selected compounds displaying IC50s between 0.05 and 5 nM on MDM2, a slightly modified assay is used with the following adaptations: 0.1 nM MDM2, 0.1 nM Europium labeled streptavidin and Tecan genios Pro is used as a microplate reader for the fluorescence measurements (p53-MDM2 Assay 2).",B,,,BAO_0000190,BAO_0000224,protein format,COc1ccc(C(N)=O)cc1-c1cc2c(n1C(C)C)C(c1ccc(Cl)cc1)N(c1cc(Cl)ccc1C)C2=O,,,CHEMBL3886789,,2016,"{'bei': '18.20', 'le': '0.36', 'lle': '2.77', 'sei': '12.87'}",CHEMBL3935668,,CHEMBL3935668,9.98,False,http://www.openphacts.org/units/Nanomolar,2885910,=,37,True,=,,IC50,nM,,0.104,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,0.104
411693,17776509,[],CHEMBL3888635,"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: Assay 2: The test is performed in white 384-well plates (Greiner Bio-One, reference 781207) in a total volume of 60 L by adding 1 L of compounds tested at different concentrations diluted in 100% DMSO (1.7% final DMSO concentration) in reaction buffer (PBS, 125 mM NaCl, 0.001% Novexin (consists of carbohydrate polymers), designed to increase the solubility and stability of proteins; Expedeon Ltd., Cambridgeshire, United Kingdom), 0.01% Gelatin, 0.01% 0.2%, Pluronic F-127 (block copolymer from ethylenoxide and propyleneoxide), 1 mM DTT). After addition of 1.25 nM MDM2-biotinylated or 2.5 nM MDM4-biotinylated (internal preparations), and 0.625 nM Europium labeled streptavidin (Perkin Elmer), the solution is pre-incubated for 15 minutes at room temperature, then 10 nM Cy5-p53 peptide (internal preparation) is added before an incubation at room temperature for 15 minutes prior to reading the plate. For measurement of samples, a Victor II microplate reader (Perkin Elmer) is used with the following settings: Excitation 340 nm, Emission Donor 620 nm and Emission Acceptor 665 nm. For selected compounds displaying IC50s between 0.05 and 5 nM on MDM2, a slightly modified assay is used with the following adaptations: 0.1 nM MDM2, 0.1 nM Europium labeled streptavidin and Tecan genios Pro is used as a microplate reader for the fluorescence measurements (p53-MDM2 Assay 2).",B,,,BAO_0000190,BAO_0000224,protein format,CNS(=O)(=O)c1ccc(OC)c(-c2cc3c(n2C(C)C)C(c2ccc(Cl)cc2)N(c2cc(Cl)ccc2C)C3=O)c1,,,CHEMBL3886789,,2016,"{'bei': '16.33', 'le': '0.33', 'lle': '2.75', 'sei': '12.12'}",CHEMBL3904160,,CHEMBL3904160,9.77,False,http://www.openphacts.org/units/Nanomolar,2885911,=,37,True,=,,IC50,nM,,0.169,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,0.169
411694,17776510,[],CHEMBL3888635,"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: Assay 2: The test is performed in white 384-well plates (Greiner Bio-One, reference 781207) in a total volume of 60 L by adding 1 L of compounds tested at different concentrations diluted in 100% DMSO (1.7% final DMSO concentration) in reaction buffer (PBS, 125 mM NaCl, 0.001% Novexin (consists of carbohydrate polymers), designed to increase the solubility and stability of proteins; Expedeon Ltd., Cambridgeshire, United Kingdom), 0.01% Gelatin, 0.01% 0.2%, Pluronic F-127 (block copolymer from ethylenoxide and propyleneoxide), 1 mM DTT). After addition of 1.25 nM MDM2-biotinylated or 2.5 nM MDM4-biotinylated (internal preparations), and 0.625 nM Europium labeled streptavidin (Perkin Elmer), the solution is pre-incubated for 15 minutes at room temperature, then 10 nM Cy5-p53 peptide (internal preparation) is added before an incubation at room temperature for 15 minutes prior to reading the plate. For measurement of samples, a Victor II microplate reader (Perkin Elmer) is used with the following settings: Excitation 340 nm, Emission Donor 620 nm and Emission Acceptor 665 nm. For selected compounds displaying IC50s between 0.05 and 5 nM on MDM2, a slightly modified assay is used with the following adaptations: 0.1 nM MDM2, 0.1 nM Europium labeled streptavidin and Tecan genios Pro is used as a microplate reader for the fluorescence measurements (p53-MDM2 Assay 2).",B,,,BAO_0000190,BAO_0000224,protein format,COc1ccccc1-c1cc2c(n1C(C)C)C(c1ccc(Cl)cc1)N([C@H]1CC[C@H](O)CC1)C2=O,,,CHEMBL3886789,,2016,"{'bei': '16.89', 'le': '0.32', 'lle': '1.84', 'sei': '14.79'}",CHEMBL3979783,,CHEMBL3979783,8.09,False,http://www.openphacts.org/units/Nanomolar,2885912,=,37,True,=,,IC50,nM,,8.132,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,8.132
411695,17776511,[],CHEMBL3888635,"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: Assay 2: The test is performed in white 384-well plates (Greiner Bio-One, reference 781207) in a total volume of 60 L by adding 1 L of compounds tested at different concentrations diluted in 100% DMSO (1.7% final DMSO concentration) in reaction buffer (PBS, 125 mM NaCl, 0.001% Novexin (consists of carbohydrate polymers), designed to increase the solubility and stability of proteins; Expedeon Ltd., Cambridgeshire, United Kingdom), 0.01% Gelatin, 0.01% 0.2%, Pluronic F-127 (block copolymer from ethylenoxide and propyleneoxide), 1 mM DTT). After addition of 1.25 nM MDM2-biotinylated or 2.5 nM MDM4-biotinylated (internal preparations), and 0.625 nM Europium labeled streptavidin (Perkin Elmer), the solution is pre-incubated for 15 minutes at room temperature, then 10 nM Cy5-p53 peptide (internal preparation) is added before an incubation at room temperature for 15 minutes prior to reading the plate. For measurement of samples, a Victor II microplate reader (Perkin Elmer) is used with the following settings: Excitation 340 nm, Emission Donor 620 nm and Emission Acceptor 665 nm. For selected compounds displaying IC50s between 0.05 and 5 nM on MDM2, a slightly modified assay is used with the following adaptations: 0.1 nM MDM2, 0.1 nM Europium labeled streptavidin and Tecan genios Pro is used as a microplate reader for the fluorescence measurements (p53-MDM2 Assay 2).",B,,,BAO_0000190,BAO_0000224,protein format,CNC(=O)c1ccc(OC)c(-c2cc3c(n2C(C)C)C(c2ccc(Cl)cc2)N([C@H]2CC[C@H](O)CC2)C3=O)c1,,,CHEMBL3886789,,2016,"{'bei': '16.79', 'le': '0.32', 'lle': '3.39', 'sei': '10.74'}",CHEMBL3912203,,CHEMBL3912203,9.00,False,http://www.openphacts.org/units/Nanomolar,2885913,=,37,True,=,,IC50,nM,,1.001,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,1.001
411696,17776512,[],CHEMBL3888635,"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: Assay 2: The test is performed in white 384-well plates (Greiner Bio-One, reference 781207) in a total volume of 60 L by adding 1 L of compounds tested at different concentrations diluted in 100% DMSO (1.7% final DMSO concentration) in reaction buffer (PBS, 125 mM NaCl, 0.001% Novexin (consists of carbohydrate polymers), designed to increase the solubility and stability of proteins; Expedeon Ltd., Cambridgeshire, United Kingdom), 0.01% Gelatin, 0.01% 0.2%, Pluronic F-127 (block copolymer from ethylenoxide and propyleneoxide), 1 mM DTT). After addition of 1.25 nM MDM2-biotinylated or 2.5 nM MDM4-biotinylated (internal preparations), and 0.625 nM Europium labeled streptavidin (Perkin Elmer), the solution is pre-incubated for 15 minutes at room temperature, then 10 nM Cy5-p53 peptide (internal preparation) is added before an incubation at room temperature for 15 minutes prior to reading the plate. For measurement of samples, a Victor II microplate reader (Perkin Elmer) is used with the following settings: Excitation 340 nm, Emission Donor 620 nm and Emission Acceptor 665 nm. For selected compounds displaying IC50s between 0.05 and 5 nM on MDM2, a slightly modified assay is used with the following adaptations: 0.1 nM MDM2, 0.1 nM Europium labeled streptavidin and Tecan genios Pro is used as a microplate reader for the fluorescence measurements (p53-MDM2 Assay 2).",B,,,BAO_0000190,BAO_0000224,protein format,COc1ccc(C(=O)O)cc1-c1cc2c(n1C(C)C)C(c1ccc(Cl)cc1)N([C@H]1CC[C@H](O)CC1)C2=O,,,CHEMBL3886789,,2016,"{'bei': '15.89', 'le': '0.31', 'lle': '2.37', 'sei': '9.03'}",CHEMBL3894034,,CHEMBL3894034,8.31,False,http://www.openphacts.org/units/Nanomolar,2885845,=,37,True,=,,IC50,nM,,4.907,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,4.907
411697,17776513,[],CHEMBL3888635,"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: Assay 2: The test is performed in white 384-well plates (Greiner Bio-One, reference 781207) in a total volume of 60 L by adding 1 L of compounds tested at different concentrations diluted in 100% DMSO (1.7% final DMSO concentration) in reaction buffer (PBS, 125 mM NaCl, 0.001% Novexin (consists of carbohydrate polymers), designed to increase the solubility and stability of proteins; Expedeon Ltd., Cambridgeshire, United Kingdom), 0.01% Gelatin, 0.01% 0.2%, Pluronic F-127 (block copolymer from ethylenoxide and propyleneoxide), 1 mM DTT). After addition of 1.25 nM MDM2-biotinylated or 2.5 nM MDM4-biotinylated (internal preparations), and 0.625 nM Europium labeled streptavidin (Perkin Elmer), the solution is pre-incubated for 15 minutes at room temperature, then 10 nM Cy5-p53 peptide (internal preparation) is added before an incubation at room temperature for 15 minutes prior to reading the plate. For measurement of samples, a Victor II microplate reader (Perkin Elmer) is used with the following settings: Excitation 340 nm, Emission Donor 620 nm and Emission Acceptor 665 nm. For selected compounds displaying IC50s between 0.05 and 5 nM on MDM2, a slightly modified assay is used with the following adaptations: 0.1 nM MDM2, 0.1 nM Europium labeled streptavidin and Tecan genios Pro is used as a microplate reader for the fluorescence measurements (p53-MDM2 Assay 2).",B,,,BAO_0000190,BAO_0000224,protein format,COc1ncc(-c2cc3c(n2C(C)C)C(c2ccc(Cl)cc2)N([C@H]2CC[C@H](O)CC2)C3=O)c(OC)n1,,,CHEMBL3886789,,2016,"{'bei': '17.34', 'le': '0.34', 'lle': '3.81', 'sei': '9.87'}",CHEMBL3967624,,CHEMBL3967624,8.86,False,http://www.openphacts.org/units/Nanomolar,2885914,=,37,True,=,,IC50,nM,,1.385,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,1.385
411698,17776514,[],CHEMBL3888635,"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: Assay 2: The test is performed in white 384-well plates (Greiner Bio-One, reference 781207) in a total volume of 60 L by adding 1 L of compounds tested at different concentrations diluted in 100% DMSO (1.7% final DMSO concentration) in reaction buffer (PBS, 125 mM NaCl, 0.001% Novexin (consists of carbohydrate polymers), designed to increase the solubility and stability of proteins; Expedeon Ltd., Cambridgeshire, United Kingdom), 0.01% Gelatin, 0.01% 0.2%, Pluronic F-127 (block copolymer from ethylenoxide and propyleneoxide), 1 mM DTT). After addition of 1.25 nM MDM2-biotinylated or 2.5 nM MDM4-biotinylated (internal preparations), and 0.625 nM Europium labeled streptavidin (Perkin Elmer), the solution is pre-incubated for 15 minutes at room temperature, then 10 nM Cy5-p53 peptide (internal preparation) is added before an incubation at room temperature for 15 minutes prior to reading the plate. For measurement of samples, a Victor II microplate reader (Perkin Elmer) is used with the following settings: Excitation 340 nm, Emission Donor 620 nm and Emission Acceptor 665 nm. For selected compounds displaying IC50s between 0.05 and 5 nM on MDM2, a slightly modified assay is used with the following adaptations: 0.1 nM MDM2, 0.1 nM Europium labeled streptavidin and Tecan genios Pro is used as a microplate reader for the fluorescence measurements (p53-MDM2 Assay 2).",B,,,BAO_0000190,BAO_0000224,protein format,COc1ccc(C#N)cc1-c1cc2c(n1C(C)C)C(c1ccc(Cl)cc1)N([C@H]1CC[C@H](O)CC1)C2=O,,,CHEMBL3886789,,2016,"{'bei': '17.07', 'le': '0.33', 'lle': '2.48', 'sei': '10.96'}",CHEMBL3966414,,CHEMBL3966414,8.60,False,http://www.openphacts.org/units/Nanomolar,2885915,=,37,True,=,,IC50,nM,,2.486,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,2.486
411699,17776515,[],CHEMBL3888635,"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: Assay 2: The test is performed in white 384-well plates (Greiner Bio-One, reference 781207) in a total volume of 60 L by adding 1 L of compounds tested at different concentrations diluted in 100% DMSO (1.7% final DMSO concentration) in reaction buffer (PBS, 125 mM NaCl, 0.001% Novexin (consists of carbohydrate polymers), designed to increase the solubility and stability of proteins; Expedeon Ltd., Cambridgeshire, United Kingdom), 0.01% Gelatin, 0.01% 0.2%, Pluronic F-127 (block copolymer from ethylenoxide and propyleneoxide), 1 mM DTT). After addition of 1.25 nM MDM2-biotinylated or 2.5 nM MDM4-biotinylated (internal preparations), and 0.625 nM Europium labeled streptavidin (Perkin Elmer), the solution is pre-incubated for 15 minutes at room temperature, then 10 nM Cy5-p53 peptide (internal preparation) is added before an incubation at room temperature for 15 minutes prior to reading the plate. For measurement of samples, a Victor II microplate reader (Perkin Elmer) is used with the following settings: Excitation 340 nm, Emission Donor 620 nm and Emission Acceptor 665 nm. For selected compounds displaying IC50s between 0.05 and 5 nM on MDM2, a slightly modified assay is used with the following adaptations: 0.1 nM MDM2, 0.1 nM Europium labeled streptavidin and Tecan genios Pro is used as a microplate reader for the fluorescence measurements (p53-MDM2 Assay 2).",B,,,BAO_0000190,BAO_0000224,protein format,COc1nc(N)ncc1-c1cc2c(n1C(C)C)C(c1ccc(Cl)cc1)N([C@H]1CC[C@H](O)CC1)C2=O,,,CHEMBL3886789,,2016,"{'bei': '15.82', 'le': '0.31', 'lle': '3.23', 'sei': '7.37'}",CHEMBL3895110,,CHEMBL3895110,7.85,False,http://www.openphacts.org/units/Nanomolar,2885846,=,37,True,=,,IC50,nM,,14.17,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,14.168
411700,17776516,[],CHEMBL3888635,"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: Assay 2: The test is performed in white 384-well plates (Greiner Bio-One, reference 781207) in a total volume of 60 L by adding 1 L of compounds tested at different concentrations diluted in 100% DMSO (1.7% final DMSO concentration) in reaction buffer (PBS, 125 mM NaCl, 0.001% Novexin (consists of carbohydrate polymers), designed to increase the solubility and stability of proteins; Expedeon Ltd., Cambridgeshire, United Kingdom), 0.01% Gelatin, 0.01% 0.2%, Pluronic F-127 (block copolymer from ethylenoxide and propyleneoxide), 1 mM DTT). After addition of 1.25 nM MDM2-biotinylated or 2.5 nM MDM4-biotinylated (internal preparations), and 0.625 nM Europium labeled streptavidin (Perkin Elmer), the solution is pre-incubated for 15 minutes at room temperature, then 10 nM Cy5-p53 peptide (internal preparation) is added before an incubation at room temperature for 15 minutes prior to reading the plate. For measurement of samples, a Victor II microplate reader (Perkin Elmer) is used with the following settings: Excitation 340 nm, Emission Donor 620 nm and Emission Acceptor 665 nm. For selected compounds displaying IC50s between 0.05 and 5 nM on MDM2, a slightly modified assay is used with the following adaptations: 0.1 nM MDM2, 0.1 nM Europium labeled streptavidin and Tecan genios Pro is used as a microplate reader for the fluorescence measurements (p53-MDM2 Assay 2).",B,,,BAO_0000190,BAO_0000224,protein format,COc1nc(N(C)C)ncc1-c1cc2c(n1C(C)C)C(c1ccc(Cl)cc1)N([C@H]1CC[C@H](O)CC1)C2=O,,,CHEMBL3886789,,2016,"{'bei': '17.38', 'le': '0.34', 'lle': '4.01', 'sei': '10.88'}",CHEMBL3983285,,CHEMBL3983285,9.11,False,http://www.openphacts.org/units/Nanomolar,2885916,=,37,True,=,,IC50,nM,,0.777,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,0.777
411701,17776517,[],CHEMBL3888635,"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: Assay 2: The test is performed in white 384-well plates (Greiner Bio-One, reference 781207) in a total volume of 60 L by adding 1 L of compounds tested at different concentrations diluted in 100% DMSO (1.7% final DMSO concentration) in reaction buffer (PBS, 125 mM NaCl, 0.001% Novexin (consists of carbohydrate polymers), designed to increase the solubility and stability of proteins; Expedeon Ltd., Cambridgeshire, United Kingdom), 0.01% Gelatin, 0.01% 0.2%, Pluronic F-127 (block copolymer from ethylenoxide and propyleneoxide), 1 mM DTT). After addition of 1.25 nM MDM2-biotinylated or 2.5 nM MDM4-biotinylated (internal preparations), and 0.625 nM Europium labeled streptavidin (Perkin Elmer), the solution is pre-incubated for 15 minutes at room temperature, then 10 nM Cy5-p53 peptide (internal preparation) is added before an incubation at room temperature for 15 minutes prior to reading the plate. For measurement of samples, a Victor II microplate reader (Perkin Elmer) is used with the following settings: Excitation 340 nm, Emission Donor 620 nm and Emission Acceptor 665 nm. For selected compounds displaying IC50s between 0.05 and 5 nM on MDM2, a slightly modified assay is used with the following adaptations: 0.1 nM MDM2, 0.1 nM Europium labeled streptavidin and Tecan genios Pro is used as a microplate reader for the fluorescence measurements (p53-MDM2 Assay 2).",B,,,BAO_0000190,BAO_0000224,protein format,COc1ncc(-c2cc3c(n2C(C)C)C(c2ccc(Cl)cc2)N(c2cc(Cl)cn(C)c2=O)C3=O)c(OC)n1,,,CHEMBL3886789,,2016,"{'bei': '17.37', 'le': '0.35', 'lle': '4.33', 'sei': '10.53'}",CHEMBL3964492,,CHEMBL3964492,9.63,False,http://www.openphacts.org/units/Nanomolar,2885917,=,37,True,=,,IC50,nM,,0.235,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,0.235
411702,17776518,[],CHEMBL3888635,"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: Assay 2: The test is performed in white 384-well plates (Greiner Bio-One, reference 781207) in a total volume of 60 L by adding 1 L of compounds tested at different concentrations diluted in 100% DMSO (1.7% final DMSO concentration) in reaction buffer (PBS, 125 mM NaCl, 0.001% Novexin (consists of carbohydrate polymers), designed to increase the solubility and stability of proteins; Expedeon Ltd., Cambridgeshire, United Kingdom), 0.01% Gelatin, 0.01% 0.2%, Pluronic F-127 (block copolymer from ethylenoxide and propyleneoxide), 1 mM DTT). After addition of 1.25 nM MDM2-biotinylated or 2.5 nM MDM4-biotinylated (internal preparations), and 0.625 nM Europium labeled streptavidin (Perkin Elmer), the solution is pre-incubated for 15 minutes at room temperature, then 10 nM Cy5-p53 peptide (internal preparation) is added before an incubation at room temperature for 15 minutes prior to reading the plate. For measurement of samples, a Victor II microplate reader (Perkin Elmer) is used with the following settings: Excitation 340 nm, Emission Donor 620 nm and Emission Acceptor 665 nm. For selected compounds displaying IC50s between 0.05 and 5 nM on MDM2, a slightly modified assay is used with the following adaptations: 0.1 nM MDM2, 0.1 nM Europium labeled streptavidin and Tecan genios Pro is used as a microplate reader for the fluorescence measurements (p53-MDM2 Assay 2).",B,,,BAO_0000190,BAO_0000224,protein format,COc1nc(N)ncc1-c1cc2c(n1C(C)C)C(c1ccc(Cl)cc1)N(c1cc(Cl)cn(C)c1=O)C2=O,,,CHEMBL3886789,,2016,"{'bei': '17.05', 'le': '0.34', 'lle': '4.33', 'sei': '8.49'}",CHEMBL3942945,,CHEMBL3942945,9.20,False,http://www.openphacts.org/units/Nanomolar,2885918,=,37,True,=,,IC50,nM,,0.635,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,0.635
411703,17776519,[],CHEMBL3888635,"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: Assay 2: The test is performed in white 384-well plates (Greiner Bio-One, reference 781207) in a total volume of 60 L by adding 1 L of compounds tested at different concentrations diluted in 100% DMSO (1.7% final DMSO concentration) in reaction buffer (PBS, 125 mM NaCl, 0.001% Novexin (consists of carbohydrate polymers), designed to increase the solubility and stability of proteins; Expedeon Ltd., Cambridgeshire, United Kingdom), 0.01% Gelatin, 0.01% 0.2%, Pluronic F-127 (block copolymer from ethylenoxide and propyleneoxide), 1 mM DTT). After addition of 1.25 nM MDM2-biotinylated or 2.5 nM MDM4-biotinylated (internal preparations), and 0.625 nM Europium labeled streptavidin (Perkin Elmer), the solution is pre-incubated for 15 minutes at room temperature, then 10 nM Cy5-p53 peptide (internal preparation) is added before an incubation at room temperature for 15 minutes prior to reading the plate. For measurement of samples, a Victor II microplate reader (Perkin Elmer) is used with the following settings: Excitation 340 nm, Emission Donor 620 nm and Emission Acceptor 665 nm. For selected compounds displaying IC50s between 0.05 and 5 nM on MDM2, a slightly modified assay is used with the following adaptations: 0.1 nM MDM2, 0.1 nM Europium labeled streptavidin and Tecan genios Pro is used as a microplate reader for the fluorescence measurements (p53-MDM2 Assay 2).",B,,,BAO_0000190,BAO_0000224,protein format,CNc1ncc(-c2cc3c(n2C(C)C)C(c2ccc(Cl)cc2)N(c2cc(Cl)cn(C)c2=O)C3=O)c(OC)n1,,,CHEMBL3886789,,2016,"{'bei': '17.22', 'le': '0.34', 'lle': '4.20', 'sei': '10.11'}",CHEMBL3962264,,CHEMBL3962264,9.53,False,http://www.openphacts.org/units/Nanomolar,2885919,=,37,True,=,,IC50,nM,,0.295,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,0.295
411704,17776520,[],CHEMBL3888635,"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: Assay 2: The test is performed in white 384-well plates (Greiner Bio-One, reference 781207) in a total volume of 60 L by adding 1 L of compounds tested at different concentrations diluted in 100% DMSO (1.7% final DMSO concentration) in reaction buffer (PBS, 125 mM NaCl, 0.001% Novexin (consists of carbohydrate polymers), designed to increase the solubility and stability of proteins; Expedeon Ltd., Cambridgeshire, United Kingdom), 0.01% Gelatin, 0.01% 0.2%, Pluronic F-127 (block copolymer from ethylenoxide and propyleneoxide), 1 mM DTT). After addition of 1.25 nM MDM2-biotinylated or 2.5 nM MDM4-biotinylated (internal preparations), and 0.625 nM Europium labeled streptavidin (Perkin Elmer), the solution is pre-incubated for 15 minutes at room temperature, then 10 nM Cy5-p53 peptide (internal preparation) is added before an incubation at room temperature for 15 minutes prior to reading the plate. For measurement of samples, a Victor II microplate reader (Perkin Elmer) is used with the following settings: Excitation 340 nm, Emission Donor 620 nm and Emission Acceptor 665 nm. For selected compounds displaying IC50s between 0.05 and 5 nM on MDM2, a slightly modified assay is used with the following adaptations: 0.1 nM MDM2, 0.1 nM Europium labeled streptavidin and Tecan genios Pro is used as a microplate reader for the fluorescence measurements (p53-MDM2 Assay 2).",B,,,BAO_0000190,BAO_0000224,protein format,COc1nc(N(C)C)ncc1-c1cc2c(n1C(C)C)C(c1ccc(Cl)cc1)N(c1cc(Cl)cn(C)c1=O)C2=O,,,CHEMBL3886789,,2016,"{'bei': '17.26', 'le': '0.34', 'lle': '4.43', 'sei': '11.46'}",CHEMBL3911216,,CHEMBL3911216,9.79,False,http://www.openphacts.org/units/Nanomolar,2885920,=,37,True,=,,IC50,nM,,0.161,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,0.161
411705,17776521,[],CHEMBL3888635,"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: Assay 2: The test is performed in white 384-well plates (Greiner Bio-One, reference 781207) in a total volume of 60 L by adding 1 L of compounds tested at different concentrations diluted in 100% DMSO (1.7% final DMSO concentration) in reaction buffer (PBS, 125 mM NaCl, 0.001% Novexin (consists of carbohydrate polymers), designed to increase the solubility and stability of proteins; Expedeon Ltd., Cambridgeshire, United Kingdom), 0.01% Gelatin, 0.01% 0.2%, Pluronic F-127 (block copolymer from ethylenoxide and propyleneoxide), 1 mM DTT). After addition of 1.25 nM MDM2-biotinylated or 2.5 nM MDM4-biotinylated (internal preparations), and 0.625 nM Europium labeled streptavidin (Perkin Elmer), the solution is pre-incubated for 15 minutes at room temperature, then 10 nM Cy5-p53 peptide (internal preparation) is added before an incubation at room temperature for 15 minutes prior to reading the plate. For measurement of samples, a Victor II microplate reader (Perkin Elmer) is used with the following settings: Excitation 340 nm, Emission Donor 620 nm and Emission Acceptor 665 nm. For selected compounds displaying IC50s between 0.05 and 5 nM on MDM2, a slightly modified assay is used with the following adaptations: 0.1 nM MDM2, 0.1 nM Europium labeled streptavidin and Tecan genios Pro is used as a microplate reader for the fluorescence measurements (p53-MDM2 Assay 2).",B,,,BAO_0000190,BAO_0000224,protein format,COc1ccccc1-c1cc2c(n1C(C)C)C(c1ccc(Cl)cc1)N(C1CCOCC1)C2=O,,,CHEMBL3886789,,2016,"{'bei': '18.48', 'le': '0.36', 'lle': '2.47', 'sei': '19.66'}",CHEMBL3981229,,CHEMBL3981229,8.59,False,http://www.openphacts.org/units/Nanomolar,2885921,=,37,True,=,,IC50,nM,,2.566,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,2.566
411706,17776522,[],CHEMBL3888635,"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: Assay 2: The test is performed in white 384-well plates (Greiner Bio-One, reference 781207) in a total volume of 60 L by adding 1 L of compounds tested at different concentrations diluted in 100% DMSO (1.7% final DMSO concentration) in reaction buffer (PBS, 125 mM NaCl, 0.001% Novexin (consists of carbohydrate polymers), designed to increase the solubility and stability of proteins; Expedeon Ltd., Cambridgeshire, United Kingdom), 0.01% Gelatin, 0.01% 0.2%, Pluronic F-127 (block copolymer from ethylenoxide and propyleneoxide), 1 mM DTT). After addition of 1.25 nM MDM2-biotinylated or 2.5 nM MDM4-biotinylated (internal preparations), and 0.625 nM Europium labeled streptavidin (Perkin Elmer), the solution is pre-incubated for 15 minutes at room temperature, then 10 nM Cy5-p53 peptide (internal preparation) is added before an incubation at room temperature for 15 minutes prior to reading the plate. For measurement of samples, a Victor II microplate reader (Perkin Elmer) is used with the following settings: Excitation 340 nm, Emission Donor 620 nm and Emission Acceptor 665 nm. For selected compounds displaying IC50s between 0.05 and 5 nM on MDM2, a slightly modified assay is used with the following adaptations: 0.1 nM MDM2, 0.1 nM Europium labeled streptavidin and Tecan genios Pro is used as a microplate reader for the fluorescence measurements (p53-MDM2 Assay 2).",B,,,BAO_0000190,BAO_0000224,protein format,CNC(=O)c1ccc(OC)c(-c2cc3c(n2C(C)C)C(c2ccc(Cl)cc2)N(C2CCOCC2)C3=O)c1,,,CHEMBL3886789,,2016,"{'bei': '17.17', 'le': '0.33', 'lle': '3.48', 'sei': '12.31'}",CHEMBL3944419,,CHEMBL3944419,8.96,False,http://www.openphacts.org/units/Nanomolar,2885922,=,37,True,=,,IC50,nM,,1.087,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,1.087
411707,17776523,[],CHEMBL3888635,"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: Assay 2: The test is performed in white 384-well plates (Greiner Bio-One, reference 781207) in a total volume of 60 L by adding 1 L of compounds tested at different concentrations diluted in 100% DMSO (1.7% final DMSO concentration) in reaction buffer (PBS, 125 mM NaCl, 0.001% Novexin (consists of carbohydrate polymers), designed to increase the solubility and stability of proteins; Expedeon Ltd., Cambridgeshire, United Kingdom), 0.01% Gelatin, 0.01% 0.2%, Pluronic F-127 (block copolymer from ethylenoxide and propyleneoxide), 1 mM DTT). After addition of 1.25 nM MDM2-biotinylated or 2.5 nM MDM4-biotinylated (internal preparations), and 0.625 nM Europium labeled streptavidin (Perkin Elmer), the solution is pre-incubated for 15 minutes at room temperature, then 10 nM Cy5-p53 peptide (internal preparation) is added before an incubation at room temperature for 15 minutes prior to reading the plate. For measurement of samples, a Victor II microplate reader (Perkin Elmer) is used with the following settings: Excitation 340 nm, Emission Donor 620 nm and Emission Acceptor 665 nm. For selected compounds displaying IC50s between 0.05 and 5 nM on MDM2, a slightly modified assay is used with the following adaptations: 0.1 nM MDM2, 0.1 nM Europium labeled streptavidin and Tecan genios Pro is used as a microplate reader for the fluorescence measurements (p53-MDM2 Assay 2).",B,,,BAO_0000190,BAO_0000224,protein format,COc1ncc(-c2cc3c(n2C(C)C)C(c2ccc(Cl)cc2)N(C2CCOCC2)C3=O)c(OC)n1,,,CHEMBL3886789,,2016,"{'bei': '17.68', 'le': '0.34', 'lle': '3.87', 'sei': '11.16'}",CHEMBL3955006,,CHEMBL3955006,8.79,False,http://www.openphacts.org/units/Nanomolar,2885923,=,37,True,=,,IC50,nM,,1.64,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,1.64
411708,17776524,[],CHEMBL3888635,"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: Assay 2: The test is performed in white 384-well plates (Greiner Bio-One, reference 781207) in a total volume of 60 L by adding 1 L of compounds tested at different concentrations diluted in 100% DMSO (1.7% final DMSO concentration) in reaction buffer (PBS, 125 mM NaCl, 0.001% Novexin (consists of carbohydrate polymers), designed to increase the solubility and stability of proteins; Expedeon Ltd., Cambridgeshire, United Kingdom), 0.01% Gelatin, 0.01% 0.2%, Pluronic F-127 (block copolymer from ethylenoxide and propyleneoxide), 1 mM DTT). After addition of 1.25 nM MDM2-biotinylated or 2.5 nM MDM4-biotinylated (internal preparations), and 0.625 nM Europium labeled streptavidin (Perkin Elmer), the solution is pre-incubated for 15 minutes at room temperature, then 10 nM Cy5-p53 peptide (internal preparation) is added before an incubation at room temperature for 15 minutes prior to reading the plate. For measurement of samples, a Victor II microplate reader (Perkin Elmer) is used with the following settings: Excitation 340 nm, Emission Donor 620 nm and Emission Acceptor 665 nm. For selected compounds displaying IC50s between 0.05 and 5 nM on MDM2, a slightly modified assay is used with the following adaptations: 0.1 nM MDM2, 0.1 nM Europium labeled streptavidin and Tecan genios Pro is used as a microplate reader for the fluorescence measurements (p53-MDM2 Assay 2).",B,,,BAO_0000190,BAO_0000224,protein format,COc1ccc(C#N)cc1-c1cc2c(n1C(C)C)C(c1ccc(Cl)cc1)N(C1CCOCC1)C2=O,,,CHEMBL3886789,,2016,"{'bei': '18.00', 'le': '0.34', 'lle': '2.83', 'sei': '13.07'}",CHEMBL3925643,,CHEMBL3925643,8.82,False,http://www.openphacts.org/units/Nanomolar,2885924,=,37,True,=,,IC50,nM,,1.509,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,1.509
411709,17776525,[],CHEMBL3888635,"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: Assay 2: The test is performed in white 384-well plates (Greiner Bio-One, reference 781207) in a total volume of 60 L by adding 1 L of compounds tested at different concentrations diluted in 100% DMSO (1.7% final DMSO concentration) in reaction buffer (PBS, 125 mM NaCl, 0.001% Novexin (consists of carbohydrate polymers), designed to increase the solubility and stability of proteins; Expedeon Ltd., Cambridgeshire, United Kingdom), 0.01% Gelatin, 0.01% 0.2%, Pluronic F-127 (block copolymer from ethylenoxide and propyleneoxide), 1 mM DTT). After addition of 1.25 nM MDM2-biotinylated or 2.5 nM MDM4-biotinylated (internal preparations), and 0.625 nM Europium labeled streptavidin (Perkin Elmer), the solution is pre-incubated for 15 minutes at room temperature, then 10 nM Cy5-p53 peptide (internal preparation) is added before an incubation at room temperature for 15 minutes prior to reading the plate. For measurement of samples, a Victor II microplate reader (Perkin Elmer) is used with the following settings: Excitation 340 nm, Emission Donor 620 nm and Emission Acceptor 665 nm. For selected compounds displaying IC50s between 0.05 and 5 nM on MDM2, a slightly modified assay is used with the following adaptations: 0.1 nM MDM2, 0.1 nM Europium labeled streptavidin and Tecan genios Pro is used as a microplate reader for the fluorescence measurements (p53-MDM2 Assay 2).",B,,,BAO_0000190,BAO_0000224,protein format,COc1nc(N)ncc1-c1cc2c(n1C(C)C)C(c1ccc(Cl)cc1)N(C1CCOCC1)C2=O,,,CHEMBL3886789,,2016,"{'bei': '17.21', 'le': '0.33', 'lle': '3.80', 'sei': '8.68'}",CHEMBL3916949,,CHEMBL3916949,8.29,False,http://www.openphacts.org/units/Nanomolar,2885847,=,37,True,=,,IC50,nM,,5.081,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,5.081
411710,17776526,[],CHEMBL3888635,"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: Assay 2: The test is performed in white 384-well plates (Greiner Bio-One, reference 781207) in a total volume of 60 L by adding 1 L of compounds tested at different concentrations diluted in 100% DMSO (1.7% final DMSO concentration) in reaction buffer (PBS, 125 mM NaCl, 0.001% Novexin (consists of carbohydrate polymers), designed to increase the solubility and stability of proteins; Expedeon Ltd., Cambridgeshire, United Kingdom), 0.01% Gelatin, 0.01% 0.2%, Pluronic F-127 (block copolymer from ethylenoxide and propyleneoxide), 1 mM DTT). After addition of 1.25 nM MDM2-biotinylated or 2.5 nM MDM4-biotinylated (internal preparations), and 0.625 nM Europium labeled streptavidin (Perkin Elmer), the solution is pre-incubated for 15 minutes at room temperature, then 10 nM Cy5-p53 peptide (internal preparation) is added before an incubation at room temperature for 15 minutes prior to reading the plate. For measurement of samples, a Victor II microplate reader (Perkin Elmer) is used with the following settings: Excitation 340 nm, Emission Donor 620 nm and Emission Acceptor 665 nm. For selected compounds displaying IC50s between 0.05 and 5 nM on MDM2, a slightly modified assay is used with the following adaptations: 0.1 nM MDM2, 0.1 nM Europium labeled streptavidin and Tecan genios Pro is used as a microplate reader for the fluorescence measurements (p53-MDM2 Assay 2).",B,,,BAO_0000190,BAO_0000224,protein format,COc1nc(N(C)C)ncc1-c1cc2c(n1C(C)C)C(c1ccc(Cl)cc1)N(C1CCOCC1)C2=O,,,CHEMBL3886789,,2016,"{'bei': '18.38', 'le': '0.36', 'lle': '4.39', 'sei': '12.89'}",CHEMBL3953706,,CHEMBL3953706,9.37,False,http://www.openphacts.org/units/Nanomolar,2885925,=,37,True,=,,IC50,nM,,0.423,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,0.423
411711,17776527,[],CHEMBL3888635,"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: Assay 2: The test is performed in white 384-well plates (Greiner Bio-One, reference 781207) in a total volume of 60 L by adding 1 L of compounds tested at different concentrations diluted in 100% DMSO (1.7% final DMSO concentration) in reaction buffer (PBS, 125 mM NaCl, 0.001% Novexin (consists of carbohydrate polymers), designed to increase the solubility and stability of proteins; Expedeon Ltd., Cambridgeshire, United Kingdom), 0.01% Gelatin, 0.01% 0.2%, Pluronic F-127 (block copolymer from ethylenoxide and propyleneoxide), 1 mM DTT). After addition of 1.25 nM MDM2-biotinylated or 2.5 nM MDM4-biotinylated (internal preparations), and 0.625 nM Europium labeled streptavidin (Perkin Elmer), the solution is pre-incubated for 15 minutes at room temperature, then 10 nM Cy5-p53 peptide (internal preparation) is added before an incubation at room temperature for 15 minutes prior to reading the plate. For measurement of samples, a Victor II microplate reader (Perkin Elmer) is used with the following settings: Excitation 340 nm, Emission Donor 620 nm and Emission Acceptor 665 nm. For selected compounds displaying IC50s between 0.05 and 5 nM on MDM2, a slightly modified assay is used with the following adaptations: 0.1 nM MDM2, 0.1 nM Europium labeled streptavidin and Tecan genios Pro is used as a microplate reader for the fluorescence measurements (p53-MDM2 Assay 2).",B,,,BAO_0000190,BAO_0000224,protein format,COc1ccc(CC(N)=O)cc1-c1cc2c(n1C(C)C)C(c1ccc(Cl)cc1)N(c1cc(Cl)ccc1C)C2=O,,,CHEMBL3886789,,2016,"{'bei': '17.67', 'le': '0.35', 'lle': '2.80', 'sei': '12.81'}",CHEMBL3889539,,CHEMBL3889539,9.94,False,http://www.openphacts.org/units/Nanomolar,2885926,=,37,True,=,,IC50,nM,,0.115,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,0.115
411712,17776528,[],CHEMBL3888635,"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: Assay 2: The test is performed in white 384-well plates (Greiner Bio-One, reference 781207) in a total volume of 60 L by adding 1 L of compounds tested at different concentrations diluted in 100% DMSO (1.7% final DMSO concentration) in reaction buffer (PBS, 125 mM NaCl, 0.001% Novexin (consists of carbohydrate polymers), designed to increase the solubility and stability of proteins; Expedeon Ltd., Cambridgeshire, United Kingdom), 0.01% Gelatin, 0.01% 0.2%, Pluronic F-127 (block copolymer from ethylenoxide and propyleneoxide), 1 mM DTT). After addition of 1.25 nM MDM2-biotinylated or 2.5 nM MDM4-biotinylated (internal preparations), and 0.625 nM Europium labeled streptavidin (Perkin Elmer), the solution is pre-incubated for 15 minutes at room temperature, then 10 nM Cy5-p53 peptide (internal preparation) is added before an incubation at room temperature for 15 minutes prior to reading the plate. For measurement of samples, a Victor II microplate reader (Perkin Elmer) is used with the following settings: Excitation 340 nm, Emission Donor 620 nm and Emission Acceptor 665 nm. For selected compounds displaying IC50s between 0.05 and 5 nM on MDM2, a slightly modified assay is used with the following adaptations: 0.1 nM MDM2, 0.1 nM Europium labeled streptavidin and Tecan genios Pro is used as a microplate reader for the fluorescence measurements (p53-MDM2 Assay 2).",B,,,BAO_0000190,BAO_0000224,protein format,CNC(=O)Cc1ccc(OC)c(-c2cc3c(n2C(C)C)C(c2ccc(Cl)cc2)N(c2cc(Cl)ccc2C)C3=O)c1,,,CHEMBL3886789,,2016,"{'bei': '17.05', 'le': '0.34', 'lle': '2.43', 'sei': '15.46'}",CHEMBL3946895,,CHEMBL3946895,9.83,False,http://www.openphacts.org/units/Nanomolar,2885927,=,37,True,=,,IC50,nM,,0.148,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,0.148
411713,17776529,[],CHEMBL3888635,"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: Assay 2: The test is performed in white 384-well plates (Greiner Bio-One, reference 781207) in a total volume of 60 L by adding 1 L of compounds tested at different concentrations diluted in 100% DMSO (1.7% final DMSO concentration) in reaction buffer (PBS, 125 mM NaCl, 0.001% Novexin (consists of carbohydrate polymers), designed to increase the solubility and stability of proteins; Expedeon Ltd., Cambridgeshire, United Kingdom), 0.01% Gelatin, 0.01% 0.2%, Pluronic F-127 (block copolymer from ethylenoxide and propyleneoxide), 1 mM DTT). After addition of 1.25 nM MDM2-biotinylated or 2.5 nM MDM4-biotinylated (internal preparations), and 0.625 nM Europium labeled streptavidin (Perkin Elmer), the solution is pre-incubated for 15 minutes at room temperature, then 10 nM Cy5-p53 peptide (internal preparation) is added before an incubation at room temperature for 15 minutes prior to reading the plate. For measurement of samples, a Victor II microplate reader (Perkin Elmer) is used with the following settings: Excitation 340 nm, Emission Donor 620 nm and Emission Acceptor 665 nm. For selected compounds displaying IC50s between 0.05 and 5 nM on MDM2, a slightly modified assay is used with the following adaptations: 0.1 nM MDM2, 0.1 nM Europium labeled streptavidin and Tecan genios Pro is used as a microplate reader for the fluorescence measurements (p53-MDM2 Assay 2).",B,,,BAO_0000190,BAO_0000224,protein format,COc1ccc(CC(=O)N(C)C)cc1-c1cc2c(n1C(C)C)C(c1ccc(Cl)cc1)N(c1cc(Cl)ccc1C)C2=O,,,CHEMBL3886789,,2016,"{'bei': '16.63', 'le': '0.33', 'lle': '2.08', 'sei': '17.92'}",CHEMBL3919093,,CHEMBL3919093,9.82,False,http://www.openphacts.org/units/Nanomolar,2885928,=,37,True,=,,IC50,nM,,0.152,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,0.152
411714,17776530,[],CHEMBL3888635,"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: Assay 2: The test is performed in white 384-well plates (Greiner Bio-One, reference 781207) in a total volume of 60 L by adding 1 L of compounds tested at different concentrations diluted in 100% DMSO (1.7% final DMSO concentration) in reaction buffer (PBS, 125 mM NaCl, 0.001% Novexin (consists of carbohydrate polymers), designed to increase the solubility and stability of proteins; Expedeon Ltd., Cambridgeshire, United Kingdom), 0.01% Gelatin, 0.01% 0.2%, Pluronic F-127 (block copolymer from ethylenoxide and propyleneoxide), 1 mM DTT). After addition of 1.25 nM MDM2-biotinylated or 2.5 nM MDM4-biotinylated (internal preparations), and 0.625 nM Europium labeled streptavidin (Perkin Elmer), the solution is pre-incubated for 15 minutes at room temperature, then 10 nM Cy5-p53 peptide (internal preparation) is added before an incubation at room temperature for 15 minutes prior to reading the plate. For measurement of samples, a Victor II microplate reader (Perkin Elmer) is used with the following settings: Excitation 340 nm, Emission Donor 620 nm and Emission Acceptor 665 nm. For selected compounds displaying IC50s between 0.05 and 5 nM on MDM2, a slightly modified assay is used with the following adaptations: 0.1 nM MDM2, 0.1 nM Europium labeled streptavidin and Tecan genios Pro is used as a microplate reader for the fluorescence measurements (p53-MDM2 Assay 2).",B,,,BAO_0000190,BAO_0000224,protein format,CCOC(=O)Cc1cnc(OC)c(-c2cc3c(n2C(C)C)C(c2ccc(C#N)cc2)N(c2cccc(Cl)c2F)C3=O)c1,,,CHEMBL3886789,,2016,"{'bei': '14.28', 'le': '0.27', 'lle': '1.72', 'sei': '8.60'}",CHEMBL3954185,,CHEMBL3954185,8.38,False,http://www.openphacts.org/units/Nanomolar,2885929,=,37,True,=,,IC50,nM,,4.163,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,4.163
411715,17776531,[],CHEMBL3888635,"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: Assay 2: The test is performed in white 384-well plates (Greiner Bio-One, reference 781207) in a total volume of 60 L by adding 1 L of compounds tested at different concentrations diluted in 100% DMSO (1.7% final DMSO concentration) in reaction buffer (PBS, 125 mM NaCl, 0.001% Novexin (consists of carbohydrate polymers), designed to increase the solubility and stability of proteins; Expedeon Ltd., Cambridgeshire, United Kingdom), 0.01% Gelatin, 0.01% 0.2%, Pluronic F-127 (block copolymer from ethylenoxide and propyleneoxide), 1 mM DTT). After addition of 1.25 nM MDM2-biotinylated or 2.5 nM MDM4-biotinylated (internal preparations), and 0.625 nM Europium labeled streptavidin (Perkin Elmer), the solution is pre-incubated for 15 minutes at room temperature, then 10 nM Cy5-p53 peptide (internal preparation) is added before an incubation at room temperature for 15 minutes prior to reading the plate. For measurement of samples, a Victor II microplate reader (Perkin Elmer) is used with the following settings: Excitation 340 nm, Emission Donor 620 nm and Emission Acceptor 665 nm. For selected compounds displaying IC50s between 0.05 and 5 nM on MDM2, a slightly modified assay is used with the following adaptations: 0.1 nM MDM2, 0.1 nM Europium labeled streptavidin and Tecan genios Pro is used as a microplate reader for the fluorescence measurements (p53-MDM2 Assay 2).",B,,,BAO_0000190,BAO_0000224,protein format,COc1cnc(CC(=O)O)cc1-c1cc2c(n1C(C)C)C(c1ccc(C#N)cc1)N(c1cccc(Cl)c1F)C2=O,,,CHEMBL3886789,,2016,"{'bei': '16.67', 'le': '0.32', 'lle': '3.14', 'sei': '8.59'}",CHEMBL3965576,,CHEMBL3965576,9.32,False,http://www.openphacts.org/units/Nanomolar,2885930,=,37,True,=,,IC50,nM,,0.482,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,0.482
411716,17776532,[],CHEMBL3888635,"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: Assay 2: The test is performed in white 384-well plates (Greiner Bio-One, reference 781207) in a total volume of 60 L by adding 1 L of compounds tested at different concentrations diluted in 100% DMSO (1.7% final DMSO concentration) in reaction buffer (PBS, 125 mM NaCl, 0.001% Novexin (consists of carbohydrate polymers), designed to increase the solubility and stability of proteins; Expedeon Ltd., Cambridgeshire, United Kingdom), 0.01% Gelatin, 0.01% 0.2%, Pluronic F-127 (block copolymer from ethylenoxide and propyleneoxide), 1 mM DTT). After addition of 1.25 nM MDM2-biotinylated or 2.5 nM MDM4-biotinylated (internal preparations), and 0.625 nM Europium labeled streptavidin (Perkin Elmer), the solution is pre-incubated for 15 minutes at room temperature, then 10 nM Cy5-p53 peptide (internal preparation) is added before an incubation at room temperature for 15 minutes prior to reading the plate. For measurement of samples, a Victor II microplate reader (Perkin Elmer) is used with the following settings: Excitation 340 nm, Emission Donor 620 nm and Emission Acceptor 665 nm. For selected compounds displaying IC50s between 0.05 and 5 nM on MDM2, a slightly modified assay is used with the following adaptations: 0.1 nM MDM2, 0.1 nM Europium labeled streptavidin and Tecan genios Pro is used as a microplate reader for the fluorescence measurements (p53-MDM2 Assay 2).",B,,,BAO_0000190,BAO_0000224,protein format,CNC(=O)Cc1cnc(OC)c(-c2cc3c(n2C(C)C)C(c2ccc(C#N)cc2)N(c2cccc(Cl)c2F)C3=O)c1,,,CHEMBL3886789,,2016,"{'bei': '14.86', 'le': '0.28', 'lle': '2.66', 'sei': '8.48'}",CHEMBL3954045,,CHEMBL3954045,8.50,False,http://www.openphacts.org/units/Nanomolar,2885931,=,37,True,=,,IC50,nM,,3.158,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,3.158
411717,17776533,[],CHEMBL3888635,"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: Assay 2: The test is performed in white 384-well plates (Greiner Bio-One, reference 781207) in a total volume of 60 L by adding 1 L of compounds tested at different concentrations diluted in 100% DMSO (1.7% final DMSO concentration) in reaction buffer (PBS, 125 mM NaCl, 0.001% Novexin (consists of carbohydrate polymers), designed to increase the solubility and stability of proteins; Expedeon Ltd., Cambridgeshire, United Kingdom), 0.01% Gelatin, 0.01% 0.2%, Pluronic F-127 (block copolymer from ethylenoxide and propyleneoxide), 1 mM DTT). After addition of 1.25 nM MDM2-biotinylated or 2.5 nM MDM4-biotinylated (internal preparations), and 0.625 nM Europium labeled streptavidin (Perkin Elmer), the solution is pre-incubated for 15 minutes at room temperature, then 10 nM Cy5-p53 peptide (internal preparation) is added before an incubation at room temperature for 15 minutes prior to reading the plate. For measurement of samples, a Victor II microplate reader (Perkin Elmer) is used with the following settings: Excitation 340 nm, Emission Donor 620 nm and Emission Acceptor 665 nm. For selected compounds displaying IC50s between 0.05 and 5 nM on MDM2, a slightly modified assay is used with the following adaptations: 0.1 nM MDM2, 0.1 nM Europium labeled streptavidin and Tecan genios Pro is used as a microplate reader for the fluorescence measurements (p53-MDM2 Assay 2).",B,,,BAO_0000190,BAO_0000224,protein format,CNC(=O)Cc1cc(-c2cc3c(n2C(C)C)C(c2ccc(C#N)cc2)N(c2cccc(Cl)c2F)C3=O)c(OC)cn1,,,CHEMBL3886789,,2016,"{'bei': '16.57', 'le': '0.32', 'lle': '3.64', 'sei': '9.45'}",CHEMBL3978059,,CHEMBL3978059,9.48,False,http://www.openphacts.org/units/Nanomolar,2885932,=,37,True,=,,IC50,nM,,0.334,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,0.334
411718,17776534,[],CHEMBL3888635,"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: Assay 2: The test is performed in white 384-well plates (Greiner Bio-One, reference 781207) in a total volume of 60 L by adding 1 L of compounds tested at different concentrations diluted in 100% DMSO (1.7% final DMSO concentration) in reaction buffer (PBS, 125 mM NaCl, 0.001% Novexin (consists of carbohydrate polymers), designed to increase the solubility and stability of proteins; Expedeon Ltd., Cambridgeshire, United Kingdom), 0.01% Gelatin, 0.01% 0.2%, Pluronic F-127 (block copolymer from ethylenoxide and propyleneoxide), 1 mM DTT). After addition of 1.25 nM MDM2-biotinylated or 2.5 nM MDM4-biotinylated (internal preparations), and 0.625 nM Europium labeled streptavidin (Perkin Elmer), the solution is pre-incubated for 15 minutes at room temperature, then 10 nM Cy5-p53 peptide (internal preparation) is added before an incubation at room temperature for 15 minutes prior to reading the plate. For measurement of samples, a Victor II microplate reader (Perkin Elmer) is used with the following settings: Excitation 340 nm, Emission Donor 620 nm and Emission Acceptor 665 nm. For selected compounds displaying IC50s between 0.05 and 5 nM on MDM2, a slightly modified assay is used with the following adaptations: 0.1 nM MDM2, 0.1 nM Europium labeled streptavidin and Tecan genios Pro is used as a microplate reader for the fluorescence measurements (p53-MDM2 Assay 2).",B,,,BAO_0000190,BAO_0000224,protein format,COc1cnc(CC#N)cc1-c1cc2c(n1C(C)C)C(c1ccc(C#N)cc1)N(c1cccc(Cl)c1F)C2=O,,,CHEMBL3886789,,2016,"{'bei': '17.49', 'le': '0.33', 'lle': '2.82', 'sei': '9.95'}",CHEMBL3920785,,CHEMBL3920785,9.45,False,http://www.openphacts.org/units/Nanomolar,2885933,=,37,True,=,,IC50,nM,,0.359,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,0.359
411719,17776535,[],CHEMBL3888635,"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: Assay 2: The test is performed in white 384-well plates (Greiner Bio-One, reference 781207) in a total volume of 60 L by adding 1 L of compounds tested at different concentrations diluted in 100% DMSO (1.7% final DMSO concentration) in reaction buffer (PBS, 125 mM NaCl, 0.001% Novexin (consists of carbohydrate polymers), designed to increase the solubility and stability of proteins; Expedeon Ltd., Cambridgeshire, United Kingdom), 0.01% Gelatin, 0.01% 0.2%, Pluronic F-127 (block copolymer from ethylenoxide and propyleneoxide), 1 mM DTT). After addition of 1.25 nM MDM2-biotinylated or 2.5 nM MDM4-biotinylated (internal preparations), and 0.625 nM Europium labeled streptavidin (Perkin Elmer), the solution is pre-incubated for 15 minutes at room temperature, then 10 nM Cy5-p53 peptide (internal preparation) is added before an incubation at room temperature for 15 minutes prior to reading the plate. For measurement of samples, a Victor II microplate reader (Perkin Elmer) is used with the following settings: Excitation 340 nm, Emission Donor 620 nm and Emission Acceptor 665 nm. For selected compounds displaying IC50s between 0.05 and 5 nM on MDM2, a slightly modified assay is used with the following adaptations: 0.1 nM MDM2, 0.1 nM Europium labeled streptavidin and Tecan genios Pro is used as a microplate reader for the fluorescence measurements (p53-MDM2 Assay 2).",B,,,BAO_0000190,BAO_0000224,protein format,COc1ncc(CC#N)cc1-c1cc2c(n1C(C)C)C(c1ccc(C#N)cc1)N(c1cccc(Cl)c1F)C2=O,,,CHEMBL3886789,,2016,"{'bei': '16.27', 'le': '0.31', 'lle': '2.17', 'sei': '9.25'}",CHEMBL3902919,,CHEMBL3902919,8.79,False,http://www.openphacts.org/units/Nanomolar,2885934,=,37,True,=,,IC50,nM,,1.64,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,1.64
411720,17776536,[],CHEMBL3888635,"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: Assay 2: The test is performed in white 384-well plates (Greiner Bio-One, reference 781207) in a total volume of 60 L by adding 1 L of compounds tested at different concentrations diluted in 100% DMSO (1.7% final DMSO concentration) in reaction buffer (PBS, 125 mM NaCl, 0.001% Novexin (consists of carbohydrate polymers), designed to increase the solubility and stability of proteins; Expedeon Ltd., Cambridgeshire, United Kingdom), 0.01% Gelatin, 0.01% 0.2%, Pluronic F-127 (block copolymer from ethylenoxide and propyleneoxide), 1 mM DTT). After addition of 1.25 nM MDM2-biotinylated or 2.5 nM MDM4-biotinylated (internal preparations), and 0.625 nM Europium labeled streptavidin (Perkin Elmer), the solution is pre-incubated for 15 minutes at room temperature, then 10 nM Cy5-p53 peptide (internal preparation) is added before an incubation at room temperature for 15 minutes prior to reading the plate. For measurement of samples, a Victor II microplate reader (Perkin Elmer) is used with the following settings: Excitation 340 nm, Emission Donor 620 nm and Emission Acceptor 665 nm. For selected compounds displaying IC50s between 0.05 and 5 nM on MDM2, a slightly modified assay is used with the following adaptations: 0.1 nM MDM2, 0.1 nM Europium labeled streptavidin and Tecan genios Pro is used as a microplate reader for the fluorescence measurements (p53-MDM2 Assay 2).",B,,,BAO_0000190,BAO_0000224,protein format,COc1ccc(C(=O)O)cc1-c1cc2c(n1C(C)C)[C@H](c1ccc(Cl)cc1)N(c1cc(Cl)ccc1C)C2=O,,,CHEMBL3886789,,2016,"{'bei': '18.38', 'le': '0.36', 'lle': '2.29', 'sei': '14.07'}",CHEMBL3893972,,CHEMBL3893972,10.10,False,http://www.openphacts.org/units/Nanomolar,2885935,=,37,True,=,,IC50,nM,,0.08,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,0.08
411721,17776537,[],CHEMBL3888635,"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: Assay 2: The test is performed in white 384-well plates (Greiner Bio-One, reference 781207) in a total volume of 60 L by adding 1 L of compounds tested at different concentrations diluted in 100% DMSO (1.7% final DMSO concentration) in reaction buffer (PBS, 125 mM NaCl, 0.001% Novexin (consists of carbohydrate polymers), designed to increase the solubility and stability of proteins; Expedeon Ltd., Cambridgeshire, United Kingdom), 0.01% Gelatin, 0.01% 0.2%, Pluronic F-127 (block copolymer from ethylenoxide and propyleneoxide), 1 mM DTT). After addition of 1.25 nM MDM2-biotinylated or 2.5 nM MDM4-biotinylated (internal preparations), and 0.625 nM Europium labeled streptavidin (Perkin Elmer), the solution is pre-incubated for 15 minutes at room temperature, then 10 nM Cy5-p53 peptide (internal preparation) is added before an incubation at room temperature for 15 minutes prior to reading the plate. For measurement of samples, a Victor II microplate reader (Perkin Elmer) is used with the following settings: Excitation 340 nm, Emission Donor 620 nm and Emission Acceptor 665 nm. For selected compounds displaying IC50s between 0.05 and 5 nM on MDM2, a slightly modified assay is used with the following adaptations: 0.1 nM MDM2, 0.1 nM Europium labeled streptavidin and Tecan genios Pro is used as a microplate reader for the fluorescence measurements (p53-MDM2 Assay 2).",B,,,BAO_0000190,BAO_0000224,protein format,COc1ccc(C(=O)O)cc1-c1cc2c(n1C(C)C)[C@@H](c1ccc(Cl)cc1)N(c1cc(Cl)ccc1C)C2=O,,,CHEMBL3886789,,2016,"{'bei': '14.94', 'le': '0.29', 'lle': '0.40', 'sei': '11.44'}",CHEMBL4110383,,CHEMBL4110383,8.21,False,http://www.openphacts.org/units/Nanomolar,2885936,=,37,True,=,,IC50,nM,,6.21,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,6.21
411722,17776538,[],CHEMBL3888635,"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: Assay 2: The test is performed in white 384-well plates (Greiner Bio-One, reference 781207) in a total volume of 60 L by adding 1 L of compounds tested at different concentrations diluted in 100% DMSO (1.7% final DMSO concentration) in reaction buffer (PBS, 125 mM NaCl, 0.001% Novexin (consists of carbohydrate polymers), designed to increase the solubility and stability of proteins; Expedeon Ltd., Cambridgeshire, United Kingdom), 0.01% Gelatin, 0.01% 0.2%, Pluronic F-127 (block copolymer from ethylenoxide and propyleneoxide), 1 mM DTT). After addition of 1.25 nM MDM2-biotinylated or 2.5 nM MDM4-biotinylated (internal preparations), and 0.625 nM Europium labeled streptavidin (Perkin Elmer), the solution is pre-incubated for 15 minutes at room temperature, then 10 nM Cy5-p53 peptide (internal preparation) is added before an incubation at room temperature for 15 minutes prior to reading the plate. For measurement of samples, a Victor II microplate reader (Perkin Elmer) is used with the following settings: Excitation 340 nm, Emission Donor 620 nm and Emission Acceptor 665 nm. For selected compounds displaying IC50s between 0.05 and 5 nM on MDM2, a slightly modified assay is used with the following adaptations: 0.1 nM MDM2, 0.1 nM Europium labeled streptavidin and Tecan genios Pro is used as a microplate reader for the fluorescence measurements (p53-MDM2 Assay 2).",B,,,BAO_0000190,BAO_0000224,protein format,COc1ccc(CC(=O)O)cc1-c1cc2c(n1C(C)C)[C@H](c1ccc(Cl)cc1)N(c1cc(Cl)ccc1C)C2=O,,,CHEMBL3886789,,2016,"{'bei': '18.13', 'le': '0.36', 'lle': '2.47', 'sei': '14.23'}",CHEMBL3892862,,CHEMBL3892862,10.21,False,http://www.openphacts.org/units/Nanomolar,2885937,=,37,True,=,,IC50,nM,,0.061,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,0.061
411723,17776539,[],CHEMBL3888635,"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: Assay 2: The test is performed in white 384-well plates (Greiner Bio-One, reference 781207) in a total volume of 60 L by adding 1 L of compounds tested at different concentrations diluted in 100% DMSO (1.7% final DMSO concentration) in reaction buffer (PBS, 125 mM NaCl, 0.001% Novexin (consists of carbohydrate polymers), designed to increase the solubility and stability of proteins; Expedeon Ltd., Cambridgeshire, United Kingdom), 0.01% Gelatin, 0.01% 0.2%, Pluronic F-127 (block copolymer from ethylenoxide and propyleneoxide), 1 mM DTT). After addition of 1.25 nM MDM2-biotinylated or 2.5 nM MDM4-biotinylated (internal preparations), and 0.625 nM Europium labeled streptavidin (Perkin Elmer), the solution is pre-incubated for 15 minutes at room temperature, then 10 nM Cy5-p53 peptide (internal preparation) is added before an incubation at room temperature for 15 minutes prior to reading the plate. For measurement of samples, a Victor II microplate reader (Perkin Elmer) is used with the following settings: Excitation 340 nm, Emission Donor 620 nm and Emission Acceptor 665 nm. For selected compounds displaying IC50s between 0.05 and 5 nM on MDM2, a slightly modified assay is used with the following adaptations: 0.1 nM MDM2, 0.1 nM Europium labeled streptavidin and Tecan genios Pro is used as a microplate reader for the fluorescence measurements (p53-MDM2 Assay 2).",B,,,BAO_0000190,BAO_0000224,protein format,COc1ccc(CC(=O)O)cc1-c1cc2c(n1C(C)C)[C@@H](c1ccc(Cl)cc1)N(c1cc(Cl)ccc1C)C2=O,,,CHEMBL3886789,,2016,"{'bei': '13.09', 'le': '0.26', 'lle': '-0.36', 'sei': '10.28'}",CHEMBL4110714,,CHEMBL4110714,7.38,False,http://www.openphacts.org/units/Nanomolar,2885938,=,37,True,=,,IC50,nM,,41.92,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,41.925
411724,17776540,[],CHEMBL3888635,"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: Assay 2: The test is performed in white 384-well plates (Greiner Bio-One, reference 781207) in a total volume of 60 L by adding 1 L of compounds tested at different concentrations diluted in 100% DMSO (1.7% final DMSO concentration) in reaction buffer (PBS, 125 mM NaCl, 0.001% Novexin (consists of carbohydrate polymers), designed to increase the solubility and stability of proteins; Expedeon Ltd., Cambridgeshire, United Kingdom), 0.01% Gelatin, 0.01% 0.2%, Pluronic F-127 (block copolymer from ethylenoxide and propyleneoxide), 1 mM DTT). After addition of 1.25 nM MDM2-biotinylated or 2.5 nM MDM4-biotinylated (internal preparations), and 0.625 nM Europium labeled streptavidin (Perkin Elmer), the solution is pre-incubated for 15 minutes at room temperature, then 10 nM Cy5-p53 peptide (internal preparation) is added before an incubation at room temperature for 15 minutes prior to reading the plate. For measurement of samples, a Victor II microplate reader (Perkin Elmer) is used with the following settings: Excitation 340 nm, Emission Donor 620 nm and Emission Acceptor 665 nm. For selected compounds displaying IC50s between 0.05 and 5 nM on MDM2, a slightly modified assay is used with the following adaptations: 0.1 nM MDM2, 0.1 nM Europium labeled streptavidin and Tecan genios Pro is used as a microplate reader for the fluorescence measurements (p53-MDM2 Assay 2).",B,,,BAO_0000190,BAO_0000224,protein format,COc1nc(N(C)C)ncc1-c1cc2c(n1C(C)C)C(c1ccc(C#N)cc1)N(c1ccc(F)c(Cl)c1)C2=O,,,CHEMBL3886789,,2016,"{'bei': '17.33', 'le': '0.33', 'lle': '3.43', 'sei': '10.82'}",CHEMBL3895323,,CHEMBL3895323,9.44,False,http://www.openphacts.org/units/Nanomolar,2885939,=,37,True,=,,IC50,nM,,0.361,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,0.361
411725,17776541,[],CHEMBL3888635,"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: Assay 2: The test is performed in white 384-well plates (Greiner Bio-One, reference 781207) in a total volume of 60 L by adding 1 L of compounds tested at different concentrations diluted in 100% DMSO (1.7% final DMSO concentration) in reaction buffer (PBS, 125 mM NaCl, 0.001% Novexin (consists of carbohydrate polymers), designed to increase the solubility and stability of proteins; Expedeon Ltd., Cambridgeshire, United Kingdom), 0.01% Gelatin, 0.01% 0.2%, Pluronic F-127 (block copolymer from ethylenoxide and propyleneoxide), 1 mM DTT). After addition of 1.25 nM MDM2-biotinylated or 2.5 nM MDM4-biotinylated (internal preparations), and 0.625 nM Europium labeled streptavidin (Perkin Elmer), the solution is pre-incubated for 15 minutes at room temperature, then 10 nM Cy5-p53 peptide (internal preparation) is added before an incubation at room temperature for 15 minutes prior to reading the plate. For measurement of samples, a Victor II microplate reader (Perkin Elmer) is used with the following settings: Excitation 340 nm, Emission Donor 620 nm and Emission Acceptor 665 nm. For selected compounds displaying IC50s between 0.05 and 5 nM on MDM2, a slightly modified assay is used with the following adaptations: 0.1 nM MDM2, 0.1 nM Europium labeled streptavidin and Tecan genios Pro is used as a microplate reader for the fluorescence measurements (p53-MDM2 Assay 2).",B,,,BAO_0000190,BAO_0000224,protein format,COc1nc(N(C)C)ncc1-c1cc2c(n1C(C)C)C(c1ccc(C#N)cc1)N(c1cccc(Cl)c1F)C2=O,,,CHEMBL3886789,,2016,"{'bei': '17.84', 'le': '0.34', 'lle': '3.72', 'sei': '11.14'}",CHEMBL3969971,,CHEMBL3969971,9.73,False,http://www.openphacts.org/units/Nanomolar,2885940,=,37,True,=,,IC50,nM,,0.188,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,0.188
411726,17776542,[],CHEMBL3888635,"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: Assay 2: The test is performed in white 384-well plates (Greiner Bio-One, reference 781207) in a total volume of 60 L by adding 1 L of compounds tested at different concentrations diluted in 100% DMSO (1.7% final DMSO concentration) in reaction buffer (PBS, 125 mM NaCl, 0.001% Novexin (consists of carbohydrate polymers), designed to increase the solubility and stability of proteins; Expedeon Ltd., Cambridgeshire, United Kingdom), 0.01% Gelatin, 0.01% 0.2%, Pluronic F-127 (block copolymer from ethylenoxide and propyleneoxide), 1 mM DTT). After addition of 1.25 nM MDM2-biotinylated or 2.5 nM MDM4-biotinylated (internal preparations), and 0.625 nM Europium labeled streptavidin (Perkin Elmer), the solution is pre-incubated for 15 minutes at room temperature, then 10 nM Cy5-p53 peptide (internal preparation) is added before an incubation at room temperature for 15 minutes prior to reading the plate. For measurement of samples, a Victor II microplate reader (Perkin Elmer) is used with the following settings: Excitation 340 nm, Emission Donor 620 nm and Emission Acceptor 665 nm. For selected compounds displaying IC50s between 0.05 and 5 nM on MDM2, a slightly modified assay is used with the following adaptations: 0.1 nM MDM2, 0.1 nM Europium labeled streptavidin and Tecan genios Pro is used as a microplate reader for the fluorescence measurements (p53-MDM2 Assay 2).",B,,,BAO_0000190,BAO_0000224,protein format,COc1nc(N(C)C)ncc1-c1cc2c(n1C(C)C)C(c1ccc(C#N)cc1)N(c1cc(Cl)ccc1C)C2=O,,,CHEMBL3886789,,2016,"{'bei': '17.95', 'le': '0.34', 'lle': '3.53', 'sei': '11.13'}",CHEMBL3914415,,CHEMBL3914415,9.71,False,http://www.openphacts.org/units/Nanomolar,2885941,=,37,True,=,,IC50,nM,,0.194,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,0.194
411727,17776543,[],CHEMBL3888635,"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: Assay 2: The test is performed in white 384-well plates (Greiner Bio-One, reference 781207) in a total volume of 60 L by adding 1 L of compounds tested at different concentrations diluted in 100% DMSO (1.7% final DMSO concentration) in reaction buffer (PBS, 125 mM NaCl, 0.001% Novexin (consists of carbohydrate polymers), designed to increase the solubility and stability of proteins; Expedeon Ltd., Cambridgeshire, United Kingdom), 0.01% Gelatin, 0.01% 0.2%, Pluronic F-127 (block copolymer from ethylenoxide and propyleneoxide), 1 mM DTT). After addition of 1.25 nM MDM2-biotinylated or 2.5 nM MDM4-biotinylated (internal preparations), and 0.625 nM Europium labeled streptavidin (Perkin Elmer), the solution is pre-incubated for 15 minutes at room temperature, then 10 nM Cy5-p53 peptide (internal preparation) is added before an incubation at room temperature for 15 minutes prior to reading the plate. For measurement of samples, a Victor II microplate reader (Perkin Elmer) is used with the following settings: Excitation 340 nm, Emission Donor 620 nm and Emission Acceptor 665 nm. For selected compounds displaying IC50s between 0.05 and 5 nM on MDM2, a slightly modified assay is used with the following adaptations: 0.1 nM MDM2, 0.1 nM Europium labeled streptavidin and Tecan genios Pro is used as a microplate reader for the fluorescence measurements (p53-MDM2 Assay 2).",B,,,BAO_0000190,BAO_0000224,protein format,COc1ccccc1-c1cc2c(n1C(C)C)C(c1ccc(Cl)cc1)N(c1cc(Cl)ccc1C#N)C2=O,,,CHEMBL3886789,,2016,"{'bei': '16.87', 'le': '0.33', 'lle': '1.04', 'sei': '14.95'}",CHEMBL3984231,,CHEMBL3984231,8.71,False,http://www.openphacts.org/units/Nanomolar,2885942,=,37,True,=,,IC50,nM,,1.949,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,1.949
411728,17776544,[],CHEMBL3888635,"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: Assay 2: The test is performed in white 384-well plates (Greiner Bio-One, reference 781207) in a total volume of 60 L by adding 1 L of compounds tested at different concentrations diluted in 100% DMSO (1.7% final DMSO concentration) in reaction buffer (PBS, 125 mM NaCl, 0.001% Novexin (consists of carbohydrate polymers), designed to increase the solubility and stability of proteins; Expedeon Ltd., Cambridgeshire, United Kingdom), 0.01% Gelatin, 0.01% 0.2%, Pluronic F-127 (block copolymer from ethylenoxide and propyleneoxide), 1 mM DTT). After addition of 1.25 nM MDM2-biotinylated or 2.5 nM MDM4-biotinylated (internal preparations), and 0.625 nM Europium labeled streptavidin (Perkin Elmer), the solution is pre-incubated for 15 minutes at room temperature, then 10 nM Cy5-p53 peptide (internal preparation) is added before an incubation at room temperature for 15 minutes prior to reading the plate. For measurement of samples, a Victor II microplate reader (Perkin Elmer) is used with the following settings: Excitation 340 nm, Emission Donor 620 nm and Emission Acceptor 665 nm. For selected compounds displaying IC50s between 0.05 and 5 nM on MDM2, a slightly modified assay is used with the following adaptations: 0.1 nM MDM2, 0.1 nM Europium labeled streptavidin and Tecan genios Pro is used as a microplate reader for the fluorescence measurements (p53-MDM2 Assay 2).",B,,,BAO_0000190,BAO_0000224,protein format,CNC(=O)c1ccc(OC)c(-c2cc3c(n2C(C)C)C(c2ccc(Cl)cc2)N(c2cc(Cl)ccc2C#N)C3=O)c1,,,CHEMBL3886789,,2016,"{'bei': '16.43', 'le': '0.32', 'lle': '2.39', 'sei': '10.79'}",CHEMBL3909065,,CHEMBL3909065,9.42,False,http://www.openphacts.org/units/Nanomolar,2885943,=,37,True,=,,IC50,nM,,0.378,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,0.378
411729,17776545,[],CHEMBL3888635,"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: Assay 2: The test is performed in white 384-well plates (Greiner Bio-One, reference 781207) in a total volume of 60 L by adding 1 L of compounds tested at different concentrations diluted in 100% DMSO (1.7% final DMSO concentration) in reaction buffer (PBS, 125 mM NaCl, 0.001% Novexin (consists of carbohydrate polymers), designed to increase the solubility and stability of proteins; Expedeon Ltd., Cambridgeshire, United Kingdom), 0.01% Gelatin, 0.01% 0.2%, Pluronic F-127 (block copolymer from ethylenoxide and propyleneoxide), 1 mM DTT). After addition of 1.25 nM MDM2-biotinylated or 2.5 nM MDM4-biotinylated (internal preparations), and 0.625 nM Europium labeled streptavidin (Perkin Elmer), the solution is pre-incubated for 15 minutes at room temperature, then 10 nM Cy5-p53 peptide (internal preparation) is added before an incubation at room temperature for 15 minutes prior to reading the plate. For measurement of samples, a Victor II microplate reader (Perkin Elmer) is used with the following settings: Excitation 340 nm, Emission Donor 620 nm and Emission Acceptor 665 nm. For selected compounds displaying IC50s between 0.05 and 5 nM on MDM2, a slightly modified assay is used with the following adaptations: 0.1 nM MDM2, 0.1 nM Europium labeled streptavidin and Tecan genios Pro is used as a microplate reader for the fluorescence measurements (p53-MDM2 Assay 2).",B,,,BAO_0000190,BAO_0000224,protein format,COc1ncc(-c2cc3c(n2C(C)C)C(c2ccc(Cl)cc2)N(c2cc(Cl)ccc2C#N)C3=O)c(OC)n1,,,CHEMBL3886789,,2016,"{'bei': '17.32', 'le': '0.34', 'lle': '3.03', 'sei': '10.19'}",CHEMBL3976189,,CHEMBL3976189,9.50,False,http://www.openphacts.org/units/Nanomolar,2885944,=,37,True,=,,IC50,nM,,0.316,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,0.316
411730,17776546,[],CHEMBL3888635,"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: Assay 2: The test is performed in white 384-well plates (Greiner Bio-One, reference 781207) in a total volume of 60 L by adding 1 L of compounds tested at different concentrations diluted in 100% DMSO (1.7% final DMSO concentration) in reaction buffer (PBS, 125 mM NaCl, 0.001% Novexin (consists of carbohydrate polymers), designed to increase the solubility and stability of proteins; Expedeon Ltd., Cambridgeshire, United Kingdom), 0.01% Gelatin, 0.01% 0.2%, Pluronic F-127 (block copolymer from ethylenoxide and propyleneoxide), 1 mM DTT). After addition of 1.25 nM MDM2-biotinylated or 2.5 nM MDM4-biotinylated (internal preparations), and 0.625 nM Europium labeled streptavidin (Perkin Elmer), the solution is pre-incubated for 15 minutes at room temperature, then 10 nM Cy5-p53 peptide (internal preparation) is added before an incubation at room temperature for 15 minutes prior to reading the plate. For measurement of samples, a Victor II microplate reader (Perkin Elmer) is used with the following settings: Excitation 340 nm, Emission Donor 620 nm and Emission Acceptor 665 nm. For selected compounds displaying IC50s between 0.05 and 5 nM on MDM2, a slightly modified assay is used with the following adaptations: 0.1 nM MDM2, 0.1 nM Europium labeled streptavidin and Tecan genios Pro is used as a microplate reader for the fluorescence measurements (p53-MDM2 Assay 2).",B,,,BAO_0000190,BAO_0000224,protein format,COc1nc(N)ncc1-c1cc2c(n1C(C)C)C(c1ccc(Cl)cc1)N(c1cc(Cl)ccc1C#N)C2=O,,,CHEMBL3886789,,2016,"{'bei': '16.57', 'le': '0.33', 'lle': '2.79', 'sei': '8.03'}",CHEMBL3900015,,CHEMBL3900015,8.84,False,http://www.openphacts.org/units/Nanomolar,2885945,=,37,True,=,,IC50,nM,,1.441,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,1.441
411731,17776547,[],CHEMBL3888635,"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: Assay 2: The test is performed in white 384-well plates (Greiner Bio-One, reference 781207) in a total volume of 60 L by adding 1 L of compounds tested at different concentrations diluted in 100% DMSO (1.7% final DMSO concentration) in reaction buffer (PBS, 125 mM NaCl, 0.001% Novexin (consists of carbohydrate polymers), designed to increase the solubility and stability of proteins; Expedeon Ltd., Cambridgeshire, United Kingdom), 0.01% Gelatin, 0.01% 0.2%, Pluronic F-127 (block copolymer from ethylenoxide and propyleneoxide), 1 mM DTT). After addition of 1.25 nM MDM2-biotinylated or 2.5 nM MDM4-biotinylated (internal preparations), and 0.625 nM Europium labeled streptavidin (Perkin Elmer), the solution is pre-incubated for 15 minutes at room temperature, then 10 nM Cy5-p53 peptide (internal preparation) is added before an incubation at room temperature for 15 minutes prior to reading the plate. For measurement of samples, a Victor II microplate reader (Perkin Elmer) is used with the following settings: Excitation 340 nm, Emission Donor 620 nm and Emission Acceptor 665 nm. For selected compounds displaying IC50s between 0.05 and 5 nM on MDM2, a slightly modified assay is used with the following adaptations: 0.1 nM MDM2, 0.1 nM Europium labeled streptavidin and Tecan genios Pro is used as a microplate reader for the fluorescence measurements (p53-MDM2 Assay 2).",B,,,BAO_0000190,BAO_0000224,protein format,COc1nc(N(C)C)ncc1-c1cc2c(n1C(C)C)C(c1ccc(Cl)cc1)N(c1cc(Cl)ccc1C#N)C2=O,,,CHEMBL3886789,,2016,"{'bei': '16.92', 'le': '0.33', 'lle': '2.97', 'sei': '10.88'}",CHEMBL3971176,,CHEMBL3971176,9.50,False,http://www.openphacts.org/units/Nanomolar,2885946,=,37,True,=,,IC50,nM,,0.316,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,0.316
411732,17776548,[],CHEMBL3888635,"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: Assay 2: The test is performed in white 384-well plates (Greiner Bio-One, reference 781207) in a total volume of 60 L by adding 1 L of compounds tested at different concentrations diluted in 100% DMSO (1.7% final DMSO concentration) in reaction buffer (PBS, 125 mM NaCl, 0.001% Novexin (consists of carbohydrate polymers), designed to increase the solubility and stability of proteins; Expedeon Ltd., Cambridgeshire, United Kingdom), 0.01% Gelatin, 0.01% 0.2%, Pluronic F-127 (block copolymer from ethylenoxide and propyleneoxide), 1 mM DTT). After addition of 1.25 nM MDM2-biotinylated or 2.5 nM MDM4-biotinylated (internal preparations), and 0.625 nM Europium labeled streptavidin (Perkin Elmer), the solution is pre-incubated for 15 minutes at room temperature, then 10 nM Cy5-p53 peptide (internal preparation) is added before an incubation at room temperature for 15 minutes prior to reading the plate. For measurement of samples, a Victor II microplate reader (Perkin Elmer) is used with the following settings: Excitation 340 nm, Emission Donor 620 nm and Emission Acceptor 665 nm. For selected compounds displaying IC50s between 0.05 and 5 nM on MDM2, a slightly modified assay is used with the following adaptations: 0.1 nM MDM2, 0.1 nM Europium labeled streptavidin and Tecan genios Pro is used as a microplate reader for the fluorescence measurements (p53-MDM2 Assay 2).",B,,,BAO_0000190,BAO_0000224,protein format,COc1ccccc1-c1cc2c(n1C(C)C)C(c1ccc(Cl)cc1C)N([C@H]1CC[C@H](O)CC1)C2=O,,,CHEMBL3886789,,2016,"{'bei': '15.20', 'le': '0.29', 'lle': '0.94', 'sei': '13.71'}",CHEMBL3931174,,CHEMBL3931174,7.50,False,http://www.openphacts.org/units/Nanomolar,2885848,=,37,True,=,,IC50,nM,,31.86,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,31.855
411733,17776549,[],CHEMBL3888635,"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: Assay 2: The test is performed in white 384-well plates (Greiner Bio-One, reference 781207) in a total volume of 60 L by adding 1 L of compounds tested at different concentrations diluted in 100% DMSO (1.7% final DMSO concentration) in reaction buffer (PBS, 125 mM NaCl, 0.001% Novexin (consists of carbohydrate polymers), designed to increase the solubility and stability of proteins; Expedeon Ltd., Cambridgeshire, United Kingdom), 0.01% Gelatin, 0.01% 0.2%, Pluronic F-127 (block copolymer from ethylenoxide and propyleneoxide), 1 mM DTT). After addition of 1.25 nM MDM2-biotinylated or 2.5 nM MDM4-biotinylated (internal preparations), and 0.625 nM Europium labeled streptavidin (Perkin Elmer), the solution is pre-incubated for 15 minutes at room temperature, then 10 nM Cy5-p53 peptide (internal preparation) is added before an incubation at room temperature for 15 minutes prior to reading the plate. For measurement of samples, a Victor II microplate reader (Perkin Elmer) is used with the following settings: Excitation 340 nm, Emission Donor 620 nm and Emission Acceptor 665 nm. For selected compounds displaying IC50s between 0.05 and 5 nM on MDM2, a slightly modified assay is used with the following adaptations: 0.1 nM MDM2, 0.1 nM Europium labeled streptavidin and Tecan genios Pro is used as a microplate reader for the fluorescence measurements (p53-MDM2 Assay 2).",B,,,BAO_0000190,BAO_0000224,protein format,CNC(=O)c1ccc(OC)c(-c2cc3c(n2C(C)C)C(c2ccc(Cl)cc2C)N([C@H]2CC[C@H](O)CC2)C3=O)c1,,,CHEMBL3886789,,2016,"{'bei': '14.30', 'le': '0.28', 'lle': '1.96', 'sei': '9.39'}",CHEMBL3906706,,CHEMBL3906706,7.87,False,http://www.openphacts.org/units/Nanomolar,2885849,=,37,True,=,,IC50,nM,,13.59,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,13.586
411734,17776550,[],CHEMBL3888635,"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: Assay 2: The test is performed in white 384-well plates (Greiner Bio-One, reference 781207) in a total volume of 60 L by adding 1 L of compounds tested at different concentrations diluted in 100% DMSO (1.7% final DMSO concentration) in reaction buffer (PBS, 125 mM NaCl, 0.001% Novexin (consists of carbohydrate polymers), designed to increase the solubility and stability of proteins; Expedeon Ltd., Cambridgeshire, United Kingdom), 0.01% Gelatin, 0.01% 0.2%, Pluronic F-127 (block copolymer from ethylenoxide and propyleneoxide), 1 mM DTT). After addition of 1.25 nM MDM2-biotinylated or 2.5 nM MDM4-biotinylated (internal preparations), and 0.625 nM Europium labeled streptavidin (Perkin Elmer), the solution is pre-incubated for 15 minutes at room temperature, then 10 nM Cy5-p53 peptide (internal preparation) is added before an incubation at room temperature for 15 minutes prior to reading the plate. For measurement of samples, a Victor II microplate reader (Perkin Elmer) is used with the following settings: Excitation 340 nm, Emission Donor 620 nm and Emission Acceptor 665 nm. For selected compounds displaying IC50s between 0.05 and 5 nM on MDM2, a slightly modified assay is used with the following adaptations: 0.1 nM MDM2, 0.1 nM Europium labeled streptavidin and Tecan genios Pro is used as a microplate reader for the fluorescence measurements (p53-MDM2 Assay 2).",B,,,BAO_0000190,BAO_0000224,protein format,COc1ncc(-c2cc3c(n2C(C)C)C(c2ccc(Cl)cc2C)N([C@H]2CC[C@H](O)CC2)C3=O)c(OC)n1,,,CHEMBL3886789,,2016,"{'bei': '14.32', 'le': '0.28', 'lle': '2.17', 'sei': '8.38'}",CHEMBL3937960,,CHEMBL3937960,7.52,False,http://www.openphacts.org/units/Nanomolar,2885850,=,37,True,=,,IC50,nM,,30.15,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,30.146
411735,17776551,[],CHEMBL3888635,"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: Assay 2: The test is performed in white 384-well plates (Greiner Bio-One, reference 781207) in a total volume of 60 L by adding 1 L of compounds tested at different concentrations diluted in 100% DMSO (1.7% final DMSO concentration) in reaction buffer (PBS, 125 mM NaCl, 0.001% Novexin (consists of carbohydrate polymers), designed to increase the solubility and stability of proteins; Expedeon Ltd., Cambridgeshire, United Kingdom), 0.01% Gelatin, 0.01% 0.2%, Pluronic F-127 (block copolymer from ethylenoxide and propyleneoxide), 1 mM DTT). After addition of 1.25 nM MDM2-biotinylated or 2.5 nM MDM4-biotinylated (internal preparations), and 0.625 nM Europium labeled streptavidin (Perkin Elmer), the solution is pre-incubated for 15 minutes at room temperature, then 10 nM Cy5-p53 peptide (internal preparation) is added before an incubation at room temperature for 15 minutes prior to reading the plate. For measurement of samples, a Victor II microplate reader (Perkin Elmer) is used with the following settings: Excitation 340 nm, Emission Donor 620 nm and Emission Acceptor 665 nm. For selected compounds displaying IC50s between 0.05 and 5 nM on MDM2, a slightly modified assay is used with the following adaptations: 0.1 nM MDM2, 0.1 nM Europium labeled streptavidin and Tecan genios Pro is used as a microplate reader for the fluorescence measurements (p53-MDM2 Assay 2).",B,,,BAO_0000190,BAO_0000224,protein format,COc1ccccc1-c1cc2c(n1C(C)C)C(c1ccc(Cl)cc1C)N(C1CCOCC1)C2=O,,,CHEMBL3886789,,2016,"{'bei': '16.31', 'le': '0.31', 'lle': '1.38', 'sei': '17.88'}",CHEMBL3957542,,CHEMBL3957542,7.81,False,http://www.openphacts.org/units/Nanomolar,2885947,=,37,True,=,,IC50,nM,,15.34,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,15.344
411736,17776552,[],CHEMBL3888635,"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: Assay 2: The test is performed in white 384-well plates (Greiner Bio-One, reference 781207) in a total volume of 60 L by adding 1 L of compounds tested at different concentrations diluted in 100% DMSO (1.7% final DMSO concentration) in reaction buffer (PBS, 125 mM NaCl, 0.001% Novexin (consists of carbohydrate polymers), designed to increase the solubility and stability of proteins; Expedeon Ltd., Cambridgeshire, United Kingdom), 0.01% Gelatin, 0.01% 0.2%, Pluronic F-127 (block copolymer from ethylenoxide and propyleneoxide), 1 mM DTT). After addition of 1.25 nM MDM2-biotinylated or 2.5 nM MDM4-biotinylated (internal preparations), and 0.625 nM Europium labeled streptavidin (Perkin Elmer), the solution is pre-incubated for 15 minutes at room temperature, then 10 nM Cy5-p53 peptide (internal preparation) is added before an incubation at room temperature for 15 minutes prior to reading the plate. For measurement of samples, a Victor II microplate reader (Perkin Elmer) is used with the following settings: Excitation 340 nm, Emission Donor 620 nm and Emission Acceptor 665 nm. For selected compounds displaying IC50s between 0.05 and 5 nM on MDM2, a slightly modified assay is used with the following adaptations: 0.1 nM MDM2, 0.1 nM Europium labeled streptavidin and Tecan genios Pro is used as a microplate reader for the fluorescence measurements (p53-MDM2 Assay 2).",B,,,BAO_0000190,BAO_0000224,protein format,COc1ncc(-c2cc3c(n2C(C)C)C(c2ccc(Cl)cc2C)N(C2CCOCC2)C3=O)c(OC)n1,,,CHEMBL3886789,,2016,"{'bei': '15.35', 'le': '0.30', 'lle': '2.61', 'sei': '9.97'}",CHEMBL3920354,,CHEMBL3920354,7.84,False,http://www.openphacts.org/units/Nanomolar,2885851,=,37,True,=,,IC50,nM,,14.33,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,14.333
411737,17776553,[],CHEMBL3888635,"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: Assay 2: The test is performed in white 384-well plates (Greiner Bio-One, reference 781207) in a total volume of 60 L by adding 1 L of compounds tested at different concentrations diluted in 100% DMSO (1.7% final DMSO concentration) in reaction buffer (PBS, 125 mM NaCl, 0.001% Novexin (consists of carbohydrate polymers), designed to increase the solubility and stability of proteins; Expedeon Ltd., Cambridgeshire, United Kingdom), 0.01% Gelatin, 0.01% 0.2%, Pluronic F-127 (block copolymer from ethylenoxide and propyleneoxide), 1 mM DTT). After addition of 1.25 nM MDM2-biotinylated or 2.5 nM MDM4-biotinylated (internal preparations), and 0.625 nM Europium labeled streptavidin (Perkin Elmer), the solution is pre-incubated for 15 minutes at room temperature, then 10 nM Cy5-p53 peptide (internal preparation) is added before an incubation at room temperature for 15 minutes prior to reading the plate. For measurement of samples, a Victor II microplate reader (Perkin Elmer) is used with the following settings: Excitation 340 nm, Emission Donor 620 nm and Emission Acceptor 665 nm. For selected compounds displaying IC50s between 0.05 and 5 nM on MDM2, a slightly modified assay is used with the following adaptations: 0.1 nM MDM2, 0.1 nM Europium labeled streptavidin and Tecan genios Pro is used as a microplate reader for the fluorescence measurements (p53-MDM2 Assay 2).",B,,,BAO_0000190,BAO_0000224,protein format,COc1ncc(-c2cc3c(n2C(C)C)C(c2ccc(Cl)cc2)N(C2CCNCC2)C3=O)c(OC)n1,,,CHEMBL3886789,,2016,"{'bei': '12.18', 'le': '0.24', 'lle': '1.55', 'sei': '7.41'}",CHEMBL3914272,,CHEMBL3914272,6.04,False,http://www.openphacts.org/units/Nanomolar,2885948,=,37,True,=,,IC50,nM,,904.2,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,904.2
411738,17776554,[],CHEMBL3888635,"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: Assay 2: The test is performed in white 384-well plates (Greiner Bio-One, reference 781207) in a total volume of 60 L by adding 1 L of compounds tested at different concentrations diluted in 100% DMSO (1.7% final DMSO concentration) in reaction buffer (PBS, 125 mM NaCl, 0.001% Novexin (consists of carbohydrate polymers), designed to increase the solubility and stability of proteins; Expedeon Ltd., Cambridgeshire, United Kingdom), 0.01% Gelatin, 0.01% 0.2%, Pluronic F-127 (block copolymer from ethylenoxide and propyleneoxide), 1 mM DTT). After addition of 1.25 nM MDM2-biotinylated or 2.5 nM MDM4-biotinylated (internal preparations), and 0.625 nM Europium labeled streptavidin (Perkin Elmer), the solution is pre-incubated for 15 minutes at room temperature, then 10 nM Cy5-p53 peptide (internal preparation) is added before an incubation at room temperature for 15 minutes prior to reading the plate. For measurement of samples, a Victor II microplate reader (Perkin Elmer) is used with the following settings: Excitation 340 nm, Emission Donor 620 nm and Emission Acceptor 665 nm. For selected compounds displaying IC50s between 0.05 and 5 nM on MDM2, a slightly modified assay is used with the following adaptations: 0.1 nM MDM2, 0.1 nM Europium labeled streptavidin and Tecan genios Pro is used as a microplate reader for the fluorescence measurements (p53-MDM2 Assay 2).",B,,,BAO_0000190,BAO_0000224,protein format,CNC(=O)N1CCC(N2C(=O)c3cc(-c4cnc(OC)nc4OC)n(C(C)C)c3C2c2ccc(Cl)cc2)CC1,,,CHEMBL3886789,,2016,"{'bei': '15.50', 'le': '0.30', 'lle': '4.02', 'sei': '8.42'}",CHEMBL3906442,,CHEMBL3906442,8.57,False,http://www.openphacts.org/units/Nanomolar,2885852,=,37,True,=,,IC50,nM,,2.692,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,2.692
411739,17776555,[],CHEMBL3888635,"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: Assay 2: The test is performed in white 384-well plates (Greiner Bio-One, reference 781207) in a total volume of 60 L by adding 1 L of compounds tested at different concentrations diluted in 100% DMSO (1.7% final DMSO concentration) in reaction buffer (PBS, 125 mM NaCl, 0.001% Novexin (consists of carbohydrate polymers), designed to increase the solubility and stability of proteins; Expedeon Ltd., Cambridgeshire, United Kingdom), 0.01% Gelatin, 0.01% 0.2%, Pluronic F-127 (block copolymer from ethylenoxide and propyleneoxide), 1 mM DTT). After addition of 1.25 nM MDM2-biotinylated or 2.5 nM MDM4-biotinylated (internal preparations), and 0.625 nM Europium labeled streptavidin (Perkin Elmer), the solution is pre-incubated for 15 minutes at room temperature, then 10 nM Cy5-p53 peptide (internal preparation) is added before an incubation at room temperature for 15 minutes prior to reading the plate. For measurement of samples, a Victor II microplate reader (Perkin Elmer) is used with the following settings: Excitation 340 nm, Emission Donor 620 nm and Emission Acceptor 665 nm. For selected compounds displaying IC50s between 0.05 and 5 nM on MDM2, a slightly modified assay is used with the following adaptations: 0.1 nM MDM2, 0.1 nM Europium labeled streptavidin and Tecan genios Pro is used as a microplate reader for the fluorescence measurements (p53-MDM2 Assay 2).",B,,,BAO_0000190,BAO_0000224,protein format,COc1nc(N)ncc1-c1cc2c(n1C(C)C)C(c1ccc(Cl)cc1)N(C1CCC(=O)N(C)C1)C2=O,,,CHEMBL3886789,,2016,"{'bei': '16.57', 'le': '0.32', 'lle': '4.49', 'sei': '7.91'}",CHEMBL3980916,,CHEMBL3980916,8.43,False,http://www.openphacts.org/units/Nanomolar,2885853,=,37,True,=,,IC50,nM,,3.698,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,3.698
411740,17776556,[],CHEMBL3888635,"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: Assay 2: The test is performed in white 384-well plates (Greiner Bio-One, reference 781207) in a total volume of 60 L by adding 1 L of compounds tested at different concentrations diluted in 100% DMSO (1.7% final DMSO concentration) in reaction buffer (PBS, 125 mM NaCl, 0.001% Novexin (consists of carbohydrate polymers), designed to increase the solubility and stability of proteins; Expedeon Ltd., Cambridgeshire, United Kingdom), 0.01% Gelatin, 0.01% 0.2%, Pluronic F-127 (block copolymer from ethylenoxide and propyleneoxide), 1 mM DTT). After addition of 1.25 nM MDM2-biotinylated or 2.5 nM MDM4-biotinylated (internal preparations), and 0.625 nM Europium labeled streptavidin (Perkin Elmer), the solution is pre-incubated for 15 minutes at room temperature, then 10 nM Cy5-p53 peptide (internal preparation) is added before an incubation at room temperature for 15 minutes prior to reading the plate. For measurement of samples, a Victor II microplate reader (Perkin Elmer) is used with the following settings: Excitation 340 nm, Emission Donor 620 nm and Emission Acceptor 665 nm. For selected compounds displaying IC50s between 0.05 and 5 nM on MDM2, a slightly modified assay is used with the following adaptations: 0.1 nM MDM2, 0.1 nM Europium labeled streptavidin and Tecan genios Pro is used as a microplate reader for the fluorescence measurements (p53-MDM2 Assay 2).",B,,,BAO_0000190,BAO_0000224,protein format,COc1ncc(-c2cc3c(n2C(C)C)C(c2ccc(Cl)cc2)N(C2CCC(=O)N(C)C2)C3=O)c(OC)n1,,,CHEMBL3886789,,2016,"{'bei': '16.79', 'le': '0.32', 'lle': '4.44', 'sei': '9.80'}",CHEMBL3936711,,CHEMBL3936711,8.80,False,http://www.openphacts.org/units/Nanomolar,2885949,=,37,True,=,,IC50,nM,,1.6,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,1.6
411741,17776557,[],CHEMBL3888635,"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: Assay 2: The test is performed in white 384-well plates (Greiner Bio-One, reference 781207) in a total volume of 60 L by adding 1 L of compounds tested at different concentrations diluted in 100% DMSO (1.7% final DMSO concentration) in reaction buffer (PBS, 125 mM NaCl, 0.001% Novexin (consists of carbohydrate polymers), designed to increase the solubility and stability of proteins; Expedeon Ltd., Cambridgeshire, United Kingdom), 0.01% Gelatin, 0.01% 0.2%, Pluronic F-127 (block copolymer from ethylenoxide and propyleneoxide), 1 mM DTT). After addition of 1.25 nM MDM2-biotinylated or 2.5 nM MDM4-biotinylated (internal preparations), and 0.625 nM Europium labeled streptavidin (Perkin Elmer), the solution is pre-incubated for 15 minutes at room temperature, then 10 nM Cy5-p53 peptide (internal preparation) is added before an incubation at room temperature for 15 minutes prior to reading the plate. For measurement of samples, a Victor II microplate reader (Perkin Elmer) is used with the following settings: Excitation 340 nm, Emission Donor 620 nm and Emission Acceptor 665 nm. For selected compounds displaying IC50s between 0.05 and 5 nM on MDM2, a slightly modified assay is used with the following adaptations: 0.1 nM MDM2, 0.1 nM Europium labeled streptavidin and Tecan genios Pro is used as a microplate reader for the fluorescence measurements (p53-MDM2 Assay 2).",B,,,BAO_0000190,BAO_0000224,protein format,COc1ncc(-c2cc3c(n2C(C)C)C(c2ccc(Cl)cc2)N(C2CN(C)C(=O)N(C)C2)C3=O)c(OC)n1,,,CHEMBL3886789,,2016,"{'bei': '16.94', 'le': '0.33', 'lle': '5.02', 'sei': '9.81'}",CHEMBL3929622,,CHEMBL3929622,9.13,False,http://www.openphacts.org/units/Nanomolar,2885950,=,37,True,=,,IC50,nM,,0.741,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,0.741
411742,17776558,[],CHEMBL3888635,"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: Assay 2: The test is performed in white 384-well plates (Greiner Bio-One, reference 781207) in a total volume of 60 L by adding 1 L of compounds tested at different concentrations diluted in 100% DMSO (1.7% final DMSO concentration) in reaction buffer (PBS, 125 mM NaCl, 0.001% Novexin (consists of carbohydrate polymers), designed to increase the solubility and stability of proteins; Expedeon Ltd., Cambridgeshire, United Kingdom), 0.01% Gelatin, 0.01% 0.2%, Pluronic F-127 (block copolymer from ethylenoxide and propyleneoxide), 1 mM DTT). After addition of 1.25 nM MDM2-biotinylated or 2.5 nM MDM4-biotinylated (internal preparations), and 0.625 nM Europium labeled streptavidin (Perkin Elmer), the solution is pre-incubated for 15 minutes at room temperature, then 10 nM Cy5-p53 peptide (internal preparation) is added before an incubation at room temperature for 15 minutes prior to reading the plate. For measurement of samples, a Victor II microplate reader (Perkin Elmer) is used with the following settings: Excitation 340 nm, Emission Donor 620 nm and Emission Acceptor 665 nm. For selected compounds displaying IC50s between 0.05 and 5 nM on MDM2, a slightly modified assay is used with the following adaptations: 0.1 nM MDM2, 0.1 nM Europium labeled streptavidin and Tecan genios Pro is used as a microplate reader for the fluorescence measurements (p53-MDM2 Assay 2).",B,,,BAO_0000190,BAO_0000224,protein format,COc1ncc(-c2cc3c(n2C(C)C)C(c2ccc(Cl)cc2)N(c2cn(C)c(=O)cc2C)C3=O)c(OC)n1,,,CHEMBL3886789,,2016,"{'bei': '16.36', 'le': '0.31', 'lle': '3.78', 'sei': '9.55'}",CHEMBL3945611,,CHEMBL3945611,8.73,False,http://www.openphacts.org/units/Nanomolar,2885951,=,37,True,=,,IC50,nM,,1.843,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,1.843
411743,17776559,[],CHEMBL3888635,"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: Assay 2: The test is performed in white 384-well plates (Greiner Bio-One, reference 781207) in a total volume of 60 L by adding 1 L of compounds tested at different concentrations diluted in 100% DMSO (1.7% final DMSO concentration) in reaction buffer (PBS, 125 mM NaCl, 0.001% Novexin (consists of carbohydrate polymers), designed to increase the solubility and stability of proteins; Expedeon Ltd., Cambridgeshire, United Kingdom), 0.01% Gelatin, 0.01% 0.2%, Pluronic F-127 (block copolymer from ethylenoxide and propyleneoxide), 1 mM DTT). After addition of 1.25 nM MDM2-biotinylated or 2.5 nM MDM4-biotinylated (internal preparations), and 0.625 nM Europium labeled streptavidin (Perkin Elmer), the solution is pre-incubated for 15 minutes at room temperature, then 10 nM Cy5-p53 peptide (internal preparation) is added before an incubation at room temperature for 15 minutes prior to reading the plate. For measurement of samples, a Victor II microplate reader (Perkin Elmer) is used with the following settings: Excitation 340 nm, Emission Donor 620 nm and Emission Acceptor 665 nm. For selected compounds displaying IC50s between 0.05 and 5 nM on MDM2, a slightly modified assay is used with the following adaptations: 0.1 nM MDM2, 0.1 nM Europium labeled streptavidin and Tecan genios Pro is used as a microplate reader for the fluorescence measurements (p53-MDM2 Assay 2).",B,,,BAO_0000190,BAO_0000224,protein format,COc1nc(N(C)C)ncc1-c1cc2c(n1C(C)C)C(c1ccc(Cl)cc1)N(c1cn(C)c(=O)cc1C)C2=O,,,CHEMBL3886789,,2016,"{'bei': '17.19', 'le': '0.33', 'lle': '4.40', 'sei': '11.00'}",CHEMBL3974998,,CHEMBL3974998,9.41,False,http://www.openphacts.org/units/Nanomolar,2885952,=,37,True,=,,IC50,nM,,0.393,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,0.393
411744,17776560,[],CHEMBL3888635,"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: Assay 2: The test is performed in white 384-well plates (Greiner Bio-One, reference 781207) in a total volume of 60 L by adding 1 L of compounds tested at different concentrations diluted in 100% DMSO (1.7% final DMSO concentration) in reaction buffer (PBS, 125 mM NaCl, 0.001% Novexin (consists of carbohydrate polymers), designed to increase the solubility and stability of proteins; Expedeon Ltd., Cambridgeshire, United Kingdom), 0.01% Gelatin, 0.01% 0.2%, Pluronic F-127 (block copolymer from ethylenoxide and propyleneoxide), 1 mM DTT). After addition of 1.25 nM MDM2-biotinylated or 2.5 nM MDM4-biotinylated (internal preparations), and 0.625 nM Europium labeled streptavidin (Perkin Elmer), the solution is pre-incubated for 15 minutes at room temperature, then 10 nM Cy5-p53 peptide (internal preparation) is added before an incubation at room temperature for 15 minutes prior to reading the plate. For measurement of samples, a Victor II microplate reader (Perkin Elmer) is used with the following settings: Excitation 340 nm, Emission Donor 620 nm and Emission Acceptor 665 nm. For selected compounds displaying IC50s between 0.05 and 5 nM on MDM2, a slightly modified assay is used with the following adaptations: 0.1 nM MDM2, 0.1 nM Europium labeled streptavidin and Tecan genios Pro is used as a microplate reader for the fluorescence measurements (p53-MDM2 Assay 2).",B,,,BAO_0000190,BAO_0000224,protein format,COc1cccnc1-c1cc2c(n1C(C)C)C(c1ccc(Cl)cc1)N(c1cc(Cl)ccc1C)C2=O,,,CHEMBL3886789,,2016,"{'bei': '19.09', 'le': '0.38', 'lle': '2.17', 'sei': '20.41'}",CHEMBL3918896,,CHEMBL3918896,9.67,False,http://www.openphacts.org/units/Nanomolar,2885953,=,37,True,=,,IC50,nM,,0.216,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,0.216
411745,17776561,[],CHEMBL3888635,"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: Assay 2: The test is performed in white 384-well plates (Greiner Bio-One, reference 781207) in a total volume of 60 L by adding 1 L of compounds tested at different concentrations diluted in 100% DMSO (1.7% final DMSO concentration) in reaction buffer (PBS, 125 mM NaCl, 0.001% Novexin (consists of carbohydrate polymers), designed to increase the solubility and stability of proteins; Expedeon Ltd., Cambridgeshire, United Kingdom), 0.01% Gelatin, 0.01% 0.2%, Pluronic F-127 (block copolymer from ethylenoxide and propyleneoxide), 1 mM DTT). After addition of 1.25 nM MDM2-biotinylated or 2.5 nM MDM4-biotinylated (internal preparations), and 0.625 nM Europium labeled streptavidin (Perkin Elmer), the solution is pre-incubated for 15 minutes at room temperature, then 10 nM Cy5-p53 peptide (internal preparation) is added before an incubation at room temperature for 15 minutes prior to reading the plate. For measurement of samples, a Victor II microplate reader (Perkin Elmer) is used with the following settings: Excitation 340 nm, Emission Donor 620 nm and Emission Acceptor 665 nm. For selected compounds displaying IC50s between 0.05 and 5 nM on MDM2, a slightly modified assay is used with the following adaptations: 0.1 nM MDM2, 0.1 nM Europium labeled streptavidin and Tecan genios Pro is used as a microplate reader for the fluorescence measurements (p53-MDM2 Assay 2).",B,,,BAO_0000190,BAO_0000224,protein format,COc1ccc(S(C)(=O)=O)cc1-c1cc2c(n1C(C)C)C(c1ccc(Cl)cc1)N(c1cc(Cl)ccc1C)C2=O,,,CHEMBL3886789,,2016,"{'bei': '16.68', 'le': '0.34', 'lle': '2.23', 'sei': '14.19'}",CHEMBL3945906,,CHEMBL3945906,9.73,False,http://www.openphacts.org/units/Nanomolar,2885954,=,37,True,=,,IC50,nM,,0.184,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,0.184
411746,17776562,[],CHEMBL3888635,"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: Assay 2: The test is performed in white 384-well plates (Greiner Bio-One, reference 781207) in a total volume of 60 L by adding 1 L of compounds tested at different concentrations diluted in 100% DMSO (1.7% final DMSO concentration) in reaction buffer (PBS, 125 mM NaCl, 0.001% Novexin (consists of carbohydrate polymers), designed to increase the solubility and stability of proteins; Expedeon Ltd., Cambridgeshire, United Kingdom), 0.01% Gelatin, 0.01% 0.2%, Pluronic F-127 (block copolymer from ethylenoxide and propyleneoxide), 1 mM DTT). After addition of 1.25 nM MDM2-biotinylated or 2.5 nM MDM4-biotinylated (internal preparations), and 0.625 nM Europium labeled streptavidin (Perkin Elmer), the solution is pre-incubated for 15 minutes at room temperature, then 10 nM Cy5-p53 peptide (internal preparation) is added before an incubation at room temperature for 15 minutes prior to reading the plate. For measurement of samples, a Victor II microplate reader (Perkin Elmer) is used with the following settings: Excitation 340 nm, Emission Donor 620 nm and Emission Acceptor 665 nm. For selected compounds displaying IC50s between 0.05 and 5 nM on MDM2, a slightly modified assay is used with the following adaptations: 0.1 nM MDM2, 0.1 nM Europium labeled streptavidin and Tecan genios Pro is used as a microplate reader for the fluorescence measurements (p53-MDM2 Assay 2).",B,,,BAO_0000190,BAO_0000224,protein format,COc1ccccc1-c1c(F)c2c(n1C(C)C)C(c1ccc(Cl)cc1)N(c1cc(Cl)ccc1C)C2=O,,,CHEMBL3886789,,2016,"{'bei': '17.79', 'le': '0.35', 'lle': '1.06', 'sei': '27.02'}",CHEMBL3974082,,CHEMBL3974082,9.31,False,http://www.openphacts.org/units/Nanomolar,2885955,=,37,True,=,,IC50,nM,,0.485,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,0.485
411747,17776563,[],CHEMBL3888635,"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: Assay 2: The test is performed in white 384-well plates (Greiner Bio-One, reference 781207) in a total volume of 60 L by adding 1 L of compounds tested at different concentrations diluted in 100% DMSO (1.7% final DMSO concentration) in reaction buffer (PBS, 125 mM NaCl, 0.001% Novexin (consists of carbohydrate polymers), designed to increase the solubility and stability of proteins; Expedeon Ltd., Cambridgeshire, United Kingdom), 0.01% Gelatin, 0.01% 0.2%, Pluronic F-127 (block copolymer from ethylenoxide and propyleneoxide), 1 mM DTT). After addition of 1.25 nM MDM2-biotinylated or 2.5 nM MDM4-biotinylated (internal preparations), and 0.625 nM Europium labeled streptavidin (Perkin Elmer), the solution is pre-incubated for 15 minutes at room temperature, then 10 nM Cy5-p53 peptide (internal preparation) is added before an incubation at room temperature for 15 minutes prior to reading the plate. For measurement of samples, a Victor II microplate reader (Perkin Elmer) is used with the following settings: Excitation 340 nm, Emission Donor 620 nm and Emission Acceptor 665 nm. For selected compounds displaying IC50s between 0.05 and 5 nM on MDM2, a slightly modified assay is used with the following adaptations: 0.1 nM MDM2, 0.1 nM Europium labeled streptavidin and Tecan genios Pro is used as a microplate reader for the fluorescence measurements (p53-MDM2 Assay 2).",B,,,BAO_0000190,BAO_0000224,protein format,COc1ccccc1-c1cc2c(n1C(C)C)C(C)(c1ccc(Cl)cc1)N(c1cc(Cl)ccc1C)C2=O,,,CHEMBL3886789,,2016,"{'bei': '17.91', 'le': '0.35', 'lle': '1.02', 'sei': '26.99'}",CHEMBL3943855,,CHEMBL3943855,9.30,False,http://www.openphacts.org/units/Nanomolar,2885956,=,37,True,=,,IC50,nM,,0.496,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,0.496
411748,17776564,[],CHEMBL3888635,"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: Assay 2: The test is performed in white 384-well plates (Greiner Bio-One, reference 781207) in a total volume of 60 L by adding 1 L of compounds tested at different concentrations diluted in 100% DMSO (1.7% final DMSO concentration) in reaction buffer (PBS, 125 mM NaCl, 0.001% Novexin (consists of carbohydrate polymers), designed to increase the solubility and stability of proteins; Expedeon Ltd., Cambridgeshire, United Kingdom), 0.01% Gelatin, 0.01% 0.2%, Pluronic F-127 (block copolymer from ethylenoxide and propyleneoxide), 1 mM DTT). After addition of 1.25 nM MDM2-biotinylated or 2.5 nM MDM4-biotinylated (internal preparations), and 0.625 nM Europium labeled streptavidin (Perkin Elmer), the solution is pre-incubated for 15 minutes at room temperature, then 10 nM Cy5-p53 peptide (internal preparation) is added before an incubation at room temperature for 15 minutes prior to reading the plate. For measurement of samples, a Victor II microplate reader (Perkin Elmer) is used with the following settings: Excitation 340 nm, Emission Donor 620 nm and Emission Acceptor 665 nm. For selected compounds displaying IC50s between 0.05 and 5 nM on MDM2, a slightly modified assay is used with the following adaptations: 0.1 nM MDM2, 0.1 nM Europium labeled streptavidin and Tecan genios Pro is used as a microplate reader for the fluorescence measurements (p53-MDM2 Assay 2).",B,,,BAO_0000190,BAO_0000224,protein format,COc1ncc(-c2cc3c(n2C(C)C)C(C)(c2ccc(Cl)cc2)N(c2cc(Cl)c(=O)n(C)c2)C3=O)c(OC)n1,,,CHEMBL3886789,,2016,"{'bei': '17.03', 'le': '0.34', 'lle': '4.21', 'sei': '10.58'}",CHEMBL3955785,,CHEMBL3955785,9.68,False,http://www.openphacts.org/units/Nanomolar,2885957,=,37,True,=,,IC50,nM,,0.208,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,0.208
411749,17776565,[],CHEMBL3888635,"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: Assay 2: The test is performed in white 384-well plates (Greiner Bio-One, reference 781207) in a total volume of 60 L by adding 1 L of compounds tested at different concentrations diluted in 100% DMSO (1.7% final DMSO concentration) in reaction buffer (PBS, 125 mM NaCl, 0.001% Novexin (consists of carbohydrate polymers), designed to increase the solubility and stability of proteins; Expedeon Ltd., Cambridgeshire, United Kingdom), 0.01% Gelatin, 0.01% 0.2%, Pluronic F-127 (block copolymer from ethylenoxide and propyleneoxide), 1 mM DTT). After addition of 1.25 nM MDM2-biotinylated or 2.5 nM MDM4-biotinylated (internal preparations), and 0.625 nM Europium labeled streptavidin (Perkin Elmer), the solution is pre-incubated for 15 minutes at room temperature, then 10 nM Cy5-p53 peptide (internal preparation) is added before an incubation at room temperature for 15 minutes prior to reading the plate. For measurement of samples, a Victor II microplate reader (Perkin Elmer) is used with the following settings: Excitation 340 nm, Emission Donor 620 nm and Emission Acceptor 665 nm. For selected compounds displaying IC50s between 0.05 and 5 nM on MDM2, a slightly modified assay is used with the following adaptations: 0.1 nM MDM2, 0.1 nM Europium labeled streptavidin and Tecan genios Pro is used as a microplate reader for the fluorescence measurements (p53-MDM2 Assay 2).",B,,,BAO_0000190,BAO_0000224,protein format,COc1ccc(CC(=O)O)cc1-c1cc2c(n1C(C)C)C(c1ccc(Cl)cc1)N(c1cc(Cl)c(=O)n(C)c1)C2=O,,,CHEMBL3886789,,2016,"{'bei': '16.38', 'le': '0.32', 'lle': '3.38', 'sei': '10.14'}",CHEMBL3983558,,CHEMBL3983558,9.51,False,http://www.openphacts.org/units/Nanomolar,2885958,=,37,True,=,,IC50,nM,,0.311,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,0.311
411750,17776566,[],CHEMBL3888635,"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: Assay 2: The test is performed in white 384-well plates (Greiner Bio-One, reference 781207) in a total volume of 60 L by adding 1 L of compounds tested at different concentrations diluted in 100% DMSO (1.7% final DMSO concentration) in reaction buffer (PBS, 125 mM NaCl, 0.001% Novexin (consists of carbohydrate polymers), designed to increase the solubility and stability of proteins; Expedeon Ltd., Cambridgeshire, United Kingdom), 0.01% Gelatin, 0.01% 0.2%, Pluronic F-127 (block copolymer from ethylenoxide and propyleneoxide), 1 mM DTT). After addition of 1.25 nM MDM2-biotinylated or 2.5 nM MDM4-biotinylated (internal preparations), and 0.625 nM Europium labeled streptavidin (Perkin Elmer), the solution is pre-incubated for 15 minutes at room temperature, then 10 nM Cy5-p53 peptide (internal preparation) is added before an incubation at room temperature for 15 minutes prior to reading the plate. For measurement of samples, a Victor II microplate reader (Perkin Elmer) is used with the following settings: Excitation 340 nm, Emission Donor 620 nm and Emission Acceptor 665 nm. For selected compounds displaying IC50s between 0.05 and 5 nM on MDM2, a slightly modified assay is used with the following adaptations: 0.1 nM MDM2, 0.1 nM Europium labeled streptavidin and Tecan genios Pro is used as a microplate reader for the fluorescence measurements (p53-MDM2 Assay 2).",B,,,BAO_0000190,BAO_0000224,protein format,COc1ccc(S(C)(=O)=O)cc1-c1cc2c(n1C(C)C)C(c1ccc(Cl)cc1)N(c1cc(Cl)c(=O)n(C)c1)C2=O,,,CHEMBL3886789,,2016,"{'bei': '16.28', 'le': '0.33', 'lle': '3.87', 'sei': '10.79'}",CHEMBL3953644,,CHEMBL3953644,9.78,False,http://www.openphacts.org/units/Nanomolar,2885959,=,37,True,=,,IC50,nM,,0.168,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,0.168
411751,17776567,[],CHEMBL3888635,"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: Assay 2: The test is performed in white 384-well plates (Greiner Bio-One, reference 781207) in a total volume of 60 L by adding 1 L of compounds tested at different concentrations diluted in 100% DMSO (1.7% final DMSO concentration) in reaction buffer (PBS, 125 mM NaCl, 0.001% Novexin (consists of carbohydrate polymers), designed to increase the solubility and stability of proteins; Expedeon Ltd., Cambridgeshire, United Kingdom), 0.01% Gelatin, 0.01% 0.2%, Pluronic F-127 (block copolymer from ethylenoxide and propyleneoxide), 1 mM DTT). After addition of 1.25 nM MDM2-biotinylated or 2.5 nM MDM4-biotinylated (internal preparations), and 0.625 nM Europium labeled streptavidin (Perkin Elmer), the solution is pre-incubated for 15 minutes at room temperature, then 10 nM Cy5-p53 peptide (internal preparation) is added before an incubation at room temperature for 15 minutes prior to reading the plate. For measurement of samples, a Victor II microplate reader (Perkin Elmer) is used with the following settings: Excitation 340 nm, Emission Donor 620 nm and Emission Acceptor 665 nm. For selected compounds displaying IC50s between 0.05 and 5 nM on MDM2, a slightly modified assay is used with the following adaptations: 0.1 nM MDM2, 0.1 nM Europium labeled streptavidin and Tecan genios Pro is used as a microplate reader for the fluorescence measurements (p53-MDM2 Assay 2).",B,,,BAO_0000190,BAO_0000224,protein format,COc1ncc(-c2c(C#N)c3c(n2C(C)C)C(c2ccc(Cl)cc2)N(c2cc(Cl)c(=O)n(C)c2)C3=O)c(OC)n1,,,CHEMBL3886789,,2016,"{'bei': '16.87', 'le': '0.33', 'lle': '4.61', 'sei': '8.48'}",CHEMBL3918527,,CHEMBL3918527,9.78,False,http://www.openphacts.org/units/Nanomolar,2885960,=,37,True,=,,IC50,nM,,0.167,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,0.167
411752,17776568,[],CHEMBL3888635,"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: Assay 2: The test is performed in white 384-well plates (Greiner Bio-One, reference 781207) in a total volume of 60 L by adding 1 L of compounds tested at different concentrations diluted in 100% DMSO (1.7% final DMSO concentration) in reaction buffer (PBS, 125 mM NaCl, 0.001% Novexin (consists of carbohydrate polymers), designed to increase the solubility and stability of proteins; Expedeon Ltd., Cambridgeshire, United Kingdom), 0.01% Gelatin, 0.01% 0.2%, Pluronic F-127 (block copolymer from ethylenoxide and propyleneoxide), 1 mM DTT). After addition of 1.25 nM MDM2-biotinylated or 2.5 nM MDM4-biotinylated (internal preparations), and 0.625 nM Europium labeled streptavidin (Perkin Elmer), the solution is pre-incubated for 15 minutes at room temperature, then 10 nM Cy5-p53 peptide (internal preparation) is added before an incubation at room temperature for 15 minutes prior to reading the plate. For measurement of samples, a Victor II microplate reader (Perkin Elmer) is used with the following settings: Excitation 340 nm, Emission Donor 620 nm and Emission Acceptor 665 nm. For selected compounds displaying IC50s between 0.05 and 5 nM on MDM2, a slightly modified assay is used with the following adaptations: 0.1 nM MDM2, 0.1 nM Europium labeled streptavidin and Tecan genios Pro is used as a microplate reader for the fluorescence measurements (p53-MDM2 Assay 2).",B,,,BAO_0000190,BAO_0000224,protein format,COc1ncc(-c2cc3c(n2C(C)C)[C@H](c2ccc(Cl)cc2)N(c2cc(Cl)c(=O)n(C)c2)C3=O)c(OC)n1,,,CHEMBL3886789,,2016,"{'bei': '18.15', 'le': '0.36', 'lle': '4.76', 'sei': '11.00'}",CHEMBL3895404,,CHEMBL3895404,10.06,False,http://www.openphacts.org/units/Nanomolar,2885854,=,37,True,=,,IC50,nM,,0.087,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,0.087
411753,17776569,[],CHEMBL3888635,"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: Assay 2: The test is performed in white 384-well plates (Greiner Bio-One, reference 781207) in a total volume of 60 L by adding 1 L of compounds tested at different concentrations diluted in 100% DMSO (1.7% final DMSO concentration) in reaction buffer (PBS, 125 mM NaCl, 0.001% Novexin (consists of carbohydrate polymers), designed to increase the solubility and stability of proteins; Expedeon Ltd., Cambridgeshire, United Kingdom), 0.01% Gelatin, 0.01% 0.2%, Pluronic F-127 (block copolymer from ethylenoxide and propyleneoxide), 1 mM DTT). After addition of 1.25 nM MDM2-biotinylated or 2.5 nM MDM4-biotinylated (internal preparations), and 0.625 nM Europium labeled streptavidin (Perkin Elmer), the solution is pre-incubated for 15 minutes at room temperature, then 10 nM Cy5-p53 peptide (internal preparation) is added before an incubation at room temperature for 15 minutes prior to reading the plate. For measurement of samples, a Victor II microplate reader (Perkin Elmer) is used with the following settings: Excitation 340 nm, Emission Donor 620 nm and Emission Acceptor 665 nm. For selected compounds displaying IC50s between 0.05 and 5 nM on MDM2, a slightly modified assay is used with the following adaptations: 0.1 nM MDM2, 0.1 nM Europium labeled streptavidin and Tecan genios Pro is used as a microplate reader for the fluorescence measurements (p53-MDM2 Assay 2).",B,,,BAO_0000190,BAO_0000224,protein format,COc1ncc(-c2cc3c(n2C(C)C)[C@@H](c2ccc(Cl)cc2)N(c2cc(Cl)c(=O)n(C)c2)C3=O)c(OC)n1,,,CHEMBL3886789,,2016,"{'bei': '12.83', 'le': '0.26', 'lle': '1.81', 'sei': '7.78'}",CHEMBL4108456,,CHEMBL4108456,7.11,False,http://www.openphacts.org/units/Nanomolar,2885961,=,37,True,=,,IC50,nM,,76.87,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,76.872
411754,17776570,[],CHEMBL3888635,"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: Assay 2: The test is performed in white 384-well plates (Greiner Bio-One, reference 781207) in a total volume of 60 L by adding 1 L of compounds tested at different concentrations diluted in 100% DMSO (1.7% final DMSO concentration) in reaction buffer (PBS, 125 mM NaCl, 0.001% Novexin (consists of carbohydrate polymers), designed to increase the solubility and stability of proteins; Expedeon Ltd., Cambridgeshire, United Kingdom), 0.01% Gelatin, 0.01% 0.2%, Pluronic F-127 (block copolymer from ethylenoxide and propyleneoxide), 1 mM DTT). After addition of 1.25 nM MDM2-biotinylated or 2.5 nM MDM4-biotinylated (internal preparations), and 0.625 nM Europium labeled streptavidin (Perkin Elmer), the solution is pre-incubated for 15 minutes at room temperature, then 10 nM Cy5-p53 peptide (internal preparation) is added before an incubation at room temperature for 15 minutes prior to reading the plate. For measurement of samples, a Victor II microplate reader (Perkin Elmer) is used with the following settings: Excitation 340 nm, Emission Donor 620 nm and Emission Acceptor 665 nm. For selected compounds displaying IC50s between 0.05 and 5 nM on MDM2, a slightly modified assay is used with the following adaptations: 0.1 nM MDM2, 0.1 nM Europium labeled streptavidin and Tecan genios Pro is used as a microplate reader for the fluorescence measurements (p53-MDM2 Assay 2).",B,,,BAO_0000190,BAO_0000224,protein format,COc1nc(N(C)C)ncc1-c1cc2c(n1C(C)C)C(c1ccc(Cl)cc1)N(c1cc(Cl)c[nH]c1=O)C2=O,,,CHEMBL3886789,,2016,"{'bei': '18.02', 'le': '0.36', 'lle': '4.62', 'sei': '10.35'}",CHEMBL3975933,,CHEMBL3975933,9.97,False,http://www.openphacts.org/units/Nanomolar,2885962,=,37,True,=,,IC50,nM,,0.106,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,0.106
411755,17776571,[],CHEMBL3888635,"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: Assay 2: The test is performed in white 384-well plates (Greiner Bio-One, reference 781207) in a total volume of 60 L by adding 1 L of compounds tested at different concentrations diluted in 100% DMSO (1.7% final DMSO concentration) in reaction buffer (PBS, 125 mM NaCl, 0.001% Novexin (consists of carbohydrate polymers), designed to increase the solubility and stability of proteins; Expedeon Ltd., Cambridgeshire, United Kingdom), 0.01% Gelatin, 0.01% 0.2%, Pluronic F-127 (block copolymer from ethylenoxide and propyleneoxide), 1 mM DTT). After addition of 1.25 nM MDM2-biotinylated or 2.5 nM MDM4-biotinylated (internal preparations), and 0.625 nM Europium labeled streptavidin (Perkin Elmer), the solution is pre-incubated for 15 minutes at room temperature, then 10 nM Cy5-p53 peptide (internal preparation) is added before an incubation at room temperature for 15 minutes prior to reading the plate. For measurement of samples, a Victor II microplate reader (Perkin Elmer) is used with the following settings: Excitation 340 nm, Emission Donor 620 nm and Emission Acceptor 665 nm. For selected compounds displaying IC50s between 0.05 and 5 nM on MDM2, a slightly modified assay is used with the following adaptations: 0.1 nM MDM2, 0.1 nM Europium labeled streptavidin and Tecan genios Pro is used as a microplate reader for the fluorescence measurements (p53-MDM2 Assay 2).",B,,,BAO_0000190,BAO_0000224,protein format,CNc1ncc(-c2cc3c(n2C(C)C)C(c2ccc(Cl)cc2)N(c2cc(Cl)c[nH]c2=O)C3=O)c(OC)n1,,,CHEMBL3886789,,2016,"{'bei': '18.04', 'le': '0.36', 'lle': '4.41', 'sei': '9.26'}",CHEMBL3962110,,CHEMBL3962110,9.73,False,http://www.openphacts.org/units/Nanomolar,2885963,=,37,True,=,,IC50,nM,,0.185,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,0.185
411756,17776572,[],CHEMBL3888635,"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: Assay 2: The test is performed in white 384-well plates (Greiner Bio-One, reference 781207) in a total volume of 60 L by adding 1 L of compounds tested at different concentrations diluted in 100% DMSO (1.7% final DMSO concentration) in reaction buffer (PBS, 125 mM NaCl, 0.001% Novexin (consists of carbohydrate polymers), designed to increase the solubility and stability of proteins; Expedeon Ltd., Cambridgeshire, United Kingdom), 0.01% Gelatin, 0.01% 0.2%, Pluronic F-127 (block copolymer from ethylenoxide and propyleneoxide), 1 mM DTT). After addition of 1.25 nM MDM2-biotinylated or 2.5 nM MDM4-biotinylated (internal preparations), and 0.625 nM Europium labeled streptavidin (Perkin Elmer), the solution is pre-incubated for 15 minutes at room temperature, then 10 nM Cy5-p53 peptide (internal preparation) is added before an incubation at room temperature for 15 minutes prior to reading the plate. For measurement of samples, a Victor II microplate reader (Perkin Elmer) is used with the following settings: Excitation 340 nm, Emission Donor 620 nm and Emission Acceptor 665 nm. For selected compounds displaying IC50s between 0.05 and 5 nM on MDM2, a slightly modified assay is used with the following adaptations: 0.1 nM MDM2, 0.1 nM Europium labeled streptavidin and Tecan genios Pro is used as a microplate reader for the fluorescence measurements (p53-MDM2 Assay 2).",B,,,BAO_0000190,BAO_0000224,protein format,COc1nc(N)ncc1-c1cc2c(n1C(C)C)C(c1ccc(C#N)cc1)N(c1cc(Cl)c[nH]c1=O)C2=O,,,CHEMBL3886789,,2016,"{'bei': '16.46', 'le': '0.31', 'lle': '4.41', 'sei': '5.94'}",CHEMBL3961711,,CHEMBL3961711,8.49,False,http://www.openphacts.org/units/Nanomolar,2885964,=,37,True,=,,IC50,nM,,3.22,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,3.22
411757,17776573,[],CHEMBL3888635,"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: Assay 2: The test is performed in white 384-well plates (Greiner Bio-One, reference 781207) in a total volume of 60 L by adding 1 L of compounds tested at different concentrations diluted in 100% DMSO (1.7% final DMSO concentration) in reaction buffer (PBS, 125 mM NaCl, 0.001% Novexin (consists of carbohydrate polymers), designed to increase the solubility and stability of proteins; Expedeon Ltd., Cambridgeshire, United Kingdom), 0.01% Gelatin, 0.01% 0.2%, Pluronic F-127 (block copolymer from ethylenoxide and propyleneoxide), 1 mM DTT). After addition of 1.25 nM MDM2-biotinylated or 2.5 nM MDM4-biotinylated (internal preparations), and 0.625 nM Europium labeled streptavidin (Perkin Elmer), the solution is pre-incubated for 15 minutes at room temperature, then 10 nM Cy5-p53 peptide (internal preparation) is added before an incubation at room temperature for 15 minutes prior to reading the plate. For measurement of samples, a Victor II microplate reader (Perkin Elmer) is used with the following settings: Excitation 340 nm, Emission Donor 620 nm and Emission Acceptor 665 nm. For selected compounds displaying IC50s between 0.05 and 5 nM on MDM2, a slightly modified assay is used with the following adaptations: 0.1 nM MDM2, 0.1 nM Europium labeled streptavidin and Tecan genios Pro is used as a microplate reader for the fluorescence measurements (p53-MDM2 Assay 2).",B,,,BAO_0000190,BAO_0000224,protein format,COc1ncc(-c2cc3c(n2C(C)C)C(c2ccc(C#N)cc2)N(c2cc(Cl)c[nH]c2=O)C3=O)c(OC)n1,,,CHEMBL3886789,,2016,"{'bei': '17.15', 'le': '0.33', 'lle': '4.60', 'sei': '7.22'}",CHEMBL3892710,,CHEMBL3892710,9.11,False,http://www.openphacts.org/units/Nanomolar,2885965,=,37,True,=,,IC50,nM,,0.779,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,0.779
411758,17776574,[],CHEMBL3888635,"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: Assay 2: The test is performed in white 384-well plates (Greiner Bio-One, reference 781207) in a total volume of 60 L by adding 1 L of compounds tested at different concentrations diluted in 100% DMSO (1.7% final DMSO concentration) in reaction buffer (PBS, 125 mM NaCl, 0.001% Novexin (consists of carbohydrate polymers), designed to increase the solubility and stability of proteins; Expedeon Ltd., Cambridgeshire, United Kingdom), 0.01% Gelatin, 0.01% 0.2%, Pluronic F-127 (block copolymer from ethylenoxide and propyleneoxide), 1 mM DTT). After addition of 1.25 nM MDM2-biotinylated or 2.5 nM MDM4-biotinylated (internal preparations), and 0.625 nM Europium labeled streptavidin (Perkin Elmer), the solution is pre-incubated for 15 minutes at room temperature, then 10 nM Cy5-p53 peptide (internal preparation) is added before an incubation at room temperature for 15 minutes prior to reading the plate. For measurement of samples, a Victor II microplate reader (Perkin Elmer) is used with the following settings: Excitation 340 nm, Emission Donor 620 nm and Emission Acceptor 665 nm. For selected compounds displaying IC50s between 0.05 and 5 nM on MDM2, a slightly modified assay is used with the following adaptations: 0.1 nM MDM2, 0.1 nM Europium labeled streptavidin and Tecan genios Pro is used as a microplate reader for the fluorescence measurements (p53-MDM2 Assay 2).",B,,,BAO_0000190,BAO_0000224,protein format,COc1nc(N(C)C)ncc1-c1cc2c(n1C(C)C)C(c1ccc(C#N)cc1)N(c1cc(Cl)c[nH]c1=O)C2=O,,,CHEMBL3886789,,2016,"{'bei': '17.36', 'le': '0.33', 'lle': '4.88', 'sei': '7.86'}",CHEMBL3925187,,CHEMBL3925187,9.45,False,http://www.openphacts.org/units/Nanomolar,2885966,=,37,True,=,,IC50,nM,,0.359,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,0.359
411759,17776575,[],CHEMBL3888635,"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: Assay 2: The test is performed in white 384-well plates (Greiner Bio-One, reference 781207) in a total volume of 60 L by adding 1 L of compounds tested at different concentrations diluted in 100% DMSO (1.7% final DMSO concentration) in reaction buffer (PBS, 125 mM NaCl, 0.001% Novexin (consists of carbohydrate polymers), designed to increase the solubility and stability of proteins; Expedeon Ltd., Cambridgeshire, United Kingdom), 0.01% Gelatin, 0.01% 0.2%, Pluronic F-127 (block copolymer from ethylenoxide and propyleneoxide), 1 mM DTT). After addition of 1.25 nM MDM2-biotinylated or 2.5 nM MDM4-biotinylated (internal preparations), and 0.625 nM Europium labeled streptavidin (Perkin Elmer), the solution is pre-incubated for 15 minutes at room temperature, then 10 nM Cy5-p53 peptide (internal preparation) is added before an incubation at room temperature for 15 minutes prior to reading the plate. For measurement of samples, a Victor II microplate reader (Perkin Elmer) is used with the following settings: Excitation 340 nm, Emission Donor 620 nm and Emission Acceptor 665 nm. For selected compounds displaying IC50s between 0.05 and 5 nM on MDM2, a slightly modified assay is used with the following adaptations: 0.1 nM MDM2, 0.1 nM Europium labeled streptavidin and Tecan genios Pro is used as a microplate reader for the fluorescence measurements (p53-MDM2 Assay 2).",B,,,BAO_0000190,BAO_0000224,protein format,CNc1ncc(-c2cc3c(n2C(C)C)C(c2ccc(C#N)cc2)N(c2cc(Cl)c[nH]c2=O)C3=O)c(OC)n1,,,CHEMBL3886789,,2016,"{'bei': '17.51', 'le': '0.33', 'lle': '4.74', 'sei': '7.20'}",CHEMBL3985001,,CHEMBL3985001,9.28,False,http://www.openphacts.org/units/Nanomolar,2885967,=,37,True,=,,IC50,nM,,0.527,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,0.527
411760,17776576,[],CHEMBL3888635,"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: Assay 2: The test is performed in white 384-well plates (Greiner Bio-One, reference 781207) in a total volume of 60 L by adding 1 L of compounds tested at different concentrations diluted in 100% DMSO (1.7% final DMSO concentration) in reaction buffer (PBS, 125 mM NaCl, 0.001% Novexin (consists of carbohydrate polymers), designed to increase the solubility and stability of proteins; Expedeon Ltd., Cambridgeshire, United Kingdom), 0.01% Gelatin, 0.01% 0.2%, Pluronic F-127 (block copolymer from ethylenoxide and propyleneoxide), 1 mM DTT). After addition of 1.25 nM MDM2-biotinylated or 2.5 nM MDM4-biotinylated (internal preparations), and 0.625 nM Europium labeled streptavidin (Perkin Elmer), the solution is pre-incubated for 15 minutes at room temperature, then 10 nM Cy5-p53 peptide (internal preparation) is added before an incubation at room temperature for 15 minutes prior to reading the plate. For measurement of samples, a Victor II microplate reader (Perkin Elmer) is used with the following settings: Excitation 340 nm, Emission Donor 620 nm and Emission Acceptor 665 nm. For selected compounds displaying IC50s between 0.05 and 5 nM on MDM2, a slightly modified assay is used with the following adaptations: 0.1 nM MDM2, 0.1 nM Europium labeled streptavidin and Tecan genios Pro is used as a microplate reader for the fluorescence measurements (p53-MDM2 Assay 2).",B,,,BAO_0000190,BAO_0000224,protein format,COc1nc(N)ncc1-c1cc2c(n1C(C)C)C(c1ccc(C#N)cc1)N(c1cc(Cl)cn(C)c1=O)C2=O,,,CHEMBL3886789,,2016,"{'bei': '15.56', 'le': '0.30', 'lle': '4.16', 'sei': '6.25'}",CHEMBL3919729,,CHEMBL3919729,8.25,False,http://www.openphacts.org/units/Nanomolar,2885968,=,37,True,=,,IC50,nM,,5.658,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,5.658
411761,17776577,[],CHEMBL3888635,"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: Assay 2: The test is performed in white 384-well plates (Greiner Bio-One, reference 781207) in a total volume of 60 L by adding 1 L of compounds tested at different concentrations diluted in 100% DMSO (1.7% final DMSO concentration) in reaction buffer (PBS, 125 mM NaCl, 0.001% Novexin (consists of carbohydrate polymers), designed to increase the solubility and stability of proteins; Expedeon Ltd., Cambridgeshire, United Kingdom), 0.01% Gelatin, 0.01% 0.2%, Pluronic F-127 (block copolymer from ethylenoxide and propyleneoxide), 1 mM DTT). After addition of 1.25 nM MDM2-biotinylated or 2.5 nM MDM4-biotinylated (internal preparations), and 0.625 nM Europium labeled streptavidin (Perkin Elmer), the solution is pre-incubated for 15 minutes at room temperature, then 10 nM Cy5-p53 peptide (internal preparation) is added before an incubation at room temperature for 15 minutes prior to reading the plate. For measurement of samples, a Victor II microplate reader (Perkin Elmer) is used with the following settings: Excitation 340 nm, Emission Donor 620 nm and Emission Acceptor 665 nm. For selected compounds displaying IC50s between 0.05 and 5 nM on MDM2, a slightly modified assay is used with the following adaptations: 0.1 nM MDM2, 0.1 nM Europium labeled streptavidin and Tecan genios Pro is used as a microplate reader for the fluorescence measurements (p53-MDM2 Assay 2).",B,,,BAO_0000190,BAO_0000224,protein format,CNc1ncc(-c2cc3c(n2C(C)C)C(c2ccc(C#N)cc2)N(c2cc(Cl)cn(C)c2=O)C3=O)c(OC)n1,,,CHEMBL3886789,,2016,"{'bei': '16.49', 'le': '0.31', 'lle': '4.42', 'sei': '7.60'}",CHEMBL3947519,,CHEMBL3947519,8.97,False,http://www.openphacts.org/units/Nanomolar,2885969,=,37,True,=,,IC50,nM,,1.076,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,1.076
411762,17776578,[],CHEMBL3888635,"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: Assay 2: The test is performed in white 384-well plates (Greiner Bio-One, reference 781207) in a total volume of 60 L by adding 1 L of compounds tested at different concentrations diluted in 100% DMSO (1.7% final DMSO concentration) in reaction buffer (PBS, 125 mM NaCl, 0.001% Novexin (consists of carbohydrate polymers), designed to increase the solubility and stability of proteins; Expedeon Ltd., Cambridgeshire, United Kingdom), 0.01% Gelatin, 0.01% 0.2%, Pluronic F-127 (block copolymer from ethylenoxide and propyleneoxide), 1 mM DTT). After addition of 1.25 nM MDM2-biotinylated or 2.5 nM MDM4-biotinylated (internal preparations), and 0.625 nM Europium labeled streptavidin (Perkin Elmer), the solution is pre-incubated for 15 minutes at room temperature, then 10 nM Cy5-p53 peptide (internal preparation) is added before an incubation at room temperature for 15 minutes prior to reading the plate. For measurement of samples, a Victor II microplate reader (Perkin Elmer) is used with the following settings: Excitation 340 nm, Emission Donor 620 nm and Emission Acceptor 665 nm. For selected compounds displaying IC50s between 0.05 and 5 nM on MDM2, a slightly modified assay is used with the following adaptations: 0.1 nM MDM2, 0.1 nM Europium labeled streptavidin and Tecan genios Pro is used as a microplate reader for the fluorescence measurements (p53-MDM2 Assay 2).",B,,,BAO_0000190,BAO_0000224,protein format,COc1nc(N(C)C)ncc1-c1cc2c(n1C(C)C)C(c1ccc(C#N)cc1)N(c1cc(Cl)cn(C)c1=O)C2=O,,,CHEMBL3886789,,2016,"{'bei': '17.08', 'le': '0.33', 'lle': '4.96', 'sei': '8.72'}",CHEMBL3910791,,CHEMBL3910791,9.53,False,http://www.openphacts.org/units/Nanomolar,2885970,=,37,True,=,,IC50,nM,,0.295,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,0.295
411763,17776579,[],CHEMBL3888635,"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: Assay 2: The test is performed in white 384-well plates (Greiner Bio-One, reference 781207) in a total volume of 60 L by adding 1 L of compounds tested at different concentrations diluted in 100% DMSO (1.7% final DMSO concentration) in reaction buffer (PBS, 125 mM NaCl, 0.001% Novexin (consists of carbohydrate polymers), designed to increase the solubility and stability of proteins; Expedeon Ltd., Cambridgeshire, United Kingdom), 0.01% Gelatin, 0.01% 0.2%, Pluronic F-127 (block copolymer from ethylenoxide and propyleneoxide), 1 mM DTT). After addition of 1.25 nM MDM2-biotinylated or 2.5 nM MDM4-biotinylated (internal preparations), and 0.625 nM Europium labeled streptavidin (Perkin Elmer), the solution is pre-incubated for 15 minutes at room temperature, then 10 nM Cy5-p53 peptide (internal preparation) is added before an incubation at room temperature for 15 minutes prior to reading the plate. For measurement of samples, a Victor II microplate reader (Perkin Elmer) is used with the following settings: Excitation 340 nm, Emission Donor 620 nm and Emission Acceptor 665 nm. For selected compounds displaying IC50s between 0.05 and 5 nM on MDM2, a slightly modified assay is used with the following adaptations: 0.1 nM MDM2, 0.1 nM Europium labeled streptavidin and Tecan genios Pro is used as a microplate reader for the fluorescence measurements (p53-MDM2 Assay 2).",B,,,BAO_0000190,BAO_0000224,protein format,COc1ncc(-c2cc3c(n2C(C)C)C(c2ccc(C#N)cc2)N(c2cc(Cl)cn(C)c2=O)C3=O)c(OC)n1,,,CHEMBL3886789,,2016,"{'bei': '16.40', 'le': '0.31', 'lle': '4.42', 'sei': '7.76'}",CHEMBL3935157,,CHEMBL3935157,8.94,False,http://www.openphacts.org/units/Nanomolar,2885971,=,37,True,=,,IC50,nM,,1.15,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,1.15
411764,17776580,[],CHEMBL3888635,"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: Assay 2: The test is performed in white 384-well plates (Greiner Bio-One, reference 781207) in a total volume of 60 L by adding 1 L of compounds tested at different concentrations diluted in 100% DMSO (1.7% final DMSO concentration) in reaction buffer (PBS, 125 mM NaCl, 0.001% Novexin (consists of carbohydrate polymers), designed to increase the solubility and stability of proteins; Expedeon Ltd., Cambridgeshire, United Kingdom), 0.01% Gelatin, 0.01% 0.2%, Pluronic F-127 (block copolymer from ethylenoxide and propyleneoxide), 1 mM DTT). After addition of 1.25 nM MDM2-biotinylated or 2.5 nM MDM4-biotinylated (internal preparations), and 0.625 nM Europium labeled streptavidin (Perkin Elmer), the solution is pre-incubated for 15 minutes at room temperature, then 10 nM Cy5-p53 peptide (internal preparation) is added before an incubation at room temperature for 15 minutes prior to reading the plate. For measurement of samples, a Victor II microplate reader (Perkin Elmer) is used with the following settings: Excitation 340 nm, Emission Donor 620 nm and Emission Acceptor 665 nm. For selected compounds displaying IC50s between 0.05 and 5 nM on MDM2, a slightly modified assay is used with the following adaptations: 0.1 nM MDM2, 0.1 nM Europium labeled streptavidin and Tecan genios Pro is used as a microplate reader for the fluorescence measurements (p53-MDM2 Assay 2).",B,,,BAO_0000190,BAO_0000224,protein format,CNc1ncc(-c2cc3c(n2C(C)C)C(c2ccc(C#N)cc2)N(c2cc(Cl)c(=O)n(C)c2)C3=O)c(OC)n1,,,CHEMBL3886789,,2016,"{'bei': '17.44', 'le': '0.33', 'lle': '4.94', 'sei': '8.03'}",CHEMBL3958779,,CHEMBL3958779,9.48,False,http://www.openphacts.org/units/Nanomolar,2885972,=,37,True,=,,IC50,nM,,0.327,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,0.327
411765,17776581,[],CHEMBL3888635,"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: Assay 2: The test is performed in white 384-well plates (Greiner Bio-One, reference 781207) in a total volume of 60 L by adding 1 L of compounds tested at different concentrations diluted in 100% DMSO (1.7% final DMSO concentration) in reaction buffer (PBS, 125 mM NaCl, 0.001% Novexin (consists of carbohydrate polymers), designed to increase the solubility and stability of proteins; Expedeon Ltd., Cambridgeshire, United Kingdom), 0.01% Gelatin, 0.01% 0.2%, Pluronic F-127 (block copolymer from ethylenoxide and propyleneoxide), 1 mM DTT). After addition of 1.25 nM MDM2-biotinylated or 2.5 nM MDM4-biotinylated (internal preparations), and 0.625 nM Europium labeled streptavidin (Perkin Elmer), the solution is pre-incubated for 15 minutes at room temperature, then 10 nM Cy5-p53 peptide (internal preparation) is added before an incubation at room temperature for 15 minutes prior to reading the plate. For measurement of samples, a Victor II microplate reader (Perkin Elmer) is used with the following settings: Excitation 340 nm, Emission Donor 620 nm and Emission Acceptor 665 nm. For selected compounds displaying IC50s between 0.05 and 5 nM on MDM2, a slightly modified assay is used with the following adaptations: 0.1 nM MDM2, 0.1 nM Europium labeled streptavidin and Tecan genios Pro is used as a microplate reader for the fluorescence measurements (p53-MDM2 Assay 2).",B,,,BAO_0000190,BAO_0000224,protein format,COc1nc(N)ncc1-c1cc2c(n1C(C)C)C(c1ccc(C#N)cc1)N(c1c[nH]c(=O)c(Cl)c1)C2=O,,,CHEMBL3886789,,2016,"{'bei': '17.25', 'le': '0.33', 'lle': '4.82', 'sei': '6.23'}",CHEMBL3927773,,CHEMBL3927773,8.90,False,http://www.openphacts.org/units/Nanomolar,2885973,=,37,True,=,,IC50,nM,,1.252,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,1.252
411766,17776582,[],CHEMBL3888635,"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: Assay 2: The test is performed in white 384-well plates (Greiner Bio-One, reference 781207) in a total volume of 60 L by adding 1 L of compounds tested at different concentrations diluted in 100% DMSO (1.7% final DMSO concentration) in reaction buffer (PBS, 125 mM NaCl, 0.001% Novexin (consists of carbohydrate polymers), designed to increase the solubility and stability of proteins; Expedeon Ltd., Cambridgeshire, United Kingdom), 0.01% Gelatin, 0.01% 0.2%, Pluronic F-127 (block copolymer from ethylenoxide and propyleneoxide), 1 mM DTT). After addition of 1.25 nM MDM2-biotinylated or 2.5 nM MDM4-biotinylated (internal preparations), and 0.625 nM Europium labeled streptavidin (Perkin Elmer), the solution is pre-incubated for 15 minutes at room temperature, then 10 nM Cy5-p53 peptide (internal preparation) is added before an incubation at room temperature for 15 minutes prior to reading the plate. For measurement of samples, a Victor II microplate reader (Perkin Elmer) is used with the following settings: Excitation 340 nm, Emission Donor 620 nm and Emission Acceptor 665 nm. For selected compounds displaying IC50s between 0.05 and 5 nM on MDM2, a slightly modified assay is used with the following adaptations: 0.1 nM MDM2, 0.1 nM Europium labeled streptavidin and Tecan genios Pro is used as a microplate reader for the fluorescence measurements (p53-MDM2 Assay 2).",B,,,BAO_0000190,BAO_0000224,protein format,COc1ncc(-c2cc3c(n2C(C)C)C(c2ccc(C#N)cc2)N(c2c[nH]c(=O)c(Cl)c2)C3=O)c(OC)n1,,,CHEMBL3886789,,2016,"{'bei': '17.65', 'le': '0.34', 'lle': '4.86', 'sei': '7.43'}",CHEMBL3961386,,CHEMBL3961386,9.37,False,http://www.openphacts.org/units/Nanomolar,2885974,=,37,True,=,,IC50,nM,,0.427,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,0.427
411767,17776583,[],CHEMBL3888635,"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: Assay 2: The test is performed in white 384-well plates (Greiner Bio-One, reference 781207) in a total volume of 60 L by adding 1 L of compounds tested at different concentrations diluted in 100% DMSO (1.7% final DMSO concentration) in reaction buffer (PBS, 125 mM NaCl, 0.001% Novexin (consists of carbohydrate polymers), designed to increase the solubility and stability of proteins; Expedeon Ltd., Cambridgeshire, United Kingdom), 0.01% Gelatin, 0.01% 0.2%, Pluronic F-127 (block copolymer from ethylenoxide and propyleneoxide), 1 mM DTT). After addition of 1.25 nM MDM2-biotinylated or 2.5 nM MDM4-biotinylated (internal preparations), and 0.625 nM Europium labeled streptavidin (Perkin Elmer), the solution is pre-incubated for 15 minutes at room temperature, then 10 nM Cy5-p53 peptide (internal preparation) is added before an incubation at room temperature for 15 minutes prior to reading the plate. For measurement of samples, a Victor II microplate reader (Perkin Elmer) is used with the following settings: Excitation 340 nm, Emission Donor 620 nm and Emission Acceptor 665 nm. For selected compounds displaying IC50s between 0.05 and 5 nM on MDM2, a slightly modified assay is used with the following adaptations: 0.1 nM MDM2, 0.1 nM Europium labeled streptavidin and Tecan genios Pro is used as a microplate reader for the fluorescence measurements (p53-MDM2 Assay 2).",B,,,BAO_0000190,BAO_0000224,protein format,COc1nc(N(C)C)ncc1-c1cc2c(n1C(C)C)C(c1ccc(C#N)cc1)N(c1c[nH]c(=O)c(Cl)c1)C2=O,,,CHEMBL3886789,,2016,"{'bei': '18.17', 'le': '0.35', 'lle': '5.32', 'sei': '8.23'}",CHEMBL3922357,,CHEMBL3922357,9.88,False,http://www.openphacts.org/units/Nanomolar,2885975,=,37,True,=,,IC50,nM,,0.131,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,0.131
411768,17776584,[],CHEMBL3888635,"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: Assay 2: The test is performed in white 384-well plates (Greiner Bio-One, reference 781207) in a total volume of 60 L by adding 1 L of compounds tested at different concentrations diluted in 100% DMSO (1.7% final DMSO concentration) in reaction buffer (PBS, 125 mM NaCl, 0.001% Novexin (consists of carbohydrate polymers), designed to increase the solubility and stability of proteins; Expedeon Ltd., Cambridgeshire, United Kingdom), 0.01% Gelatin, 0.01% 0.2%, Pluronic F-127 (block copolymer from ethylenoxide and propyleneoxide), 1 mM DTT). After addition of 1.25 nM MDM2-biotinylated or 2.5 nM MDM4-biotinylated (internal preparations), and 0.625 nM Europium labeled streptavidin (Perkin Elmer), the solution is pre-incubated for 15 minutes at room temperature, then 10 nM Cy5-p53 peptide (internal preparation) is added before an incubation at room temperature for 15 minutes prior to reading the plate. For measurement of samples, a Victor II microplate reader (Perkin Elmer) is used with the following settings: Excitation 340 nm, Emission Donor 620 nm and Emission Acceptor 665 nm. For selected compounds displaying IC50s between 0.05 and 5 nM on MDM2, a slightly modified assay is used with the following adaptations: 0.1 nM MDM2, 0.1 nM Europium labeled streptavidin and Tecan genios Pro is used as a microplate reader for the fluorescence measurements (p53-MDM2 Assay 2).",B,,,BAO_0000190,BAO_0000224,protein format,CNc1ncc(-c2cc3c(n2C(C)C)C(c2ccc(C#N)cc2)N(c2c[nH]c(=O)c(Cl)c2)C3=O)c(OC)n1,,,CHEMBL3886789,,2016,"{'bei': '17.91', 'le': '0.34', 'lle': '4.95', 'sei': '7.36'}",CHEMBL3975023,,CHEMBL3975023,9.49,False,http://www.openphacts.org/units/Nanomolar,2885976,=,37,True,=,,IC50,nM,,0.321,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,0.321
411769,17776585,[],CHEMBL3888635,"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: Assay 2: The test is performed in white 384-well plates (Greiner Bio-One, reference 781207) in a total volume of 60 L by adding 1 L of compounds tested at different concentrations diluted in 100% DMSO (1.7% final DMSO concentration) in reaction buffer (PBS, 125 mM NaCl, 0.001% Novexin (consists of carbohydrate polymers), designed to increase the solubility and stability of proteins; Expedeon Ltd., Cambridgeshire, United Kingdom), 0.01% Gelatin, 0.01% 0.2%, Pluronic F-127 (block copolymer from ethylenoxide and propyleneoxide), 1 mM DTT). After addition of 1.25 nM MDM2-biotinylated or 2.5 nM MDM4-biotinylated (internal preparations), and 0.625 nM Europium labeled streptavidin (Perkin Elmer), the solution is pre-incubated for 15 minutes at room temperature, then 10 nM Cy5-p53 peptide (internal preparation) is added before an incubation at room temperature for 15 minutes prior to reading the plate. For measurement of samples, a Victor II microplate reader (Perkin Elmer) is used with the following settings: Excitation 340 nm, Emission Donor 620 nm and Emission Acceptor 665 nm. For selected compounds displaying IC50s between 0.05 and 5 nM on MDM2, a slightly modified assay is used with the following adaptations: 0.1 nM MDM2, 0.1 nM Europium labeled streptavidin and Tecan genios Pro is used as a microplate reader for the fluorescence measurements (p53-MDM2 Assay 2).",B,,,BAO_0000190,BAO_0000224,protein format,COc1nc(N)ncc1-c1cc2c(n1C(C)C)C(c1ccc(Cl)cc1)N(c1c[nH]c(=O)c(Cl)c1)C2=O,,,CHEMBL3886789,,2016,"{'bei': '18.02', 'le': '0.36', 'lle': '4.61', 'sei': '7.95'}",CHEMBL3949094,,CHEMBL3949094,9.47,False,http://www.openphacts.org/units/Nanomolar,2885977,=,37,True,=,,IC50,nM,,0.341,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,0.341
411770,17776586,[],CHEMBL3888635,"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: Assay 2: The test is performed in white 384-well plates (Greiner Bio-One, reference 781207) in a total volume of 60 L by adding 1 L of compounds tested at different concentrations diluted in 100% DMSO (1.7% final DMSO concentration) in reaction buffer (PBS, 125 mM NaCl, 0.001% Novexin (consists of carbohydrate polymers), designed to increase the solubility and stability of proteins; Expedeon Ltd., Cambridgeshire, United Kingdom), 0.01% Gelatin, 0.01% 0.2%, Pluronic F-127 (block copolymer from ethylenoxide and propyleneoxide), 1 mM DTT). After addition of 1.25 nM MDM2-biotinylated or 2.5 nM MDM4-biotinylated (internal preparations), and 0.625 nM Europium labeled streptavidin (Perkin Elmer), the solution is pre-incubated for 15 minutes at room temperature, then 10 nM Cy5-p53 peptide (internal preparation) is added before an incubation at room temperature for 15 minutes prior to reading the plate. For measurement of samples, a Victor II microplate reader (Perkin Elmer) is used with the following settings: Excitation 340 nm, Emission Donor 620 nm and Emission Acceptor 665 nm. For selected compounds displaying IC50s between 0.05 and 5 nM on MDM2, a slightly modified assay is used with the following adaptations: 0.1 nM MDM2, 0.1 nM Europium labeled streptavidin and Tecan genios Pro is used as a microplate reader for the fluorescence measurements (p53-MDM2 Assay 2).",B,,,BAO_0000190,BAO_0000224,protein format,COc1ncc(-c2cc3c(n2C(C)C)C(c2ccc(Cl)cc2)N(c2c[nH]c(=O)c(Cl)c2)C3=O)c(OC)n1,,,CHEMBL3886789,,2016,"{'bei': '17.72', 'le': '0.35', 'lle': '4.29', 'sei': '9.36'}",CHEMBL3966525,,CHEMBL3966525,9.57,False,http://www.openphacts.org/units/Nanomolar,2885978,=,37,True,=,,IC50,nM,,0.266,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,0.266
411771,17776587,[],CHEMBL3888635,"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: Assay 2: The test is performed in white 384-well plates (Greiner Bio-One, reference 781207) in a total volume of 60 L by adding 1 L of compounds tested at different concentrations diluted in 100% DMSO (1.7% final DMSO concentration) in reaction buffer (PBS, 125 mM NaCl, 0.001% Novexin (consists of carbohydrate polymers), designed to increase the solubility and stability of proteins; Expedeon Ltd., Cambridgeshire, United Kingdom), 0.01% Gelatin, 0.01% 0.2%, Pluronic F-127 (block copolymer from ethylenoxide and propyleneoxide), 1 mM DTT). After addition of 1.25 nM MDM2-biotinylated or 2.5 nM MDM4-biotinylated (internal preparations), and 0.625 nM Europium labeled streptavidin (Perkin Elmer), the solution is pre-incubated for 15 minutes at room temperature, then 10 nM Cy5-p53 peptide (internal preparation) is added before an incubation at room temperature for 15 minutes prior to reading the plate. For measurement of samples, a Victor II microplate reader (Perkin Elmer) is used with the following settings: Excitation 340 nm, Emission Donor 620 nm and Emission Acceptor 665 nm. For selected compounds displaying IC50s between 0.05 and 5 nM on MDM2, a slightly modified assay is used with the following adaptations: 0.1 nM MDM2, 0.1 nM Europium labeled streptavidin and Tecan genios Pro is used as a microplate reader for the fluorescence measurements (p53-MDM2 Assay 2).",B,,,BAO_0000190,BAO_0000224,protein format,COc1nc(N(C)C)ncc1-c1cc2c(n1C(C)C)C(c1ccc(Cl)cc1)N(c1c[nH]c(=O)c(Cl)c1)C2=O,,,CHEMBL3886789,,2016,"{'bei': '17.41', 'le': '0.35', 'lle': '4.29', 'sei': '10.00'}",CHEMBL3936752,,CHEMBL3936752,9.64,False,http://www.openphacts.org/units/Nanomolar,2885979,=,37,True,=,,IC50,nM,,0.231,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,0.231
411772,17776588,[],CHEMBL3888635,"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: Assay 2: The test is performed in white 384-well plates (Greiner Bio-One, reference 781207) in a total volume of 60 L by adding 1 L of compounds tested at different concentrations diluted in 100% DMSO (1.7% final DMSO concentration) in reaction buffer (PBS, 125 mM NaCl, 0.001% Novexin (consists of carbohydrate polymers), designed to increase the solubility and stability of proteins; Expedeon Ltd., Cambridgeshire, United Kingdom), 0.01% Gelatin, 0.01% 0.2%, Pluronic F-127 (block copolymer from ethylenoxide and propyleneoxide), 1 mM DTT). After addition of 1.25 nM MDM2-biotinylated or 2.5 nM MDM4-biotinylated (internal preparations), and 0.625 nM Europium labeled streptavidin (Perkin Elmer), the solution is pre-incubated for 15 minutes at room temperature, then 10 nM Cy5-p53 peptide (internal preparation) is added before an incubation at room temperature for 15 minutes prior to reading the plate. For measurement of samples, a Victor II microplate reader (Perkin Elmer) is used with the following settings: Excitation 340 nm, Emission Donor 620 nm and Emission Acceptor 665 nm. For selected compounds displaying IC50s between 0.05 and 5 nM on MDM2, a slightly modified assay is used with the following adaptations: 0.1 nM MDM2, 0.1 nM Europium labeled streptavidin and Tecan genios Pro is used as a microplate reader for the fluorescence measurements (p53-MDM2 Assay 2).",B,,,BAO_0000190,BAO_0000224,protein format,COc1nc(N)ncc1-c1cc2c(n1C(C)C)C(c1ccc(Cl)cc1)N([C@H]1CC[C@H](OC)CC1)C2=O,,,CHEMBL3886789,,2016,"{'bei': '16.01', 'le': '0.31', 'lle': '2.89', 'sei': '8.55'}",CHEMBL3968623,,CHEMBL3968623,8.16,False,http://www.openphacts.org/units/Nanomolar,2885980,=,37,True,=,,IC50,nM,,6.845,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,6.845
411773,17776589,[],CHEMBL3888635,"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: Assay 2: The test is performed in white 384-well plates (Greiner Bio-One, reference 781207) in a total volume of 60 L by adding 1 L of compounds tested at different concentrations diluted in 100% DMSO (1.7% final DMSO concentration) in reaction buffer (PBS, 125 mM NaCl, 0.001% Novexin (consists of carbohydrate polymers), designed to increase the solubility and stability of proteins; Expedeon Ltd., Cambridgeshire, United Kingdom), 0.01% Gelatin, 0.01% 0.2%, Pluronic F-127 (block copolymer from ethylenoxide and propyleneoxide), 1 mM DTT). After addition of 1.25 nM MDM2-biotinylated or 2.5 nM MDM4-biotinylated (internal preparations), and 0.625 nM Europium labeled streptavidin (Perkin Elmer), the solution is pre-incubated for 15 minutes at room temperature, then 10 nM Cy5-p53 peptide (internal preparation) is added before an incubation at room temperature for 15 minutes prior to reading the plate. For measurement of samples, a Victor II microplate reader (Perkin Elmer) is used with the following settings: Excitation 340 nm, Emission Donor 620 nm and Emission Acceptor 665 nm. For selected compounds displaying IC50s between 0.05 and 5 nM on MDM2, a slightly modified assay is used with the following adaptations: 0.1 nM MDM2, 0.1 nM Europium labeled streptavidin and Tecan genios Pro is used as a microplate reader for the fluorescence measurements (p53-MDM2 Assay 2).",B,,,BAO_0000190,BAO_0000224,protein format,COc1nc(N(C)C)ncc1-c1cc2c(n1C(C)C)C(c1ccc(Cl)cc1)N([C@H]1CC[C@H](OC)CC1)C2=O,,,CHEMBL3886789,,2016,"{'bei': '16.97', 'le': '0.33', 'lle': '3.37', 'sei': '12.56'}",CHEMBL3895549,,CHEMBL3895549,9.13,False,http://www.openphacts.org/units/Nanomolar,2885981,=,37,True,=,,IC50,nM,,0.74,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,0.74
411774,17776590,[],CHEMBL3888635,"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: Assay 2: The test is performed in white 384-well plates (Greiner Bio-One, reference 781207) in a total volume of 60 L by adding 1 L of compounds tested at different concentrations diluted in 100% DMSO (1.7% final DMSO concentration) in reaction buffer (PBS, 125 mM NaCl, 0.001% Novexin (consists of carbohydrate polymers), designed to increase the solubility and stability of proteins; Expedeon Ltd., Cambridgeshire, United Kingdom), 0.01% Gelatin, 0.01% 0.2%, Pluronic F-127 (block copolymer from ethylenoxide and propyleneoxide), 1 mM DTT). After addition of 1.25 nM MDM2-biotinylated or 2.5 nM MDM4-biotinylated (internal preparations), and 0.625 nM Europium labeled streptavidin (Perkin Elmer), the solution is pre-incubated for 15 minutes at room temperature, then 10 nM Cy5-p53 peptide (internal preparation) is added before an incubation at room temperature for 15 minutes prior to reading the plate. For measurement of samples, a Victor II microplate reader (Perkin Elmer) is used with the following settings: Excitation 340 nm, Emission Donor 620 nm and Emission Acceptor 665 nm. For selected compounds displaying IC50s between 0.05 and 5 nM on MDM2, a slightly modified assay is used with the following adaptations: 0.1 nM MDM2, 0.1 nM Europium labeled streptavidin and Tecan genios Pro is used as a microplate reader for the fluorescence measurements (p53-MDM2 Assay 2).",B,,,BAO_0000190,BAO_0000224,protein format,COc1ncc(-c2cc3c(n2C(C)C)C(c2ccc(Cl)cc2)N([C@H]2CC[C@H](OC)CC2)C3=O)c(OC)n1,,,CHEMBL3886789,,2016,"{'bei': '16.71', 'le': '0.32', 'lle': '3.07', 'sei': '11.15'}",CHEMBL3949558,,CHEMBL3949558,8.77,False,http://www.openphacts.org/units/Nanomolar,2885982,=,37,True,=,,IC50,nM,,1.688,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,1.688
411775,17776591,[],CHEMBL3888635,"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: Assay 2: The test is performed in white 384-well plates (Greiner Bio-One, reference 781207) in a total volume of 60 L by adding 1 L of compounds tested at different concentrations diluted in 100% DMSO (1.7% final DMSO concentration) in reaction buffer (PBS, 125 mM NaCl, 0.001% Novexin (consists of carbohydrate polymers), designed to increase the solubility and stability of proteins; Expedeon Ltd., Cambridgeshire, United Kingdom), 0.01% Gelatin, 0.01% 0.2%, Pluronic F-127 (block copolymer from ethylenoxide and propyleneoxide), 1 mM DTT). After addition of 1.25 nM MDM2-biotinylated or 2.5 nM MDM4-biotinylated (internal preparations), and 0.625 nM Europium labeled streptavidin (Perkin Elmer), the solution is pre-incubated for 15 minutes at room temperature, then 10 nM Cy5-p53 peptide (internal preparation) is added before an incubation at room temperature for 15 minutes prior to reading the plate. For measurement of samples, a Victor II microplate reader (Perkin Elmer) is used with the following settings: Excitation 340 nm, Emission Donor 620 nm and Emission Acceptor 665 nm. For selected compounds displaying IC50s between 0.05 and 5 nM on MDM2, a slightly modified assay is used with the following adaptations: 0.1 nM MDM2, 0.1 nM Europium labeled streptavidin and Tecan genios Pro is used as a microplate reader for the fluorescence measurements (p53-MDM2 Assay 2).",B,,,BAO_0000190,BAO_0000224,protein format,COc1ccccc1-c1cc2c(n1C(C)C)C(c1ccc(Cl)cc1C)N(c1cc(Cl)c(=O)n(C)c1)C2=O,,,CHEMBL3886789,,2016,"{'bei': '17.25', 'le': '0.34', 'lle': '2.45', 'sei': '16.39'}",CHEMBL3978626,,CHEMBL3978626,9.26,False,http://www.openphacts.org/units/Nanomolar,2885983,=,37,True,=,,IC50,nM,,0.554,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,0.554
411776,17776592,[],CHEMBL3888635,"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: Assay 2: The test is performed in white 384-well plates (Greiner Bio-One, reference 781207) in a total volume of 60 L by adding 1 L of compounds tested at different concentrations diluted in 100% DMSO (1.7% final DMSO concentration) in reaction buffer (PBS, 125 mM NaCl, 0.001% Novexin (consists of carbohydrate polymers), designed to increase the solubility and stability of proteins; Expedeon Ltd., Cambridgeshire, United Kingdom), 0.01% Gelatin, 0.01% 0.2%, Pluronic F-127 (block copolymer from ethylenoxide and propyleneoxide), 1 mM DTT). After addition of 1.25 nM MDM2-biotinylated or 2.5 nM MDM4-biotinylated (internal preparations), and 0.625 nM Europium labeled streptavidin (Perkin Elmer), the solution is pre-incubated for 15 minutes at room temperature, then 10 nM Cy5-p53 peptide (internal preparation) is added before an incubation at room temperature for 15 minutes prior to reading the plate. For measurement of samples, a Victor II microplate reader (Perkin Elmer) is used with the following settings: Excitation 340 nm, Emission Donor 620 nm and Emission Acceptor 665 nm. For selected compounds displaying IC50s between 0.05 and 5 nM on MDM2, a slightly modified assay is used with the following adaptations: 0.1 nM MDM2, 0.1 nM Europium labeled streptavidin and Tecan genios Pro is used as a microplate reader for the fluorescence measurements (p53-MDM2 Assay 2).",B,,,BAO_0000190,BAO_0000224,protein format,CNC(=O)c1ccc(OC)c(-c2cc3c(n2C(C)C)C(c2ccc(Cl)cc2C)N(c2cc(Cl)c(=O)n(C)c2)C3=O)c1,,,CHEMBL3886789,,2016,"{'bei': '16.39', 'le': '0.32', 'lle': '3.56', 'sei': '11.37'}",CHEMBL3961681,,CHEMBL3961681,9.73,False,http://www.openphacts.org/units/Nanomolar,2885984,=,37,True,=,,IC50,nM,,0.187,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,0.187
411777,17776593,[],CHEMBL3888635,"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: Assay 2: The test is performed in white 384-well plates (Greiner Bio-One, reference 781207) in a total volume of 60 L by adding 1 L of compounds tested at different concentrations diluted in 100% DMSO (1.7% final DMSO concentration) in reaction buffer (PBS, 125 mM NaCl, 0.001% Novexin (consists of carbohydrate polymers), designed to increase the solubility and stability of proteins; Expedeon Ltd., Cambridgeshire, United Kingdom), 0.01% Gelatin, 0.01% 0.2%, Pluronic F-127 (block copolymer from ethylenoxide and propyleneoxide), 1 mM DTT). After addition of 1.25 nM MDM2-biotinylated or 2.5 nM MDM4-biotinylated (internal preparations), and 0.625 nM Europium labeled streptavidin (Perkin Elmer), the solution is pre-incubated for 15 minutes at room temperature, then 10 nM Cy5-p53 peptide (internal preparation) is added before an incubation at room temperature for 15 minutes prior to reading the plate. For measurement of samples, a Victor II microplate reader (Perkin Elmer) is used with the following settings: Excitation 340 nm, Emission Donor 620 nm and Emission Acceptor 665 nm. For selected compounds displaying IC50s between 0.05 and 5 nM on MDM2, a slightly modified assay is used with the following adaptations: 0.1 nM MDM2, 0.1 nM Europium labeled streptavidin and Tecan genios Pro is used as a microplate reader for the fluorescence measurements (p53-MDM2 Assay 2).",B,,,BAO_0000190,BAO_0000224,protein format,COc1ncc(-c2cc3c(n2C(C)C)C(c2ccc(Cl)cc2C)N(c2cc(Cl)c(=O)n(C)c2)C3=O)c(OC)n1,,,CHEMBL3886789,,2016,"{'bei': '17.00', 'le': '0.34', 'lle': '4.06', 'sei': '10.57'}",CHEMBL3986913,,CHEMBL3986913,9.67,False,http://www.openphacts.org/units/Nanomolar,2885985,=,37,True,=,,IC50,nM,,0.216,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,0.216
411778,17776594,[],CHEMBL3888635,"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: Assay 2: The test is performed in white 384-well plates (Greiner Bio-One, reference 781207) in a total volume of 60 L by adding 1 L of compounds tested at different concentrations diluted in 100% DMSO (1.7% final DMSO concentration) in reaction buffer (PBS, 125 mM NaCl, 0.001% Novexin (consists of carbohydrate polymers), designed to increase the solubility and stability of proteins; Expedeon Ltd., Cambridgeshire, United Kingdom), 0.01% Gelatin, 0.01% 0.2%, Pluronic F-127 (block copolymer from ethylenoxide and propyleneoxide), 1 mM DTT). After addition of 1.25 nM MDM2-biotinylated or 2.5 nM MDM4-biotinylated (internal preparations), and 0.625 nM Europium labeled streptavidin (Perkin Elmer), the solution is pre-incubated for 15 minutes at room temperature, then 10 nM Cy5-p53 peptide (internal preparation) is added before an incubation at room temperature for 15 minutes prior to reading the plate. For measurement of samples, a Victor II microplate reader (Perkin Elmer) is used with the following settings: Excitation 340 nm, Emission Donor 620 nm and Emission Acceptor 665 nm. For selected compounds displaying IC50s between 0.05 and 5 nM on MDM2, a slightly modified assay is used with the following adaptations: 0.1 nM MDM2, 0.1 nM Europium labeled streptavidin and Tecan genios Pro is used as a microplate reader for the fluorescence measurements (p53-MDM2 Assay 2).",B,,,BAO_0000190,BAO_0000224,protein format,COc1nc(N(C)C)ncc1-c1cc2c(n1C(C)C)C(c1ccc(Cl)cc1C)N(c1cc(Cl)c(=O)n(C)c1)C2=O,,,CHEMBL3886789,,2016,"{'bei': '16.83', 'le': '0.33', 'lle': '4.13', 'sei': '11.45'}",CHEMBL3935262,,CHEMBL3935262,9.79,False,http://www.openphacts.org/units/Nanomolar,2885986,=,37,True,=,,IC50,nM,,0.164,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,0.164
411779,17776595,[],CHEMBL3888635,"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: Assay 2: The test is performed in white 384-well plates (Greiner Bio-One, reference 781207) in a total volume of 60 L by adding 1 L of compounds tested at different concentrations diluted in 100% DMSO (1.7% final DMSO concentration) in reaction buffer (PBS, 125 mM NaCl, 0.001% Novexin (consists of carbohydrate polymers), designed to increase the solubility and stability of proteins; Expedeon Ltd., Cambridgeshire, United Kingdom), 0.01% Gelatin, 0.01% 0.2%, Pluronic F-127 (block copolymer from ethylenoxide and propyleneoxide), 1 mM DTT). After addition of 1.25 nM MDM2-biotinylated or 2.5 nM MDM4-biotinylated (internal preparations), and 0.625 nM Europium labeled streptavidin (Perkin Elmer), the solution is pre-incubated for 15 minutes at room temperature, then 10 nM Cy5-p53 peptide (internal preparation) is added before an incubation at room temperature for 15 minutes prior to reading the plate. For measurement of samples, a Victor II microplate reader (Perkin Elmer) is used with the following settings: Excitation 340 nm, Emission Donor 620 nm and Emission Acceptor 665 nm. For selected compounds displaying IC50s between 0.05 and 5 nM on MDM2, a slightly modified assay is used with the following adaptations: 0.1 nM MDM2, 0.1 nM Europium labeled streptavidin and Tecan genios Pro is used as a microplate reader for the fluorescence measurements (p53-MDM2 Assay 2).",B,,,BAO_0000190,BAO_0000224,protein format,COc1nc(N)ncc1-c1cc2c(n1C(C)C)C(c1ccc(Cl)cc1C)N(c1cc(Cl)c(=O)n(C)c1)C2=O,,,CHEMBL3886789,,2016,"{'bei': '16.67', 'le': '0.33', 'lle': '4.05', 'sei': '8.52'}",CHEMBL3962752,,CHEMBL3962752,9.23,False,http://www.openphacts.org/units/Nanomolar,2885987,=,37,True,=,,IC50,nM,,0.592,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,0.592
411780,17776596,[],CHEMBL3888635,"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: Assay 2: The test is performed in white 384-well plates (Greiner Bio-One, reference 781207) in a total volume of 60 L by adding 1 L of compounds tested at different concentrations diluted in 100% DMSO (1.7% final DMSO concentration) in reaction buffer (PBS, 125 mM NaCl, 0.001% Novexin (consists of carbohydrate polymers), designed to increase the solubility and stability of proteins; Expedeon Ltd., Cambridgeshire, United Kingdom), 0.01% Gelatin, 0.01% 0.2%, Pluronic F-127 (block copolymer from ethylenoxide and propyleneoxide), 1 mM DTT). After addition of 1.25 nM MDM2-biotinylated or 2.5 nM MDM4-biotinylated (internal preparations), and 0.625 nM Europium labeled streptavidin (Perkin Elmer), the solution is pre-incubated for 15 minutes at room temperature, then 10 nM Cy5-p53 peptide (internal preparation) is added before an incubation at room temperature for 15 minutes prior to reading the plate. For measurement of samples, a Victor II microplate reader (Perkin Elmer) is used with the following settings: Excitation 340 nm, Emission Donor 620 nm and Emission Acceptor 665 nm. For selected compounds displaying IC50s between 0.05 and 5 nM on MDM2, a slightly modified assay is used with the following adaptations: 0.1 nM MDM2, 0.1 nM Europium labeled streptavidin and Tecan genios Pro is used as a microplate reader for the fluorescence measurements (p53-MDM2 Assay 2).",B,,,BAO_0000190,BAO_0000224,protein format,COc1cn(C)c(=O)cc1-c1cc2c(n1C(C)C)C(c1ccc(Cl)cc1)N(c1cc(Cl)ccc1C)C2=O,,,CHEMBL3886789,,2016,"{'bei': '18.56', 'le': '0.37', 'lle': '3.15', 'sei': '17.64'}",CHEMBL3940794,,CHEMBL3940794,9.96,False,http://www.openphacts.org/units/Nanomolar,2885988,=,37,True,=,,IC50,nM,,0.11,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,0.11
411781,17776597,[],CHEMBL3888635,"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: Assay 2: The test is performed in white 384-well plates (Greiner Bio-One, reference 781207) in a total volume of 60 L by adding 1 L of compounds tested at different concentrations diluted in 100% DMSO (1.7% final DMSO concentration) in reaction buffer (PBS, 125 mM NaCl, 0.001% Novexin (consists of carbohydrate polymers), designed to increase the solubility and stability of proteins; Expedeon Ltd., Cambridgeshire, United Kingdom), 0.01% Gelatin, 0.01% 0.2%, Pluronic F-127 (block copolymer from ethylenoxide and propyleneoxide), 1 mM DTT). After addition of 1.25 nM MDM2-biotinylated or 2.5 nM MDM4-biotinylated (internal preparations), and 0.625 nM Europium labeled streptavidin (Perkin Elmer), the solution is pre-incubated for 15 minutes at room temperature, then 10 nM Cy5-p53 peptide (internal preparation) is added before an incubation at room temperature for 15 minutes prior to reading the plate. For measurement of samples, a Victor II microplate reader (Perkin Elmer) is used with the following settings: Excitation 340 nm, Emission Donor 620 nm and Emission Acceptor 665 nm. For selected compounds displaying IC50s between 0.05 and 5 nM on MDM2, a slightly modified assay is used with the following adaptations: 0.1 nM MDM2, 0.1 nM Europium labeled streptavidin and Tecan genios Pro is used as a microplate reader for the fluorescence measurements (p53-MDM2 Assay 2).",B,,,BAO_0000190,BAO_0000224,protein format,COc1cn(C)c(=O)cc1-c1cc2c(n1C(C)C)C(c1ccc(Cl)cc1)N(c1cc(Cl)c(=O)n(C)c1)C2=O,,,CHEMBL3886789,,2016,"{'bei': '17.34', 'le': '0.34', 'lle': '4.40', 'sei': '12.23'}",CHEMBL3973707,,CHEMBL3973707,9.60,False,http://www.openphacts.org/units/Nanomolar,2885989,=,37,True,=,,IC50,nM,,0.254,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,0.254
411782,17776598,[],CHEMBL3888635,"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: Assay 2: The test is performed in white 384-well plates (Greiner Bio-One, reference 781207) in a total volume of 60 L by adding 1 L of compounds tested at different concentrations diluted in 100% DMSO (1.7% final DMSO concentration) in reaction buffer (PBS, 125 mM NaCl, 0.001% Novexin (consists of carbohydrate polymers), designed to increase the solubility and stability of proteins; Expedeon Ltd., Cambridgeshire, United Kingdom), 0.01% Gelatin, 0.01% 0.2%, Pluronic F-127 (block copolymer from ethylenoxide and propyleneoxide), 1 mM DTT). After addition of 1.25 nM MDM2-biotinylated or 2.5 nM MDM4-biotinylated (internal preparations), and 0.625 nM Europium labeled streptavidin (Perkin Elmer), the solution is pre-incubated for 15 minutes at room temperature, then 10 nM Cy5-p53 peptide (internal preparation) is added before an incubation at room temperature for 15 minutes prior to reading the plate. For measurement of samples, a Victor II microplate reader (Perkin Elmer) is used with the following settings: Excitation 340 nm, Emission Donor 620 nm and Emission Acceptor 665 nm. For selected compounds displaying IC50s between 0.05 and 5 nM on MDM2, a slightly modified assay is used with the following adaptations: 0.1 nM MDM2, 0.1 nM Europium labeled streptavidin and Tecan genios Pro is used as a microplate reader for the fluorescence measurements (p53-MDM2 Assay 2).",B,,,BAO_0000190,BAO_0000224,protein format,CNc1ncc(-c2cc3c(n2C(C)C)C(c2ccc(Cl)cc2C)N(c2cc(Cl)c(=O)n(C)c2)C3=O)c(OC)n1,,,CHEMBL3886789,,2016,"{'bei': '16.94', 'le': '0.34', 'lle': '3.97', 'sei': '10.20'}",CHEMBL3941966,,CHEMBL3941966,9.61,False,http://www.openphacts.org/units/Nanomolar,2885990,=,37,True,=,,IC50,nM,,0.243,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,0.243
411783,17776599,[],CHEMBL3888635,"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: Assay 2: The test is performed in white 384-well plates (Greiner Bio-One, reference 781207) in a total volume of 60 L by adding 1 L of compounds tested at different concentrations diluted in 100% DMSO (1.7% final DMSO concentration) in reaction buffer (PBS, 125 mM NaCl, 0.001% Novexin (consists of carbohydrate polymers), designed to increase the solubility and stability of proteins; Expedeon Ltd., Cambridgeshire, United Kingdom), 0.01% Gelatin, 0.01% 0.2%, Pluronic F-127 (block copolymer from ethylenoxide and propyleneoxide), 1 mM DTT). After addition of 1.25 nM MDM2-biotinylated or 2.5 nM MDM4-biotinylated (internal preparations), and 0.625 nM Europium labeled streptavidin (Perkin Elmer), the solution is pre-incubated for 15 minutes at room temperature, then 10 nM Cy5-p53 peptide (internal preparation) is added before an incubation at room temperature for 15 minutes prior to reading the plate. For measurement of samples, a Victor II microplate reader (Perkin Elmer) is used with the following settings: Excitation 340 nm, Emission Donor 620 nm and Emission Acceptor 665 nm. For selected compounds displaying IC50s between 0.05 and 5 nM on MDM2, a slightly modified assay is used with the following adaptations: 0.1 nM MDM2, 0.1 nM Europium labeled streptavidin and Tecan genios Pro is used as a microplate reader for the fluorescence measurements (p53-MDM2 Assay 2).",B,,,BAO_0000190,BAO_0000224,protein format,CNc1ncc(-c2cc3c(n2C(C)C)C(c2ccc(Cl)cc2)N(c2c[nH]c(=O)c(Cl)c2)C3=O)c(OC)n1,,,CHEMBL3886789,,2016,"{'bei': '18.13', 'le': '0.36', 'lle': '4.46', 'sei': '9.30'}",CHEMBL3971557,,CHEMBL3971557,9.78,False,http://www.openphacts.org/units/Nanomolar,2885991,=,37,True,=,,IC50,nM,,0.166,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,0.166
411784,17776600,[],CHEMBL3888635,"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: Assay 2: The test is performed in white 384-well plates (Greiner Bio-One, reference 781207) in a total volume of 60 L by adding 1 L of compounds tested at different concentrations diluted in 100% DMSO (1.7% final DMSO concentration) in reaction buffer (PBS, 125 mM NaCl, 0.001% Novexin (consists of carbohydrate polymers), designed to increase the solubility and stability of proteins; Expedeon Ltd., Cambridgeshire, United Kingdom), 0.01% Gelatin, 0.01% 0.2%, Pluronic F-127 (block copolymer from ethylenoxide and propyleneoxide), 1 mM DTT). After addition of 1.25 nM MDM2-biotinylated or 2.5 nM MDM4-biotinylated (internal preparations), and 0.625 nM Europium labeled streptavidin (Perkin Elmer), the solution is pre-incubated for 15 minutes at room temperature, then 10 nM Cy5-p53 peptide (internal preparation) is added before an incubation at room temperature for 15 minutes prior to reading the plate. For measurement of samples, a Victor II microplate reader (Perkin Elmer) is used with the following settings: Excitation 340 nm, Emission Donor 620 nm and Emission Acceptor 665 nm. For selected compounds displaying IC50s between 0.05 and 5 nM on MDM2, a slightly modified assay is used with the following adaptations: 0.1 nM MDM2, 0.1 nM Europium labeled streptavidin and Tecan genios Pro is used as a microplate reader for the fluorescence measurements (p53-MDM2 Assay 2).",B,,,BAO_0000190,BAO_0000224,protein format,COc1ncc(-c2cc3c(n2C(C)C)C(c2ccc(C#N)cc2)N(c2cc(Cl)c(=O)n(C)c2)C3=O)c(OC)n1,,,CHEMBL3886789,,2016,"{'bei': '17.20', 'le': '0.33', 'lle': '4.85', 'sei': '8.13'}",CHEMBL3964391,,CHEMBL3964391,9.38,False,http://www.openphacts.org/units/Nanomolar,2885992,=,37,True,=,,IC50,nM,,0.422,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,0.422
411785,17776601,[],CHEMBL3888635,"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: Assay 2: The test is performed in white 384-well plates (Greiner Bio-One, reference 781207) in a total volume of 60 L by adding 1 L of compounds tested at different concentrations diluted in 100% DMSO (1.7% final DMSO concentration) in reaction buffer (PBS, 125 mM NaCl, 0.001% Novexin (consists of carbohydrate polymers), designed to increase the solubility and stability of proteins; Expedeon Ltd., Cambridgeshire, United Kingdom), 0.01% Gelatin, 0.01% 0.2%, Pluronic F-127 (block copolymer from ethylenoxide and propyleneoxide), 1 mM DTT). After addition of 1.25 nM MDM2-biotinylated or 2.5 nM MDM4-biotinylated (internal preparations), and 0.625 nM Europium labeled streptavidin (Perkin Elmer), the solution is pre-incubated for 15 minutes at room temperature, then 10 nM Cy5-p53 peptide (internal preparation) is added before an incubation at room temperature for 15 minutes prior to reading the plate. For measurement of samples, a Victor II microplate reader (Perkin Elmer) is used with the following settings: Excitation 340 nm, Emission Donor 620 nm and Emission Acceptor 665 nm. For selected compounds displaying IC50s between 0.05 and 5 nM on MDM2, a slightly modified assay is used with the following adaptations: 0.1 nM MDM2, 0.1 nM Europium labeled streptavidin and Tecan genios Pro is used as a microplate reader for the fluorescence measurements (p53-MDM2 Assay 2).",B,,,BAO_0000190,BAO_0000224,protein format,COc1nc(N)ncc1-c1cc2c(n1C(C)C)[C@H](c1ccc(C#N)cc1)N(c1cccc(Cl)c1F)C2=O,,,CHEMBL3886789,,2016,"{'bei': '18.35', 'le': '0.35', 'lle': '3.95', 'sei': '8.62'}",CHEMBL3907520,,CHEMBL3907520,9.48,False,http://www.openphacts.org/units/Nanomolar,2885993,=,37,True,=,,IC50,nM,,0.328,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,0.328
411786,17776602,[],CHEMBL3888635,"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: Assay 2: The test is performed in white 384-well plates (Greiner Bio-One, reference 781207) in a total volume of 60 L by adding 1 L of compounds tested at different concentrations diluted in 100% DMSO (1.7% final DMSO concentration) in reaction buffer (PBS, 125 mM NaCl, 0.001% Novexin (consists of carbohydrate polymers), designed to increase the solubility and stability of proteins; Expedeon Ltd., Cambridgeshire, United Kingdom), 0.01% Gelatin, 0.01% 0.2%, Pluronic F-127 (block copolymer from ethylenoxide and propyleneoxide), 1 mM DTT). After addition of 1.25 nM MDM2-biotinylated or 2.5 nM MDM4-biotinylated (internal preparations), and 0.625 nM Europium labeled streptavidin (Perkin Elmer), the solution is pre-incubated for 15 minutes at room temperature, then 10 nM Cy5-p53 peptide (internal preparation) is added before an incubation at room temperature for 15 minutes prior to reading the plate. For measurement of samples, a Victor II microplate reader (Perkin Elmer) is used with the following settings: Excitation 340 nm, Emission Donor 620 nm and Emission Acceptor 665 nm. For selected compounds displaying IC50s between 0.05 and 5 nM on MDM2, a slightly modified assay is used with the following adaptations: 0.1 nM MDM2, 0.1 nM Europium labeled streptavidin and Tecan genios Pro is used as a microplate reader for the fluorescence measurements (p53-MDM2 Assay 2).",B,,,BAO_0000190,BAO_0000224,protein format,COc1nc(N)ncc1-c1cc2c(n1C(C)C)[C@@H](c1ccc(C#N)cc1)N(c1cccc(Cl)c1F)C2=O,,,CHEMBL3886789,,2016,"{'bei': '14.25', 'le': '0.27', 'lle': '1.84', 'sei': '6.69'}",CHEMBL4114205,,CHEMBL4114205,7.37,False,http://www.openphacts.org/units/Nanomolar,2885994,=,37,True,=,,IC50,nM,,43.01,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,43.009
411787,17776603,[],CHEMBL3888635,"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: Assay 2: The test is performed in white 384-well plates (Greiner Bio-One, reference 781207) in a total volume of 60 L by adding 1 L of compounds tested at different concentrations diluted in 100% DMSO (1.7% final DMSO concentration) in reaction buffer (PBS, 125 mM NaCl, 0.001% Novexin (consists of carbohydrate polymers), designed to increase the solubility and stability of proteins; Expedeon Ltd., Cambridgeshire, United Kingdom), 0.01% Gelatin, 0.01% 0.2%, Pluronic F-127 (block copolymer from ethylenoxide and propyleneoxide), 1 mM DTT). After addition of 1.25 nM MDM2-biotinylated or 2.5 nM MDM4-biotinylated (internal preparations), and 0.625 nM Europium labeled streptavidin (Perkin Elmer), the solution is pre-incubated for 15 minutes at room temperature, then 10 nM Cy5-p53 peptide (internal preparation) is added before an incubation at room temperature for 15 minutes prior to reading the plate. For measurement of samples, a Victor II microplate reader (Perkin Elmer) is used with the following settings: Excitation 340 nm, Emission Donor 620 nm and Emission Acceptor 665 nm. For selected compounds displaying IC50s between 0.05 and 5 nM on MDM2, a slightly modified assay is used with the following adaptations: 0.1 nM MDM2, 0.1 nM Europium labeled streptavidin and Tecan genios Pro is used as a microplate reader for the fluorescence measurements (p53-MDM2 Assay 2).",B,,,BAO_0000190,BAO_0000224,protein format,COc1ncc(-c2cc3c(n2C(C)C)C(c2ccc(Cl)cc2)N(c2cc(Cl)c(=O)n(C)c2F)C3=O)c(OC)n1,,,CHEMBL3886789,,2016,"{'bei': '17.32', 'le': '0.35', 'lle': '4.47', 'sei': '10.84'}",CHEMBL3956352,,CHEMBL3956352,9.91,False,http://www.openphacts.org/units/Nanomolar,2885995,=,37,True,=,,IC50,nM,,0.122,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,0.122
411788,17776604,[],CHEMBL3888635,"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: Assay 2: The test is performed in white 384-well plates (Greiner Bio-One, reference 781207) in a total volume of 60 L by adding 1 L of compounds tested at different concentrations diluted in 100% DMSO (1.7% final DMSO concentration) in reaction buffer (PBS, 125 mM NaCl, 0.001% Novexin (consists of carbohydrate polymers), designed to increase the solubility and stability of proteins; Expedeon Ltd., Cambridgeshire, United Kingdom), 0.01% Gelatin, 0.01% 0.2%, Pluronic F-127 (block copolymer from ethylenoxide and propyleneoxide), 1 mM DTT). After addition of 1.25 nM MDM2-biotinylated or 2.5 nM MDM4-biotinylated (internal preparations), and 0.625 nM Europium labeled streptavidin (Perkin Elmer), the solution is pre-incubated for 15 minutes at room temperature, then 10 nM Cy5-p53 peptide (internal preparation) is added before an incubation at room temperature for 15 minutes prior to reading the plate. For measurement of samples, a Victor II microplate reader (Perkin Elmer) is used with the following settings: Excitation 340 nm, Emission Donor 620 nm and Emission Acceptor 665 nm. For selected compounds displaying IC50s between 0.05 and 5 nM on MDM2, a slightly modified assay is used with the following adaptations: 0.1 nM MDM2, 0.1 nM Europium labeled streptavidin and Tecan genios Pro is used as a microplate reader for the fluorescence measurements (p53-MDM2 Assay 2).",B,,,BAO_0000190,BAO_0000224,protein format,COc1ncc(-c2cc3c(n2C(C)C)C(c2ccc(C#N)cc2)N(C2CCOCC2)C3=O)c(OC)n1,,,CHEMBL3886789,,2016,"{'bei': '16.62', 'le': '0.31', 'lle': '3.96', 'sei': '7.90'}",CHEMBL3893708,,CHEMBL3893708,8.10,False,http://www.openphacts.org/units/Nanomolar,2885996,=,37,True,=,,IC50,nM,,7.896,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,7.896
411789,17776605,[],CHEMBL3888635,"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: Assay 2: The test is performed in white 384-well plates (Greiner Bio-One, reference 781207) in a total volume of 60 L by adding 1 L of compounds tested at different concentrations diluted in 100% DMSO (1.7% final DMSO concentration) in reaction buffer (PBS, 125 mM NaCl, 0.001% Novexin (consists of carbohydrate polymers), designed to increase the solubility and stability of proteins; Expedeon Ltd., Cambridgeshire, United Kingdom), 0.01% Gelatin, 0.01% 0.2%, Pluronic F-127 (block copolymer from ethylenoxide and propyleneoxide), 1 mM DTT). After addition of 1.25 nM MDM2-biotinylated or 2.5 nM MDM4-biotinylated (internal preparations), and 0.625 nM Europium labeled streptavidin (Perkin Elmer), the solution is pre-incubated for 15 minutes at room temperature, then 10 nM Cy5-p53 peptide (internal preparation) is added before an incubation at room temperature for 15 minutes prior to reading the plate. For measurement of samples, a Victor II microplate reader (Perkin Elmer) is used with the following settings: Excitation 340 nm, Emission Donor 620 nm and Emission Acceptor 665 nm. For selected compounds displaying IC50s between 0.05 and 5 nM on MDM2, a slightly modified assay is used with the following adaptations: 0.1 nM MDM2, 0.1 nM Europium labeled streptavidin and Tecan genios Pro is used as a microplate reader for the fluorescence measurements (p53-MDM2 Assay 2).",B,,,BAO_0000190,BAO_0000224,protein format,COc1nc(N(C)C)ncc1-c1cc2c(n1C(C)C)C(c1ccc(C#N)cc1)N(C1CCOCC1)C2=O,,,CHEMBL3886789,,2016,"{'bei': '17.72', 'le': '0.33', 'lle': '4.67', 'sei': '9.19'}",CHEMBL3921717,,CHEMBL3921717,8.87,False,http://www.openphacts.org/units/Nanomolar,2885997,=,37,True,=,,IC50,nM,,1.344,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,1.344
411790,17776606,[],CHEMBL3888635,"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: Assay 2: The test is performed in white 384-well plates (Greiner Bio-One, reference 781207) in a total volume of 60 L by adding 1 L of compounds tested at different concentrations diluted in 100% DMSO (1.7% final DMSO concentration) in reaction buffer (PBS, 125 mM NaCl, 0.001% Novexin (consists of carbohydrate polymers), designed to increase the solubility and stability of proteins; Expedeon Ltd., Cambridgeshire, United Kingdom), 0.01% Gelatin, 0.01% 0.2%, Pluronic F-127 (block copolymer from ethylenoxide and propyleneoxide), 1 mM DTT). After addition of 1.25 nM MDM2-biotinylated or 2.5 nM MDM4-biotinylated (internal preparations), and 0.625 nM Europium labeled streptavidin (Perkin Elmer), the solution is pre-incubated for 15 minutes at room temperature, then 10 nM Cy5-p53 peptide (internal preparation) is added before an incubation at room temperature for 15 minutes prior to reading the plate. For measurement of samples, a Victor II microplate reader (Perkin Elmer) is used with the following settings: Excitation 340 nm, Emission Donor 620 nm and Emission Acceptor 665 nm. For selected compounds displaying IC50s between 0.05 and 5 nM on MDM2, a slightly modified assay is used with the following adaptations: 0.1 nM MDM2, 0.1 nM Europium labeled streptavidin and Tecan genios Pro is used as a microplate reader for the fluorescence measurements (p53-MDM2 Assay 2).",B,,,BAO_0000190,BAO_0000224,protein format,COc1nc(N(C)C)ncc1-c1cc2c(n1C(C)C)C(c1ccc(Cl)cc1)N(C1CN(C)C(=O)N(C)C1)C2=O,,,CHEMBL3886789,,2016,"{'bei': '17.74', 'le': '0.34', 'lle': '5.62', 'sei': '11.25'}",CHEMBL3899074,,CHEMBL3899074,9.79,False,http://www.openphacts.org/units/Nanomolar,2885998,=,37,True,=,,IC50,nM,,0.161,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,0.161
411791,17776607,[],CHEMBL3888635,"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: Assay 2: The test is performed in white 384-well plates (Greiner Bio-One, reference 781207) in a total volume of 60 L by adding 1 L of compounds tested at different concentrations diluted in 100% DMSO (1.7% final DMSO concentration) in reaction buffer (PBS, 125 mM NaCl, 0.001% Novexin (consists of carbohydrate polymers), designed to increase the solubility and stability of proteins; Expedeon Ltd., Cambridgeshire, United Kingdom), 0.01% Gelatin, 0.01% 0.2%, Pluronic F-127 (block copolymer from ethylenoxide and propyleneoxide), 1 mM DTT). After addition of 1.25 nM MDM2-biotinylated or 2.5 nM MDM4-biotinylated (internal preparations), and 0.625 nM Europium labeled streptavidin (Perkin Elmer), the solution is pre-incubated for 15 minutes at room temperature, then 10 nM Cy5-p53 peptide (internal preparation) is added before an incubation at room temperature for 15 minutes prior to reading the plate. For measurement of samples, a Victor II microplate reader (Perkin Elmer) is used with the following settings: Excitation 340 nm, Emission Donor 620 nm and Emission Acceptor 665 nm. For selected compounds displaying IC50s between 0.05 and 5 nM on MDM2, a slightly modified assay is used with the following adaptations: 0.1 nM MDM2, 0.1 nM Europium labeled streptavidin and Tecan genios Pro is used as a microplate reader for the fluorescence measurements (p53-MDM2 Assay 2).",B,,,BAO_0000190,BAO_0000224,protein format,COc1ncc(-c2cc3c(n2C(C)C)[C@H](c2ccc(Cl)cc2C)N(c2cc(Cl)c(=O)n(C)c2)C3=O)c(OC)n1,,,CHEMBL3886789,,2016,"{'bei': '17.31', 'le': '0.34', 'lle': '4.23', 'sei': '10.76'}",CHEMBL3915879,,CHEMBL3915879,9.84,False,http://www.openphacts.org/units/Nanomolar,2885999,=,37,True,=,,IC50,nM,,0.144,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,0.144
411792,17776608,[],CHEMBL3888635,"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: Assay 2: The test is performed in white 384-well plates (Greiner Bio-One, reference 781207) in a total volume of 60 L by adding 1 L of compounds tested at different concentrations diluted in 100% DMSO (1.7% final DMSO concentration) in reaction buffer (PBS, 125 mM NaCl, 0.001% Novexin (consists of carbohydrate polymers), designed to increase the solubility and stability of proteins; Expedeon Ltd., Cambridgeshire, United Kingdom), 0.01% Gelatin, 0.01% 0.2%, Pluronic F-127 (block copolymer from ethylenoxide and propyleneoxide), 1 mM DTT). After addition of 1.25 nM MDM2-biotinylated or 2.5 nM MDM4-biotinylated (internal preparations), and 0.625 nM Europium labeled streptavidin (Perkin Elmer), the solution is pre-incubated for 15 minutes at room temperature, then 10 nM Cy5-p53 peptide (internal preparation) is added before an incubation at room temperature for 15 minutes prior to reading the plate. For measurement of samples, a Victor II microplate reader (Perkin Elmer) is used with the following settings: Excitation 340 nm, Emission Donor 620 nm and Emission Acceptor 665 nm. For selected compounds displaying IC50s between 0.05 and 5 nM on MDM2, a slightly modified assay is used with the following adaptations: 0.1 nM MDM2, 0.1 nM Europium labeled streptavidin and Tecan genios Pro is used as a microplate reader for the fluorescence measurements (p53-MDM2 Assay 2).",B,,,BAO_0000190,BAO_0000224,protein format,COc1ncc(-c2cc3c(n2C(C)C)[C@@H](c2ccc(Cl)cc2C)N(c2cc(Cl)c(=O)n(C)c2)C3=O)c(OC)n1,,,CHEMBL3886789,,2016,"{'bei': '11.46', 'le': '0.23', 'lle': '0.90', 'sei': '7.12'}",CHEMBL4109562,,CHEMBL4109562,6.51,False,http://www.openphacts.org/units/Nanomolar,2886000,=,37,True,=,,IC50,nM,,307.54,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,307.543
411793,17776609,[],CHEMBL3888635,"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: Assay 2: The test is performed in white 384-well plates (Greiner Bio-One, reference 781207) in a total volume of 60 L by adding 1 L of compounds tested at different concentrations diluted in 100% DMSO (1.7% final DMSO concentration) in reaction buffer (PBS, 125 mM NaCl, 0.001% Novexin (consists of carbohydrate polymers), designed to increase the solubility and stability of proteins; Expedeon Ltd., Cambridgeshire, United Kingdom), 0.01% Gelatin, 0.01% 0.2%, Pluronic F-127 (block copolymer from ethylenoxide and propyleneoxide), 1 mM DTT). After addition of 1.25 nM MDM2-biotinylated or 2.5 nM MDM4-biotinylated (internal preparations), and 0.625 nM Europium labeled streptavidin (Perkin Elmer), the solution is pre-incubated for 15 minutes at room temperature, then 10 nM Cy5-p53 peptide (internal preparation) is added before an incubation at room temperature for 15 minutes prior to reading the plate. For measurement of samples, a Victor II microplate reader (Perkin Elmer) is used with the following settings: Excitation 340 nm, Emission Donor 620 nm and Emission Acceptor 665 nm. For selected compounds displaying IC50s between 0.05 and 5 nM on MDM2, a slightly modified assay is used with the following adaptations: 0.1 nM MDM2, 0.1 nM Europium labeled streptavidin and Tecan genios Pro is used as a microplate reader for the fluorescence measurements (p53-MDM2 Assay 2).",B,,,BAO_0000190,BAO_0000224,protein format,COc1ncc(-c2cc3c(n2C(C)C)[C@](C)(c2ccc(Cl)cc2)N(c2cc(Cl)c(=O)n(C)c2)C3=O)c(OC)n1,,,CHEMBL3886789,,2016,"{'bei': '12.86', 'le': '0.26', 'lle': '1.84', 'sei': '7.99'}",CHEMBL3943828,,CHEMBL3943828,7.31,False,http://www.openphacts.org/units/Nanomolar,2886001,=,37,True,=,,IC50,nM,,49.02,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,49.021
411794,17776610,[],CHEMBL3888635,"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: Assay 2: The test is performed in white 384-well plates (Greiner Bio-One, reference 781207) in a total volume of 60 L by adding 1 L of compounds tested at different concentrations diluted in 100% DMSO (1.7% final DMSO concentration) in reaction buffer (PBS, 125 mM NaCl, 0.001% Novexin (consists of carbohydrate polymers), designed to increase the solubility and stability of proteins; Expedeon Ltd., Cambridgeshire, United Kingdom), 0.01% Gelatin, 0.01% 0.2%, Pluronic F-127 (block copolymer from ethylenoxide and propyleneoxide), 1 mM DTT). After addition of 1.25 nM MDM2-biotinylated or 2.5 nM MDM4-biotinylated (internal preparations), and 0.625 nM Europium labeled streptavidin (Perkin Elmer), the solution is pre-incubated for 15 minutes at room temperature, then 10 nM Cy5-p53 peptide (internal preparation) is added before an incubation at room temperature for 15 minutes prior to reading the plate. For measurement of samples, a Victor II microplate reader (Perkin Elmer) is used with the following settings: Excitation 340 nm, Emission Donor 620 nm and Emission Acceptor 665 nm. For selected compounds displaying IC50s between 0.05 and 5 nM on MDM2, a slightly modified assay is used with the following adaptations: 0.1 nM MDM2, 0.1 nM Europium labeled streptavidin and Tecan genios Pro is used as a microplate reader for the fluorescence measurements (p53-MDM2 Assay 2).",B,,,BAO_0000190,BAO_0000224,protein format,COc1ncc(-c2cc3c(n2C(C)C)[C@@](C)(c2ccc(Cl)cc2)N(c2cc(Cl)c(=O)n(C)c2)C3=O)c(OC)n1,,,CHEMBL3886789,,2016,"{'bei': '12.96', 'le': '0.26', 'lle': '1.90', 'sei': '8.06'}",CHEMBL4110741,,CHEMBL4110741,7.37,False,http://www.openphacts.org/units/Nanomolar,2886002,=,37,True,=,,IC50,nM,,42.73,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,42.727
411795,17776611,[],CHEMBL3888635,"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: Assay 2: The test is performed in white 384-well plates (Greiner Bio-One, reference 781207) in a total volume of 60 L by adding 1 L of compounds tested at different concentrations diluted in 100% DMSO (1.7% final DMSO concentration) in reaction buffer (PBS, 125 mM NaCl, 0.001% Novexin (consists of carbohydrate polymers), designed to increase the solubility and stability of proteins; Expedeon Ltd., Cambridgeshire, United Kingdom), 0.01% Gelatin, 0.01% 0.2%, Pluronic F-127 (block copolymer from ethylenoxide and propyleneoxide), 1 mM DTT). After addition of 1.25 nM MDM2-biotinylated or 2.5 nM MDM4-biotinylated (internal preparations), and 0.625 nM Europium labeled streptavidin (Perkin Elmer), the solution is pre-incubated for 15 minutes at room temperature, then 10 nM Cy5-p53 peptide (internal preparation) is added before an incubation at room temperature for 15 minutes prior to reading the plate. For measurement of samples, a Victor II microplate reader (Perkin Elmer) is used with the following settings: Excitation 340 nm, Emission Donor 620 nm and Emission Acceptor 665 nm. For selected compounds displaying IC50s between 0.05 and 5 nM on MDM2, a slightly modified assay is used with the following adaptations: 0.1 nM MDM2, 0.1 nM Europium labeled streptavidin and Tecan genios Pro is used as a microplate reader for the fluorescence measurements (p53-MDM2 Assay 2).",B,,,BAO_0000190,BAO_0000224,protein format,COc1nc(N(C)C)ncc1-c1c(C#N)c2c(n1C(C)C)C(c1ccc(Cl)cc1)N(c1cc(Cl)c(=O)n(C)c1)C2=O,,,CHEMBL3886789,,2016,"{'bei': '16.74', 'le': '0.33', 'lle': '4.69', 'sei': '9.08'}",CHEMBL3964289,,CHEMBL3964289,9.92,False,http://www.openphacts.org/units/Nanomolar,2886003,=,37,True,=,,IC50,nM,,0.121,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,0.121
411796,17776612,[],CHEMBL3888635,"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: Assay 2: The test is performed in white 384-well plates (Greiner Bio-One, reference 781207) in a total volume of 60 L by adding 1 L of compounds tested at different concentrations diluted in 100% DMSO (1.7% final DMSO concentration) in reaction buffer (PBS, 125 mM NaCl, 0.001% Novexin (consists of carbohydrate polymers), designed to increase the solubility and stability of proteins; Expedeon Ltd., Cambridgeshire, United Kingdom), 0.01% Gelatin, 0.01% 0.2%, Pluronic F-127 (block copolymer from ethylenoxide and propyleneoxide), 1 mM DTT). After addition of 1.25 nM MDM2-biotinylated or 2.5 nM MDM4-biotinylated (internal preparations), and 0.625 nM Europium labeled streptavidin (Perkin Elmer), the solution is pre-incubated for 15 minutes at room temperature, then 10 nM Cy5-p53 peptide (internal preparation) is added before an incubation at room temperature for 15 minutes prior to reading the plate. For measurement of samples, a Victor II microplate reader (Perkin Elmer) is used with the following settings: Excitation 340 nm, Emission Donor 620 nm and Emission Acceptor 665 nm. For selected compounds displaying IC50s between 0.05 and 5 nM on MDM2, a slightly modified assay is used with the following adaptations: 0.1 nM MDM2, 0.1 nM Europium labeled streptavidin and Tecan genios Pro is used as a microplate reader for the fluorescence measurements (p53-MDM2 Assay 2).",B,,,BAO_0000190,BAO_0000224,protein format,CNc1ncc(-c2cc3c(n2C(C)C)[C@H](c2ccc(C#N)cc2)N(c2cc(Cl)cn(C)c2=O)C3=O)c(OC)n1,,,CHEMBL3886789,,2016,"{'bei': '16.98', 'le': '0.32', 'lle': '4.69', 'sei': '7.82'}",CHEMBL3897997,,CHEMBL3897997,9.24,False,http://www.openphacts.org/units/Nanomolar,2886004,=,37,True,=,,IC50,nM,,0.578,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,0.578
411797,17776613,[],CHEMBL3888635,"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: Assay 2: The test is performed in white 384-well plates (Greiner Bio-One, reference 781207) in a total volume of 60 L by adding 1 L of compounds tested at different concentrations diluted in 100% DMSO (1.7% final DMSO concentration) in reaction buffer (PBS, 125 mM NaCl, 0.001% Novexin (consists of carbohydrate polymers), designed to increase the solubility and stability of proteins; Expedeon Ltd., Cambridgeshire, United Kingdom), 0.01% Gelatin, 0.01% 0.2%, Pluronic F-127 (block copolymer from ethylenoxide and propyleneoxide), 1 mM DTT). After addition of 1.25 nM MDM2-biotinylated or 2.5 nM MDM4-biotinylated (internal preparations), and 0.625 nM Europium labeled streptavidin (Perkin Elmer), the solution is pre-incubated for 15 minutes at room temperature, then 10 nM Cy5-p53 peptide (internal preparation) is added before an incubation at room temperature for 15 minutes prior to reading the plate. For measurement of samples, a Victor II microplate reader (Perkin Elmer) is used with the following settings: Excitation 340 nm, Emission Donor 620 nm and Emission Acceptor 665 nm. For selected compounds displaying IC50s between 0.05 and 5 nM on MDM2, a slightly modified assay is used with the following adaptations: 0.1 nM MDM2, 0.1 nM Europium labeled streptavidin and Tecan genios Pro is used as a microplate reader for the fluorescence measurements (p53-MDM2 Assay 2).",B,,,BAO_0000190,BAO_0000224,protein format,CNc1ncc(-c2cc3c(n2C(C)C)[C@@H](c2ccc(C#N)cc2)N(c2cc(Cl)cn(C)c2=O)C3=O)c(OC)n1,,,CHEMBL3886789,,2016,"{'bei': '12.01', 'le': '0.23', 'lle': '1.98', 'sei': '5.53'}",CHEMBL4114518,,CHEMBL4114518,6.53,False,http://www.openphacts.org/units/Nanomolar,2886005,=,37,True,=,,IC50,nM,,293.2,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,293.2
411798,17776614,[],CHEMBL3888635,"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: Assay 2: The test is performed in white 384-well plates (Greiner Bio-One, reference 781207) in a total volume of 60 L by adding 1 L of compounds tested at different concentrations diluted in 100% DMSO (1.7% final DMSO concentration) in reaction buffer (PBS, 125 mM NaCl, 0.001% Novexin (consists of carbohydrate polymers), designed to increase the solubility and stability of proteins; Expedeon Ltd., Cambridgeshire, United Kingdom), 0.01% Gelatin, 0.01% 0.2%, Pluronic F-127 (block copolymer from ethylenoxide and propyleneoxide), 1 mM DTT). After addition of 1.25 nM MDM2-biotinylated or 2.5 nM MDM4-biotinylated (internal preparations), and 0.625 nM Europium labeled streptavidin (Perkin Elmer), the solution is pre-incubated for 15 minutes at room temperature, then 10 nM Cy5-p53 peptide (internal preparation) is added before an incubation at room temperature for 15 minutes prior to reading the plate. For measurement of samples, a Victor II microplate reader (Perkin Elmer) is used with the following settings: Excitation 340 nm, Emission Donor 620 nm and Emission Acceptor 665 nm. For selected compounds displaying IC50s between 0.05 and 5 nM on MDM2, a slightly modified assay is used with the following adaptations: 0.1 nM MDM2, 0.1 nM Europium labeled streptavidin and Tecan genios Pro is used as a microplate reader for the fluorescence measurements (p53-MDM2 Assay 2).",B,,,BAO_0000190,BAO_0000224,protein format,COc1nc(N(C)C)ncc1-c1cc2c(n1C(C)C)[C@H](c1ccc(C#N)cc1)N(c1cc(Cl)c[nH]c1=O)C2=O,,,CHEMBL3886789,,2016,"{'bei': '18.00', 'le': '0.34', 'lle': '5.23', 'sei': '8.15'}",CHEMBL3924973,,CHEMBL3924973,9.79,False,http://www.openphacts.org/units/Nanomolar,2885855,=,37,True,=,,IC50,nM,,0.161,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,0.161
411799,17776615,[],CHEMBL3888635,"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: Assay 2: The test is performed in white 384-well plates (Greiner Bio-One, reference 781207) in a total volume of 60 L by adding 1 L of compounds tested at different concentrations diluted in 100% DMSO (1.7% final DMSO concentration) in reaction buffer (PBS, 125 mM NaCl, 0.001% Novexin (consists of carbohydrate polymers), designed to increase the solubility and stability of proteins; Expedeon Ltd., Cambridgeshire, United Kingdom), 0.01% Gelatin, 0.01% 0.2%, Pluronic F-127 (block copolymer from ethylenoxide and propyleneoxide), 1 mM DTT). After addition of 1.25 nM MDM2-biotinylated or 2.5 nM MDM4-biotinylated (internal preparations), and 0.625 nM Europium labeled streptavidin (Perkin Elmer), the solution is pre-incubated for 15 minutes at room temperature, then 10 nM Cy5-p53 peptide (internal preparation) is added before an incubation at room temperature for 15 minutes prior to reading the plate. For measurement of samples, a Victor II microplate reader (Perkin Elmer) is used with the following settings: Excitation 340 nm, Emission Donor 620 nm and Emission Acceptor 665 nm. For selected compounds displaying IC50s between 0.05 and 5 nM on MDM2, a slightly modified assay is used with the following adaptations: 0.1 nM MDM2, 0.1 nM Europium labeled streptavidin and Tecan genios Pro is used as a microplate reader for the fluorescence measurements (p53-MDM2 Assay 2).",B,,,BAO_0000190,BAO_0000224,protein format,COc1nc(N(C)C)ncc1-c1cc2c(n1C(C)C)[C@@H](c1ccc(C#N)cc1)N(c1cc(Cl)c[nH]c1=O)C2=O,,,CHEMBL3886789,,2016,"{'bei': '12.81', 'le': '0.24', 'lle': '2.41', 'sei': '5.80'}",CHEMBL4106757,,CHEMBL4106757,6.97,False,http://www.openphacts.org/units/Nanomolar,2886006,=,37,True,=,,IC50,nM,,107.25,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,107.25
411800,17776616,[],CHEMBL3888635,"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: Assay 2: The test is performed in white 384-well plates (Greiner Bio-One, reference 781207) in a total volume of 60 L by adding 1 L of compounds tested at different concentrations diluted in 100% DMSO (1.7% final DMSO concentration) in reaction buffer (PBS, 125 mM NaCl, 0.001% Novexin (consists of carbohydrate polymers), designed to increase the solubility and stability of proteins; Expedeon Ltd., Cambridgeshire, United Kingdom), 0.01% Gelatin, 0.01% 0.2%, Pluronic F-127 (block copolymer from ethylenoxide and propyleneoxide), 1 mM DTT). After addition of 1.25 nM MDM2-biotinylated or 2.5 nM MDM4-biotinylated (internal preparations), and 0.625 nM Europium labeled streptavidin (Perkin Elmer), the solution is pre-incubated for 15 minutes at room temperature, then 10 nM Cy5-p53 peptide (internal preparation) is added before an incubation at room temperature for 15 minutes prior to reading the plate. For measurement of samples, a Victor II microplate reader (Perkin Elmer) is used with the following settings: Excitation 340 nm, Emission Donor 620 nm and Emission Acceptor 665 nm. For selected compounds displaying IC50s between 0.05 and 5 nM on MDM2, a slightly modified assay is used with the following adaptations: 0.1 nM MDM2, 0.1 nM Europium labeled streptavidin and Tecan genios Pro is used as a microplate reader for the fluorescence measurements (p53-MDM2 Assay 2).",B,,,BAO_0000190,BAO_0000224,protein format,COc1nc(N(C)C)ncc1-c1cc2c(n1C(C)C)[C@H](c1ccc(C#N)cc1)N(c1ccc(F)c(Cl)c1)C2=O,,,CHEMBL3886789,,2016,"{'bei': '17.33', 'le': '0.33', 'lle': '3.44', 'sei': '10.82'}",CHEMBL3929867,,CHEMBL3929867,9.45,False,http://www.openphacts.org/units/Nanomolar,2886007,=,37,True,=,,IC50,nM,,0.357,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,0.357
411801,17776617,[],CHEMBL3888635,"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: Assay 2: The test is performed in white 384-well plates (Greiner Bio-One, reference 781207) in a total volume of 60 L by adding 1 L of compounds tested at different concentrations diluted in 100% DMSO (1.7% final DMSO concentration) in reaction buffer (PBS, 125 mM NaCl, 0.001% Novexin (consists of carbohydrate polymers), designed to increase the solubility and stability of proteins; Expedeon Ltd., Cambridgeshire, United Kingdom), 0.01% Gelatin, 0.01% 0.2%, Pluronic F-127 (block copolymer from ethylenoxide and propyleneoxide), 1 mM DTT). After addition of 1.25 nM MDM2-biotinylated or 2.5 nM MDM4-biotinylated (internal preparations), and 0.625 nM Europium labeled streptavidin (Perkin Elmer), the solution is pre-incubated for 15 minutes at room temperature, then 10 nM Cy5-p53 peptide (internal preparation) is added before an incubation at room temperature for 15 minutes prior to reading the plate. For measurement of samples, a Victor II microplate reader (Perkin Elmer) is used with the following settings: Excitation 340 nm, Emission Donor 620 nm and Emission Acceptor 665 nm. For selected compounds displaying IC50s between 0.05 and 5 nM on MDM2, a slightly modified assay is used with the following adaptations: 0.1 nM MDM2, 0.1 nM Europium labeled streptavidin and Tecan genios Pro is used as a microplate reader for the fluorescence measurements (p53-MDM2 Assay 2).",B,,,BAO_0000190,BAO_0000224,protein format,COc1nc(N(C)C)ncc1-c1cc2c(n1C(C)C)[C@@H](c1ccc(C#N)cc1)N(c1ccc(F)c(Cl)c1)C2=O,,,CHEMBL3886789,,2016,"{'bei': '13.77', 'le': '0.26', 'lle': '1.49', 'sei': '8.60'}",CHEMBL4106953,,CHEMBL4106953,7.50,False,http://www.openphacts.org/units/Nanomolar,2886008,=,37,True,=,,IC50,nM,,31.31,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,31.31
411802,17776618,[],CHEMBL3888635,"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: Assay 2: The test is performed in white 384-well plates (Greiner Bio-One, reference 781207) in a total volume of 60 L by adding 1 L of compounds tested at different concentrations diluted in 100% DMSO (1.7% final DMSO concentration) in reaction buffer (PBS, 125 mM NaCl, 0.001% Novexin (consists of carbohydrate polymers), designed to increase the solubility and stability of proteins; Expedeon Ltd., Cambridgeshire, United Kingdom), 0.01% Gelatin, 0.01% 0.2%, Pluronic F-127 (block copolymer from ethylenoxide and propyleneoxide), 1 mM DTT). After addition of 1.25 nM MDM2-biotinylated or 2.5 nM MDM4-biotinylated (internal preparations), and 0.625 nM Europium labeled streptavidin (Perkin Elmer), the solution is pre-incubated for 15 minutes at room temperature, then 10 nM Cy5-p53 peptide (internal preparation) is added before an incubation at room temperature for 15 minutes prior to reading the plate. For measurement of samples, a Victor II microplate reader (Perkin Elmer) is used with the following settings: Excitation 340 nm, Emission Donor 620 nm and Emission Acceptor 665 nm. For selected compounds displaying IC50s between 0.05 and 5 nM on MDM2, a slightly modified assay is used with the following adaptations: 0.1 nM MDM2, 0.1 nM Europium labeled streptavidin and Tecan genios Pro is used as a microplate reader for the fluorescence measurements (p53-MDM2 Assay 2).",B,,,BAO_0000190,BAO_0000224,protein format,COc1nc(N)ncc1-c1cc2c(n1C(C)C)[C@H](c1ccc(C#N)cc1)N(c1ccc(F)c(Cl)c1)C2=O,,,CHEMBL3886789,,2016,"{'bei': '17.71', 'le': '0.34', 'lle': '3.63', 'sei': '8.32'}",CHEMBL3921044,,CHEMBL3921044,9.16,False,http://www.openphacts.org/units/Nanomolar,2886009,=,37,True,=,,IC50,nM,,0.699,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,0.699
411803,17776619,[],CHEMBL3888635,"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: Assay 2: The test is performed in white 384-well plates (Greiner Bio-One, reference 781207) in a total volume of 60 L by adding 1 L of compounds tested at different concentrations diluted in 100% DMSO (1.7% final DMSO concentration) in reaction buffer (PBS, 125 mM NaCl, 0.001% Novexin (consists of carbohydrate polymers), designed to increase the solubility and stability of proteins; Expedeon Ltd., Cambridgeshire, United Kingdom), 0.01% Gelatin, 0.01% 0.2%, Pluronic F-127 (block copolymer from ethylenoxide and propyleneoxide), 1 mM DTT). After addition of 1.25 nM MDM2-biotinylated or 2.5 nM MDM4-biotinylated (internal preparations), and 0.625 nM Europium labeled streptavidin (Perkin Elmer), the solution is pre-incubated for 15 minutes at room temperature, then 10 nM Cy5-p53 peptide (internal preparation) is added before an incubation at room temperature for 15 minutes prior to reading the plate. For measurement of samples, a Victor II microplate reader (Perkin Elmer) is used with the following settings: Excitation 340 nm, Emission Donor 620 nm and Emission Acceptor 665 nm. For selected compounds displaying IC50s between 0.05 and 5 nM on MDM2, a slightly modified assay is used with the following adaptations: 0.1 nM MDM2, 0.1 nM Europium labeled streptavidin and Tecan genios Pro is used as a microplate reader for the fluorescence measurements (p53-MDM2 Assay 2).",B,,,BAO_0000190,BAO_0000224,protein format,COc1nc(N)ncc1-c1cc2c(n1C(C)C)[C@@H](c1ccc(C#N)cc1)N(c1ccc(F)c(Cl)c1)C2=O,,,CHEMBL3886789,,2016,"{'bei': '13.42', 'le': '0.26', 'lle': '1.41', 'sei': '6.30'}",CHEMBL4115066,,CHEMBL4115066,6.94,False,http://www.openphacts.org/units/Nanomolar,2886010,=,37,True,=,,IC50,nM,,115.01,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,115.009
411804,17776620,[],CHEMBL3888635,"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: Assay 2: The test is performed in white 384-well plates (Greiner Bio-One, reference 781207) in a total volume of 60 L by adding 1 L of compounds tested at different concentrations diluted in 100% DMSO (1.7% final DMSO concentration) in reaction buffer (PBS, 125 mM NaCl, 0.001% Novexin (consists of carbohydrate polymers), designed to increase the solubility and stability of proteins; Expedeon Ltd., Cambridgeshire, United Kingdom), 0.01% Gelatin, 0.01% 0.2%, Pluronic F-127 (block copolymer from ethylenoxide and propyleneoxide), 1 mM DTT). After addition of 1.25 nM MDM2-biotinylated or 2.5 nM MDM4-biotinylated (internal preparations), and 0.625 nM Europium labeled streptavidin (Perkin Elmer), the solution is pre-incubated for 15 minutes at room temperature, then 10 nM Cy5-p53 peptide (internal preparation) is added before an incubation at room temperature for 15 minutes prior to reading the plate. For measurement of samples, a Victor II microplate reader (Perkin Elmer) is used with the following settings: Excitation 340 nm, Emission Donor 620 nm and Emission Acceptor 665 nm. For selected compounds displaying IC50s between 0.05 and 5 nM on MDM2, a slightly modified assay is used with the following adaptations: 0.1 nM MDM2, 0.1 nM Europium labeled streptavidin and Tecan genios Pro is used as a microplate reader for the fluorescence measurements (p53-MDM2 Assay 2).",B,,,BAO_0000190,BAO_0000224,protein format,COc1ncc(-c2cc3c(n2C(C)C)C(c2ccc(C#N)cc2)N([C@H]2CC[C@H](O)CC2)C3=O)c(OC)n1,,,CHEMBL3886789,,2016,"{'bei': '15.68', 'le': '0.29', 'lle': '3.61', 'sei': '6.93'}",CHEMBL3980581,,CHEMBL3980581,7.87,False,http://www.openphacts.org/units/Nanomolar,2886011,=,37,True,=,,IC50,nM,,13.64,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,13.637
411805,17776621,[],CHEMBL3888635,"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: Assay 2: The test is performed in white 384-well plates (Greiner Bio-One, reference 781207) in a total volume of 60 L by adding 1 L of compounds tested at different concentrations diluted in 100% DMSO (1.7% final DMSO concentration) in reaction buffer (PBS, 125 mM NaCl, 0.001% Novexin (consists of carbohydrate polymers), designed to increase the solubility and stability of proteins; Expedeon Ltd., Cambridgeshire, United Kingdom), 0.01% Gelatin, 0.01% 0.2%, Pluronic F-127 (block copolymer from ethylenoxide and propyleneoxide), 1 mM DTT). After addition of 1.25 nM MDM2-biotinylated or 2.5 nM MDM4-biotinylated (internal preparations), and 0.625 nM Europium labeled streptavidin (Perkin Elmer), the solution is pre-incubated for 15 minutes at room temperature, then 10 nM Cy5-p53 peptide (internal preparation) is added before an incubation at room temperature for 15 minutes prior to reading the plate. For measurement of samples, a Victor II microplate reader (Perkin Elmer) is used with the following settings: Excitation 340 nm, Emission Donor 620 nm and Emission Acceptor 665 nm. For selected compounds displaying IC50s between 0.05 and 5 nM on MDM2, a slightly modified assay is used with the following adaptations: 0.1 nM MDM2, 0.1 nM Europium labeled streptavidin and Tecan genios Pro is used as a microplate reader for the fluorescence measurements (p53-MDM2 Assay 2).",B,,,BAO_0000190,BAO_0000224,protein format,COc1nc(N(C)C)ncc1-c1cc2c(n1C(C)C)C(c1ccc(C#N)cc1)N([C@H]1CC[C@H](O)CC1)C2=O,,,CHEMBL3886789,,2016,"{'bei': '17.06', 'le': '0.32', 'lle': '4.46', 'sei': '8.17'}",CHEMBL3895513,,CHEMBL3895513,8.78,False,http://www.openphacts.org/units/Nanomolar,2886012,=,37,True,=,,IC50,nM,,1.666,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,1.666
411806,17776622,[],CHEMBL3888635,"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: Assay 2: The test is performed in white 384-well plates (Greiner Bio-One, reference 781207) in a total volume of 60 L by adding 1 L of compounds tested at different concentrations diluted in 100% DMSO (1.7% final DMSO concentration) in reaction buffer (PBS, 125 mM NaCl, 0.001% Novexin (consists of carbohydrate polymers), designed to increase the solubility and stability of proteins; Expedeon Ltd., Cambridgeshire, United Kingdom), 0.01% Gelatin, 0.01% 0.2%, Pluronic F-127 (block copolymer from ethylenoxide and propyleneoxide), 1 mM DTT). After addition of 1.25 nM MDM2-biotinylated or 2.5 nM MDM4-biotinylated (internal preparations), and 0.625 nM Europium labeled streptavidin (Perkin Elmer), the solution is pre-incubated for 15 minutes at room temperature, then 10 nM Cy5-p53 peptide (internal preparation) is added before an incubation at room temperature for 15 minutes prior to reading the plate. For measurement of samples, a Victor II microplate reader (Perkin Elmer) is used with the following settings: Excitation 340 nm, Emission Donor 620 nm and Emission Acceptor 665 nm. For selected compounds displaying IC50s between 0.05 and 5 nM on MDM2, a slightly modified assay is used with the following adaptations: 0.1 nM MDM2, 0.1 nM Europium labeled streptavidin and Tecan genios Pro is used as a microplate reader for the fluorescence measurements (p53-MDM2 Assay 2).",B,,,BAO_0000190,BAO_0000224,protein format,COc1nc(N)ncc1-c1cc2c(n1C(C)C)C(c1ccc(Cl)cc1)N(c1cc(C)nn1C)C2=O,,,CHEMBL3886789,,2016,"{'bei': '17.13', 'le': '0.33', 'lle': '3.87', 'sei': '8.10'}",CHEMBL3975723,,CHEMBL3975723,8.43,False,http://www.openphacts.org/units/Nanomolar,2886013,=,37,True,=,,IC50,nM,,3.717,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,3.717
411807,17776623,[],CHEMBL3888635,"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: Assay 2: The test is performed in white 384-well plates (Greiner Bio-One, reference 781207) in a total volume of 60 L by adding 1 L of compounds tested at different concentrations diluted in 100% DMSO (1.7% final DMSO concentration) in reaction buffer (PBS, 125 mM NaCl, 0.001% Novexin (consists of carbohydrate polymers), designed to increase the solubility and stability of proteins; Expedeon Ltd., Cambridgeshire, United Kingdom), 0.01% Gelatin, 0.01% 0.2%, Pluronic F-127 (block copolymer from ethylenoxide and propyleneoxide), 1 mM DTT). After addition of 1.25 nM MDM2-biotinylated or 2.5 nM MDM4-biotinylated (internal preparations), and 0.625 nM Europium labeled streptavidin (Perkin Elmer), the solution is pre-incubated for 15 minutes at room temperature, then 10 nM Cy5-p53 peptide (internal preparation) is added before an incubation at room temperature for 15 minutes prior to reading the plate. For measurement of samples, a Victor II microplate reader (Perkin Elmer) is used with the following settings: Excitation 340 nm, Emission Donor 620 nm and Emission Acceptor 665 nm. For selected compounds displaying IC50s between 0.05 and 5 nM on MDM2, a slightly modified assay is used with the following adaptations: 0.1 nM MDM2, 0.1 nM Europium labeled streptavidin and Tecan genios Pro is used as a microplate reader for the fluorescence measurements (p53-MDM2 Assay 2).",B,,,BAO_0000190,BAO_0000224,protein format,COc1ncc(-c2cc3c(n2C(C)C)C(c2ccc(Cl)cc2)N(c2cc(C)nn2C)C3=O)c(OC)n1,,,CHEMBL3886789,,2016,"{'bei': '17.87', 'le': '0.34', 'lle': '4.07', 'sei': '10.38'}",CHEMBL3904935,,CHEMBL3904935,9.06,False,http://www.openphacts.org/units/Nanomolar,2886014,=,37,True,=,,IC50,nM,,0.87,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,0.87
411808,17776624,[],CHEMBL3888635,"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: Assay 2: The test is performed in white 384-well plates (Greiner Bio-One, reference 781207) in a total volume of 60 L by adding 1 L of compounds tested at different concentrations diluted in 100% DMSO (1.7% final DMSO concentration) in reaction buffer (PBS, 125 mM NaCl, 0.001% Novexin (consists of carbohydrate polymers), designed to increase the solubility and stability of proteins; Expedeon Ltd., Cambridgeshire, United Kingdom), 0.01% Gelatin, 0.01% 0.2%, Pluronic F-127 (block copolymer from ethylenoxide and propyleneoxide), 1 mM DTT). After addition of 1.25 nM MDM2-biotinylated or 2.5 nM MDM4-biotinylated (internal preparations), and 0.625 nM Europium labeled streptavidin (Perkin Elmer), the solution is pre-incubated for 15 minutes at room temperature, then 10 nM Cy5-p53 peptide (internal preparation) is added before an incubation at room temperature for 15 minutes prior to reading the plate. For measurement of samples, a Victor II microplate reader (Perkin Elmer) is used with the following settings: Excitation 340 nm, Emission Donor 620 nm and Emission Acceptor 665 nm. For selected compounds displaying IC50s between 0.05 and 5 nM on MDM2, a slightly modified assay is used with the following adaptations: 0.1 nM MDM2, 0.1 nM Europium labeled streptavidin and Tecan genios Pro is used as a microplate reader for the fluorescence measurements (p53-MDM2 Assay 2).",B,,,BAO_0000190,BAO_0000224,protein format,COc1nc(N(C)C)ncc1-c1cc2c(n1C(C)C)C(c1ccc(Cl)cc1)N(c1cc(C)nn1C)C2=O,,,CHEMBL3886789,,2016,"{'bei': '17.86', 'le': '0.34', 'lle': '4.24', 'sei': '11.42'}",CHEMBL3974644,,CHEMBL3974644,9.29,False,http://www.openphacts.org/units/Nanomolar,2886015,=,37,True,=,,IC50,nM,,0.514,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,0.514
411809,17776625,[],CHEMBL3888635,"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: Assay 2: The test is performed in white 384-well plates (Greiner Bio-One, reference 781207) in a total volume of 60 L by adding 1 L of compounds tested at different concentrations diluted in 100% DMSO (1.7% final DMSO concentration) in reaction buffer (PBS, 125 mM NaCl, 0.001% Novexin (consists of carbohydrate polymers), designed to increase the solubility and stability of proteins; Expedeon Ltd., Cambridgeshire, United Kingdom), 0.01% Gelatin, 0.01% 0.2%, Pluronic F-127 (block copolymer from ethylenoxide and propyleneoxide), 1 mM DTT). After addition of 1.25 nM MDM2-biotinylated or 2.5 nM MDM4-biotinylated (internal preparations), and 0.625 nM Europium labeled streptavidin (Perkin Elmer), the solution is pre-incubated for 15 minutes at room temperature, then 10 nM Cy5-p53 peptide (internal preparation) is added before an incubation at room temperature for 15 minutes prior to reading the plate. For measurement of samples, a Victor II microplate reader (Perkin Elmer) is used with the following settings: Excitation 340 nm, Emission Donor 620 nm and Emission Acceptor 665 nm. For selected compounds displaying IC50s between 0.05 and 5 nM on MDM2, a slightly modified assay is used with the following adaptations: 0.1 nM MDM2, 0.1 nM Europium labeled streptavidin and Tecan genios Pro is used as a microplate reader for the fluorescence measurements (p53-MDM2 Assay 2).",B,,,BAO_0000190,BAO_0000224,protein format,COc1cn(C)c(=O)cc1-c1cc2c(n1C(C)C)C(c1ccc(Cl)cc1)N(c1cc(C)nn1C)C2=O,,,CHEMBL3886789,,2016,"{'bei': '17.72', 'le': '0.34', 'lle': '4.08', 'sei': '12.07'}",CHEMBL3900233,,CHEMBL3900233,8.97,False,http://www.openphacts.org/units/Nanomolar,2886016,=,37,True,=,,IC50,nM,,1.074,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,1.074
411810,17776626,[],CHEMBL3888635,"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: Assay 2: The test is performed in white 384-well plates (Greiner Bio-One, reference 781207) in a total volume of 60 L by adding 1 L of compounds tested at different concentrations diluted in 100% DMSO (1.7% final DMSO concentration) in reaction buffer (PBS, 125 mM NaCl, 0.001% Novexin (consists of carbohydrate polymers), designed to increase the solubility and stability of proteins; Expedeon Ltd., Cambridgeshire, United Kingdom), 0.01% Gelatin, 0.01% 0.2%, Pluronic F-127 (block copolymer from ethylenoxide and propyleneoxide), 1 mM DTT). After addition of 1.25 nM MDM2-biotinylated or 2.5 nM MDM4-biotinylated (internal preparations), and 0.625 nM Europium labeled streptavidin (Perkin Elmer), the solution is pre-incubated for 15 minutes at room temperature, then 10 nM Cy5-p53 peptide (internal preparation) is added before an incubation at room temperature for 15 minutes prior to reading the plate. For measurement of samples, a Victor II microplate reader (Perkin Elmer) is used with the following settings: Excitation 340 nm, Emission Donor 620 nm and Emission Acceptor 665 nm. For selected compounds displaying IC50s between 0.05 and 5 nM on MDM2, a slightly modified assay is used with the following adaptations: 0.1 nM MDM2, 0.1 nM Europium labeled streptavidin and Tecan genios Pro is used as a microplate reader for the fluorescence measurements (p53-MDM2 Assay 2).",B,,,BAO_0000190,BAO_0000224,protein format,COc1ncc(-c2cc3c(n2C(C)C)C(c2ccc(C#N)cc2)N(c2cc(C)nn2C)C3=O)c(OC)n1,,,CHEMBL3886789,,2016,"{'bei': '17.00', 'le': '0.31', 'lle': '4.25', 'sei': '7.62'}",CHEMBL3891351,,CHEMBL3891351,8.46,False,http://www.openphacts.org/units/Nanomolar,2886017,=,37,True,=,,IC50,nM,,3.462,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,3.462
411811,17776627,[],CHEMBL3888635,"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: Assay 2: The test is performed in white 384-well plates (Greiner Bio-One, reference 781207) in a total volume of 60 L by adding 1 L of compounds tested at different concentrations diluted in 100% DMSO (1.7% final DMSO concentration) in reaction buffer (PBS, 125 mM NaCl, 0.001% Novexin (consists of carbohydrate polymers), designed to increase the solubility and stability of proteins; Expedeon Ltd., Cambridgeshire, United Kingdom), 0.01% Gelatin, 0.01% 0.2%, Pluronic F-127 (block copolymer from ethylenoxide and propyleneoxide), 1 mM DTT). After addition of 1.25 nM MDM2-biotinylated or 2.5 nM MDM4-biotinylated (internal preparations), and 0.625 nM Europium labeled streptavidin (Perkin Elmer), the solution is pre-incubated for 15 minutes at room temperature, then 10 nM Cy5-p53 peptide (internal preparation) is added before an incubation at room temperature for 15 minutes prior to reading the plate. For measurement of samples, a Victor II microplate reader (Perkin Elmer) is used with the following settings: Excitation 340 nm, Emission Donor 620 nm and Emission Acceptor 665 nm. For selected compounds displaying IC50s between 0.05 and 5 nM on MDM2, a slightly modified assay is used with the following adaptations: 0.1 nM MDM2, 0.1 nM Europium labeled streptavidin and Tecan genios Pro is used as a microplate reader for the fluorescence measurements (p53-MDM2 Assay 2).",B,,,BAO_0000190,BAO_0000224,protein format,COc1nc(N(C)C)ncc1-c1cc2c(n1C(C)C)C(c1ccc(C#N)cc1)N(c1cc(C)nn1C)C2=O,,,CHEMBL3886789,,2016,"{'bei': '18.00', 'le': '0.33', 'lle': '4.93', 'sei': '8.74'}",CHEMBL3919420,,CHEMBL3919420,9.19,False,http://www.openphacts.org/units/Nanomolar,2886018,=,37,True,=,,IC50,nM,,0.647,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,0.647
411812,17776628,[],CHEMBL3888635,"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: Assay 2: The test is performed in white 384-well plates (Greiner Bio-One, reference 781207) in a total volume of 60 L by adding 1 L of compounds tested at different concentrations diluted in 100% DMSO (1.7% final DMSO concentration) in reaction buffer (PBS, 125 mM NaCl, 0.001% Novexin (consists of carbohydrate polymers), designed to increase the solubility and stability of proteins; Expedeon Ltd., Cambridgeshire, United Kingdom), 0.01% Gelatin, 0.01% 0.2%, Pluronic F-127 (block copolymer from ethylenoxide and propyleneoxide), 1 mM DTT). After addition of 1.25 nM MDM2-biotinylated or 2.5 nM MDM4-biotinylated (internal preparations), and 0.625 nM Europium labeled streptavidin (Perkin Elmer), the solution is pre-incubated for 15 minutes at room temperature, then 10 nM Cy5-p53 peptide (internal preparation) is added before an incubation at room temperature for 15 minutes prior to reading the plate. For measurement of samples, a Victor II microplate reader (Perkin Elmer) is used with the following settings: Excitation 340 nm, Emission Donor 620 nm and Emission Acceptor 665 nm. For selected compounds displaying IC50s between 0.05 and 5 nM on MDM2, a slightly modified assay is used with the following adaptations: 0.1 nM MDM2, 0.1 nM Europium labeled streptavidin and Tecan genios Pro is used as a microplate reader for the fluorescence measurements (p53-MDM2 Assay 2).",B,,,BAO_0000190,BAO_0000224,protein format,COc1ncc(-c2cc3c(n2C(C)C)C(c2ccc(Cl)cc2)N(c2cn(C)nc2C)C3=O)c(OC)n1,,,CHEMBL3886789,,2016,"{'bei': '17.01', 'le': '0.33', 'lle': '3.63', 'sei': '9.88'}",CHEMBL3890144,,CHEMBL3890144,8.62,False,http://www.openphacts.org/units/Nanomolar,2886019,=,37,True,=,,IC50,nM,,2.391,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,2.391
411813,17776629,[],CHEMBL3888635,"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: Assay 2: The test is performed in white 384-well plates (Greiner Bio-One, reference 781207) in a total volume of 60 L by adding 1 L of compounds tested at different concentrations diluted in 100% DMSO (1.7% final DMSO concentration) in reaction buffer (PBS, 125 mM NaCl, 0.001% Novexin (consists of carbohydrate polymers), designed to increase the solubility and stability of proteins; Expedeon Ltd., Cambridgeshire, United Kingdom), 0.01% Gelatin, 0.01% 0.2%, Pluronic F-127 (block copolymer from ethylenoxide and propyleneoxide), 1 mM DTT). After addition of 1.25 nM MDM2-biotinylated or 2.5 nM MDM4-biotinylated (internal preparations), and 0.625 nM Europium labeled streptavidin (Perkin Elmer), the solution is pre-incubated for 15 minutes at room temperature, then 10 nM Cy5-p53 peptide (internal preparation) is added before an incubation at room temperature for 15 minutes prior to reading the plate. For measurement of samples, a Victor II microplate reader (Perkin Elmer) is used with the following settings: Excitation 340 nm, Emission Donor 620 nm and Emission Acceptor 665 nm. For selected compounds displaying IC50s between 0.05 and 5 nM on MDM2, a slightly modified assay is used with the following adaptations: 0.1 nM MDM2, 0.1 nM Europium labeled streptavidin and Tecan genios Pro is used as a microplate reader for the fluorescence measurements (p53-MDM2 Assay 2).",B,,,BAO_0000190,BAO_0000224,protein format,COc1nc(N(C)C)ncc1-c1cc2c(n1C(C)C)C(c1ccc(Cl)cc1)N(c1cn(C)nc1C)C2=O,,,CHEMBL3886789,,2016,"{'bei': '17.65', 'le': '0.34', 'lle': '4.13', 'sei': '11.29'}",CHEMBL3921731,,CHEMBL3921731,9.18,False,http://www.openphacts.org/units/Nanomolar,2886020,=,37,True,=,,IC50,nM,,0.659,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,0.659
411814,17776630,[],CHEMBL3888635,"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: Assay 2: The test is performed in white 384-well plates (Greiner Bio-One, reference 781207) in a total volume of 60 L by adding 1 L of compounds tested at different concentrations diluted in 100% DMSO (1.7% final DMSO concentration) in reaction buffer (PBS, 125 mM NaCl, 0.001% Novexin (consists of carbohydrate polymers), designed to increase the solubility and stability of proteins; Expedeon Ltd., Cambridgeshire, United Kingdom), 0.01% Gelatin, 0.01% 0.2%, Pluronic F-127 (block copolymer from ethylenoxide and propyleneoxide), 1 mM DTT). After addition of 1.25 nM MDM2-biotinylated or 2.5 nM MDM4-biotinylated (internal preparations), and 0.625 nM Europium labeled streptavidin (Perkin Elmer), the solution is pre-incubated for 15 minutes at room temperature, then 10 nM Cy5-p53 peptide (internal preparation) is added before an incubation at room temperature for 15 minutes prior to reading the plate. For measurement of samples, a Victor II microplate reader (Perkin Elmer) is used with the following settings: Excitation 340 nm, Emission Donor 620 nm and Emission Acceptor 665 nm. For selected compounds displaying IC50s between 0.05 and 5 nM on MDM2, a slightly modified assay is used with the following adaptations: 0.1 nM MDM2, 0.1 nM Europium labeled streptavidin and Tecan genios Pro is used as a microplate reader for the fluorescence measurements (p53-MDM2 Assay 2).",B,,,BAO_0000190,BAO_0000224,protein format,COc1ccc(S(C)(=O)=O)cc1-c1cc2c(n1C(C)C)C(c1ccc(Cl)cc1)N(c1cn(C)nc1C)C2=O,,,CHEMBL3886789,,2016,"{'bei': '15.53', 'le': '0.31', 'lle': '3.00', 'sei': '9.94'}",CHEMBL3896773,,CHEMBL3896773,8.59,False,http://www.openphacts.org/units/Nanomolar,2886021,=,37,True,=,,IC50,nM,,2.573,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,2.573
411815,17776631,[],CHEMBL3888635,"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: Assay 2: The test is performed in white 384-well plates (Greiner Bio-One, reference 781207) in a total volume of 60 L by adding 1 L of compounds tested at different concentrations diluted in 100% DMSO (1.7% final DMSO concentration) in reaction buffer (PBS, 125 mM NaCl, 0.001% Novexin (consists of carbohydrate polymers), designed to increase the solubility and stability of proteins; Expedeon Ltd., Cambridgeshire, United Kingdom), 0.01% Gelatin, 0.01% 0.2%, Pluronic F-127 (block copolymer from ethylenoxide and propyleneoxide), 1 mM DTT). After addition of 1.25 nM MDM2-biotinylated or 2.5 nM MDM4-biotinylated (internal preparations), and 0.625 nM Europium labeled streptavidin (Perkin Elmer), the solution is pre-incubated for 15 minutes at room temperature, then 10 nM Cy5-p53 peptide (internal preparation) is added before an incubation at room temperature for 15 minutes prior to reading the plate. For measurement of samples, a Victor II microplate reader (Perkin Elmer) is used with the following settings: Excitation 340 nm, Emission Donor 620 nm and Emission Acceptor 665 nm. For selected compounds displaying IC50s between 0.05 and 5 nM on MDM2, a slightly modified assay is used with the following adaptations: 0.1 nM MDM2, 0.1 nM Europium labeled streptavidin and Tecan genios Pro is used as a microplate reader for the fluorescence measurements (p53-MDM2 Assay 2).",B,,,BAO_0000190,BAO_0000224,protein format,COc1cn(C)c(=O)cc1-c1cc2c(n1C(C)C)C(c1ccc(Cl)cc1)N(c1cn(C)nc1C)C2=O,,,CHEMBL3886789,,2016,"{'bei': '16.31', 'le': '0.31', 'lle': '3.36', 'sei': '11.11'}",CHEMBL3906793,,CHEMBL3906793,8.25,False,http://www.openphacts.org/units/Nanomolar,2886022,=,37,True,=,,IC50,nM,,5.599,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,5.599
411816,17776632,[],CHEMBL3888635,"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: Assay 2: The test is performed in white 384-well plates (Greiner Bio-One, reference 781207) in a total volume of 60 L by adding 1 L of compounds tested at different concentrations diluted in 100% DMSO (1.7% final DMSO concentration) in reaction buffer (PBS, 125 mM NaCl, 0.001% Novexin (consists of carbohydrate polymers), designed to increase the solubility and stability of proteins; Expedeon Ltd., Cambridgeshire, United Kingdom), 0.01% Gelatin, 0.01% 0.2%, Pluronic F-127 (block copolymer from ethylenoxide and propyleneoxide), 1 mM DTT). After addition of 1.25 nM MDM2-biotinylated or 2.5 nM MDM4-biotinylated (internal preparations), and 0.625 nM Europium labeled streptavidin (Perkin Elmer), the solution is pre-incubated for 15 minutes at room temperature, then 10 nM Cy5-p53 peptide (internal preparation) is added before an incubation at room temperature for 15 minutes prior to reading the plate. For measurement of samples, a Victor II microplate reader (Perkin Elmer) is used with the following settings: Excitation 340 nm, Emission Donor 620 nm and Emission Acceptor 665 nm. For selected compounds displaying IC50s between 0.05 and 5 nM on MDM2, a slightly modified assay is used with the following adaptations: 0.1 nM MDM2, 0.1 nM Europium labeled streptavidin and Tecan genios Pro is used as a microplate reader for the fluorescence measurements (p53-MDM2 Assay 2).",B,,,BAO_0000190,BAO_0000224,protein format,COc1nc(N(C)C)ncc1-c1cc2c(n1C(C)C)C(c1ccc(C#N)cc1)N(c1cc(Cl)c(=O)n(C)c1)C2=O,,,CHEMBL3886789,,2016,"{'bei': '17.29', 'le': '0.33', 'lle': '5.08', 'sei': '8.83'}",CHEMBL3945499,,CHEMBL3945499,9.65,False,http://www.openphacts.org/units/Nanomolar,2886023,=,37,True,=,,IC50,nM,,0.225,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,0.225
411817,17776633,[],CHEMBL3888635,"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: Assay 2: The test is performed in white 384-well plates (Greiner Bio-One, reference 781207) in a total volume of 60 L by adding 1 L of compounds tested at different concentrations diluted in 100% DMSO (1.7% final DMSO concentration) in reaction buffer (PBS, 125 mM NaCl, 0.001% Novexin (consists of carbohydrate polymers), designed to increase the solubility and stability of proteins; Expedeon Ltd., Cambridgeshire, United Kingdom), 0.01% Gelatin, 0.01% 0.2%, Pluronic F-127 (block copolymer from ethylenoxide and propyleneoxide), 1 mM DTT). After addition of 1.25 nM MDM2-biotinylated or 2.5 nM MDM4-biotinylated (internal preparations), and 0.625 nM Europium labeled streptavidin (Perkin Elmer), the solution is pre-incubated for 15 minutes at room temperature, then 10 nM Cy5-p53 peptide (internal preparation) is added before an incubation at room temperature for 15 minutes prior to reading the plate. For measurement of samples, a Victor II microplate reader (Perkin Elmer) is used with the following settings: Excitation 340 nm, Emission Donor 620 nm and Emission Acceptor 665 nm. For selected compounds displaying IC50s between 0.05 and 5 nM on MDM2, a slightly modified assay is used with the following adaptations: 0.1 nM MDM2, 0.1 nM Europium labeled streptavidin and Tecan genios Pro is used as a microplate reader for the fluorescence measurements (p53-MDM2 Assay 2).",B,,,BAO_0000190,BAO_0000224,protein format,COc1ncc(-c2cc3c(n2C(C)C)[C@H](c2ccc(C#N)cc2)N(c2cc(Cl)c(=O)n(C)c2)C3=O)c(OC)n1,,,CHEMBL3886789,,2016,"{'bei': '18.29', 'le': '0.35', 'lle': '5.45', 'sei': '8.65'}",CHEMBL3914063,,CHEMBL3914063,9.97,False,http://www.openphacts.org/units/Nanomolar,2886024,=,37,True,=,,IC50,nM,,0.108,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,0.108
411818,17776634,[],CHEMBL3888635,"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: Assay 2: The test is performed in white 384-well plates (Greiner Bio-One, reference 781207) in a total volume of 60 L by adding 1 L of compounds tested at different concentrations diluted in 100% DMSO (1.7% final DMSO concentration) in reaction buffer (PBS, 125 mM NaCl, 0.001% Novexin (consists of carbohydrate polymers), designed to increase the solubility and stability of proteins; Expedeon Ltd., Cambridgeshire, United Kingdom), 0.01% Gelatin, 0.01% 0.2%, Pluronic F-127 (block copolymer from ethylenoxide and propyleneoxide), 1 mM DTT). After addition of 1.25 nM MDM2-biotinylated or 2.5 nM MDM4-biotinylated (internal preparations), and 0.625 nM Europium labeled streptavidin (Perkin Elmer), the solution is pre-incubated for 15 minutes at room temperature, then 10 nM Cy5-p53 peptide (internal preparation) is added before an incubation at room temperature for 15 minutes prior to reading the plate. For measurement of samples, a Victor II microplate reader (Perkin Elmer) is used with the following settings: Excitation 340 nm, Emission Donor 620 nm and Emission Acceptor 665 nm. For selected compounds displaying IC50s between 0.05 and 5 nM on MDM2, a slightly modified assay is used with the following adaptations: 0.1 nM MDM2, 0.1 nM Europium labeled streptavidin and Tecan genios Pro is used as a microplate reader for the fluorescence measurements (p53-MDM2 Assay 2).",B,,,BAO_0000190,BAO_0000224,protein format,COc1ncc(-c2cc3c(n2C(C)C)[C@@H](c2ccc(C#N)cc2)N(c2cc(Cl)c(=O)n(C)c2)C3=O)c(OC)n1,,,CHEMBL3886789,,2016,"{'bei': '12.55', 'le': '0.24', 'lle': '2.32', 'sei': '5.94'}",CHEMBL4110257,,CHEMBL4110257,6.84,False,http://www.openphacts.org/units/Nanomolar,2886025,=,37,True,=,,IC50,nM,,143.8,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,143.802
411819,17776635,[],CHEMBL3888635,"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: Assay 2: The test is performed in white 384-well plates (Greiner Bio-One, reference 781207) in a total volume of 60 L by adding 1 L of compounds tested at different concentrations diluted in 100% DMSO (1.7% final DMSO concentration) in reaction buffer (PBS, 125 mM NaCl, 0.001% Novexin (consists of carbohydrate polymers), designed to increase the solubility and stability of proteins; Expedeon Ltd., Cambridgeshire, United Kingdom), 0.01% Gelatin, 0.01% 0.2%, Pluronic F-127 (block copolymer from ethylenoxide and propyleneoxide), 1 mM DTT). After addition of 1.25 nM MDM2-biotinylated or 2.5 nM MDM4-biotinylated (internal preparations), and 0.625 nM Europium labeled streptavidin (Perkin Elmer), the solution is pre-incubated for 15 minutes at room temperature, then 10 nM Cy5-p53 peptide (internal preparation) is added before an incubation at room temperature for 15 minutes prior to reading the plate. For measurement of samples, a Victor II microplate reader (Perkin Elmer) is used with the following settings: Excitation 340 nm, Emission Donor 620 nm and Emission Acceptor 665 nm. For selected compounds displaying IC50s between 0.05 and 5 nM on MDM2, a slightly modified assay is used with the following adaptations: 0.1 nM MDM2, 0.1 nM Europium labeled streptavidin and Tecan genios Pro is used as a microplate reader for the fluorescence measurements (p53-MDM2 Assay 2).",B,,,BAO_0000190,BAO_0000224,protein format,COc1nc(N(C)C)ncc1-c1cc2c(n1C(C)C)[C@H](c1ccc(Cl)cc1)N(c1c[nH]c(=O)c(Cl)c1)C2=O,,,CHEMBL3886789,,2016,"{'bei': '18.25', 'le': '0.36', 'lle': '4.75', 'sei': '10.49'}",CHEMBL3928320,,CHEMBL3928320,10.10,False,http://www.openphacts.org/units/Nanomolar,2886026,=,37,True,=,,IC50,nM,,0.079,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,0.079
411820,17776636,[],CHEMBL3888635,"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: Assay 2: The test is performed in white 384-well plates (Greiner Bio-One, reference 781207) in a total volume of 60 L by adding 1 L of compounds tested at different concentrations diluted in 100% DMSO (1.7% final DMSO concentration) in reaction buffer (PBS, 125 mM NaCl, 0.001% Novexin (consists of carbohydrate polymers), designed to increase the solubility and stability of proteins; Expedeon Ltd., Cambridgeshire, United Kingdom), 0.01% Gelatin, 0.01% 0.2%, Pluronic F-127 (block copolymer from ethylenoxide and propyleneoxide), 1 mM DTT). After addition of 1.25 nM MDM2-biotinylated or 2.5 nM MDM4-biotinylated (internal preparations), and 0.625 nM Europium labeled streptavidin (Perkin Elmer), the solution is pre-incubated for 15 minutes at room temperature, then 10 nM Cy5-p53 peptide (internal preparation) is added before an incubation at room temperature for 15 minutes prior to reading the plate. For measurement of samples, a Victor II microplate reader (Perkin Elmer) is used with the following settings: Excitation 340 nm, Emission Donor 620 nm and Emission Acceptor 665 nm. For selected compounds displaying IC50s between 0.05 and 5 nM on MDM2, a slightly modified assay is used with the following adaptations: 0.1 nM MDM2, 0.1 nM Europium labeled streptavidin and Tecan genios Pro is used as a microplate reader for the fluorescence measurements (p53-MDM2 Assay 2).",B,,,BAO_0000190,BAO_0000224,protein format,COc1nc(N(C)C)ncc1-c1cc2c(n1C(C)C)[C@@H](c1ccc(Cl)cc1)N(c1c[nH]c(=O)c(Cl)c1)C2=O,,,CHEMBL3886789,,2016,"{'bei': '14.41', 'le': '0.29', 'lle': '2.63', 'sei': '8.28'}",CHEMBL4108538,,CHEMBL4108538,7.97,False,http://www.openphacts.org/units/Nanomolar,2886027,=,37,True,=,,IC50,nM,,10.59,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,10.588
411821,17776637,[],CHEMBL3888635,"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: Assay 2: The test is performed in white 384-well plates (Greiner Bio-One, reference 781207) in a total volume of 60 L by adding 1 L of compounds tested at different concentrations diluted in 100% DMSO (1.7% final DMSO concentration) in reaction buffer (PBS, 125 mM NaCl, 0.001% Novexin (consists of carbohydrate polymers), designed to increase the solubility and stability of proteins; Expedeon Ltd., Cambridgeshire, United Kingdom), 0.01% Gelatin, 0.01% 0.2%, Pluronic F-127 (block copolymer from ethylenoxide and propyleneoxide), 1 mM DTT). After addition of 1.25 nM MDM2-biotinylated or 2.5 nM MDM4-biotinylated (internal preparations), and 0.625 nM Europium labeled streptavidin (Perkin Elmer), the solution is pre-incubated for 15 minutes at room temperature, then 10 nM Cy5-p53 peptide (internal preparation) is added before an incubation at room temperature for 15 minutes prior to reading the plate. For measurement of samples, a Victor II microplate reader (Perkin Elmer) is used with the following settings: Excitation 340 nm, Emission Donor 620 nm and Emission Acceptor 665 nm. For selected compounds displaying IC50s between 0.05 and 5 nM on MDM2, a slightly modified assay is used with the following adaptations: 0.1 nM MDM2, 0.1 nM Europium labeled streptavidin and Tecan genios Pro is used as a microplate reader for the fluorescence measurements (p53-MDM2 Assay 2).",B,,,BAO_0000190,BAO_0000224,protein format,COc1nc(N(C)C)ncc1-c1cc2c(n1C(C)C)[C@H](c1ccc(C#N)cc1)N(C1CCOCC1)C2=O,,,CHEMBL3886789,,2016,"{'bei': '18.38', 'le': '0.34', 'lle': '5.00', 'sei': '9.53'}",CHEMBL3909949,,CHEMBL3909949,9.20,False,http://www.openphacts.org/units/Nanomolar,2886028,=,37,True,=,,IC50,nM,,0.631,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,0.631
411822,17776638,[],CHEMBL3888635,"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: Assay 2: The test is performed in white 384-well plates (Greiner Bio-One, reference 781207) in a total volume of 60 L by adding 1 L of compounds tested at different concentrations diluted in 100% DMSO (1.7% final DMSO concentration) in reaction buffer (PBS, 125 mM NaCl, 0.001% Novexin (consists of carbohydrate polymers), designed to increase the solubility and stability of proteins; Expedeon Ltd., Cambridgeshire, United Kingdom), 0.01% Gelatin, 0.01% 0.2%, Pluronic F-127 (block copolymer from ethylenoxide and propyleneoxide), 1 mM DTT). After addition of 1.25 nM MDM2-biotinylated or 2.5 nM MDM4-biotinylated (internal preparations), and 0.625 nM Europium labeled streptavidin (Perkin Elmer), the solution is pre-incubated for 15 minutes at room temperature, then 10 nM Cy5-p53 peptide (internal preparation) is added before an incubation at room temperature for 15 minutes prior to reading the plate. For measurement of samples, a Victor II microplate reader (Perkin Elmer) is used with the following settings: Excitation 340 nm, Emission Donor 620 nm and Emission Acceptor 665 nm. For selected compounds displaying IC50s between 0.05 and 5 nM on MDM2, a slightly modified assay is used with the following adaptations: 0.1 nM MDM2, 0.1 nM Europium labeled streptavidin and Tecan genios Pro is used as a microplate reader for the fluorescence measurements (p53-MDM2 Assay 2).",B,,,BAO_0000190,BAO_0000224,protein format,COc1nc(N(C)C)ncc1-c1cc2c(n1C(C)C)[C@@H](c1ccc(C#N)cc1)N(C1CCOCC1)C2=O,,,CHEMBL3886789,,2016,"{'bei': '13.09', 'le': '0.24', 'lle': '2.35', 'sei': '6.79'}",CHEMBL4107940,,CHEMBL4107940,6.55,False,http://www.openphacts.org/units/Nanomolar,2886029,=,37,True,=,,IC50,nM,,279.88,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,279.883
411823,17776639,[],CHEMBL3888635,"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: Assay 2: The test is performed in white 384-well plates (Greiner Bio-One, reference 781207) in a total volume of 60 L by adding 1 L of compounds tested at different concentrations diluted in 100% DMSO (1.7% final DMSO concentration) in reaction buffer (PBS, 125 mM NaCl, 0.001% Novexin (consists of carbohydrate polymers), designed to increase the solubility and stability of proteins; Expedeon Ltd., Cambridgeshire, United Kingdom), 0.01% Gelatin, 0.01% 0.2%, Pluronic F-127 (block copolymer from ethylenoxide and propyleneoxide), 1 mM DTT). After addition of 1.25 nM MDM2-biotinylated or 2.5 nM MDM4-biotinylated (internal preparations), and 0.625 nM Europium labeled streptavidin (Perkin Elmer), the solution is pre-incubated for 15 minutes at room temperature, then 10 nM Cy5-p53 peptide (internal preparation) is added before an incubation at room temperature for 15 minutes prior to reading the plate. For measurement of samples, a Victor II microplate reader (Perkin Elmer) is used with the following settings: Excitation 340 nm, Emission Donor 620 nm and Emission Acceptor 665 nm. For selected compounds displaying IC50s between 0.05 and 5 nM on MDM2, a slightly modified assay is used with the following adaptations: 0.1 nM MDM2, 0.1 nM Europium labeled streptavidin and Tecan genios Pro is used as a microplate reader for the fluorescence measurements (p53-MDM2 Assay 2).",B,,,BAO_0000190,BAO_0000224,protein format,COc1ncc(-c2cc3c(n2C(C)C)C(c2ccc(Cl)c(F)c2)N(c2cc(Cl)c(=O)n(C)c2)C3=O)c(OC)n1,,,CHEMBL3886789,,2016,"{'bei': '17.28', 'le': '0.35', 'lle': '4.45', 'sei': '10.81'}",CHEMBL3953073,,CHEMBL3953073,9.89,False,http://www.openphacts.org/units/Nanomolar,2886030,=,37,True,=,,IC50,nM,,0.128,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,0.128
411824,17776640,[],CHEMBL3888635,"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: Assay 2: The test is performed in white 384-well plates (Greiner Bio-One, reference 781207) in a total volume of 60 L by adding 1 L of compounds tested at different concentrations diluted in 100% DMSO (1.7% final DMSO concentration) in reaction buffer (PBS, 125 mM NaCl, 0.001% Novexin (consists of carbohydrate polymers), designed to increase the solubility and stability of proteins; Expedeon Ltd., Cambridgeshire, United Kingdom), 0.01% Gelatin, 0.01% 0.2%, Pluronic F-127 (block copolymer from ethylenoxide and propyleneoxide), 1 mM DTT). After addition of 1.25 nM MDM2-biotinylated or 2.5 nM MDM4-biotinylated (internal preparations), and 0.625 nM Europium labeled streptavidin (Perkin Elmer), the solution is pre-incubated for 15 minutes at room temperature, then 10 nM Cy5-p53 peptide (internal preparation) is added before an incubation at room temperature for 15 minutes prior to reading the plate. For measurement of samples, a Victor II microplate reader (Perkin Elmer) is used with the following settings: Excitation 340 nm, Emission Donor 620 nm and Emission Acceptor 665 nm. For selected compounds displaying IC50s between 0.05 and 5 nM on MDM2, a slightly modified assay is used with the following adaptations: 0.1 nM MDM2, 0.1 nM Europium labeled streptavidin and Tecan genios Pro is used as a microplate reader for the fluorescence measurements (p53-MDM2 Assay 2).",B,,,BAO_0000190,BAO_0000224,protein format,COc1nc(N(C)C)ncc1-c1cc2c(n1C(C)C)C(c1ccc(Cl)c(F)c1)N(c1cc(Cl)c(=O)n(C)c1)C2=O,,,CHEMBL3886789,,2016,"{'bei': '16.84', 'le': '0.34', 'lle': '4.36', 'sei': '11.53'}",CHEMBL3903662,,CHEMBL3903662,9.86,False,http://www.openphacts.org/units/Nanomolar,2886031,=,37,True,=,,IC50,nM,,0.139,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,0.139
411825,17776641,[],CHEMBL3888635,"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: Assay 2: The test is performed in white 384-well plates (Greiner Bio-One, reference 781207) in a total volume of 60 L by adding 1 L of compounds tested at different concentrations diluted in 100% DMSO (1.7% final DMSO concentration) in reaction buffer (PBS, 125 mM NaCl, 0.001% Novexin (consists of carbohydrate polymers), designed to increase the solubility and stability of proteins; Expedeon Ltd., Cambridgeshire, United Kingdom), 0.01% Gelatin, 0.01% 0.2%, Pluronic F-127 (block copolymer from ethylenoxide and propyleneoxide), 1 mM DTT). After addition of 1.25 nM MDM2-biotinylated or 2.5 nM MDM4-biotinylated (internal preparations), and 0.625 nM Europium labeled streptavidin (Perkin Elmer), the solution is pre-incubated for 15 minutes at room temperature, then 10 nM Cy5-p53 peptide (internal preparation) is added before an incubation at room temperature for 15 minutes prior to reading the plate. For measurement of samples, a Victor II microplate reader (Perkin Elmer) is used with the following settings: Excitation 340 nm, Emission Donor 620 nm and Emission Acceptor 665 nm. For selected compounds displaying IC50s between 0.05 and 5 nM on MDM2, a slightly modified assay is used with the following adaptations: 0.1 nM MDM2, 0.1 nM Europium labeled streptavidin and Tecan genios Pro is used as a microplate reader for the fluorescence measurements (p53-MDM2 Assay 2).",B,,,BAO_0000190,BAO_0000224,protein format,COc1nc(N(C)C)ncc1-c1cc2c(n1C(C)C)C(c1ccc(C#N)c(F)c1)N(c1cc(Cl)c(=O)n(C)c1)C2=O,,,CHEMBL3886789,,2016,"{'bei': '16.86', 'le': '0.32', 'lle': '5.00', 'sei': '8.89'}",CHEMBL3949589,,CHEMBL3949589,9.71,False,http://www.openphacts.org/units/Nanomolar,2886032,=,37,True,=,,IC50,nM,,0.194,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,0.194
411826,17776642,[],CHEMBL3888635,"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: Assay 2: The test is performed in white 384-well plates (Greiner Bio-One, reference 781207) in a total volume of 60 L by adding 1 L of compounds tested at different concentrations diluted in 100% DMSO (1.7% final DMSO concentration) in reaction buffer (PBS, 125 mM NaCl, 0.001% Novexin (consists of carbohydrate polymers), designed to increase the solubility and stability of proteins; Expedeon Ltd., Cambridgeshire, United Kingdom), 0.01% Gelatin, 0.01% 0.2%, Pluronic F-127 (block copolymer from ethylenoxide and propyleneoxide), 1 mM DTT). After addition of 1.25 nM MDM2-biotinylated or 2.5 nM MDM4-biotinylated (internal preparations), and 0.625 nM Europium labeled streptavidin (Perkin Elmer), the solution is pre-incubated for 15 minutes at room temperature, then 10 nM Cy5-p53 peptide (internal preparation) is added before an incubation at room temperature for 15 minutes prior to reading the plate. For measurement of samples, a Victor II microplate reader (Perkin Elmer) is used with the following settings: Excitation 340 nm, Emission Donor 620 nm and Emission Acceptor 665 nm. For selected compounds displaying IC50s between 0.05 and 5 nM on MDM2, a slightly modified assay is used with the following adaptations: 0.1 nM MDM2, 0.1 nM Europium labeled streptavidin and Tecan genios Pro is used as a microplate reader for the fluorescence measurements (p53-MDM2 Assay 2).",B,,,BAO_0000190,BAO_0000224,protein format,COc1ncc(-c2cc3c(n2C(C)C)C(c2ccc(C#N)c(F)c2)N(c2cc(Cl)c(=O)n(C)c2)C3=O)c(OC)n1,,,CHEMBL3886789,,2016,"{'bei': '17.05', 'le': '0.33', 'lle': '4.94', 'sei': '8.33'}",CHEMBL3909197,,CHEMBL3909197,9.60,False,http://www.openphacts.org/units/Nanomolar,2886033,=,37,True,=,,IC50,nM,,0.252,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,0.252
411827,17776643,[],CHEMBL3888635,"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: Assay 2: The test is performed in white 384-well plates (Greiner Bio-One, reference 781207) in a total volume of 60 L by adding 1 L of compounds tested at different concentrations diluted in 100% DMSO (1.7% final DMSO concentration) in reaction buffer (PBS, 125 mM NaCl, 0.001% Novexin (consists of carbohydrate polymers), designed to increase the solubility and stability of proteins; Expedeon Ltd., Cambridgeshire, United Kingdom), 0.01% Gelatin, 0.01% 0.2%, Pluronic F-127 (block copolymer from ethylenoxide and propyleneoxide), 1 mM DTT). After addition of 1.25 nM MDM2-biotinylated or 2.5 nM MDM4-biotinylated (internal preparations), and 0.625 nM Europium labeled streptavidin (Perkin Elmer), the solution is pre-incubated for 15 minutes at room temperature, then 10 nM Cy5-p53 peptide (internal preparation) is added before an incubation at room temperature for 15 minutes prior to reading the plate. For measurement of samples, a Victor II microplate reader (Perkin Elmer) is used with the following settings: Excitation 340 nm, Emission Donor 620 nm and Emission Acceptor 665 nm. For selected compounds displaying IC50s between 0.05 and 5 nM on MDM2, a slightly modified assay is used with the following adaptations: 0.1 nM MDM2, 0.1 nM Europium labeled streptavidin and Tecan genios Pro is used as a microplate reader for the fluorescence measurements (p53-MDM2 Assay 2).",B,,,BAO_0000190,BAO_0000224,protein format,COc1ncc(-c2cc3c(n2C(C)C)C(c2ccc(Cl)c(F)c2)N(c2cc(Cl)cn(C)c2=O)C3=O)c(OC)n1,,,CHEMBL3886789,,2016,"{'bei': '16.43', 'le': '0.33', 'lle': '3.96', 'sei': '10.28'}",CHEMBL3911364,,CHEMBL3911364,9.40,False,http://www.openphacts.org/units/Nanomolar,2886034,=,37,True,=,,IC50,nM,,0.395,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,0.395
411828,17776644,[],CHEMBL3888635,"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: Assay 2: The test is performed in white 384-well plates (Greiner Bio-One, reference 781207) in a total volume of 60 L by adding 1 L of compounds tested at different concentrations diluted in 100% DMSO (1.7% final DMSO concentration) in reaction buffer (PBS, 125 mM NaCl, 0.001% Novexin (consists of carbohydrate polymers), designed to increase the solubility and stability of proteins; Expedeon Ltd., Cambridgeshire, United Kingdom), 0.01% Gelatin, 0.01% 0.2%, Pluronic F-127 (block copolymer from ethylenoxide and propyleneoxide), 1 mM DTT). After addition of 1.25 nM MDM2-biotinylated or 2.5 nM MDM4-biotinylated (internal preparations), and 0.625 nM Europium labeled streptavidin (Perkin Elmer), the solution is pre-incubated for 15 minutes at room temperature, then 10 nM Cy5-p53 peptide (internal preparation) is added before an incubation at room temperature for 15 minutes prior to reading the plate. For measurement of samples, a Victor II microplate reader (Perkin Elmer) is used with the following settings: Excitation 340 nm, Emission Donor 620 nm and Emission Acceptor 665 nm. For selected compounds displaying IC50s between 0.05 and 5 nM on MDM2, a slightly modified assay is used with the following adaptations: 0.1 nM MDM2, 0.1 nM Europium labeled streptavidin and Tecan genios Pro is used as a microplate reader for the fluorescence measurements (p53-MDM2 Assay 2).",B,,,BAO_0000190,BAO_0000224,protein format,COc1nc(N(C)C)ncc1-c1cc2c(n1C(C)C)C(c1ccc(Cl)c(F)c1)N(c1cc(Cl)cn(C)c1=O)C2=O,,,CHEMBL3886789,,2016,"{'bei': '16.14', 'le': '0.32', 'lle': '3.95', 'sei': '11.05'}",CHEMBL3918131,,CHEMBL3918131,9.45,False,http://www.openphacts.org/units/Nanomolar,2886035,=,37,True,=,,IC50,nM,,0.356,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,0.356
411829,17776645,[],CHEMBL3888635,"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: Assay 2: The test is performed in white 384-well plates (Greiner Bio-One, reference 781207) in a total volume of 60 L by adding 1 L of compounds tested at different concentrations diluted in 100% DMSO (1.7% final DMSO concentration) in reaction buffer (PBS, 125 mM NaCl, 0.001% Novexin (consists of carbohydrate polymers), designed to increase the solubility and stability of proteins; Expedeon Ltd., Cambridgeshire, United Kingdom), 0.01% Gelatin, 0.01% 0.2%, Pluronic F-127 (block copolymer from ethylenoxide and propyleneoxide), 1 mM DTT). After addition of 1.25 nM MDM2-biotinylated or 2.5 nM MDM4-biotinylated (internal preparations), and 0.625 nM Europium labeled streptavidin (Perkin Elmer), the solution is pre-incubated for 15 minutes at room temperature, then 10 nM Cy5-p53 peptide (internal preparation) is added before an incubation at room temperature for 15 minutes prior to reading the plate. For measurement of samples, a Victor II microplate reader (Perkin Elmer) is used with the following settings: Excitation 340 nm, Emission Donor 620 nm and Emission Acceptor 665 nm. For selected compounds displaying IC50s between 0.05 and 5 nM on MDM2, a slightly modified assay is used with the following adaptations: 0.1 nM MDM2, 0.1 nM Europium labeled streptavidin and Tecan genios Pro is used as a microplate reader for the fluorescence measurements (p53-MDM2 Assay 2).",B,,,BAO_0000190,BAO_0000224,protein format,COc1ncc(-c2cc3c(n2C(C)C)C(c2ccc(C#N)c(F)c2)N(c2cc(Cl)cn(C)c2=O)C3=O)c(OC)n1,,,CHEMBL3886789,,2016,"{'bei': '16.27', 'le': '0.31', 'lle': '4.50', 'sei': '7.95'}",CHEMBL3946024,,CHEMBL3946024,9.16,False,http://www.openphacts.org/units/Nanomolar,2886036,=,37,True,=,,IC50,nM,,0.691,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,0.691
411830,17776646,[],CHEMBL3888635,"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: Assay 2: The test is performed in white 384-well plates (Greiner Bio-One, reference 781207) in a total volume of 60 L by adding 1 L of compounds tested at different concentrations diluted in 100% DMSO (1.7% final DMSO concentration) in reaction buffer (PBS, 125 mM NaCl, 0.001% Novexin (consists of carbohydrate polymers), designed to increase the solubility and stability of proteins; Expedeon Ltd., Cambridgeshire, United Kingdom), 0.01% Gelatin, 0.01% 0.2%, Pluronic F-127 (block copolymer from ethylenoxide and propyleneoxide), 1 mM DTT). After addition of 1.25 nM MDM2-biotinylated or 2.5 nM MDM4-biotinylated (internal preparations), and 0.625 nM Europium labeled streptavidin (Perkin Elmer), the solution is pre-incubated for 15 minutes at room temperature, then 10 nM Cy5-p53 peptide (internal preparation) is added before an incubation at room temperature for 15 minutes prior to reading the plate. For measurement of samples, a Victor II microplate reader (Perkin Elmer) is used with the following settings: Excitation 340 nm, Emission Donor 620 nm and Emission Acceptor 665 nm. For selected compounds displaying IC50s between 0.05 and 5 nM on MDM2, a slightly modified assay is used with the following adaptations: 0.1 nM MDM2, 0.1 nM Europium labeled streptavidin and Tecan genios Pro is used as a microplate reader for the fluorescence measurements (p53-MDM2 Assay 2).",B,,,BAO_0000190,BAO_0000224,protein format,COc1nc(N(C)C)ncc1-c1cc2c(n1C(C)C)C(c1ccc(C#N)c(F)c1)N(c1cc(Cl)cn(C)c1=O)C2=O,,,CHEMBL3886789,,2016,"{'bei': '16.65', 'le': '0.32', 'lle': '4.88', 'sei': '8.78'}",CHEMBL3930604,,CHEMBL3930604,9.59,False,http://www.openphacts.org/units/Nanomolar,2886037,=,37,True,=,,IC50,nM,,0.257,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,0.257
411831,17776647,[],CHEMBL3888635,"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: Assay 2: The test is performed in white 384-well plates (Greiner Bio-One, reference 781207) in a total volume of 60 L by adding 1 L of compounds tested at different concentrations diluted in 100% DMSO (1.7% final DMSO concentration) in reaction buffer (PBS, 125 mM NaCl, 0.001% Novexin (consists of carbohydrate polymers), designed to increase the solubility and stability of proteins; Expedeon Ltd., Cambridgeshire, United Kingdom), 0.01% Gelatin, 0.01% 0.2%, Pluronic F-127 (block copolymer from ethylenoxide and propyleneoxide), 1 mM DTT). After addition of 1.25 nM MDM2-biotinylated or 2.5 nM MDM4-biotinylated (internal preparations), and 0.625 nM Europium labeled streptavidin (Perkin Elmer), the solution is pre-incubated for 15 minutes at room temperature, then 10 nM Cy5-p53 peptide (internal preparation) is added before an incubation at room temperature for 15 minutes prior to reading the plate. For measurement of samples, a Victor II microplate reader (Perkin Elmer) is used with the following settings: Excitation 340 nm, Emission Donor 620 nm and Emission Acceptor 665 nm. For selected compounds displaying IC50s between 0.05 and 5 nM on MDM2, a slightly modified assay is used with the following adaptations: 0.1 nM MDM2, 0.1 nM Europium labeled streptavidin and Tecan genios Pro is used as a microplate reader for the fluorescence measurements (p53-MDM2 Assay 2).",B,,,BAO_0000190,BAO_0000224,protein format,COc1ncc(-c2cc3c(n2C(C)C)C(c2ccc(C#N)c(F)c2)N(c2cc(Cl)c[nH]c2=O)C3=O)c(OC)n1,,,CHEMBL3886789,,2016,"{'bei': '17.18', 'le': '0.33', 'lle': '4.78', 'sei': '7.48'}",CHEMBL3954710,,CHEMBL3954710,9.43,False,http://www.openphacts.org/units/Nanomolar,2886038,=,37,True,=,,IC50,nM,,0.37,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,0.37
411832,17776648,[],CHEMBL3888635,"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: Assay 2: The test is performed in white 384-well plates (Greiner Bio-One, reference 781207) in a total volume of 60 L by adding 1 L of compounds tested at different concentrations diluted in 100% DMSO (1.7% final DMSO concentration) in reaction buffer (PBS, 125 mM NaCl, 0.001% Novexin (consists of carbohydrate polymers), designed to increase the solubility and stability of proteins; Expedeon Ltd., Cambridgeshire, United Kingdom), 0.01% Gelatin, 0.01% 0.2%, Pluronic F-127 (block copolymer from ethylenoxide and propyleneoxide), 1 mM DTT). After addition of 1.25 nM MDM2-biotinylated or 2.5 nM MDM4-biotinylated (internal preparations), and 0.625 nM Europium labeled streptavidin (Perkin Elmer), the solution is pre-incubated for 15 minutes at room temperature, then 10 nM Cy5-p53 peptide (internal preparation) is added before an incubation at room temperature for 15 minutes prior to reading the plate. For measurement of samples, a Victor II microplate reader (Perkin Elmer) is used with the following settings: Excitation 340 nm, Emission Donor 620 nm and Emission Acceptor 665 nm. For selected compounds displaying IC50s between 0.05 and 5 nM on MDM2, a slightly modified assay is used with the following adaptations: 0.1 nM MDM2, 0.1 nM Europium labeled streptavidin and Tecan genios Pro is used as a microplate reader for the fluorescence measurements (p53-MDM2 Assay 2).",B,,,BAO_0000190,BAO_0000224,protein format,COc1nc(N(C)C)ncc1-c1cc2c(n1C(C)C)C(c1ccc(C#N)c(F)c1)N(c1cc(Cl)c[nH]c1=O)C2=O,,,CHEMBL3886789,,2016,"{'bei': '17.09', 'le': '0.33', 'lle': '4.90', 'sei': '7.99'}",CHEMBL3939598,,CHEMBL3939598,9.60,False,http://www.openphacts.org/units/Nanomolar,2886039,=,37,True,=,,IC50,nM,,0.25,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,0.25
411833,17776649,[],CHEMBL3888635,"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: Assay 2: The test is performed in white 384-well plates (Greiner Bio-One, reference 781207) in a total volume of 60 L by adding 1 L of compounds tested at different concentrations diluted in 100% DMSO (1.7% final DMSO concentration) in reaction buffer (PBS, 125 mM NaCl, 0.001% Novexin (consists of carbohydrate polymers), designed to increase the solubility and stability of proteins; Expedeon Ltd., Cambridgeshire, United Kingdom), 0.01% Gelatin, 0.01% 0.2%, Pluronic F-127 (block copolymer from ethylenoxide and propyleneoxide), 1 mM DTT). After addition of 1.25 nM MDM2-biotinylated or 2.5 nM MDM4-biotinylated (internal preparations), and 0.625 nM Europium labeled streptavidin (Perkin Elmer), the solution is pre-incubated for 15 minutes at room temperature, then 10 nM Cy5-p53 peptide (internal preparation) is added before an incubation at room temperature for 15 minutes prior to reading the plate. For measurement of samples, a Victor II microplate reader (Perkin Elmer) is used with the following settings: Excitation 340 nm, Emission Donor 620 nm and Emission Acceptor 665 nm. For selected compounds displaying IC50s between 0.05 and 5 nM on MDM2, a slightly modified assay is used with the following adaptations: 0.1 nM MDM2, 0.1 nM Europium labeled streptavidin and Tecan genios Pro is used as a microplate reader for the fluorescence measurements (p53-MDM2 Assay 2).",B,,,BAO_0000190,BAO_0000224,protein format,COc1ncc(-c2cc3c(n2C(C)C)C(c2ccc(Cl)c(F)c2)N(c2cc(Cl)c[nH]c2=O)C3=O)c(OC)n1,,,CHEMBL3886789,,2016,"{'bei': '17.37', 'le': '0.35', 'lle': '4.27', 'sei': '9.48'}",CHEMBL3969153,,CHEMBL3969153,9.70,False,http://www.openphacts.org/units/Nanomolar,2886040,=,37,True,=,,IC50,nM,,0.201,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,0.201
411834,17776650,[],CHEMBL3888635,"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: Assay 2: The test is performed in white 384-well plates (Greiner Bio-One, reference 781207) in a total volume of 60 L by adding 1 L of compounds tested at different concentrations diluted in 100% DMSO (1.7% final DMSO concentration) in reaction buffer (PBS, 125 mM NaCl, 0.001% Novexin (consists of carbohydrate polymers), designed to increase the solubility and stability of proteins; Expedeon Ltd., Cambridgeshire, United Kingdom), 0.01% Gelatin, 0.01% 0.2%, Pluronic F-127 (block copolymer from ethylenoxide and propyleneoxide), 1 mM DTT). After addition of 1.25 nM MDM2-biotinylated or 2.5 nM MDM4-biotinylated (internal preparations), and 0.625 nM Europium labeled streptavidin (Perkin Elmer), the solution is pre-incubated for 15 minutes at room temperature, then 10 nM Cy5-p53 peptide (internal preparation) is added before an incubation at room temperature for 15 minutes prior to reading the plate. For measurement of samples, a Victor II microplate reader (Perkin Elmer) is used with the following settings: Excitation 340 nm, Emission Donor 620 nm and Emission Acceptor 665 nm. For selected compounds displaying IC50s between 0.05 and 5 nM on MDM2, a slightly modified assay is used with the following adaptations: 0.1 nM MDM2, 0.1 nM Europium labeled streptavidin and Tecan genios Pro is used as a microplate reader for the fluorescence measurements (p53-MDM2 Assay 2).",B,,,BAO_0000190,BAO_0000224,protein format,COc1nc(N(C)C)ncc1-c1cc2c(n1C(C)C)C(c1ccc(Cl)c(F)c1)N(c1cc(Cl)c[nH]c1=O)C2=O,,,CHEMBL3886789,,2016,"{'bei': '17.37', 'le': '0.35', 'lle': '4.44', 'sei': '10.30'}",CHEMBL3966324,,CHEMBL3966324,9.92,False,http://www.openphacts.org/units/Nanomolar,2886041,=,37,True,=,,IC50,nM,,0.119,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,0.119
411835,17776651,[],CHEMBL3888635,"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: Assay 2: The test is performed in white 384-well plates (Greiner Bio-One, reference 781207) in a total volume of 60 L by adding 1 L of compounds tested at different concentrations diluted in 100% DMSO (1.7% final DMSO concentration) in reaction buffer (PBS, 125 mM NaCl, 0.001% Novexin (consists of carbohydrate polymers), designed to increase the solubility and stability of proteins; Expedeon Ltd., Cambridgeshire, United Kingdom), 0.01% Gelatin, 0.01% 0.2%, Pluronic F-127 (block copolymer from ethylenoxide and propyleneoxide), 1 mM DTT). After addition of 1.25 nM MDM2-biotinylated or 2.5 nM MDM4-biotinylated (internal preparations), and 0.625 nM Europium labeled streptavidin (Perkin Elmer), the solution is pre-incubated for 15 minutes at room temperature, then 10 nM Cy5-p53 peptide (internal preparation) is added before an incubation at room temperature for 15 minutes prior to reading the plate. For measurement of samples, a Victor II microplate reader (Perkin Elmer) is used with the following settings: Excitation 340 nm, Emission Donor 620 nm and Emission Acceptor 665 nm. For selected compounds displaying IC50s between 0.05 and 5 nM on MDM2, a slightly modified assay is used with the following adaptations: 0.1 nM MDM2, 0.1 nM Europium labeled streptavidin and Tecan genios Pro is used as a microplate reader for the fluorescence measurements (p53-MDM2 Assay 2).",B,,,BAO_0000190,BAO_0000224,protein format,COc1ncc(-c2cc3c(n2C(C)C)C(c2ccc(Cl)cc2)N(c2cc(Cl)c[nH]c2=O)C3=O)c(OC)n1,,,CHEMBL3886789,,2016,"{'bei': '17.97', 'le': '0.36', 'lle': '4.42', 'sei': '9.49'}",CHEMBL3940087,,CHEMBL3940087,9.71,False,http://www.openphacts.org/units/Nanomolar,2886042,=,37,True,=,,IC50,nM,,0.195,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,0.195
411836,17776652,[],CHEMBL3888635,"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: Assay 2: The test is performed in white 384-well plates (Greiner Bio-One, reference 781207) in a total volume of 60 L by adding 1 L of compounds tested at different concentrations diluted in 100% DMSO (1.7% final DMSO concentration) in reaction buffer (PBS, 125 mM NaCl, 0.001% Novexin (consists of carbohydrate polymers), designed to increase the solubility and stability of proteins; Expedeon Ltd., Cambridgeshire, United Kingdom), 0.01% Gelatin, 0.01% 0.2%, Pluronic F-127 (block copolymer from ethylenoxide and propyleneoxide), 1 mM DTT). After addition of 1.25 nM MDM2-biotinylated or 2.5 nM MDM4-biotinylated (internal preparations), and 0.625 nM Europium labeled streptavidin (Perkin Elmer), the solution is pre-incubated for 15 minutes at room temperature, then 10 nM Cy5-p53 peptide (internal preparation) is added before an incubation at room temperature for 15 minutes prior to reading the plate. For measurement of samples, a Victor II microplate reader (Perkin Elmer) is used with the following settings: Excitation 340 nm, Emission Donor 620 nm and Emission Acceptor 665 nm. For selected compounds displaying IC50s between 0.05 and 5 nM on MDM2, a slightly modified assay is used with the following adaptations: 0.1 nM MDM2, 0.1 nM Europium labeled streptavidin and Tecan genios Pro is used as a microplate reader for the fluorescence measurements (p53-MDM2 Assay 2).",B,,,BAO_0000190,BAO_0000224,protein format,COc1cn(C)c(=O)cc1-c1cc2c(n1C(C)C)C(c1ccc(Cl)cc1)N(c1cc(Cl)cnc1OC)C2=O,,,CHEMBL3886789,,2016,"{'bei': '17.53', 'le': '0.35', 'lle': '3.80', 'sei': '12.35'}",CHEMBL3955169,,CHEMBL3955169,9.70,False,http://www.openphacts.org/units/Nanomolar,2886043,=,37,True,=,,IC50,nM,,0.198,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,0.198
411837,17776653,[],CHEMBL3888635,"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: Assay 2: The test is performed in white 384-well plates (Greiner Bio-One, reference 781207) in a total volume of 60 L by adding 1 L of compounds tested at different concentrations diluted in 100% DMSO (1.7% final DMSO concentration) in reaction buffer (PBS, 125 mM NaCl, 0.001% Novexin (consists of carbohydrate polymers), designed to increase the solubility and stability of proteins; Expedeon Ltd., Cambridgeshire, United Kingdom), 0.01% Gelatin, 0.01% 0.2%, Pluronic F-127 (block copolymer from ethylenoxide and propyleneoxide), 1 mM DTT). After addition of 1.25 nM MDM2-biotinylated or 2.5 nM MDM4-biotinylated (internal preparations), and 0.625 nM Europium labeled streptavidin (Perkin Elmer), the solution is pre-incubated for 15 minutes at room temperature, then 10 nM Cy5-p53 peptide (internal preparation) is added before an incubation at room temperature for 15 minutes prior to reading the plate. For measurement of samples, a Victor II microplate reader (Perkin Elmer) is used with the following settings: Excitation 340 nm, Emission Donor 620 nm and Emission Acceptor 665 nm. For selected compounds displaying IC50s between 0.05 and 5 nM on MDM2, a slightly modified assay is used with the following adaptations: 0.1 nM MDM2, 0.1 nM Europium labeled streptavidin and Tecan genios Pro is used as a microplate reader for the fluorescence measurements (p53-MDM2 Assay 2).",B,,,BAO_0000190,BAO_0000224,protein format,COc1nc(N)ncc1-c1cc2c(n1C(C)C)C(c1ccc(Cl)cc1)N(c1cc(Cl)cnc1OC)C2=O,,,CHEMBL3886789,,2016,"{'bei': '17.23', 'le': '0.34', 'lle': '3.71', 'sei': '8.57'}",CHEMBL3927561,,CHEMBL3927561,9.29,False,http://www.openphacts.org/units/Nanomolar,2886044,=,37,True,=,,IC50,nM,,0.509,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,0.509
411838,17776654,[],CHEMBL3888635,"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: Assay 2: The test is performed in white 384-well plates (Greiner Bio-One, reference 781207) in a total volume of 60 L by adding 1 L of compounds tested at different concentrations diluted in 100% DMSO (1.7% final DMSO concentration) in reaction buffer (PBS, 125 mM NaCl, 0.001% Novexin (consists of carbohydrate polymers), designed to increase the solubility and stability of proteins; Expedeon Ltd., Cambridgeshire, United Kingdom), 0.01% Gelatin, 0.01% 0.2%, Pluronic F-127 (block copolymer from ethylenoxide and propyleneoxide), 1 mM DTT). After addition of 1.25 nM MDM2-biotinylated or 2.5 nM MDM4-biotinylated (internal preparations), and 0.625 nM Europium labeled streptavidin (Perkin Elmer), the solution is pre-incubated for 15 minutes at room temperature, then 10 nM Cy5-p53 peptide (internal preparation) is added before an incubation at room temperature for 15 minutes prior to reading the plate. For measurement of samples, a Victor II microplate reader (Perkin Elmer) is used with the following settings: Excitation 340 nm, Emission Donor 620 nm and Emission Acceptor 665 nm. For selected compounds displaying IC50s between 0.05 and 5 nM on MDM2, a slightly modified assay is used with the following adaptations: 0.1 nM MDM2, 0.1 nM Europium labeled streptavidin and Tecan genios Pro is used as a microplate reader for the fluorescence measurements (p53-MDM2 Assay 2).",B,,,BAO_0000190,BAO_0000224,protein format,COc1nc(N(C)C)ncc1-c1cc2c(n1C(C)C)C(c1ccc(C#N)cc1)N(c1cc(Cl)cnc1OC)C2=O,,,CHEMBL3886789,,2016,"{'bei': '17.44', 'le': '0.33', 'lle': '4.45', 'sei': '8.90'}",CHEMBL3949888,,CHEMBL3949888,9.73,False,http://www.openphacts.org/units/Nanomolar,2886045,=,37,True,=,,IC50,nM,,0.185,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,0.185
411839,17776655,[],CHEMBL3888635,"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: Assay 2: The test is performed in white 384-well plates (Greiner Bio-One, reference 781207) in a total volume of 60 L by adding 1 L of compounds tested at different concentrations diluted in 100% DMSO (1.7% final DMSO concentration) in reaction buffer (PBS, 125 mM NaCl, 0.001% Novexin (consists of carbohydrate polymers), designed to increase the solubility and stability of proteins; Expedeon Ltd., Cambridgeshire, United Kingdom), 0.01% Gelatin, 0.01% 0.2%, Pluronic F-127 (block copolymer from ethylenoxide and propyleneoxide), 1 mM DTT). After addition of 1.25 nM MDM2-biotinylated or 2.5 nM MDM4-biotinylated (internal preparations), and 0.625 nM Europium labeled streptavidin (Perkin Elmer), the solution is pre-incubated for 15 minutes at room temperature, then 10 nM Cy5-p53 peptide (internal preparation) is added before an incubation at room temperature for 15 minutes prior to reading the plate. For measurement of samples, a Victor II microplate reader (Perkin Elmer) is used with the following settings: Excitation 340 nm, Emission Donor 620 nm and Emission Acceptor 665 nm. For selected compounds displaying IC50s between 0.05 and 5 nM on MDM2, a slightly modified assay is used with the following adaptations: 0.1 nM MDM2, 0.1 nM Europium labeled streptavidin and Tecan genios Pro is used as a microplate reader for the fluorescence measurements (p53-MDM2 Assay 2).",B,,,BAO_0000190,BAO_0000224,protein format,COc1cn(C)c(=O)cc1-c1cc2c(n1C(C)C)C(c1ccc(Cl)cc1)N(c1c(F)c(C)nn1C)C2=O,,,CHEMBL3886789,,2016,"{'bei': '17.30', 'le': '0.33', 'lle': '4.03', 'sei': '12.20'}",CHEMBL3918620,,CHEMBL3918620,9.06,False,http://www.openphacts.org/units/Nanomolar,2886046,=,37,True,=,,IC50,nM,,0.861,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,0.861
411840,17776656,[],CHEMBL3888635,"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: Assay 2: The test is performed in white 384-well plates (Greiner Bio-One, reference 781207) in a total volume of 60 L by adding 1 L of compounds tested at different concentrations diluted in 100% DMSO (1.7% final DMSO concentration) in reaction buffer (PBS, 125 mM NaCl, 0.001% Novexin (consists of carbohydrate polymers), designed to increase the solubility and stability of proteins; Expedeon Ltd., Cambridgeshire, United Kingdom), 0.01% Gelatin, 0.01% 0.2%, Pluronic F-127 (block copolymer from ethylenoxide and propyleneoxide), 1 mM DTT). After addition of 1.25 nM MDM2-biotinylated or 2.5 nM MDM4-biotinylated (internal preparations), and 0.625 nM Europium labeled streptavidin (Perkin Elmer), the solution is pre-incubated for 15 minutes at room temperature, then 10 nM Cy5-p53 peptide (internal preparation) is added before an incubation at room temperature for 15 minutes prior to reading the plate. For measurement of samples, a Victor II microplate reader (Perkin Elmer) is used with the following settings: Excitation 340 nm, Emission Donor 620 nm and Emission Acceptor 665 nm. For selected compounds displaying IC50s between 0.05 and 5 nM on MDM2, a slightly modified assay is used with the following adaptations: 0.1 nM MDM2, 0.1 nM Europium labeled streptavidin and Tecan genios Pro is used as a microplate reader for the fluorescence measurements (p53-MDM2 Assay 2).",B,,,BAO_0000190,BAO_0000224,protein format,COc1nc(N(C)C)ncc1-c1cc2c(n1C(C)C)C(c1ccc(Cl)cc1)N(c1c(F)c(C)nn1C)C2=O,,,CHEMBL3886789,,2016,"{'bei': '18.22', 'le': '0.35', 'lle': '4.62', 'sei': '12.05'}",CHEMBL3941149,,CHEMBL3941149,9.80,False,http://www.openphacts.org/units/Nanomolar,2886047,=,37,True,=,,IC50,nM,,0.158,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,0.158
411841,17776657,[],CHEMBL3888635,"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: Assay 2: The test is performed in white 384-well plates (Greiner Bio-One, reference 781207) in a total volume of 60 L by adding 1 L of compounds tested at different concentrations diluted in 100% DMSO (1.7% final DMSO concentration) in reaction buffer (PBS, 125 mM NaCl, 0.001% Novexin (consists of carbohydrate polymers), designed to increase the solubility and stability of proteins; Expedeon Ltd., Cambridgeshire, United Kingdom), 0.01% Gelatin, 0.01% 0.2%, Pluronic F-127 (block copolymer from ethylenoxide and propyleneoxide), 1 mM DTT). After addition of 1.25 nM MDM2-biotinylated or 2.5 nM MDM4-biotinylated (internal preparations), and 0.625 nM Europium labeled streptavidin (Perkin Elmer), the solution is pre-incubated for 15 minutes at room temperature, then 10 nM Cy5-p53 peptide (internal preparation) is added before an incubation at room temperature for 15 minutes prior to reading the plate. For measurement of samples, a Victor II microplate reader (Perkin Elmer) is used with the following settings: Excitation 340 nm, Emission Donor 620 nm and Emission Acceptor 665 nm. For selected compounds displaying IC50s between 0.05 and 5 nM on MDM2, a slightly modified assay is used with the following adaptations: 0.1 nM MDM2, 0.1 nM Europium labeled streptavidin and Tecan genios Pro is used as a microplate reader for the fluorescence measurements (p53-MDM2 Assay 2).",B,,,BAO_0000190,BAO_0000224,protein format,COc1nc(N)ncc1-c1cc2c(n1C(C)C)C(c1ccc(Cl)cc1)N(c1c(F)c(C)nn1C)C2=O,,,CHEMBL3886789,,2016,"{'bei': '16.49', 'le': '0.32', 'lle': '3.71', 'sei': '8.08'}",CHEMBL3913136,,CHEMBL3913136,8.41,False,http://www.openphacts.org/units/Nanomolar,2886048,=,37,True,=,,IC50,nM,,3.901,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,3.901
411842,17776658,[],CHEMBL3888635,"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: Assay 2: The test is performed in white 384-well plates (Greiner Bio-One, reference 781207) in a total volume of 60 L by adding 1 L of compounds tested at different concentrations diluted in 100% DMSO (1.7% final DMSO concentration) in reaction buffer (PBS, 125 mM NaCl, 0.001% Novexin (consists of carbohydrate polymers), designed to increase the solubility and stability of proteins; Expedeon Ltd., Cambridgeshire, United Kingdom), 0.01% Gelatin, 0.01% 0.2%, Pluronic F-127 (block copolymer from ethylenoxide and propyleneoxide), 1 mM DTT). After addition of 1.25 nM MDM2-biotinylated or 2.5 nM MDM4-biotinylated (internal preparations), and 0.625 nM Europium labeled streptavidin (Perkin Elmer), the solution is pre-incubated for 15 minutes at room temperature, then 10 nM Cy5-p53 peptide (internal preparation) is added before an incubation at room temperature for 15 minutes prior to reading the plate. For measurement of samples, a Victor II microplate reader (Perkin Elmer) is used with the following settings: Excitation 340 nm, Emission Donor 620 nm and Emission Acceptor 665 nm. For selected compounds displaying IC50s between 0.05 and 5 nM on MDM2, a slightly modified assay is used with the following adaptations: 0.1 nM MDM2, 0.1 nM Europium labeled streptavidin and Tecan genios Pro is used as a microplate reader for the fluorescence measurements (p53-MDM2 Assay 2).",B,,,BAO_0000190,BAO_0000224,protein format,COc1ncc(-c2cc3c(n2C(C)C)C(c2ccc(C#N)cc2)N(c2c(F)c(C)nn2C)C3=O)c(OC)n1,,,CHEMBL3886789,,2016,"{'bei': '17.02', 'le': '0.32', 'lle': '4.43', 'sei': '7.90'}",CHEMBL3973720,,CHEMBL3973720,8.78,False,http://www.openphacts.org/units/Nanomolar,2886049,=,37,True,=,,IC50,nM,,1.675,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,1.675
411843,17776659,[],CHEMBL3888635,"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: Assay 2: The test is performed in white 384-well plates (Greiner Bio-One, reference 781207) in a total volume of 60 L by adding 1 L of compounds tested at different concentrations diluted in 100% DMSO (1.7% final DMSO concentration) in reaction buffer (PBS, 125 mM NaCl, 0.001% Novexin (consists of carbohydrate polymers), designed to increase the solubility and stability of proteins; Expedeon Ltd., Cambridgeshire, United Kingdom), 0.01% Gelatin, 0.01% 0.2%, Pluronic F-127 (block copolymer from ethylenoxide and propyleneoxide), 1 mM DTT). After addition of 1.25 nM MDM2-biotinylated or 2.5 nM MDM4-biotinylated (internal preparations), and 0.625 nM Europium labeled streptavidin (Perkin Elmer), the solution is pre-incubated for 15 minutes at room temperature, then 10 nM Cy5-p53 peptide (internal preparation) is added before an incubation at room temperature for 15 minutes prior to reading the plate. For measurement of samples, a Victor II microplate reader (Perkin Elmer) is used with the following settings: Excitation 340 nm, Emission Donor 620 nm and Emission Acceptor 665 nm. For selected compounds displaying IC50s between 0.05 and 5 nM on MDM2, a slightly modified assay is used with the following adaptations: 0.1 nM MDM2, 0.1 nM Europium labeled streptavidin and Tecan genios Pro is used as a microplate reader for the fluorescence measurements (p53-MDM2 Assay 2).",B,,,BAO_0000190,BAO_0000224,protein format,COc1nc(N(C)C)ncc1-c1cc2c(n1C(C)C)C(c1ccc(Cl)cc1F)N(c1cc(C)nn1C)C2=O,,,CHEMBL3886789,,2016,"{'bei': '16.94', 'le': '0.33', 'lle': '3.93', 'sei': '11.21'}",CHEMBL3947634,,CHEMBL3947634,9.11,False,http://www.openphacts.org/units/Nanomolar,2886050,=,37,True,=,,IC50,nM,,0.769,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,0.769
411844,17776660,[],CHEMBL3888635,"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: Assay 2: The test is performed in white 384-well plates (Greiner Bio-One, reference 781207) in a total volume of 60 L by adding 1 L of compounds tested at different concentrations diluted in 100% DMSO (1.7% final DMSO concentration) in reaction buffer (PBS, 125 mM NaCl, 0.001% Novexin (consists of carbohydrate polymers), designed to increase the solubility and stability of proteins; Expedeon Ltd., Cambridgeshire, United Kingdom), 0.01% Gelatin, 0.01% 0.2%, Pluronic F-127 (block copolymer from ethylenoxide and propyleneoxide), 1 mM DTT). After addition of 1.25 nM MDM2-biotinylated or 2.5 nM MDM4-biotinylated (internal preparations), and 0.625 nM Europium labeled streptavidin (Perkin Elmer), the solution is pre-incubated for 15 minutes at room temperature, then 10 nM Cy5-p53 peptide (internal preparation) is added before an incubation at room temperature for 15 minutes prior to reading the plate. For measurement of samples, a Victor II microplate reader (Perkin Elmer) is used with the following settings: Excitation 340 nm, Emission Donor 620 nm and Emission Acceptor 665 nm. For selected compounds displaying IC50s between 0.05 and 5 nM on MDM2, a slightly modified assay is used with the following adaptations: 0.1 nM MDM2, 0.1 nM Europium labeled streptavidin and Tecan genios Pro is used as a microplate reader for the fluorescence measurements (p53-MDM2 Assay 2).",B,,,BAO_0000190,BAO_0000224,protein format,COc1ncc(-c2cc3c(n2C(C)C)C(c2ccc(Cl)cn2)N(c2cc(Cl)cn(C)c2=O)C3=O)c(OC)n1,,,CHEMBL3886789,,2016,"{'bei': '14.13', 'le': '0.28', 'lle': '3.16', 'sei': '7.52'}",CHEMBL3959690,,CHEMBL3959690,7.85,False,http://www.openphacts.org/units/Nanomolar,2886051,=,37,True,=,,IC50,nM,,14.24,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,14.236
411845,17776661,[],CHEMBL3888635,"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: Assay 2: The test is performed in white 384-well plates (Greiner Bio-One, reference 781207) in a total volume of 60 L by adding 1 L of compounds tested at different concentrations diluted in 100% DMSO (1.7% final DMSO concentration) in reaction buffer (PBS, 125 mM NaCl, 0.001% Novexin (consists of carbohydrate polymers), designed to increase the solubility and stability of proteins; Expedeon Ltd., Cambridgeshire, United Kingdom), 0.01% Gelatin, 0.01% 0.2%, Pluronic F-127 (block copolymer from ethylenoxide and propyleneoxide), 1 mM DTT). After addition of 1.25 nM MDM2-biotinylated or 2.5 nM MDM4-biotinylated (internal preparations), and 0.625 nM Europium labeled streptavidin (Perkin Elmer), the solution is pre-incubated for 15 minutes at room temperature, then 10 nM Cy5-p53 peptide (internal preparation) is added before an incubation at room temperature for 15 minutes prior to reading the plate. For measurement of samples, a Victor II microplate reader (Perkin Elmer) is used with the following settings: Excitation 340 nm, Emission Donor 620 nm and Emission Acceptor 665 nm. For selected compounds displaying IC50s between 0.05 and 5 nM on MDM2, a slightly modified assay is used with the following adaptations: 0.1 nM MDM2, 0.1 nM Europium labeled streptavidin and Tecan genios Pro is used as a microplate reader for the fluorescence measurements (p53-MDM2 Assay 2).",B,,,BAO_0000190,BAO_0000224,protein format,COc1ncc(-c2cc3c(n2C(C)C)C(c2ccc(Cl)cn2)N(c2ccc(F)c(Cl)c2)C3=O)c(OC)n1,,,CHEMBL3886789,,2016,"{'bei': '16.08', 'le': '0.32', 'lle': '2.59', 'sei': '10.59'}",CHEMBL3912023,,CHEMBL3912023,8.72,False,http://www.openphacts.org/units/Nanomolar,2886052,=,37,True,=,,IC50,nM,,1.887,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,1.887
411846,17776662,[],CHEMBL3888635,"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: Assay 2: The test is performed in white 384-well plates (Greiner Bio-One, reference 781207) in a total volume of 60 L by adding 1 L of compounds tested at different concentrations diluted in 100% DMSO (1.7% final DMSO concentration) in reaction buffer (PBS, 125 mM NaCl, 0.001% Novexin (consists of carbohydrate polymers), designed to increase the solubility and stability of proteins; Expedeon Ltd., Cambridgeshire, United Kingdom), 0.01% Gelatin, 0.01% 0.2%, Pluronic F-127 (block copolymer from ethylenoxide and propyleneoxide), 1 mM DTT). After addition of 1.25 nM MDM2-biotinylated or 2.5 nM MDM4-biotinylated (internal preparations), and 0.625 nM Europium labeled streptavidin (Perkin Elmer), the solution is pre-incubated for 15 minutes at room temperature, then 10 nM Cy5-p53 peptide (internal preparation) is added before an incubation at room temperature for 15 minutes prior to reading the plate. For measurement of samples, a Victor II microplate reader (Perkin Elmer) is used with the following settings: Excitation 340 nm, Emission Donor 620 nm and Emission Acceptor 665 nm. For selected compounds displaying IC50s between 0.05 and 5 nM on MDM2, a slightly modified assay is used with the following adaptations: 0.1 nM MDM2, 0.1 nM Europium labeled streptavidin and Tecan genios Pro is used as a microplate reader for the fluorescence measurements (p53-MDM2 Assay 2).",B,,,BAO_0000190,BAO_0000224,protein format,COc1ncc(-c2cc3c(n2C(C)C)[C@H](c2ccc(C#N)cc2)N(c2cc(Cl)cn(C)c2=O)C3=O)c(OC)n1,,,CHEMBL3886789,,2016,"{'bei': '17.02', 'le': '0.32', 'lle': '4.76', 'sei': '8.05'}",CHEMBL3913159,,CHEMBL3913159,9.28,False,http://www.openphacts.org/units/Nanomolar,2886053,=,37,True,=,,IC50,nM,,0.527,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,0.527
411847,17776663,[],CHEMBL3888635,"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: Assay 2: The test is performed in white 384-well plates (Greiner Bio-One, reference 781207) in a total volume of 60 L by adding 1 L of compounds tested at different concentrations diluted in 100% DMSO (1.7% final DMSO concentration) in reaction buffer (PBS, 125 mM NaCl, 0.001% Novexin (consists of carbohydrate polymers), designed to increase the solubility and stability of proteins; Expedeon Ltd., Cambridgeshire, United Kingdom), 0.01% Gelatin, 0.01% 0.2%, Pluronic F-127 (block copolymer from ethylenoxide and propyleneoxide), 1 mM DTT). After addition of 1.25 nM MDM2-biotinylated or 2.5 nM MDM4-biotinylated (internal preparations), and 0.625 nM Europium labeled streptavidin (Perkin Elmer), the solution is pre-incubated for 15 minutes at room temperature, then 10 nM Cy5-p53 peptide (internal preparation) is added before an incubation at room temperature for 15 minutes prior to reading the plate. For measurement of samples, a Victor II microplate reader (Perkin Elmer) is used with the following settings: Excitation 340 nm, Emission Donor 620 nm and Emission Acceptor 665 nm. For selected compounds displaying IC50s between 0.05 and 5 nM on MDM2, a slightly modified assay is used with the following adaptations: 0.1 nM MDM2, 0.1 nM Europium labeled streptavidin and Tecan genios Pro is used as a microplate reader for the fluorescence measurements (p53-MDM2 Assay 2).",B,,,BAO_0000190,BAO_0000224,protein format,COc1ncc(-c2cc3c(n2C(C)C)[C@@H](c2ccc(C#N)cc2)N(c2cc(Cl)cn(C)c2=O)C3=O)c(OC)n1,,,CHEMBL3886789,,2016,"{'bei': '11.11', 'le': '0.21', 'lle': '1.53', 'sei': '5.25'}",CHEMBL4115541,,CHEMBL4115541,6.05,False,http://www.openphacts.org/units/Nanomolar,2886054,=,37,True,=,,IC50,nM,,883.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,883.0
411848,17776664,[],CHEMBL3888635,"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: Assay 2: The test is performed in white 384-well plates (Greiner Bio-One, reference 781207) in a total volume of 60 L by adding 1 L of compounds tested at different concentrations diluted in 100% DMSO (1.7% final DMSO concentration) in reaction buffer (PBS, 125 mM NaCl, 0.001% Novexin (consists of carbohydrate polymers), designed to increase the solubility and stability of proteins; Expedeon Ltd., Cambridgeshire, United Kingdom), 0.01% Gelatin, 0.01% 0.2%, Pluronic F-127 (block copolymer from ethylenoxide and propyleneoxide), 1 mM DTT). After addition of 1.25 nM MDM2-biotinylated or 2.5 nM MDM4-biotinylated (internal preparations), and 0.625 nM Europium labeled streptavidin (Perkin Elmer), the solution is pre-incubated for 15 minutes at room temperature, then 10 nM Cy5-p53 peptide (internal preparation) is added before an incubation at room temperature for 15 minutes prior to reading the plate. For measurement of samples, a Victor II microplate reader (Perkin Elmer) is used with the following settings: Excitation 340 nm, Emission Donor 620 nm and Emission Acceptor 665 nm. For selected compounds displaying IC50s between 0.05 and 5 nM on MDM2, a slightly modified assay is used with the following adaptations: 0.1 nM MDM2, 0.1 nM Europium labeled streptavidin and Tecan genios Pro is used as a microplate reader for the fluorescence measurements (p53-MDM2 Assay 2).",B,,,BAO_0000190,BAO_0000224,protein format,COc1ncc(-c2cc3c(n2C(C)C)[C@H](c2ccc(Cl)cc2)N(c2cc(Cl)c(=O)n(C)c2)C3=O)c(OC)n1,,,CHEMBL3886789,,2016,"{'bei': '17.99', 'le': '0.36', 'lle': '4.67', 'sei': '10.90'}",CHEMBL3895404,,CHEMBL3895404,9.97,False,http://www.openphacts.org/units/Nanomolar,2885854,=,37,True,=,,IC50,nM,,0.106,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,0.106
411849,17776665,[],CHEMBL3888635,"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: Assay 2: The test is performed in white 384-well plates (Greiner Bio-One, reference 781207) in a total volume of 60 L by adding 1 L of compounds tested at different concentrations diluted in 100% DMSO (1.7% final DMSO concentration) in reaction buffer (PBS, 125 mM NaCl, 0.001% Novexin (consists of carbohydrate polymers), designed to increase the solubility and stability of proteins; Expedeon Ltd., Cambridgeshire, United Kingdom), 0.01% Gelatin, 0.01% 0.2%, Pluronic F-127 (block copolymer from ethylenoxide and propyleneoxide), 1 mM DTT). After addition of 1.25 nM MDM2-biotinylated or 2.5 nM MDM4-biotinylated (internal preparations), and 0.625 nM Europium labeled streptavidin (Perkin Elmer), the solution is pre-incubated for 15 minutes at room temperature, then 10 nM Cy5-p53 peptide (internal preparation) is added before an incubation at room temperature for 15 minutes prior to reading the plate. For measurement of samples, a Victor II microplate reader (Perkin Elmer) is used with the following settings: Excitation 340 nm, Emission Donor 620 nm and Emission Acceptor 665 nm. For selected compounds displaying IC50s between 0.05 and 5 nM on MDM2, a slightly modified assay is used with the following adaptations: 0.1 nM MDM2, 0.1 nM Europium labeled streptavidin and Tecan genios Pro is used as a microplate reader for the fluorescence measurements (p53-MDM2 Assay 2).",B,,,BAO_0000190,BAO_0000224,protein format,COc1ncc(-c2cc3c(n2C(C)C)[C@@H](c2ccc(Cl)cc2)N(c2cc(Cl)c(=O)n(C)c2)C3=O)c(OC)n1,,,CHEMBL3886789,,2016,"{'bei': '13.61', 'le': '0.27', 'lle': '2.25', 'sei': '8.25'}",CHEMBL4108456,,CHEMBL4108456,7.55,False,http://www.openphacts.org/units/Nanomolar,2885961,=,37,True,=,,IC50,nM,,28.32,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,28.315
411850,17776666,[],CHEMBL3888635,"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: Assay 2: The test is performed in white 384-well plates (Greiner Bio-One, reference 781207) in a total volume of 60 L by adding 1 L of compounds tested at different concentrations diluted in 100% DMSO (1.7% final DMSO concentration) in reaction buffer (PBS, 125 mM NaCl, 0.001% Novexin (consists of carbohydrate polymers), designed to increase the solubility and stability of proteins; Expedeon Ltd., Cambridgeshire, United Kingdom), 0.01% Gelatin, 0.01% 0.2%, Pluronic F-127 (block copolymer from ethylenoxide and propyleneoxide), 1 mM DTT). After addition of 1.25 nM MDM2-biotinylated or 2.5 nM MDM4-biotinylated (internal preparations), and 0.625 nM Europium labeled streptavidin (Perkin Elmer), the solution is pre-incubated for 15 minutes at room temperature, then 10 nM Cy5-p53 peptide (internal preparation) is added before an incubation at room temperature for 15 minutes prior to reading the plate. For measurement of samples, a Victor II microplate reader (Perkin Elmer) is used with the following settings: Excitation 340 nm, Emission Donor 620 nm and Emission Acceptor 665 nm. For selected compounds displaying IC50s between 0.05 and 5 nM on MDM2, a slightly modified assay is used with the following adaptations: 0.1 nM MDM2, 0.1 nM Europium labeled streptavidin and Tecan genios Pro is used as a microplate reader for the fluorescence measurements (p53-MDM2 Assay 2).",B,,,BAO_0000190,BAO_0000224,protein format,CCOC(=O)c1c2c(n(C(C)C)c1-c1cnc(OC)nc1OC)C(c1ccc(Cl)cc1)N(c1cc(Cl)c(=O)n(C)c1)C2=O,,,CHEMBL3886789,,2016,"{'bei': '15.76', 'le': '0.31', 'lle': '4.39', 'sei': '8.38'}",CHEMBL3978654,,CHEMBL3978654,9.87,False,http://www.openphacts.org/units/Nanomolar,2886055,=,37,True,=,,IC50,nM,,0.134,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,0.134
411851,17776667,[],CHEMBL3888635,"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: Assay 2: The test is performed in white 384-well plates (Greiner Bio-One, reference 781207) in a total volume of 60 L by adding 1 L of compounds tested at different concentrations diluted in 100% DMSO (1.7% final DMSO concentration) in reaction buffer (PBS, 125 mM NaCl, 0.001% Novexin (consists of carbohydrate polymers), designed to increase the solubility and stability of proteins; Expedeon Ltd., Cambridgeshire, United Kingdom), 0.01% Gelatin, 0.01% 0.2%, Pluronic F-127 (block copolymer from ethylenoxide and propyleneoxide), 1 mM DTT). After addition of 1.25 nM MDM2-biotinylated or 2.5 nM MDM4-biotinylated (internal preparations), and 0.625 nM Europium labeled streptavidin (Perkin Elmer), the solution is pre-incubated for 15 minutes at room temperature, then 10 nM Cy5-p53 peptide (internal preparation) is added before an incubation at room temperature for 15 minutes prior to reading the plate. For measurement of samples, a Victor II microplate reader (Perkin Elmer) is used with the following settings: Excitation 340 nm, Emission Donor 620 nm and Emission Acceptor 665 nm. For selected compounds displaying IC50s between 0.05 and 5 nM on MDM2, a slightly modified assay is used with the following adaptations: 0.1 nM MDM2, 0.1 nM Europium labeled streptavidin and Tecan genios Pro is used as a microplate reader for the fluorescence measurements (p53-MDM2 Assay 2).",B,,,BAO_0000190,BAO_0000224,protein format,COc1ncc(-c2c(C(=O)O)c3c(n2C(C)C)C(c2ccc(Cl)cc2)N(c2cc(Cl)c(=O)n(C)c2)C3=O)c(OC)n1,,,CHEMBL3886789,,2016,"{'bei': '16.47', 'le': '0.33', 'lle': '4.85', 'sei': '7.65'}",CHEMBL3922965,,CHEMBL3922965,9.85,False,http://www.openphacts.org/units/Nanomolar,2886056,=,37,True,=,,IC50,nM,,0.14,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,0.14
411852,17776668,[],CHEMBL3888635,"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: Assay 2: The test is performed in white 384-well plates (Greiner Bio-One, reference 781207) in a total volume of 60 L by adding 1 L of compounds tested at different concentrations diluted in 100% DMSO (1.7% final DMSO concentration) in reaction buffer (PBS, 125 mM NaCl, 0.001% Novexin (consists of carbohydrate polymers), designed to increase the solubility and stability of proteins; Expedeon Ltd., Cambridgeshire, United Kingdom), 0.01% Gelatin, 0.01% 0.2%, Pluronic F-127 (block copolymer from ethylenoxide and propyleneoxide), 1 mM DTT). After addition of 1.25 nM MDM2-biotinylated or 2.5 nM MDM4-biotinylated (internal preparations), and 0.625 nM Europium labeled streptavidin (Perkin Elmer), the solution is pre-incubated for 15 minutes at room temperature, then 10 nM Cy5-p53 peptide (internal preparation) is added before an incubation at room temperature for 15 minutes prior to reading the plate. For measurement of samples, a Victor II microplate reader (Perkin Elmer) is used with the following settings: Excitation 340 nm, Emission Donor 620 nm and Emission Acceptor 665 nm. For selected compounds displaying IC50s between 0.05 and 5 nM on MDM2, a slightly modified assay is used with the following adaptations: 0.1 nM MDM2, 0.1 nM Europium labeled streptavidin and Tecan genios Pro is used as a microplate reader for the fluorescence measurements (p53-MDM2 Assay 2).",B,,,BAO_0000190,BAO_0000224,protein format,COC[C@@H](C)n1c(-c2cnc(OC)nc2OC)cc2c1C(c1ccc(C#N)cc1)N(c1ccc(F)c(Cl)c1)C2=O,,,CHEMBL3886789,,2016,"{'bei': '16.94', 'le': '0.32', 'lle': '3.94', 'sei': '9.29'}",CHEMBL4113499,,CHEMBL4113499,9.52,False,http://www.openphacts.org/units/Nanomolar,2886057,=,37,True,=,,IC50,nM,,0.303,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,0.303
411853,17776669,[],CHEMBL3888635,"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: Assay 2: The test is performed in white 384-well plates (Greiner Bio-One, reference 781207) in a total volume of 60 L by adding 1 L of compounds tested at different concentrations diluted in 100% DMSO (1.7% final DMSO concentration) in reaction buffer (PBS, 125 mM NaCl, 0.001% Novexin (consists of carbohydrate polymers), designed to increase the solubility and stability of proteins; Expedeon Ltd., Cambridgeshire, United Kingdom), 0.01% Gelatin, 0.01% 0.2%, Pluronic F-127 (block copolymer from ethylenoxide and propyleneoxide), 1 mM DTT). After addition of 1.25 nM MDM2-biotinylated or 2.5 nM MDM4-biotinylated (internal preparations), and 0.625 nM Europium labeled streptavidin (Perkin Elmer), the solution is pre-incubated for 15 minutes at room temperature, then 10 nM Cy5-p53 peptide (internal preparation) is added before an incubation at room temperature for 15 minutes prior to reading the plate. For measurement of samples, a Victor II microplate reader (Perkin Elmer) is used with the following settings: Excitation 340 nm, Emission Donor 620 nm and Emission Acceptor 665 nm. For selected compounds displaying IC50s between 0.05 and 5 nM on MDM2, a slightly modified assay is used with the following adaptations: 0.1 nM MDM2, 0.1 nM Europium labeled streptavidin and Tecan genios Pro is used as a microplate reader for the fluorescence measurements (p53-MDM2 Assay 2).",B,,,BAO_0000190,BAO_0000224,protein format,COC[C@@H](C)n1c(-c2cnc(N)nc2OC)cc2c1C(c1ccc(C#N)cc1)N(c1ccc(F)c(Cl)c1)C2=O,,,CHEMBL3886789,,2016,"{'bei': '16.82', 'le': '0.32', 'lle': '4.04', 'sei': '7.71'}",CHEMBL4111895,,CHEMBL4111895,9.20,False,http://www.openphacts.org/units/Nanomolar,2886058,=,37,True,=,,IC50,nM,,0.631,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,0.631
411854,17776670,[],CHEMBL3888635,"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: Assay 2: The test is performed in white 384-well plates (Greiner Bio-One, reference 781207) in a total volume of 60 L by adding 1 L of compounds tested at different concentrations diluted in 100% DMSO (1.7% final DMSO concentration) in reaction buffer (PBS, 125 mM NaCl, 0.001% Novexin (consists of carbohydrate polymers), designed to increase the solubility and stability of proteins; Expedeon Ltd., Cambridgeshire, United Kingdom), 0.01% Gelatin, 0.01% 0.2%, Pluronic F-127 (block copolymer from ethylenoxide and propyleneoxide), 1 mM DTT). After addition of 1.25 nM MDM2-biotinylated or 2.5 nM MDM4-biotinylated (internal preparations), and 0.625 nM Europium labeled streptavidin (Perkin Elmer), the solution is pre-incubated for 15 minutes at room temperature, then 10 nM Cy5-p53 peptide (internal preparation) is added before an incubation at room temperature for 15 minutes prior to reading the plate. For measurement of samples, a Victor II microplate reader (Perkin Elmer) is used with the following settings: Excitation 340 nm, Emission Donor 620 nm and Emission Acceptor 665 nm. For selected compounds displaying IC50s between 0.05 and 5 nM on MDM2, a slightly modified assay is used with the following adaptations: 0.1 nM MDM2, 0.1 nM Europium labeled streptavidin and Tecan genios Pro is used as a microplate reader for the fluorescence measurements (p53-MDM2 Assay 2).",B,,,BAO_0000190,BAO_0000224,protein format,COC[C@@H](C)n1c(-c2cnc(N)nc2OC)cc2c1C(c1ccc(Cl)cc1)N(c1ccc(F)c(Cl)c1)C2=O,,,CHEMBL3886789,,2016,"{'bei': '16.97', 'le': '0.34', 'lle': '3.50', 'sei': '9.89'}",CHEMBL4110421,,CHEMBL4110421,9.44,False,http://www.openphacts.org/units/Nanomolar,2886059,=,37,True,=,,IC50,nM,,0.362,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,0.362
411855,17776671,[],CHEMBL3888635,"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: Assay 2: The test is performed in white 384-well plates (Greiner Bio-One, reference 781207) in a total volume of 60 L by adding 1 L of compounds tested at different concentrations diluted in 100% DMSO (1.7% final DMSO concentration) in reaction buffer (PBS, 125 mM NaCl, 0.001% Novexin (consists of carbohydrate polymers), designed to increase the solubility and stability of proteins; Expedeon Ltd., Cambridgeshire, United Kingdom), 0.01% Gelatin, 0.01% 0.2%, Pluronic F-127 (block copolymer from ethylenoxide and propyleneoxide), 1 mM DTT). After addition of 1.25 nM MDM2-biotinylated or 2.5 nM MDM4-biotinylated (internal preparations), and 0.625 nM Europium labeled streptavidin (Perkin Elmer), the solution is pre-incubated for 15 minutes at room temperature, then 10 nM Cy5-p53 peptide (internal preparation) is added before an incubation at room temperature for 15 minutes prior to reading the plate. For measurement of samples, a Victor II microplate reader (Perkin Elmer) is used with the following settings: Excitation 340 nm, Emission Donor 620 nm and Emission Acceptor 665 nm. For selected compounds displaying IC50s between 0.05 and 5 nM on MDM2, a slightly modified assay is used with the following adaptations: 0.1 nM MDM2, 0.1 nM Europium labeled streptavidin and Tecan genios Pro is used as a microplate reader for the fluorescence measurements (p53-MDM2 Assay 2).",B,,,BAO_0000190,BAO_0000224,protein format,COC[C@@H](C)n1c(-c2cnc(OC)nc2OC)cc2c1C(c1ccc(Cl)cc1)N(c1cc(Cl)c(=O)n(C)c1)C2=O,,,CHEMBL3886789,,2016,"{'bei': '16.35', 'le': '0.33', 'lle': '4.63', 'sei': '9.49'}",CHEMBL4112637,,CHEMBL4112637,9.56,False,http://www.openphacts.org/units/Nanomolar,2886060,=,37,True,=,,IC50,nM,,0.277,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,0.277
411856,17776672,[],CHEMBL3888635,"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: Assay 2: The test is performed in white 384-well plates (Greiner Bio-One, reference 781207) in a total volume of 60 L by adding 1 L of compounds tested at different concentrations diluted in 100% DMSO (1.7% final DMSO concentration) in reaction buffer (PBS, 125 mM NaCl, 0.001% Novexin (consists of carbohydrate polymers), designed to increase the solubility and stability of proteins; Expedeon Ltd., Cambridgeshire, United Kingdom), 0.01% Gelatin, 0.01% 0.2%, Pluronic F-127 (block copolymer from ethylenoxide and propyleneoxide), 1 mM DTT). After addition of 1.25 nM MDM2-biotinylated or 2.5 nM MDM4-biotinylated (internal preparations), and 0.625 nM Europium labeled streptavidin (Perkin Elmer), the solution is pre-incubated for 15 minutes at room temperature, then 10 nM Cy5-p53 peptide (internal preparation) is added before an incubation at room temperature for 15 minutes prior to reading the plate. For measurement of samples, a Victor II microplate reader (Perkin Elmer) is used with the following settings: Excitation 340 nm, Emission Donor 620 nm and Emission Acceptor 665 nm. For selected compounds displaying IC50s between 0.05 and 5 nM on MDM2, a slightly modified assay is used with the following adaptations: 0.1 nM MDM2, 0.1 nM Europium labeled streptavidin and Tecan genios Pro is used as a microplate reader for the fluorescence measurements (p53-MDM2 Assay 2).",B,,,BAO_0000190,BAO_0000224,protein format,COc1nc(N(C)C)ncc1-c1c(C(=O)O)c2c(n1C(C)C)C(c1ccc(Cl)cc1)N(c1cc(Cl)c(=O)n(C)c1)C2=O,,,CHEMBL3886789,,2016,"{'bei': '16.16', 'le': '0.32', 'lle': '4.83', 'sei': '8.05'}",CHEMBL3948248,,CHEMBL3948248,9.88,False,http://www.openphacts.org/units/Nanomolar,2886061,=,37,True,=,,IC50,nM,,0.132,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,0.132
411857,17776673,[],CHEMBL3888635,"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: Assay 2: The test is performed in white 384-well plates (Greiner Bio-One, reference 781207) in a total volume of 60 L by adding 1 L of compounds tested at different concentrations diluted in 100% DMSO (1.7% final DMSO concentration) in reaction buffer (PBS, 125 mM NaCl, 0.001% Novexin (consists of carbohydrate polymers), designed to increase the solubility and stability of proteins; Expedeon Ltd., Cambridgeshire, United Kingdom), 0.01% Gelatin, 0.01% 0.2%, Pluronic F-127 (block copolymer from ethylenoxide and propyleneoxide), 1 mM DTT). After addition of 1.25 nM MDM2-biotinylated or 2.5 nM MDM4-biotinylated (internal preparations), and 0.625 nM Europium labeled streptavidin (Perkin Elmer), the solution is pre-incubated for 15 minutes at room temperature, then 10 nM Cy5-p53 peptide (internal preparation) is added before an incubation at room temperature for 15 minutes prior to reading the plate. For measurement of samples, a Victor II microplate reader (Perkin Elmer) is used with the following settings: Excitation 340 nm, Emission Donor 620 nm and Emission Acceptor 665 nm. For selected compounds displaying IC50s between 0.05 and 5 nM on MDM2, a slightly modified assay is used with the following adaptations: 0.1 nM MDM2, 0.1 nM Europium labeled streptavidin and Tecan genios Pro is used as a microplate reader for the fluorescence measurements (p53-MDM2 Assay 2).",B,,,BAO_0000190,BAO_0000224,protein format,COc1nc(N(C)C)ncc1-c1cc2c(n1C(C)C)[C@H](c1ccc(Cl)c(F)c1)N(c1cc(Cl)c[nH]c1=O)C2=O,,,CHEMBL3886789,,2016,"{'bei': '17.76', 'le': '0.36', 'lle': '4.67', 'sei': '10.53'}",CHEMBL3920430,,CHEMBL3920430,10.15,False,http://www.openphacts.org/units/Nanomolar,2886062,=,37,True,=,,IC50,nM,,0.071,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,0.071
411858,17776674,[],CHEMBL3888635,"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: Assay 2: The test is performed in white 384-well plates (Greiner Bio-One, reference 781207) in a total volume of 60 L by adding 1 L of compounds tested at different concentrations diluted in 100% DMSO (1.7% final DMSO concentration) in reaction buffer (PBS, 125 mM NaCl, 0.001% Novexin (consists of carbohydrate polymers), designed to increase the solubility and stability of proteins; Expedeon Ltd., Cambridgeshire, United Kingdom), 0.01% Gelatin, 0.01% 0.2%, Pluronic F-127 (block copolymer from ethylenoxide and propyleneoxide), 1 mM DTT). After addition of 1.25 nM MDM2-biotinylated or 2.5 nM MDM4-biotinylated (internal preparations), and 0.625 nM Europium labeled streptavidin (Perkin Elmer), the solution is pre-incubated for 15 minutes at room temperature, then 10 nM Cy5-p53 peptide (internal preparation) is added before an incubation at room temperature for 15 minutes prior to reading the plate. For measurement of samples, a Victor II microplate reader (Perkin Elmer) is used with the following settings: Excitation 340 nm, Emission Donor 620 nm and Emission Acceptor 665 nm. For selected compounds displaying IC50s between 0.05 and 5 nM on MDM2, a slightly modified assay is used with the following adaptations: 0.1 nM MDM2, 0.1 nM Europium labeled streptavidin and Tecan genios Pro is used as a microplate reader for the fluorescence measurements (p53-MDM2 Assay 2).",B,,,BAO_0000190,BAO_0000224,protein format,COc1nc(N(C)C)ncc1-c1cc2c(n1C(C)C)[C@@H](c1ccc(Cl)c(F)c1)N(c1cc(Cl)c[nH]c1=O)C2=O,,,CHEMBL3886789,,2016,"{'bei': '12.80', 'le': '0.26', 'lle': '1.83', 'sei': '7.59'}",CHEMBL4114920,,CHEMBL4114920,7.31,False,http://www.openphacts.org/units/Nanomolar,2886063,=,37,True,=,,IC50,nM,,48.68,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,48.682
411859,17776675,[],CHEMBL3888635,"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: Assay 2: The test is performed in white 384-well plates (Greiner Bio-One, reference 781207) in a total volume of 60 L by adding 1 L of compounds tested at different concentrations diluted in 100% DMSO (1.7% final DMSO concentration) in reaction buffer (PBS, 125 mM NaCl, 0.001% Novexin (consists of carbohydrate polymers), designed to increase the solubility and stability of proteins; Expedeon Ltd., Cambridgeshire, United Kingdom), 0.01% Gelatin, 0.01% 0.2%, Pluronic F-127 (block copolymer from ethylenoxide and propyleneoxide), 1 mM DTT). After addition of 1.25 nM MDM2-biotinylated or 2.5 nM MDM4-biotinylated (internal preparations), and 0.625 nM Europium labeled streptavidin (Perkin Elmer), the solution is pre-incubated for 15 minutes at room temperature, then 10 nM Cy5-p53 peptide (internal preparation) is added before an incubation at room temperature for 15 minutes prior to reading the plate. For measurement of samples, a Victor II microplate reader (Perkin Elmer) is used with the following settings: Excitation 340 nm, Emission Donor 620 nm and Emission Acceptor 665 nm. For selected compounds displaying IC50s between 0.05 and 5 nM on MDM2, a slightly modified assay is used with the following adaptations: 0.1 nM MDM2, 0.1 nM Europium labeled streptavidin and Tecan genios Pro is used as a microplate reader for the fluorescence measurements (p53-MDM2 Assay 2).",B,,,BAO_0000190,BAO_0000224,protein format,COC[C@@H](C)n1c(-c2cnc(N)nc2OC)cc2c1[C@H](c1ccc(Cl)cc1)N(c1ccc(F)c(Cl)c1)C2=O,,,CHEMBL3886789,,2016,"{'bei': '18.17', 'le': '0.36', 'lle': '4.17', 'sei': '10.58'}",CHEMBL4110580,,CHEMBL4110580,10.11,False,http://www.openphacts.org/units/Nanomolar,2886064,=,37,True,=,,IC50,nM,,0.078,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,0.078
411860,17776676,[],CHEMBL3888635,"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: Assay 2: The test is performed in white 384-well plates (Greiner Bio-One, reference 781207) in a total volume of 60 L by adding 1 L of compounds tested at different concentrations diluted in 100% DMSO (1.7% final DMSO concentration) in reaction buffer (PBS, 125 mM NaCl, 0.001% Novexin (consists of carbohydrate polymers), designed to increase the solubility and stability of proteins; Expedeon Ltd., Cambridgeshire, United Kingdom), 0.01% Gelatin, 0.01% 0.2%, Pluronic F-127 (block copolymer from ethylenoxide and propyleneoxide), 1 mM DTT). After addition of 1.25 nM MDM2-biotinylated or 2.5 nM MDM4-biotinylated (internal preparations), and 0.625 nM Europium labeled streptavidin (Perkin Elmer), the solution is pre-incubated for 15 minutes at room temperature, then 10 nM Cy5-p53 peptide (internal preparation) is added before an incubation at room temperature for 15 minutes prior to reading the plate. For measurement of samples, a Victor II microplate reader (Perkin Elmer) is used with the following settings: Excitation 340 nm, Emission Donor 620 nm and Emission Acceptor 665 nm. For selected compounds displaying IC50s between 0.05 and 5 nM on MDM2, a slightly modified assay is used with the following adaptations: 0.1 nM MDM2, 0.1 nM Europium labeled streptavidin and Tecan genios Pro is used as a microplate reader for the fluorescence measurements (p53-MDM2 Assay 2).",B,,,BAO_0000190,BAO_0000224,protein format,COC[C@@H](C)n1c(-c2cnc(N)nc2OC)cc2c1[C@@H](c1ccc(Cl)cc1)N(c1ccc(F)c(Cl)c1)C2=O,,,CHEMBL3886789,,2016,"{'bei': '11.77', 'le': '0.24', 'lle': '0.61', 'sei': '6.86'}",CHEMBL4107344,,CHEMBL4107344,6.55,False,http://www.openphacts.org/units/Nanomolar,2886065,=,37,True,=,,IC50,nM,,281.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,280.998
411861,17776677,[],CHEMBL3888635,"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: Assay 2: The test is performed in white 384-well plates (Greiner Bio-One, reference 781207) in a total volume of 60 L by adding 1 L of compounds tested at different concentrations diluted in 100% DMSO (1.7% final DMSO concentration) in reaction buffer (PBS, 125 mM NaCl, 0.001% Novexin (consists of carbohydrate polymers), designed to increase the solubility and stability of proteins; Expedeon Ltd., Cambridgeshire, United Kingdom), 0.01% Gelatin, 0.01% 0.2%, Pluronic F-127 (block copolymer from ethylenoxide and propyleneoxide), 1 mM DTT). After addition of 1.25 nM MDM2-biotinylated or 2.5 nM MDM4-biotinylated (internal preparations), and 0.625 nM Europium labeled streptavidin (Perkin Elmer), the solution is pre-incubated for 15 minutes at room temperature, then 10 nM Cy5-p53 peptide (internal preparation) is added before an incubation at room temperature for 15 minutes prior to reading the plate. For measurement of samples, a Victor II microplate reader (Perkin Elmer) is used with the following settings: Excitation 340 nm, Emission Donor 620 nm and Emission Acceptor 665 nm. For selected compounds displaying IC50s between 0.05 and 5 nM on MDM2, a slightly modified assay is used with the following adaptations: 0.1 nM MDM2, 0.1 nM Europium labeled streptavidin and Tecan genios Pro is used as a microplate reader for the fluorescence measurements (p53-MDM2 Assay 2).",B,,,BAO_0000190,BAO_0000224,protein format,COc1nc(N(C)C)ncc1-c1cc2c(n1C(C)C)C(c1ccc(C#N)cc1)N(c1c(F)c(C)nn1C)C2=O,,,CHEMBL3886789,,2016,"{'bei': '18.26', 'le': '0.34', 'lle': '5.25', 'sei': '9.18'}",CHEMBL3905941,,CHEMBL3905941,9.65,False,http://www.openphacts.org/units/Nanomolar,2886066,=,37,True,=,,IC50,nM,,0.224,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,0.224
411862,17776678,[],CHEMBL3888635,"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: Assay 2: The test is performed in white 384-well plates (Greiner Bio-One, reference 781207) in a total volume of 60 L by adding 1 L of compounds tested at different concentrations diluted in 100% DMSO (1.7% final DMSO concentration) in reaction buffer (PBS, 125 mM NaCl, 0.001% Novexin (consists of carbohydrate polymers), designed to increase the solubility and stability of proteins; Expedeon Ltd., Cambridgeshire, United Kingdom), 0.01% Gelatin, 0.01% 0.2%, Pluronic F-127 (block copolymer from ethylenoxide and propyleneoxide), 1 mM DTT). After addition of 1.25 nM MDM2-biotinylated or 2.5 nM MDM4-biotinylated (internal preparations), and 0.625 nM Europium labeled streptavidin (Perkin Elmer), the solution is pre-incubated for 15 minutes at room temperature, then 10 nM Cy5-p53 peptide (internal preparation) is added before an incubation at room temperature for 15 minutes prior to reading the plate. For measurement of samples, a Victor II microplate reader (Perkin Elmer) is used with the following settings: Excitation 340 nm, Emission Donor 620 nm and Emission Acceptor 665 nm. For selected compounds displaying IC50s between 0.05 and 5 nM on MDM2, a slightly modified assay is used with the following adaptations: 0.1 nM MDM2, 0.1 nM Europium labeled streptavidin and Tecan genios Pro is used as a microplate reader for the fluorescence measurements (p53-MDM2 Assay 2).",B,,,BAO_0000190,BAO_0000224,protein format,COc1nc(N(C)C)ncc1-c1cc2c(n1C(C)C)[C@H](c1ccc(C#N)cc1)N(c1cc(Cl)c(=O)n(C)c1)C2=O,,,CHEMBL3886789,,2016,"{'bei': '18.21', 'le': '0.35', 'lle': '5.59', 'sei': '9.30'}",CHEMBL3911501,,CHEMBL3911501,10.16,False,http://www.openphacts.org/units/Nanomolar,2886067,=,37,True,=,,IC50,nM,,0.069,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,0.069
411863,17776679,[],CHEMBL3888635,"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: Assay 2: The test is performed in white 384-well plates (Greiner Bio-One, reference 781207) in a total volume of 60 L by adding 1 L of compounds tested at different concentrations diluted in 100% DMSO (1.7% final DMSO concentration) in reaction buffer (PBS, 125 mM NaCl, 0.001% Novexin (consists of carbohydrate polymers), designed to increase the solubility and stability of proteins; Expedeon Ltd., Cambridgeshire, United Kingdom), 0.01% Gelatin, 0.01% 0.2%, Pluronic F-127 (block copolymer from ethylenoxide and propyleneoxide), 1 mM DTT). After addition of 1.25 nM MDM2-biotinylated or 2.5 nM MDM4-biotinylated (internal preparations), and 0.625 nM Europium labeled streptavidin (Perkin Elmer), the solution is pre-incubated for 15 minutes at room temperature, then 10 nM Cy5-p53 peptide (internal preparation) is added before an incubation at room temperature for 15 minutes prior to reading the plate. For measurement of samples, a Victor II microplate reader (Perkin Elmer) is used with the following settings: Excitation 340 nm, Emission Donor 620 nm and Emission Acceptor 665 nm. For selected compounds displaying IC50s between 0.05 and 5 nM on MDM2, a slightly modified assay is used with the following adaptations: 0.1 nM MDM2, 0.1 nM Europium labeled streptavidin and Tecan genios Pro is used as a microplate reader for the fluorescence measurements (p53-MDM2 Assay 2).",B,,,BAO_0000190,BAO_0000224,protein format,COc1nc(N(C)C)ncc1-c1cc2c(n1C(C)C)[C@@H](c1ccc(C#N)cc1)N(c1cc(Cl)c(=O)n(C)c1)C2=O,,,CHEMBL3886789,,2016,"{'bei': '12.94', 'le': '0.25', 'lle': '2.65', 'sei': '6.61'}",CHEMBL4112168,,CHEMBL4112168,7.22,False,http://www.openphacts.org/units/Nanomolar,2886068,=,37,True,=,,IC50,nM,,60.2,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,60.198
411864,17776680,[],CHEMBL3888635,"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: Assay 2: The test is performed in white 384-well plates (Greiner Bio-One, reference 781207) in a total volume of 60 L by adding 1 L of compounds tested at different concentrations diluted in 100% DMSO (1.7% final DMSO concentration) in reaction buffer (PBS, 125 mM NaCl, 0.001% Novexin (consists of carbohydrate polymers), designed to increase the solubility and stability of proteins; Expedeon Ltd., Cambridgeshire, United Kingdom), 0.01% Gelatin, 0.01% 0.2%, Pluronic F-127 (block copolymer from ethylenoxide and propyleneoxide), 1 mM DTT). After addition of 1.25 nM MDM2-biotinylated or 2.5 nM MDM4-biotinylated (internal preparations), and 0.625 nM Europium labeled streptavidin (Perkin Elmer), the solution is pre-incubated for 15 minutes at room temperature, then 10 nM Cy5-p53 peptide (internal preparation) is added before an incubation at room temperature for 15 minutes prior to reading the plate. For measurement of samples, a Victor II microplate reader (Perkin Elmer) is used with the following settings: Excitation 340 nm, Emission Donor 620 nm and Emission Acceptor 665 nm. For selected compounds displaying IC50s between 0.05 and 5 nM on MDM2, a slightly modified assay is used with the following adaptations: 0.1 nM MDM2, 0.1 nM Europium labeled streptavidin and Tecan genios Pro is used as a microplate reader for the fluorescence measurements (p53-MDM2 Assay 2).",B,,,BAO_0000190,BAO_0000224,protein format,COc1nc(N(C)C)ncc1-c1cc2c(n1C(C)C)C(c1ccc(Cl)cn1)N(c1cccc(Cl)c1F)C2=O,,,CHEMBL3886789,,2016,"{'bei': '16.53', 'le': '0.33', 'lle': '2.99', 'sei': '12.02'}",CHEMBL3940681,,CHEMBL3940681,9.18,False,http://www.openphacts.org/units/Nanomolar,2886069,=,37,True,=,,IC50,nM,,0.657,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,0.657
411865,17776681,[],CHEMBL3888635,"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: Assay 2: The test is performed in white 384-well plates (Greiner Bio-One, reference 781207) in a total volume of 60 L by adding 1 L of compounds tested at different concentrations diluted in 100% DMSO (1.7% final DMSO concentration) in reaction buffer (PBS, 125 mM NaCl, 0.001% Novexin (consists of carbohydrate polymers), designed to increase the solubility and stability of proteins; Expedeon Ltd., Cambridgeshire, United Kingdom), 0.01% Gelatin, 0.01% 0.2%, Pluronic F-127 (block copolymer from ethylenoxide and propyleneoxide), 1 mM DTT). After addition of 1.25 nM MDM2-biotinylated or 2.5 nM MDM4-biotinylated (internal preparations), and 0.625 nM Europium labeled streptavidin (Perkin Elmer), the solution is pre-incubated for 15 minutes at room temperature, then 10 nM Cy5-p53 peptide (internal preparation) is added before an incubation at room temperature for 15 minutes prior to reading the plate. For measurement of samples, a Victor II microplate reader (Perkin Elmer) is used with the following settings: Excitation 340 nm, Emission Donor 620 nm and Emission Acceptor 665 nm. For selected compounds displaying IC50s between 0.05 and 5 nM on MDM2, a slightly modified assay is used with the following adaptations: 0.1 nM MDM2, 0.1 nM Europium labeled streptavidin and Tecan genios Pro is used as a microplate reader for the fluorescence measurements (p53-MDM2 Assay 2).",B,,,BAO_0000190,BAO_0000224,protein format,COc1ncc(-c2cc3c(n2C(C)C)C(c2ccc(Cl)cn2)N(c2cc(Cl)ccc2C)C3=O)c(OC)n1,,,CHEMBL3886789,,2016,"{'bei': '15.13', 'le': '0.30', 'lle': '1.85', 'sei': '9.89'}",CHEMBL3912687,,CHEMBL3912687,8.14,False,http://www.openphacts.org/units/Nanomolar,2886070,=,37,True,=,,IC50,nM,,7.156,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,7.156
411866,17776682,[],CHEMBL3888635,"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: Assay 2: The test is performed in white 384-well plates (Greiner Bio-One, reference 781207) in a total volume of 60 L by adding 1 L of compounds tested at different concentrations diluted in 100% DMSO (1.7% final DMSO concentration) in reaction buffer (PBS, 125 mM NaCl, 0.001% Novexin (consists of carbohydrate polymers), designed to increase the solubility and stability of proteins; Expedeon Ltd., Cambridgeshire, United Kingdom), 0.01% Gelatin, 0.01% 0.2%, Pluronic F-127 (block copolymer from ethylenoxide and propyleneoxide), 1 mM DTT). After addition of 1.25 nM MDM2-biotinylated or 2.5 nM MDM4-biotinylated (internal preparations), and 0.625 nM Europium labeled streptavidin (Perkin Elmer), the solution is pre-incubated for 15 minutes at room temperature, then 10 nM Cy5-p53 peptide (internal preparation) is added before an incubation at room temperature for 15 minutes prior to reading the plate. For measurement of samples, a Victor II microplate reader (Perkin Elmer) is used with the following settings: Excitation 340 nm, Emission Donor 620 nm and Emission Acceptor 665 nm. For selected compounds displaying IC50s between 0.05 and 5 nM on MDM2, a slightly modified assay is used with the following adaptations: 0.1 nM MDM2, 0.1 nM Europium labeled streptavidin and Tecan genios Pro is used as a microplate reader for the fluorescence measurements (p53-MDM2 Assay 2).",B,,,BAO_0000190,BAO_0000224,protein format,COc1ncncc1-c1cc2c(n1C(C)C)C(c1ccc(C#N)cc1)N(c1cc(Cl)c(=O)n(C)c1)C2=O,,,CHEMBL3886789,,2016,"{'bei': '16.56', 'le': '0.31', 'lle': '4.02', 'sei': '8.04'}",CHEMBL3979827,,CHEMBL3979827,8.53,False,http://www.openphacts.org/units/Nanomolar,2886071,=,37,True,=,,IC50,nM,,2.98,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,2.98
411867,17776683,[],CHEMBL3888635,"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: Assay 2: The test is performed in white 384-well plates (Greiner Bio-One, reference 781207) in a total volume of 60 L by adding 1 L of compounds tested at different concentrations diluted in 100% DMSO (1.7% final DMSO concentration) in reaction buffer (PBS, 125 mM NaCl, 0.001% Novexin (consists of carbohydrate polymers), designed to increase the solubility and stability of proteins; Expedeon Ltd., Cambridgeshire, United Kingdom), 0.01% Gelatin, 0.01% 0.2%, Pluronic F-127 (block copolymer from ethylenoxide and propyleneoxide), 1 mM DTT). After addition of 1.25 nM MDM2-biotinylated or 2.5 nM MDM4-biotinylated (internal preparations), and 0.625 nM Europium labeled streptavidin (Perkin Elmer), the solution is pre-incubated for 15 minutes at room temperature, then 10 nM Cy5-p53 peptide (internal preparation) is added before an incubation at room temperature for 15 minutes prior to reading the plate. For measurement of samples, a Victor II microplate reader (Perkin Elmer) is used with the following settings: Excitation 340 nm, Emission Donor 620 nm and Emission Acceptor 665 nm. For selected compounds displaying IC50s between 0.05 and 5 nM on MDM2, a slightly modified assay is used with the following adaptations: 0.1 nM MDM2, 0.1 nM Europium labeled streptavidin and Tecan genios Pro is used as a microplate reader for the fluorescence measurements (p53-MDM2 Assay 2).",B,,,BAO_0000190,BAO_0000224,protein format,COc1ncc(-c2cc3c(n2C(C)C)[C@H](c2ccc(C#N)c(F)c2)N(c2cc(Cl)c(=O)n(C)c2)C3=O)c(OC)n1,,,CHEMBL3886789,,2016,"{'bei': '17.71', 'le': '0.34', 'lle': '5.31', 'sei': '8.65'}",CHEMBL3894082,,CHEMBL3894082,9.97,False,http://www.openphacts.org/units/Nanomolar,2886072,=,37,True,=,,IC50,nM,,0.107,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,0.107
411868,17776684,[],CHEMBL3888635,"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: Assay 2: The test is performed in white 384-well plates (Greiner Bio-One, reference 781207) in a total volume of 60 L by adding 1 L of compounds tested at different concentrations diluted in 100% DMSO (1.7% final DMSO concentration) in reaction buffer (PBS, 125 mM NaCl, 0.001% Novexin (consists of carbohydrate polymers), designed to increase the solubility and stability of proteins; Expedeon Ltd., Cambridgeshire, United Kingdom), 0.01% Gelatin, 0.01% 0.2%, Pluronic F-127 (block copolymer from ethylenoxide and propyleneoxide), 1 mM DTT). After addition of 1.25 nM MDM2-biotinylated or 2.5 nM MDM4-biotinylated (internal preparations), and 0.625 nM Europium labeled streptavidin (Perkin Elmer), the solution is pre-incubated for 15 minutes at room temperature, then 10 nM Cy5-p53 peptide (internal preparation) is added before an incubation at room temperature for 15 minutes prior to reading the plate. For measurement of samples, a Victor II microplate reader (Perkin Elmer) is used with the following settings: Excitation 340 nm, Emission Donor 620 nm and Emission Acceptor 665 nm. For selected compounds displaying IC50s between 0.05 and 5 nM on MDM2, a slightly modified assay is used with the following adaptations: 0.1 nM MDM2, 0.1 nM Europium labeled streptavidin and Tecan genios Pro is used as a microplate reader for the fluorescence measurements (p53-MDM2 Assay 2).",B,,,BAO_0000190,BAO_0000224,protein format,COc1ncc(-c2cc3c(n2C(C)C)[C@@H](c2ccc(C#N)c(F)c2)N(c2cc(Cl)c(=O)n(C)c2)C3=O)c(OC)n1,,,CHEMBL3886789,,2016,"{'bei': '12.25', 'le': '0.24', 'lle': '2.24', 'sei': '5.99'}",CHEMBL4108457,,CHEMBL4108457,6.90,False,http://www.openphacts.org/units/Nanomolar,2886073,=,37,True,=,,IC50,nM,,126.14,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,126.144
411869,17776685,[],CHEMBL3888635,"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: Assay 2: The test is performed in white 384-well plates (Greiner Bio-One, reference 781207) in a total volume of 60 L by adding 1 L of compounds tested at different concentrations diluted in 100% DMSO (1.7% final DMSO concentration) in reaction buffer (PBS, 125 mM NaCl, 0.001% Novexin (consists of carbohydrate polymers), designed to increase the solubility and stability of proteins; Expedeon Ltd., Cambridgeshire, United Kingdom), 0.01% Gelatin, 0.01% 0.2%, Pluronic F-127 (block copolymer from ethylenoxide and propyleneoxide), 1 mM DTT). After addition of 1.25 nM MDM2-biotinylated or 2.5 nM MDM4-biotinylated (internal preparations), and 0.625 nM Europium labeled streptavidin (Perkin Elmer), the solution is pre-incubated for 15 minutes at room temperature, then 10 nM Cy5-p53 peptide (internal preparation) is added before an incubation at room temperature for 15 minutes prior to reading the plate. For measurement of samples, a Victor II microplate reader (Perkin Elmer) is used with the following settings: Excitation 340 nm, Emission Donor 620 nm and Emission Acceptor 665 nm. For selected compounds displaying IC50s between 0.05 and 5 nM on MDM2, a slightly modified assay is used with the following adaptations: 0.1 nM MDM2, 0.1 nM Europium labeled streptavidin and Tecan genios Pro is used as a microplate reader for the fluorescence measurements (p53-MDM2 Assay 2).",B,,,BAO_0000190,BAO_0000224,protein format,COc1ncc(-c2cc3c(n2C(C)C)C(c2ccc(Cl)cc2)N(c2cc(C)cn(C)c2=O)C3=O)c(OC)n1,,,CHEMBL3886789,,2016,"{'bei': '16.74', 'le': '0.32', 'lle': '3.99', 'sei': '9.77'}",CHEMBL3918559,,CHEMBL3918559,8.94,False,http://www.openphacts.org/units/Nanomolar,2886074,=,37,True,=,,IC50,nM,,1.156,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,1.156
417024,17780487,[],CHEMBL3888805,"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: Assay 1: This assay was used to evaluate compounds displaying inhibition of p53-MDM2 interaction and p53-MDM4 interaction at IC50s of 0.005 to 50 M (p53-MDM2 Assay 1 and p53-MDM4 Assay 1, respectively). The test is performed in white 384-well plates (Greiner Bio-One, reference 781207) in a total volume of 60 L by adding 1 L of compounds tested at different concentrations diluted in 100% DMSO (1.7% final DMSO concentration) in reaction buffer (PBS, 125 mM NaCl, 0.001% Novexin (consists of carbohydrate polymers), designed to increase the solubility and stability of proteins; Expedeon Ltd., Cambridgeshire, United Kingdom), 0.01% Gelatin, 0.01% 0.2%, Pluronic F-127 (block copolymer from ethylenoxide and propyleneoxide), 1 mM DTT). After addition of 1.25 nM MDM2-biotinylated or 2.5 nM MDM4-biotinylated (internal preparations, both MDM2 and MDM4 are biotinylated at the C-terminal of the peptide construct), and 0.625 nM Europium labeled streptavidin (Perkin Elmer), the solution is pre-incubated for 15 minutes at room temperature, then 10 nM Cy5-p53 peptide (internal preparation, the Cy5 dye is directly bound to the N-terminal part of p53 peptide construct) is added before an incubation at room temperature for 15 minutes prior to reading the plate. For measurement of samples, a Victor II microplate reader (Perkin Elmer) is used with the following settings: Excitation 340 nm, Emission Donor 620 nm and Emission Acceptor 665 nm.",B,,,BAO_0000190,BAO_0000224,protein format,COc1ccccc1-c1nc2c(n1C(C)C)C(c1ccc(Cl)cc1)N(c1cccc(Cl)c1F)C(=O)N2,,,CHEMBL3886839,,2016,"{'bei': '16.56', 'le': '0.33', 'lle': '0.97', 'sei': '14.65'}",CHEMBL3904825,,CHEMBL3904825,8.70,False,http://www.openphacts.org/units/Nanomolar,2888189,=,37,True,=,,IC50,nM,,2.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,2.0
417025,17780488,[],CHEMBL3888805,"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: Assay 1: This assay was used to evaluate compounds displaying inhibition of p53-MDM2 interaction and p53-MDM4 interaction at IC50s of 0.005 to 50 M (p53-MDM2 Assay 1 and p53-MDM4 Assay 1, respectively). The test is performed in white 384-well plates (Greiner Bio-One, reference 781207) in a total volume of 60 L by adding 1 L of compounds tested at different concentrations diluted in 100% DMSO (1.7% final DMSO concentration) in reaction buffer (PBS, 125 mM NaCl, 0.001% Novexin (consists of carbohydrate polymers), designed to increase the solubility and stability of proteins; Expedeon Ltd., Cambridgeshire, United Kingdom), 0.01% Gelatin, 0.01% 0.2%, Pluronic F-127 (block copolymer from ethylenoxide and propyleneoxide), 1 mM DTT). After addition of 1.25 nM MDM2-biotinylated or 2.5 nM MDM4-biotinylated (internal preparations, both MDM2 and MDM4 are biotinylated at the C-terminal of the peptide construct), and 0.625 nM Europium labeled streptavidin (Perkin Elmer), the solution is pre-incubated for 15 minutes at room temperature, then 10 nM Cy5-p53 peptide (internal preparation, the Cy5 dye is directly bound to the N-terminal part of p53 peptide construct) is added before an incubation at room temperature for 15 minutes prior to reading the plate. For measurement of samples, a Victor II microplate reader (Perkin Elmer) is used with the following settings: Excitation 340 nm, Emission Donor 620 nm and Emission Acceptor 665 nm.",B,,,BAO_0000190,BAO_0000224,protein format,COc1ccccc1-c1nc2c(n1C(C)C)C(c1ccc(Cl)cc1C)N(c1cccc(Cl)c1F)C(=O)N2,,,CHEMBL3886839,,2016,"{'bei': '16.09', 'le': '0.32', 'lle': '0.64', 'sei': '14.61'}",CHEMBL3963661,,CHEMBL3963661,8.68,False,http://www.openphacts.org/units/Nanomolar,2888190,=,37,True,=,,IC50,nM,,2.1,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,2.1
417026,17780489,[],CHEMBL3888805,"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: Assay 1: This assay was used to evaluate compounds displaying inhibition of p53-MDM2 interaction and p53-MDM4 interaction at IC50s of 0.005 to 50 M (p53-MDM2 Assay 1 and p53-MDM4 Assay 1, respectively). The test is performed in white 384-well plates (Greiner Bio-One, reference 781207) in a total volume of 60 L by adding 1 L of compounds tested at different concentrations diluted in 100% DMSO (1.7% final DMSO concentration) in reaction buffer (PBS, 125 mM NaCl, 0.001% Novexin (consists of carbohydrate polymers), designed to increase the solubility and stability of proteins; Expedeon Ltd., Cambridgeshire, United Kingdom), 0.01% Gelatin, 0.01% 0.2%, Pluronic F-127 (block copolymer from ethylenoxide and propyleneoxide), 1 mM DTT). After addition of 1.25 nM MDM2-biotinylated or 2.5 nM MDM4-biotinylated (internal preparations, both MDM2 and MDM4 are biotinylated at the C-terminal of the peptide construct), and 0.625 nM Europium labeled streptavidin (Perkin Elmer), the solution is pre-incubated for 15 minutes at room temperature, then 10 nM Cy5-p53 peptide (internal preparation, the Cy5 dye is directly bound to the N-terminal part of p53 peptide construct) is added before an incubation at room temperature for 15 minutes prior to reading the plate. For measurement of samples, a Victor II microplate reader (Perkin Elmer) is used with the following settings: Excitation 340 nm, Emission Donor 620 nm and Emission Acceptor 665 nm.",B,,,BAO_0000190,BAO_0000224,protein format,COc1ccccc1-c1nc2c(n1C(C)C)C(c1ccc(Cl)cc1C)N(c1cc(Cl)ccc1C)C(=O)N2,,,CHEMBL3886839,,2016,"{'bei': '16.33', 'le': '0.32', 'lle': '0.54', 'sei': '14.72'}",CHEMBL3982177,,CHEMBL3982177,8.74,False,http://www.openphacts.org/units/Nanomolar,2888191,=,37,True,=,,IC50,nM,,1.8,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,1.8
417027,17780490,[],CHEMBL3888805,"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: Assay 1: This assay was used to evaluate compounds displaying inhibition of p53-MDM2 interaction and p53-MDM4 interaction at IC50s of 0.005 to 50 M (p53-MDM2 Assay 1 and p53-MDM4 Assay 1, respectively). The test is performed in white 384-well plates (Greiner Bio-One, reference 781207) in a total volume of 60 L by adding 1 L of compounds tested at different concentrations diluted in 100% DMSO (1.7% final DMSO concentration) in reaction buffer (PBS, 125 mM NaCl, 0.001% Novexin (consists of carbohydrate polymers), designed to increase the solubility and stability of proteins; Expedeon Ltd., Cambridgeshire, United Kingdom), 0.01% Gelatin, 0.01% 0.2%, Pluronic F-127 (block copolymer from ethylenoxide and propyleneoxide), 1 mM DTT). After addition of 1.25 nM MDM2-biotinylated or 2.5 nM MDM4-biotinylated (internal preparations, both MDM2 and MDM4 are biotinylated at the C-terminal of the peptide construct), and 0.625 nM Europium labeled streptavidin (Perkin Elmer), the solution is pre-incubated for 15 minutes at room temperature, then 10 nM Cy5-p53 peptide (internal preparation, the Cy5 dye is directly bound to the N-terminal part of p53 peptide construct) is added before an incubation at room temperature for 15 minutes prior to reading the plate. For measurement of samples, a Victor II microplate reader (Perkin Elmer) is used with the following settings: Excitation 340 nm, Emission Donor 620 nm and Emission Acceptor 665 nm.",B,,,BAO_0000190,BAO_0000224,protein format,COc1ccncc1-c1nc2c(n1C(C)C)C(c1ccc(Cl)cc1C)N(c1cc(Cl)ccc1C)C(=O)N2,,,CHEMBL3886839,,2016,"{'bei': '15.86', 'le': '0.31', 'lle': '0.91', 'sei': '11.77'}",CHEMBL3911189,,CHEMBL3911189,8.51,False,http://www.openphacts.org/units/Nanomolar,2888192,=,37,True,=,,IC50,nM,,3.1,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,3.1
417028,17780491,[],CHEMBL3888805,"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: Assay 1: This assay was used to evaluate compounds displaying inhibition of p53-MDM2 interaction and p53-MDM4 interaction at IC50s of 0.005 to 50 M (p53-MDM2 Assay 1 and p53-MDM4 Assay 1, respectively). The test is performed in white 384-well plates (Greiner Bio-One, reference 781207) in a total volume of 60 L by adding 1 L of compounds tested at different concentrations diluted in 100% DMSO (1.7% final DMSO concentration) in reaction buffer (PBS, 125 mM NaCl, 0.001% Novexin (consists of carbohydrate polymers), designed to increase the solubility and stability of proteins; Expedeon Ltd., Cambridgeshire, United Kingdom), 0.01% Gelatin, 0.01% 0.2%, Pluronic F-127 (block copolymer from ethylenoxide and propyleneoxide), 1 mM DTT). After addition of 1.25 nM MDM2-biotinylated or 2.5 nM MDM4-biotinylated (internal preparations, both MDM2 and MDM4 are biotinylated at the C-terminal of the peptide construct), and 0.625 nM Europium labeled streptavidin (Perkin Elmer), the solution is pre-incubated for 15 minutes at room temperature, then 10 nM Cy5-p53 peptide (internal preparation, the Cy5 dye is directly bound to the N-terminal part of p53 peptide construct) is added before an incubation at room temperature for 15 minutes prior to reading the plate. For measurement of samples, a Victor II microplate reader (Perkin Elmer) is used with the following settings: Excitation 340 nm, Emission Donor 620 nm and Emission Acceptor 665 nm.",B,,,BAO_0000190,BAO_0000224,protein format,,,,CHEMBL3886839,,2016,,CHEMBL3948860,,CHEMBL3948860,6.92,False,http://www.openphacts.org/units/Nanomolar,2888193,=,37,True,=,,IC50,nM,,120.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,120.0
417029,17780492,[],CHEMBL3888805,"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: Assay 1: This assay was used to evaluate compounds displaying inhibition of p53-MDM2 interaction and p53-MDM4 interaction at IC50s of 0.005 to 50 M (p53-MDM2 Assay 1 and p53-MDM4 Assay 1, respectively). The test is performed in white 384-well plates (Greiner Bio-One, reference 781207) in a total volume of 60 L by adding 1 L of compounds tested at different concentrations diluted in 100% DMSO (1.7% final DMSO concentration) in reaction buffer (PBS, 125 mM NaCl, 0.001% Novexin (consists of carbohydrate polymers), designed to increase the solubility and stability of proteins; Expedeon Ltd., Cambridgeshire, United Kingdom), 0.01% Gelatin, 0.01% 0.2%, Pluronic F-127 (block copolymer from ethylenoxide and propyleneoxide), 1 mM DTT). After addition of 1.25 nM MDM2-biotinylated or 2.5 nM MDM4-biotinylated (internal preparations, both MDM2 and MDM4 are biotinylated at the C-terminal of the peptide construct), and 0.625 nM Europium labeled streptavidin (Perkin Elmer), the solution is pre-incubated for 15 minutes at room temperature, then 10 nM Cy5-p53 peptide (internal preparation, the Cy5 dye is directly bound to the N-terminal part of p53 peptide construct) is added before an incubation at room temperature for 15 minutes prior to reading the plate. For measurement of samples, a Victor II microplate reader (Perkin Elmer) is used with the following settings: Excitation 340 nm, Emission Donor 620 nm and Emission Acceptor 665 nm.",B,,,BAO_0000190,BAO_0000224,protein format,COc1ccncc1-c1nc2c(n1C(C)C)C(c1ccc(Cl)cc1)N(c1cccc(Cl)c1F)C(=O)N2,,,CHEMBL3886839,,2016,"{'bei': '15.33', 'le': '0.31', 'lle': '0.95', 'sei': '11.17'}",CHEMBL3962130,,CHEMBL3962130,8.07,False,http://www.openphacts.org/units/Nanomolar,2888194,=,37,True,=,,IC50,nM,,8.5,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,8.5
417035,17780498,[],CHEMBL3888807,"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: Assay 2: For selected compounds displaying IC50s between 0.05 and 5 nM on MDM2, a slightly modified assay is used with the following adaptations: 0.1 nM MDM2, 0.1 nM Europium labeled streptavidin and Tecan genios Pro is used as a microplate reader for the fluorescence measurements (p53-MDM2 Assay 2). The test is performed in white 384-well plates (Greiner Bio-One, reference 781207) in a total volume of 60 L by adding 1 L of compounds tested at different concentrations diluted in 100% DMSO (1.7% final DMSO concentration) in reaction buffer (PBS, 125 mM NaCl, 0.001% Novexin (consists of carbohydrate polymers), designed to increase the solubility and stability of proteins; Expedeon Ltd., Cambridgeshire, United Kingdom), 0.01% Gelatin, 0.01% 0.2%, Pluronic F-127 (block copolymer from ethylenoxide and propyleneoxide), 1 mM DTT). After addition of 1.25 nM MDM2-biotinylated or 2.5 nM MDM4-biotinylated (internal preparations, both MDM2 and MDM4 are biotinylated at the C-terminal of the peptide construct), and 0.625 nM Europium labeled streptavidin (Perkin Elmer), the solution is pre-incubated for 15 minutes at room temperature, then 10 nM Cy5-p53 peptide (internal preparation, the Cy5 dye is directly bound to the N-terminal part of p53 peptide construct) is added before an incubation at room temperature for 15 minutes prior to reading the plate. For measurement of samples, a Victor II microplate reader (Perkin Elmer) is used with the following settings: Excitation 340 nm, Emission Donor 620 nm and Emission Acceptor 665 nm.",B,,,BAO_0000190,BAO_0000224,protein format,COc1ccccc1-c1nc2c(n1C(C)C)C(c1ccc(Cl)cc1)N(c1cccc(Cl)c1F)C(=O)N2,,,CHEMBL3886839,,2016,"{'bei': '11.52', 'le': '0.23', 'lle': '-1.68', 'sei': '10.19'}",CHEMBL3904825,,CHEMBL3904825,6.05,False,http://www.openphacts.org/units/Nanomolar,2888189,=,37,True,=,,IC50,nM,,882.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,882.0
417036,17780499,[],CHEMBL3888807,"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: Assay 2: For selected compounds displaying IC50s between 0.05 and 5 nM on MDM2, a slightly modified assay is used with the following adaptations: 0.1 nM MDM2, 0.1 nM Europium labeled streptavidin and Tecan genios Pro is used as a microplate reader for the fluorescence measurements (p53-MDM2 Assay 2). The test is performed in white 384-well plates (Greiner Bio-One, reference 781207) in a total volume of 60 L by adding 1 L of compounds tested at different concentrations diluted in 100% DMSO (1.7% final DMSO concentration) in reaction buffer (PBS, 125 mM NaCl, 0.001% Novexin (consists of carbohydrate polymers), designed to increase the solubility and stability of proteins; Expedeon Ltd., Cambridgeshire, United Kingdom), 0.01% Gelatin, 0.01% 0.2%, Pluronic F-127 (block copolymer from ethylenoxide and propyleneoxide), 1 mM DTT). After addition of 1.25 nM MDM2-biotinylated or 2.5 nM MDM4-biotinylated (internal preparations, both MDM2 and MDM4 are biotinylated at the C-terminal of the peptide construct), and 0.625 nM Europium labeled streptavidin (Perkin Elmer), the solution is pre-incubated for 15 minutes at room temperature, then 10 nM Cy5-p53 peptide (internal preparation, the Cy5 dye is directly bound to the N-terminal part of p53 peptide construct) is added before an incubation at room temperature for 15 minutes prior to reading the plate. For measurement of samples, a Victor II microplate reader (Perkin Elmer) is used with the following settings: Excitation 340 nm, Emission Donor 620 nm and Emission Acceptor 665 nm.",B,,,BAO_0000190,BAO_0000224,protein format,COc1ccccc1-c1nc2c(n1C(C)C)C(c1ccc(Cl)cc1C)N(c1cccc(Cl)c1F)C(=O)N2,,,CHEMBL3886839,,2016,"{'bei': '11.32', 'le': '0.23', 'lle': '-1.93', 'sei': '10.29'}",CHEMBL3963661,,CHEMBL3963661,6.11,False,http://www.openphacts.org/units/Nanomolar,2888190,=,37,True,=,,IC50,nM,,779.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,779.0
417037,17780500,[],CHEMBL3888807,"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: Assay 2: For selected compounds displaying IC50s between 0.05 and 5 nM on MDM2, a slightly modified assay is used with the following adaptations: 0.1 nM MDM2, 0.1 nM Europium labeled streptavidin and Tecan genios Pro is used as a microplate reader for the fluorescence measurements (p53-MDM2 Assay 2). The test is performed in white 384-well plates (Greiner Bio-One, reference 781207) in a total volume of 60 L by adding 1 L of compounds tested at different concentrations diluted in 100% DMSO (1.7% final DMSO concentration) in reaction buffer (PBS, 125 mM NaCl, 0.001% Novexin (consists of carbohydrate polymers), designed to increase the solubility and stability of proteins; Expedeon Ltd., Cambridgeshire, United Kingdom), 0.01% Gelatin, 0.01% 0.2%, Pluronic F-127 (block copolymer from ethylenoxide and propyleneoxide), 1 mM DTT). After addition of 1.25 nM MDM2-biotinylated or 2.5 nM MDM4-biotinylated (internal preparations, both MDM2 and MDM4 are biotinylated at the C-terminal of the peptide construct), and 0.625 nM Europium labeled streptavidin (Perkin Elmer), the solution is pre-incubated for 15 minutes at room temperature, then 10 nM Cy5-p53 peptide (internal preparation, the Cy5 dye is directly bound to the N-terminal part of p53 peptide construct) is added before an incubation at room temperature for 15 minutes prior to reading the plate. For measurement of samples, a Victor II microplate reader (Perkin Elmer) is used with the following settings: Excitation 340 nm, Emission Donor 620 nm and Emission Acceptor 665 nm.",B,,,BAO_0000190,BAO_0000224,protein format,COc1ccc(F)cc1-c1nc2c(n1C(C)C)C(c1ccc(Cl)cc1C)N(c1cc(Cl)ccc1C)C(=O)N2,,,CHEMBL3886839,,2016,"{'bei': '11.34', 'le': '0.23', 'lle': '-2.07', 'sei': '10.57'}",CHEMBL3938216,,CHEMBL3938216,6.28,False,http://www.openphacts.org/units/Nanomolar,2888195,=,37,True,=,,IC50,nM,,531.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,531.0
417038,17780501,[],CHEMBL3888807,"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: Assay 2: For selected compounds displaying IC50s between 0.05 and 5 nM on MDM2, a slightly modified assay is used with the following adaptations: 0.1 nM MDM2, 0.1 nM Europium labeled streptavidin and Tecan genios Pro is used as a microplate reader for the fluorescence measurements (p53-MDM2 Assay 2). The test is performed in white 384-well plates (Greiner Bio-One, reference 781207) in a total volume of 60 L by adding 1 L of compounds tested at different concentrations diluted in 100% DMSO (1.7% final DMSO concentration) in reaction buffer (PBS, 125 mM NaCl, 0.001% Novexin (consists of carbohydrate polymers), designed to increase the solubility and stability of proteins; Expedeon Ltd., Cambridgeshire, United Kingdom), 0.01% Gelatin, 0.01% 0.2%, Pluronic F-127 (block copolymer from ethylenoxide and propyleneoxide), 1 mM DTT). After addition of 1.25 nM MDM2-biotinylated or 2.5 nM MDM4-biotinylated (internal preparations, both MDM2 and MDM4 are biotinylated at the C-terminal of the peptide construct), and 0.625 nM Europium labeled streptavidin (Perkin Elmer), the solution is pre-incubated for 15 minutes at room temperature, then 10 nM Cy5-p53 peptide (internal preparation, the Cy5 dye is directly bound to the N-terminal part of p53 peptide construct) is added before an incubation at room temperature for 15 minutes prior to reading the plate. For measurement of samples, a Victor II microplate reader (Perkin Elmer) is used with the following settings: Excitation 340 nm, Emission Donor 620 nm and Emission Acceptor 665 nm.",B,,,BAO_0000190,BAO_0000224,protein format,COc1ccc(C(=O)NCCO)cc1-c1nc2c(n1C(C)C)C(c1ccc(Cl)cc1C)N(c1cc(Cl)ccc1C)C(=O)N2,,,CHEMBL3886839,,2016,"{'bei': '10.20', 'le': '0.20', 'lle': '-0.58', 'sei': '5.84'}",CHEMBL3953377,,CHEMBL3953377,6.35,False,http://www.openphacts.org/units/Nanomolar,2888196,=,37,True,=,,IC50,nM,,447.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,447.0
417039,17780502,[],CHEMBL3888807,"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: Assay 2: For selected compounds displaying IC50s between 0.05 and 5 nM on MDM2, a slightly modified assay is used with the following adaptations: 0.1 nM MDM2, 0.1 nM Europium labeled streptavidin and Tecan genios Pro is used as a microplate reader for the fluorescence measurements (p53-MDM2 Assay 2). The test is performed in white 384-well plates (Greiner Bio-One, reference 781207) in a total volume of 60 L by adding 1 L of compounds tested at different concentrations diluted in 100% DMSO (1.7% final DMSO concentration) in reaction buffer (PBS, 125 mM NaCl, 0.001% Novexin (consists of carbohydrate polymers), designed to increase the solubility and stability of proteins; Expedeon Ltd., Cambridgeshire, United Kingdom), 0.01% Gelatin, 0.01% 0.2%, Pluronic F-127 (block copolymer from ethylenoxide and propyleneoxide), 1 mM DTT). After addition of 1.25 nM MDM2-biotinylated or 2.5 nM MDM4-biotinylated (internal preparations, both MDM2 and MDM4 are biotinylated at the C-terminal of the peptide construct), and 0.625 nM Europium labeled streptavidin (Perkin Elmer), the solution is pre-incubated for 15 minutes at room temperature, then 10 nM Cy5-p53 peptide (internal preparation, the Cy5 dye is directly bound to the N-terminal part of p53 peptide construct) is added before an incubation at room temperature for 15 minutes prior to reading the plate. For measurement of samples, a Victor II microplate reader (Perkin Elmer) is used with the following settings: Excitation 340 nm, Emission Donor 620 nm and Emission Acceptor 665 nm.",B,,,BAO_0000190,BAO_0000224,protein format,CNC(=O)c1ccc(OC)c(-c2nc3c(n2C(C)C)C(c2ccc(Cl)cc2C)N(c2cc(Cl)ccc2C)C(=O)N3)c1,,,CHEMBL3886839,,2016,"{'bei': '11.27', 'le': '0.22', 'lle': '-0.88', 'sei': '7.55'}",CHEMBL3911759,,CHEMBL3911759,6.68,False,http://www.openphacts.org/units/Nanomolar,2888197,=,37,True,=,,IC50,nM,,210.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,210.0
417040,17780503,[],CHEMBL3888807,"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: Assay 2: For selected compounds displaying IC50s between 0.05 and 5 nM on MDM2, a slightly modified assay is used with the following adaptations: 0.1 nM MDM2, 0.1 nM Europium labeled streptavidin and Tecan genios Pro is used as a microplate reader for the fluorescence measurements (p53-MDM2 Assay 2). The test is performed in white 384-well plates (Greiner Bio-One, reference 781207) in a total volume of 60 L by adding 1 L of compounds tested at different concentrations diluted in 100% DMSO (1.7% final DMSO concentration) in reaction buffer (PBS, 125 mM NaCl, 0.001% Novexin (consists of carbohydrate polymers), designed to increase the solubility and stability of proteins; Expedeon Ltd., Cambridgeshire, United Kingdom), 0.01% Gelatin, 0.01% 0.2%, Pluronic F-127 (block copolymer from ethylenoxide and propyleneoxide), 1 mM DTT). After addition of 1.25 nM MDM2-biotinylated or 2.5 nM MDM4-biotinylated (internal preparations, both MDM2 and MDM4 are biotinylated at the C-terminal of the peptide construct), and 0.625 nM Europium labeled streptavidin (Perkin Elmer), the solution is pre-incubated for 15 minutes at room temperature, then 10 nM Cy5-p53 peptide (internal preparation, the Cy5 dye is directly bound to the N-terminal part of p53 peptide construct) is added before an incubation at room temperature for 15 minutes prior to reading the plate. For measurement of samples, a Victor II microplate reader (Perkin Elmer) is used with the following settings: Excitation 340 nm, Emission Donor 620 nm and Emission Acceptor 665 nm.",B,,,BAO_0000190,BAO_0000224,protein format,COc1ccc(C(=O)N(C)C)cc1-c1nc2c(n1C(C)C)C(c1ccc(Cl)cc1C)N(c1cc(Cl)ccc1C)C(=O)N2,,,CHEMBL3886839,,2016,"{'bei': '10.49', 'le': '0.21', 'lle': '-1.55', 'sei': '7.99'}",CHEMBL3982187,,CHEMBL3982187,6.37,False,http://www.openphacts.org/units/Nanomolar,2888198,=,37,True,=,,IC50,nM,,432.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,432.0
417041,17780504,[],CHEMBL3888807,"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: Assay 2: For selected compounds displaying IC50s between 0.05 and 5 nM on MDM2, a slightly modified assay is used with the following adaptations: 0.1 nM MDM2, 0.1 nM Europium labeled streptavidin and Tecan genios Pro is used as a microplate reader for the fluorescence measurements (p53-MDM2 Assay 2). The test is performed in white 384-well plates (Greiner Bio-One, reference 781207) in a total volume of 60 L by adding 1 L of compounds tested at different concentrations diluted in 100% DMSO (1.7% final DMSO concentration) in reaction buffer (PBS, 125 mM NaCl, 0.001% Novexin (consists of carbohydrate polymers), designed to increase the solubility and stability of proteins; Expedeon Ltd., Cambridgeshire, United Kingdom), 0.01% Gelatin, 0.01% 0.2%, Pluronic F-127 (block copolymer from ethylenoxide and propyleneoxide), 1 mM DTT). After addition of 1.25 nM MDM2-biotinylated or 2.5 nM MDM4-biotinylated (internal preparations, both MDM2 and MDM4 are biotinylated at the C-terminal of the peptide construct), and 0.625 nM Europium labeled streptavidin (Perkin Elmer), the solution is pre-incubated for 15 minutes at room temperature, then 10 nM Cy5-p53 peptide (internal preparation, the Cy5 dye is directly bound to the N-terminal part of p53 peptide construct) is added before an incubation at room temperature for 15 minutes prior to reading the plate. For measurement of samples, a Victor II microplate reader (Perkin Elmer) is used with the following settings: Excitation 340 nm, Emission Donor 620 nm and Emission Acceptor 665 nm.",B,,,BAO_0000190,BAO_0000224,protein format,COc1ccc(CO)cc1-c1nc2c(n1C(C)C)C(c1ccc(Cl)cc1C)N(c1cc(Cl)ccc1C)C(=O)N2,,,CHEMBL3886839,,2016,"{'bei': '11.37', 'le': '0.23', 'lle': '-1.27', 'sei': '8.08'}",CHEMBL3950029,,CHEMBL3950029,6.43,False,http://www.openphacts.org/units/Nanomolar,2888199,=,37,True,=,,IC50,nM,,371.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,371.0
417042,17780505,[],CHEMBL3888807,"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: Assay 2: For selected compounds displaying IC50s between 0.05 and 5 nM on MDM2, a slightly modified assay is used with the following adaptations: 0.1 nM MDM2, 0.1 nM Europium labeled streptavidin and Tecan genios Pro is used as a microplate reader for the fluorescence measurements (p53-MDM2 Assay 2). The test is performed in white 384-well plates (Greiner Bio-One, reference 781207) in a total volume of 60 L by adding 1 L of compounds tested at different concentrations diluted in 100% DMSO (1.7% final DMSO concentration) in reaction buffer (PBS, 125 mM NaCl, 0.001% Novexin (consists of carbohydrate polymers), designed to increase the solubility and stability of proteins; Expedeon Ltd., Cambridgeshire, United Kingdom), 0.01% Gelatin, 0.01% 0.2%, Pluronic F-127 (block copolymer from ethylenoxide and propyleneoxide), 1 mM DTT). After addition of 1.25 nM MDM2-biotinylated or 2.5 nM MDM4-biotinylated (internal preparations, both MDM2 and MDM4 are biotinylated at the C-terminal of the peptide construct), and 0.625 nM Europium labeled streptavidin (Perkin Elmer), the solution is pre-incubated for 15 minutes at room temperature, then 10 nM Cy5-p53 peptide (internal preparation, the Cy5 dye is directly bound to the N-terminal part of p53 peptide construct) is added before an incubation at room temperature for 15 minutes prior to reading the plate. For measurement of samples, a Victor II microplate reader (Perkin Elmer) is used with the following settings: Excitation 340 nm, Emission Donor 620 nm and Emission Acceptor 665 nm.",B,,,BAO_0000190,BAO_0000224,protein format,COc1ccc(C#N)cc1-c1nc2c(n1C(C)C)C(c1ccc(Cl)cc1C)N(c1cc(Cl)ccc1C)C(=O)N2,,,CHEMBL3886839,,2016,"{'bei': '11.39', 'le': '0.22', 'lle': '-1.70', 'sei': '7.67'}",CHEMBL3927572,,CHEMBL3927572,6.38,False,http://www.openphacts.org/units/Nanomolar,2888200,=,37,True,=,,IC50,nM,,414.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,414.0
417043,17780506,[],CHEMBL3888807,"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: Assay 2: For selected compounds displaying IC50s between 0.05 and 5 nM on MDM2, a slightly modified assay is used with the following adaptations: 0.1 nM MDM2, 0.1 nM Europium labeled streptavidin and Tecan genios Pro is used as a microplate reader for the fluorescence measurements (p53-MDM2 Assay 2). The test is performed in white 384-well plates (Greiner Bio-One, reference 781207) in a total volume of 60 L by adding 1 L of compounds tested at different concentrations diluted in 100% DMSO (1.7% final DMSO concentration) in reaction buffer (PBS, 125 mM NaCl, 0.001% Novexin (consists of carbohydrate polymers), designed to increase the solubility and stability of proteins; Expedeon Ltd., Cambridgeshire, United Kingdom), 0.01% Gelatin, 0.01% 0.2%, Pluronic F-127 (block copolymer from ethylenoxide and propyleneoxide), 1 mM DTT). After addition of 1.25 nM MDM2-biotinylated or 2.5 nM MDM4-biotinylated (internal preparations, both MDM2 and MDM4 are biotinylated at the C-terminal of the peptide construct), and 0.625 nM Europium labeled streptavidin (Perkin Elmer), the solution is pre-incubated for 15 minutes at room temperature, then 10 nM Cy5-p53 peptide (internal preparation, the Cy5 dye is directly bound to the N-terminal part of p53 peptide construct) is added before an incubation at room temperature for 15 minutes prior to reading the plate. For measurement of samples, a Victor II microplate reader (Perkin Elmer) is used with the following settings: Excitation 340 nm, Emission Donor 620 nm and Emission Acceptor 665 nm.",B,,,BAO_0000190,BAO_0000224,protein format,COc1ccccc1-c1nc2c(n1C(C)C)C(c1ccc(C#N)cc1)N(c1cc(Cl)ccc1C)C(=O)N2,,,CHEMBL3886839,,2016,"{'bei': '11.99', 'le': '0.23', 'lle': '-0.97', 'sei': '7.38'}",CHEMBL3955184,,CHEMBL3955184,6.14,False,http://www.openphacts.org/units/Nanomolar,2888201,=,37,True,=,,IC50,nM,,724.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,724.0
417044,17780507,[],CHEMBL3888807,"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: Assay 2: For selected compounds displaying IC50s between 0.05 and 5 nM on MDM2, a slightly modified assay is used with the following adaptations: 0.1 nM MDM2, 0.1 nM Europium labeled streptavidin and Tecan genios Pro is used as a microplate reader for the fluorescence measurements (p53-MDM2 Assay 2). The test is performed in white 384-well plates (Greiner Bio-One, reference 781207) in a total volume of 60 L by adding 1 L of compounds tested at different concentrations diluted in 100% DMSO (1.7% final DMSO concentration) in reaction buffer (PBS, 125 mM NaCl, 0.001% Novexin (consists of carbohydrate polymers), designed to increase the solubility and stability of proteins; Expedeon Ltd., Cambridgeshire, United Kingdom), 0.01% Gelatin, 0.01% 0.2%, Pluronic F-127 (block copolymer from ethylenoxide and propyleneoxide), 1 mM DTT). After addition of 1.25 nM MDM2-biotinylated or 2.5 nM MDM4-biotinylated (internal preparations, both MDM2 and MDM4 are biotinylated at the C-terminal of the peptide construct), and 0.625 nM Europium labeled streptavidin (Perkin Elmer), the solution is pre-incubated for 15 minutes at room temperature, then 10 nM Cy5-p53 peptide (internal preparation, the Cy5 dye is directly bound to the N-terminal part of p53 peptide construct) is added before an incubation at room temperature for 15 minutes prior to reading the plate. For measurement of samples, a Victor II microplate reader (Perkin Elmer) is used with the following settings: Excitation 340 nm, Emission Donor 620 nm and Emission Acceptor 665 nm.",B,,,BAO_0000190,BAO_0000224,protein format,COc1ccccc1-c1nc2c(n1C(C)C)C(c1ccc(C#N)cc1)N(c1cccc(Cl)c1F)C(=O)N2,,,CHEMBL3886839,,2016,"{'bei': '12.26', 'le': '0.23', 'lle': '-0.62', 'sei': '7.60'}",CHEMBL3940097,,CHEMBL3940097,6.33,False,http://www.openphacts.org/units/Nanomolar,2888202,=,37,True,=,,IC50,nM,,473.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,473.0
417045,17780508,[],CHEMBL3888807,"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: Assay 2: For selected compounds displaying IC50s between 0.05 and 5 nM on MDM2, a slightly modified assay is used with the following adaptations: 0.1 nM MDM2, 0.1 nM Europium labeled streptavidin and Tecan genios Pro is used as a microplate reader for the fluorescence measurements (p53-MDM2 Assay 2). The test is performed in white 384-well plates (Greiner Bio-One, reference 781207) in a total volume of 60 L by adding 1 L of compounds tested at different concentrations diluted in 100% DMSO (1.7% final DMSO concentration) in reaction buffer (PBS, 125 mM NaCl, 0.001% Novexin (consists of carbohydrate polymers), designed to increase the solubility and stability of proteins; Expedeon Ltd., Cambridgeshire, United Kingdom), 0.01% Gelatin, 0.01% 0.2%, Pluronic F-127 (block copolymer from ethylenoxide and propyleneoxide), 1 mM DTT). After addition of 1.25 nM MDM2-biotinylated or 2.5 nM MDM4-biotinylated (internal preparations, both MDM2 and MDM4 are biotinylated at the C-terminal of the peptide construct), and 0.625 nM Europium labeled streptavidin (Perkin Elmer), the solution is pre-incubated for 15 minutes at room temperature, then 10 nM Cy5-p53 peptide (internal preparation, the Cy5 dye is directly bound to the N-terminal part of p53 peptide construct) is added before an incubation at room temperature for 15 minutes prior to reading the plate. For measurement of samples, a Victor II microplate reader (Perkin Elmer) is used with the following settings: Excitation 340 nm, Emission Donor 620 nm and Emission Acceptor 665 nm.",B,,,BAO_0000190,BAO_0000224,protein format,COc1ncc(-c2nc3c(n2C(C)C)C(c2ccc(Cl)c(F)c2)N(c2ccc(F)c(Cl)c2)C(=O)N3)c(OC)n1,,,CHEMBL3886839,,2016,"{'bei': '11.03', 'le': '0.22', 'lle': '-0.31', 'sei': '6.72'}",CHEMBL3966333,,CHEMBL3966333,6.35,False,http://www.openphacts.org/units/Nanomolar,2888203,=,37,True,=,,IC50,nM,,451.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,451.0
417046,17780509,[],CHEMBL3888807,"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: Assay 2: For selected compounds displaying IC50s between 0.05 and 5 nM on MDM2, a slightly modified assay is used with the following adaptations: 0.1 nM MDM2, 0.1 nM Europium labeled streptavidin and Tecan genios Pro is used as a microplate reader for the fluorescence measurements (p53-MDM2 Assay 2). The test is performed in white 384-well plates (Greiner Bio-One, reference 781207) in a total volume of 60 L by adding 1 L of compounds tested at different concentrations diluted in 100% DMSO (1.7% final DMSO concentration) in reaction buffer (PBS, 125 mM NaCl, 0.001% Novexin (consists of carbohydrate polymers), designed to increase the solubility and stability of proteins; Expedeon Ltd., Cambridgeshire, United Kingdom), 0.01% Gelatin, 0.01% 0.2%, Pluronic F-127 (block copolymer from ethylenoxide and propyleneoxide), 1 mM DTT). After addition of 1.25 nM MDM2-biotinylated or 2.5 nM MDM4-biotinylated (internal preparations, both MDM2 and MDM4 are biotinylated at the C-terminal of the peptide construct), and 0.625 nM Europium labeled streptavidin (Perkin Elmer), the solution is pre-incubated for 15 minutes at room temperature, then 10 nM Cy5-p53 peptide (internal preparation, the Cy5 dye is directly bound to the N-terminal part of p53 peptide construct) is added before an incubation at room temperature for 15 minutes prior to reading the plate. For measurement of samples, a Victor II microplate reader (Perkin Elmer) is used with the following settings: Excitation 340 nm, Emission Donor 620 nm and Emission Acceptor 665 nm.",B,,,BAO_0000190,BAO_0000224,protein format,COc1ncc(-c2nc3c(n2C(C)C)C(c2ccc(Cl)cc2C)N(c2cc(Cl)c(=O)n(C)c2)C(=O)N3)c(OC)n1,,,CHEMBL3886839,,2016,"{'bei': '9.42', 'le': '0.19', 'lle': '0.12', 'sei': '4.73'}",CHEMBL3913154,,CHEMBL3913154,5.51,False,http://www.openphacts.org/units/Nanomolar,2888204,=,37,True,=,,IC50,nM,,3106.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,3106.0
417047,17780510,[],CHEMBL3888807,"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: Assay 2: For selected compounds displaying IC50s between 0.05 and 5 nM on MDM2, a slightly modified assay is used with the following adaptations: 0.1 nM MDM2, 0.1 nM Europium labeled streptavidin and Tecan genios Pro is used as a microplate reader for the fluorescence measurements (p53-MDM2 Assay 2). The test is performed in white 384-well plates (Greiner Bio-One, reference 781207) in a total volume of 60 L by adding 1 L of compounds tested at different concentrations diluted in 100% DMSO (1.7% final DMSO concentration) in reaction buffer (PBS, 125 mM NaCl, 0.001% Novexin (consists of carbohydrate polymers), designed to increase the solubility and stability of proteins; Expedeon Ltd., Cambridgeshire, United Kingdom), 0.01% Gelatin, 0.01% 0.2%, Pluronic F-127 (block copolymer from ethylenoxide and propyleneoxide), 1 mM DTT). After addition of 1.25 nM MDM2-biotinylated or 2.5 nM MDM4-biotinylated (internal preparations, both MDM2 and MDM4 are biotinylated at the C-terminal of the peptide construct), and 0.625 nM Europium labeled streptavidin (Perkin Elmer), the solution is pre-incubated for 15 minutes at room temperature, then 10 nM Cy5-p53 peptide (internal preparation, the Cy5 dye is directly bound to the N-terminal part of p53 peptide construct) is added before an incubation at room temperature for 15 minutes prior to reading the plate. For measurement of samples, a Victor II microplate reader (Perkin Elmer) is used with the following settings: Excitation 340 nm, Emission Donor 620 nm and Emission Acceptor 665 nm.",B,,,BAO_0000190,BAO_0000224,protein format,COc1ncc(-c2nc3c(n2C(C)C)C(c2ccc(Cl)c(F)c2)N(c2cc(Cl)cn(C)c2=O)C(=O)N3)c(OC)n1,,,CHEMBL3886839,,2016,"{'bei': '9.82', 'le': '0.20', 'lle': '0.56', 'sei': '4.96'}",CHEMBL3906849,,CHEMBL3906849,5.78,False,http://www.openphacts.org/units/Nanomolar,2888205,=,37,True,=,,IC50,nM,,1668.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,1668.0
417048,17780511,[],CHEMBL3888807,"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: Assay 2: For selected compounds displaying IC50s between 0.05 and 5 nM on MDM2, a slightly modified assay is used with the following adaptations: 0.1 nM MDM2, 0.1 nM Europium labeled streptavidin and Tecan genios Pro is used as a microplate reader for the fluorescence measurements (p53-MDM2 Assay 2). The test is performed in white 384-well plates (Greiner Bio-One, reference 781207) in a total volume of 60 L by adding 1 L of compounds tested at different concentrations diluted in 100% DMSO (1.7% final DMSO concentration) in reaction buffer (PBS, 125 mM NaCl, 0.001% Novexin (consists of carbohydrate polymers), designed to increase the solubility and stability of proteins; Expedeon Ltd., Cambridgeshire, United Kingdom), 0.01% Gelatin, 0.01% 0.2%, Pluronic F-127 (block copolymer from ethylenoxide and propyleneoxide), 1 mM DTT). After addition of 1.25 nM MDM2-biotinylated or 2.5 nM MDM4-biotinylated (internal preparations, both MDM2 and MDM4 are biotinylated at the C-terminal of the peptide construct), and 0.625 nM Europium labeled streptavidin (Perkin Elmer), the solution is pre-incubated for 15 minutes at room temperature, then 10 nM Cy5-p53 peptide (internal preparation, the Cy5 dye is directly bound to the N-terminal part of p53 peptide construct) is added before an incubation at room temperature for 15 minutes prior to reading the plate. For measurement of samples, a Victor II microplate reader (Perkin Elmer) is used with the following settings: Excitation 340 nm, Emission Donor 620 nm and Emission Acceptor 665 nm.",B,,,BAO_0000190,BAO_0000224,protein format,COc1ncc(-c2nc3c(n2C(C)C)C(c2ccc(Cl)cc2)N(c2cc(Cl)cn(C)c2=O)C(=O)N3)c(OC)n1,,,CHEMBL3886839,,2016,"{'bei': '9.70', 'le': '0.19', 'lle': '0.45', 'sei': '4.76'}",CHEMBL3918635,,CHEMBL3918635,5.54,False,http://www.openphacts.org/units/Nanomolar,2888206,=,37,True,=,,IC50,nM,,2914.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,2914.0
417049,17780512,[],CHEMBL3888807,"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: Assay 2: For selected compounds displaying IC50s between 0.05 and 5 nM on MDM2, a slightly modified assay is used with the following adaptations: 0.1 nM MDM2, 0.1 nM Europium labeled streptavidin and Tecan genios Pro is used as a microplate reader for the fluorescence measurements (p53-MDM2 Assay 2). The test is performed in white 384-well plates (Greiner Bio-One, reference 781207) in a total volume of 60 L by adding 1 L of compounds tested at different concentrations diluted in 100% DMSO (1.7% final DMSO concentration) in reaction buffer (PBS, 125 mM NaCl, 0.001% Novexin (consists of carbohydrate polymers), designed to increase the solubility and stability of proteins; Expedeon Ltd., Cambridgeshire, United Kingdom), 0.01% Gelatin, 0.01% 0.2%, Pluronic F-127 (block copolymer from ethylenoxide and propyleneoxide), 1 mM DTT). After addition of 1.25 nM MDM2-biotinylated or 2.5 nM MDM4-biotinylated (internal preparations, both MDM2 and MDM4 are biotinylated at the C-terminal of the peptide construct), and 0.625 nM Europium labeled streptavidin (Perkin Elmer), the solution is pre-incubated for 15 minutes at room temperature, then 10 nM Cy5-p53 peptide (internal preparation, the Cy5 dye is directly bound to the N-terminal part of p53 peptide construct) is added before an incubation at room temperature for 15 minutes prior to reading the plate. For measurement of samples, a Victor II microplate reader (Perkin Elmer) is used with the following settings: Excitation 340 nm, Emission Donor 620 nm and Emission Acceptor 665 nm.",B,,,BAO_0000190,BAO_0000224,protein format,COc1ncc(-c2nc3c(n2C(C)C)C(c2ccc(Cl)c(F)c2)N(c2cc(Cl)c(=O)n(C)c2)C(=O)N3)c(OC)n1,,,CHEMBL3886839,,2016,"{'bei': '10.25', 'le': '0.21', 'lle': '0.81', 'sei': '5.18'}",CHEMBL3949903,,CHEMBL3949903,6.03,False,http://www.openphacts.org/units/Nanomolar,2888207,=,37,True,=,,IC50,nM,,930.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,930.0
417050,17780513,[],CHEMBL3888807,"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: Assay 2: For selected compounds displaying IC50s between 0.05 and 5 nM on MDM2, a slightly modified assay is used with the following adaptations: 0.1 nM MDM2, 0.1 nM Europium labeled streptavidin and Tecan genios Pro is used as a microplate reader for the fluorescence measurements (p53-MDM2 Assay 2). The test is performed in white 384-well plates (Greiner Bio-One, reference 781207) in a total volume of 60 L by adding 1 L of compounds tested at different concentrations diluted in 100% DMSO (1.7% final DMSO concentration) in reaction buffer (PBS, 125 mM NaCl, 0.001% Novexin (consists of carbohydrate polymers), designed to increase the solubility and stability of proteins; Expedeon Ltd., Cambridgeshire, United Kingdom), 0.01% Gelatin, 0.01% 0.2%, Pluronic F-127 (block copolymer from ethylenoxide and propyleneoxide), 1 mM DTT). After addition of 1.25 nM MDM2-biotinylated or 2.5 nM MDM4-biotinylated (internal preparations, both MDM2 and MDM4 are biotinylated at the C-terminal of the peptide construct), and 0.625 nM Europium labeled streptavidin (Perkin Elmer), the solution is pre-incubated for 15 minutes at room temperature, then 10 nM Cy5-p53 peptide (internal preparation, the Cy5 dye is directly bound to the N-terminal part of p53 peptide construct) is added before an incubation at room temperature for 15 minutes prior to reading the plate. For measurement of samples, a Victor II microplate reader (Perkin Elmer) is used with the following settings: Excitation 340 nm, Emission Donor 620 nm and Emission Acceptor 665 nm.",B,,,BAO_0000190,BAO_0000224,protein format,COc1nc(N(C)C)ncc1-c1nc2c(n1C(C)C)C(c1ccc(Cl)c(F)c1)N(c1cc(Cl)c[nH]c1=O)C(=O)N2,,,CHEMBL3886839,,2016,"{'bei': '10.98', 'le': '0.22', 'lle': '1.18', 'sei': '5.32'}",CHEMBL3894069,,CHEMBL3894069,6.45,False,http://www.openphacts.org/units/Nanomolar,2888208,=,37,True,=,,IC50,nM,,354.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,354.0
417051,17780514,[],CHEMBL3888807,"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: Assay 2: For selected compounds displaying IC50s between 0.05 and 5 nM on MDM2, a slightly modified assay is used with the following adaptations: 0.1 nM MDM2, 0.1 nM Europium labeled streptavidin and Tecan genios Pro is used as a microplate reader for the fluorescence measurements (p53-MDM2 Assay 2). The test is performed in white 384-well plates (Greiner Bio-One, reference 781207) in a total volume of 60 L by adding 1 L of compounds tested at different concentrations diluted in 100% DMSO (1.7% final DMSO concentration) in reaction buffer (PBS, 125 mM NaCl, 0.001% Novexin (consists of carbohydrate polymers), designed to increase the solubility and stability of proteins; Expedeon Ltd., Cambridgeshire, United Kingdom), 0.01% Gelatin, 0.01% 0.2%, Pluronic F-127 (block copolymer from ethylenoxide and propyleneoxide), 1 mM DTT). After addition of 1.25 nM MDM2-biotinylated or 2.5 nM MDM4-biotinylated (internal preparations, both MDM2 and MDM4 are biotinylated at the C-terminal of the peptide construct), and 0.625 nM Europium labeled streptavidin (Perkin Elmer), the solution is pre-incubated for 15 minutes at room temperature, then 10 nM Cy5-p53 peptide (internal preparation, the Cy5 dye is directly bound to the N-terminal part of p53 peptide construct) is added before an incubation at room temperature for 15 minutes prior to reading the plate. For measurement of samples, a Victor II microplate reader (Perkin Elmer) is used with the following settings: Excitation 340 nm, Emission Donor 620 nm and Emission Acceptor 665 nm.",B,,,BAO_0000190,BAO_0000224,protein format,COc1nc(N)ncc1-c1nc2c(n1C(C)C)C(c1ccc(Cl)cc1)N(c1cc(Cl)cn(C)c1=O)C(=O)N2,,,CHEMBL3886839,,2016,"{'bei': '9.66', 'le': '0.19', 'lle': '0.71', 'sei': '4.03'}",CHEMBL3922073,,CHEMBL3922073,5.37,False,http://www.openphacts.org/units/Nanomolar,2888209,=,37,True,=,,IC50,nM,,4298.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,4298.0
417052,17780515,[],CHEMBL3888807,"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: Assay 2: For selected compounds displaying IC50s between 0.05 and 5 nM on MDM2, a slightly modified assay is used with the following adaptations: 0.1 nM MDM2, 0.1 nM Europium labeled streptavidin and Tecan genios Pro is used as a microplate reader for the fluorescence measurements (p53-MDM2 Assay 2). The test is performed in white 384-well plates (Greiner Bio-One, reference 781207) in a total volume of 60 L by adding 1 L of compounds tested at different concentrations diluted in 100% DMSO (1.7% final DMSO concentration) in reaction buffer (PBS, 125 mM NaCl, 0.001% Novexin (consists of carbohydrate polymers), designed to increase the solubility and stability of proteins; Expedeon Ltd., Cambridgeshire, United Kingdom), 0.01% Gelatin, 0.01% 0.2%, Pluronic F-127 (block copolymer from ethylenoxide and propyleneoxide), 1 mM DTT). After addition of 1.25 nM MDM2-biotinylated or 2.5 nM MDM4-biotinylated (internal preparations, both MDM2 and MDM4 are biotinylated at the C-terminal of the peptide construct), and 0.625 nM Europium labeled streptavidin (Perkin Elmer), the solution is pre-incubated for 15 minutes at room temperature, then 10 nM Cy5-p53 peptide (internal preparation, the Cy5 dye is directly bound to the N-terminal part of p53 peptide construct) is added before an incubation at room temperature for 15 minutes prior to reading the plate. For measurement of samples, a Victor II microplate reader (Perkin Elmer) is used with the following settings: Excitation 340 nm, Emission Donor 620 nm and Emission Acceptor 665 nm.",B,,,BAO_0000190,BAO_0000224,protein format,COc1nc(N(C)C)ncc1-c1nc2c(n1C(C)C)C(c1ccc(Cl)cc1)N(c1cc(Cl)cn(C)c1=O)C(=O)N2,,,CHEMBL3886839,,2016,"{'bei': '10.68', 'le': '0.21', 'lle': '1.09', 'sei': '5.64'}",CHEMBL3955672,,CHEMBL3955672,6.23,False,http://www.openphacts.org/units/Nanomolar,2888210,=,37,True,=,,IC50,nM,,587.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,587.0
417053,17780516,[],CHEMBL3888807,"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: Assay 2: For selected compounds displaying IC50s between 0.05 and 5 nM on MDM2, a slightly modified assay is used with the following adaptations: 0.1 nM MDM2, 0.1 nM Europium labeled streptavidin and Tecan genios Pro is used as a microplate reader for the fluorescence measurements (p53-MDM2 Assay 2). The test is performed in white 384-well plates (Greiner Bio-One, reference 781207) in a total volume of 60 L by adding 1 L of compounds tested at different concentrations diluted in 100% DMSO (1.7% final DMSO concentration) in reaction buffer (PBS, 125 mM NaCl, 0.001% Novexin (consists of carbohydrate polymers), designed to increase the solubility and stability of proteins; Expedeon Ltd., Cambridgeshire, United Kingdom), 0.01% Gelatin, 0.01% 0.2%, Pluronic F-127 (block copolymer from ethylenoxide and propyleneoxide), 1 mM DTT). After addition of 1.25 nM MDM2-biotinylated or 2.5 nM MDM4-biotinylated (internal preparations, both MDM2 and MDM4 are biotinylated at the C-terminal of the peptide construct), and 0.625 nM Europium labeled streptavidin (Perkin Elmer), the solution is pre-incubated for 15 minutes at room temperature, then 10 nM Cy5-p53 peptide (internal preparation, the Cy5 dye is directly bound to the N-terminal part of p53 peptide construct) is added before an incubation at room temperature for 15 minutes prior to reading the plate. For measurement of samples, a Victor II microplate reader (Perkin Elmer) is used with the following settings: Excitation 340 nm, Emission Donor 620 nm and Emission Acceptor 665 nm.",B,,,BAO_0000190,BAO_0000224,protein format,COc1nc(N(C)C)ncc1-c1nc2c(n1C(C)C)C(c1ccc(Cl)c(F)c1)N(c1ccc(F)c(Cl)c1)C(=O)N2,,,CHEMBL3886839,,2016,"{'bei': '10.90', 'le': '0.22', 'lle': '-0.31', 'sei': '7.26'}",CHEMBL3926073,,CHEMBL3926073,6.42,False,http://www.openphacts.org/units/Nanomolar,2888211,=,37,True,=,,IC50,nM,,385.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,385.0
417054,17780517,[],CHEMBL3888807,"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: Assay 2: For selected compounds displaying IC50s between 0.05 and 5 nM on MDM2, a slightly modified assay is used with the following adaptations: 0.1 nM MDM2, 0.1 nM Europium labeled streptavidin and Tecan genios Pro is used as a microplate reader for the fluorescence measurements (p53-MDM2 Assay 2). The test is performed in white 384-well plates (Greiner Bio-One, reference 781207) in a total volume of 60 L by adding 1 L of compounds tested at different concentrations diluted in 100% DMSO (1.7% final DMSO concentration) in reaction buffer (PBS, 125 mM NaCl, 0.001% Novexin (consists of carbohydrate polymers), designed to increase the solubility and stability of proteins; Expedeon Ltd., Cambridgeshire, United Kingdom), 0.01% Gelatin, 0.01% 0.2%, Pluronic F-127 (block copolymer from ethylenoxide and propyleneoxide), 1 mM DTT). After addition of 1.25 nM MDM2-biotinylated or 2.5 nM MDM4-biotinylated (internal preparations, both MDM2 and MDM4 are biotinylated at the C-terminal of the peptide construct), and 0.625 nM Europium labeled streptavidin (Perkin Elmer), the solution is pre-incubated for 15 minutes at room temperature, then 10 nM Cy5-p53 peptide (internal preparation, the Cy5 dye is directly bound to the N-terminal part of p53 peptide construct) is added before an incubation at room temperature for 15 minutes prior to reading the plate. For measurement of samples, a Victor II microplate reader (Perkin Elmer) is used with the following settings: Excitation 340 nm, Emission Donor 620 nm and Emission Acceptor 665 nm.",B,,,BAO_0000190,BAO_0000224,protein format,COc1nc(N(C)C)ncc1-c1nc2c(n1C(C)C)C(c1ccc(Cl)c(F)c1)N(c1cc(Cl)cn(C)c1=O)C(=O)N2,,,CHEMBL3886839,,2016,"{'bei': '10.19', 'le': '0.20', 'lle': '0.85', 'sei': '5.55'}",CHEMBL3966790,,CHEMBL3966790,6.13,False,http://www.openphacts.org/units/Nanomolar,2888212,=,37,True,=,,IC50,nM,,748.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,748.0
417055,17780518,[],CHEMBL3888807,"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: Assay 2: For selected compounds displaying IC50s between 0.05 and 5 nM on MDM2, a slightly modified assay is used with the following adaptations: 0.1 nM MDM2, 0.1 nM Europium labeled streptavidin and Tecan genios Pro is used as a microplate reader for the fluorescence measurements (p53-MDM2 Assay 2). The test is performed in white 384-well plates (Greiner Bio-One, reference 781207) in a total volume of 60 L by adding 1 L of compounds tested at different concentrations diluted in 100% DMSO (1.7% final DMSO concentration) in reaction buffer (PBS, 125 mM NaCl, 0.001% Novexin (consists of carbohydrate polymers), designed to increase the solubility and stability of proteins; Expedeon Ltd., Cambridgeshire, United Kingdom), 0.01% Gelatin, 0.01% 0.2%, Pluronic F-127 (block copolymer from ethylenoxide and propyleneoxide), 1 mM DTT). After addition of 1.25 nM MDM2-biotinylated or 2.5 nM MDM4-biotinylated (internal preparations, both MDM2 and MDM4 are biotinylated at the C-terminal of the peptide construct), and 0.625 nM Europium labeled streptavidin (Perkin Elmer), the solution is pre-incubated for 15 minutes at room temperature, then 10 nM Cy5-p53 peptide (internal preparation, the Cy5 dye is directly bound to the N-terminal part of p53 peptide construct) is added before an incubation at room temperature for 15 minutes prior to reading the plate. For measurement of samples, a Victor II microplate reader (Perkin Elmer) is used with the following settings: Excitation 340 nm, Emission Donor 620 nm and Emission Acceptor 665 nm.",B,,,BAO_0000190,BAO_0000224,protein format,COc1ncc(-c2nc3c(n2C(C)C)C(c2ccc(Cl)c(F)c2)N(c2cc(Cl)c[nH]c2=O)C(=O)N3)c(OC)n1,,,CHEMBL3886839,,2016,"{'bei': '11.23', 'le': '0.23', 'lle': '1.24', 'sei': '5.07'}",CHEMBL3938597,,CHEMBL3938597,6.45,False,http://www.openphacts.org/units/Nanomolar,2888213,=,37,True,=,,IC50,nM,,356.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,356.0
,18562860,[],CHEMBL4201979,Inhibition of human MDM2 (1 to 125 residues) and p53 (unknown origin) interaction pre-incubated for 20 mins before peptide-2-biot addition and measured after 3 hrs by HTRF assay,B,,,BAO_0000190,BAO_0000224,protein format,CC(C)(C)C[C@@H]1C=C(C(=O)NCCN2CCOCC2)[C@H](c2cccc(Cl)c2F)[C@]12C(=O)Nc1cc(Cl)ccc12,,,CHEMBL4196214,J Med Chem,2018,"{'bei': '13.02', 'le': '0.26', 'lle': '1.93', 'sei': '10.59'}",CHEMBL4217905,,CHEMBL4217905,7.48,False,http://www.openphacts.org/units/Nanomolar,3081993,=,1,True,=,,IC50,nM,,33.03,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,33.03
,18562861,[],CHEMBL4201979,Inhibition of human MDM2 (1 to 125 residues) and p53 (unknown origin) interaction pre-incubated for 20 mins before peptide-2-biot addition and measured after 3 hrs by HTRF assay,B,,,BAO_0000190,BAO_0000224,protein format,CC(C)(C)C[C@H]1C=C(C(=O)NCCN2CCOCC2)[C@@H](c2cccc(Cl)c2F)[C@]12C(=O)Nc1cc(Cl)ccc12,,,CHEMBL4196214,J Med Chem,2018,"{'bei': '9.46', 'le': '0.19', 'lle': '-0.12', 'sei': '7.69'}",CHEMBL4214609,,CHEMBL4214609,5.43,False,http://www.openphacts.org/units/Nanomolar,3081994,=,1,True,=,,IC50,nM,,3680.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,3680.0
,18562862,[],CHEMBL4201979,Inhibition of human MDM2 (1 to 125 residues) and p53 (unknown origin) interaction pre-incubated for 20 mins before peptide-2-biot addition and measured after 3 hrs by HTRF assay,B,,,BAO_0000190,BAO_0000224,protein format,CC(C)(C)C[C@@H]1C=C(C(=O)NCCN2CCOCC2)[C@@H](c2cccc(Cl)c2F)[C@]12C(=O)Nc1cc(Cl)ccc12,,,CHEMBL4196214,J Med Chem,2018,"{'bei': '9.52', 'le': '0.19', 'lle': '-0.08', 'sei': '7.74'}",CHEMBL4205549,,CHEMBL4205549,5.47,False,http://www.openphacts.org/units/Nanomolar,3081995,=,1,True,=,,IC50,nM,,3384.5,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,3384.5
,18562863,[],CHEMBL4201979,Inhibition of human MDM2 (1 to 125 residues) and p53 (unknown origin) interaction pre-incubated for 20 mins before peptide-2-biot addition and measured after 3 hrs by HTRF assay,B,,,BAO_0000190,BAO_0000224,protein format,CC(C)(C)C[C@H]1C=C(C(=O)NCCN2CCOCC2)[C@H](c2cccc(Cl)c2F)[C@]12C(=O)Nc1cc(Cl)ccc12,,,CHEMBL4196214,J Med Chem,2018,"{'bei': '10.67', 'le': '0.21', 'lle': '0.58', 'sei': '8.68'}",CHEMBL4210216,,CHEMBL4210216,6.13,False,http://www.openphacts.org/units/Nanomolar,3081996,=,1,True,=,,IC50,nM,,738.8,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,738.8
,18562864,[],CHEMBL4201979,Inhibition of human MDM2 (1 to 125 residues) and p53 (unknown origin) interaction pre-incubated for 20 mins before peptide-2-biot addition and measured after 3 hrs by HTRF assay,B,,,BAO_0000190,BAO_0000224,protein format,CC(C)(C)C[C@@H]1C=C(C(=O)N[C@H]2C[C@@](C)(O)C2)[C@H](c2cccc(Cl)c2F)[C@]12C(=O)Nc1cc(Cl)ccc12,,,CHEMBL4196214,J Med Chem,2018,"{'bei': '10.82', 'le': '0.22', 'lle': '-0.23', 'sei': '7.52'}",CHEMBL4212404,,CHEMBL4212404,5.90,False,http://www.openphacts.org/units/Nanomolar,3081997,=,1,True,=,,IC50,nM,,1257.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,1257.0
,18562865,[],CHEMBL4201979,Inhibition of human MDM2 (1 to 125 residues) and p53 (unknown origin) interaction pre-incubated for 20 mins before peptide-2-biot addition and measured after 3 hrs by HTRF assay,B,,,BAO_0000190,BAO_0000224,protein format,CC(C)(C)C[C@@H]1C=C(C(=O)N[C@H]2CC[C@H](O)CC2)[C@H](c2cccc(Cl)c2F)[C@]12C(=O)Nc1cc(Cl)ccc12,,,CHEMBL4196214,J Med Chem,2018,"{'bei': '11.10', 'le': '0.22', 'lle': '-0.31', 'sei': '7.92'}",CHEMBL4212066,,CHEMBL4212066,6.21,False,http://www.openphacts.org/units/Nanomolar,3081998,=,1,True,=,,IC50,nM,,619.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,619.0
,18562866,[],CHEMBL4201979,Inhibition of human MDM2 (1 to 125 residues) and p53 (unknown origin) interaction pre-incubated for 20 mins before peptide-2-biot addition and measured after 3 hrs by HTRF assay,B,,,BAO_0000190,BAO_0000224,protein format,CC(C)(C)C[C@@H]1C=C(C(=O)Nc2ccc(C(=O)O)cc2)[C@H](c2cccc(Cl)c2F)[C@]12C(=O)Nc1cc(Cl)ccc12,,,CHEMBL4196214,J Med Chem,2018,"{'bei': '11.10', 'le': '0.22', 'lle': '-0.98', 'sei': '6.76'}",CHEMBL4211645,,CHEMBL4211645,6.46,False,http://www.openphacts.org/units/Nanomolar,3081999,=,1,True,=,,IC50,nM,,349.5,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,349.5
,18562867,[],CHEMBL4201979,Inhibition of human MDM2 (1 to 125 residues) and p53 (unknown origin) interaction pre-incubated for 20 mins before peptide-2-biot addition and measured after 3 hrs by HTRF assay,B,,,BAO_0000190,BAO_0000224,protein format,CC(C)(C)CC1C=C(C(=O)NCCN2CCOCC2)C(c2cccc(Cl)c2F)C12C(=O)Nc1cc(Cl)ccc12,,,CHEMBL4196214,J Med Chem,2018,"{'bei': '10.34', 'le': '0.21', 'lle': '0.39', 'sei': '8.41'}",CHEMBL4207959,,CHEMBL4207959,5.94,False,http://www.openphacts.org/units/Nanomolar,3082000,=,1,True,=,,IC50,nM,,1144.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,1144.0
,18562868,[],CHEMBL4201979,Inhibition of human MDM2 (1 to 125 residues) and p53 (unknown origin) interaction pre-incubated for 20 mins before peptide-2-biot addition and measured after 3 hrs by HTRF assay,B,,,BAO_0000190,BAO_0000224,protein format,CC(C)(C)CC1C=C(C(=O)NC2CC(C)(O)C2)C(c2cccc(Cl)c2F)C12C(=O)Nc1cc(Cl)ccc12,,,CHEMBL4196214,J Med Chem,2018,"{'bei': '10.12', 'le': '0.20', 'lle': '-0.61', 'sei': '7.04'}",CHEMBL4206333,,CHEMBL4206333,5.52,False,http://www.openphacts.org/units/Nanomolar,3082001,=,1,True,=,,IC50,nM,,3032.5,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,3032.5
,18562869,[],CHEMBL4201979,Inhibition of human MDM2 (1 to 125 residues) and p53 (unknown origin) interaction pre-incubated for 20 mins before peptide-2-biot addition and measured after 3 hrs by HTRF assay,B,,,BAO_0000190,BAO_0000224,protein format,CC(C)(C)CC1C=C(C(=O)NC2CCC(O)CC2)C(c2cccc(Cl)c2F)C12C(=O)Nc1cc(Cl)ccc12,,,CHEMBL4196214,J Med Chem,2018,"{'bei': '9.70', 'le': '0.20', 'lle': '-1.09', 'sei': '6.92'}",CHEMBL4209483,,CHEMBL4209483,5.43,False,http://www.openphacts.org/units/Nanomolar,3082002,=,1,True,=,,IC50,nM,,3724.7,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,3724.7
,18562870,[],CHEMBL4201979,Inhibition of human MDM2 (1 to 125 residues) and p53 (unknown origin) interaction pre-incubated for 20 mins before peptide-2-biot addition and measured after 3 hrs by HTRF assay,B,,,BAO_0000190,BAO_0000224,protein format,CC(C)(C)CC1C=C(C(=O)Nc2ccc(C(=O)O)cc2)C(c2cccc(Cl)c2F)C12C(=O)Nc1cc(Cl)ccc12,,,CHEMBL4196214,J Med Chem,2018,"{'bei': '10.29', 'le': '0.20', 'lle': '-1.46', 'sei': '6.27'}",CHEMBL4203887,,CHEMBL4203887,5.98,False,http://www.openphacts.org/units/Nanomolar,3082003,=,1,True,=,,IC50,nM,,1039.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,1039.0
,18562871,[],CHEMBL4201979,Inhibition of human MDM2 (1 to 125 residues) and p53 (unknown origin) interaction pre-incubated for 20 mins before peptide-2-biot addition and measured after 3 hrs by HTRF assay,B,,,BAO_0000190,BAO_0000224,protein format,CC(C)(C)CC1C=C(C(=O)NCCN2CCOCC2)C(c2cccc(Cl)c2F)C12C(=O)Nc1cc(Cl)ccc12,,,CHEMBL4196214,J Med Chem,2018,"{'bei': '13.27', 'le': '0.27', 'lle': '2.08', 'sei': '10.79'}",CHEMBL4207959,,CHEMBL4207959,7.62,False,http://www.openphacts.org/units/Nanomolar,3082004,=,1,True,=,,IC50,nM,,23.7,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,23.7
,18562872,[],CHEMBL4201979,Inhibition of human MDM2 (1 to 125 residues) and p53 (unknown origin) interaction pre-incubated for 20 mins before peptide-2-biot addition and measured after 3 hrs by HTRF assay,B,,,BAO_0000190,BAO_0000224,protein format,CC(C)(C)CC1C=C(C(=O)NC2CC(C)(O)C2)C(c2cccc(Cl)c2F)C12C(=O)Nc1cc(Cl)ccc12,,,CHEMBL4196214,J Med Chem,2018,"{'bei': '11.27', 'le': '0.23', 'lle': '0.02', 'sei': '7.84'}",CHEMBL4206333,,CHEMBL4206333,6.15,False,http://www.openphacts.org/units/Nanomolar,3082005,=,1,True,=,,IC50,nM,,712.2,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,712.2
,18562873,[],CHEMBL4201979,Inhibition of human MDM2 (1 to 125 residues) and p53 (unknown origin) interaction pre-incubated for 20 mins before peptide-2-biot addition and measured after 3 hrs by HTRF assay,B,,,BAO_0000190,BAO_0000224,protein format,CC(C)(C)CC1C=C(C(=O)NC2CCC(O)CC2)C(c2cccc(Cl)c2F)C12C(=O)Nc1cc(Cl)ccc12,,,CHEMBL4196214,J Med Chem,2018,"{'bei': '11.65', 'le': '0.23', 'lle': '0.00', 'sei': '8.31'}",CHEMBL4209483,,CHEMBL4209483,6.52,False,http://www.openphacts.org/units/Nanomolar,3082006,=,1,True,=,,IC50,nM,,303.5,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,303.5
,18562874,[],CHEMBL4201979,Inhibition of human MDM2 (1 to 125 residues) and p53 (unknown origin) interaction pre-incubated for 20 mins before peptide-2-biot addition and measured after 3 hrs by HTRF assay,B,,,BAO_0000190,BAO_0000224,protein format,CC(C)(C)CC1C=C(C(=O)Nc2ccc(C(=O)O)cc2)C(c2cccc(Cl)c2F)C12C(=O)Nc1cc(Cl)ccc12,,,CHEMBL4196214,J Med Chem,2018,"{'bei': '10.63', 'le': '0.21', 'lle': '-1.26', 'sei': '6.48'}",CHEMBL4203887,,CHEMBL4203887,6.18,False,http://www.openphacts.org/units/Nanomolar,3082007,=,1,True,=,,IC50,nM,,654.8,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,654.8
,18562875,[],CHEMBL4201979,Inhibition of human MDM2 (1 to 125 residues) and p53 (unknown origin) interaction pre-incubated for 20 mins before peptide-2-biot addition and measured after 3 hrs by HTRF assay,B,,,BAO_0000190,BAO_0000224,protein format,CC(C)(C)C[C@@H]1C=C(C(=O)O)[C@H](c2cccc(Cl)c2F)[C@]12C(=O)Nc1cc(Cl)ccc12,,,CHEMBL4196214,J Med Chem,2018,"{'bei': '17.29', 'le': '0.35', 'lle': '1.82', 'sei': '12.04'}",CHEMBL4218748,,CHEMBL4218748,8.00,False,http://www.openphacts.org/units/Nanomolar,3082008,=,1,True,=,,IC50,nM,,10.1,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,10.1
,18562876,[],CHEMBL4201979,Inhibition of human MDM2 (1 to 125 residues) and p53 (unknown origin) interaction pre-incubated for 20 mins before peptide-2-biot addition and measured after 3 hrs by HTRF assay,B,,,BAO_0000190,BAO_0000224,protein format,CC(C)(C)CC1C=C(C(=O)O)C(c2cccc(Cl)c2F)C12C(=O)Nc1cc(Cl)ccc12,,,CHEMBL4196214,J Med Chem,2018,"{'bei': '13.56', 'le': '0.28', 'lle': '0.09', 'sei': '9.44'}",CHEMBL4203529,,CHEMBL4203529,6.27,False,http://www.openphacts.org/units/Nanomolar,3082009,=,1,True,=,,IC50,nM,,538.2,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,538.2
,18562877,[],CHEMBL4201979,Inhibition of human MDM2 (1 to 125 residues) and p53 (unknown origin) interaction pre-incubated for 20 mins before peptide-2-biot addition and measured after 3 hrs by HTRF assay,B,,,BAO_0000190,BAO_0000224,protein format,CC(C)(C)CC1C=C(C(=O)O)C(c2cccc(Cl)c2F)C12C(=O)Nc1cc(Cl)ccc12,,,CHEMBL4196214,J Med Chem,2018,"{'bei': '18.40', 'le': '0.37', 'lle': '2.33', 'sei': '12.81'}",CHEMBL4203529,,CHEMBL4203529,8.51,False,http://www.openphacts.org/units/Nanomolar,3082010,=,1,True,=,,IC50,nM,,3.1,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,3.1
,18562878,[],CHEMBL4201979,Inhibition of human MDM2 (1 to 125 residues) and p53 (unknown origin) interaction pre-incubated for 20 mins before peptide-2-biot addition and measured after 3 hrs by HTRF assay,B,,,BAO_0000190,BAO_0000224,protein format,COc1ccc(C2=N[C@@H](c3ccc(Cl)cc3)[C@@H](c3ccc(Cl)cc3)N2C(=O)N2CCNC(=O)C2)c(OC(C)C)c1,,,CHEMBL4196214,J Med Chem,2018,"{'bei': '14.54', 'le': '0.29', 'lle': '2.57', 'sei': '10.13'}",CHEMBL191334,NUTLIN-3,CHEMBL191334,8.46,False,http://www.openphacts.org/units/Nanomolar,3082011,=,1,True,=,,IC50,nM,,3.5,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,nM,UO_0000065,,3.5
,19446165,[],CHEMBL4432632,Inhibition of C-terminal biotin-tagged streptavidin labelled human MDM2 ( 2 to 188 residues)/Cy5-labelled p53 (18 to 26 residues)(unknown origin) interaction after 15 mins by TR-FRET assay,B,,,BAO_0000190,BAO_0000224,protein format,Cc1n[nH]c2c1C(c1ccc(Cl)cc1)N(c1cccc(Cl)c1)C2=O,,,CHEMBL4431357,Bioorg Med Chem Lett,2016,"{'bei': '18.02', 'le': '0.37', 'lle': '1.69', 'sei': '13.18'}",CHEMBL4573478,,CHEMBL4573478,6.46,False,http://www.openphacts.org/units/Nanomolar,3248718,=,1,True,=,,IC50,nM,,350.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,uM,UO_0000065,,0.35
,19446166,[],CHEMBL4432632,Inhibition of C-terminal biotin-tagged streptavidin labelled human MDM2 ( 2 to 188 residues)/Cy5-labelled p53 (18 to 26 residues)(unknown origin) interaction after 15 mins by TR-FRET assay,B,,,BAO_0000190,BAO_0000224,protein format,CC(C)c1n[nH]c2c1C(c1ccc(Cl)cc1)N(c1cccc(Cl)c1)C2=O,,,CHEMBL4431357,Bioorg Med Chem Lett,2016,"{'bei': '19.40', 'le': '0.39', 'lle': '1.90', 'sei': '15.30'}",CHEMBL4466891,,CHEMBL4466891,7.50,False,http://www.openphacts.org/units/Nanomolar,3248719,=,1,True,=,,IC50,nM,,32.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,uM,UO_0000065,,0.032
,19446167,[],CHEMBL4432632,Inhibition of C-terminal biotin-tagged streptavidin labelled human MDM2 ( 2 to 188 residues)/Cy5-labelled p53 (18 to 26 residues)(unknown origin) interaction after 15 mins by TR-FRET assay,B,,,BAO_0000190,BAO_0000224,protein format,CC(C)(C)c1n[nH]c2c1C(c1ccc(Cl)cc1)N(c1cccc(Cl)c1)C2=O,,,CHEMBL4431357,Bioorg Med Chem Lett,2016,"{'bei': '19.35', 'le': '0.39', 'lle': '1.98', 'sei': '15.81'}",CHEMBL4534782,,CHEMBL4534782,7.75,False,http://www.openphacts.org/units/Nanomolar,3248720,=,1,True,=,,IC50,nM,,18.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,uM,UO_0000065,,0.018
,19446168,[],CHEMBL4432632,Inhibition of C-terminal biotin-tagged streptavidin labelled human MDM2 ( 2 to 188 residues)/Cy5-labelled p53 (18 to 26 residues)(unknown origin) interaction after 15 mins by TR-FRET assay,B,,,BAO_0000190,BAO_0000224,protein format,Cc1cc(Cl)ccc1C1c2c(C(C)C)n[nH]c2C(=O)N1c1cc(Cl)ccc1C,,,CHEMBL4431357,Bioorg Med Chem Lett,2016,"{'bei': '20.22', 'le': '0.41', 'lle': '2.17', 'sei': '17.10'}",CHEMBL4465041,,CHEMBL4465041,8.38,False,http://www.openphacts.org/units/Nanomolar,3248721,=,1,True,=,,IC50,nM,,4.2,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,uM,UO_0000065,,0.0042
,19446169,[],CHEMBL4432632,Inhibition of C-terminal biotin-tagged streptavidin labelled human MDM2 ( 2 to 188 residues)/Cy5-labelled p53 (18 to 26 residues)(unknown origin) interaction after 15 mins by TR-FRET assay,B,,,BAO_0000190,BAO_0000224,protein format,COc1ccccc1-n1nc2c(c1C(C)C)[C@H](c1ccc(Cl)cc1C)N(c1cc(Cl)ccc1C)C2=O,,,CHEMBL4431357,Bioorg Med Chem Lett,2016,"{'bei': '13.23', 'le': '0.26', 'lle': '-0.79', 'sei': '14.54'}",CHEMBL3691737,,CHEMBL3691737,6.89,False,http://www.openphacts.org/units/Nanomolar,3248722,=,1,True,=,,IC50,nM,,130.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,uM,UO_0000065,,0.13
,19446170,[],CHEMBL4432632,Inhibition of C-terminal biotin-tagged streptavidin labelled human MDM2 ( 2 to 188 residues)/Cy5-labelled p53 (18 to 26 residues)(unknown origin) interaction after 15 mins by TR-FRET assay,B,,,BAO_0000190,BAO_0000224,protein format,COc1ccccc1-n1nc2c(c1C(C)C)[C@@H](c1ccc(Cl)cc1C)N(c1cc(Cl)ccc1C)C2=O,Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL4431357,Bioorg Med Chem Lett,2016,,CHEMBL3691738,,CHEMBL3691738,,False,http://www.openphacts.org/units/Nanomolar,3248723,=,1,True,=,,IC50,nM,,506000.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,uM,UO_0000065,,506.0
,19446171,[],CHEMBL4432632,Inhibition of C-terminal biotin-tagged streptavidin labelled human MDM2 ( 2 to 188 residues)/Cy5-labelled p53 (18 to 26 residues)(unknown origin) interaction after 15 mins by TR-FRET assay,B,,,BAO_0000190,BAO_0000224,protein format,COc1ccccc1-n1nc2c(c1C(C)C)C(c1ccc(Cl)cc1C)N(c1cc(Cl)ccc1OCCN(C)C)C2=O,,,CHEMBL4431357,Bioorg Med Chem Lett,2016,"{'bei': '11.60', 'le': '0.23', 'lle': '-0.42', 'sei': '11.51'}",CHEMBL3687315,,CHEMBL3687315,6.89,False,http://www.openphacts.org/units/Nanomolar,3248724,=,1,True,=,,IC50,nM,,130.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,uM,UO_0000065,,0.13
,19446172,[],CHEMBL4432632,Inhibition of C-terminal biotin-tagged streptavidin labelled human MDM2 ( 2 to 188 residues)/Cy5-labelled p53 (18 to 26 residues)(unknown origin) interaction after 15 mins by TR-FRET assay,B,,,BAO_0000190,BAO_0000224,protein format,COc1ccc(C2=N[C@@H](c3ccc(Cl)cc3)[C@@H](c3ccc(Cl)cc3)N2C(=O)N2CCNC(=O)C2)c(OC(C)C)c1,,,CHEMBL4431357,Bioorg Med Chem Lett,2016,"{'bei': '13.76', 'le': '0.27', 'lle': '2.11', 'sei': '9.58'}",CHEMBL191334,NUTLIN-3,CHEMBL191334,8.00,False,http://www.openphacts.org/units/Nanomolar,3248725,=,1,True,=,,IC50,nM,,10.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,uM,UO_0000065,,0.01
,19446173,[],CHEMBL4432632,Inhibition of C-terminal biotin-tagged streptavidin labelled human MDM2 ( 2 to 188 residues)/Cy5-labelled p53 (18 to 26 residues)(unknown origin) interaction after 15 mins by TR-FRET assay,B,,,BAO_0000190,BAO_0000224,protein format,Cc1ccc(N2C(=O)c3[nH]nc(C)c3C2c2ccc(Cl)cc2)cc1,,,CHEMBL4431357,Bioorg Med Chem Lett,2016,"{'bei': '17.24', 'le': '0.33', 'lle': '1.39', 'sei': '11.89'}",CHEMBL1333839,,CHEMBL1333839,5.82,False,http://www.openphacts.org/units/Nanomolar,3248726,=,1,True,=,,IC50,nM,,1500.0,CHEMBL1907611,Homo sapiens,Tumour suppressor p53/oncoprotein Mdm2,9606,,,IC50,uM,UO_0000065,,1.5
